Citrus Sinensis ID: 007336
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 607 | 2.2.26 [Sep-21-2011] | |||||||
| O81905 | 850 | Receptor-like serine/thre | yes | no | 0.978 | 0.698 | 0.486 | 1e-169 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.902 | 0.699 | 0.494 | 1e-165 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.962 | 0.681 | 0.461 | 1e-157 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.981 | 0.703 | 0.472 | 1e-157 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.953 | 0.710 | 0.502 | 1e-154 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.975 | 0.702 | 0.477 | 1e-153 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.963 | 0.702 | 0.457 | 1e-149 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.963 | 0.692 | 0.455 | 1e-144 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.965 | 0.686 | 0.464 | 1e-142 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.955 | 0.688 | 0.432 | 1e-139 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 594 bits (1531), Expect = e-169, Method: Compositional matrix adjust.
Identities = 303/623 (48%), Positives = 406/623 (65%), Gaps = 29/623 (4%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K+ VWVANR P++ S G L I+ + NLV+ QS+ VWS L+ +V++P+V +
Sbjct: 73 KAISKRTYVWVANRDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAE 131
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLD+GN VLRD + + WQSFD+P+DTLLP MKLGWD KTG R + SWKS DDPS
Sbjct: 132 LLDNGNFVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPS 191
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
GDF + +E + PE+ +W + YR+GPWNG+RFS P ++P F+F ++ E+
Sbjct: 192 SGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVT 251
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y+F IT V SR+ ++ + ++R F W + Q+W + P+DQCD Y CG YG C
Sbjct: 252 YSFRITKSDVYSRLSISSSGLLQR-FTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDS 310
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
SPVC C+KGFKP++ G D S GCVR L+ DGF++ ++KLPD T++ V
Sbjct: 311 NTSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVD 370
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ + +KEC + CL + +C A+ N+DIRG GSGC W GEL D+R++ GGQD Y+R++A+
Sbjct: 371 RGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAAT 430
Query: 365 EIGAKGEPTTKIVVIVISTAALLAVVLIAGYL-IRKRRRNIAEKT--------------- 408
++ K + KI+ I + LL + I +L RK++R+I +T
Sbjct: 431 DLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMN 490
Query: 409 ----ENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDG 464
+ R +EN DLELPL E +A AT+NFS NKLG+GGFG VYKG L+DG
Sbjct: 491 EVVISSRRHISRENNTD--DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDG 548
Query: 465 QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524
QE+AVKRLSK S QG E KNEV L ++LQH NLV+LL CC+ EK+LIYE++ N SLD
Sbjct: 549 QEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLD 608
Query: 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584
S +FD++R + L+W RF II G ARGLLYLHQDSR RIIHRDLKASN+LLD+ M PKIS
Sbjct: 609 SHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKIS 668
Query: 585 DFGLVRTFGGDETEGNTNRVVGT 607
DFG+ R FG DETE NT +VVGT
Sbjct: 669 DFGMARIFGRDETEANTRKVVGT 691
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 582 bits (1499), Expect = e-165, Method: Compositional matrix adjust.
Identities = 297/601 (49%), Positives = 397/601 (66%), Gaps = 53/601 (8%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQ-----TPVVLQLLD 71
VVWVANR +P+ D G L +++ G+L L + N ++WS+ S Q P+V Q+LD
Sbjct: 73 VVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIV-QILD 131
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
+GNLV+R+ GD + Y WQS DYP D LPGMK G + TGL R +TSW++ DDPS G+
Sbjct: 132 TGNLVVRNS--GDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGN 189
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTF 190
+ ++ P+ + K S +RTGPWNGLRF+ P+L+PNPI+ + +V + E+YYT+
Sbjct: 190 YTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTY 249
Query: 191 NITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQS 250
+ N +V++R+ +N ++R + W QSW Y D CD Y LCG+YG C I +S
Sbjct: 250 KLENPSVLTRMQLNPNGALQR-YTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINES 308
Query: 251 PVCQCLKGF---KPKSGGYVDRSQGCVRSKPLNYSR-QDGFIKFTELKLPDATSSWVSKS 306
P C+CLKGF P++ D S+GCVR L+ + +DGF+K ++LKLPD +SW K+
Sbjct: 309 PACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKN 368
Query: 307 MNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASEI 366
M+L EC++ CL N +C AY+ DIR GG GC +WFG+LID+R++ GQD Y+R+++SEI
Sbjct: 369 MDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEI 428
Query: 367 GAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDLE 426
++++ +SR+ ++E DLE
Sbjct: 429 ETLQRESSRV---------------------------------SSRKQEEE------DLE 449
Query: 427 LPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNE 486
LP +L T++ AT FS NKLG+GGFGPVYKGTL GQE+AVKRLS+ S QG++E KNE
Sbjct: 450 LPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNE 509
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+ L +KLQHRNLVK+LG C+ EE++LIYE+ PNKSLDSFIFD+ RR LDW +R II
Sbjct: 510 IKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIK 569
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
G ARG+LYLH+DSRLRIIHRDLKASNVLLD DMN KISDFGL RT GGDETE NT RVVG
Sbjct: 570 GIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVG 629
Query: 607 T 607
T
Sbjct: 630 T 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 555 bits (1431), Expect = e-157, Method: Compositional matrix adjust.
Identities = 285/617 (46%), Positives = 406/617 (65%), Gaps = 33/617 (5%)
Query: 18 VWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQLLDSGNLV 76
VWVANR NP++++ G L I+ NLVL SN VW L++ ++PVV +LL +GN V
Sbjct: 83 VWVANRDNPLSNAIGTLKISG-NNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANGNFV 141
Query: 77 LRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAI 136
+RD + D+ Y WQSFDYP+DTLLP MKLG++LKTGL R +TSW+S DDPS G+F + +
Sbjct: 142 MRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKL 201
Query: 137 ERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTFNITNK 195
E Q PE + + + +R+GPWNG+RFS P + ++F+ N+ E+ YTF +TN
Sbjct: 202 ETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNEEVAYTFRMTNN 261
Query: 196 AVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRD-QCDTYGLCGAYGICIIGQSPVCQ 254
+ SR+ + Y +R W + + W + P D QCDTY +CG Y C + SPVC
Sbjct: 262 SFYSRLTLISEGYFQR-LTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNTSPVCN 320
Query: 255 CLKGFKPKSGGYVDR---SQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSKSMNLKE 311
C++GF P++ D+ + GC+R L+ S DGF + ++KLP+ T + V +S+ +KE
Sbjct: 321 CIQGFNPRNIQQWDQRVWAGGCIRRTQLSCS-GDGFTRMKKMKLPETTMATVDRSIGVKE 379
Query: 312 CREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGG---GQDFYIRMSASEIGA 368
C++ C+ + +C A+ N+DIR GGSGC +W L D+R++ GQD Y+R++A++I
Sbjct: 380 CKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAADIAK 439
Query: 369 KGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNI----- 423
K + KI+ + + + LL +++ + + KR++ A+ + S Q N++ +
Sbjct: 440 KRNASGKIISLTVGVSVLLLLIM---FCLWKRKQKRAKASAISIANTQRNQNLPMNEMVL 496
Query: 424 -------------DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVK 470
+LELPL E+ T+ AT+NFS NKLG+GGFG VYKG L+DG+EIAVK
Sbjct: 497 SSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAVK 556
Query: 471 RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ 530
RLSK S QG E NEV L ++LQH NLV++LGCCI+G+EK+LIYE++ N SLDS++F +
Sbjct: 557 RLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFGK 616
Query: 531 TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
TRR+ L+W++RF I G ARGLLYLHQDSR RIIHRDLK SN+LLD++M PKISDFG+ R
Sbjct: 617 TRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMAR 676
Query: 591 TFGGDETEGNTNRVVGT 607
F DETE NT +VVGT
Sbjct: 677 IFERDETEANTMKVVGT 693
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 554 bits (1428), Expect = e-157, Method: Compositional matrix adjust.
Identities = 293/620 (47%), Positives = 393/620 (63%), Gaps = 24/620 (3%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K P VWVANR NP++ S G L I+ NLV+ QS+ VWS ++ +V++PV +
Sbjct: 71 KIIPIRTYVWVANRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAE 129
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTG-LERRVTSWKSFDDP 127
LLD GN VLRD + + WQSFD+P+DTLL MK+GWD K+G R + SWK+ DDP
Sbjct: 130 LLDYGNFVLRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDP 189
Query: 128 SPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVEL 186
S GDF + PE ++ YR+GPW G RFS+ P ++P SF N+ ++
Sbjct: 190 SSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQV 249
Query: 187 YYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICI 246
Y++ + NK I I+ + + +R W +A QSW+ P+D CD Y CG YG C
Sbjct: 250 VYSYRV-NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCD 308
Query: 247 IGQSPVCQCLKGFKP--KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
SP+C C+KGF+P + D S GCVR L+ +DGF++ +++LPD T + V
Sbjct: 309 ANTSPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVD 368
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
K + LKEC E CL+ +C A+ N+DIR GGSGC +W G L D+R++ GGQD Y+R++A
Sbjct: 369 KGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAG 428
Query: 365 EIGAKGEPTTKIVVIVISTAALLAV-VLIAGYLIRKRRRNIAEKTE-------------- 409
++ K + KI+ I + LL + +I + RK++R+I +T
Sbjct: 429 DLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNE 488
Query: 410 --NSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEI 467
+ + E++ LELPL E +A AT+NFS +NKLG+GGFG VYKG L+DG+EI
Sbjct: 489 LVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEI 548
Query: 468 AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
AVKRLSK+S QG E NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +
Sbjct: 549 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 608
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
FDQTR + L+W +RF II G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG
Sbjct: 609 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 668
Query: 588 LVRTFGGDETEGNTNRVVGT 607
+ R FG +ETE NT RVVGT
Sbjct: 669 MARIFGREETEANTRRVVGT 688
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 546 bits (1408), Expect = e-154, Method: Compositional matrix adjust.
Identities = 306/609 (50%), Positives = 406/609 (66%), Gaps = 30/609 (4%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPV----VLQL 69
P VVWVANR NP+ + GFL ++ G+L L + +WS+ S + +L++
Sbjct: 72 PFAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKI 131
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
SGNL+ DG+ E WQSFDYP +T+L GMKLG + KT +E ++SWK+ DPSP
Sbjct: 132 SCSGNLI---SSDGE-EAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSP 187
Query: 130 GDFIWAIERQDNPEVVMWKG--SRKFYRTGPWNGLRFS-APSL-RPNPIFSFSFVSNDVE 185
GDF +++ + P++++ K S YR G WNGL F+ AP++ R N +F + F S+ E
Sbjct: 188 GDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQE 247
Query: 186 LYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGIC 245
+ Y++ ++ ++SR+V+N T + R FI +K Q W L + P D+CD Y +CGAY +C
Sbjct: 248 VNYSWTPRHR-IVSRLVLNNTGKLHR-FIQSKQNQ-WILANTAPEDECDYYSICGAYAVC 304
Query: 246 IIG--QSPVCQCLKGFKPKSGGYVDRSQG---CVRSKPLNYSRQDGFIKFTELKLPDATS 300
I +P C CL+GFKPKSG + S+G CV P N ++D F+KF LKLPD +
Sbjct: 305 GINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSW 364
Query: 301 SW--VSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFY 358
SW M L++C+ C N SC AY N+DIR GG GC +WFG+L+DMR++ GQD Y
Sbjct: 365 SWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVY 424
Query: 359 IRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQEN 418
IRM ++I KG +VV + A++ VV+ A + + +R + EN R+ +E
Sbjct: 425 IRMGFAKIEFKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKR---YRGENFRKGIEEE 481
Query: 419 EDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ 478
DL+LP+F+ TI+ ATD+FS N LG GGFGPVYKG L DGQEIAVKRLS S Q
Sbjct: 482 -----DLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQ 536
Query: 479 GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDW 538
G++E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+MPNKSLD FIFD+ R T LDW
Sbjct: 537 GVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDW 596
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+R +II G ARG+LYLHQDSRLRIIHRDLKA NVLLD DMNPKISDFGL ++FGGD++E
Sbjct: 597 KKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSE 656
Query: 599 GNTNRVVGT 607
+TNRVVGT
Sbjct: 657 SSTNRVVGT 665
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 542 bits (1396), Expect = e-153, Method: Compositional matrix adjust.
Identities = 296/620 (47%), Positives = 398/620 (64%), Gaps = 28/620 (4%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K P VWVANR NP++ S G L I+ NLV+ QS+ VWS ++ +V++PV +
Sbjct: 71 KIIPIRTYVWVANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAE 129
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLD+GN +LRD ++ WQSFD+P+DTLL MKLGWD KTG R + SWK+ DDPS
Sbjct: 130 LLDNGNFLLRDSNN----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPS 185
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
G+F +E + PE + YR+GPWNG+RFS+ P ++F ++ E+
Sbjct: 186 SGEFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVT 245
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y++ I + SR+ +N ++R W + TQSW+ P+D CD Y +CG +G C
Sbjct: 246 YSYRINKTNLYSRLYLNSAGLLQR-LTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDS 304
Query: 248 GQSPVCQCLKGFKP---KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
P C C+KGFKP ++ D S GC+R L+ +DGF + +KLPD T++ V
Sbjct: 305 NSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVD 364
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ + LK C+E CLE+ +C A+ N+DIR GGSGC +W E++DMR++ GGQD Y+R++A+
Sbjct: 365 REIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAA 424
Query: 365 EIGAKGEPTTKIVVIVISTAALLAV-VLIAGYLIRKRRRNIAEKTEN------------- 410
E+ K KI+ I + LL + +I + RK++R+I +T N
Sbjct: 425 ELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLIND 484
Query: 411 ---SRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEI 467
SR E ++ LELPL EL +A AT+NFS +NKLG+GGFG VYKG L+DG+EI
Sbjct: 485 VVVSRRGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEI 544
Query: 468 AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
AVKRLSK+S QG E NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SLDS +
Sbjct: 545 AVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHL 604
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
FDQTR + L+W +RF II G ARGLLYLHQDSR RIIHRDLKASNVLLD++M PKISDFG
Sbjct: 605 FDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFG 664
Query: 588 LVRTFGGDETEGNTNRVVGT 607
+ R FG +ETE NT RVVGT
Sbjct: 665 MARIFGREETEANTRRVVGT 684
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 530 bits (1364), Expect = e-149, Method: Compositional matrix adjust.
Identities = 283/619 (45%), Positives = 402/619 (64%), Gaps = 34/619 (5%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNI--VVWSAYLSKEVQTP-VVLQLLDSG 73
+VWVANR +PIND+ G + + GNL + + N ++WS +S + P +V L D G
Sbjct: 68 IVWVANRDHPINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLG 127
Query: 74 NLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFI 133
NLVL D G S FW+SFD+P+DT LP M+LG+ K GL+R +TSWKS DP GD I
Sbjct: 128 NLVLFDPVTGRS---FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLI 184
Query: 134 WAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTFNI 192
+ER+ P+++++KG ++R G W G R+S P + IF+ SFV+N+ E+ +T+ +
Sbjct: 185 LRMERRGFPQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGV 244
Query: 193 TNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQSPV 252
T+ +VI+R ++N+T + R F W + W + VP++QCD Y CG G C S
Sbjct: 245 TDASVITRTMVNETGTMHR-FTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKT 303
Query: 253 --CQCLKGFKPKSGGY---VDRSQGCVRSKPLNY-SRQDGFIKFTELKLPDATSSWVSKS 306
C CL GF+PK + D S GC + K + S +DGF+K +K+PD + + V +
Sbjct: 304 FECTCLPGFEPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMN 363
Query: 307 MNLKECREGCLENSSCMAYTNS--DIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ LKEC++ CL+N SC+AY ++ + + G GC W G ++D R + GQDFYIR+
Sbjct: 364 ITLKECKQRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKE 423
Query: 365 EI------GAKGEPTTKIVVI-VISTAALLAVVLIAGYLIRKRRRNIAEKTENSR----- 412
E+ G G+ +++I +I+ LL V+L ++R+RR++ ++ ++
Sbjct: 424 ELARWNRNGLSGKRRVLLILISLIAAVMLLTVILFC--VVRERRKSNRHRSSSANFAPVP 481
Query: 413 ----ETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIA 468
E+ + +D+ + ELPLF+L TI AT+NFS NKLG GGFGPVYKG L + EIA
Sbjct: 482 FDFDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIA 541
Query: 469 VKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF 528
VKRLS+ S QG++E KNEV L SKLQHRNLV++LGCC++ EEK+L+YE++PNKSLD FIF
Sbjct: 542 VKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIF 601
Query: 529 DQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+ +R LDW +R I+ G ARG+LYLHQDSRLRIIHRDLKASN+LLD +M PKISDFG+
Sbjct: 602 HEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGM 661
Query: 589 VRTFGGDETEGNTNRVVGT 607
R FGG++ EG T+RVVGT
Sbjct: 662 ARIFGGNQMEGCTSRVVGT 680
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 513 bits (1320), Expect = e-144, Method: Compositional matrix adjust.
Identities = 284/624 (45%), Positives = 405/624 (64%), Gaps = 39/624 (6%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIV--VWSAYLSKEVQTP-VVLQLLDSG 73
+VWVANR +PIND+ G + + GNL + + N +WS + +Q P +V +L D G
Sbjct: 71 IVWVANRDHPINDTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLG 130
Query: 74 NLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFI 133
NLVL D G S FW+SF++P++TLLP MK G+ ++G++R +TSW+S DP G+
Sbjct: 131 NLVLLDPVTGKS---FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNIT 187
Query: 134 WAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTFNI 192
+ IER+ P+++M+KG ++RTG W G R+S P + IF+ SFV+N E+ T+ +
Sbjct: 188 YRIERRGFPQMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGV 247
Query: 193 TNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGIC--IIGQS 250
+ +V +R+V+N+T ++R F WN + W + P D+CD Y CG G C +
Sbjct: 248 LDASVTTRMVLNETGTLQR-FRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEK 306
Query: 251 PVCQCLKGFKPKSGG---YVDRSQGCVRSKPLNYSR-QDGFIKFTELKLPDATSSWVSKS 306
C CL G++PK+ D S GC R K + ++GF K +K+P+ ++ V +
Sbjct: 307 FECSCLPGYEPKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMN 366
Query: 307 MNLKECREGCLENSSCMAYTNS--DIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ LKEC + CL+N SC+AY ++ + + G GC W G ++D R + GQDFY+R+ S
Sbjct: 367 ITLKECEQRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKS 426
Query: 365 EI------GAKGEPTTKIVVIVISTAALLAVVLIA--GYLIRKRRRNIAEKTENSRETD- 415
E+ GA G+ ++V+I+IS A++ ++LI+ YL ++R+R + + + +
Sbjct: 427 ELARWNGNGASGK--KRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFA 484
Query: 416 ------------QENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVD 463
+E ED++ ELPLFEL+TIA AT+NF+ NKLG GGFGPVYKG L +
Sbjct: 485 PSSFDLEDSFILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQN 544
Query: 464 GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523
G EIAVKRLSK S QG++E KNEV L SKLQHRNLV++LGCC++ EEK+L+YE++PNKSL
Sbjct: 545 GMEIAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSL 604
Query: 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583
D FIF + +R LDW +R II G RG+LYLHQDSRLRIIHRDLKASNVLLD +M PKI
Sbjct: 605 DYFIFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKI 664
Query: 584 SDFGLVRTFGGDETEGNTNRVVGT 607
+DFGL R FGG++ EG+TNRVVGT
Sbjct: 665 ADFGLARIFGGNQIEGSTNRVVGT 688
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 505 bits (1301), Expect = e-142, Method: Compositional matrix adjust.
Identities = 284/612 (46%), Positives = 380/612 (62%), Gaps = 26/612 (4%)
Query: 18 VWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVL 77
VWVANR P+++ G L I+ NLV+ S+ VWS L+ V++ VV +LLD+GN VL
Sbjct: 83 VWVANRDTPLSNPIGILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVL 141
Query: 78 RDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIE 137
R +S+ + WQSFD+P+DTLLP MKLG D K GL R VTSWKS DPS G F++ +E
Sbjct: 142 RGSKINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLE 201
Query: 138 RQDNPEVVMWKGSRKFYRTGPWNGLRFSAP-SLRPNPIFSFSFVSNDVELYYTFNITNKA 196
PE + + YR+GPW+GLRFS ++ ++F N E+ YTF +T+
Sbjct: 202 TLGLPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYNFTENREEVAYTFRVTDHN 261
Query: 197 VISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQSPVCQCL 256
SR+ +N T+ F+W Q W ++ +P+D CD YG+CG Y C + SP C C+
Sbjct: 262 SYSRLTIN-TVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCI 320
Query: 257 KGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSKSMNLKECR 313
KGF+P S D + C R L +D F + +K+P T++ V K + LKEC
Sbjct: 321 KGFQPLSPQDWASGDVTGRCRRKTQLTCG-EDRFFRLMNMKIPATTAAIVDKRIGLKECE 379
Query: 314 EGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASEIGAKGEPT 373
E C + +C AY NSDIR GGSGC +W GE D+R++ GQD ++R++A+E G +
Sbjct: 380 EKCKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFGERRTIR 439
Query: 374 TKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTE---NSRETDQE------------- 417
KI+ ++I + +L + I Y K+++ A T R+ QE
Sbjct: 440 GKIIGLIIGISLMLVLSFII-YCFWKKKQKRARATAAPIGYRDRIQELIITNGVVMSSGR 498
Query: 418 -NEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS 476
+ DLELPL E T+ AT+NFS +N LG GGFG VYKG L+DGQEIAVKRLS++S
Sbjct: 499 RLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQEIAVKRLSEMS 558
Query: 477 EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT-L 535
QG E KNEV L ++LQH NLV+LL CCI +EK+LIYE++ N SLDS +F+ T+ +
Sbjct: 559 SQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLFETTQSSNK 618
Query: 536 LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
L+W RF II G ARGLLYLHQDSR +IIHRDLKASNVLLD++M PKISDFG+ R F D
Sbjct: 619 LNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMARIFERD 678
Query: 596 ETEGNTNRVVGT 607
ETE NT +VVGT
Sbjct: 679 ETEANTRKVVGT 690
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 494 bits (1272), Expect = e-139, Method: Compositional matrix adjust.
Identities = 271/626 (43%), Positives = 381/626 (60%), Gaps = 46/626 (7%)
Query: 13 PPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVV-LQLLD 71
P VVWVAN+ +PIND+ G + I + GNL +T N +VWS +S V +QL+D
Sbjct: 79 PIQTVVWVANKDSPINDTSGVISIYQDGNLAVTDGRNRLVWSTNVSVPVAPNATWVQLMD 138
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
SGNL+L+D + W+SF +P D+ +P M LG D +TG ++TSW S DDPS G+
Sbjct: 139 SGNLMLQDNRNNGE--ILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGN 196
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPSLRPNPIFSFSF-VSNDVELYYTF 190
+ I PE+++WK + +R+GPWNG F + +F F +++D + +
Sbjct: 197 YTAGIAPFTFPELLIWKNNVPTWRSGPWNGQVFIGLPNMDSLLFLDGFNLNSDNQGTISM 256
Query: 191 NITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQS 250
+ N + + ++ + ++ W+ + ++W + P CD YG CG +G C G++
Sbjct: 257 SYANDSFMYHFNLDPEGIIYQK-DWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGEN 315
Query: 251 PVCQCLKGFKPKS-----GGYVDRSQGCVRSKPLNYSRQ------------DGFIKFTEL 293
P C+C+KGF PK+ GG + S GC+R PL RQ DGF+K ++
Sbjct: 316 PPCKCVKGFVPKNNTEWNGG--NWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKM 373
Query: 294 KLP-DATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPG 352
K+P A S S+ + C + CL+N SC AY G GC +W G+L+DM+ F G
Sbjct: 374 KVPISAERSEASEQV----CPKVCLDNCSCTAYAYDR----GIGCMLWSGDLVDMQSFLG 425
Query: 353 GGQDFYIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSR 412
G D +IR++ SE+ I VI + AV ++ RK ++ A + S
Sbjct: 426 SGIDLFIRVAHSELKTHSNLAVMIAAPVIGVMLIAAVCVLLA--CRKYKKRPAPAKDRSA 483
Query: 413 E----------TDQENEDQNIDL-ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTL 461
E +D E+ I L ELPLFE +A +TD+FS+ NKLG+GGFGPVYKG L
Sbjct: 484 ELMFKRMEALTSDNESASNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKL 543
Query: 462 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521
+GQEIAVKRLS+ S QGL+EL NEV++ SKLQHRNLVKLLGCCI+GEE++L+YE+MP K
Sbjct: 544 PEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKK 603
Query: 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581
SLD+++FD ++ +LDW RF+I+ G RGLLYLH+DSRL+IIHRDLKASN+LLD+++NP
Sbjct: 604 SLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNP 663
Query: 582 KISDFGLVRTFGGDETEGNTNRVVGT 607
KISDFGL R F +E E NT RVVGT
Sbjct: 664 KISDFGLARIFRANEDEANTRRVVGT 689
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 607 | ||||||
| 224113149 | 820 | predicted protein [Populus trichocarpa] | 0.981 | 0.726 | 0.640 | 0.0 | |
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.976 | 0.723 | 0.642 | 0.0 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.981 | 0.712 | 0.619 | 0.0 | |
| 224113157 | 786 | predicted protein [Populus trichocarpa] | 0.915 | 0.707 | 0.614 | 0.0 | |
| 224113153 | 785 | predicted protein [Populus trichocarpa] | 0.914 | 0.707 | 0.612 | 0.0 | |
| 224115136 | 843 | predicted protein [Populus trichocarpa] | 0.978 | 0.704 | 0.611 | 0.0 | |
| 356514895 | 821 | PREDICTED: G-type lectin S-receptor-like | 0.980 | 0.724 | 0.578 | 0.0 | |
| 356514935 | 834 | PREDICTED: G-type lectin S-receptor-like | 0.973 | 0.708 | 0.590 | 0.0 | |
| 449458261 | 814 | PREDICTED: receptor-like serine/threonin | 0.970 | 0.723 | 0.579 | 0.0 | |
| 356514913 | 829 | PREDICTED: G-type lectin S-receptor-like | 0.978 | 0.716 | 0.562 | 0.0 |
| >gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 796 bits (2056), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/607 (64%), Positives = 467/607 (76%), Gaps = 11/607 (1%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPINDS GFLM++ TGNLVL S +N VVWS+ K Q+ + +
Sbjct: 63 KNIPVRTVVWVANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQS-AMGE 121
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRDE D +S Y WQSFDYPSDTLLPGMKLGWDL+ GL+RR+++WKS DDPS
Sbjct: 122 LLDSGNLVLRDEKDANSGIYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPS 181
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
GDF W + Q NPE+VMWKGS+++YR+GPWNG+ FS P LR NP+F F FV + E+Y
Sbjct: 182 SGDFTWGTQLQSNPELVMWKGSKEYYRSGPWNGIGFSGGPELRINPVFYFDFVDDGEEVY 241
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
YT+N+ NK++I+RIVMNQ+ Y R+R+ WN+ Q+W LY++VPRD CDTY LCGAYG CII
Sbjct: 242 YTYNLKNKSLITRIVMNQSTYFRQRYTWNEINQTWVLYANVPRDYCDTYSLCGAYGNCII 301
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
QSPVC+CL+ F PKS +D SQGCVR+KPL+ + DGF+K+ LKLPDAT+SWV+
Sbjct: 302 SQSPVCECLEKFTPKSPESWNSMDWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVN 361
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
K+MNLKECR CLEN SCMAYT ++I+ SGCA+WFG+LID+ P GQ+ YIRM+AS
Sbjct: 362 KTMNLKECRSICLENCSCMAYTATNIKER-SGCAIWFGDLIDITQLPAAGQEIYIRMNAS 420
Query: 365 EIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKT----ENSRETDQENED 420
E V I +S ++L+A Y+ +++ + I + T N E DQ +
Sbjct: 421 ESSECLSLVLMAVGIALSIFVACGILLVAYYIFKRKAKLIGKVTLTAFSNREENDQIDSG 480
Query: 421 QNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGL 480
DLELPLF+ TIA AT+ FS NNKLGEGGFGPVYKGTL DGQEIA K S+ S QG+
Sbjct: 481 PKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTHSRSSGQGI 540
Query: 481 KELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+MPNKSLDSFIFDQTR LLDWS+
Sbjct: 541 NEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTRGELLDWSK 600
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
RF IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMNPKISDFGL R FGGD+TEGN
Sbjct: 601 RFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMFGGDQTEGN 660
Query: 601 TNRVVGT 607
T RVVGT
Sbjct: 661 TTRVVGT 667
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2053), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/604 (64%), Positives = 468/604 (77%), Gaps = 11/604 (1%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPINDS GFLM++ TGN VL S +N VVWS+ K Q+ + +
Sbjct: 69 KNIPVRTVVWVANRNNPINDSSGFLMLDNTGNFVLVSNNNSTVVWSSNSKKAAQS-AMGE 127
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
L DSGNLVLRDE D +S Y WQSFDYPSDTLLPGMKLGWDL+ GL+RR+++WKS DDPS
Sbjct: 128 LQDSGNLVLRDEKDDNSGIYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPS 187
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAP-SLRPNPIFSFSFVSNDVELY 187
GDF W + Q NPE+VMWKGS+K+YR+GPWNG+ FS +LR NP+F F FV + E+Y
Sbjct: 188 SGDFTWGTQLQSNPELVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDFVDDGEEVY 247
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
YT+N+ NK++I+RIVMNQT Y R+R+ WN+ Q+W LY+ VPRD CDTY LCGAYG CI+
Sbjct: 248 YTYNLKNKSLITRIVMNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNCIM 307
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
QSPVCQCL+ F P+S +D S+GCVR+KPL+ + DGF+K+ LKLPDAT+SWV+
Sbjct: 308 SQSPVCQCLEKFTPRSPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVN 367
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
K+MNLKECR CL+N SCMAYT ++I+ SGCA+WFG+LID+R F GQ+ YIR++AS
Sbjct: 368 KTMNLKECRSKCLQNCSCMAYTATNIKER-SGCAVWFGDLIDIRQFSAAGQEIYIRLNAS 426
Query: 365 EIGAKGEPTTKIVV-IVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNI 423
E AK K+ V +S ++L+A Y+ +++ ++I N E DQ +
Sbjct: 427 ESRAKAASKIKMTVGSALSIFVACGILLVAYYIFKRKAKHIGG---NREENDQIDSGPKE 483
Query: 424 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL 483
DLELPLF+ TIA AT+ FS NNKLGEGGFGPVYKGTL DGQEIA K LS+ S QGL E
Sbjct: 484 DLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTLSRSSGQGLNEF 543
Query: 484 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH 543
KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+MPNKSLDSFIFDQTR LLDWS+RF
Sbjct: 544 KNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTRGKLLDWSKRFS 603
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMNPKISDFGL R FGGD+TEGNT R
Sbjct: 604 IICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMFGGDQTEGNTTR 663
Query: 604 VVGT 607
VVGT
Sbjct: 664 VVGT 667
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 781 bits (2016), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/623 (61%), Positives = 475/623 (76%), Gaps = 27/623 (4%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPINDS GFLM++ TGNLVL S +N VVWS+ K Q+ + +
Sbjct: 63 KNIPVRTVVWVANRNNPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQS-AMGE 121
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRDE D +S +Y WQSFDYPSDT+LPGMKLGWDL+ GL+RR+++WKS DDPS
Sbjct: 122 LLDSGNLVLRDEKDVNSGSYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDDPS 181
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
GDF W + Q NPE+V+WKGS K++R+GPWNG+ FS +LR NP+F F FV N E+Y
Sbjct: 182 SGDFTWGTQLQSNPELVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFVDNGEEVY 241
Query: 188 YTFNITNKAVISRIVMNQTL-YVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICI 246
YT+N+ NK++I+R+VMNQT ++R+R+ WN+ +Q+WELY+ VPRD CD Y LCGAYG CI
Sbjct: 242 YTYNLKNKSLITRLVMNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGNCI 301
Query: 247 IGQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWV 303
I QSPVC+CL+ F PKS ++ SQGCVR+KPL+ + DGF+K+ LKLPDAT+SWV
Sbjct: 302 ISQSPVCECLEKFTPKSPESWNSMNWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWV 361
Query: 304 SKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSA 363
+K+MNLKECR CL+N SCMAYT +DI+ SGCA+WFG+LID+R FP GGQ+ YIRM+A
Sbjct: 362 NKTMNLKECRSKCLQNCSCMAYTATDIKER-SGCAIWFGDLIDIRQFPDGGQEIYIRMNA 420
Query: 364 SEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRN------------------IA 405
SE + I +S ++L+A Y+ ++ + ++
Sbjct: 421 SESSECLSLIKMEMGIALSIFVACGMLLVAYYIFKRTEKLKAHYSFLLVYHVCDSHSLLS 480
Query: 406 EKTENSRE-TDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDG 464
EKT +RE DQ + D+ELPLF+ TIA AT+ FS+NNK+GEGGFGPVYKGTL DG
Sbjct: 481 EKTGGNREENDQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIGEGGFGPVYKGTLEDG 540
Query: 465 QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524
QEIAVK LS+ S QGL E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+MPN+SLD
Sbjct: 541 QEIAVKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNRSLD 600
Query: 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584
SFIFDQTR LLDWS+RF IICG ARGLLYLHQDSRLRI+HRDLKASNVLLD+DMNPKIS
Sbjct: 601 SFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKIS 660
Query: 585 DFGLVRTFGGDETEGNTNRVVGT 607
DFGL R GGD+TEGNT RV+GT
Sbjct: 661 DFGLARMVGGDQTEGNTTRVIGT 683
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 764 bits (1973), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/602 (61%), Positives = 448/602 (74%), Gaps = 46/602 (7%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K+ P V+WVANR NPI DS GFL I+ T NL+L S N+VVWS+ + ++P+VLQL
Sbjct: 75 KNIPVRTVLWVANRRNPIEDSSGFLTIDNTANLLLVSNRNVVVWSSNSTIVAKSPIVLQL 134
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
LDSGNLVLRDE DS Y WQSFD+PSDTL+PGMKLGWDL+TGLERR++SW+S DDPSP
Sbjct: 135 LDSGNLVLRDEK-SDSGRYLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSP 193
Query: 130 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELYY 188
GD W I+ Q+NPE ++W+GS++++R+GPW G+ F+ AP L NP+F +FVS++ E+Y
Sbjct: 194 GDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYL 253
Query: 189 TFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIG 248
++N+ N + SRIV+NQT R + WN+ATQ+W LY+ VPRD CD Y CGA G CII
Sbjct: 254 SYNLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASCGANGNCIIN 313
Query: 249 QSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSK 305
P+C+CLK FKPKS +D S GCVR+KPLN + DGF+K+ LK PDAT SW++K
Sbjct: 314 DLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNK 373
Query: 306 SMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASE 365
SMNL ECR CL+N SCMAY+NSD+RGGGSGC +W+G+LID+R FP GGQ+ YIRM
Sbjct: 374 SMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGDLIDIRQFPAGGQELYIRM---- 429
Query: 366 IGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDL 425
N +E E ++ DQ + +N DL
Sbjct: 430 -------------------------------------NPSESAEMDQQNDQITDGENEDL 452
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 485
ELP FE A I NAT+NFSI NKLG+GGFGPVYKGTL DGQEIAVKRLS S QG KE KN
Sbjct: 453 ELPQFEFAKIVNATNNFSIKNKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSRQGSKEFKN 512
Query: 486 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
EVIL +KLQHRNLVKLLGC IQ EE+LL+YE+MPNKSLDSF+FDQT+ LLDWS+RF+II
Sbjct: 513 EVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNII 572
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
CG ARGLLYLHQDSRLRIIHRDLK+SNVLLD+DMNPKISDFGL RTFGGD+TEGNT+RVV
Sbjct: 573 CGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGNTSRVV 632
Query: 606 GT 607
GT
Sbjct: 633 GT 634
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 758 bits (1958), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/602 (61%), Positives = 447/602 (74%), Gaps = 47/602 (7%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K+ P V+WVANR NPI DS G L I+ T NL+L S N+VVWS+ + ++P+VLQL
Sbjct: 75 KNIPLRTVLWVANRRNPIEDSSGLLTIDNTANLLLVSNRNVVVWSSNSTIVAKSPIVLQL 134
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
LDSGNLVLRDE DS Y WQSFD+PSDTL+PGMKLGWDL+TGLERR++SW+S DDPSP
Sbjct: 135 LDSGNLVLRDEKS-DSGRYLWQSFDHPSDTLIPGMKLGWDLRTGLERRLSSWRSSDDPSP 193
Query: 130 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELYY 188
GD W I+ Q+NPE ++W+GS++++R+GPW G+ F+ AP L NP+F +FVS++ E+Y
Sbjct: 194 GDLTWGIKLQNNPETIIWRGSQQYFRSGPWTGIAFTGAPELVQNPVFKLNFVSSEDEVYL 253
Query: 189 TFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIG 248
++N+ N + SRIV+NQT R + WN+ATQ+W LY+ VPRD CD Y CGA G CII
Sbjct: 254 SYNLKNISAFSRIVVNQTTNYREAYTWNEATQTWVLYASVPRDSCDNYASCGANGNCIIN 313
Query: 249 QSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVSK 305
P+C+CLK FKPKS +D S GCVR+KPLN + DGF+K+ LK PDAT SW++K
Sbjct: 314 DLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGFVKYLGLKWPDATHSWLNK 373
Query: 306 SMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASE 365
SMNL ECR CL+N SCMAY+NSD+RGGGSGC +W+G LID+R FP GGQ+ YIRM+ SE
Sbjct: 374 SMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGGLIDIRQFPAGGQELYIRMNPSE 433
Query: 366 IGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDL 425
+E ++ DQ + +N DL
Sbjct: 434 ------------------------------------------SEMDQQNDQITDGENEDL 451
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 485
ELP FE A I NAT+NFSI NKLG+GGFGPVYKGTL DGQEIAVKRLS S QG KE KN
Sbjct: 452 ELPQFEFAKIVNATNNFSIENKLGQGGFGPVYKGTLEDGQEIAVKRLSMSSGQGSKEFKN 511
Query: 486 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
EVIL +KLQHRNLVKLLGC IQ EE+LL+YE+MPNKSLDSF+FDQT+ LLDWS+RF+II
Sbjct: 512 EVILINKLQHRNLVKLLGCSIQREERLLVYEYMPNKSLDSFLFDQTKSKLLDWSKRFNII 571
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
CG ARGLLYLHQDSRLRIIHRDLK+SNVLLD+DMNPKISDFGL RTFGGD+TEGNT+RVV
Sbjct: 572 CGIARGLLYLHQDSRLRIIHRDLKSSNVLLDKDMNPKISDFGLARTFGGDQTEGNTSRVV 631
Query: 606 GT 607
GT
Sbjct: 632 GT 633
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115136|ref|XP_002316951.1| predicted protein [Populus trichocarpa] gi|222860016|gb|EEE97563.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 752 bits (1942), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/608 (61%), Positives = 453/608 (74%), Gaps = 14/608 (2%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQ-SNIVVWSAYLSKEVQTPVVLQ 68
K+ P +VWVANR NPINDS G L ++ ++VL S +N VVWS+ +K+ +P+ LQ
Sbjct: 65 KNIPVRTIVWVANRRNPINDSSGLLKVDNCSDIVLLSNNTNTVVWSSNSTKKASSPI-LQ 123
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRD++DG S WQSFDYP DT+LPGMK+GWDL+ G + R++SWKS DDPS
Sbjct: 124 LLDSGNLVLRDKNDGRS-GLLWQSFDYPCDTMLPGMKIGWDLRAGFDWRLSSWKSSDDPS 182
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPS-LRPNPIFSFSFVSNDVELY 187
PGDF IER+ NPEVV WKGS+K YR+GPWNG+ FS + ++PNP+F F+FVSN++E+Y
Sbjct: 183 PGDFTMGIERESNPEVVAWKGSKKHYRSGPWNGVGFSGSTEVKPNPVFYFTFVSNNIEVY 242
Query: 188 YTFNITNKA-VISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICI 246
Y FN+ +++ VI+R+V+N T R+ + WN+ TQ+W L VPRD CD YGLCGA CI
Sbjct: 243 YIFNLKSESTVITRLVLNHTTSDRQCYTWNEETQTWVLQVSVPRDHCDNYGLCGANANCI 302
Query: 247 IGQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWV 303
PVCQCL+ FKPKS +D SQGCVR+K L+ + DGFIKF LKLPDAT SWV
Sbjct: 303 FNAIPVCQCLEKFKPKSPEEWNKMDWSQGCVRNKELDCQKGDGFIKFDGLKLPDATHSWV 362
Query: 304 SKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSA 363
+K MNLKEC+ CL N SCMAY+N DIRGGGSGCA WFG+L+D+R PGGGQ+ YIRM A
Sbjct: 363 NKDMNLKECKAKCLGNCSCMAYSNLDIRGGGSGCANWFGDLMDIRLVPGGGQELYIRMHA 422
Query: 364 SEIGAK-GEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAE-----KTENSRETDQE 417
SEIG + + KI I + L+ L Y + K + AE +TEN + D
Sbjct: 423 SEIGDREAKANMKIAAIATAVVGLILGTLTISYHVSKEKAKSAENTSSERTENDWKNDTN 482
Query: 418 NEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE 477
N Q D+ELPLF + IA+AT+NFS+NNKLGEGGFGPVY+G L DG EIAVKRLS+ S
Sbjct: 483 NGGQKEDMELPLFAFSAIADATNNFSVNNKLGEGGFGPVYRGKLEDGLEIAVKRLSRCSG 542
Query: 478 QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD 537
QG E KNEVIL +KLQHRNLVKLLGCC Q EEK+LIYE+MPN+SLD FIFD+T+ LLD
Sbjct: 543 QGFSEFKNEVILINKLQHRNLVKLLGCCSQREEKMLIYEYMPNRSLDFFIFDETKGRLLD 602
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
WS+RF+II G ARGLLYLHQDSRLRIIHRDLKASNVLLD MNPKISDFGL R F D+T
Sbjct: 603 WSRRFNIISGIARGLLYLHQDSRLRIIHRDLKASNVLLDDHMNPKISDFGLARMFVADQT 662
Query: 598 EGNTNRVV 605
EG+T+RV
Sbjct: 663 EGDTSRVT 670
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514895|ref|XP_003526137.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1813), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/605 (57%), Positives = 435/605 (71%), Gaps = 10/605 (1%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSN-IVVWSAYLSKEVQTPVVLQ 68
K+ P VVWVANR NPI D+ L IN GN +L +Q+N V+WS + + VV Q
Sbjct: 67 KNIPIRTVVWVANRDNPIKDNSSKLSINTAGNFILLNQNNNTVIWSTNTTTKASL-VVAQ 125
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLDSGNLVLRDE D + E Y WQSFDYPSDT LPGMK GWDLK GL R +T+WK++DDPS
Sbjct: 126 LLDSGNLVLRDEKDNNPENYSWQSFDYPSDTFLPGMKAGWDLKKGLNRVLTAWKNWDDPS 185
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELY 187
GDF R + PE VMWKG+ ++YR+GPW+G +FS +PS+ N I ++S VSN E Y
Sbjct: 186 SGDFTANSSRTNFPEEVMWKGTSEYYRSGPWDGRKFSGSPSVPTNSIVNYSVVSNKDEFY 245
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
T+++ +K++ISR+V+NQTLYVR+R WN+ +Q+W + S++P D CD Y CGA+GIC+
Sbjct: 246 ATYSMIDKSLISRVVVNQTLYVRQRLTWNEDSQTWRVSSELPGDLCDNYSTCGAFGICVA 305
Query: 248 GQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLN--YSRQDGFIKFTELKLPDATSSW 302
GQ+PVC CL GFKPKS ++ +QGCV ++ + +DGF KF+ LK PD SW
Sbjct: 306 GQAPVCNCLDGFKPKSTRNWTQMNWNQGCVHNQTWSCMEKNKDGFKKFSNLKAPDTERSW 365
Query: 303 VSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMS 362
V+ SM L EC+ C EN SC AY N D+RG GSGCA+WFG+L+D+R P GQD YIR++
Sbjct: 366 VNASMTLDECKNKCRENCSCTAYANFDMRGEGSGCAIWFGDLLDIRLIPNAGQDLYIRLA 425
Query: 363 ASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQN 422
SE K + K+VVI ++++A +LI ++ +NI E + NE Q
Sbjct: 426 VSETDEKDDSKKKVVVIASIVSSVVATLLIFIFIYWSNAKNIKEIILGIEV--KNNESQQ 483
Query: 423 IDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKE 482
D ELPLF+L +IA ATD+FS +NKLGEGGFGPVYKGTL DG E+AVKRLS+ S QGLKE
Sbjct: 484 EDFELPLFDLVSIAQATDHFSDHNKLGEGGFGPVYKGTLPDGLEVAVKRLSQTSGQGLKE 543
Query: 483 LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF 542
KNEV+L +KLQHRNLVK+LGCCIQ EKLLIYE+M NKSLD F+FD R LLDW +RF
Sbjct: 544 FKNEVMLCAKLQHRNLVKVLGCCIQENEKLLIYEYMANKSLDVFLFDSDRSKLLDWPKRF 603
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+II ARGLLYLHQDSRLRIIHRDLKASNVLLD +MNPKISDFGL R GGD+ EG T
Sbjct: 604 YIINRIARGLLYLHQDSRLRIIHRDLKASNVLLDNEMNPKISDFGLARMCGGDQIEGKTR 663
Query: 603 RVVGT 607
RVVGT
Sbjct: 664 RVVGT 668
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514935|ref|XP_003526157.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1804), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/605 (59%), Positives = 442/605 (73%), Gaps = 14/605 (2%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K+ P VVWVANR NPINDS G L +N TGN VL ++V ++ K+ Q PV + L
Sbjct: 84 KNIPIQTVVWVANRENPINDSSGILTLNNTGNFVLAQNESLVWYTNNSHKQAQNPVAV-L 142
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
LDSGNLV+R++ + + E Y WQSFDYPSDTLLPGMKLGWDL+TGL+RR+T+WKS DDPSP
Sbjct: 143 LDSGNLVIRNDGETNPEAYLWQSFDYPSDTLLPGMKLGWDLRTGLDRRLTAWKSPDDPSP 202
Query: 130 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYY 188
GD +E PE + KG++K YR GPWNGL FS P LR N IF F+F SN E YY
Sbjct: 203 GDVYRDLELYSYPEFYIMKGTKKVYRFGPWNGLYFSGVPDLRNNTIFGFNFFSNKEESYY 262
Query: 189 TFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIG 248
F+ TN V+SRIVMN++ + R ++W + Q+W +Y+ +P+D CDTYGLCG YG C+
Sbjct: 263 IFSPTND-VMSRIVMNESTTIYR-YVWVEDDQNWRIYTSLPKDFCDTYGLCGVYGNCMTT 320
Query: 249 QSPVCQCLKGFKPKS-GGYVDR--SQGCVRSKPLNYSRQ--DGFIKFTELKLPDATSSWV 303
Q+ VCQCLKGF PKS +V SQGCVR+KPL+ + DGF+K+ LK+PD +W+
Sbjct: 321 QTQVCQCLKGFSPKSPEAWVSSGWSQGCVRNKPLSCKDKLTDGFVKYEGLKVPDTRHTWL 380
Query: 304 SKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSA 363
+S+ L+EC+ CL N SCMAYTNSDIRG GSGC MWFG+LID++ GQD YIRM A
Sbjct: 381 DESIGLEECKVKCLNNCSCMAYTNSDIRGAGSGCVMWFGDLIDIKQLQTAGQDLYIRMPA 440
Query: 364 SEIGAKGEPTTKIVVIVISTAAL-LAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQN 422
SE+ + K I ST A V+L++ Y I + RRN A K+ T+ ++E
Sbjct: 441 SELESVYRHKKKTTTIAASTTAAICGVLLLSSYFICRIRRNNAGKSL----TEYDSEKDM 496
Query: 423 IDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKE 482
DL++ LF+L TI AT++FS+ NK+GEGGFGPVYKG LVDGQEIAVK LS+ S QG+ E
Sbjct: 497 DDLDIQLFDLPTITTATNDFSMENKIGEGGFGPVYKGILVDGQEIAVKTLSRSSWQGVTE 556
Query: 483 LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF 542
NEV L +KLQHRNLVKLLGCCIQG+EK+LIYE+M N SLDSFIFD +R LL W Q+F
Sbjct: 557 FINEVKLIAKLQHRNLVKLLGCCIQGQEKMLIYEYMANGSLDSFIFDDKKRKLLKWPQQF 616
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
HIICG ARGL+YLHQDSRLRIIHRDLKASNVLLD++ +PKISDFG+ RTFGGD+ EGNT+
Sbjct: 617 HIICGIARGLMYLHQDSRLRIIHRDLKASNVLLDENSSPKISDFGMARTFGGDQFEGNTS 676
Query: 603 RVVGT 607
RVVGT
Sbjct: 677 RVVGT 681
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458261|ref|XP_004146866.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1800), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/604 (57%), Positives = 438/604 (72%), Gaps = 15/604 (2%)
Query: 10 KSYPPHEVVWVANRLNPINDS--FGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVL 67
K P +VWVANR NPI +S L IN T + + +++ VVW K +TP L
Sbjct: 68 KIIPVRTIVWVANRENPIRNSSAVAVLKINSTSSDLFLFENDAVVWFGKSLKPAKTPK-L 126
Query: 68 QLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDP 127
QLLD+GNL+L+D +SE WQSFDYP+DTLLPGMKLGWD K G++RR+++WK+ DDP
Sbjct: 127 QLLDNGNLLLKD---AESEETSWQSFDYPTDTLLPGMKLGWDFKNGIQRRLSAWKTSDDP 183
Query: 128 SPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPSLRPNPIFSFSFVSNDVELY 187
SPG + PE VMW GS ++ R+GPWNGL+FSA PI +S+V+N EL
Sbjct: 184 SPGSLTMEMMNTSYPEPVMWNGSSEYMRSGPWNGLQFSAKPTSALPILVYSYVNNKSELS 243
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y++ + N ++I R+V+NQT+ R +W++ ++W+ Y+ +PRD CDTY +CGA+G C I
Sbjct: 244 YSYELINSSLIGRMVLNQTILRREALLWSEPEKNWKPYAAMPRDYCDTYSVCGAFGSCDI 303
Query: 248 GQSPVCQCLKGFKP---KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
Q P CQCL GF P + +D ++GCVR+KPLN S + GF K LKLPD SWV+
Sbjct: 304 EQVPACQCLFGFHPNVQEKWNLMDYTEGCVRNKPLNCSDKTGFAKLPGLKLPDTKQSWVN 363
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+SM+L ECRE CL N SC+A+ N+DIRG GSGCA+WFGEL+D++ GGQD Y+RM AS
Sbjct: 364 ESMSLNECREKCLRNCSCVAFANTDIRGSGSGCAIWFGELVDIKVVRRGGQDLYVRMLAS 423
Query: 365 EIGAKGEPTTKIVVIVISTAALLAVVLIAG-YLIRKRRRNIAEKTENSRETDQENEDQNI 423
E+ K + + VIV + A L+ +L+ G Y+IR +RR + E T ++ E Q
Sbjct: 424 ELETKKTSSVAVGVIVGAAALLILGLLLIGFYVIRSKRRKL-EATGAGKDL----EGQED 478
Query: 424 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKEL 483
DLELPLF LATI+NATDNFS NKLGEGGFG V++G L DG+EIAVKRLS S QG E
Sbjct: 479 DLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDGKEIAVKRLSSYSRQGTDEF 538
Query: 484 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH 543
KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE+MPNKSLDSFIFD R+ LLDWS+RF+
Sbjct: 539 KNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLDSFIFDSARKKLLDWSKRFN 598
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
IICG ARG+LYLHQDSRLRIIHRDLKASNVLLD D+NPKISDFG+ RTFGGD+TEGNT R
Sbjct: 599 IICGVARGILYLHQDSRLRIIHRDLKASNVLLDIDLNPKISDFGMARTFGGDQTEGNTRR 658
Query: 604 VVGT 607
VVGT
Sbjct: 659 VVGT 662
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514913|ref|XP_003526146.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/617 (56%), Positives = 444/617 (71%), Gaps = 23/617 (3%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K+ P VVWVANR P+ D+ L+I GNLVL +++N V WS + + P+ LQL
Sbjct: 65 KNIPVKTVVWVANRDYPLKDNSTKLIITNDGNLVLLTKNNKVQWSTNTTTKASRPI-LQL 123
Query: 70 LDSGNLVLRDEHDGD-----------SETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRV 118
L++GNLVLR++++ + + + WQSFDYPSDTLLPGMKLGW KTGL RRV
Sbjct: 124 LNTGNLVLRNDNEDNKNNNKSSNNNNEDRFLWQSFDYPSDTLLPGMKLGWYRKTGLNRRV 183
Query: 119 TSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAP-----SLRPNP 173
+WK++DDPSPG+F W I NPE+V+WKGS K++R+GPWNG+RFS L +P
Sbjct: 184 IAWKNWDDPSPGNFSWGITFDSNPEMVLWKGSFKYHRSGPWNGIRFSGAFGGSNRLSTHP 243
Query: 174 IFSFSFVSNDVELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQC 233
+F + ++ND E+YY++++TNK+VIS +VMNQTL R+R IW +W L+ PRD C
Sbjct: 244 LFVYKLINNDDEVYYSYSLTNKSVISIVVMNQTLLRRQRNIWIPENGTWRLFQTAPRDIC 303
Query: 234 DTYGLCGAYGICIIGQSPVCQCLKGFKPKSGGYVDRSQGCVRSKP--LNYSRQDGFIKFT 291
DTY CG+Y C++ SPVCQCL+GFKPKS ++ QGCVRS+P +DGF KF
Sbjct: 304 DTYNPCGSYANCMVDSSPVCQCLEGFKPKSLDTME--QGCVRSEPWSCKVEGRDGFRKFV 361
Query: 292 ELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFP 351
LK PD T SW++KSM L+EC+ C EN SC AY N DIRG GSGC++WFG+LID++
Sbjct: 362 GLKFPDTTHSWINKSMTLEECKVKCWENCSCTAYANLDIRGAGSGCSIWFGDLIDLKVVS 421
Query: 352 GGGQDFYIRMSASEIGAKGEPTTK-IVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTEN 410
GQ YIRM+ S+ AK K +++I ++ V+L+A + KR+R E+ +
Sbjct: 422 QSGQYLYIRMADSQTDAKDAHKKKELLLIGTIVPPIVLVILLAIFYSYKRKRKYEEENVS 481
Query: 411 SRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVK 470
+ D E Q +ELPLF+LAT+ NAT+NFS +NKLG+GGFGPVYKG L GQEIAVK
Sbjct: 482 VVKKD-EAGGQEHSMELPLFDLATLVNATNNFSTDNKLGQGGFGPVYKGVLAGGQEIAVK 540
Query: 471 RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ 530
RLS+ S QGL E KNEVIL +KLQHRNLVK+LGCCI+ EEK+L+YE+MPNKSLDSF+FD
Sbjct: 541 RLSRSSGQGLTEFKNEVILCAKLQHRNLVKVLGCCIEEEEKMLLYEYMPNKSLDSFLFDS 600
Query: 531 TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
T+ +LDWS+RFHI+C TARGLLYLHQDSRLRIIHRDLKASN+LLD ++NPKISDFGL R
Sbjct: 601 TKSKILDWSKRFHILCATARGLLYLHQDSRLRIIHRDLKASNILLDNNLNPKISDFGLAR 660
Query: 591 TFGGDETEGNTNRVVGT 607
GGD+ EGNTNRVVGT
Sbjct: 661 MCGGDQIEGNTNRVVGT 677
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 607 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.570 | 0.441 | 0.452 | 6e-159 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.952 | 0.709 | 0.503 | 2.5e-152 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.654 | 0.468 | 0.407 | 1.4e-148 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.650 | 0.468 | 0.405 | 1.2e-147 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.299 | 0.214 | 0.703 | 1.3e-128 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.962 | 0.703 | 0.435 | 3.1e-122 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.945 | 0.713 | 0.436 | 1.8e-119 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.952 | 0.714 | 0.423 | 2.6e-118 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.947 | 0.714 | 0.422 | 1.1e-117 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.952 | 0.710 | 0.417 | 2.3e-117 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 863 (308.9 bits), Expect = 6.0e-159, Sum P(2) = 6.0e-159
Identities = 163/360 (45%), Positives = 236/360 (65%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQ-----TPVVLQLLD 71
VVWVANR +P+ D G L +++ G+L L + N ++WS+ S Q P+V Q+LD
Sbjct: 73 VVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIV-QILD 131
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
+GNLV+R+ GD + Y WQS DYP D LPGMK G + TGL R +TSW++ DDPS G+
Sbjct: 132 TGNLVVRNS--GDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGN 189
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTF 190
+ ++ P+ + K S +RTGPWNGLRF+ P+L+PNPI+ + +V + E+YYT+
Sbjct: 190 YTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTY 249
Query: 191 NITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQS 250
+ N +V++R+ +N ++R + W QSW Y D CD Y LCG+YG C I +S
Sbjct: 250 KLENPSVLTRMQLNPNGALQR-YTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINES 308
Query: 251 PVCQCLKGFKPKSG-GYV--DRSQGCVRSKPLNYSR-QDGFIKFTELKLPDATSSWVSKS 306
P C+CLKGF K+ +V D S+GCVR L+ + +DGF+K ++LKLPD +SW K+
Sbjct: 309 PACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKN 368
Query: 307 MNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSASEI 366
M+L EC++ CL N +C AY+ DIR GG GC +WFG+LID+R++ GQD Y+R+++SEI
Sbjct: 369 MDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEI 428
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1486 (528.2 bits), Expect = 2.5e-152, P = 2.5e-152
Identities = 307/610 (50%), Positives = 410/610 (67%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAY-----LSKEVQTPVVLQ 68
P VVWVANR NP+ + GFL ++ G+L L + +WS+ SK P+ L+
Sbjct: 72 PFAVVWVANRNNPLYGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPL-LK 130
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
+ SGNL+ DG+ E WQSFDYP +T+L GMKLG + KT +E ++SWK+ DPS
Sbjct: 131 ISCSGNLI---SSDGE-EAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPS 186
Query: 129 PGDFIWAIERQDNPEVVMWK-GSRKF-YRTGPWNGLRFS-APSL-RPNPIFSFSFVSNDV 184
PGDF +++ + P++++ K G + YR G WNGL F+ AP++ R N +F + F S+
Sbjct: 187 PGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQ 246
Query: 185 ELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGI 244
E+ Y++ ++ ++SR+V+N T + R FI +K Q W L + P D+CD Y +CGAY +
Sbjct: 247 EVNYSWTPRHR-IVSRLVLNNTGKLHR-FIQSKQNQ-WILANTAPEDECDYYSICGAYAV 303
Query: 245 CIIGQ--SPVCQCLKGFKPKSGGY--VDR-SQGCVRSKPLNYSRQDGFIKFTELKLPDAT 299
C I +P C CL+GFKPKSG + R + GCV P N ++D F+KF LKLPD +
Sbjct: 304 CGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTS 363
Query: 300 SSW--VSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDF 357
SW M L++C+ C N SC AY N+DIR GG GC +WFG+L+DMR++ GQD
Sbjct: 364 WSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDV 423
Query: 358 YIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQE 417
YIRM ++I KG ++V +V+ + +AVVL+ + +++ + EN R+ +E
Sbjct: 424 YIRMGFAKIEFKGR---EVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEE 480
Query: 418 NEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE 477
DL+LP+F+ TI+ ATD+FS N LG GGFGPVYKG L DGQEIAVKRLS S
Sbjct: 481 E-----DLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSG 535
Query: 478 QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD 537
QG++E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+MPNKSLD FIFD+ R T LD
Sbjct: 536 QGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELD 595
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
W +R +II G ARG+LYLHQDSRLRIIHRDLKA NVLLD DMNPKISDFGL ++FGGD++
Sbjct: 596 WKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQS 655
Query: 598 EGNTNRVVGT 607
E +TNRVVGT
Sbjct: 656 ESSTNRVVGT 665
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 813 (291.2 bits), Expect = 1.4e-148, Sum P(2) = 1.4e-148
Identities = 165/405 (40%), Positives = 240/405 (59%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K P VWVANR NP++ S G L I+ NLV+ QS+ VWS ++ +V++PV +
Sbjct: 71 KIIPIRTYVWVANRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAE 129
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTG-LERRVTSWKSFDDP 127
LLD GN VLRD + + WQSFD+P+DTLL MK+GWD K+G R + SWK+ DDP
Sbjct: 130 LLDYGNFVLRDSKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDP 189
Query: 128 SPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVEL 186
S GDF + PE ++ YR+GPW G RFS+ P ++P SF N+ ++
Sbjct: 190 SSGDFSTKLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQV 249
Query: 187 YYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICI 246
Y++ + NK I I+ + + +R W +A QSW+ P+D CD Y CG YG C
Sbjct: 250 VYSYRV-NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCD 308
Query: 247 IGQSPVCQCLKGFKP--KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
SP+C C+KGF+P + D S GCVR L+ +DGF++ +++LPD T + V
Sbjct: 309 ANTSPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVD 368
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
K + LKEC E CL+ +C A+ N+DIR GGSGC +W G L D+R++ GGQD Y+R++A
Sbjct: 369 KGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAG 428
Query: 365 EIGAKGEPTTKIVVIVISTAALLAV-VLIAGYLIRKRRRNIAEKT 408
++ K + KI+ I + LL + +I + RK++R+I +T
Sbjct: 429 DLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQT 473
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 807 (289.1 bits), Expect = 1.2e-147, Sum P(2) = 1.2e-147
Identities = 165/407 (40%), Positives = 244/407 (59%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSK-EVQTPVVLQ 68
K P VWVANR NP++ S G L I+ NLV+ QS+ VWS ++ +V++PV +
Sbjct: 71 KIIPIRTYVWVANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAE 129
Query: 69 LLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
LLD+GN +LRD ++ WQSFD+P+DTLL MKLGWD KTG R + SWK+ DDPS
Sbjct: 130 LLDNGNFLLRDSNN----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPS 185
Query: 129 PGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELY 187
G+F +E + PE + YR+GPWNG+RFS+ P ++F ++ E+
Sbjct: 186 SGEFSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVT 245
Query: 188 YTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
Y++ I + SR+ +N ++R W + TQSW+ P+D CD Y +CG +G C
Sbjct: 246 YSYRINKTNLYSRLYLNSAGLLQR-LTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDS 304
Query: 248 GQSPVCQCLKGFKP---KSGGYVDRSQGCVRSKPLNYSRQDGFIKFTELKLPDATSSWVS 304
P C C+KGFKP ++ D S GC+R L+ +DGF + +KLPD T++ V
Sbjct: 305 NSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVD 364
Query: 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRMSAS 364
+ + LK C+E CLE+ +C A+ N+DIR GGSGC +W E++DMR++ GGQD Y+R++A+
Sbjct: 365 REIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAA 424
Query: 365 EIGAKGEPTTKIVVIVISTAALLAV-VLIAGYLIRKRRRNIAEKTEN 410
E+ K KI+ I + LL + +I + RK++R+I +T N
Sbjct: 425 ELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPN 471
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 676 (243.0 bits), Expect = 1.3e-128, Sum P(2) = 1.3e-128
Identities = 128/182 (70%), Positives = 151/182 (82%)
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKN 485
ELP+F L IA AT++F N+LG GGFGPVYKG L DG+EIAVKRLS S QG+ E KN
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572
Query: 486 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
E+IL +KLQHRNLV+LLGCC +GEEK+L+YE+MPNKSLD F+FD+T++ L+DW RF II
Sbjct: 573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G ARGLLYLH+DSRLRIIHRDLK SNVLLD +MNPKISDFG+ R FGG++ E NT RVV
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVV 692
Query: 606 GT 607
GT
Sbjct: 693 GT 694
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1202 (428.2 bits), Expect = 3.1e-122, P = 3.1e-122
Identities = 271/622 (43%), Positives = 372/622 (59%)
Query: 13 PPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVL-QLLD 71
P VVWVAN +PINDS G + I+K GNLV+ V WS + V +LL+
Sbjct: 67 PVQTVVWVANSNSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLN 126
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
+GNLVL + E W+SF++P + LP M L D KTG ++ SWKS DPSPG
Sbjct: 127 TGNLVLLGTTNTGDEI-LWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGR 185
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRF-SAPSL--RPNPIFSFSFVSNDVELYY 188
+ + PE+V+WK +R+GPWNG F P++ R N +F + +S+D
Sbjct: 186 YSAGLIPLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYRIN-LFELT-LSSDNRGSV 243
Query: 189 TFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII- 247
+ + ++ +++ V +R WN A Q W+ + VP +CDTY CG + C
Sbjct: 244 SMSYAGNTLLYHFLLDSEGSVFQRD-WNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFN 302
Query: 248 -GQSPVCQCLKGFKPKSGGYVDR---SQGCVRSKPLNY--------SRQ-DGFIKFTELK 294
G +P C C++GFKP+S + +QGCVR PL SR+ DGF++ ++K
Sbjct: 303 PGSTPPCMCIRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMK 362
Query: 295 LPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGG 354
+P N ++C E CL+N SC AY+ G GC +W G L+DM++F G G
Sbjct: 363 VPHNPQR---SGANEQDCPESCLKNCSCTAYSFDR----GIGCLLWSGNLMDMQEFSGTG 415
Query: 355 QDFYIRMSASEIGAKGEPTTKIVVIVISTAALLA-VVLIAGYLIRKRR-RNIAEKTENSR 412
FYIR++ SE + + I V ++ A L A V++A + I K R +N + N R
Sbjct: 416 VVFYIRLADSEFKKRTNRSIVITVTLLVGAFLFAGTVVLALWKIAKHREKNRNTRLLNER 475
Query: 413 ETDQENEDQNIDL-------ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQ 465
+ D L ELPLFE +A AT+NFSI NKLG+GGFG VYKG L +G
Sbjct: 476 MEALSSNDVGAILVNQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGL 535
Query: 466 EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525
+IAVKRLS+ S QG++E NEV++ SKLQHRNLV+LLG CI+GEE++L+YEFMP LD+
Sbjct: 536 DIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDA 595
Query: 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585
++FD ++ LLDW RF+II G RGL+YLH+DSRL+IIHRDLKASN+LLD+++NPKISD
Sbjct: 596 YLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISD 655
Query: 586 FGLVRTFGGDETEGNTNRVVGT 607
FGL R F G+E E +T RVVGT
Sbjct: 656 FGLARIFQGNEDEVSTVRVVGT 677
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1176 (419.0 bits), Expect = 1.8e-119, P = 1.8e-119
Identities = 265/607 (43%), Positives = 369/607 (60%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSG 73
P VVWVANR P+ DS +L I+ +G+L+L + + VWS+ ++ + +L DSG
Sbjct: 70 PRVVVWVANREKPVTDSTAYLAISSSGSLLLLNGKHGTVWSSGVTFS-SSGCRAELSDSG 128
Query: 74 NLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFI 133
NL + D SE WQSFD+ DTLL L ++L T +R +TSWKS+ DPSPGDF+
Sbjct: 129 NLKVIDNV---SERALWQSFDHLGDTLLHTSSLTYNLATAEKRVLTSWKSYTDPSPGDFL 185
Query: 134 WAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVEL--YYTF 190
I Q + + +GS ++R+GPW RF+ P + + F+ + DV Y T+
Sbjct: 186 GQITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDESYTGPFT-LHQDVNGSGYLTY 244
Query: 191 NITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQS 250
+SRI + ++ ++ WELY + P+ CD YG CG +G+C++ S
Sbjct: 245 -FQRDYKLSRITLTSEGSIK---MFRDNGMGWELYYEAPKKLCDFYGACGPFGLCVMSPS 300
Query: 251 PVCQCLKGFKPKSGGYVDRSQ---GCVRSKPL----NYSRQDG--FIKFTELKLPDATSS 301
P+C+C +GF PKS R GCVR L N + +D F + +K PD
Sbjct: 301 PMCKCFRGFVPKSVEEWKRGNWTGGCVRHTELDCLGNSTGEDADDFHQIANIKPPDFYE- 359
Query: 302 WVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQDFYIRM 361
+ S+N +EC + C+ N SC+A+ I+G GC +W +L+D F G+ IR+
Sbjct: 360 -FASSVNAEECHQRCVHNCSCLAFAY--IKG--IGCLVWNQDLMDAVQFSATGELLSIRL 414
Query: 362 SASEI-GAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENED 420
+ SE+ G K + T IV ++S + + A + R R +IA ++++ + D + +D
Sbjct: 415 ARSELDGNKRKKT--IVASIVSLTLFMILGFTAFGVWRCRVEHIAHISKDAWKNDLKPQD 472
Query: 421 QNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGL 480
L F++ TI NAT+NFS++NKLG+GGFG VYKG L DG+EIAVKRLS S QG
Sbjct: 473 VP---GLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGK 529
Query: 481 KELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
+E NE++L SKLQHRNLV++LGCCI+ EEKLLIYEFM NKSLD+F+FD +R +DW +
Sbjct: 530 EEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPK 589
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
RF II G ARGLLYLH DSRLR+IHRDLK SN+LLD+ MNPKISDFGL R + G E + N
Sbjct: 590 RFDIIQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDN 649
Query: 601 TNRVVGT 607
T RVVGT
Sbjct: 650 TRRVVGT 656
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1165 (415.2 bits), Expect = 2.6e-118, P = 2.6e-118
Identities = 261/617 (42%), Positives = 365/617 (59%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQL 69
K P VVWVANR P+ DS L I+ G+L+L ++++ VVWS +L
Sbjct: 65 KGIIPRVVVWVANREKPVTDSAANLTISSNGSLLLFNENHSVVWSIG-ETFASNGSRAEL 123
Query: 70 LDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSP 129
D+GNLV+ D + G + W+SF++ DT+LP L ++L TG +R +TSWKS DPSP
Sbjct: 124 TDNGNLVVIDNNSGRT---LWESFEHFGDTMLPFSNLMYNLATGEKRVLTSWKSHTDPSP 180
Query: 130 GDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYY 188
GDF I Q + +GS+ ++R+GPW RF+ P + FS + D
Sbjct: 181 GDFTVQITPQVPSQACTMRGSKTYWRSGPWAKTRFTGIPVMDDTYTSPFS-LQQDTNGSG 239
Query: 189 TFNITNKAV-ISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGICII 247
+F + +S I++ ++ I+ WEL + P + CD YG CG +GIC++
Sbjct: 240 SFTYFERNFKLSYIMITSEGSLK---IFQHNGMDWELNFEAPENSCDIYGFCGPFGICVM 296
Query: 248 GQSPVCQCLKGFKPKS------GGYVDRSQGCVRSKPL------NYSRQDGFIKFTELKL 295
P C+C KGF PKS G + D GCVR L N +GF +K
Sbjct: 297 SVPPKCKCFKGFVPKSIEEWKRGNWTD---GCVRHTELHCQGNTNGKTVNGFYHVANIKP 353
Query: 296 PDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGGQ 355
PD + ++ + C + CL N SC+A+ + G GC MW +L+D F GG+
Sbjct: 354 PDFYE--FASFVDAEGCYQICLHNCSCLAFAYIN----GIGCLMWNQDLMDAVQFSAGGE 407
Query: 356 DFYIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGY-LIR-KRRRNIAEKTEN--S 411
IR+++SE+G G KI+V I + +L ++ A + +R K + ++ K S
Sbjct: 408 ILSIRLASSELG--GNKRNKIIVASIVSLSLFVILAFAAFCFLRYKVKHTVSAKISKIAS 465
Query: 412 RET-DQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVK 470
+E + + E Q++ L FE+ TI ATDNFS++NKLG+GGFG VYKG L DG+EIAVK
Sbjct: 466 KEAWNNDLEPQDVS-GLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVK 524
Query: 471 RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ 530
RLS S QG +E NE++L SKLQH+NLV++LGCCI+GEE+LL+YEF+ NKSLD+F+FD
Sbjct: 525 RLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDS 584
Query: 531 TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+R +DW +RF+II G ARGL YLH+DS LR+IHRDLK SN+LLD+ MNPKISDFGL R
Sbjct: 585 RKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLAR 644
Query: 591 TFGGDETEGNTNRVVGT 607
+ G E + NT RV GT
Sbjct: 645 MYQGTEYQDNTRRVAGT 661
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1159 (413.0 bits), Expect = 1.1e-117, P = 1.1e-117
Identities = 260/615 (42%), Positives = 358/615 (58%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWS---AYLSKEVQTPVV 66
K P VVWVANR P+ S L I+ G+L+L V+WS A+ S +
Sbjct: 62 KKIVPRVVVWVANRDTPVTSSAANLTISSNGSLILLDGKQDVIWSTGKAFTSNKCHA--- 118
Query: 67 LQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDD 126
+LLD+GN V+ D+ G+ WQSF++ +T+LP L +D G +R +T+WKS D
Sbjct: 119 -ELLDTGNFVVIDDVSGNK---LWQSFEHLGNTMLPQSSLMYDTSNGKKRVLTTWKSNSD 174
Query: 127 PSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPS-LRPNPIFSFSFVSNDVE 185
PSPG+F I Q + ++ +GS ++R GPW RFS S + + + FS V +
Sbjct: 175 PSPGEFSLEITPQIPTQGLIRRGSVPYWRCGPWAKTRFSGISGIDASYVSPFSVVQDTAA 234
Query: 186 LYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCGAYGIC 245
+F+ + + + T + + +W+ +W+L+ +P + CD YG CG YG+C
Sbjct: 235 GTGSFSYSTLRNYNLSYVTLTPEGKMKILWDDGN-NWKLHLSLPENPCDLYGRCGPYGLC 293
Query: 246 IIGQSPVCQCLKGFKPKSG---GYVDRSQGCVRSKPLNYSRQ----------DGFIKFTE 292
+ P C+CLKGF PKS G + + GCVR L+ + D F + T+
Sbjct: 294 VRSDPPKCECLKGFVPKSDEEWGKGNWTSGCVRRTKLSCQAKSSMKTQGKDTDIFYRMTD 353
Query: 293 LKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPG 352
+K PD + +N ++C +GCL N SC A+ G GC +W GEL D F
Sbjct: 354 VKTPDLHQ--FASFLNAEQCYQGCLGNCSCTAFAYIS----GIGCLVWNGELADTVQFLS 407
Query: 353 GGQDFYIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSR 412
G+ +IR+++SE+ G KI+V + ++ +++ A ++ + R + +N
Sbjct: 408 SGEFLFIRLASSELA--GSSRRKIIVGTTVSLSIFLILVFAAIMLWRYRAKQNDAWKNGF 465
Query: 413 ETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL 472
E Q+ N FE+ TI AT+NFS +NKLG+GGFGPVYKG LVDG+EI VKRL
Sbjct: 466 ER-QDVSGVNF------FEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRL 518
Query: 473 SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR 532
+ S QG +E NE+ L SKLQHRNLV+LLG CI GEEKLLIYEFM NKSLD FIFD
Sbjct: 519 ASSSGQGTEEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCL 578
Query: 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
+ LDW +RF+II G ARGLLYLH+DSRLR+IHRDLK SN+LLD MNPKISDFGL R F
Sbjct: 579 KFELDWPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMF 638
Query: 593 GGDETEGNTNRVVGT 607
G + + NT RVVGT
Sbjct: 639 QGTQYQDNTRRVVGT 653
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1156 (412.0 bits), Expect = 2.3e-117, P = 2.3e-117
Identities = 259/621 (41%), Positives = 369/621 (59%)
Query: 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWS---AYLSKEVQTPVV 66
K+ P VVWVANR P+ ++ L IN G+L+L + VVWS + S E++
Sbjct: 66 KNITPRVVVWVANRDKPVTNNAANLTINSNGSLILVEREQNVVWSIGETFSSNELRA--- 122
Query: 67 LQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDD 126
+LL++GNLVL D G SE W+SF++ DT+L + +D+ +R ++SWK+ D
Sbjct: 123 -ELLENGNLVLID---GVSERNLWESFEHLGDTMLLESSVMYDVPNNKKRVLSSWKNPTD 178
Query: 127 PSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDV- 184
PSPG+F+ + Q P+ + +GSR ++R GPW +RF+ P + + + F +S DV
Sbjct: 179 PSPGEFVAELTTQVPPQGFIMRGSRPYWRGGPWARVRFTGIPEMDGSHVSKFD-ISQDVA 237
Query: 185 ----ELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQCDTYGLCG 240
L Y+ N +S + ++ IWN + W + P CD Y CG
Sbjct: 238 AGTGSLTYSLERRNSN-LSYTTLTSAGSLK--IIWNNGS-GWVTDLEAPVSSCDVYNTCG 293
Query: 241 AYGICIIGQSPVCQCLKGFKPKSGGYVDRSQ---GCVR----SKPLNYSRQ------DGF 287
+G+CI P C+CLKGF PKS ++ GC+R S +N S D F
Sbjct: 294 PFGLCIRSNPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQANNGDIF 353
Query: 288 IKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDM 347
+K PD ++S +N ++C++ CL N SC A++ + GC +W EL+D+
Sbjct: 354 DIVANVKPPDFYE-YLSL-INEEDCQQRCLGNCSCTAFSYIE----QIGCLVWNRELVDV 407
Query: 348 RDFPGGGQDFYIRMSASEIGAKGEPTTKIVVIVISTAALLAVVLIAGYLIRKRRRNIAEK 407
F GG+ IR+++SE+ G KI+V I + ++ +++ A Y + + +
Sbjct: 408 MQFVAGGETLSIRLASSELA--GSNRVKIIVASIVSISVFMILVFASYWYWRYKAKQNDS 465
Query: 408 TENSRETDQEN-EDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQE 466
ET Q+ +Q ++ F++ TI T+NFS+ NKLG+GGFGPVYKG L DG+E
Sbjct: 466 NPIPLETSQDAWREQLKPQDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQDGKE 525
Query: 467 IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF 526
IA+KRLS S QGL+E NE+IL SKLQHRNLV+LLGCCI+GEEKLLIYEFM NKSL++F
Sbjct: 526 IAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTF 585
Query: 527 IFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586
IFD T++ LDW +RF II G A GLLYLH+DS LR++HRD+K SN+LLD++MNPKISDF
Sbjct: 586 IFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDF 645
Query: 587 GLVRTFGGDETEGNTNRVVGT 607
GL R F G + + NT RVVGT
Sbjct: 646 GLARMFQGTQHQANTRRVVGT 666
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 607 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-41 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 4e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-36 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-35 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-27 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 6e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-22 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 4e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-18 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 5e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-12 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.001 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.001 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.001 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.002 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.003 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.004 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 62/160 (38%), Positives = 83/160 (51%), Gaps = 11/160 (6%)
Query: 443 SINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 496
++ KLGEG FG VYKG L E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKLLG C + E ++ E+M L S++ + R L S ARG+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
IHRDL A N L+ +++ KISDFGL R D+
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 156
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 4e-41
Identities = 47/111 (42%), Positives = 71/111 (63%), Gaps = 2/111 (1%)
Query: 154 YRTGPWNGLRFS-APSLRPNPIFSFSFVSNDVELYYTFNITNKAVISRIVMNQTLYVRRR 212
+R+GPWNG+RFS P ++ + ++F N+ E+YYT+ +TN ++ SR+ ++ + R
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLER- 59
Query: 213 FIWNKATQSWELYSDVPRDQCDTYGLCGAYGICIIGQSPVCQCLKGFKPKS 263
F W +Q W L+ P+DQCD YG CG YG C + SP C C+KGF PK+
Sbjct: 60 FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 7e-41
Identities = 62/154 (40%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 443 SINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 496
++ KLGEG FG VYKGTL E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKLLG C + E +++ E+MP L ++ R L S ARG+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
IHRDL A N L+ +++ KISDFGL R
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 57/156 (36%), Positives = 78/156 (50%), Gaps = 14/156 (8%)
Query: 446 NKLGEGGFGPVYKGTLVDGQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 500
KLGEG FG VYKG L E+AVK L + SE+ K+ E + KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFI------FDQTRRTLLDWSQRFHIICGTARGLLY 554
LLG C + E L+ E+M L ++ F ++ L A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
L + +HRDL A N L+ +D+ KISDFGL R
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 6e-38
Identities = 59/162 (36%), Positives = 82/162 (50%), Gaps = 11/162 (6%)
Query: 442 FSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQH 495
+ KLGEG FG VYKGTL ++AVK L + SE+ +E E + KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V+LLG C QGE ++ E+MP L F+ + L + A+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
+HRDL A N L+ +++ KISDFGL R D+
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY 157
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 58/163 (35%), Positives = 80/163 (49%), Gaps = 10/163 (6%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
LGEGGFG VY G+++A+K + K L E L E+ + KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
L+ E+ SL + + + L + I+ GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 566 RDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGT 607
RDLK N+LLD D K++DFGL + D++ T +VGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGT 156
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 57/112 (50%), Positives = 70/112 (62%), Gaps = 6/112 (5%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
VVWVANRLNP+ DS L++ GNLVL + VVWS+ + + V L D GNLV
Sbjct: 4 VVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSS-NTSGKGSGCVAVLQDDGNLV 62
Query: 77 LRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128
L D +S WQSFD+P+DTLLPG K G ++ G RR+TSWKS DPS
Sbjct: 63 LYD----NSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 8e-35
Identities = 53/169 (31%), Positives = 80/169 (47%), Gaps = 11/169 (6%)
Query: 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
+ + KLG G FG VYK G+ +AVK L K + + + E+ + +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+L+ + L+ E+ L ++ +R L + I RGL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH-- 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
IIHRDLK N+LLD++ KI+DFGL + + + VGT
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGT 161
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 11/168 (6%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 499
+ I KLGEG FG VY G+ +A+K + K + +E + E+ + KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L ++ L+ E+ L + + R + D ++ + L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE-DEAR--FYLRQILSALEYLHS-- 115
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
I+HRDLK N+LLD+D + K++DFGL R E VGT
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGT 159
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 61/181 (33%), Positives = 88/181 (48%), Gaps = 29/181 (16%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
++ LG G FG VY D G+ +AVK LS SE+ L+ L+ E+ + S LQH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 498 LVKLLGCCIQGEEK-LLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRF-----HIICGTAR 550
+V+ G E+ L I+ E++ SL S + ++F +I R
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL------------KKFGKLPEPVIRKYTR 108
Query: 551 ----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
GL YLH I+HRD+K +N+L+D D K++DFG + G ET T V G
Sbjct: 109 QILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 607 T 607
T
Sbjct: 166 T 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 59/167 (35%), Positives = 89/167 (53%), Gaps = 9/167 (5%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
F I K+G+GGFG VYK G+E+A+K + S++ +++ NE+ + K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
G ++ +E ++ EF SL + T +T L SQ ++ +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQT-LTESQIAYVCKELLKGLEYLHS--- 116
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
IIHRD+KA+N+LL D K+ DFGL N +VGT
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGT 160
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 58/180 (32%), Positives = 90/180 (50%), Gaps = 31/180 (17%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRN 497
N+ + + +G G FG VYKG L G +A+K++S KI E+ LK + E+ L L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 498 LVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFH------IICGTA- 549
+VK +G I+ + L I E+ N SL I ++F +
Sbjct: 61 IVKYIG-SIETSDSLYIILEYAENGSLRQII------------KKFGPFPESLVAVYVYQ 107
Query: 550 --RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+GL YLH+ +IHRD+KA+N+L +D K++DFG+ + + VVGT
Sbjct: 108 VLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 56/190 (29%), Positives = 99/190 (52%), Gaps = 19/190 (10%)
Query: 424 DLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE 482
+L+ L ++ + + + + K+GEG G VYK T G+E+A+K++ ++ +Q +
Sbjct: 3 ELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKEL 61
Query: 483 LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF 542
+ NE+++ +H N+V + G+E ++ E+M SL I Q + +
Sbjct: 62 IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNE----P 116
Query: 543 HI--ICG-TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599
I +C +GL YLH +IHRD+K+ N+LL +D + K++DFG F T+
Sbjct: 117 QIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKE 169
Query: 600 NTNR--VVGT 607
+ R VVGT
Sbjct: 170 KSKRNSVVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 6e-24
Identities = 35/65 (53%), Positives = 46/65 (70%), Gaps = 1/65 (1%)
Query: 283 RQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFG 342
DGF++ +KLPD T++ V +S+ LKEC + CL N SC AY +DIR GGSGC +W G
Sbjct: 3 GGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIR-GGSGCLIWTG 61
Query: 343 ELIDM 347
EL+DM
Sbjct: 62 ELVDM 66
|
Length = 66 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 54/157 (34%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 446 NKLGEGGFGPVYKGT---LVDGQ--EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLV 499
+LGEG FG V L D ++AVK L+ EQ + + E+ + L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 500 KLLGCC--IQGEEKLLIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGTARGLL 553
K G C G LI E++P+ SL ++ + LL +S + IC +G+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ---IC---KGMD 123
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
YL R IHRDL A N+L++ + KISDFGL +
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 10/167 (5%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
F I KLGEG +G VYK GQ +A+K + E+ L+E+ E+ + + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
G + + ++ E+ S+ S I T +TL + I+ T +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTL-TEEEIAAILYQTLKGLEYLHS--- 117
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ IHRD+KA N+LL+++ K++DFG+ T N V+GT
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-23
Identities = 48/149 (32%), Positives = 77/149 (51%), Gaps = 4/149 (2%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
F++ KLG G FG V++G + +A+K L ++ + EV +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
C GE +I E M SL +F+ + L + + C A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVR 590
IHRDL A N+L+ +D+ K++DFGL R
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLAR 152
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 6e-23
Identities = 54/169 (31%), Positives = 78/169 (46%), Gaps = 13/169 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-Q 494
D+F +GEG F V +E A+K L K I E+ +K +K E + ++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H ++KL Q EE L + E+ PN L +I + LD L
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
YLH IIHRDLK N+LLD+DM+ KI+DFG + + + +
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 49/173 (28%), Positives = 85/173 (49%), Gaps = 19/173 (10%)
Query: 442 FSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ 494
+ ++GEG +G VYK G+ +A+K++ +E ++E+K L KL+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLR 56
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+V+L + +++E+M + L + + SQ + GL
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL--DSPEVKFTESQIKCYMKQLLEGL 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
YLH + I+HRD+K SN+L++ D K++DFGL R + + TNRV+
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (245), Expect = 1e-22
Identities = 59/158 (37%), Positives = 86/158 (54%), Gaps = 15/158 (9%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKE--LKNEVILFSKLQHR 496
+ KLGEG +G VYK G+ +A+K RL E+G+ L+ E+ L +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALR-EISLLKELKHP 58
Query: 497 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+VKLL I E KL L++E+ + L ++ R L + I+ RGL Y
Sbjct: 59 NIVKLL-DVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
H RI+HRDLK N+L+++D K++DFGL R FG
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 53/161 (32%), Positives = 85/161 (52%), Gaps = 20/161 (12%)
Query: 448 LGEGGFGPVYKGT-LVDGQ----EIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG + +G+ +A+K L + S + KE+ +E + + + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR----TLLDWSQRFHIICGTARGLLYLHQ 557
LG C+ + LI + MP L ++ + LL+W + A+G+ YL +
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
R++HRDL A NVL+ + KI+DFGL + DE E
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 58/163 (35%), Positives = 83/163 (50%), Gaps = 23/163 (14%)
Query: 448 LGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 500
LGEG FG VYKG L +A+K L + +E ++ E + E L S LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIF-------------DQTRRTLLDWSQRFHIICG 547
LLG C + + +++E++ + L F+ D+T ++ LD S HI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G+ YL S +HRDL A N L+ + + KISDFGL R
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-22
Identities = 34/86 (39%), Positives = 49/86 (56%), Gaps = 8/86 (9%)
Query: 278 PLNYSR---QDGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGG 334
PLN DGF+K ++KLPD ++ +++L+ECRE CL N SC AY ++ G
Sbjct: 2 PLNCGGDGSTDGFLKLPDVKLPD--NASAITAISLEECREACLSNCSCTAYAYNN---GS 56
Query: 335 SGCAMWFGELIDMRDFPGGGQDFYIR 360
GC +W G L ++R GG Y+R
Sbjct: 57 GGCLLWNGLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 6e-22
Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 497
+ I ++G+G FG VY DG+ +K LS +SE+ ++ NEV + KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR-------TLLDWSQRFHIICGTAR 550
++K + + ++ E+ L I Q + +LDW F +C
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW---FVQLC---L 114
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
L YLH SR +I+HRD+K N+ L + K+ DFG+ + T VVGT
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 57/168 (33%), Positives = 79/168 (47%), Gaps = 20/168 (11%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVK 500
LG+G FG V LV G+ A+K L K I + ++ E + S++ H +VK
Sbjct: 1 LGKGSFGKVL---LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 501 LLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
L Q EEKL L+ E+ P L S + + RF L YLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARF-YAAEIVLALEYLH--- 110
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
L II+RDLK N+LLD D + K++DFGL + + + NT GT
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 48/161 (29%), Positives = 75/161 (46%), Gaps = 21/161 (13%)
Query: 448 LGEGGFGPVYKGT---LVDGQE---IAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 500
LGEG FG V+ G L + +AVK L + + ++ + E L + QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSF---------IFDQTRRTL--LDWSQRFHIICGTA 549
G C +G+ ++++E+M + L+ F + L SQ I A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
G++YL + +HRDL N L+ D+ KI DFG+ R
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 21/176 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
+ LG+G G VYK G+ A+K++ E+ K+L E+ L S +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESP 59
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA-----RG 551
+VK G + E ++ E+M SL + + + + + +G
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEP---VLAYIARQILKG 111
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
L YLH IIHRD+K SN+L++ KI+DFG+ + + T N VGT
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGT 163
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 17/156 (10%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSK------ISEQGLKELKNEVILFSKLQHRNLV 499
K+GEG +G VYK + G+ +A+K++ I + L+E+K L +L H N++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNII 61
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KLL + L++EFM + L I + R+ L S + +GL + H
Sbjct: 62 KLLDVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSH- 117
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
I+HRDLK N+L++ + K++DFGL R+FG
Sbjct: 118 --GILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 51/155 (32%), Positives = 73/155 (47%), Gaps = 5/155 (3%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+ KLG G FG V+ GT ++AVK L K + E + KL+H LV+L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
C + E ++ E+M SL F+ + L Q + A G+ YL
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE---SR 122
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
IHRDL A N+L+ +++ KI+DFGL R DE
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 50/168 (29%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 494
+I +G G FG V +G L +EI A+K L + S++ + E + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+++L G + ++I E+M N SLD F+ + Q ++ G A G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKY 121
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
L S + +HRDL A N+L++ ++ K+SDFGL R E T
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 7e-21
Identities = 52/146 (35%), Positives = 79/146 (54%), Gaps = 8/146 (5%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
K+G+G FG VYKG L E+AVK R + + K L+ IL + H N+VKL+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL-KQYDHPNIVKLIGV 60
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
C+Q + ++ E +P SL +F+ + ++ L + + A G+ YL + I
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVR 590
HRDL A N L+ ++ KISDFG+ R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 94.0 bits (232), Expect = 1e-20
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 10/172 (5%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH-R 496
++ I KLGEG FG VY D + +A+K L+K + ++ E+ + + L H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKL L+ E++ SL+ + R+ L S+ I+ L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 557 QDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLVRTFGGDETEGNTNRVVGT 607
IIHRD+K N+LLD+D K+ DFGL + + + + T
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 49/144 (34%), Positives = 78/144 (54%), Gaps = 8/144 (5%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507
+G+G FG V G GQ++AVK L K + E + + L+H NLV+LLG +Q
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 508 GEEKLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
G ++ E+M SL ++ ++R R ++ +Q+ G+ YL + +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL--RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 567 DLKASNVLLDQDMNPKISDFGLVR 590
DL A NVL+ +D+ K+SDFGL +
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 52/158 (32%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 446 NKLGEGGFGPVYKGTLV--DGQEI--AVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 500
+LG G FG V KG + G+E+ AVK L + K E E + ++L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
L+G C +GE +L+ E P L ++ + + D + H + A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV---AMGMAYLESK-- 114
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+HRDL A NVLL KISDFG+ R G
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 7e-20
Identities = 61/162 (37%), Positives = 75/162 (46%), Gaps = 24/162 (14%)
Query: 448 LGEGGFGPVYKGTLVD-------GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRN 497
LG G FG VY+GT D +AVK L K E+ KE E L S H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT----LLDWSQRFHIICGTARGLL 553
+VKLLG C+ E + +I E M L S++ D LL + I A+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 554 YLHQDSRLRIIHRDLKASNVLL-----DQDMNPKISDFGLVR 590
YL Q + IHRDL A N L+ D D KI DFGL R
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 57/153 (37%), Positives = 82/153 (53%), Gaps = 13/153 (8%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 503
K+GEG +G VYKG GQ +A+K++ SE +G+ E+ L +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 504 CCIQGEEKLLIYEFMP---NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
+Q LI+EF+ K LDS Q L S + I+ +G+L+ H
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCH---S 119
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
R++HRDLK N+L+D K++DFGL R FG
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-19
Identities = 52/172 (30%), Positives = 79/172 (45%), Gaps = 23/172 (13%)
Query: 442 FSINNKLGEGGFGPVYKGTLV--DG--QEIAVK--RLSKISEQGLKELKNEVILFSKLQH 495
+ LGEG FG V +G L DG ++AVK +L + ++E +E H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 496 RNLVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIF-----DQTRRTLLDWSQRFHI 544
N++KL+G C + ++I FM + L SF+ + L +F +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGD 595
A G+ YL S IHRDL A N +L +DM ++DFGL + + GD
Sbjct: 121 --DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 15/173 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 497
+F I NK+G+G FG V+K D + A+K+ LSK++ + +E +E + +KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD---WSQRFHIICGTARGLLY 554
+++ + + ++ E+ N L + Q R L + W RF I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW--RFFI--QILLGLAH 116
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
LH +I+HRD+K+ N+ LD N KI D G+ + + NT +VGT
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 21/162 (12%)
Query: 447 KLGEGGFGPVYKG---TLVDGQE---IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
+LGEG FG V+ L+ Q+ +AVK L + SE ++ + E L + LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSF---------IFDQTRRTL---LDWSQRFHIICGT 548
G C +G L+++E+M + L+ F I L Q I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G++YL + L +HRDL N L+ Q + KI DFG+ R
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 55/165 (33%), Positives = 89/165 (53%), Gaps = 20/165 (12%)
Query: 448 LGEGGFGPVYKGTLVDGQE-----IAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG V E +A+K L++ + + E +E ++ + + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQT----RRTLLDWSQRFHIICGTARGLLYLHQ 557
LG C+ +L + + MP+ L ++ + + LL+W + A+G++YL +
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
R++HRDL A NVL+ + KI+DFGL R GDE E N +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 56/159 (35%), Positives = 82/159 (51%), Gaps = 36/159 (22%)
Query: 448 LGEGGFGPVYKG-TLVDGQEIAVKRLS-----KISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VY+G L DG AVK +S + ++ +K+L+ E+ L SKLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 502 LGCCIQGEEKLLIY-EFMPNKSL-----------DSFIFDQTRRTLLDWSQRFHIICGTA 549
LG + E+ L I+ E +P SL + I TR+ LL
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------------- 113
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
GL YLH +HRD+K +N+L+D + K++DFG+
Sbjct: 114 -GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGM 148
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 19/166 (11%)
Query: 441 NFSINNKLGEGGFGPVYKG---TLVDGQE---IAVKRLSKISEQGLKELKNEVILFSKLQ 494
N + +LGEG FG V+ L Q+ +AVK L S+ K+ E L + LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI----------FDQTRRTLLDWSQRFHI 544
H ++VK G C++G+ ++++E+M + L+ F+ + R L SQ HI
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G++YL + +HRDL N L+ +++ KI DFG+ R
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 5e-18
Identities = 39/80 (48%), Positives = 45/80 (56%), Gaps = 6/80 (7%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
VVWVANR NP + S L + GNLV+ S VVWS+ + V VL LLD GNLV
Sbjct: 43 VVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS-NTTRVNGNYVLVLLDDGNLV 100
Query: 77 LRDEHDGDSETYFWQSFDYP 96
L D + WQSFDYP
Sbjct: 101 LYD----SDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
++ ++G G FG V+ G ++ +++A+K R +SE+ E E + KL H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQVMMKLSHPK 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
LV+L G C + L++EFM + L ++ + +R + G+ YL
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ +IHRDL A N L+ ++ K+SDFG+ R
Sbjct: 119 SN---VIHRDLAARNCLVGENQVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 50/155 (32%), Positives = 71/155 (45%), Gaps = 5/155 (3%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
KLG G FG V++G + +AVK L K K+ E + KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
E ++ E M SL ++ R L Q + A G+ YL + IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 567 DLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
DL A NVL+ ++ K++DFGL R D E
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 23/164 (14%)
Query: 447 KLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 499
+LGE FG VYKG L Q +A+K L +E L+E K+E ++ S+LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------------DQTRRTLLDWSQRFHIIC 546
LLG + + +I+ + + L F+ D+T ++ L+ + HI+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G+ +L S ++H+DL NVL+ +N KISD GL R
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 52/154 (33%), Positives = 79/154 (51%), Gaps = 12/154 (7%)
Query: 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHRNLV 499
KLGEG + VYK G+ +A+K++ + K+ N E+ L +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
LL L++EFM L+ I D + +L + + T RGL YLH
Sbjct: 66 GLLDVFGHKSNINLVFEFMET-DLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYLH--- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
I+HRDLK +N+L+ D K++DFGL R+FG
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 53/156 (33%), Positives = 85/156 (54%), Gaps = 8/156 (5%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELK-NEVILFSKLQHRNL 498
NF KLGEG + VYKG G+ +A+K + +E+G E+ L +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 499 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
V+L I E KL L++E+M +K L ++ R LD + +G+ + H+
Sbjct: 61 VRLHDV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
+ R++HRDLK N+L+++ K++DFGL R FG
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 59/156 (37%), Positives = 75/156 (48%), Gaps = 25/156 (16%)
Query: 448 LGEGGFG--------PVYKGTLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNL 498
LGEG FG P GT G+ +AVK L + Q K E+ + L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 499 VKLLGCCIQGEEK--LLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTARGLLY 554
VK GCC + K LI E++P SL ++ LL ++Q+ IC G+ Y
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ---IC---EGMAY 122
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
LH IHRDL A NVLLD D KI DFGL +
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 54/185 (29%), Positives = 89/185 (48%), Gaps = 25/185 (13%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-Q 494
+ T F + +GEG +G VYK GQ +A+K + I ++ +E+K E + K
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 495 HRNLVKLLGCCIQ-----GEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------ 542
H N+ G I+ +++L L+ E S+ + + L +R
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIA 116
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+I+ T RGL YLH++ ++IHRD+K N+LL ++ K+ DFG+ D T G N
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRN 171
Query: 603 RVVGT 607
+GT
Sbjct: 172 TFIGT 176
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 43/150 (28%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNL 498
+++ + ++G G +G VYK + E+ ++ K+ + ++ E+ + + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 499 VKLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
V G +KL I E+ SL I+ TR L + Q ++ T +GL YLH+
Sbjct: 63 VAYFGS-YLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSE-LQIAYVCRETLKGLAYLHE 119
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
IHRD+K +N+LL +D + K++DFG
Sbjct: 120 ---TGKIHRDIKGANILLTEDGDVKLADFG 146
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-17
Identities = 37/79 (46%), Positives = 44/79 (55%), Gaps = 6/79 (7%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
VVWVANR NP++DS L + GNLVL VVWS+ + VL LLD GNLV
Sbjct: 42 VVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWSS-NTTGANGNYVLVLLDDGNLV 99
Query: 77 LRDEHDGDSETYFWQSFDY 95
+ D + WQSFDY
Sbjct: 100 IYD----SDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 30/182 (16%)
Query: 448 LGEGGFGPVYKGT---LVDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVK 500
+G+G FG V++ L+ + +AVK L + S + + E L ++ H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF----------------HI 544
LLG C G+ L++E+M L+ F+ ++ R S
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 545 IC---GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGDETEGN 600
+C A G+ YL S + +HRDL N L+ ++M KI+DFGL R + D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 601 TN 602
N
Sbjct: 190 EN 191
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 48/157 (30%), Positives = 66/157 (42%), Gaps = 20/157 (12%)
Query: 447 KLGEGGFGPVYKGTLVDGQ----EIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKL 501
KLG+G FG V +G +AVK L + + E + L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR-----TLLDWSQRFHIICGTARGLLYLH 556
G + + + E P SL + TL D++ + A G+ YL
Sbjct: 62 YGVVLTHPLMM-VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI------ANGMRYLE 114
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
R IHRDL A N+LL D KI DFGL+R
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALP 148
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 6/154 (3%)
Query: 443 SINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
++ +KLG G +G VY+G +AVK L K ++E E + +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
LG C + +I EFM +L ++ + R ++ ++ + + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
IHRDL A N L+ ++ K++DFGL R GD
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 21/174 (12%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS------KISEQGLKELKNEVILFSKL 493
+ I ++GEG G V+K G+ +A+K+++ I Q L+E+K
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQAC 56
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQR--FHIICGTARG 551
QH +VKLL G +L+ E+MP+ L + D+ R L + + ++ +G
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDE-ERPLPEAQVKSYMRMLL---KG 111
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+ Y+H I+HRDLK +N+L+ D KI+DFGL R F +E +++V
Sbjct: 112 VAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 52/149 (34%), Positives = 84/149 (56%), Gaps = 11/149 (7%)
Query: 448 LGEGGFGPVYKGTLVD--GQEI--AVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLL 502
+G+G FG VY GTL+D GQ+I AVK L++I++ + +++ E I+ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 503 GCCIQGE-EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
G C+ E L++ +M + L +FI +T + F + A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLASK--- 117
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ +HRDL A N +LD+ K++DFGL R
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 54/157 (34%), Positives = 84/157 (53%), Gaps = 10/157 (6%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
NF K+GEG +G VYK + G+ +A+K RL +E E+ L +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+VKLL I E KL L++EF+ ++ L F+ D + + + + +GL + H
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
R++HRDLK N+L++ + K++DFGL R FG
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 55/173 (31%), Positives = 85/173 (49%), Gaps = 9/173 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-IAVKR--LSKISEQGLKELKNEVILFSKLQHR 496
D++ + +G G VY + E +A+KR L K + EL+ EV S+ H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHP 59
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VK + G+E L+ ++ SL + R LD + ++ +GL YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTNRVVGT 607
+ + IHRD+KA N+LL +D + KI+DFG+ + GGD T VGT
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 51/144 (35%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCCI 506
LG+G FG V+KGTL D +AVK + Q LK + +E + + H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
Q + ++ E +P SF+ + ++ L Q A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 567 DLKASNVLLDQDMNPKISDFGLVR 590
DL A N L+ ++ KISDFG+ R
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 16/154 (10%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 503
K+GEG +G VYK + G+ +A+K RL E E+ L +L H N+V+LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 504 CCIQGEEKLLIYEFMP---NKSLDSFIFDQTRRTLLDWSQRF-HIICGTARGLLYLHQDS 559
+ L++EF+ K +DS L+ + + + + +G+ Y H
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KSYLYQLL---QGIAYCHSH- 118
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
R++HRDLK N+L+D++ K++DFGL R FG
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 24/172 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 492
D ++ LGEG FG V K V +AVK L +E+ L +L +E+ +
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLLDWSQ 540
+ +H+N++ LLG C Q ++ E+ + +L F+ D R +Q
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 541 RFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ + ARG+ +L + IHRDL A NVL+ +D KI+DFGL R
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 51/150 (34%), Positives = 80/150 (53%), Gaps = 20/150 (13%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKR-----LSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+G FG VY VD G+E+AVK+ S +++ + L+ E+ L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 502 LGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQR---FHIICGTARGLLYLHQ 557
GC ++ +E L I+ E+MP S+ + + L + R I+ G+ YLH
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQIL----EGVEYLHS 122
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
+ I+HRD+K +N+L D N K+ DFG
Sbjct: 123 N---MIVHRDIKGANILRDSAGNVKLGDFG 149
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 54/153 (35%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 437 NATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
N D + I +LG+G FG VYK G A K + SE+ L++ E+ + S+ +H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 496 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
N+V L E KL I EF +LDS I + R L Q ++ L +
Sbjct: 62 PNIVGLYEAYFY-ENKLWILIEFCDGGALDS-IMLELERGL-TEPQIRYVCRQMLEALNF 118
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
LH ++IHRDLKA N+LL D + K++DFG
Sbjct: 119 LHSH---KVIHRDLKAGNILLTLDGDVKLADFG 148
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 54/156 (34%), Positives = 80/156 (51%), Gaps = 24/156 (15%)
Query: 448 LGEGGFGPVYK---GTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L D G+ +AVK+L + + L++ + E+ + LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 503 GCCIQ-GEEKL-LIYEFMPNKSLDSFI------FDQTRRTLLDWSQRFHIICGTARGLLY 554
G C G L L+ E++P SL ++ D R+ LL SQ IC +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD-HRKLLLYASQ----IC---KGMEY 123
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
L R +HRDL N+L++ + KI DFGL +
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 18/178 (10%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL-------SKISEQGLKELKNEVILF 490
NF I K+G+G F VYK L+DG+ +A+K++ +K + LKE+ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRTLLDWSQRFHIICGTA 549
+L H N++K L I+ E ++ E L I + ++ L+ +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
L ++H RI+HRD+K +NV + K+ D GL R F T ++ +VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 27/186 (14%)
Query: 438 ATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQ------GLKELKNEVILF 490
++ I KLGEG FG VYK + G+ +A+K++ +E+ L+E+K +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 491 SKLQHRNLVKLLGCCI-----QGEEKLLIYEFMPNKSLD-SFIFDQTRRTLLDWSQRFHI 544
KL+H N+V L+ + ++ +Y P D S + + L I
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKL----TESQI 117
Query: 545 ICGTAR---GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
C + G+ YLH++ I+HRD+KA+N+L+D KI+DFGL R + G
Sbjct: 118 KCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 602 NRVVGT 607
GT
Sbjct: 175 GGGGGT 180
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 49/162 (30%), Positives = 75/162 (46%), Gaps = 16/162 (9%)
Query: 448 LGEGGFGPVY----KGTLVDGQE--IAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVK 500
LG G FG V+ KG +G E + VK L K ++ E + E+ +F KL H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFI------FDQTRRTLLDWSQRFHIICGTARGLLY 554
LLG C + E +I E+ L F+ ++ + L Q+ + A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
L S R +HRDL A N L+ K+S L + E
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE 171
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 53/151 (35%), Positives = 81/151 (53%), Gaps = 12/151 (7%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLVK 500
++ +GEG FG V +G GQ++AVK + ++ Q E E + +KL H+NLV+
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVR 63
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDS 559
LLG I ++ E M +L +F+ +TR R L+ Q A G+ YL
Sbjct: 64 LLGV-ILHNGLYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+++HRDL A N+L+ +D K+SDFGL R
Sbjct: 120 --KLVHRDLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 17/167 (10%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLV----DGQE--IAVKRLSKI-SEQGLKELKNEVILF 490
D+ ++ LG G FG VY+G D E +AVK L + SEQ + E ++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD----QTRRTLLDWSQRFHIIC 546
SK H+N+V+L+G + + ++ E M L SF+ + R + L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLVR 590
A+G YL ++ IHRD+ A N LL KI+DFG+ R
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 52/161 (32%), Positives = 86/161 (53%), Gaps = 20/161 (12%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI----AVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG + +G+++ A+K L + S + KE+ +E + + + + ++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT----LLDWSQRFHIICGTARGLLYLHQ 557
LG C+ +L I + MP L ++ + LL+W + A+G+ YL +
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
R++HRDL A NVL+ + KI+DFGL + G DE E
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 53/164 (32%), Positives = 79/164 (48%), Gaps = 23/164 (14%)
Query: 447 KLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVK 500
+LGE FG +YKG L Q +A+K L I+ Q E + E L ++L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIF--------------DQTRRTLLDWSQRFHIIC 546
LLG Q + +++E++ L F+ D T ++ LD HI
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G+ YL S +H+DL A N+L+ + ++ KISD GL R
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 51/160 (31%), Positives = 89/160 (55%), Gaps = 18/160 (11%)
Query: 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQG--LKELKNEVILFSKLQ---HRNL 498
++GEG +G VYK L G+ +A+K++ +SE+G L L+ E+ L +L+ H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63
Query: 499 VKLLGCC--IQGEEKL---LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
V+LL C + + +L L++E + ++ L +++ + + L ++ RG+
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
+LH RI+HRDLK N+L+ D KI+DFGL R +
Sbjct: 122 FLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 51/155 (32%), Positives = 78/155 (50%), Gaps = 19/155 (12%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRL---SKISEQG-------LKELKNEVILFSKLQHR 496
+G+G +G VY V G+ +AVK++ + I+ + +K L++E+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 497 NLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V+ LG EE L I+ E++P S+ S + R + GL YL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYL 124
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
H I+HRDLKA N+L+D D KISDFG+ +
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 46/155 (29%), Positives = 77/155 (49%), Gaps = 17/155 (10%)
Query: 448 LGEGGFGPVYKGTLVDGQ-EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
LG+G +G VY + Q IA+K + + + ++ L E+ L S L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 507 QGEEKLLIYEFMPNKSLDSFI------FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
+ + E +P SL + + +T++ ++++ GL YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI------LEGLKYLHD--- 126
Query: 561 LRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGG 594
+I+HRD+K NVL++ KISDFG + G
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 28/171 (16%)
Query: 448 LGEGGFGPVYKG-TLVDGQEIAVKR--LSKISEQG-------LKELKNEVILFSKLQHRN 497
+G G FG VY G G+ +AVK+ L +S L L E+ L +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTARG 551
+V+ LG + + + E++P S+ LL+ F + + +G
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSV---------AALLNNYGAFEETLVRNFVRQILKG 118
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
L YLH IIHRD+K +N+L+D KISDFG+ + + TN
Sbjct: 119 LNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 52/181 (28%), Positives = 98/181 (54%), Gaps = 12/181 (6%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELK-NE 486
L + ++ + ++ K+G+G G VY V GQE+A+K+++ + +Q KEL NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ + +H N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T +VG
Sbjct: 123 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 607 T 607
T
Sbjct: 178 T 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 53/181 (29%), Positives = 100/181 (55%), Gaps = 12/181 (6%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKEL-KNE 486
L + +I + ++ K+G+G G V+ V GQE+A+K+++ + +Q KEL NE
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-LQKQPKKELIINE 66
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ +L++ N+V L + G+E ++ E++ SL D T +D +Q +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCR 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ NVLL D + K++DFG ++++ +T +VG
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 607 T 607
T
Sbjct: 178 T 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
LG G FG V+ G ++A+K + + +SE E E + KL H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKVMMKLSHPNLVQLYGVC 68
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ ++ E+M N L +++ + R+ L + + YL + IH
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 566 RDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
RDL A N L+ +D K+SDFGL R D+
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 51/161 (31%), Positives = 88/161 (54%), Gaps = 12/161 (7%)
Query: 444 INNKLGEGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQHRNL 498
I +G G FG V +G L + G+ +A+K L S +E+ ++ +E + + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ L G + ++I EFM N +LDSF+ + + T++ Q ++ G A G+ YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI---QLVGMLRGIAAGMKYL-- 122
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
S + +HRDL A N+L++ ++ K+SDFGL R D ++
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 22/166 (13%)
Query: 444 INNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+ +LGEG FG V+ D +AVK L + K+ + E L + LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSF-----------IFDQTRRT--LLDWSQRFHI 544
+VK G C G+ ++++E+M + L+ F + Q R+ L SQ HI
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G++YL + +HRDL N L+ ++ KI DFG+ R
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 51/162 (31%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + KLG G FG V+ G ++A+K L K + E L +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI-----FDQTRRTLLDWSQRFHIICGTARGLLY 554
+L Q E +I E+M N SL F+ T L+D + + A G+ +
Sbjct: 65 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ------IAEGMAF 117
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ R IHRDL+A+N+L+ + + KI+DFGL R +E
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 53/158 (33%), Positives = 78/158 (49%), Gaps = 7/158 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG G FG V+ G + ++AVK L K ++ E L LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+L + E +I E+M SL F+ D+ + LL F A G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS--AQIAEGMAYIE-- 120
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
R IHRDL+A+NVL+ + + KI+DFGL R +E
Sbjct: 121 -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 9/148 (6%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 499
F++ +G+G FG VYK Q +A+K + + +E +++++ E+ S+ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G ++G + +I E+ S D + LD + I+ GL YLH++
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFG 587
IHRD+KA+N+LL ++ + K++DFG
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFG 143
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 54/161 (33%), Positives = 85/161 (52%), Gaps = 20/161 (12%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI----AVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG VYKG + DG+ + A+K L + S + KE+ +E + + + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRT----LLDWSQRFHIICGTARGLLYLHQ 557
LG C+ +L + + MP L ++ + R LL+W + A+G+ YL +
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+R++HRDL A NVL+ + KI+DFGL R DETE
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 32/161 (19%)
Query: 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLS------KISEQGLKELKNEVILFSKLQHRNLV 499
LG+G +G VY G GQ IAVK++ +E+ ++L+ EV L L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI----------FDQTRRTLLDWSQRFHIICGTA 549
+ LG C+ + EF+P S+ S + F + + +LD
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD------------ 113
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
G+ YLH + ++HRD+K +NV+L + K+ DFG R
Sbjct: 114 -GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 48/149 (32%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
DNF K+GEG G V T G+++AVK++ +Q + L NEV++ QH N+
Sbjct: 22 DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V++ + G+E ++ EF+ +L I TR ++ Q + + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTR---MNEEQIATVCLAVLKALSFLHAQ 134
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFG 587
+IHRD+K+ ++LL D K+SDFG
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 47/155 (30%), Positives = 86/155 (55%), Gaps = 14/155 (9%)
Query: 448 LGEGGFGPVYKGTL-VDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLL 502
+G G FG V++G L + G++ +A+K L +E+ ++ +E + + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWS--QRFHIICGTARGLLYLHQDSR 560
G + + ++I E+M N +LD ++ D ++S Q ++ G A G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
+ +HRDL A N+L++ ++ K+SDFGL R D
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 16/151 (10%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-AVKR----LSKISE-QGLKELKNEVILFSKLQ-HRNLV 499
+LG+G FG VY + E+ A+K+ E L+E+K+ KL H N+V
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS----LRKLNEHPNIV 61
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KL + +E ++E+M +L + D+ + S II +GL ++H
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGK-PFSESVIRSIIYQILQGLAHIH--- 116
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ HRDLK N+L+ KI+DFGL R
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 50/154 (32%), Positives = 80/154 (51%), Gaps = 8/154 (5%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
+ + + I +LG+G FG VYK + G A K + SE+ L++ E+ + + H
Sbjct: 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH 68
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA-RGLLY 554
+VKLLG + ++ EF P ++D+ + + R + +IC L Y
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQY 125
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
LH ++IIHRDLKA NVLL D + K++DFG+
Sbjct: 126 LHS---MKIIHRDLKAGNVLLTLDGDIKLADFGV 156
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 54/178 (30%), Positives = 80/178 (44%), Gaps = 31/178 (17%)
Query: 441 NFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISEQG-LKELKNEVILFSKL 493
N + LGEG FG V K T +AVK L + + L++L +E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI------------FDQTRRTLLDWSQR 541
H +++KL G C Q LLI E+ SL SF+ D R + +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 542 FHIIC---------GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ +RG+ YL + ++++HRDL A NVL+ + KISDFGL R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 57/173 (32%), Positives = 78/173 (45%), Gaps = 15/173 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGT---LVDGQ---EIAVKRLSKISEQGLKE-LKNEVILFSK 492
+N S LG G FG V + T L ++AVK L + +E L +E+ + S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
L H N+V LLG C G L+I E+ L +F+ + R + L A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE---TEGNT 601
+ +L + IHRDL A NVLL KI DFGL R D +GN
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA 203
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 59/170 (34%), Positives = 86/170 (50%), Gaps = 35/170 (20%)
Query: 441 NFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQG---LKELKNEVILFSKLQHR 496
F N++GEG +G VY+ G+ +A+K++ +E+ + L+ E+ L L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF------DQTRRTLLD-------WSQRFH 543
N+V+L E + K LDS IF +Q +LLD SQ
Sbjct: 67 NIVELK-------------EVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQVKC 112
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
++ RGL YLH++ IIHRDLK SN+LL KI+DFGL RT+G
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 46/176 (26%), Positives = 79/176 (44%), Gaps = 37/176 (21%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQHRN 497
+ + +G G +G V G+++A+K++S + L + K E+ L L+H N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHEN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSF-----IFD----------QTRRTLLDWSQRF 542
++ LL + + S + F + + ++ + L D ++
Sbjct: 61 IIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY 107
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+ RGL YLH +IHRDLK SN+L++ + + KI DFGL R DE E
Sbjct: 108 -FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 48/175 (27%), Positives = 81/175 (46%), Gaps = 29/175 (16%)
Query: 447 KLGEGGFGPVY-------------KGTLVDGQE--IAVKRL-SKISEQGLKELKNEVILF 490
KLGEG FG V+ DGQ +AVK L + +++ + E+ +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLL---------DWSQR 541
S+L++ N+++LLG C+ + +I E+M N L+ F+ + + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGD 595
++ A G+ YL + L +HRDL N L+ KI+DFG+ R + GD
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 47/169 (27%), Positives = 86/169 (50%), Gaps = 25/169 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKG---TLVDGQ---EIAVKRLSK---ISEQGLKELKNEVILF 490
+ ++ +LG+G FG VY+G +V G+ +A+K +++ + E+ E NE +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWS--------QRF 542
+ ++V+LLG G+ L++ E M L S++ ++RR + + Q+F
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQKF 121
Query: 543 HIICG-TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ A G+ YL + +HRDL A N ++ +D+ KI DFG+ R
Sbjct: 122 IQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
KLG+G FG V+ GT +A+K L K + E + KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
E ++ E+M SL F+ + L Q + A G+ Y+ R+ +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 567 DLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
DL+A+N+L+ +++ K++DFGL R +E
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 29/155 (18%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLL 502
NK+G G FG VY L G+ +AVK R+ + +KE+ +E+ + L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSF-----IFDQ--TRR---TLLDWSQRFHIICGTARGL 552
G + E+ + E+ +L+ I D+ R LL GL
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL-------------EGL 112
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
YLH I+HRD+K +N+ LD + K+ DFG
Sbjct: 113 AYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFG 144
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 16/173 (9%)
Query: 446 NKLGEGGFGPVYKGTLV----DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLV 499
+G+G FG V K V DG+ + K + ++E+ ++L +EV + +L+H N+V
Sbjct: 6 ETIGKGSFGTVRK---VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 500 KLLGCCIQGEEKLL-IY-EFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLH 556
+ I + L I E+ L I + R ++ + I+ L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 557 --QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
D ++HRDLK +N+ LD + N K+ DFGL + G D + T VGT
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 50/169 (29%), Positives = 87/169 (51%), Gaps = 12/169 (7%)
Query: 441 NFSINNKLGEGGFGPVYKGTL-VDGQE---IAVKRL-SKISEQGLKELKNEVILFSKLQH 495
I +G G FG V G L + G+ +A+K L + +E+ ++ +E + + H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGLLY 554
N++ L G + + +++ E+M N SLD+F+ + T++ Q ++ G A G+ Y
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI---QLVGMLRGIASGMKY 121
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
L S + +HRDL A N+L++ ++ K+SDFGL R D T R
Sbjct: 122 L---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 22/170 (12%)
Query: 443 SINNKLGEGGFGPVYKGTLVDGQEI---AVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
++ LGEG FG V +G L I AVK +++ + +++ +E + + H N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 498 LVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIF-----DQTRRTLLDWSQRFHIIC 546
+++L+G C+Q E ++I FM + L SF+ D L +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP--QYLPTQMLVKFMT 119
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGD 595
A G+ YL S IHRDL A N +L+++MN ++DFGL + + GD
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 1e-13
Identities = 50/181 (27%), Positives = 98/181 (54%), Gaps = 12/181 (6%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELK-NE 486
L + ++ + ++ K+G+G G VY + GQE+A+K+++ + +Q KEL NE
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ + ++ N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ +T +VG
Sbjct: 123 ECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 607 T 607
T
Sbjct: 178 T 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 6/159 (3%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
++ + KLG G FG V+ GT ++AVK L K + E + KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
LV+L + E ++ E+M SL F+ D R L + A G+ Y+
Sbjct: 63 LVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE- 119
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
R+ IHRDL+++N+L+ + KI+DFGL R +E
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 53/185 (28%), Positives = 87/185 (47%), Gaps = 15/185 (8%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF 490
+L+ + + F + +G G +G VYKG V ++A ++ ++E +E+K E+ +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 491 SKL-QHRNLVKLLGCCI------QGEEKLLIYEFMPNKSLDSFIFDQTRRTLL-DWSQRF 542
K HRN+ G I ++ L+ EF S+ + + L DW
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA-- 124
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+I RGL +LH ++IHRD+K NVLL ++ K+ DFG+ D T G N
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRN 179
Query: 603 RVVGT 607
+GT
Sbjct: 180 TFIGT 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 15/168 (8%)
Query: 435 IANATDNFSINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSK-ISEQGLKELKNEVI 488
IA + D ++++ L EG FG ++ G L+D +E+ VK + SE + L E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 489 LFSKLQHRNLVKLLGCCIQGEEK-LLIYEFMPNKSLDSF-----IFDQTRRTLLDWSQRF 542
L L H+N++ +L CI+ E ++Y +M +L F + + L Q
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
H+ A G+ YLH + +IH+D+ A N ++D+++ KI+D L R
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 55/162 (33%), Positives = 86/162 (53%), Gaps = 17/162 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 496
D + K+GEG +G VYK V + IA+K RL + E E+ L ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 497 NLVKLLGCCIQGEEKL-LIYEFMP---NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N+V+L + E++L L++E++ K +DS D + L + + I+ RG+
Sbjct: 62 NIVRLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSP-DFAKNPRLIKTYLYQIL----RGI 115
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFG 593
Y H R++HRDLK N+L+D+ N K++DFGL R FG
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154
|
Length = 294 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 8/154 (5%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAV-KRLSKISEQGLKELKNEVILFSKLQH 495
N + + I +LG+G FG VYK + +A K + SE+ L++ E+ + + H
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG-TARGLLY 554
N+VKLL ++ EF ++D+ + + R + ++C T L Y
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNY 118
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
LH++ +IIHRDLKA N+L D + K++DFG+
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGV 149
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 53/174 (30%), Positives = 84/174 (48%), Gaps = 15/174 (8%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVK 500
F + +G G +G VYKG V ++A ++ ++ +E+K E+ + K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 501 LLGCCIQ------GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC-GTARGLL 553
G I+ ++ L+ EF S+ I + TL + + IC RGL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE--EWIAYICREILRGLS 125
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+LHQ ++IHRD+K NVLL ++ K+ DFG+ D T G N +GT
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGT 174
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 15/172 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHR 496
+F + +G+G FG V D +++ A+K ++K + + ++ + NE + +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 497 NLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
LV L Q EE + L+ + + L + + + +F IC L YL
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKF-WICEIVLALEYL 116
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
H IIHRD+K N+LLD+ + I+DF + D T GT
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGT 162
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 52/163 (31%), Positives = 81/163 (49%), Gaps = 17/163 (10%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELK-NEVI-------LFSKL 493
+ + +LG+G FG VY + D + +A +RL + E + EL NE + L SKL
Sbjct: 2 YILQQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL 59
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTARG 551
H +VK ++ + +I E+ + LD + T +TL + +Q G
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSE-NQVCEWFIQLLLG 118
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
+ Y+HQ RI+HRDLKA N+ L ++ KI DFG+ R G
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 53/161 (32%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 448 LGEGGFGPVYKGTL-VDG--QEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLL 502
+GEG FG V K + DG + A+KR+ + S+ ++ E+ + KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRT--LLDWSQRFHIICGTA 549
G C L E+ P+ +L F+ F T L Q H A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
RG+ YL Q + IHRDL A N+L+ ++ KI+DFGL R
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 5e-13
Identities = 48/181 (26%), Positives = 97/181 (53%), Gaps = 12/181 (6%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELK-NE 486
L + ++ + ++ K+G+G G VY + GQE+A+++++ + +Q KEL NE
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINE 67
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+++ + ++ N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 123
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ L +LH + ++IHRD+K+ N+LL D + K++DFG ++++ + +VG
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVG 178
Query: 607 T 607
T
Sbjct: 179 T 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 54/159 (33%), Positives = 81/159 (50%), Gaps = 17/159 (10%)
Query: 448 LGEGGFGPVY------KGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVK 500
LGEG FG V +G G+++AVK L S + +LK E+ + L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 501 LLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI-ICGTARGLLYLHQ 557
G C + LI EF+P+ SL ++ + L ++ + IC +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQIC---KGMDYL-- 125
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
SR + +HRDL A NVL++ + KI DFGL + D+
Sbjct: 126 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 11/171 (6%)
Query: 441 NFSINNKLGEGGFGPVYK-GTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRN 497
+F + KLG+G +G VYK L D Q A+K L +S++ ++ NE+ + + + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLYLH 556
++ + G + ++ E+ P L I + +R L+ + + I RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ +I+HRDLK++N+LL + KI D G+ + + +GT
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 46/151 (30%), Positives = 83/151 (54%), Gaps = 11/151 (7%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-AVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 503
K+GEG +G V+K + EI A+KR+ + +G+ E+ L +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
+ ++KL L++E+ ++ L + FD + D + +GL + H
Sbjct: 67 V-LHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
++HRDLK N+L++++ K++DFGL R FG
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 7e-13
Identities = 45/148 (30%), Positives = 66/148 (44%), Gaps = 14/148 (9%)
Query: 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRL-----SKISEQGLKELKNEVILFSKLQHRNLV 499
+LG G G V K G+ +AVK + I +Q L+EL IL K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD---ILH-KCNSPYIV 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
G + + E+M SLD + + R + I +GL YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLH--E 118
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFG 587
+ +IIHRD+K SN+L++ K+ DFG
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFG 146
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 51/156 (32%), Positives = 79/156 (50%), Gaps = 18/156 (11%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+LG G FG V+ G ++A+K +++ +SE+ E E + KL H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLVQLYGV 67
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQ----TRRTLLDWSQRFHIICGTARGLLYLHQDSR 560
C Q + ++ EFM N L +++ + ++ LL Q +C G+ YL ++S
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD---VC---EGMEYLERNS- 120
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
IHRDL A N L+ K+SDFG+ R DE
Sbjct: 121 --FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 8e-13
Identities = 49/152 (32%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+LG G FG V G ++A+K + + +SE E E + KL H LV+L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGV 67
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
C + ++ E+M N L +++ + +R SQ + G+ YL + I
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFI 122
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
HRDL A N L+D K+SDFGL R DE
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 18/176 (10%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 496
NF I K+G G F VY+ T L+D + +A+K++ + + ++ E+ L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLD---WSQRFHIICGTARG 551
N++K L I+ E ++ E L I F + +R + + W + F +C
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW-KYFVQLCSAVE- 120
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
H SR R++HRD+K +NV + K+ D GL R F T ++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 9e-13
Identities = 55/172 (31%), Positives = 86/172 (50%), Gaps = 27/172 (15%)
Query: 442 FSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI-----SEQGLKELKNEVILFSKL 493
+ I KLG+G +G V+K +D + +A+K KI + + E++ +L
Sbjct: 9 YEILQKLGKGAYGIVWKA--IDRRTKEVVALK---KIFDAFRNATDAQRTFREIMFLQEL 63
Query: 494 -QHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
H N+VKLL I+ E IY E+M L + I R +L+ + +I+
Sbjct: 64 GDHPNIVKLLNV-IKAENDKDIYLVFEYM-ETDLHAVI----RANILEDVHKRYIMYQLL 117
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG-GDETEGN 600
+ L Y+H S +IHRDLK SN+LL+ D K++DFGL R+ +E N
Sbjct: 118 KALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 27/160 (16%)
Query: 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN----EVILFSKLQHRNLVKL 501
+GEG +G V K + GQ +A+K+ + + K +K E+ + +L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFI-------FDQTRRTLLDWSQRFHIICGTARGLLY 554
+ + + L++EF+ + LD + R+ L F I+ RG+ +
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL------FQIL----RGIEF 115
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
H + IIHRD+K N+L+ Q K+ DFG RT
Sbjct: 116 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 44/187 (23%)
Query: 447 KLGEGGFGPVYKGTLVDGQE-----------------IAVKRL-SKISEQGLKELKNEVI 488
KLGEG FG V+ +V+ Q+ +AVK L ++ + EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD----------- 537
+ S+L+ N+++LLG C+ + +I E+M N L+ F+ + L D
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128
Query: 538 --------WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589
+S H+ A G+ YL S L +HRDL N L+ +++ KI+DFG+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 590 RT-FGGD 595
R + GD
Sbjct: 186 RNLYAGD 192
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 53/176 (30%), Positives = 83/176 (47%), Gaps = 31/176 (17%)
Query: 442 FSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
F++ LG+G FG V + L Q++AVK L S ++E E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 496 RNLVKLLGCCIQGEEK------LLIYEFMPNKSLDSFI---------FDQTRRTLLDWSQ 540
N++KL+G ++ K ++I FM + L +F+ F +TL+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV---- 116
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-FGGD 595
RF I A G+ YL S IHRDL A N +L+++M ++DFGL + + GD
Sbjct: 117 RFMI--DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 57/174 (32%), Positives = 83/174 (47%), Gaps = 26/174 (14%)
Query: 440 DNFSINNKLGEGGFGPVYK----GTLVDGQE----IAVKRLS-KISEQGLKELKNEVILF 490
D + LGEG FG V + G + +AVK L +++ L +L +E+ L
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTR--RTLL 536
+ +H+N++ LLG C Q +I E+ +L F+ FD T+ L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ ARG+ YL +SR R IHRDL A NVL+ +D KI+DFGL R
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-12
Identities = 29/81 (35%), Positives = 39/81 (48%), Gaps = 6/81 (7%)
Query: 282 SRQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLE-NSSCMAYTNSDIRGGGSGCAMW 340
D F++ KLP S V +L+EC CL N SC ++T ++ G GC +W
Sbjct: 1 KSDDCFVRLPNTKLPG-FSRIVISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLW 56
Query: 341 -FGELIDMRDFPGGGQDFYIR 360
L D R FP GG D Y +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 49/148 (33%), Positives = 77/148 (52%), Gaps = 16/148 (10%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKLL 502
++G G FG VY V E+ A+K++S K S + +++ EV +L+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--IC-GTARGLLYLHQDS 559
GC ++ L+ E+ + D I + ++ L Q I IC G +GL YLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--ILEVHKKPL----QEVEIAAICHGALQGLAYLHSHE 135
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFG 587
R IHRD+KA N+LL + K++DFG
Sbjct: 136 R---IHRDIKAGNILLTEPGTVKLADFG 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 45/143 (31%), Positives = 72/143 (50%), Gaps = 8/143 (5%)
Query: 447 KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
K+GEG G V T G+++AVK++ +Q + L NEV++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ G+E ++ EF+ +L D T ++ Q + R L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 566 RDLKASNVLLDQDMNPKISDFGL 588
RD+K+ ++LL D K+SDFG
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGF 164
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 45/145 (31%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507
+G+G FG V G G ++AVK + ++ + E + ++L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 508 GEEKLLIY-EFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ L I E+M SL ++ ++R R++L + YL ++ +H
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 566 RDLKASNVLLDQDMNPKISDFGLVR 590
RDL A NVL+ +D K+SDFGL +
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 52/176 (29%), Positives = 81/176 (46%), Gaps = 34/176 (19%)
Query: 451 GGFGPVY----KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 503
G +G V+ K T G A+K + K I + + ++ E + S+ Q +VKL
Sbjct: 4 GAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFI-----FDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
QG++ L L+ E++P L S + D+ D ++ I L YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVAR--IYIAEIVLALEYLHS 111
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLV------RTFGGDETEGNTNRVVGT 607
IIHRDLK N+L+D + + K++DFGL R ++ E R+VGT
Sbjct: 112 ---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 16/162 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG G FG V+ T ++AVK + K ++ E + LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI-FDQTRRT----LLDWSQRFHIICGTARGLLY 554
KL + E +I EFM SL F+ D+ + L+D+S + A G+ +
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAF 117
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ Q + IHRDL+A+N+L+ + KI+DFGL R +E
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 448 LGEGGFGPVY------KGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+G G FG V+ LV ++I V++++K + NE + L H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
++ + +++ E+ P +L +I + +LLD H L ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL-- 121
Query: 562 RIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
I+HRDLK N+LLD+ M KI DFG+ + ++ VVGT
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 11/150 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
DNF K+GEG G V T+ G+ +AVK++ +Q + L NEV++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V++ + G+E ++ EF+ +L D T ++ Q + + L LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+IHRD+K+ ++LL D K+SDFG
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 48/151 (31%), Positives = 77/151 (50%), Gaps = 10/151 (6%)
Query: 447 KLGEGGFGPV-YKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
K+GEG G V G+++AVK + +Q + L NEV++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA-RGLLYLHQDSRLRII 564
+ GEE ++ EF+ +L I QTR ++ +C + + L YLH +I
Sbjct: 88 LVGEELWVLMEFLQGGALTD-IVSQTRLN----EEQIATVCESVLQALCYLHSQG---VI 139
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
HRD+K+ ++LL D K+SDFG D
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 23/165 (13%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ-----GLKELKNEVILF 490
+ + + +GEG +G V T G ++A+K++S Q L+E+K +
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 491 SKLQHRNLVKLLGCCIQG-----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+ +H N++ +L + ++ E M D + +T+ D Q F +
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMET---DLYKLIKTQHLSNDHIQYF--L 112
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
RGL Y+H + ++HRDLK SN+LL+ + + KI DFGL R
Sbjct: 113 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 47/193 (24%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
D F I ++GEG +G VYK D G+ +A+K++ +E+ ++E+K + +
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK----ILRQ 62
Query: 493 LQHRNLVKLLGCCIQGEEKL----------LIYEFMPN-------KSLDSFIFDQTR--- 532
L HRN+V L ++ L L++E+M + L F D +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
+ LL+ GL Y H+ + L HRD+K SN+LL+ K++DFGL R +
Sbjct: 123 KQLLE-------------GLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 593 GGDETEGNTNRVV 605
+E+ TN+V+
Sbjct: 167 NSEESRPYTNKVI 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 48/155 (30%), Positives = 71/155 (45%), Gaps = 18/155 (11%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKE---LKNEVILFSKLQHRN 497
F I ++G+GG+G V+ D EI A+KR+ K L E + E + + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI---ICGTARGLL 553
LVKLL Q +E L L E++P + + L + RF++
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDA--- 116
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
LH L IHRDLK N L+D + K++DFGL
Sbjct: 117 -LH---ELGYIHRDLKPENFLIDASGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 48/157 (30%), Positives = 70/157 (44%), Gaps = 25/157 (15%)
Query: 446 NKLGEGGFGPVYKG---TLVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLV 499
+++G G FG V G + + VK L + EQ L EV + +L H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL--FLQEVQPYRELNHPNVL 58
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFI--------FDQTRRTLLDWSQRFHIICGTARG 551
+ LG CI+ LL+ EF P L +++ + L + C A G
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASG 112
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
LL+LHQ IH DL N L D++ KI D+GL
Sbjct: 113 LLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ ++ KLG+G FG V+ GT ++A+K L K + E + KL+H LV
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
L + E ++ EFM SL F+ + + L Q + A G+ Y+
Sbjct: 65 PLYAV-VSEEPIYIVTEFMGKGSLLDFLKEGDGKYL-KLPQLVDMAAQIADGMAYIE--- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
R+ IHRDL+A+N+L+ ++ KI+DFGL R +E
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 11/156 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQ----EIAVKRLSKISEQGLKEL-KNEVILFSKLQ 494
++ ++ +GEG FG VY+G + + +AVK + ++E E + +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + ++ E P L S++ Q + LD + + L Y
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAY 122
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
L R +HRD+ A NVL+ K+ DFGL R
Sbjct: 123 LES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 448 LGEGGFGP--VYK----GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+G FG +Y+ +LV +E+ + RLS E+ ++ NE+++ S LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAY 64
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+ L+ E+ +L I + + L + + + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
I+HRD+K N+ L + K+ DFG+ + G + + T VVGT
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 62/189 (32%), Positives = 91/189 (48%), Gaps = 24/189 (12%)
Query: 432 LATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-IL 489
L ++ + TD + I +G+G +G VYK T DG AVK L IS+ +E++ E IL
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 490 FSKLQHRNLVKLLGCCIQ-----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF-- 542
S H N+VK G + G + L+ E S+ + + LL QR
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDE 127
Query: 543 ----HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+I+ G GL +LH + RIIHRD+K +N+LL + K+ DFG+
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184
Query: 599 GNTNRVVGT 607
NT+ VGT
Sbjct: 185 RNTS--VGT 191
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 24/169 (14%)
Query: 432 LATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELK 484
T+ T+ + +G G FG V + GQ +A+K++ K ++++ +ELK
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 485 NEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF- 542
L L+H N++ L I E + + E + D +R + Q F
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQYFL 114
Query: 543 -HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
I+ RGL Y+H ++HRDLK SN+L++++ + KI DFGL R
Sbjct: 115 YQIL----RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 46/179 (25%)
Query: 442 FSINNKLGEGGFGPVYKG---TLVDGQEIAVKRL--SKISEQGLKELK-NEVILFSKLQH 495
+ I +G G +G VYK DG+E A+K+ K G+ + E+ L +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD--------------QTRRTLLD---- 537
N+V L+ ++ +K + +FD Q +R +
Sbjct: 62 ENVVSLVEVFLEHADKSV-----------YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTF 592
S + I+ G+ YLH + ++HRDLK +N+L+ + KI D GL R F
Sbjct: 111 KSLLWQILN----GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 9e-12
Identities = 44/153 (28%), Positives = 81/153 (52%), Gaps = 7/153 (4%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQH 495
N ++F + ++G G +G VYK V+ E+A ++ K+ + ++ E+I+ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V G ++ ++ + EF SL I+ T L SQ ++ T +GL YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYL 122
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
H + +HRD+K +N+LL + + K++DFG+
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGV 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 54/186 (29%), Positives = 91/186 (48%), Gaps = 44/186 (23%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKLQHRNL 498
K+G+G FG V+K Q +A+K++ +E+ L+E+K IL L+H N+
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK---IL-QLLKHENV 73
Query: 499 VKLLGCC---IQGEEK-----LLIYEF--------MPNKSLDSFIFDQTRRTLLDWSQRF 542
V L+ C + L++EF + NK++ F + ++ +
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK-FTLSEIKKVMK------ 126
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-- 600
++ GL Y+H R +I+HRD+KA+N+L+ +D K++DFGL R F +
Sbjct: 127 MLL----NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 601 -TNRVV 605
TNRVV
Sbjct: 180 YTNRVV 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 28/162 (17%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 494
N+ + LG G FG VY D G+E+AVK++ S+ + + + L+ E+ L L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 495 HRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQ-------TRRTLLDWSQRFHII 545
H +V+ GC EEK L E+MP S I DQ T ++++
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQI--- 115
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
+G+ YLH + I+HRD+K +N+L D N K+ DFG
Sbjct: 116 ---LQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 52/148 (35%), Positives = 80/148 (54%), Gaps = 10/148 (6%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 504
KLGEG + VYKG + ++GQ +A+K +S +E+G+ E L L+H N+V LL
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHD 70
Query: 505 CIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
I +E L ++E+M + L ++ Q L ++ R + RGL Y+H I
Sbjct: 71 IIHTKETLTFVFEYM-HTDLAQYMI-QHPGGLHPYNVRLFMF-QLLRGLAYIH---GQHI 124
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRT 591
+HRDLK N+L+ K++DFGL R
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 11/178 (6%)
Query: 413 ETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL 472
++ E++D + D +P + A A+ +++ L G G V+ T GQ V +
Sbjct: 39 DSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPV--V 95
Query: 473 SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR 532
KI ++G + E +L + H +++++ + G ++ +P+ S D + + R
Sbjct: 96 LKIGQKGTTLI--EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKR 150
Query: 533 RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
L Q I GL YLH RIIHRD+K N+ ++ I D G +
Sbjct: 151 SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 50/149 (33%), Positives = 71/149 (47%), Gaps = 16/149 (10%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A K+L K +G + NE + K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDS 559
+ ++ L L+ M L I++ + F+ IICG L +LHQ
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ-- 113
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGL 588
RI++RDLK NVLLD N +ISD GL
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGL 141
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 20/151 (13%)
Query: 448 LGEGGFGPVYK------GTLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQHRNLV 499
LG G F Y+ GTL+ +++ R + SEQ ++ L+ E+ L ++L H +++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS-SEQEEVVEALRKEIRLMARLNHPHII 66
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
++LG + L E+M S+ + + RGL YLH++
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL---RGLSYLHEN- 122
Query: 560 RLRIIHRDLKASNVLLD---QDMNPKISDFG 587
+IIHRD+K +N+L+D Q + +I+DFG
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRL--RIADFG 149
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 46/147 (31%), Positives = 75/147 (51%), Gaps = 12/147 (8%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI----AVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G FG V+KG + +G I A+K + + Q +E+ + ++ L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
LG C G L+ + P SL + + R LD + + A+G+ YL +
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGL 588
R++HR+L A N+LL D +I+DFG+
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGV 155
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 51/176 (28%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 496
NF I K+G G F VY+ T L+DG +A+K++ + + + E+ L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLD---WSQRFHIICGTARG 551
N++K I+ E ++ E L I F + +R + + W + F +C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW-KYFVQLCSALE- 120
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
H SR R++HRD+K +NV + K+ D GL R F T ++ +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 44/146 (30%), Positives = 75/146 (51%), Gaps = 10/146 (6%)
Query: 446 NKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKL 501
+++G G FG VY T E+ AVK++S K + + +++ EV +L+H N ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
GC ++ L+ E+ + D + + L + I G +GL YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFG 587
+IHRD+KA N+LL + K++DFG
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFG 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 28/165 (16%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 494
N+ + LG+G FG VY D G+E+AVK++ S + + + L+ E+ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 495 HRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQ-------TRRTLLDWSQRFHII 545
H +V+ GC E+ L E MP S I DQ T ++++
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQI--- 115
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
G+ YLH + I+HRD+K +N+L D N K+ DFG +
Sbjct: 116 ---LEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 44/150 (29%), Positives = 76/150 (50%), Gaps = 10/150 (6%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 497
F+ ++G G FG VY V E+ A+K++S K S + +++ EV +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ GC ++ L+ E+ + D + + L + I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
+ +IHRD+KA N+LL + K++DFG
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFG 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 49/148 (33%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 447 KLGEGGFGPVYKGTLVDG---QEIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKLL 502
++G G FG V G + G ++ VK L S Q + E + LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLL--DWSQRFHIICGTARGLLYLHQDSR 560
G C + LL+ EF P L ++ + L+ D + + C A GLL+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGL 588
IH DL N LL D+ KI D+GL
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 441 NFSINNKLGEGGFGPVY--KGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHR 496
+ I K+GEG FG +Y K D + +K L+K+ + + K EVIL +K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 497 NLVKLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+V Q +L I E+ L I Q R L Q + GL ++
Sbjct: 60 NIVTFFA-SFQENGRLFIVMEYCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHI 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDETE 598
H +I+HRD+K+ N+ L ++ M K+ DFG+ R D E
Sbjct: 118 HDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSME 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 46/168 (27%), Positives = 87/168 (51%), Gaps = 11/168 (6%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLV 499
F+ ++G+G FG VYKG +E+ ++ + +E +++++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+ G ++G + +I E++ S D + L+ + I+ +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
R IHRD+KA+NVLL + + K++DFG+ +T+ N VGT
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 10/150 (6%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS---KISEQGLKELKNEVILFSKLQHRN 497
FS ++G G FG VY V E+ A+K++S K S + +++ EV KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ GC ++ L+ E+ + D + + L + + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
+ +IHRD+KA N+LL + K+ DFG
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFG 160
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 10/155 (6%)
Query: 447 KLGEGGFGPVYKGT--LVDGQ-EIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLL 502
+LG G FG V KG + Q ++A+K L +E+ ++ E+ E + +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
G C + E +L+ E L+ F+ ++ + S ++ + G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
+HRDL A NVLL KISDFGL + G D++
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 48/168 (28%), Positives = 88/168 (52%), Gaps = 11/168 (6%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 499
F+ ++G+G FG V+KG Q++ A+K + + +E +++++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G ++G + +I E++ S D R D Q ++ +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ IHRD+KA+NVLL + + K++DFG+ +T+ N VGT
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 438 ATDNFSINNKLGEGGFGPVY----KGTLVDGQE--IAVKRLSKISEQGLK-ELKNEVILF 490
A + +++ +LG+G FG VY KG + D E +A+K +++ + + E NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------DQTRRTLLDWSQRFH 543
+ ++V+LLG QG+ L+I E M L S++ + + +
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ A G+ YL+ + + +HRDL A N ++ +D KI DFG+ R
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 26/176 (14%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLV--DGQE------IAVKRL-SKISEQGLKELKNEVI 488
D + LGEG FG V + D ++ +AVK L S +E+ L +L +E+
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 489 LFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLL 536
+ + +H+N++ LLG C Q +I E+ +L ++ ++ T+
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 537 DWSQRFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
S + + C ARG+ YL + + IHRDL A NVL+ +D KI+DFGL R
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 43/153 (28%), Positives = 79/153 (51%), Gaps = 26/153 (16%)
Query: 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQG-LKELKNEVILFSKLQH---RNLVKLL 502
+G G +G VY+G V G+ +A+K ++ + + +++ EV L S+L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD---WSQRFHIICGTARGLL----YL 555
G ++G +I E+ S+ RTL+ ++++ I R +L Y+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV---------RTLMKAGPIAEKY--ISVIIREVLVALKYI 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
H+ +IHRD+KA+N+L+ N K+ DFG+
Sbjct: 118 HKVG---VIHRDIKAANILVTNTGNVKLCDFGV 147
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 4e-11
Identities = 47/168 (27%), Positives = 85/168 (50%), Gaps = 11/168 (6%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLV 499
F+ K+G+G FG V+KG Q++ ++ + +E +++++ E+ + S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G ++ + +I E++ S D LD +Q I+ +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ IHRD+KA+NVLL + K++DFG+ +T+ N VGT
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 49/176 (27%), Positives = 70/176 (39%), Gaps = 41/176 (23%)
Query: 447 KLGEGGFGPVYKGTLVDGQEI-----------------AVKRLSK-ISEQGLKELKNEVI 488
KLGEG FG V+ Q+ AVK L S+ ++ EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-----IFDQT---------RRT 534
+ S+L N+ +LLG C +I E+M N L+ F T
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
LL ++ A G+ YL L +HRDL N L+ ++ KI+DFG+ R
Sbjct: 132 LL------YMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 44/146 (30%), Positives = 69/146 (47%), Gaps = 7/146 (4%)
Query: 447 KLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 504
++G G FG V+ G L D +AVK + LK + E + + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
C Q + ++ E + +F+ +T L + ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVR 590
HRDL A N L+ + KISDFG+ R
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 4e-11
Identities = 51/159 (32%), Positives = 77/159 (48%), Gaps = 36/159 (22%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRL-----SKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+G FG VY VD G+E+A K++ S + + + L+ E+ L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 502 LGCCI-QGEEKLLIY-EFMPNKSL-----------DSFIFDQTRRTLLDWSQRFHIICGT 548
GC + E+ L I+ E+MP S+ +S TR+ L
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL------------- 116
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
G+ YLH + I+HRD+K +N+L D N K+ DFG
Sbjct: 117 -EGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 30/183 (16%)
Query: 440 DNFSINNKLGEGGFGPVY------------KGTLVDGQE-----IAVKRL-SKISEQGLK 481
+ KLGEG FG V+ K +D +AVK L ++
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 482 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--------FDQTRR 533
+ E+ + S+L+ N+++LL CI + +I E+M N L+ F+ ++
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 534 TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT-F 592
+ +S + A G+ YL S L +HRDL N L+ ++ KI+DFG+ R +
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 593 GGD 595
GD
Sbjct: 182 SGD 184
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 26/174 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLS-KISEQGLKELKNEVILF 490
D ++ LGEG FG V + + +AVK L +E+ L +L +E+ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLLDW 538
+ +H+N++ LLG C Q +I E+ +L ++ +D R
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 539 SQRFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ + + C ARG+ YL + + IHRDL A NVL+ ++ KI+DFGL R
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 24/154 (15%)
Query: 447 KLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 504
KLGEG + VYKG + + GQ +A+K + E+G E L L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70
Query: 505 CIQGEEKL-LIYEFMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTARGLLYLH 556
I ++ L L++E++ + L ++ D R L F ++ RGL Y H
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFL-----FQLL----RGLAYCH 120
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
Q R++HRDLK N+L+ + K++DFGL R
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 30/171 (17%)
Query: 444 INNKLGEGGFGPVYKG-TLVDGQEIAVKRL-------------SKISEQG-----LKELK 484
LGEG +G V K + G+ +A+K++ + G L+ELK
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 485 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI 544
+ ++++H N++ L+ ++G+ L+ + M S + D R+ L SQ I
Sbjct: 73 ----IMNEIKHENIMGLVDVYVEGDFINLVMDIM--ASDLKKVVD--RKIRLTESQVKCI 124
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
+ GL LH+ +HRDL +N+ ++ KI+DFGL R +G
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYP 172
|
Length = 335 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 42/158 (26%), Positives = 69/158 (43%), Gaps = 18/158 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL------SKISEQGLKELKNEVILFSKL 493
+ ++LGEG G V K L + I + + +Q L+EL+ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSC 56
Query: 494 QHRNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTA 549
+ +VK G + + E+ SLDS I+ + ++ ++ I
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
+GL YLH +IIHRD+K SN+LL + K+ DFG
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 50/155 (32%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 447 KLGEGGFGPVYKG---TLVDGQEIAVKRLSKIS-EQGLK-ELKNEVILFSKLQHRNLVKL 501
+LG G FG V KG + +AVK L + + LK EL E + +L + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+G C + E +L+ E L+ F+ T + ++ H + + G+ YL + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQV---SMGMKYLEETN-- 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+HRDL A NVLL KISDFGL + G DE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 52/156 (33%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 448 LGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILF---SKLQHRN 497
LG G FG V YK T G+ A+K L K I+ ++ L E +F + +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGTARGL 552
LV L C Q E+ + + E+ L I F + R F+ C GL
Sbjct: 64 LVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPR-------AVFYAAC-VVLGL 114
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
YLH++ +I++RDLK N+LLD + KI+DFGL
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 52/174 (29%), Positives = 79/174 (45%), Gaps = 34/174 (19%)
Query: 446 NKLGEGGFGPVYK----GTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 500
N++G G G VYK T G+ A+K + E ++ ++ E+ + + H N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPT---GRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDS-------FIFDQTRRTLLDWSQRFHIICGTARGLL 553
E ++ EFM SL+ F+ D R+ L G+
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQIL--------------SGIA 182
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
YLH R I+HRD+K SN+L++ N KI+DFG+ R +T N VGT
Sbjct: 183 YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA--QTMDPCNSSVGT 231
|
Length = 353 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 58/164 (35%), Positives = 77/164 (46%), Gaps = 34/164 (20%)
Query: 440 DNFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSK 492
D+F LG G FG V +KG+ G+ A+K LSK I + E + NE +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR- 550
++H LV L G Q + L L+ E++P L F R+ S RF AR
Sbjct: 58 IRHPFLVNLYGS-FQDDSNLYLVMEYVPGGEL----FSHLRK-----SGRFPE--PVARF 105
Query: 551 -------GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
L YLH L I++RDLK N+LLD D KI+DFG
Sbjct: 106 YAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFG 146
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG--LKELKNEVILFSKLQ 494
N ++ + ++G G +G VYK + E+A ++ K+ E G ++ E+ + + +
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECK 64
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+V G + E+ + E+ SL I+ T L Q ++ T +GL Y
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGP--LSELQIAYVCRETLQGLAY 121
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
LH ++ HRD+K +N+LL + + K++DFG+
Sbjct: 122 LHSKGKM---HRDIKGANILLTDNGDVKLADFGV 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 378 VIVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDLEL---PLFELAT 434
I + A L + L+A + R RN E ENED +L+ + + T
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKR------VENEDGTWELQFFDSKVSKSIT 684
Query: 435 IANATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 493
I + + N + G G YKG ++ +G + VK ++ ++ +E+ KL
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS----SEIADMGKL 740
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
QH N+VKL+G C + LI+E++ K+L + + L W +R I G A+ L
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALR 794
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583
+LH ++ +L +++D P +
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 46/149 (30%), Positives = 69/149 (46%), Gaps = 29/149 (19%)
Query: 461 LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518
V GQ +A+K+LS+ + K E++L + H+N++ LL F
Sbjct: 38 TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FT 85
Query: 519 PNKSLDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHR 566
P KSL+ F + D Q + LD + +++ G+ +LH IIHR
Sbjct: 86 PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHR 142
Query: 567 DLKASNVLLDQDMNPKISDFGLVRTFGGD 595
DLK SN+++ D KI DFGL RT G
Sbjct: 143 DLKPSNIVVKSDCTLKILDFGLARTAGTS 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 13/157 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN----EVILFSKLQ 494
+ + + +GEG +G V K G+ +A+K+ K SE +++K EV + +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDD-EDVKKTALREVKVLRQLR 58
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+V L + L++E++ L+ + L I + + Y
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591
H IIHRD+K N+L+ + K+ DFG R
Sbjct: 116 CH---SHNIIHRDIKPENILVSESGVLKLCDFGFARA 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 49/148 (33%), Positives = 79/148 (53%), Gaps = 10/148 (6%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 503
+KLGEG + VYKG + + +A+K + E+G EV L L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
I E+ L L++E++ +K L ++ D + + F + RGL Y H R +
Sbjct: 72 I-IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRK 124
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVR 590
++HRDLK N+L+++ K++DFGL R
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEI--AVKRLSKI-SEQGLKELKNEVILFSKL-Q 494
++ + +GEG FG V + + DG ++ A+K L + SE ++ E+ + KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSL-------------DSFIFDQTRRTLLDWSQR 541
H N++ LLG C + E+ P +L +F + + L Q
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G+ YL S + IHRDL A NVL+ +++ KI+DFGL R
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 47/152 (30%), Positives = 76/152 (50%), Gaps = 20/152 (13%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHRNLVKL 501
+G G FG V K G +AVKR+ ++ KE K +V++ S +VK
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSS-DCPYIVKF 68
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSF---IFDQTRRTLLDWSQRF--HIICGTARGLLYLH 556
G + + + E M + SLD F +++ + + + I T + L YL
Sbjct: 69 YGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVI---PEEILGKIAVATVKALNYLK 124
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
++ L+IIHRD+K SN+LLD++ N K+ DFG+
Sbjct: 125 EE--LKIIHRDVKPSNILLDRNGNIKLCDFGI 154
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 44/167 (26%), Positives = 80/167 (47%), Gaps = 17/167 (10%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGT---LVDGQ---EIAVKRLSK-ISEQGLKELKNEVILF 490
+ + ++ +LG+G FG VY+G ++ G+ +AVK +++ S + E NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------DQTRRTLLDWSQRFH 543
++V+LLG +G+ L++ E M + L S++ + R +
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ A G+ YL+ + +HRDL A N ++ D KI DFG+ R
Sbjct: 124 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 48/172 (27%), Positives = 81/172 (47%), Gaps = 26/172 (15%)
Query: 442 FSINNKLGEGGFGPVYKGTLVDGQE--------IAVKRLSK-ISEQGLKELKNEVILFSK 492
++ LGEG FG V + + +AVK L +++ L +L +E+ +
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM 73
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----------FDQTRRTLLDWSQ 540
+ +H+N++ LLG C Q ++ E+ +L ++ FD + +
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 541 RFHIICG--TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ + C ARG+ YL + + IHRDL A NVL+ +D KI+DFGL R
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 49/187 (26%), Positives = 87/187 (46%), Gaps = 31/187 (16%)
Query: 441 NFSINNKLGEGGFGPVYK-------GTLVDGQEIAVKRLS-----KISEQGLKELKNEV- 487
+++ LG G FG VYK L+ +EI V + + ++ + ++ +EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-DSFIFDQTRRTLLDWSQRF---- 542
I+ +L+H N+V+ ++ + ++ + + L + F +L + QRF
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFN------SLKEKKQRFTEER 114
Query: 543 --HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
+I L YLH++ R I+HRDL +N++L +D I+DFGL + E
Sbjct: 115 IWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ---PESK 169
Query: 601 TNRVVGT 607
VVGT
Sbjct: 170 LTSVVGT 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 48/162 (29%), Positives = 70/162 (43%), Gaps = 37/162 (22%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+G G +G V G+++A+K+LS+ S K E+ L + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 505 CIQGEEKLLIYEFMPNKSLDSF----------------IFDQTRRTLLDWSQRFHIICGT 548
F P SL+ F I + L D +F ++
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQF-LVYQI 127
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
RGL Y+H IIHRDLK SN+ +++D KI DFGL R
Sbjct: 128 LRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 440 DNFSIN--NKLGEGGFGPVYKG--TLVDGQE--IAVKRL-SKISEQGLKELKNEVILFSK 492
DN SI LG G FG + +G L +E +A+ L + S++ + E + +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+V+L G +G +++ E+M N +LDSF+ + L Q ++ G A G+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGM 120
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
YL S + +H+ L A VL++ D+ KIS F
Sbjct: 121 KYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 51/154 (33%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRN 497
D++ KLGEG + VYKG + V+G+ +A+K + E+G E L L+H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+V LL I +E L L++E++ + L ++ + + F + RGL Y+H
Sbjct: 65 IV-LLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLF--LFQLLRGLSYIH 120
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
Q I+HRDLK N+L+ K++DFGL R
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 20/167 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKR-LSKISEQGLKELK-NEVILFSKLQHR 496
D + K+GEG +G VYK G+ +A+K+ ++ E+G+ E+ L L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 497 N-LVKLLGCCIQGEEKL------LIYEFMPNKSLDSFIFDQTRR---TLLDWSQRFHIIC 546
+V+LL EEK L++E++ + L F+ D R L +
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMY 117
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTF 592
+G+ + H + ++HRDLK N+L+D+ KI+D GL R F
Sbjct: 118 QLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 46/146 (31%), Positives = 72/146 (49%), Gaps = 14/146 (9%)
Query: 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LG GGFG V + + A+K + K I E G +E + +E + + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLD-WSQRFHIICGTARGLLYLHQDSRL 561
+ ++ + ++ E+ L + + D R L D ++ RF+I C YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARFYIACVV-LAFEYLH---NR 112
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFG 587
II+RDLK N+LLD + K+ DFG
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFG 138
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 48/172 (27%), Positives = 81/172 (47%), Gaps = 35/172 (20%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQG----LKELKNEVILFSKLQ 494
D + N++ EG +G VY+ EI A+K+L K+ ++ + L+ E+ + KLQ
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLR-EINILLKLQ 62
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS-FI----FDQTRRTLLD-WSQRFHI---- 544
H N+V + E + +LD ++ + ++L++ Q F
Sbjct: 63 HPNIVT-------------VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK 109
Query: 545 --ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
+ G+ +LH + I+HRDLK SN+LL+ KI DFGL R +G
Sbjct: 110 CLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 51/161 (31%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 448 LGEGGFGPVYKGTLV-DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLL 502
+GEG FG V K + DG + A+KR+ + S+ ++ E+ + KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 503 GCCIQGEEKLLIYEFMPNKSL-------------DSFIFDQTRRTLLDWSQRFHIICGTA 549
G C L E+ P+ +L +F + + L Q H A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
RG+ YL S+ + IHRDL A N+L+ ++ KI+DFGL R
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 8/147 (5%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 503
KLGEG + V+KG + + +A+K + E+G EV L L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
+ L++E++ +K L ++ D + + F + RGL Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRKV 125
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVR 590
+HRDLK N+L+++ K++DFGL R
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 25/157 (15%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVK 500
+G G +G V + +++A+K+++ + + L+E+K L L H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK----LLRHLDHENVIA 68
Query: 501 LLGCCI-----QGEEKLLIYEFMPNKSLDSFIFDQTRRTLL-DWSQRFHIICGTARGLLY 554
+ + ++YE M + L I ++ +TL D Q F + RGL Y
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELM-DTDLHQII--RSSQTLSDDHCQYF--LYQLLRGLKY 123
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591
+H + ++HRDLK SN+LL+ + + KI DFGL RT
Sbjct: 124 IHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 53/156 (33%), Positives = 71/156 (45%), Gaps = 28/156 (17%)
Query: 448 LGEGGFGPVY------KGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+GGFG V G L +++ KRL K +G + E + +K+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 502 LGCCIQGEEKL-LIYEFMPNKSLDSFIFD--------QTRRTLLDWSQRFHIICGTARGL 552
Q + L L+ M L I++ R +Q II G L
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ---IISG----L 110
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+LHQ RII+RDLK NVLLD D N +ISD GL
Sbjct: 111 EHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGL 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 13/146 (8%)
Query: 451 GGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN----EVILFSKLQHRNLVKLLGCC 505
G FG VY G A+K L K ++ N I+ + + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTL-LDWSQRFHIICGTARGLLYLHQDSRLRII 564
+ L+ E++ S I +T L DW++++ I G+ LHQ II
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---II 119
Query: 565 HRDLKASNVLLDQDMNPKISDFGLVR 590
HRD+K N+L+DQ + K++DFGL R
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSR 145
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 38/149 (25%), Positives = 60/149 (40%), Gaps = 23/149 (15%)
Query: 448 LGEGGFGPVYK----GTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+ + K TLV AVK+ L S++ LK L+ E+I +LQH N++
Sbjct: 10 FEDLMIVHLAKHKPTNTLV-----AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 502 LGCCIQGEEKLLIYEFMPNKS----LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ I E ++ M S L + + + F I+ L Y+H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI----AF-ILKDVLNALDYIHS 119
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDF 586
IHR +KAS++LL D +S
Sbjct: 120 ---KGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 38/160 (23%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQH 495
D+ +G G FG V+ + A+K ++ I + + + NE + ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 496 RNLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTAR 550
+++L + +++ L + E++P L S++ + + + F+ I+C
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCA--- 113
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
L YLH I++RDLK N+LLD++ + K++DFG +
Sbjct: 114 -LEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 6e-09
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 23/155 (14%)
Query: 447 KLGEGGFGPVYKGTLV----DGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLVK 500
K+GEG FG K LV DG++ +K + SK+S + +E + EV + S ++H N+V+
Sbjct: 7 KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ-----TRRTLLDWSQRFHIICGTARGLLYL 555
+ ++ ++ L I Q +LDW F IC L ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW---FVQIC---LALKHV 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
H +I+HRD+K+ N+ L +D K+ DFG+ R
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 448 LGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLV 499
LG+G FG V KGT + AVK L K + + ++ E + + +H L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+L C Q +++L + E++ L I Q + RF+ GL +LH+
Sbjct: 60 QLH-SCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAE-IVLGLQFLHER 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVR--TFGGDET 597
II+RDLK NVLLD + + KI+DFG+ + GG T
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 11/155 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
D+ + +LG G +G V K V G +AVKR+ + ++ Q K L ++ I +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSF---IFDQTRRTLLDWSQRFHIICGTARGLL 553
V G + + + E M + SLD F ++D+ D + I + L
Sbjct: 61 YTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALE 117
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
YLH S+L +IHRD+K SNVL++++ K+ DFG+
Sbjct: 118 YLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGI 150
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 56/166 (33%), Positives = 77/166 (46%), Gaps = 15/166 (9%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V DG AVK L K + KE + + +L L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q EKL + +++ L F Q R L+ RF+ A + YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYA-AEVASAIGYLHS---L 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
II+RDLK N+LLD + ++DFGL + G E E T+ GT
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 40/155 (25%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLG 503
K+GEG +G V+K + GQ +A+K+ + + + K E+ + +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
+ + L++E+ + L+ ++ R + + + II T + + + H+
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIK-KIIWQTLQAVNFCHK---HNC 121
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
IHRD+K N+L+ + K+ DFG R G +
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 12/149 (8%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLG- 503
+G G +G V G+++A+K+LS+ SE K E+ L +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 504 --CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+ G+E Y MP D + L + +++ GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVR 590
IIHRDLK N+ +++D KI DFGL R
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 29/143 (20%)
Query: 465 QEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522
+ +A+K+LS+ ++ K E++L + H+N++ LL F P KS
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKS 97
Query: 523 LDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L+ F + D Q + LD + +++ G+ +LH IIHRDLK
Sbjct: 98 LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 154
Query: 571 SNVLLDQDMNPKISDFGLVRTFG 593
SN+++ D KI DFGL RT G
Sbjct: 155 SNIVVKSDCTLKILDFGLARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 26/155 (16%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
+GEG FG + LV Q+ A+K RL K S +++ + E +L +K++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 502 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQ-----TRRTLLDWSQRFHIICGTARGLLYL 555
+ + L ++ E+ L I Q T+L W F +C G+ ++
Sbjct: 64 KES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---FVQMC---LGVQHI 116
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
H+ R++HRD+K+ N+ L Q+ K+ DFG R
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 44/171 (25%)
Query: 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLS-KISEQGLK-ELKNEVILFSKLQ---HRNLVK 500
++G G +G VYK G +A+K + + +E GL EV L +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 501 LLGCCIQG----EEKL-LIYEFMPNKSLDSFIFDQTRRTLL--------------DWSQR 541
L+ C E K+ L++E + DQ RT L D ++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV----------DQDLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
F RGL +LH + I+HRDLK N+L+ K++DFGL R +
Sbjct: 117 F------LRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 33/166 (19%)
Query: 447 KLGEGGFGPVYKGTLVD--GQEIAVKRLS-KISEQG--LKELKNEVIL--FSKLQHRNLV 499
++GEG +G V+K + G+ +A+KR+ + E+G L ++ +L +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 500 KLLGCCIQG----EEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA----- 549
+L C E KL L++E + DQ T LD + T
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 550 ---RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
RGL +LH R++HRDLK N+L+ K++DFGL R +
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 45/144 (31%), Positives = 67/144 (46%), Gaps = 29/144 (20%)
Query: 462 VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519
V G +AVK+LS+ ++ K E++L + H+N++ LL F P
Sbjct: 44 VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTP 91
Query: 520 NKSLDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRD 567
KSL+ F + D Q LD + +++ G+ +LH IIHRD
Sbjct: 92 QKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRD 148
Query: 568 LKASNVLLDQDMNPKISDFGLVRT 591
LK SN+++ D KI DFGL RT
Sbjct: 149 LKPSNIVVKSDCTLKILDFGLART 172
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 39/154 (25%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKN--EVILFSKLQ-HRNLVKL 501
K+GEG F V K + G+ A+K + K + L+++ N E+ +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 502 LGCCIQGEEK--LLIYEFMPNKSLDSFIFD--QTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ + L++E M D +++ + R+ L + + + L ++H+
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591
+ I HRD+K N+L+ D K++DFG R
Sbjct: 119 NG---IFHRDIKPENILIKDD-ILKLADFGSCRG 148
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 29/143 (20%)
Query: 465 QEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522
+ +A+K+LS+ ++ K E++L + H+N++ LL F P KS
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKS 90
Query: 523 LDSF--------IFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L+ F + D Q + LD + +++ G+ +LH IIHRDLK
Sbjct: 91 LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 147
Query: 571 SNVLLDQDMNPKISDFGLVRTFG 593
SN+++ D KI DFGL RT G
Sbjct: 148 SNIVVKSDCTLKILDFGLARTAG 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 54/166 (32%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V DG+ AVK L K + KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q +KL + +++ L F Q R+ + RF+ A L YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYA-AEIASALGYLHS---L 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
II+RDLK N+LLD + ++DFGL + G E T+ GT
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 30/163 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
D+F + +G G FG V+ LV GQ A+K L K +K +N++
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRK--SDMIK--RNQIAHV--RAE 51
Query: 496 RN---------LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
R+ +VKL Q EE L L+ E+MP L + + + + + RF+I
Sbjct: 52 RDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYI- 107
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
A +L L +L IHRD+K N+L+D D + K++DFGL
Sbjct: 108 ---AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGL 147
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 446 NKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLG 503
+KLGEG + V+KG + + +A+K + E+G EV L L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
I E L L++E++ + L ++ L+ + RGL Y H + +
Sbjct: 71 I-IHTERCLTLVFEYLDS-DLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVR 590
I+HRDLK N+L+++ K++DFGL R
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 42/178 (23%), Positives = 72/178 (40%), Gaps = 54/178 (30%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISE------QGLKELKNEVILF 490
+ +G G +G V +D G+++A+K++ + + L+ELK +
Sbjct: 5 SRYKPIENIGSGAYGVVCSA--IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----IL 58
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL--DSF-IFDQTRRTLLDWSQRFHIICG 547
+H N++ + P + D + + D L S HII
Sbjct: 59 RHFKHDNIIAIRDI------------LRPPGADFKDVYVVMD------LMESDLHHIIHS 100
Query: 548 TA---------------RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
RGL Y+H + +IHRDLK SN+L+++D +I DFG+ R
Sbjct: 101 DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 33/174 (18%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGL--KELKNEVILF 490
TI + + + +G G +G V G +AVK+LS+ + + K E+ L
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 491 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF--IFDQTR------------RTLL 536
++H N++ LL F P +SL+ F ++ T + L
Sbjct: 71 KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 118
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
D +F +I RGL Y+H IIHRDLK SN+ +++D KI DFGL R
Sbjct: 119 DDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 14/150 (9%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIA---VKRLSKISEQGLKELKNEVIL----FSKLQHRNLV 499
++G G FG V + +A VK L + KE +NE + + LQH N++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELK--ANASSKE-QNEFLQQGDPYRILQHPNIL 58
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIF-DQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ LG C++ LL++E+ L S++ +Q R + C A G+ ++H
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH-- 116
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+ +H DL N L D+ K+ D+G+
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 29/168 (17%)
Query: 441 NFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSKI------SEQGLKELKNEVILF 490
+ + +LG+G +G V T + + +A+K+++ + +++ L+ELK +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELK---LLR 56
Query: 491 SKLQHRNLVKLLGCCI---QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--- 544
H+N+ L I +L +YE + L I ++ + L D H
Sbjct: 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTD----AHFQSF 110
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
I GL Y+H + ++HRDLK N+L++ D KI DFGL R F
Sbjct: 111 IYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 43/169 (25%), Positives = 67/169 (39%), Gaps = 44/169 (26%)
Query: 448 LGEGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 504
LG G G V+ VD + +AVK++ Q +K E+ + +L H N+VK
Sbjct: 13 LGCGSNGLVFSA--VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK---- 66
Query: 505 CIQGEEKLLIYE--FMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTA------ 549
+YE L + T + ++ + G
Sbjct: 67 ---------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 550 -------RGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVR 590
RGL Y+H + ++HRDLK +NV ++ D+ KI DFGL R
Sbjct: 118 LFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 50/172 (29%), Positives = 78/172 (45%), Gaps = 27/172 (15%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKI------SEQGLKELKNEVILFSKLQHRNLVK 500
+G G FG V+ T DG+ +A+K++ + ++ +ELK + +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELK----MLCFFKHDNVLS 63
Query: 501 LLGCCIQG-----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTARGLL 553
L EE ++ E M L I + D + F I+ RGL
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSS-DHVKVFLYQIL----RGLK 117
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
YLH I+HRD+K N+L++ + KI DFGL R DE++ T VV
Sbjct: 118 YLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 49/149 (32%), Positives = 74/149 (49%), Gaps = 13/149 (8%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLK-ELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L G+ AVK L K + + ++ + + IL H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 503 GCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
CC Q ++L + EF+ L I Q R + RF+ T+ L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITS-ALMFLHDKG-- 116
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVR 590
II+RDLK NVLLD + + K++DFG+ +
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 51/157 (32%), Positives = 75/157 (47%), Gaps = 34/157 (21%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKE----LKNEVILFSKLQHRNLV 499
+G G FG V LV G A+K+L K SE KE ++ E + ++ + +V
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSL-------DSFIFDQTRRTLLDWSQRFHIICGTARG 551
KL Q E L LI E++P + D+F ++TR F+I A
Sbjct: 65 KLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR---------FYI----AET 110
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+L + +L IHRD+K N+LLD + K+SDFGL
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 448 LGEGGFGPV------YKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG+GGFG V G + +++ KRL K S + + L+ E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
L+ M L I++ R L + + H G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---M 114
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGL 588
I++RD+K NVLLD N ++SD GL
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGL 141
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 448 LGEGGFGPVYKGT---LVDGQ-----EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
LG+G F ++KG + D E+ +K L K + + S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
G C+ G+E +++ E++ SLD+++ + + L++ S + + A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 560 RLRIIHRDLKASNVLL-----DQDMNP---KISDFGL 588
+ H ++ A NVLL + NP K+SD G+
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 54/177 (30%), Positives = 77/177 (43%), Gaps = 47/177 (26%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF-----SKLQHRNLVKL- 501
LG+G FG V L E +K LK +V+L + R ++ L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFF----------AIKALKKDVVLEDDDVECTMVERRVLALA 52
Query: 502 --------LGCCIQGEEKLL-IYEFMPNKSL-----DSFIFDQTRRTLLDWSQRFH---I 544
L C Q +E L + E++ L S FD+ R RF+ I
Sbjct: 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR-------ARFYAAEI 105
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
ICG L +LH+ II+RDLK NVLLD+D + KI+DFG+ + E + +T
Sbjct: 106 ICG----LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 34/169 (20%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLGC 504
+G G +G V Q++AVK+LS+ + + + E+ L ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 505 CIQGEEKLLIYEFMPNKSLDSF--IFDQTR------------RTLLDWSQRFHIICGTAR 550
F P S+++F ++ T + L D +F +I R
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQLLR 129
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599
GL Y+H IIHRDLK SNV +++D +I DFGL R DE G
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG 174
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 35/171 (20%)
Query: 441 NFSINNKLGEGGFGPV----YKGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKL 493
+F + LG G FG V +KGT G+ A+K L K + + ++ + E + +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTR---RTLLDWSQRFHIICGTA 549
H +V ++ C Q E ++ + EF+ L F R R D ++ +H A
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYH-----A 125
Query: 550 RGLL---YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV-----RTF 592
+L YLH II+RDLK N+LLD + K++DFG RTF
Sbjct: 126 ELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173
|
Length = 329 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 24/184 (13%)
Query: 437 NATDNFSINNKLGEGGFGPVYK-GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ- 494
+ +D + I +G+G +G V+K +G + AVK L I + +E++ E + L
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSD 73
Query: 495 HRNLVKLLGC-----CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------H 543
H N+VK G G++ L+ E S+ + + L +R +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEEPIIAY 128
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
I+ GL +LH + + IHRD+K +N+LL + K+ DFG+ NT+
Sbjct: 129 ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 184
Query: 604 VVGT 607
VGT
Sbjct: 185 -VGT 187
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 54/151 (35%), Positives = 79/151 (52%), Gaps = 20/151 (13%)
Query: 448 LGEGGFGPVY---KGTLVD-GQEIAVKRLSKISEQGLK-----ELKNEVILFSKLQHRNL 498
LG+G FG V+ K T D GQ A+K L K + LK K E + +++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 499 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
VKL Q E KL LI +F+ L + + + T D +F++ A L +LH
Sbjct: 61 VKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFYL-AELALALDHLH- 115
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
L II+RDLK N+LLD++ + K++DFGL
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGL 144
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 49/149 (32%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V +DG+ AVK L K KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q EKL + +F+ L F Q R+ + RF+ A L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYA-AEIASALGYLHS---I 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVR 590
I++RDLK N+LLD + ++DFGL +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 9e-07
Identities = 39/124 (31%), Positives = 61/124 (49%), Gaps = 15/124 (12%)
Query: 459 GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518
GTLV + + L +E+ LK L+NEV+L +H N++ G +I FM
Sbjct: 25 GTLV---TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81
Query: 519 ----PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574
N L ++ + L+ +I+ G RGL YLHQ+ IHR++KAS++L
Sbjct: 82 AYGSANSLLKTYFPEGMSEALIG-----NILFGALRGLNYLHQNG---YIHRNIKASHIL 133
Query: 575 LDQD 578
+ D
Sbjct: 134 ISGD 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 24/51 (47%), Positives = 32/51 (62%), Gaps = 5/51 (9%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR--TFGGDET 597
A GL +LH II+RDLK NV+LD + + KI+DFG+ + FGG T
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 32/156 (20%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKLQHR--NLV 499
+G G G VYK G +AVK++ + + +E K +V+L S H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKS---HDCPYIV 77
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF-------HIICGTARGL 552
K G I + + E M S D+ LL Q + + L
Sbjct: 78 KCYGYFITDSDVFICMELM------STCLDK----LLKRIQGPIPEDILGKMTVAIVKAL 127
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
YL + +IHRD+K SN+LLD N K+ DFG+
Sbjct: 128 HYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGI 161
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 46/159 (28%), Positives = 69/159 (43%), Gaps = 31/159 (19%)
Query: 448 LGEGGFGPV-YKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGC 504
+G G +G V G ++A+K+L + SE K E+ L ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 505 CIQGEEKLLIYEFMPNKSLDSFI-------FDQTRRTLLDWSQRF------HIICGTARG 551
F P+ SLD F F T L ++ ++ +G
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
L Y+H IIHRDLK N+ +++D KI DFGL R
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 44/167 (26%), Positives = 78/167 (46%), Gaps = 15/167 (8%)
Query: 441 NFSINNKLGEGGFGPVY----KGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSK 492
NF + LG G +G V+ G G+ A+K L K + + + + E +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
++ + L Q + KL LI +++ L + ++ + T + R +I A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE--VRVYI----AEI 114
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+L L +L II+RD+K N+LLD + + ++DFGL + F +E E
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 15/167 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSKIS----EQGLKELKNEVILFSK 492
NF + LG G +G V+ V G + A+K L K + + + + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
++ + L Q + KL LI +++ L + + + R Q I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEI-- 114
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+L L +L II+RD+K N+LLD + + ++DFGL + F DE E
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 51/157 (32%), Positives = 72/157 (45%), Gaps = 29/157 (18%)
Query: 448 LGEGGFGPVY----KGTLVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLV 499
LG+G FG V+ KGT Q A+K L K + + + + +L +H L
Sbjct: 3 LGKGSFGKVFLAELKGT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 500 KLLGCCIQGEEKLL-IYEFMPNKSLDSFI-----FDQTRRTLLDWSQRFHIICGTARGLL 553
L C Q +E L + E++ L I FD R T IICG L
Sbjct: 60 HLY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY----AAEIICG----LQ 110
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+LH I++RDLK N+LLD D + KI+DFG+ +
Sbjct: 111 FLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 27/175 (15%)
Query: 448 LGEGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501
LG G G V K GT++ + + + S + +Q L+EL+ + + + +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ----IMHECRSPYIVSF 68
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
G + + EFM SLD +L I GL YL+ +
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--N 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFG--------LVRTFGGDETEGNTNRVVG 606
RI+HRD+K SN+L++ K+ DFG + TF G T + R+ G
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQG 176
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 47/165 (28%), Positives = 72/165 (43%), Gaps = 15/165 (9%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A KRL K +G NE + K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSR 560
+ L+ M L I++ + F+ I+CG L LH+++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LEDLHREN- 122
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGL-VRTFGGDETEGNTNRV 604
++RDLK N+LLD + +ISD GL V+ G+ G V
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTV 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 46/148 (31%), Positives = 65/148 (43%), Gaps = 14/148 (9%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A K+L K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSR 560
+ L+ M L I+ + F+ I CG L LHQ+
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQE-- 121
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGL 588
RI++RDLK N+LLD + +ISD GL
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGL 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 16/151 (10%)
Query: 448 LGEGGFGPVYKGTLV----DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLVKL 501
+G+G +G V +LV DG++ +K+L+ S + K + E L S+L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 502 LGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+GE+ LL + F L + +Q + L + +Q A L YLH+
Sbjct: 65 RESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLHEK- 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
I+HRDLK NV L + K+ D G+ R
Sbjct: 122 --HILHRDLKTQNVFLTRTNIIKVGDLGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 51/152 (33%), Positives = 74/152 (48%), Gaps = 19/152 (12%)
Query: 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L G+ AVK L K I + + + +L ++ L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 503 GCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQD 558
C Q +E L + EF+ L I D+ R L + F+ I+CG L +LH
Sbjct: 63 -CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL--YRATFYAAEIVCG----LQFLHSK 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
II+RDLK NV+LD+D + KI+DFG+ +
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 40/155 (25%), Positives = 67/155 (43%), Gaps = 12/155 (7%)
Query: 440 DNFSINNKLGEGGFGPVYK------GTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL 493
D + ++LG+G +G VYK G + +EI RL + E ++ E+ + K
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE-LDESKFNQIIMELDILHKA 56
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
+V G + E+M SLD + I +GL
Sbjct: 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+L ++ IIHRD+K +NVL++ + K+ DFG+
Sbjct: 117 FLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGV 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 15/150 (10%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLK-ELKNEVILFSKLQHRNLVKLL 502
LG+G FG V L E+ A+K L K + + + + + IL +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 503 GCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQ-RFHIICGTARGLLYLHQDSR 560
CC Q +++L + E++ L +F R D + RF+ T L++LH+
Sbjct: 63 -CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTL-ALMFLHRHG- 116
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+I+RDLK N+LLD + + K++DFG+ +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 30/195 (15%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQ 465
E++ N+ + E+E++ ID ++ + ++ + N +G G FG VY+ +D
Sbjct: 39 ERSHNNNAGEDEDEEKMIDNDIN-------RSPNKSYKLGNIIGNGSFGVVYEAICIDTS 91
Query: 466 E-IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC----CIQGEEKLL----IYE 516
E +A+K++ + + +EL ++ L H N++ L C + EK + + E
Sbjct: 92 EKVAIKKVLQDPQYKNREL----LIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147
Query: 517 FMP---NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573
F+P +K + + + L + +C R L Y+H I HRDLK N+
Sbjct: 148 FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC---RALAYIHSKF---ICHRDLKPQNL 201
Query: 574 LLDQDMNP-KISDFG 587
L+D + + K+ DFG
Sbjct: 202 LIDPNTHTLKLCDFG 216
|
Length = 440 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 44/167 (26%), Positives = 75/167 (44%), Gaps = 25/167 (14%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNE----------VILFSKLQHR 496
LG+G F +YKG L V V ++S LK L ++ L S+L H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVV-LKVLGSDHRDSLAFFETASLMSQLSHK 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+LVKL G C++ +E +++ E++ LD F+ + L W + + A L YL
Sbjct: 62 HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNP-------KISDFGLVRTFGGDE 596
+++H ++ N+L+ + K+SD G+ T E
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQ--EIAVKRLSK---ISEQGLKELKNEVILFSKLQ 494
++F+ LG G FG V T + +A+KR K I ++ + + +E + + +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG---TARG 551
H V L G L+ EF+ +F+ RR ++RF G A+
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL----RR-----NKRFPNDVGCFYAAQI 140
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+L L I++RDLK N+LLD+D K++DFG +
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179
|
Length = 340 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 48/167 (28%), Positives = 74/167 (44%), Gaps = 30/167 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSK 492
++F +G+G FG V LV G+ A+K L K + L +K E + ++
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-------DSFIFDQTRRTLLDWSQRFHII 545
+V L + LI EF+P L D+F D TR F++
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR---------FYM- 107
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
A +L + +L IHRD+K N+L+D+ + K+SDFGL F
Sbjct: 108 ---AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 18/153 (11%)
Query: 448 LGEGGFGPVYKGTLVDGQE----IAVKRLSKI----SEQGLKELKNEVILFSKLQHRNLV 499
LG+GG+G V++ V G + A+K L K +++ K E + ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR--TLLDWSQRFHIICGTARGLLYLHQ 557
L+ G + LI E++ L F R ++ + F++ + L +LHQ
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYL-SEISLALEHLHQ 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
II+RDLK N+LLD + K++DFGL +
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 22/153 (14%)
Query: 447 KLGEGGFGPVY----KGTLVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQHRNLV 499
LG+G G V+ KGT G+ A+K L K ++K E + + L H L
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYL 555
L Q E L L+ ++ P L + Q + L + RF+ ++ L YL
Sbjct: 65 TLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA----LEYL 119
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
H L I++RDLK N+LL + + +SDF L
Sbjct: 120 HL---LGIVYRDLKPENILLHESGHIMLSDFDL 149
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 15/166 (9%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV----ILFSKLQHRNLVKLL 502
+G+G FG V + + AVK L K + KE K+ + +L ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 503 GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
Q +KL + +++ L F Q R L+ RF+ A L YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYA-AEIASALGYLHS---L 115
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
I++RDLK N+LLD + ++DFGL + E G T+ GT
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-05
Identities = 48/181 (26%), Positives = 76/181 (41%), Gaps = 39/181 (21%)
Query: 442 FSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSK-ISEQGL--KELKNEVILFSKLQHRN 497
+ I +G+GG G VY V + +A+K++ + +SE L K E + + L H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLD--WSQR-------------- 541
+V + C G+ +Y MP +I T ++LL W +
Sbjct: 64 IVPVYSICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 542 ----FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
FH IC T Y+H S+ ++HRDLK N+LL I D+G +E
Sbjct: 115 FLSIFHKICATIE---YVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEE 168
Query: 598 E 598
+
Sbjct: 169 D 169
|
Length = 932 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 50/161 (31%), Positives = 68/161 (42%), Gaps = 40/161 (24%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELK------NEVILFSKLQHRNLVK 500
LG+GGFG V + G+ A K+L K + +K+ K NE + K+ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 501 LL-------GCCI------QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
L C+ G+ K IY FD+ R I CG
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG------FDEERAVFY----AAEITCG 114
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
L LH R RI++RDLK N+LLD + +ISD GL
Sbjct: 115 ----LEDLH---RERIVYRDLKPENILLDDYGHIRISDLGL 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 57/221 (25%), Positives = 84/221 (38%), Gaps = 76/221 (34%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL---SKISEQG--LKELKNEVI 488
D + LG G FG V + + ++ +AVK L + SE + ELK I
Sbjct: 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK---I 63
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLI------------------YEFMPNKS-------- 522
L H N+V LLG C + L++ F P ++
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREM 123
Query: 523 ---------LDS-----------FIFDQTRRTLL------DWSQRF----HIICGT---A 549
LDS FI D++ + + + +I + A
Sbjct: 124 KQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVA 183
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
RG+ +L SR + IHRDL A N+LL ++ KI DFGL R
Sbjct: 184 RGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 10/153 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
D+F +G G FG V D G A+K L K + ++ + ++ E + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+VK+ LI EF+P + + + + TL + + +F+I A +L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFYI----AETVLAI 114
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 32/86 (37%), Positives = 44/86 (51%), Gaps = 8/86 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQE-----IAVKRLSKISEQGLKE-LKNEVILFSK 492
DN LG G FG V + T G+E +AVK L + +E L +E+ + S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEF 517
L QH+N+V LLG C G L+I E+
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 9e-05
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 10/153 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F +G G FG V D G A+K L K + ++ + ++ E + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+VK+ LI EF+P + + + + TL + +F+I A +L +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFYI----AETVLAI 114
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+L IHRD+K N+LLD + K+SDFGL
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 20/50 (40%), Positives = 31/50 (62%), Gaps = 6/50 (12%)
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
L YLH +++RDLK N++LD+D + KI+DFGL + ++G T
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGAT 151
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 15/150 (10%)
Query: 448 LGEGGFGPVYKGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLG 503
+G G + V L +I ++ K ++ + ++ E +F + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLLYLHQDSR 560
C Q +L L+ E++ L Q +R L + RF+ IC L +LH+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEIC---IALNFLHERG- 116
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
II+RDLK NVLLD D + K++D+G+ +
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 41/145 (28%), Positives = 67/145 (46%), Gaps = 12/145 (8%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLS-KISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505
LG G G VYK + + I AVK + I+ + K++ +E+ + K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ EFM SLD ++ + +L I +GL YL L+I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKILH 118
Query: 566 RDLKASNVLLDQDMNPKISDFGLVR 590
RD+K SN+L++ K+ DFG+
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 15/167 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSKIS----EQGLKELKNEVILFSK 492
NF + LG G +G V+ V G + A+K L K + + ++ + E +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
++ + L Q E KL LI +++ + + ++ R + RF+ +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFY----SGEI 114
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+L L +L I++RD+K N+LLD + + ++DFGL + F +E E
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 43/148 (29%), Positives = 63/148 (42%), Gaps = 14/148 (9%)
Query: 448 LGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG+GGFG V + G+ A K+L K +G NE + K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSR 560
+ L+ M L I++ + F+ + CG L R
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG-------LEDLQR 120
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGL 588
RI++RDLK N+LLD + +ISD GL
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGL 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 19/41 (46%), Positives = 24/41 (58%), Gaps = 3/41 (7%)
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
R L Y+H + + HRDLK N+L + D KI DFGL R
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 33/124 (26%), Positives = 57/124 (45%), Gaps = 28/124 (22%)
Query: 482 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE---FMPNKSLD----SFIFDQTRRT 534
+L+NE++ +L H N++K+ E++L E +M + D SF++D+
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEA--- 257
Query: 535 LLDWS------QRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
DW Q I+ + Y+H ++IHRD+K N+ L+ D + DFG
Sbjct: 258 -FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGT 313
Query: 589 VRTF 592
F
Sbjct: 314 AMPF 317
|
Length = 501 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 46/183 (25%), Positives = 88/183 (48%), Gaps = 26/183 (14%)
Query: 419 EDQNIDLELPLFE-----LATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRL 472
+++NID L +E + + +++ + +G G FG V Q++ A+K L
Sbjct: 17 KNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL 76
Query: 473 SKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSF 526
SK S+ + +++ F+ + V L C Q ++ L ++ E+MP L +
Sbjct: 77 SKFEMIKRSDSAFFWEERDIMAFA---NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL 133
Query: 527 I--FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584
+ +D + W++ + TA +L L + +IHRD+K N+LLD+ + K++
Sbjct: 134 MSNYDVPEK----WAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLA 184
Query: 585 DFG 587
DFG
Sbjct: 185 DFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 39/158 (24%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 505
K+G G +G VYK DG++ L +I G+ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 506 IQGEEK--LLIYEFMPNKSLDSFIFDQTRRT-----LLDWSQRFHIICGTARGLLYLHQD 558
+ ++ L++++ + F + + L S ++ G+ YLH +
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 559 SRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTF 592
++HRDLK +N+L+ + KI+D G R F
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 41/175 (23%), Positives = 81/175 (46%), Gaps = 18/175 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRL------SKISEQGLKELKNEVILFSK 492
+ F + +GEG +G V K + +EI A+K+ ++ E L+ELK +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK----MLRT 56
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
L+ N+V+L + + L++E++ L+ + ++ + R +I + +
Sbjct: 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIY-QLIKAI 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ H++ I+HRD+K N+L+ + K+ DFG R + + N V T
Sbjct: 114 HWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVAT 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 44/188 (23%), Positives = 72/188 (38%), Gaps = 19/188 (10%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATD----NFSINNKLGEGGFGPVYKGTL- 461
+ D+E+ D+ E + ++ ++I + L G G V+ T
Sbjct: 55 THATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKH 114
Query: 462 --VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519
+++ VK ++ G K E+ + + HR ++ L+ K + MP
Sbjct: 115 GDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAY---RWKSTVCMVMP 166
Query: 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579
D F + R L Q I L YLH IIHRD+K N+ LD+
Sbjct: 167 KYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPE 222
Query: 580 NPKISDFG 587
N + DFG
Sbjct: 223 NAVLGDFG 230
|
Length = 392 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 38/161 (23%), Positives = 72/161 (44%), Gaps = 25/161 (15%)
Query: 448 LGEGGFGPVYKGTLVD---------GQEIAVKRLSKISEQGLKELK----NEVILFSKLQ 494
LG G +Y G L E +K + K+ + +++ + ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H+++V L G C++ E +++ EF+ LD F+ ++ +L +F + A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSY 120
Query: 555 LHQDSRLRIIHRDLKASNVLL-----DQDMNP--KISDFGL 588
L +D L +H ++ N+LL D + P K+SD G+
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 10/149 (6%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 503
LG G FG V VD + A+K L K ++ + +K E + ++ + +VKL
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
+ + +++P + S + + RF+I A L + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYI----AELTLAIESVHKMGF 122
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVRTF 592
IHRD+K N+L+D D + K++DFGL F
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 22/155 (14%)
Query: 448 LGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 503
+G G FG V VD + A+K L K + +K E + ++ + +VKL
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSF-----IFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
Q ++ L + +++P + S IF++ RF+I A +
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-------ARFYI----AELTCAIES 116
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
++ IHRD+K N+L+D+D + K++DFGL F
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 11/92 (11%)
Query: 502 LGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLLYLHQD 558
L C Q E +L + EF+ L Q +R L + RF+ I L +LH+
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEIS---LALNFLHER 115
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
II+RDLK NVLLD + + K++D+G+ +
Sbjct: 116 G---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 22/58 (37%), Positives = 33/58 (56%), Gaps = 6/58 (10%)
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
RGL YL + + +I+HRD+K SN+L++ K+ DFG+ G + N VGT
Sbjct: 110 RGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGT 161
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 45/172 (26%), Positives = 75/172 (43%), Gaps = 44/172 (25%)
Query: 440 DNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSK---ISEQGLKELKNE--------- 486
+ F I + G FG VY G + + AVK + K I++ + +++ E
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 487 ---VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-----FDQTRRTLLDW 538
V L+ LQ N V L+ E++ + S + FD+ +
Sbjct: 64 PFIVHLYYSLQSANNV------------YLVMEYLIGGDVKSLLHIYGYFDE------EM 105
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ ++ I A L YLH+ IIHRDLK N+L+ + + K++DFGL +
Sbjct: 106 AVKY--ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 15/158 (9%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCC 505
K+G G +G VYK DG++ L +I G+ E+ L +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 506 IQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY-----LHQD 558
+ ++ L++++ + F + + + + G + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 559 SRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTF 592
++HRDLK +N+L+ + KI+D G R F
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 15/172 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--- 496
D+F ++LG G G V K I ++L + + ++N++I ++ H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62
Query: 497 -NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+V G E + E M SLD + + +R + + I RGL YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKEAKRIPEEILGKVSI--AVLRGLAYL 119
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ + +I+HRD+K SN+L++ K+ DFG+ G + N VGT
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGT 165
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 15/26 (57%), Positives = 19/26 (73%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQ 465
D+F + KLGEG FG VYK +LV+ Q
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQ 157
|
Length = 566 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 31/143 (21%), Positives = 52/143 (36%), Gaps = 15/143 (10%)
Query: 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV--KLLGC 504
L G VY ++ +K S + + + EV + L + L K+L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINP--SREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
L+ E++ ++LD + ++ I A L LHQ L +
Sbjct: 62 GESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 565 HRDLKASNVLLDQDMNPKISDFG 587
H DL N+L+D I D+
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 9e-04
Identities = 50/161 (31%), Positives = 67/161 (41%), Gaps = 31/161 (19%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLG 503
+G GGFG VY D G+ A+K L K +QG NE I+ S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 504 C----CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL---- 555
C C+ Y F L SFI D L + H + A Y
Sbjct: 56 CPFIVCMS-------YAFHTPDKL-SFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 556 ----HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
H +R +++RDLK +N+LLD+ + +ISD GL F
Sbjct: 108 LGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDF 147
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 19/42 (45%), Positives = 29/42 (69%), Gaps = 3/42 (7%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ GL +LH+ II+RDLK NV+LD + + KI+DFG+ +
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 20/42 (47%), Positives = 28/42 (66%), Gaps = 3/42 (7%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A GL +LH II+RDLK NV+LD + + KI+DFG+ +
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 31/132 (23%), Positives = 57/132 (43%), Gaps = 13/132 (9%)
Query: 464 GQEIAVKRLSKISEQGLKE---LKNEVILFSKLQHRNLVKLLGCCIQGEEKLL-IYEFMP 519
G E+A+K L + + + + E L ++L H N+V LL L ++E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---D 576
++L + L + ++ L H I+HRDLK N+++
Sbjct: 63 GRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 577 QDMNPKISDFGL 588
+ K+ DFG+
Sbjct: 117 VRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 32/115 (27%), Positives = 58/115 (50%), Gaps = 7/115 (6%)
Query: 477 EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTL 535
++ + ++ E +F + + + L C Q E +L + E++ L Q +R L
Sbjct: 36 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKL 93
Query: 536 LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ RF+ + L YLH+ II+RDLK NVLLD + + K++D+G+ +
Sbjct: 94 PEEHARFYS-AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 23/51 (45%), Positives = 32/51 (62%), Gaps = 6/51 (11%)
Query: 543 HIICGT---ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+IC + A+G+ +L SR + IHRDL A N+LL ++ KI DFGL R
Sbjct: 180 DLICYSFQVAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 18/40 (45%), Positives = 28/40 (70%), Gaps = 2/40 (5%)
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
L YLH + +++RDLK N++LD+D + KI+DFGL +
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 22/42 (52%), Positives = 28/42 (66%), Gaps = 3/42 (7%)
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
ARG+ +L SR + IHRDL A N+LL ++ KI DFGL R
Sbjct: 184 ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 19/40 (47%), Positives = 28/40 (70%), Gaps = 3/40 (7%)
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
L YLH +I++RDLK N++LD+D + KI+DFGL +
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 49/162 (30%), Positives = 67/162 (41%), Gaps = 33/162 (20%)
Query: 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLG 503
+G GGFG VY D G+ A+K L K +QG NE I+ S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 504 C----CIQGEEKLLIYEF-MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL--- 555
C C + Y F P+K FI D L + H + Y
Sbjct: 56 CPFIVC-------MTYAFHTPDKL--CFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEI 106
Query: 556 -----HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
H +R +++RDLK +N+LLD+ + +ISD GL F
Sbjct: 107 ILGLEHMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDF 147
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 607 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.98 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.97 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.95 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.95 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.95 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.94 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.94 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.94 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.94 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.94 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.93 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.93 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.93 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.93 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.92 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.92 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.92 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.92 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.92 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.92 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.92 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.92 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.92 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.92 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.91 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.91 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.91 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.91 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.91 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.91 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.91 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.91 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.91 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.91 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.91 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.91 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.91 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.91 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.91 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.91 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.9 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.9 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.9 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.9 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.9 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.9 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.9 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.9 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.9 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.9 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.9 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.9 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.9 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.9 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.9 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.9 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.9 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.9 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.9 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.9 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.9 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.9 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.9 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.9 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.9 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.9 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.9 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.9 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.89 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.89 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.89 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.89 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.89 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.89 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.89 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.89 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.89 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.89 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.89 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.89 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.89 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.89 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.89 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.89 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.89 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.89 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.89 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.89 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.89 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.89 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.89 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.89 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.89 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.89 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.89 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.88 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.88 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.88 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.88 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.88 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.88 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.88 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.88 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.88 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.88 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.88 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.88 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.88 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.88 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.88 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.88 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.88 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.88 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.88 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.88 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.88 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.88 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.88 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.88 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.88 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.88 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.88 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.88 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.88 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.88 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.88 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.87 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.87 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.87 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.87 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.87 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.87 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.87 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.87 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.87 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.87 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.87 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.87 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.87 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.87 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.87 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.87 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.87 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.87 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.87 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.87 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.87 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.86 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.86 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.86 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.86 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.86 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.86 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.86 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.86 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.86 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.86 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.86 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.86 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.86 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.86 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.86 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.86 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.86 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.86 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.86 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.86 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.86 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.86 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.86 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.86 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.86 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.85 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.85 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.85 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.85 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.85 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.85 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.85 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.85 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.85 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.85 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.85 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.85 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.85 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.85 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.85 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.85 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.85 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.84 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.84 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.84 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.84 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.84 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.84 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.84 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.84 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.84 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.84 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.84 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.84 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.84 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.84 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.84 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.84 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.84 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.84 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.84 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.84 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.83 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.83 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.83 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.83 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.83 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.83 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.83 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.83 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.83 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.83 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.83 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.82 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.82 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.82 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.82 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.82 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.82 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.82 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.82 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.82 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.82 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.81 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.81 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.81 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.81 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.81 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.81 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.81 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.81 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.81 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.81 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.8 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.8 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.8 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.8 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.8 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.8 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.78 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.78 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.78 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.78 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.78 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.77 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.77 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.77 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.77 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.76 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.75 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.74 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.72 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.65 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.65 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.61 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.61 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.58 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.49 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.24 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.23 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.19 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.19 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.09 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.04 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.02 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.7 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.53 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.43 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.42 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.42 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.34 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.34 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.33 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.29 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.26 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.21 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.2 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.16 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.14 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.09 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.94 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.88 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.81 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.75 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.75 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.67 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.51 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.49 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.46 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.3 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.26 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.23 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.08 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.95 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.93 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.86 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.84 | |
| PLN02236 | 344 | choline kinase | 96.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.61 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.52 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.35 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.03 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.99 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.77 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.72 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.51 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.43 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.21 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.19 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.97 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.92 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.91 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.97 Aligned_cols=168 Identities=52% Similarity=0.859 Sum_probs=153.3
Q ss_pred CCCchhHHhHHhhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEE
Q 007336 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 505 (607)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~ 505 (607)
....|++.++..+|++|+..+.||+|+||.||+|.+.++..||||++.....+..++|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46678999999999999999999999999999999999999999988764332156699999999999999999999999
Q ss_pred EeCC-eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEe
Q 007336 506 IQGE-EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (607)
Q Consensus 506 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~ 584 (607)
.+.+ +++||||||++|+|.++|+..... .++|..|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875443 78999999999999999999999988899999999999999999999999
Q ss_pred ecccceeecC
Q 007336 585 DFGLVRTFGG 594 (607)
Q Consensus 585 DfGla~~~~~ 594 (607)
|||||+....
T Consensus 220 DFGLa~~~~~ 229 (361)
T KOG1187|consen 220 DFGLAKLGPE 229 (361)
T ss_pred CccCcccCCc
Confidence 9999976543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=269.71 Aligned_cols=161 Identities=30% Similarity=0.536 Sum_probs=140.9
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
..++|.+.+.||+|+|++||+|++.. +.+||||.+.+. .....+.+..|+.+++.++|||||+|++++..++..+||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 34678888999999999999999865 789999999764 556677889999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC------CceEEeeccc
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD------MNPKISDFGL 588 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~------~~~ki~DfGl 588 (607)
||||.+|+|.+||+. ...+++.....++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999964 346899999999999999999999988 9999999999999865 4589999999
Q ss_pred ceeecCCCCccCccceecC
Q 007336 589 VRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 589 a~~~~~~~~~~~~~~~~GT 607 (607)
||.+.+.. +..+++|+
T Consensus 162 AR~L~~~~---~a~tlcGS 177 (429)
T KOG0595|consen 162 ARFLQPGS---MAETLCGS 177 (429)
T ss_pred hhhCCchh---HHHHhhCC
Confidence 99987433 33345664
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=263.60 Aligned_cols=151 Identities=37% Similarity=0.619 Sum_probs=133.1
Q ss_pred CcccceeecccCceeEEEEEecCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCC-eEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey 517 (607)
.+.+.+.||+|+||+||+|.+.....||||++.... ....++|.+|+.+|.+++|||||+++|+|.+.. ...+||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 344456799999999999999655559999997532 222679999999999999999999999999988 78999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-ceEEeecccceeecC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGG 594 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~-~~ki~DfGla~~~~~ 594 (607)
+++|+|..+|+.. +...+++..+++||.|||+||.|||++.+ ||||||||+||||+.++ ++||+|||+++....
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 9999999999764 45679999999999999999999999763 99999999999999998 999999999998764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=254.58 Aligned_cols=161 Identities=27% Similarity=0.438 Sum_probs=135.9
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccch-------hhHHHHHHHHHHHccCCCCceeceEEEEEeCC
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~ 509 (607)
..+.|.+.+.||+|+||.|-+|..+ +++.||||++.+... .......+|+++|++++|||||++.+++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456778899999999999999864 589999999975211 12234579999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC---CceEEeec
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDF 586 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~---~~~ki~Df 586 (607)
..||||||+++|+|.+++-. ...+.+.....++.|++.|+.|||+++ |+||||||+||||..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999854 344666777889999999999999998 9999999999999766 77999999
Q ss_pred ccceeecCCCCccCccceecC
Q 007336 587 GLVRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~GT 607 (607)
||||..+... .+.++|||
T Consensus 324 GlAK~~g~~s---fm~TlCGT 341 (475)
T KOG0615|consen 324 GLAKVSGEGS---FMKTLCGT 341 (475)
T ss_pred chhhccccce---ehhhhcCC
Confidence 9999887433 34567887
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=265.73 Aligned_cols=152 Identities=36% Similarity=0.611 Sum_probs=137.0
Q ss_pred CCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
..+.+.+.||+|.||.|+.|.+.....||+|.++.. ....+.|.+|+.+|++|+|+|||+++|+|..+++++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 345566899999999999999988889999999764 3456789999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
.|+|.+||++ ..+..+...+.+.++.|||+||+||++++ +|||||+++||||+++..+||+||||||.+.+++
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 9999999976 34566889999999999999999999987 9999999999999999999999999999766554
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-31 Score=226.31 Aligned_cols=110 Identities=48% Similarity=0.743 Sum_probs=80.4
Q ss_pred CCceEEEccCCCCCCCC--cceEEEecCCcEEEEcCCCcEEEee-CCccCc-CCceEEEEecCCCeEEeeCCCCCCCcee
Q 007336 14 PHEVVWVANRLNPINDS--FGFLMINKTGNLVLTSQSNIVVWSA-YLSKEV-QTPVVLQLLDSGNLVLRDEHDGDSETYF 89 (607)
Q Consensus 14 ~~t~VW~Anr~~pv~~~--~~~l~~~~~G~L~l~d~~g~~vWst-~~~~~~-~~~~~~~Lld~GNlVl~~~~~~~~~~~l 89 (607)
++||||+|||+.|+..+ ..+|.|..||+|+|.|..|+++|++ ++.+.. ....+ .|+|+|||||++.. +.+|
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~-~L~~~GNlvl~d~~----~~~l 75 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYL-VLQDDGNLVLYDSS----GNVL 75 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEE-EEETTSEEEEEETT----SEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEE-EEeCCCCEEEEeec----ceEE
Confidence 47999999999999543 3889999999999999999999999 555432 35666 99999999999964 7899
Q ss_pred EeeccCCCcccCCCCeeccccccCccceEEEeccCCCCC
Q 007336 90 WQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPS 128 (607)
Q Consensus 90 WQSFd~PTDTlLpgq~l~~~~~~g~~~~L~s~~s~~dps 128 (607)
||||||||||+||+|+|+.+..++.+..|+||++.+|||
T Consensus 76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999999999988887777899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=262.42 Aligned_cols=160 Identities=31% Similarity=0.466 Sum_probs=145.7
Q ss_pred CCcccceeecccCceeEEEEEe-cCCcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
..|...+.||+|+|++||+++. ..|..||+|++.+ ......+.+.+|+++.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999998 6699999999976 34556778999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|+|++++|..++. ++..+++.+...+..||+.||.|||+.+ |||||||..|++|++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999984 5677999999999999999999999987 999999999999999999999999999999877
Q ss_pred CCccCccceecC
Q 007336 596 ETEGNTNRVVGT 607 (607)
Q Consensus 596 ~~~~~~~~~~GT 607 (607)
+.+.+| ++||
T Consensus 172 ~Erk~T--lCGT 181 (592)
T KOG0575|consen 172 GERKKT--LCGT 181 (592)
T ss_pred ccccce--ecCC
Confidence 655433 7888
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=249.10 Aligned_cols=162 Identities=30% Similarity=0.437 Sum_probs=142.0
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|+++++||+|+||+||+++..+ ++.+|+|.+++ ......+..++|..++.+++||+||+++-.+++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 45689999999999999999999766 78999999976 233457789999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+||+.||.|..+|.+ ...+++....-++.+|+.||.|||+.+ ||||||||+|||||++|+++|+||||++.-.
T Consensus 103 Vld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999943 445778877778889999999999988 9999999999999999999999999999664
Q ss_pred CCCCccCccceecC
Q 007336 594 GDETEGNTNRVVGT 607 (607)
Q Consensus 594 ~~~~~~~~~~~~GT 607 (607)
.+.. .|.+++||
T Consensus 177 ~~~~--~t~tfcGT 188 (357)
T KOG0598|consen 177 KDGD--ATRTFCGT 188 (357)
T ss_pred cCCC--ccccccCC
Confidence 4332 35568998
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=251.76 Aligned_cols=161 Identities=34% Similarity=0.569 Sum_probs=140.2
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHcc--CCCCceeceEEEEEeCC----eEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQGE----EKL 512 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~--l~H~nIv~l~g~~~~~~----~~~ 512 (607)
....++.++||+|+||.||||++. ++.||||++. .+....|.+|-.+++. ++|+||+++++.-..+. +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345666789999999999999995 5999999985 4566778888888765 58999999999977665 789
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceEecccCCCcEEEcCCCceEEeec
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDF 586 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~------~~~~ivHrDlkp~Nill~~~~~~ki~Df 586 (607)
||+||.+.|+|.+||. ...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+||
T Consensus 285 LVt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999993 46789999999999999999999975 3568999999999999999999999999
Q ss_pred ccceeecCCCCccCccceecC
Q 007336 587 GLVRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~GT 607 (607)
|||.++......+.+...+||
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT 381 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGT 381 (534)
T ss_pred ceeEEecCCCCCcchhhhhhh
Confidence 999999887777666667777
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=265.70 Aligned_cols=154 Identities=31% Similarity=0.525 Sum_probs=138.7
Q ss_pred CCcccceeecccCceeEEEEEecC----CcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
....+.++||.|.||.|++|+++- ...||||.++. ..+.+..+|+.|+.+|.+++||||++|.|+.....+.++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 456788999999999999999853 35799999986 4556778999999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
.|||++|+|+.||+.+ ...+.+.++..|.++||.||.||.+.+ +|||||+++||||+.+..+||+||||+|.+++
T Consensus 709 TEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999999753 344889999999999999999999877 99999999999999999999999999999977
Q ss_pred CCCc
Q 007336 595 DETE 598 (607)
Q Consensus 595 ~~~~ 598 (607)
+...
T Consensus 784 d~~~ 787 (996)
T KOG0196|consen 784 DPEA 787 (996)
T ss_pred CCCc
Confidence 6633
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=251.84 Aligned_cols=161 Identities=30% Similarity=0.448 Sum_probs=138.6
Q ss_pred cCCcccceeecccCceeEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeC--CeEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 513 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l 513 (607)
.+.|+.+++||+|.||.||+|+. .+|+.||+|++.-. .+....-..+|+.+|++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 34677888999999999999986 45899999998643 234455678999999999999999999998876 67999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+|||++ +|.-++.. ..-.++..++..++.|++.||+|+|+.+ |+|||||.+|||||.+|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999984 77777732 3445889999999999999999999988 9999999999999999999999999999998
Q ss_pred CCCCccCcccee
Q 007336 594 GDETEGNTNRVV 605 (607)
Q Consensus 594 ~~~~~~~~~~~~ 605 (607)
.......|++++
T Consensus 270 ~~~~~~~T~rVv 281 (560)
T KOG0600|consen 270 PSGSAPYTSRVV 281 (560)
T ss_pred CCCCcccccceE
Confidence 877666777764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=270.03 Aligned_cols=155 Identities=35% Similarity=0.605 Sum_probs=136.4
Q ss_pred HHhhcCCcccceeecccCceeEEEEEec------CCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCceeceEEEEEe
Q 007336 435 IANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (607)
Q Consensus 435 ~~~~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~ 507 (607)
....+.+....+.||+|+||+||+|+.. +...||||.++.... +...+|++|+++++.++|||||+|+|+|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3445567777899999999999999853 246799999987544 478899999999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhcCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQTR-----------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~ 576 (607)
+++.+||+|||..|+|.+||..... ...|+..+.+.||.|||.||+||-++. +|||||++||+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceec
Confidence 9999999999999999999963211 234889999999999999999999877 99999999999999
Q ss_pred CCCceEEeecccceee
Q 007336 577 QDMNPKISDFGLVRTF 592 (607)
Q Consensus 577 ~~~~~ki~DfGla~~~ 592 (607)
++..|||+||||+|.+
T Consensus 638 e~l~VKIsDfGLsRdi 653 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDI 653 (774)
T ss_pred cceEEEecccccchhh
Confidence 9999999999999965
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=242.56 Aligned_cols=158 Identities=30% Similarity=0.385 Sum_probs=136.9
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCC-eEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lV~Ey 517 (607)
+++..+.||+|..|+|||+.++. ++.+|+|.+.. ..+...+++.+|++++++.+||+||+++|.|.... ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 44556799999999999999865 78899999843 34566788999999999999999999999999988 59999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~~ 597 (607)
|.+|+|++++.. ...+++...-.|+.+|++||.|||+.. +||||||||+||||+..|++||+|||.++.+.+.
T Consensus 160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999853 356899999999999999999999632 4999999999999999999999999999988654
Q ss_pred ccCccceecC
Q 007336 598 EGNTNRVVGT 607 (607)
Q Consensus 598 ~~~~~~~~GT 607 (607)
..++.+||
T Consensus 233 --~a~tfvGT 240 (364)
T KOG0581|consen 233 --IANTFVGT 240 (364)
T ss_pred --hccccccc
Confidence 23445666
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=230.09 Aligned_cols=159 Identities=30% Similarity=0.421 Sum_probs=141.9
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|+..+.||.|+||+|..++.+. +.-+|+|++++ ....+.+...+|..+|+.+.||+++++.+.+.+....+|
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 34578889999999999999999865 78899999976 334567788999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++|.|.++|++ ...++.....-+|.||+.||+|||+.. |++|||||+|||||.+|.+||+|||+||...
T Consensus 122 vmeyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 9999999999999954 345788888889999999999999987 9999999999999999999999999999885
Q ss_pred CCCCccCccceecC
Q 007336 594 GDETEGNTNRVVGT 607 (607)
Q Consensus 594 ~~~~~~~~~~~~GT 607 (607)
+ .|.+++||
T Consensus 196 ~-----rT~TlCGT 204 (355)
T KOG0616|consen 196 G-----RTWTLCGT 204 (355)
T ss_pred C-----cEEEecCC
Confidence 3 36678887
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=253.57 Aligned_cols=152 Identities=34% Similarity=0.556 Sum_probs=134.8
Q ss_pred HhhcCCcccceeecccCceeEEEEEecC--C---cEEEEEEecc---cchhhHHHHHHHHHHHccCCCCceeceEEEEEe
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVD--G---QEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~--~---~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~ 507 (607)
+...++..+.++||+|+||.||+|++.. + ..||||..+. .......+|.+|+++|++++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3444566677999999999999999754 2 2389999874 456778899999999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
..+++||||+|+||+|.++|.+.. ..++..+++.++.++|+||+|||+.+ +|||||++||||++.++.+||+|||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence 999999999999999999996533 36899999999999999999999987 9999999999999999999999999
Q ss_pred cceee
Q 007336 588 LVRTF 592 (607)
Q Consensus 588 la~~~ 592 (607)
|++.-
T Consensus 308 Ls~~~ 312 (474)
T KOG0194|consen 308 LSRAG 312 (474)
T ss_pred cccCC
Confidence 98854
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=244.64 Aligned_cols=155 Identities=32% Similarity=0.457 Sum_probs=136.1
Q ss_pred HhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecc---cchhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCe
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 510 (607)
.....+|...+.||+|+|++|++|+... ++++|||++.+ ..+...+-...|-..|.+| .||.|++|+..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3345689999999999999999999755 89999999875 2333445567788888888 89999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
+|+|+||+++|+|.++|.+ ...+++.-...++.+|+.||+|||+.+ ||||||||+|||||++|++||+|||-|+
T Consensus 149 LYFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 9999999999999999954 456788888889999999999999988 9999999999999999999999999999
Q ss_pred eecCCC
Q 007336 591 TFGGDE 596 (607)
Q Consensus 591 ~~~~~~ 596 (607)
++.+.+
T Consensus 223 ~l~~~~ 228 (604)
T KOG0592|consen 223 ILSPSQ 228 (604)
T ss_pred cCChhh
Confidence 996543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=231.24 Aligned_cols=148 Identities=26% Similarity=0.411 Sum_probs=128.8
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.|+.+.++|+|+||.||+++.++ |+.||||++.... +.-.+--++|++++++++|+|+|.|+.+|......+||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 57777899999999999999876 8999999986532 33345578999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|+.--|+++- . ...-++.....+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+||.+..
T Consensus 83 ~dhTvL~eLe-~--~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 83 CDHTVLHELE-R--YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred cchHHHHHHH-h--ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9876665543 2 2334788888999999999999999988 99999999999999999999999999999973
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=222.77 Aligned_cols=150 Identities=34% Similarity=0.566 Sum_probs=131.9
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
++|...++||+|.||.||+|+.. .|+.||||+++... ..-.....+|+..++.++|+||+.+++++-..+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46777889999999999999974 48999999997532 1223456789999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+ -+|+..+++ +...+...+...++.++++||+|||++. |+||||||.|+||+++|.+||+||||||.++..
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 997 589999865 3456888999999999999999999988 999999999999999999999999999999744
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=244.48 Aligned_cols=152 Identities=31% Similarity=0.526 Sum_probs=136.0
Q ss_pred hhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
.+++...+.++||+|.||.|..+....+..||||+++.... ....+|..|+++|.+++|||||+|+|+|..+++++||+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 34566778899999999999999998889999999987544 44589999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|||++|+|..||..+.... ++.....+|+.|||.||+||.+.. +|||||.++|||++.++++||+||||+|-+
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccc
Confidence 9999999999997654332 566777889999999999999877 999999999999999999999999999955
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=201.35 Aligned_cols=109 Identities=50% Similarity=1.141 Sum_probs=104.3
Q ss_pred EEeCCCCCccccC-CCCCCCCceEEEEEecCceEEEEEEecCCCeEEEEEEeeecceEEEEEEecCCCcEEEEeeecCCC
Q 007336 154 YRTGPWNGLRFSA-PSLRPNPIFSFSFVSNDVELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQ 232 (607)
Q Consensus 154 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~~~~~~~~~~~~~~W~~~~~~~~~~ 232 (607)
||+|+|+|..|++ |++.....+.+.|+.++.+.+++|...+.+++.|++||.+| ++++|.|++.++.|.+.|.+|.|+
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G-~l~~~~w~~~~~~W~~~~~~p~d~ 79 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDG-QLQRYIWNESTQSWSVFWSAPKDQ 79 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeee-EEEEEEEecCCCcEEEEEEecccC
Confidence 8999999999999 99988888999999999999999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCccccccCCCCcccccCCceeCC
Q 007336 233 CDTYGLCGAYGICIIGQSPVCQCLKGFKPKS 263 (607)
Q Consensus 233 C~~~~~CG~~g~C~~~~~~~C~C~~gf~~~~ 263 (607)
||+|+.||+||+|+.+..+.|+|++||+|++
T Consensus 80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999999999988888999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=234.83 Aligned_cols=151 Identities=28% Similarity=0.524 Sum_probs=137.5
Q ss_pred cCCcccceeecccCceeEEEEEe-cCCcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
..+|++.+.||+|.||.|-++.. ..|+.||||.+++ .+.+..-.+++|+++|+.|+||||+.++.+|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35788889999999999999986 5699999999875 3556677899999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||..+|.|.+|+.+ ...|+++...++++||..|+.|.|.+. ++|||||.+|||||.++++||+||||+-++..
T Consensus 132 MEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999954 455899999999999999999999987 99999999999999999999999999988754
Q ss_pred C
Q 007336 595 D 595 (607)
Q Consensus 595 ~ 595 (607)
.
T Consensus 206 ~ 206 (668)
T KOG0611|consen 206 K 206 (668)
T ss_pred c
Confidence 3
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=237.44 Aligned_cols=152 Identities=28% Similarity=0.400 Sum_probs=137.7
Q ss_pred HhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 511 (607)
....++|++++.||+|+||.||.++-++ |..+|+|++++. ...+.+..+.|..+|...++|.||+|+..|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 4466899999999999999999999766 899999999873 445678899999999999999999999999999999
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
||||||+|||++..+| .+...|+......++.+++.|+.-||+.+ +|||||||+|+|||..|++||+||||+.-
T Consensus 217 YLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999999 44567888888888899999999999988 99999999999999999999999999975
Q ss_pred ec
Q 007336 592 FG 593 (607)
Q Consensus 592 ~~ 593 (607)
+.
T Consensus 291 l~ 292 (550)
T KOG0605|consen 291 LD 292 (550)
T ss_pred hh
Confidence 53
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=260.00 Aligned_cols=153 Identities=37% Similarity=0.649 Sum_probs=137.0
Q ss_pred hhcCCcccceeecccCceeEEEEEecC--Cc----EEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCC
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVD--GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~--~~----~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~ 509 (607)
....+.++.+.||+|.||.||.|++.+ +. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 345677788999999999999999754 33 4999999874 5677889999999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEee
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQT----RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~D 585 (607)
..++++|||++|+|..||++.. ....|.....+.++.|||+|+.||++++ +|||||+++||||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence 9999999999999999997642 2456889999999999999999999887 99999999999999999999999
Q ss_pred cccceee
Q 007336 586 FGLVRTF 592 (607)
Q Consensus 586 fGla~~~ 592 (607)
|||||.+
T Consensus 846 FGlArDi 852 (1025)
T KOG1095|consen 846 FGLARDI 852 (1025)
T ss_pred cchhHhh
Confidence 9999954
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-28 Score=228.56 Aligned_cols=166 Identities=28% Similarity=0.475 Sum_probs=139.0
Q ss_pred CCcccceeecccCceeEEEEE-ecCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEE-EEeCCe-EEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC-CIQGEE-KLLI 514 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~-~~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~-~~~~~~-~~lV 514 (607)
.+|+++++||+|+||+||++. +.+|..||.|.+.- .+.........|+.++++|+|||||+.+++ +.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468888999999999999997 46799999998863 445566788999999999999999999984 444545 7899
Q ss_pred EEcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 515 YEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDS-RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
||||..|+|...+..- +....++++.+++++.|+++||.++|..- +..|+||||||.||+|+.+|.+||.||||+|.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999998542 34567899999999999999999999842 123999999999999999999999999999999
Q ss_pred cCCCCccCccceecC
Q 007336 593 GGDETEGNTNRVVGT 607 (607)
Q Consensus 593 ~~~~~~~~~~~~~GT 607 (607)
....+- +.+.+||
T Consensus 179 ~s~~tf--A~S~VGT 191 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGT 191 (375)
T ss_pred cchhHH--HHhhcCC
Confidence 765542 3446676
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=227.91 Aligned_cols=162 Identities=25% Similarity=0.423 Sum_probs=135.2
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHc--cCCCCceeceEEEEEeCC----eE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFS--KLQHRNLVKLLGCCIQGE----EK 511 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~--~l~H~nIv~l~g~~~~~~----~~ 511 (607)
...+..+.+.||+|.||.||+|.+ .|+.||||++... +.+.+.+|.++.. .|+|+||+.+++.-..+. .+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 335788899999999999999999 5889999999653 3445666777665 469999999998865443 47
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCceEecccCCCcEEEcCCCceEEeec
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-----DSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----~~~~~ivHrDlkp~Nill~~~~~~ki~Df 586 (607)
+||++|.++|||.+||. ...++....+++++.+|.||+|||. ++++.|.|||||++||||..++.+.|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 89999999999999993 3678999999999999999999994 57889999999999999999999999999
Q ss_pred ccceeecCCCCc--cCccceecC
Q 007336 587 GLVRTFGGDETE--GNTNRVVGT 607 (607)
Q Consensus 587 Gla~~~~~~~~~--~~~~~~~GT 607 (607)
|||-....+... ...+..+||
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGT 383 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGT 383 (513)
T ss_pred eeeEEecccCCcccCCCCCccce
Confidence 999988765432 344555776
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-27 Score=238.42 Aligned_cols=159 Identities=31% Similarity=0.495 Sum_probs=140.3
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
++|.+.+.||+|+||.||||+-+. .+.||+|.+.+. .....+.+++|++++++++|||||.++++++...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 468888999999999999998654 788999999763 34567789999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
|+.+ +|..+|.. ...+++.....|+.+++.||.|||+.. |+|||+||+||||+.++++|++|||+||.++...
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 99999954 456899999999999999999999987 9999999999999999999999999999886533
Q ss_pred CccCccceecC
Q 007336 597 TEGNTNRVVGT 607 (607)
Q Consensus 597 ~~~~~~~~~GT 607 (607)
...+++.||
T Consensus 155 --~vltsikGt 163 (808)
T KOG0597|consen 155 --SVLTSIKGT 163 (808)
T ss_pred --eeeeeccCc
Confidence 345566776
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=237.69 Aligned_cols=152 Identities=30% Similarity=0.453 Sum_probs=132.2
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccch-hhHHHHHHHHHHHccCC-CCceeceEEEEEeCC-eEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE-EKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~-~~~lV 514 (607)
.++|...++||.|.||.||+|+-. .+..||||++++.-. -+.-.-.+|+..|++|. |||||+|..++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 457889999999999999999864 488999999976321 12223457999999998 999999999999888 89999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||||+ .+|.+++.++ ...+++..+..|+.||++||+|+|++| +.|||+||+|||+.....+||+||||||.+..
T Consensus 89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 99997 5899988664 667999999999999999999999988 99999999999999999999999999998864
Q ss_pred CC
Q 007336 595 DE 596 (607)
Q Consensus 595 ~~ 596 (607)
.+
T Consensus 163 kp 164 (538)
T KOG0661|consen 163 KP 164 (538)
T ss_pred CC
Confidence 43
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=226.27 Aligned_cols=151 Identities=32% Similarity=0.485 Sum_probs=132.1
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCC--eEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLIY 515 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV~ 515 (607)
..++...+.||+|+||+||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|.....+ .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3457777899999999999999865 8999999987643333677899999999999999999999855444 688999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~-~~~~ki~DfGla~~~~~ 594 (607)
||+++|+|.+++..... .++...+..+..||++||+|||+++ ||||||||+||||+. ++.+||+|||+|+....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999965332 6899999999999999999999887 999999999999999 79999999999998874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=233.19 Aligned_cols=162 Identities=25% Similarity=0.425 Sum_probs=138.0
Q ss_pred hhcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc----ch-hhHHHHHHHHHHHccCC-CCceeceEEEEEeCC
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI----SE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 509 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~----~~-~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~ 509 (607)
...++|.+.+.||+|+||+|+.|... .+..||||.+.+. .. ...+.+.+|+.++++++ ||||++++.+.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568999999999999999999865 4799999977652 11 23456678999999999 999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CceEEeeccc
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGL 588 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~-~~~ki~DfGl 588 (607)
..++||||+.+|+|.+++.+ ...+.+.....++.|++.|++|+|+.+ |+||||||+||||+.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999965 345777888999999999999999987 9999999999999999 9999999999
Q ss_pred ceeec-CCCCccCccceecC
Q 007336 589 VRTFG-GDETEGNTNRVVGT 607 (607)
Q Consensus 589 a~~~~-~~~~~~~~~~~~GT 607 (607)
+.... .+. ...+.+||
T Consensus 168 s~~~~~~~~---~l~t~cGs 184 (370)
T KOG0583|consen 168 SAISPGEDG---LLKTFCGS 184 (370)
T ss_pred ccccCCCCC---cccCCCCC
Confidence 99884 222 23445665
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.9e-26 Score=226.47 Aligned_cols=149 Identities=30% Similarity=0.472 Sum_probs=128.3
Q ss_pred hhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc--------------hhhHHHHHHHHHHHccCCCCceece
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--------------EQGLKELKNEVILFSKLQHRNLVKL 501 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--------------~~~~~~f~~E~~~l~~l~H~nIv~l 501 (607)
...++|++.+.||+|.||.|-+|+.. +++.||||++.+.. ....+..++|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999974 58999999986521 1124678999999999999999999
Q ss_pred EEEEEe--CCeEEEEEEcCCCCChHHHHhcCCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC
Q 007336 502 LGCCIQ--GEEKLLIYEFMPNKSLDSFIFDQTRRTL-LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (607)
Q Consensus 502 ~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~ 578 (607)
+.+..+ .+..|||+|||..|.+... ..... +...+..++++++..||+|||.++ ||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 999765 4568999999999988543 22333 889999999999999999999998 9999999999999999
Q ss_pred CceEEeecccceee
Q 007336 579 MNPKISDFGLVRTF 592 (607)
Q Consensus 579 ~~~ki~DfGla~~~ 592 (607)
+++||+|||.+-.+
T Consensus 247 g~VKIsDFGVs~~~ 260 (576)
T KOG0585|consen 247 GTVKISDFGVSNEF 260 (576)
T ss_pred CcEEeeccceeeec
Confidence 99999999999877
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=212.40 Aligned_cols=162 Identities=31% Similarity=0.432 Sum_probs=137.8
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|++.+.||+|-||.||.|+.+. +..||+|++.+. ..+...++++|+++-+.|+||||+++++++.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 45689999999999999999999754 678999998762 22345679999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++||.+.|.|...|.+. +...++......++.|+|.||.|+|..+ ||||||||+|+|++..+..||+|||.+-.-.
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999753 3345677778889999999999999876 9999999999999999999999999987442
Q ss_pred CCCCccCccceecC
Q 007336 594 GDETEGNTNRVVGT 607 (607)
Q Consensus 594 ~~~~~~~~~~~~GT 607 (607)
.++. .+++||
T Consensus 176 --~~kR--~tlcgt 185 (281)
T KOG0580|consen 176 --SNKR--KTLCGT 185 (281)
T ss_pred --CCCc--eeeecc
Confidence 2222 236776
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-26 Score=218.55 Aligned_cols=152 Identities=28% Similarity=0.431 Sum_probs=128.2
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccch--hhHHHHHHHHHHHccCCCCceeceEEEEEeC--CeEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 512 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~ 512 (607)
..+.|+.++.|++|+||.||+|+... ++.||+|+++.... .---.-.+|+.++.+++|||||.+..+.... +..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 34578889999999999999999854 78999999875321 1122357899999999999999999887653 4689
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
||||||+ .+|...+.. ....+...+...+..|+++|++|||.+. |+||||||+|+|++..|.+||+||||||.+
T Consensus 154 ~VMe~~E-hDLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVE-HDLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHH-hhHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 9999997 588888854 2345677888889999999999999988 999999999999999999999999999999
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
+..
T Consensus 228 gsp 230 (419)
T KOG0663|consen 228 GSP 230 (419)
T ss_pred cCC
Confidence 765
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=235.83 Aligned_cols=152 Identities=32% Similarity=0.572 Sum_probs=134.5
Q ss_pred HhHHhhcCCcccceeecccCceeEEEEEecCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe
Q 007336 433 ATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 433 ~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 510 (607)
.+..+..+.+.+.+.||+|+||+||+|++. ..||||.+.. ......+.|++|+..+++-+|.||+-+.|+|...+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 344455566778899999999999999984 4799999864 345678899999999999999999999999998877
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.+|+.+|++.+|..+|+.. ...++..+...||.|||+||.|||.++ |||||||..||+|++++.|||.|||||.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 9999999999999999753 355888999999999999999999988 9999999999999999999999999987
Q ss_pred ee
Q 007336 591 TF 592 (607)
Q Consensus 591 ~~ 592 (607)
.-
T Consensus 537 vk 538 (678)
T KOG0193|consen 537 VK 538 (678)
T ss_pred ee
Confidence 54
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=231.06 Aligned_cols=154 Identities=31% Similarity=0.490 Sum_probs=130.0
Q ss_pred hcCCcccceeecccCceeEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCC
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~ 509 (607)
+.++|++.++||+|+||.||+|... .+..||||++... .....+.+.+|+.++..+ +||||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4568999999999999999999742 2467999998653 233456799999999999 8999999999987644
Q ss_pred -eEEEEEEcCCCCChHHHHhcCCC--------------------------------------------------------
Q 007336 510 -EKLLIYEFMPNKSLDSFIFDQTR-------------------------------------------------------- 532 (607)
Q Consensus 510 -~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 532 (607)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999864211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 533 ---RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 533 ---~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 134778888999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-25 Score=224.41 Aligned_cols=153 Identities=30% Similarity=0.535 Sum_probs=131.6
Q ss_pred cCCcccceeecccCceeEEEEEecC-----------------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceec
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-----------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 500 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-----------------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~ 500 (607)
.++|.+.++||+|+||.||++.+.+ +..||+|.+... ......+|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578888999999999999997532 336999988653 3344567999999999999999999
Q ss_pred eEEEEEeCCeEEEEEEcCCCCChHHHHhcCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 007336 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQT----------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564 (607)
Q Consensus 501 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iv 564 (607)
+++++.+.+..++||||+++|+|.+++.... ....+++.....++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999985421 1134688899999999999999999987 99
Q ss_pred ecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 565 HRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 565 HrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||||||+|||+++++.+||+|||+++.+..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~ 190 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYA 190 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceeccc
Confidence 999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=231.38 Aligned_cols=161 Identities=30% Similarity=0.522 Sum_probs=142.8
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
....|...++||+|+.|.||.++.. .++.||||++........+-+.+|+.+|+..+|+|||+++..+..++++++|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 3456777789999999999999864 488999999987656666778999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
||++|+|.+.+. ...+++.++..|++++++||+|||.++ |||||||.+||||+.++.+||+|||++..+....
T Consensus 351 ym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 351 YMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred ecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999999883 345899999999999999999999988 9999999999999999999999999999998777
Q ss_pred CccCccceecC
Q 007336 597 TEGNTNRVVGT 607 (607)
Q Consensus 597 ~~~~~~~~~GT 607 (607)
.+. .+++||
T Consensus 424 ~KR--~TmVGT 432 (550)
T KOG0578|consen 424 SKR--STMVGT 432 (550)
T ss_pred Ccc--ccccCC
Confidence 643 346787
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-26 Score=234.92 Aligned_cols=157 Identities=29% Similarity=0.502 Sum_probs=140.8
Q ss_pred HHhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 435 IANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 435 ~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
.+..+.++....+||-|.||.||.|.++. .-.||||.++. +....++|+.|..+|+.++|||+|+|+|+|......||
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 34444566777899999999999999866 67899999976 45678999999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+|||.+|+|.+||++.. +..++.-..+.||.||+.||+||...+ +|||||.++|+|+.++..+||+||||+|++.
T Consensus 341 iTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999998744 456788888999999999999999877 9999999999999999999999999999997
Q ss_pred CCC
Q 007336 594 GDE 596 (607)
Q Consensus 594 ~~~ 596 (607)
++.
T Consensus 417 gDT 419 (1157)
T KOG4278|consen 417 GDT 419 (1157)
T ss_pred CCc
Confidence 765
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-26 Score=244.31 Aligned_cols=151 Identities=34% Similarity=0.581 Sum_probs=132.1
Q ss_pred ccceeecccCceeEEEEEec-CC----cEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 443 SINNKLGEGGFGPVYKGTLV-DG----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 443 ~~~~~lg~G~fg~Vy~g~~~-~~----~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
...++||+|+||+||+|.+. .+ .+||||.+.. ...+...+|.+|+.+|.+++||||++|+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34479999999999999863 33 4789998865 34456789999999999999999999999998766 789999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
|||.|.|.+|++. .+..+-.+..+.+..|||+||.|||++. +|||||.++||||.+-.++||.|||+|+++..++
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999975 3455788899999999999999999876 9999999999999999999999999999998776
Q ss_pred Ccc
Q 007336 597 TEG 599 (607)
Q Consensus 597 ~~~ 599 (607)
.+.
T Consensus 853 ~ey 855 (1177)
T KOG1025|consen 853 KEY 855 (1177)
T ss_pred ccc
Confidence 553
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=216.61 Aligned_cols=150 Identities=30% Similarity=0.483 Sum_probs=127.7
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCc-eeceEEEEEeCC------
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRN-LVKLLGCCIQGE------ 509 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~n-Iv~l~g~~~~~~------ 509 (607)
..|...++||+|+||+||+|+.. +|+.||+|++.-... ..-..-.+|+.++++++|+| ||+|.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 35666788999999999999964 488999999864322 12334578999999999999 999999998877
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccc
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGl 588 (607)
..+||+||+. -+|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||++.+.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 6789999996 6899999654432 45777889999999999999999988 99999999999999999999999999
Q ss_pred ceeec
Q 007336 589 VRTFG 593 (607)
Q Consensus 589 a~~~~ 593 (607)
|+.+.
T Consensus 167 Ara~~ 171 (323)
T KOG0594|consen 167 ARAFS 171 (323)
T ss_pred HHHhc
Confidence 99775
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=232.40 Aligned_cols=163 Identities=30% Similarity=0.460 Sum_probs=140.8
Q ss_pred HhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecc---cchhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCe
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 510 (607)
....++|.++++||+|.||+|+++.++. ++.+|||.+++ ...+..+..+.|.+++..+ +||.|+.|++.+...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3455789999999999999999999865 78899999987 3456778888898888777 59999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
+++||||+.||++..+. ....+++....-+|..|+.||.|||+++ ||+||||.+|||||.+|++||+||||+|
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999954433 3356888888889999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCccCccceecC
Q 007336 591 TFGGDETEGNTNRVVGT 607 (607)
Q Consensus 591 ~~~~~~~~~~~~~~~GT 607 (607)
.-..... .|.+++||
T Consensus 517 e~m~~g~--~TsTfCGT 531 (694)
T KOG0694|consen 517 EGMGQGD--RTSTFCGT 531 (694)
T ss_pred ccCCCCC--ccccccCC
Confidence 7653333 46778998
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=229.13 Aligned_cols=154 Identities=21% Similarity=0.275 Sum_probs=135.0
Q ss_pred hHHhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCC
Q 007336 434 TIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (607)
Q Consensus 434 ~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~ 509 (607)
.+....++|++.+.||+|+||.||+++... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 344455789999999999999999999864 788999998642 2234556889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
..++||||+++|+|.+++.. ..++......++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+|
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 99999999999999999843 24688888999999999999999887 999999999999999999999999999
Q ss_pred eeecC
Q 007336 590 RTFGG 594 (607)
Q Consensus 590 ~~~~~ 594 (607)
+.+..
T Consensus 190 ~~~~~ 194 (370)
T cd05621 190 MKMDE 194 (370)
T ss_pred eeccc
Confidence 98753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=227.78 Aligned_cols=148 Identities=27% Similarity=0.395 Sum_probs=132.0
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||+||++.... ++.||||++.+. .......+..|+.++.+++|+||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 468889999999999999998754 789999998752 2234467889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999854 345889999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=223.81 Aligned_cols=149 Identities=27% Similarity=0.417 Sum_probs=132.7
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||.||+|+... ++.||||++.+.. ....+.+..|+.++..++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 468899999999999999999864 7899999987531 234567889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+++|+|.+++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999953 345788899999999999999999987 99999999999999999999999999986643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=223.64 Aligned_cols=151 Identities=25% Similarity=0.350 Sum_probs=132.9
Q ss_pred hcCCcccceeecccCceeEEEEEecC--CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~--~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
..++|++.+.||+|+||.||+|.... +..||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34578999999999999999998654 368999998642 2334567889999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 108 lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999999954 335789999999999999999999987 999999999999999999999999999977
Q ss_pred cC
Q 007336 593 GG 594 (607)
Q Consensus 593 ~~ 594 (607)
..
T Consensus 182 ~~ 183 (340)
T PTZ00426 182 DT 183 (340)
T ss_pred CC
Confidence 43
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=227.55 Aligned_cols=146 Identities=25% Similarity=0.376 Sum_probs=130.3
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.|++.+.||+|+||+||+|+... ++.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57888999999999999998754 789999998652 23445678999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999999854 335788888889999999999999887 999999999999999999999999998755
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=227.60 Aligned_cols=147 Identities=26% Similarity=0.371 Sum_probs=130.7
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.++||+|+||.||++... +++.||||.+.+. .....+.+.+|+.++++++||||+++++++.+....+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888999999999999999875 4889999998642 2334567889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999853 345788888889999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=227.06 Aligned_cols=148 Identities=26% Similarity=0.385 Sum_probs=132.6
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||+||+++.. +++.||||++... .......+.+|+.++..++||||+++++++.++...+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999975 4889999998752 2334567889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999854 335889999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=219.16 Aligned_cols=149 Identities=31% Similarity=0.464 Sum_probs=120.2
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe-----EEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-----KLLI 514 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~-----~~lV 514 (607)
.|...+++|.|+||.||+|.+.. ++.||||++-...+ .-.+|+++|++++|||||+|+-++..... ..||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667899999999999999865 68999999754222 12358899999999999999988865322 3599
Q ss_pred EEcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CceEEeecccceee
Q 007336 515 YEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTF 592 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~-~~~ki~DfGla~~~ 592 (607)
|||||. +|..+++.- .....++...+.-+..||.+||+|||+.+ |+||||||+|+|+|.+ +.+||+|||-||.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999985 888887532 12344666667779999999999999976 9999999999999976 89999999999999
Q ss_pred cCCCC
Q 007336 593 GGDET 597 (607)
Q Consensus 593 ~~~~~ 597 (607)
...+.
T Consensus 177 ~~~ep 181 (364)
T KOG0658|consen 177 VKGEP 181 (364)
T ss_pred ccCCC
Confidence 76554
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=223.01 Aligned_cols=150 Identities=24% Similarity=0.364 Sum_probs=133.2
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
.++|++.+.||+|+||.||+++... ++.||||.+.+. .....+.+.+|+.++.+++||||+++++.+.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 3578899999999999999999864 789999998652 223456788999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+..
T Consensus 97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999854 335788888899999999999999987 99999999999999999999999999997743
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=214.37 Aligned_cols=153 Identities=27% Similarity=0.389 Sum_probs=135.6
Q ss_pred hcCCcccceeecccCceeEEEEEe-cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
..+.|++.++||.|..++||+|+. +.+..||||++.-. .....+.+++|+..|+.++||||++.+..|..+..+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 345799999999999999999985 45799999998642 2234688999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
.||.+|++.++++..-+. -+++..+..|.+++++||.|||.++ .||||||+.||||+++|.|||+|||.+-.+..
T Consensus 104 pfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999999765443 3889999999999999999999988 99999999999999999999999998776643
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=219.74 Aligned_cols=149 Identities=23% Similarity=0.341 Sum_probs=132.2
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999976 4889999998642 2234567889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999854 335788899999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=224.36 Aligned_cols=156 Identities=21% Similarity=0.265 Sum_probs=135.8
Q ss_pred HHhHHhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEe
Q 007336 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (607)
Q Consensus 432 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~ 507 (607)
+.++....++|++.+.||+|+||.||+++... ++.+|+|.+.+. .......+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 33445566899999999999999999999864 788999998642 22344568899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
+...++||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999999843 23678888889999999999999987 9999999999999999999999999
Q ss_pred cceeecC
Q 007336 588 LVRTFGG 594 (607)
Q Consensus 588 la~~~~~ 594 (607)
+++.+..
T Consensus 188 ~a~~~~~ 194 (371)
T cd05622 188 TCMKMNK 194 (371)
T ss_pred ceeEcCc
Confidence 9998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=225.68 Aligned_cols=147 Identities=24% Similarity=0.380 Sum_probs=130.2
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
.+|++.+.||+|+||.||+++... ++.||||.+.+.. ......+.+|+.++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 368899999999999999999754 7899999986521 233566889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
||+++|+|.+++.. ...++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999954 345788888889999999999999987 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=225.35 Aligned_cols=151 Identities=23% Similarity=0.282 Sum_probs=132.6
Q ss_pred hhcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
...++|++.++||+|+||.||+++... +..||+|.+.+. .....+.+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 345689999999999999999999754 789999998642 2234456789999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||+++|+|.+++.. ..++......++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999853 23677888889999999999999987 999999999999999999999999999877
Q ss_pred cC
Q 007336 593 GG 594 (607)
Q Consensus 593 ~~ 594 (607)
..
T Consensus 193 ~~ 194 (370)
T cd05596 193 DA 194 (370)
T ss_pred cC
Confidence 54
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-24 Score=219.68 Aligned_cols=141 Identities=25% Similarity=0.292 Sum_probs=125.6
Q ss_pred eeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCC
Q 007336 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 521 (607)
+.||+|+||.||+++.. +++.||||++++. .......+.+|+.++++++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 5889999998752 2334567889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 99998853 345789999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=214.66 Aligned_cols=149 Identities=28% Similarity=0.375 Sum_probs=130.5
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.|+..+.||+|+||.||++... +++.||+|.+.+.. ......+.+|+.++.+++|+||+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677899999999999999874 58999999986421 2334568899999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+++|+|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 999999998885432 235789999999999999999999887 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=225.79 Aligned_cols=146 Identities=25% Similarity=0.377 Sum_probs=129.9
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.|+..++||+|+||.||+++... ++.||+|++.+. .......+.+|+.++++++||||+++++.+.+.+..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58888999999999999998754 788999998652 23345678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 9999999999854 235788888889999999999999987 999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=229.97 Aligned_cols=152 Identities=18% Similarity=0.236 Sum_probs=133.2
Q ss_pred CcccceeecccCceeEEEEEecC--CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~--~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
.|.+.+.||+|+||.||++.... +..||+|.+..........+++|+.+++.++||||+++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 48889999999999999998643 5678888775545555667889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 519 PNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 519 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
++|+|.++|... .....+++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999988542 23445788899999999999999999887 999999999999999999999999999987543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=226.32 Aligned_cols=154 Identities=32% Similarity=0.481 Sum_probs=132.2
Q ss_pred hcCCcccceeecccCceeEEEEEe------cCCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCC
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~ 509 (607)
..++|++.++||+|+||.||+++. ..+..||||+++.. .....+.+.+|+.++..+ +||||++++++|.+++
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345788999999999999999974 22568999998643 234456788999999999 8999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhcCCC---------------------------------------------------------
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTR--------------------------------------------------------- 532 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 532 (607)
..++||||+++|+|.+++.....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999854211
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 533 ---------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 533 ---------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 124788999999999999999999887 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=219.89 Aligned_cols=151 Identities=22% Similarity=0.312 Sum_probs=133.7
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||.||+++.. +++.||+|+++.. .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999875 4889999998752 2234567889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+++|+|.+++... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999643 245889999999999999999999987 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=218.96 Aligned_cols=150 Identities=23% Similarity=0.297 Sum_probs=132.6
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||.||+++... ++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468899999999999999999754 889999998642 2234566889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999998542 345788899999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-24 Score=219.03 Aligned_cols=141 Identities=26% Similarity=0.311 Sum_probs=125.9
Q ss_pred eeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCC
Q 007336 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 521 (607)
+.||+|+||.||++... +++.||+|++.+. .......+.+|+.+++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 4889999998752 2344567889999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 99988843 345789999999999999999999887 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=217.58 Aligned_cols=140 Identities=25% Similarity=0.293 Sum_probs=125.1
Q ss_pred ecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCCh
Q 007336 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (607)
Q Consensus 448 lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (607)
||+|+||.||+++..+ ++.||+|.+.+. .......+..|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999864 789999998652 334556788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM 144 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence 999854 335789999999999999999999887 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=229.54 Aligned_cols=161 Identities=29% Similarity=0.451 Sum_probs=137.0
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCC------eEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------EKL 512 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~ 512 (607)
.+...+.||+|+||.||+|+.+ .|+.||||.+... .....+...+|++++++++|+|||++++.-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3455578999999999999964 4999999998763 3455677889999999999999999999865543 458
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc--CCCc--eEEeeccc
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMN--PKISDFGL 588 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~--~~~~--~ki~DfGl 588 (607)
+|||||++|+|...|.+.....-|++...+.+..+++.||.|||+++ ||||||||.||++- +++. -||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999988777778999999999999999999999887 99999999999983 3343 59999999
Q ss_pred ceeecCCCCccCccceecC
Q 007336 589 VRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 589 a~~~~~~~~~~~~~~~~GT 607 (607)
||.+.+++ ..+.+.||
T Consensus 171 Arel~d~s---~~~S~vGT 186 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGT 186 (732)
T ss_pred cccCCCCC---eeeeecCc
Confidence 99997665 35567887
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=218.52 Aligned_cols=151 Identities=22% Similarity=0.272 Sum_probs=132.7
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||.||+++... ++.||+|.+.+. .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478899999999999999999754 788999998652 2233456888999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..+
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999642 235788888999999999999999887 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=218.02 Aligned_cols=141 Identities=24% Similarity=0.299 Sum_probs=125.5
Q ss_pred eeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCC
Q 007336 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 521 (607)
+.||+|+||.||+++.. ++..||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999875 4889999998752 2334567788999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 99988843 335789999999999999999999887 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=223.00 Aligned_cols=156 Identities=31% Similarity=0.449 Sum_probs=132.9
Q ss_pred HhhcCCcccceeecccCceeEEEEEecC------CcEEEEEEeccc-chhhHHHHHHHHHHHccCC-CCceeceEEEEEe
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ 507 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~ 507 (607)
....++|.+.++||+|+||.||+|+... +..||||++... .....+.|.+|+.+++++. ||||++++++|.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3446789999999999999999998632 346999998653 3344567999999999996 9999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhcCCC-------------------------------------------------------
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQTR------------------------------------------------------- 532 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------------- 532 (607)
....+|||||+++|+|.++|.....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999999854210
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEE
Q 007336 533 --------------------------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (607)
Q Consensus 533 --------------------------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nil 574 (607)
...+++..+..++.||++||.|||+.+ |+||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence 124778888999999999999999887 999999999999
Q ss_pred EcCCCceEEeecccceeecC
Q 007336 575 LDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 575 l~~~~~~ki~DfGla~~~~~ 594 (607)
+++++.+||+|||+++.+..
T Consensus 270 l~~~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMH 289 (400)
T ss_pred EeCCCEEEEEeCCcceeccc
Confidence 99999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=216.14 Aligned_cols=155 Identities=31% Similarity=0.478 Sum_probs=131.1
Q ss_pred ceeecccCceeEEEEEecC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCC
Q 007336 445 NNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 521 (607)
.++||+|.||+||-|+.+. |+.||||.+.+ ....+...+++|+.++.+++||.||.|-..|+..+..++|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 3789999999999999854 99999999976 34456688999999999999999999999999999999999999765
Q ss_pred ChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC---CceEEeecccceeecCCCCc
Q 007336 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRTFGGDETE 598 (607)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~---~~~ki~DfGla~~~~~~~~~ 598 (607)
-|+-+|.. ....|+++.-..++.||+.||.|||.++ |+|+||||+||||.+. -++||+|||+||++++...+
T Consensus 649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 55555532 3456788888889999999999999987 9999999999999654 46999999999999876654
Q ss_pred cCccceecC
Q 007336 599 GNTNRVVGT 607 (607)
Q Consensus 599 ~~~~~~~GT 607 (607)
. .++||
T Consensus 724 r---sVVGT 729 (888)
T KOG4236|consen 724 R---SVVGT 729 (888)
T ss_pred h---hhcCC
Confidence 2 35665
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-24 Score=221.08 Aligned_cols=150 Identities=27% Similarity=0.413 Sum_probs=134.2
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||+||+++.. +++.||||++.+. .......+..|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999986 4889999998752 2244567899999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999543 45889999999999999999999977 999999999999999999999999999977543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=215.62 Aligned_cols=142 Identities=25% Similarity=0.286 Sum_probs=125.0
Q ss_pred eeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCC
Q 007336 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 521 (607)
+.||+|+||.||++... .+..||+|.+.+. .......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 4889999998752 2334567788999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~ 147 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 147 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence 99988843 3457899999999999999999997 45 9999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=231.76 Aligned_cols=156 Identities=31% Similarity=0.453 Sum_probs=136.0
Q ss_pred HHhhcCCcccceeecccCceeEEEEEecCC-cEEEEEEecccchhhHHHHHHHHHHHccCC-CCceeceEEE-EEe----
Q 007336 435 IANATDNFSINNKLGEGGFGPVYKGTLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGC-CIQ---- 507 (607)
Q Consensus 435 ~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~-~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~-~~~---- 507 (607)
+.....++++.+.|.+|||+.||.++...+ .++|+|++-..++...+..++|+.+|++|+ |+|||.+++. ...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 344566888999999999999999998776 999999987778888999999999999997 9999999993 221
Q ss_pred --CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEee
Q 007336 508 --GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (607)
Q Consensus 508 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~D 585 (607)
.-+.+|+||||++|.|-+++...... .|++.++++|+.++++|+++||... ++|||||||.+||||+.+++.||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence 13568999999999999999654333 3899999999999999999999874 7899999999999999999999999
Q ss_pred cccceee
Q 007336 586 FGLVRTF 592 (607)
Q Consensus 586 fGla~~~ 592 (607)
||-|.-.
T Consensus 190 FGSatt~ 196 (738)
T KOG1989|consen 190 FGSATTK 196 (738)
T ss_pred ccccccc
Confidence 9988643
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=217.11 Aligned_cols=150 Identities=19% Similarity=0.263 Sum_probs=131.6
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.++||+|+||.||+++... ++.+|+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368889999999999999999865 678999998642 2233456889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+++|+|.+++... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999642 235788889999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=223.05 Aligned_cols=155 Identities=34% Similarity=0.507 Sum_probs=132.1
Q ss_pred hhcCCcccceeecccCceeEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEeC
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~ 508 (607)
...++|++.+.||+|+||.||++... ++..||||++... .....+.+.+|+.+++.+ +|+||++++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34457889999999999999998742 2357999998753 334456788999999999 899999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCC--------------------------------------------------------
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTR-------------------------------------------------------- 532 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 532 (607)
...++||||+++|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999999854210
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 533 -----------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 533 -----------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
...+++....+|+.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 124788889999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=216.92 Aligned_cols=148 Identities=25% Similarity=0.354 Sum_probs=129.2
Q ss_pred CcccceeecccCceeEEEEEec----CCcEEEEEEeccc----chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~----~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 511 (607)
+|++.+.||+|+||.||+++.. .++.||+|.+.+. .....+.+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999998753 4789999998652 123345688899999999 599999999999999999
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++||||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999854 345788999999999999999999887 99999999999999999999999999987
Q ss_pred ecC
Q 007336 592 FGG 594 (607)
Q Consensus 592 ~~~ 594 (607)
+..
T Consensus 155 ~~~ 157 (332)
T cd05614 155 FLS 157 (332)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=219.73 Aligned_cols=148 Identities=28% Similarity=0.403 Sum_probs=131.6
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||.||++.... ++.||||++... .......+..|+.++..++||||+++++.+.+.+..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468888999999999999998754 789999998642 2334567889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999853 345788899999999999999999887 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=210.57 Aligned_cols=149 Identities=28% Similarity=0.475 Sum_probs=131.5
Q ss_pred cCCcccceeecccCceeEEEEEec----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.. .....+.|.+|+.++++++||||+++++++..++..+|
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 346888899999999999999863 3568999998753 33445679999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998542 245889999999999999999999887 999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=216.25 Aligned_cols=150 Identities=31% Similarity=0.582 Sum_probs=129.7
Q ss_pred CCcccceeecccCceeEEEEEecC-Cc----EEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
.+|++.+.||+|+||.||+|++.. +. .||+|.++.. .....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468899999999999999998643 33 4899998653 334567899999999999999999999999765 5679
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+||+++|+|.+++... ...+++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998643 345789999999999999999999887 9999999999999999999999999999875
Q ss_pred CC
Q 007336 594 GD 595 (607)
Q Consensus 594 ~~ 595 (607)
..
T Consensus 161 ~~ 162 (316)
T cd05108 161 AD 162 (316)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=223.73 Aligned_cols=149 Identities=27% Similarity=0.412 Sum_probs=133.1
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
+-|++.+.||.|+.|.|..|++. .|+.+|||++.+. .......+.+|+.+|+.+.|||++++++++++..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45788899999999999999975 4999999998753 3334556888999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+++|-|+++|.. ...+++++..+++.||+.|+.|.|+.+ |+||||||+|+|||.++++||+|||||-+--+
T Consensus 92 Eyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999954 456788999999999999999999987 99999999999999999999999999986543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=212.47 Aligned_cols=148 Identities=28% Similarity=0.457 Sum_probs=129.2
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++|++.++||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999875 47899999986422 23345678999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++ +|.+++... ...+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 984 898888542 345788999999999999999999887 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=214.60 Aligned_cols=150 Identities=25% Similarity=0.313 Sum_probs=132.8
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.++|++.+.||+|+||.||+++... +..+|+|.+... .....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4689999999999999999999764 788999988643 33445679999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 9999999999854 234789999999999999999999853 49999999999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=208.44 Aligned_cols=150 Identities=29% Similarity=0.333 Sum_probs=133.7
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++++.||.|.-|+||++++.+ +..+|+|++.+. .+....+...|.+||+.++||.++.|++.++.++..+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 467788999999999999999976 588999999863 3445567788999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|||+||+|...++++ ....++.....-++.+|+.||+|||-.+ ||.|||||+||||.++|++-|+||.|+....
T Consensus 157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999988654 4456788888889999999999999887 9999999999999999999999999998763
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=214.98 Aligned_cols=141 Identities=29% Similarity=0.427 Sum_probs=124.0
Q ss_pred eeecccCceeEEEEEec----CCcEEEEEEeccc----chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 446 NKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~----~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+.||+|+||.||+++.. .++.||||.+++. .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999863 4788999998752 123345678899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+++++|.+++.. ...+.+.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 999999999853 345678888889999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=208.09 Aligned_cols=146 Identities=40% Similarity=0.668 Sum_probs=127.0
Q ss_pred cceeecccCceeEEEEEec-----CCcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 444 INNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 444 ~~~~lg~G~fg~Vy~g~~~-----~~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+.+.||.|.||.||+|++. .+..|+||.++. ......+.|.+|+..+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4589999999999999987 256899999964 3344578999999999999999999999999988889999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++|+|.++|... ....+++..+..|+.|||+||+|||+.+ ++|+||+++||+|++++.+||+|||+++...
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence 9999999999764 2355899999999999999999999987 9999999999999999999999999999873
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=213.86 Aligned_cols=143 Identities=29% Similarity=0.333 Sum_probs=125.9
Q ss_pred eeecccCceeEEEEEe----cCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 446 NKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~----~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
+.||+|+||.||+++. ..++.+|+|++.+.. ......+..|+.++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999875 247899999987522 2234567789999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 9999999843 345899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=209.20 Aligned_cols=151 Identities=32% Similarity=0.559 Sum_probs=131.4
Q ss_pred CCcccceeecccCceeEEEEEec-----CCcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-----~~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
++|++.+.||+|+||.||+|... .+..|++|.+.. ........|.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46788899999999999999852 357899999874 333445789999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC
Q 007336 514 IYEFMPNKSLDSFIFDQTR--------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~ 579 (607)
||||+++++|.+++..... ...+++...+.++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853221 235788999999999999999999887 99999999999999999
Q ss_pred ceEEeecccceeec
Q 007336 580 NPKISDFGLVRTFG 593 (607)
Q Consensus 580 ~~ki~DfGla~~~~ 593 (607)
.+||+|||+++.+.
T Consensus 162 ~~kl~dfg~~~~~~ 175 (283)
T cd05090 162 HVKISDLGLSREIY 175 (283)
T ss_pred cEEecccccccccc
Confidence 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=213.65 Aligned_cols=144 Identities=30% Similarity=0.440 Sum_probs=124.6
Q ss_pred cccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHH---ccCCCCceeceEEEEEeCCeEEEE
Q 007336 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILF---SKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l---~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
|++.+.||+|+||.||++... +++.||||.+++. .....+.+..|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999875 4889999998752 223345566666554 577899999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|||+++++|..++.. ..+++.....++.||+.||.|||+.+ |+||||||+||||++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999988742 35899999999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=206.33 Aligned_cols=151 Identities=30% Similarity=0.485 Sum_probs=135.4
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
..++|++.+.||+|+||.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 345788899999999999999998778899999986532 3456789999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 99999999996533 345799999999999999999999887 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=212.74 Aligned_cols=147 Identities=26% Similarity=0.339 Sum_probs=126.8
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
+|++.+.||+|+||.||+++... ++.||||.+.+. .....+.+..|..++..+ +|++|+++.+++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788999999999999998764 679999998752 223345567777777776 6899999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999998854 234788999999999999999999887 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=212.96 Aligned_cols=146 Identities=26% Similarity=0.352 Sum_probs=127.1
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCC-CceeceEEEEEeCCeEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~ 515 (607)
+|++.+.||+|+||.||+|+..+ ++.||||++.+. .....+.+..|.+++..++| ++|+++.+++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47888999999999999999765 678999998752 23445678889999999876 56888999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 99999999999853 334788999999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=211.71 Aligned_cols=149 Identities=31% Similarity=0.448 Sum_probs=129.4
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.++|++.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999986 58899999986432 2234467889999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|++ ++|.+++... ...++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 996 6787777532 345788889999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=210.37 Aligned_cols=149 Identities=21% Similarity=0.388 Sum_probs=130.1
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
++|++.+.||+|+||.||+++... ++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 468899999999999999999864 788999998642 23345678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|++++.+..+.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999987765542 2345788999999999999999999887 99999999999999999999999999997743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=214.13 Aligned_cols=150 Identities=24% Similarity=0.327 Sum_probs=132.2
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.++|++.++||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++||||+++++++.+++..+||||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999986 4778899987643 33445679999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+++|+|.+++.. ...+++.....++.+++.||.|||+.+ +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999854 334788899999999999999999742 39999999999999999999999999998663
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=212.43 Aligned_cols=142 Identities=29% Similarity=0.377 Sum_probs=121.2
Q ss_pred eeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHcc-CCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+.||+|+||.||+|+..+ ++.||||.++.. .....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999754 788999998752 12334455566666654 5899999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+|..++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 999998854 235788899999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-23 Score=213.29 Aligned_cols=141 Identities=25% Similarity=0.356 Sum_probs=123.6
Q ss_pred eeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+.||+|+||.||+++... ++.||+|.+++. .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999754 789999998752 233455678888888776 899999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 999988853 245789999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-24 Score=218.18 Aligned_cols=162 Identities=26% Similarity=0.455 Sum_probs=140.5
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe-EEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-KLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~-~~lV~ 515 (607)
++|...+++|+|+||.++..+.+ ++..+++|++.- ......+....|+.++++++|||||...+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888899999999999988865 367899998753 334445577899999999999999999999999888 89999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
+|++||+|.+.|.+++ ...+++..+..++.||+.|+.|||++. |+|||||+.||+++.+..|||.|||+||+++.+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997644 567899999999999999999999776 999999999999999999999999999999876
Q ss_pred CCccCccceecC
Q 007336 596 ETEGNTNRVVGT 607 (607)
Q Consensus 596 ~~~~~~~~~~GT 607 (607)
... ..+++||
T Consensus 160 ~~~--a~tvvGT 169 (426)
T KOG0589|consen 160 DSL--ASTVVGT 169 (426)
T ss_pred hhh--hheecCC
Confidence 632 3346776
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=220.15 Aligned_cols=138 Identities=33% Similarity=0.505 Sum_probs=122.8
Q ss_pred ceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCChH
Q 007336 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 524 (607)
++-||.|+-|.||+|++ .++.||||+++...+ .+++.|++|+||||+.+.|+|....-++||||||+.|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 46799999999999999 478999998865332 3778899999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 525 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
..|.. ...+.......+..+||.||.|||.+. |||||||.-||||..+..+||+|||-++.+.+-.
T Consensus 201 ~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S 266 (904)
T KOG4721|consen 201 EVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS 266 (904)
T ss_pred HHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh
Confidence 99943 445677888899999999999999987 9999999999999999999999999999886543
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=224.72 Aligned_cols=157 Identities=22% Similarity=0.302 Sum_probs=133.6
Q ss_pred HhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCC---
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--- 509 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~--- 509 (607)
....++|++.+.||+|+||+||+++.. +++.||||++.. ........+.+|+..+..++|+||+++...+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344569999999999999999999864 589999999864 23455677889999999999999999988765432
Q ss_pred -----eEEEEEEcCCCCChHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEE
Q 007336 510 -----EKLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (607)
Q Consensus 510 -----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki 583 (607)
..++||||+++|+|.++|.... ....+++.....++.|++.||.|||+.+ |+||||||+||||+.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 3579999999999999986432 2356889999999999999999999887 999999999999999999999
Q ss_pred eecccceeecCC
Q 007336 584 SDFGLVRTFGGD 595 (607)
Q Consensus 584 ~DfGla~~~~~~ 595 (607)
+|||+++.+...
T Consensus 185 ~DFGls~~~~~~ 196 (496)
T PTZ00283 185 GDFGFSKMYAAT 196 (496)
T ss_pred EecccCeecccc
Confidence 999999987543
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=217.01 Aligned_cols=145 Identities=28% Similarity=0.419 Sum_probs=126.6
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++|+..++||+|+||.||+++.. +++.||||.+... .....+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 35667789999999999999975 4889999998643 334456799999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+++|+|.... ..++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+..
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999986432 3456777889999999999999987 99999999999999999999999999997753
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=215.16 Aligned_cols=161 Identities=27% Similarity=0.432 Sum_probs=139.9
Q ss_pred hhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccch---hhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~ 511 (607)
.....|++.+.||+|.||.||+++... |+.+|+|.+.+... ...+.+.+|+.+|+++. |||||.+.+++++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678888999999999999999876 89999999976332 24568999999999998 99999999999999999
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC----CceEEeecc
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDFG 587 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~----~~~ki~DfG 587 (607)
++|||++.+|.|.+.+... . +++.....++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999654 2 899999999999999999999977 9999999999999643 479999999
Q ss_pred cceeecCCCCccCccceecC
Q 007336 588 LVRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 588 la~~~~~~~~~~~~~~~~GT 607 (607)
+|+.+.+ ......++||
T Consensus 185 la~~~~~---~~~~~~~~Gt 201 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGT 201 (382)
T ss_pred CceEccC---CceEeeecCC
Confidence 9999876 2234556776
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=218.20 Aligned_cols=143 Identities=20% Similarity=0.302 Sum_probs=126.2
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
...+|++.++||+|+||.||++.... ++.||+|.... ..+.+|+.++++++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 34679999999999999999999754 78999996532 346789999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++. ++|..++.. ...+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+...
T Consensus 164 ~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 164 RYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred cCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 996 788888743 235789999999999999999999987 9999999999999999999999999998643
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=208.18 Aligned_cols=149 Identities=29% Similarity=0.383 Sum_probs=130.7
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
+|++.++||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999875 48899999986421 2234567889999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++.+.
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 999999998886432 345899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=213.02 Aligned_cols=140 Identities=25% Similarity=0.370 Sum_probs=124.0
Q ss_pred eeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+.||+|+||.||+++... ++.||||.+++. .......+..|..++..+ +||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999999754 789999999752 223445688899999888 799999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence 999988853 245899999999999999999999887 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=212.19 Aligned_cols=141 Identities=26% Similarity=0.376 Sum_probs=123.5
Q ss_pred eeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+.||+|+||.||+|+... ++.||||.+.+. .....+.+..|.+++..+ +||||+++++++...+..+|||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999999765 789999998752 233455677888888765 899999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|+|..++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence 999988854 235788899999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-23 Score=207.59 Aligned_cols=150 Identities=29% Similarity=0.550 Sum_probs=131.9
Q ss_pred CCcccceeecccCceeEEEEEec-----CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEe--CCeEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKL 512 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-----~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~ 512 (607)
.+|++.+.||+|+||.||++... .+..||+|++........+.|.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 47888899999999999999753 477899999876666667889999999999999999999998754 34578
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998542 345899999999999999999999887 999999999999999999999999999976
Q ss_pred cC
Q 007336 593 GG 594 (607)
Q Consensus 593 ~~ 594 (607)
..
T Consensus 159 ~~ 160 (284)
T cd05081 159 PQ 160 (284)
T ss_pred cC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=211.78 Aligned_cols=141 Identities=28% Similarity=0.354 Sum_probs=120.9
Q ss_pred eeecccCceeEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHH-HHccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+.||+|+||+||+++.. +++.||||++.+.. .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999985 48899999986521 223344555544 56789999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|+|..++.. ...+++.....++.||++||.|||+.+ |+||||||+||||++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999999854 345788889999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=205.38 Aligned_cols=148 Identities=29% Similarity=0.462 Sum_probs=132.0
Q ss_pred CCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
++|++.+.||+|+||.||++...++..+|+|.+... ....+.|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457888999999999999999888889999987642 2335678999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 99999998542 235789999999999999999999887 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=213.99 Aligned_cols=146 Identities=25% Similarity=0.469 Sum_probs=125.9
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCC-----eEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 512 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~ 512 (607)
+|++.++||+|+||.||+|... ++..||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999975 4889999998642 2234567889999999999999999999886432 479
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||++ ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 689888843 335889999999999999999999987 999999999999999999999999999865
Q ss_pred c
Q 007336 593 G 593 (607)
Q Consensus 593 ~ 593 (607)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-23 Score=207.04 Aligned_cols=144 Identities=31% Similarity=0.412 Sum_probs=125.9
Q ss_pred ecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCCh
Q 007336 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (607)
Q Consensus 448 lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (607)
||+|+||+||++... +++.||+|.+.+. .....+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 4789999998642 123446778899999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 524 DSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 524 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 98875432 3456899999999999999999999987 99999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-23 Score=204.31 Aligned_cols=149 Identities=30% Similarity=0.470 Sum_probs=132.5
Q ss_pred CCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
++|++.+.||+|+||.||++...++..+|+|.+... ....++|.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 357788999999999999999877778999988753 2335679999999999999999999999999888999999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+|+|.+++.... ..+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 999999985432 35899999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-23 Score=217.85 Aligned_cols=154 Identities=31% Similarity=0.479 Sum_probs=131.1
Q ss_pred hhcCCcccceeecccCceeEEEEEecC------CcEEEEEEeccc-chhhHHHHHHHHHHHccCC-CCceeceEEEEEeC
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG 508 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~ 508 (607)
...++|.+.++||+|+||.||+|++.+ +..||||+++.. .......+..|+.++.++. ||||++++++|...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 344567888999999999999998632 458999999753 2333457889999999997 99999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhcCC---------------------------------------------------------
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQT--------------------------------------------------------- 531 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~--------------------------------------------------------- 531 (607)
+..++||||+++|+|.++|+...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999996421
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcE
Q 007336 532 --------------------------------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573 (607)
Q Consensus 532 --------------------------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Ni 573 (607)
....+++...+.|+.||+.||+|||+.+ ++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence 1124677888999999999999999876 99999999999
Q ss_pred EEcCCCceEEeecccceeec
Q 007336 574 LLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 574 ll~~~~~~ki~DfGla~~~~ 593 (607)
|+++++.+||+|||+++.+.
T Consensus 271 Ll~~~~~~kL~DfGla~~~~ 290 (401)
T cd05107 271 LICEGKLVKICDFGLARDIM 290 (401)
T ss_pred EEeCCCEEEEEecCcceecc
Confidence 99999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-23 Score=205.15 Aligned_cols=151 Identities=30% Similarity=0.496 Sum_probs=134.9
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
.++|++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 4578899999999999999999888889999988653 234678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999998653 2345788899999999999999999877 99999999999999999999999999997753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.6e-23 Score=228.88 Aligned_cols=150 Identities=21% Similarity=0.315 Sum_probs=131.7
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.++||+|+||.||+|+... ++.||||++... .....++|.+|+.++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 578999999999999999999754 889999998642 2234567999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 516 EFMPNKSLDSFIFDQT--------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
||+++|+|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999985321 1233567788899999999999999987 9999999999999999999999999
Q ss_pred cceee
Q 007336 588 LVRTF 592 (607)
Q Consensus 588 la~~~ 592 (607)
+|+..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99977
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.5e-23 Score=206.73 Aligned_cols=153 Identities=29% Similarity=0.523 Sum_probs=131.5
Q ss_pred hcCCcccceeecccCceeEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 510 (607)
..++|++.+.||+|+||.||+|... .+..||||++... ......+|.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999753 2467999988642 23445678999999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEE
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki 583 (607)
.++||||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999864221 234678889999999999999999876 999999999999999999999
Q ss_pred eecccceeec
Q 007336 584 SDFGLVRTFG 593 (607)
Q Consensus 584 ~DfGla~~~~ 593 (607)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05062 161 GDFGMTRDIY 170 (277)
T ss_pred CCCCCccccC
Confidence 9999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.5e-23 Score=211.65 Aligned_cols=147 Identities=26% Similarity=0.354 Sum_probs=126.9
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 515 (607)
+|+..+.||+|+||+||+++.. +++.||+|++.+. .....+.+..|..++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677799999999999999875 4789999998752 2234566788888888875 577888999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999999853 345889999999999999999999887 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=206.75 Aligned_cols=153 Identities=31% Similarity=0.570 Sum_probs=137.7
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+..+|++.++||+|+||.||+|...++..+++|.+..........+..|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999999988999999998765555667899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+++++|.+++.+. ....+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999999653 2345799999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=220.11 Aligned_cols=145 Identities=25% Similarity=0.326 Sum_probs=127.5
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
...|.+.+.||+|+||.||++.... ++.||||... ...+.+|++++++++|+|||++++++..++..+||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999999865 7889999642 23456899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
+. ++|..++... ...+++..++.|+.||++||.|||+.+ ||||||||+||||+.++.+||+|||+++.+...
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 95 7888887532 335899999999999999999999887 999999999999999999999999999987543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=204.39 Aligned_cols=150 Identities=30% Similarity=0.527 Sum_probs=132.7
Q ss_pred cCCcccceeecccCceeEEEEEecC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
.++|++.+.||+|+||.||+|.+.. ...||||.++.. ......+|.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578889999999999999998743 357999988653 33445679999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998542 236889999999999999999999877 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-23 Score=211.02 Aligned_cols=141 Identities=27% Similarity=0.335 Sum_probs=120.2
Q ss_pred eeecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHHH-HHccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
++||+|+||.||+++... ++.||+|.+.+.. .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999854 7899999986521 223344555554 67889999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|+|..++.. ...++......++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 999988843 345778888889999999999999887 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.2e-23 Score=211.20 Aligned_cols=141 Identities=28% Similarity=0.354 Sum_probs=121.2
Q ss_pred eeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHH-HHccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+.||+|+||+||+++.. +++.+|+|++.+. ......++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 4889999998652 2233445555554 56789999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|+|..++.. ...+++.....++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 999988843 345789999999999999999999887 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.6e-23 Score=211.32 Aligned_cols=141 Identities=30% Similarity=0.426 Sum_probs=123.4
Q ss_pred eeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+.||+|+||.||+++... ++.||||.+.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999754 789999998752 223456677888888776 699999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 999998854 235788999999999999999999887 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=205.46 Aligned_cols=143 Identities=31% Similarity=0.495 Sum_probs=122.8
Q ss_pred eecccCceeEEEEEecC---CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCC
Q 007336 447 KLGEGGFGPVYKGTLVD---GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (607)
Q Consensus 447 ~lg~G~fg~Vy~g~~~~---~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 522 (607)
.||+|+||.||+|...+ ...+++|.+... .......|.+|+.+++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 68999999999997643 346888877542 23445678899999999999999999999999999999999999999
Q ss_pred hHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 523 LDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 523 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 9999965332 233567888899999999999999887 999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=213.94 Aligned_cols=153 Identities=29% Similarity=0.460 Sum_probs=134.2
Q ss_pred hhcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
.....|.+.+.||+|.|+.|..++... +.+||||.+++. .......+.+|+++|..++|||||+++.+......+++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 345689999999999999999999754 899999999873 22333458899999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+.+|.+++||....+ +.......++.|+..+++|||+++ |||||||++||||+.++++||+|||++-.+.
T Consensus 133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999965443 334677788999999999999988 9999999999999999999999999999886
Q ss_pred CC
Q 007336 594 GD 595 (607)
Q Consensus 594 ~~ 595 (607)
..
T Consensus 207 ~~ 208 (596)
T KOG0586|consen 207 YG 208 (596)
T ss_pred cc
Confidence 43
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-23 Score=204.13 Aligned_cols=149 Identities=30% Similarity=0.482 Sum_probs=128.7
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEe-----CCeE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-----GEEK 511 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-----~~~~ 511 (607)
..|...+.||+|+||.|.++.... +..||||++.. ......++-.+|+++++.++|+||+.++..... -+..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 455556899999999999999754 89999999873 345567888999999999999999999999865 3457
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
|+|+|+| .-+|...|.. +..|+......+++||++||.|+|+.+ |+||||||.|+|++.+...||+||||||.
T Consensus 102 YiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred EEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 9999999 4688888843 344788888889999999999999988 99999999999999999999999999999
Q ss_pred ecCC
Q 007336 592 FGGD 595 (607)
Q Consensus 592 ~~~~ 595 (607)
+...
T Consensus 175 ~~~~ 178 (359)
T KOG0660|consen 175 LDKF 178 (359)
T ss_pred cccc
Confidence 8653
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=207.24 Aligned_cols=143 Identities=18% Similarity=0.319 Sum_probs=124.5
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccchh---hHHHHHHHHHHHccCCCCceeceEEEEEe----CCeEEEEEEcC
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ---GLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFM 518 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~---~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~ 518 (607)
..|++|+++.||+|.+ +++.||||+++..... ..+.|.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 6889999998753222 25778899999999999999999999987 34678999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++|+|.+++.. ...+++.....++.+++.||.|||+.. +++||||||+|||+++++.+||+|||+++.+..
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 99999999954 345789999999999999999999742 278999999999999999999999999997643
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=206.85 Aligned_cols=153 Identities=28% Similarity=0.518 Sum_probs=130.8
Q ss_pred hcCCcccceeecccCceeEEEEEecC------CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 510 (607)
..++|++.++||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45689999999999999999997532 4579999886432 2344568899999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEE
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki 583 (607)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964221 234567888899999999999999887 999999999999999999999
Q ss_pred eecccceeec
Q 007336 584 SDFGLVRTFG 593 (607)
Q Consensus 584 ~DfGla~~~~ 593 (607)
+|||+++.+.
T Consensus 161 ~Dfg~~~~~~ 170 (288)
T cd05061 161 GDFGMTRDIY 170 (288)
T ss_pred CcCCcccccc
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=210.32 Aligned_cols=141 Identities=26% Similarity=0.350 Sum_probs=124.3
Q ss_pred eeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+.||+|+||+||+++... ++.||+|++++. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999754 789999999752 223456688899998888 699999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 999988843 235899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-24 Score=187.34 Aligned_cols=147 Identities=29% Similarity=0.495 Sum_probs=126.7
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+|...++||+|.||+||+|+..+ ++.||+|+++- .++..-..-.+|+-+++.++|.|||+++++...++..-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45556899999999999999765 77899998863 2222335567899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|. .+|.+|... -...++......++.|+++||.|.|+++ +.||||||+|.||+.+|+.|++||||||-++
T Consensus 83 cd-qdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafg 152 (292)
T KOG0662|consen 83 CD-QDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFG 152 (292)
T ss_pred hh-HHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcC
Confidence 96 578888643 2455788888999999999999999987 9999999999999999999999999999875
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=203.82 Aligned_cols=145 Identities=32% Similarity=0.473 Sum_probs=124.3
Q ss_pred eeecccCceeEEEEEecC---CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~---~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 521 (607)
+.||+|+||.||+|...+ +..+++|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 3579999886532 334567899999999999999999999999999999999999999
Q ss_pred ChHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 522 SLDSFIFDQT--RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 522 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+|.+++.... .....++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999996432 2234677788899999999999999887 9999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=208.95 Aligned_cols=141 Identities=29% Similarity=0.398 Sum_probs=122.1
Q ss_pred eeecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHHHHHcc-CCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+.||+|+||.||+|+... ++.||||.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999865 7899999987521 2334556667777765 5999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999999853 245788999999999999999999887 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=205.25 Aligned_cols=151 Identities=36% Similarity=0.626 Sum_probs=131.4
Q ss_pred CCcccceeecccCceeEEEEEecC------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
++|++.+.||+|+||.||+|.... ...|++|.+... .......|.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 368888999999999999998643 257999988643 3344567999999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC
Q 007336 513 LIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~ 579 (607)
++|||+++++|.+++..... ...+++.....++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999964321 145788999999999999999999987 99999999999999999
Q ss_pred ceEEeecccceeec
Q 007336 580 NPKISDFGLVRTFG 593 (607)
Q Consensus 580 ~~ki~DfGla~~~~ 593 (607)
.+||+|||+++...
T Consensus 162 ~~~L~dfg~~~~~~ 175 (283)
T cd05048 162 TVKISDFGLSRDIY 175 (283)
T ss_pred cEEECCCcceeecc
Confidence 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=205.12 Aligned_cols=150 Identities=30% Similarity=0.519 Sum_probs=126.7
Q ss_pred CCcccceeecccCceeEEEEEecC-Cc----EEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
++|++.+.||+|+||.||+|.... ++ .+++|.+... ......++..|+..+++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 467788999999999999998743 43 4777877542 2334567888999999999999999999875 455789
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999642 345899999999999999999999877 9999999999999999999999999999775
Q ss_pred CC
Q 007336 594 GD 595 (607)
Q Consensus 594 ~~ 595 (607)
..
T Consensus 161 ~~ 162 (279)
T cd05111 161 PD 162 (279)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=209.59 Aligned_cols=141 Identities=26% Similarity=0.334 Sum_probs=119.1
Q ss_pred eeecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHH-HHHccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~-~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+.||+|+||.||+++... ++.||+|.+.+.. ......+..|. .+++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999764 6789999986521 12233444444 456789999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|+|.+++.. ...+.......++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 999999854 234677788889999999999999987 999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=204.97 Aligned_cols=154 Identities=31% Similarity=0.533 Sum_probs=134.2
Q ss_pred hcCCcccceeecccCceeEEEEEecC-----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEe-CCe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEE 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-----~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~ 510 (607)
..++|++.+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45688899999999999999999865 678999988653 34556778999999999999999999999876 467
Q ss_pred EEEEEEcCCCCChHHHHhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEee
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRR-----TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~D 585 (607)
.++++||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998653322 56899999999999999999999877 99999999999999999999999
Q ss_pred cccceeecC
Q 007336 586 FGLVRTFGG 594 (607)
Q Consensus 586 fGla~~~~~ 594 (607)
||+++.+..
T Consensus 161 ~g~~~~~~~ 169 (280)
T cd05043 161 NALSRDLFP 169 (280)
T ss_pred CCCcccccC
Confidence 999997643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=205.62 Aligned_cols=151 Identities=34% Similarity=0.621 Sum_probs=133.3
Q ss_pred CCcccceeecccCceeEEEEEec------CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888899999999999999852 245689999876555667789999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEE
Q 007336 514 IYEFMPNKSLDSFIFDQT----------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki 583 (607)
||||+++++|.+++.... +...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 2235899999999999999999999887 999999999999999999999
Q ss_pred eecccceeec
Q 007336 584 SDFGLVRTFG 593 (607)
Q Consensus 584 ~DfGla~~~~ 593 (607)
+|||+++.+.
T Consensus 162 ~dfg~~~~~~ 171 (288)
T cd05093 162 GDFGMSRDVY 171 (288)
T ss_pred ccCCcccccc
Confidence 9999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=207.42 Aligned_cols=152 Identities=28% Similarity=0.479 Sum_probs=130.6
Q ss_pred cCCcccceeecccCceeEEEEEecC---------------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD---------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLL 502 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~---------------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~ 502 (607)
.++|++.++||+|+||.||++...+ ...||+|.+... .......|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578899999999999999987642 235899988653 334456799999999999999999999
Q ss_pred EEEEeCCeEEEEEEcCCCCChHHHHhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcE
Q 007336 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTR---------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573 (607)
Q Consensus 503 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Ni 573 (607)
+++...+..++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999854211 124688999999999999999999887 99999999999
Q ss_pred EEcCCCceEEeecccceeec
Q 007336 574 LLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 574 ll~~~~~~ki~DfGla~~~~ 593 (607)
|+++++.+||+|||+++.+.
T Consensus 161 ll~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred EEcCCCcEEecccccccccc
Confidence 99999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=204.99 Aligned_cols=150 Identities=26% Similarity=0.475 Sum_probs=122.4
Q ss_pred CCcccceeecccCceeEEEEEec--CCcEEEEEEecccc--hhhHHHHHHHHHHHcc---CCCCceeceEEEEEe-----
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKIS--EQGLKELKNEVILFSK---LQHRNLVKLLGCCIQ----- 507 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~--~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~---l~H~nIv~l~g~~~~----- 507 (607)
++|++.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.+++. ++||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999873 36789999886421 2223445566666655 479999999999863
Q ss_pred CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999997 68998885432 335789999999999999999999987 9999999999999999999999999
Q ss_pred cceeecC
Q 007336 588 LVRTFGG 594 (607)
Q Consensus 588 la~~~~~ 594 (607)
+++.+..
T Consensus 156 ~~~~~~~ 162 (290)
T cd07862 156 LARIYSF 162 (290)
T ss_pred ceEeccC
Confidence 9987753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=202.48 Aligned_cols=148 Identities=28% Similarity=0.468 Sum_probs=131.5
Q ss_pred CcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+|++.+.||+|+||.||++....+..+|+|.+.+. ......|.+|+.++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 57788999999999999999877778999988642 22345788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence 9999998643 236899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=202.90 Aligned_cols=151 Identities=30% Similarity=0.520 Sum_probs=132.0
Q ss_pred CCcccceeecccCceeEEEEEecC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
.+|++.+.||+|+||.||+|+... ...+|+|.++.. .....+.|.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 468888999999999999998642 347999988652 234467899999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++++|.+++... ...+++.....++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999543 245789999999999999999999887 99999999999999999999999999997754
Q ss_pred C
Q 007336 595 D 595 (607)
Q Consensus 595 ~ 595 (607)
.
T Consensus 159 ~ 159 (267)
T cd05066 159 D 159 (267)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=201.78 Aligned_cols=149 Identities=26% Similarity=0.446 Sum_probs=133.0
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++.+++||||+++++.+...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357889999999999999999974 5788999998654444556788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++.+.
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 999999998853 235789999999999999999999877 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=208.58 Aligned_cols=141 Identities=30% Similarity=0.410 Sum_probs=121.9
Q ss_pred eeecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHHHHHcc-CCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
++||+|+||.||+++... +..||+|.+++.. ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999864 7899999987521 2334556777777765 4899999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|+|..++.. ...+++.....++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999998854 235788899999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-24 Score=198.19 Aligned_cols=161 Identities=27% Similarity=0.428 Sum_probs=135.7
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-----ch---hhHHHHHHHHHHHccC-CCCceeceEEEEEe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-----SE---QGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-----~~---~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~ 507 (607)
.-..|...+.||.|..+.|.+.... .+.+.|+|++... ++ .-.+.-+.|+.+++++ -||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456778889999999999988765 4889999988631 11 2234567889999987 69999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
+...++|+|.|+.|.|.++|. ..-.++++...+|++|+.+|++|||... ||||||||+|||+|++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 999999999999999999994 3456889999999999999999999987 9999999999999999999999999
Q ss_pred cceeecCCCCccCccceecC
Q 007336 588 LVRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 588 la~~~~~~~~~~~~~~~~GT 607 (607)
+|..+.+.+. ...++||
T Consensus 169 Fa~~l~~Gek---LrelCGT 185 (411)
T KOG0599|consen 169 FACQLEPGEK---LRELCGT 185 (411)
T ss_pred eeeccCCchh---HHHhcCC
Confidence 9999876542 3335665
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=212.27 Aligned_cols=152 Identities=29% Similarity=0.491 Sum_probs=128.3
Q ss_pred cCCcccceeecccCceeEEEEEe------cCCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEeC-C
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG-E 509 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~-~ 509 (607)
.++|++.+.||+|+||.||+|.. ..++.||||+++.. .......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45789999999999999999974 23678999998753 233456788999999999 789999999988654 4
Q ss_pred eEEEEEEcCCCCChHHHHhcCCC---------------------------------------------------------
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTR--------------------------------------------------------- 532 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 532 (607)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999854210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 533 -------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 533 -------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 123678888999999999999999887 9999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=212.50 Aligned_cols=154 Identities=29% Similarity=0.485 Sum_probs=129.5
Q ss_pred hcCCcccceeecccCceeEEEEEecC------CcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEeC-
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG- 508 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~- 508 (607)
+.++|++.+.||+|+||.||+|...+ ++.||+|++... .......+..|+.++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 34579999999999999999997422 468999998642 233456788899999999 899999999988754
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCC--------------------------------------------------------
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTR-------------------------------------------------------- 532 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 532 (607)
...+++|||+++++|.++|.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 567899999999999999853211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 533 --RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 533 --~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 125789999999999999999999887 99999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=214.05 Aligned_cols=153 Identities=26% Similarity=0.514 Sum_probs=133.0
Q ss_pred hcCCcccceeecccCceeEEEEEecC---C--cEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD---G--QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~---~--~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 511 (607)
.+....+.++||+|.||.||+|.+.+ | -.||||..+. ......+.|+.|..+|++++||||++|+|+|.+ .+.
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 34455566899999999999999743 2 3599999876 455668899999999999999999999999975 567
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++|||.++.|.|..||.. +...|+......++.||..+|+|||+.. +|||||+++|||+.+..-+||+||||+|-
T Consensus 466 WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 999999999999999964 3455888999999999999999999876 99999999999999999999999999998
Q ss_pred ecCCC
Q 007336 592 FGGDE 596 (607)
Q Consensus 592 ~~~~~ 596 (607)
++.+.
T Consensus 541 ~ed~~ 545 (974)
T KOG4257|consen 541 LEDDA 545 (974)
T ss_pred ccccc
Confidence 86554
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=204.95 Aligned_cols=152 Identities=30% Similarity=0.481 Sum_probs=132.7
Q ss_pred cCCcccceeecccCceeEEEEEecC-----------------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceec
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-----------------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 500 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-----------------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~ 500 (607)
.++|++.+.||+|+||.||+++..+ +..||+|.+... .....+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578899999999999999998643 245899988753 3345678999999999999999999
Q ss_pred eEEEEEeCCeEEEEEEcCCCCChHHHHhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCc
Q 007336 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQT--------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (607)
Q Consensus 501 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~N 572 (607)
+++++..++..++|+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999996532 1235899999999999999999999887 9999999999
Q ss_pred EEEcCCCceEEeecccceeec
Q 007336 573 VLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 573 ill~~~~~~ki~DfGla~~~~ 593 (607)
|+++.++.+||+|||+++.+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred eeecCCCceEEccccceeecc
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=204.29 Aligned_cols=141 Identities=24% Similarity=0.362 Sum_probs=120.8
Q ss_pred eecccCceeEEEEEecC-------------------------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceece
Q 007336 447 KLGEGGFGPVYKGTLVD-------------------------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 501 (607)
Q Consensus 447 ~lg~G~fg~Vy~g~~~~-------------------------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l 501 (607)
+||+|+||.||+|.+.. ...|++|.+.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 13588998875444456688999999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC--
Q 007336 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-- 579 (607)
Q Consensus 502 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~-- 579 (607)
+++|.+....+|||||+++|+|..++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999998542 345789999999999999999999876 99999999999997643
Q ss_pred -----ceEEeecccceee
Q 007336 580 -----NPKISDFGLVRTF 592 (607)
Q Consensus 580 -----~~ki~DfGla~~~ 592 (607)
.+||+|||+++..
T Consensus 157 ~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCccceeeecCCcccccc
Confidence 3799999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=202.37 Aligned_cols=150 Identities=30% Similarity=0.576 Sum_probs=126.1
Q ss_pred cccceeecccCceeEEEEEecCCc---EEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeC------Ce
Q 007336 442 FSINNKLGEGGFGPVYKGTLVDGQ---EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EE 510 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~~~~---~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------~~ 510 (607)
|.+.++||+|+||.||+|...+.. .||+|.++.. .....+.+..|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 346689999999999999976532 5899987642 345567899999999999999999999988543 24
Q ss_pred EEEEEEcCCCCChHHHHhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 511 KLLIYEFMPNKSLDSFIFDQ---TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
.++||||+++|+|.+++... .....+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987432 12345889999999999999999999876 9999999999999999999999999
Q ss_pred cceeecC
Q 007336 588 LVRTFGG 594 (607)
Q Consensus 588 la~~~~~ 594 (607)
+++.+..
T Consensus 158 ~~~~~~~ 164 (272)
T cd05075 158 LSKKIYN 164 (272)
T ss_pred cccccCc
Confidence 9997643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=207.25 Aligned_cols=148 Identities=28% Similarity=0.469 Sum_probs=128.8
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++|.+.++||+|+||.||+|+.. .++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999875 47889999986432 23345678899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 985 888887542 345788899999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=206.19 Aligned_cols=154 Identities=31% Similarity=0.542 Sum_probs=132.6
Q ss_pred hcCCcccceeecccCceeEEEEEec--------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~ 507 (607)
..++|.+.+.||+|+||.||+++.. ++..||+|.+... .....+++.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3457888899999999999999742 2357999988642 234567899999999999 89999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEE
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nil 574 (607)
....++||||+++|+|.+++..... ...+++..+..++.||++||.|||+.+ ++||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999965321 235788999999999999999999887 999999999999
Q ss_pred EcCCCceEEeecccceeecC
Q 007336 575 LDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 575 l~~~~~~ki~DfGla~~~~~ 594 (607)
+++++.+||+|||+++.+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 170 VTENNVMKIADFGLARDVNN 189 (304)
T ss_pred EcCCCcEEECCCccceeccc
Confidence 99999999999999997753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=226.67 Aligned_cols=150 Identities=26% Similarity=0.385 Sum_probs=133.2
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
.++|.+.++||+|+||.||+|... .++.||||++... .......+..|+.++..++||||+++++++......+||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 357899999999999999999986 4889999998642 233456788999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++++|.+++.. ...+++...+.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++....
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 999999999999853 234788889999999999999999876 99999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=203.93 Aligned_cols=151 Identities=32% Similarity=0.609 Sum_probs=132.7
Q ss_pred CCcccceeecccCceeEEEEEecC------CcEEEEEEecccchh-hHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
++|.+.+.||+|+||.||+|+..+ +..||||.++..... ..+.|.+|+.++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468888999999999999998643 478999998764333 5678999999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCce
Q 007336 513 LIYEFMPNKSLDSFIFDQT-----------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ 581 (607)
+||||+++++|.+++.... ....+++.....++.||+.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996432 1245788999999999999999999887 9999999999999999999
Q ss_pred EEeecccceeec
Q 007336 582 KISDFGLVRTFG 593 (607)
Q Consensus 582 ki~DfGla~~~~ 593 (607)
||+|||+++.+.
T Consensus 162 kl~d~g~~~~~~ 173 (280)
T cd05049 162 KIGDFGMSRDVY 173 (280)
T ss_pred EECCcccceecc
Confidence 999999998763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-24 Score=204.89 Aligned_cols=159 Identities=30% Similarity=0.526 Sum_probs=140.0
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
.-|.++++||+|+||.||++.++. |+.||||++.. .....++..|+.+|.+.+.|++|+.+|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 347778899999999999998865 89999999864 345778999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCCCc
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~~~ 598 (607)
..|++.+.++. ++..|.+..+..+++..++||+|||... -||||||+.||||+.+|.+||+|||.|..+.+.-
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-- 183 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-- 183 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--
Confidence 99999999954 5667899999999999999999999865 7999999999999999999999999999886432
Q ss_pred cCccceecC
Q 007336 599 GNTNRVVGT 607 (607)
Q Consensus 599 ~~~~~~~GT 607 (607)
+.-++++||
T Consensus 184 AKRNTVIGT 192 (502)
T KOG0574|consen 184 AKRNTVIGT 192 (502)
T ss_pred HhhCccccC
Confidence 334557887
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=204.02 Aligned_cols=150 Identities=36% Similarity=0.541 Sum_probs=129.2
Q ss_pred CcccceeecccCceeEEEEEecC------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
+|++.+.||+|+||.||+|+... ...+++|.+... .......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778999999999999998632 357888887643 23445789999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCc
Q 007336 514 IYEFMPNKSLDSFIFDQT---------------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~N 572 (607)
|+||+++++|.+++.... ....+++...+.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999985321 1234789999999999999999999877 9999999999
Q ss_pred EEEcCCCceEEeecccceeec
Q 007336 573 VLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 573 ill~~~~~~ki~DfGla~~~~ 593 (607)
||+++++.+||+|||+++.+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred EEEcCCCcEEecccccccccc
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=205.06 Aligned_cols=156 Identities=32% Similarity=0.530 Sum_probs=134.4
Q ss_pred HhhcCCcccceeecccCceeEEEEEecC------CcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEe
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~ 507 (607)
....++|++.+.||+|+||.||++.... ...+|+|.+... ......++.+|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3455678889999999999999998643 367999988652 334456789999999999 89999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEE
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQ-------------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nil 574 (607)
++..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 99999999999999999998542 12346889999999999999999999877 999999999999
Q ss_pred EcCCCceEEeecccceeecC
Q 007336 575 LDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 575 l~~~~~~ki~DfGla~~~~~ 594 (607)
++.++.+||+|||+++.+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHH 184 (293)
T ss_pred EcCCCeEEeCcccccccccc
Confidence 99999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=212.90 Aligned_cols=147 Identities=28% Similarity=0.443 Sum_probs=127.9
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCC-----eEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 512 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~ 512 (607)
+|++.+.||+|+||.||++... +++.||||++... .....+++.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999974 5899999998642 2334567889999999999999999999998776 789
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+|+||++ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 578777743 345889999999999999999999987 999999999999999999999999999876
Q ss_pred cC
Q 007336 593 GG 594 (607)
Q Consensus 593 ~~ 594 (607)
..
T Consensus 154 ~~ 155 (372)
T cd07853 154 EP 155 (372)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=207.37 Aligned_cols=141 Identities=29% Similarity=0.396 Sum_probs=123.9
Q ss_pred eeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+.||+|+||.||++.... ++.||||.+.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999865 789999998752 233456677888888877 799999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|+|..++.. ...+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 999988854 235899999999999999999999887 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=200.33 Aligned_cols=143 Identities=29% Similarity=0.513 Sum_probs=127.0
Q ss_pred eeecccCceeEEEEEec-CCcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCCh
Q 007336 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (607)
+.||+|+||.||+|+.. +++.||+|.+.. ........|.+|+.++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 588999998764 2344567799999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 9998532 345789999999999999999999887 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=201.47 Aligned_cols=150 Identities=30% Similarity=0.525 Sum_probs=133.3
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
..|++.+.||+|+||.||+|...+ +..||+|.+... .....++.+|+.++++++|+||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 457788999999999999999754 788999988753 344678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999985432 345799999999999999999999877 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=204.06 Aligned_cols=152 Identities=32% Similarity=0.577 Sum_probs=132.6
Q ss_pred CCcccceeecccCceeEEEEEec------CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
.+|.+.+.||+|+||.||+++.. +...+++|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35778899999999999999753 245689998876555556789999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc
Q 007336 514 IYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~ 580 (607)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996432 1234789999999999999999999887 999999999999999999
Q ss_pred eEEeecccceeecC
Q 007336 581 PKISDFGLVRTFGG 594 (607)
Q Consensus 581 ~ki~DfGla~~~~~ 594 (607)
+||+|||+++....
T Consensus 162 ~~l~dfg~a~~~~~ 175 (291)
T cd05094 162 VKIGDFGMSRDVYS 175 (291)
T ss_pred EEECCCCcccccCC
Confidence 99999999986643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=203.11 Aligned_cols=153 Identities=27% Similarity=0.489 Sum_probs=132.6
Q ss_pred cCCcccceeecccCceeEEEEEecC------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 511 (607)
.++|++.+.||+|+||.||+|.... +..||+|.+... .......+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578889999999999999998743 368999998643 234456789999999999999999999999999999
Q ss_pred EEEEEcCCCCChHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEe
Q 007336 512 LLIYEFMPNKSLDSFIFDQTR-------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~ 584 (607)
++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864321 234788999999999999999999877 9999999999999999999999
Q ss_pred ecccceeecC
Q 007336 585 DFGLVRTFGG 594 (607)
Q Consensus 585 DfGla~~~~~ 594 (607)
|||+++.+..
T Consensus 162 dfg~~~~~~~ 171 (277)
T cd05032 162 DFGMTRDIYE 171 (277)
T ss_pred Ccccchhhcc
Confidence 9999986643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-22 Score=200.85 Aligned_cols=150 Identities=30% Similarity=0.540 Sum_probs=128.6
Q ss_pred cccceeecccCceeEEEEEecC----CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe-----
Q 007336 442 FSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 510 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~----- 510 (607)
|++.+.||+|+||.||+|.... +..||||+++. ........+.+|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998743 36799999864 233456789999999999999999999999876554
Q ss_pred -EEEEEEcCCCCChHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeec
Q 007336 511 -KLLIYEFMPNKSLDSFIFDQT---RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (607)
Q Consensus 511 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~Df 586 (607)
.++|+||+++|+|..++.... ....+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999985432 2346899999999999999999999887 999999999999999999999999
Q ss_pred ccceeecC
Q 007336 587 GLVRTFGG 594 (607)
Q Consensus 587 Gla~~~~~ 594 (607)
|+++.+..
T Consensus 158 g~~~~~~~ 165 (273)
T cd05035 158 GLSKKIYS 165 (273)
T ss_pred cceeeccc
Confidence 99997643
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=201.81 Aligned_cols=150 Identities=29% Similarity=0.493 Sum_probs=130.8
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
.++|++.++||+|+||.||+|+..+...||+|+++... ...+.|.+|+.++++++||||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35789999999999999999998777789999987522 23467899999999999999999999874 45678999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++|+|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999999643 2345789999999999999999999877 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=200.01 Aligned_cols=155 Identities=28% Similarity=0.396 Sum_probs=133.1
Q ss_pred HhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
+.+++++.....||+|+||.||+|+..+ +..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 3455666666799999999999999754 678999998765556677899999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCceEEeecccceeec
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFG 593 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~-~~~~ki~DfGla~~~~ 593 (607)
+||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++..+.
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999965322212378888899999999999999877 999999999999986 6789999999998764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=201.30 Aligned_cols=150 Identities=31% Similarity=0.528 Sum_probs=132.0
Q ss_pred CCcccceeecccCceeEEEEEecC-C---cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~---~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
..|++.+.||+|+||.||+|.... + ..||||.+... ......+|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999999754 2 36999998753 345567899999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998542 345789999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=200.72 Aligned_cols=145 Identities=32% Similarity=0.554 Sum_probs=128.5
Q ss_pred cccceeecccCceeEEEEEecC-CcEEEEEEecccchhh--HHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQG--LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~--~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
|++.+.||+|+||+||++.... ++.+|+|.+....... ......|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678999999999999999866 5689999997643322 223456999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
++++|.+++. ....+++..+..++.||++||.|||+.+ |+|+||||+||++++++.++|+|||++..+
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999996 3455799999999999999999999987 999999999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=204.31 Aligned_cols=152 Identities=28% Similarity=0.496 Sum_probs=131.1
Q ss_pred cCCcccceeecccCceeEEEEEec-----------------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceec
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-----------------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 500 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-----------------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~ 500 (607)
.++|++.++||+|+||.||++... +...||+|.+... .......|.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999998532 1346899988653 3445678999999999999999999
Q ss_pred eEEEEEeCCeEEEEEEcCCCCChHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCc
Q 007336 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR--------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (607)
Q Consensus 501 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~N 572 (607)
+++++...+..++||||+++++|.+++..... ...+++.....++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999865321 134778899999999999999999987 9999999999
Q ss_pred EEEcCCCceEEeecccceeec
Q 007336 573 VLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 573 ill~~~~~~ki~DfGla~~~~ 593 (607)
||+++++.+||+|||+++.+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred EEEcCCCCEEeccCccccccc
Confidence 999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=205.08 Aligned_cols=149 Identities=26% Similarity=0.310 Sum_probs=130.7
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++|++.+.||+|+||.||++.... +..+|+|.+... .......+.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 368899999999999999998754 778888887642 334456788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++++|.+++... ..+++..+..++.|+++||.|||+.. +++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 9999999999542 45788999999999999999999742 39999999999999999999999999998663
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=204.13 Aligned_cols=150 Identities=33% Similarity=0.544 Sum_probs=129.4
Q ss_pred CcccceeecccCceeEEEEEecC------CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
+|++.+.||+|+||.||+|...+ +..||||++.... ....+.|.+|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46777899999999999998643 4689999987532 2335678999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc
Q 007336 514 IYEFMPNKSLDSFIFDQ-------------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~ 580 (607)
++||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998421 11235788899999999999999999887 999999999999999999
Q ss_pred eEEeecccceeec
Q 007336 581 PKISDFGLVRTFG 593 (607)
Q Consensus 581 ~ki~DfGla~~~~ 593 (607)
+||+|||+++.+.
T Consensus 163 ~kl~Dfg~~~~~~ 175 (283)
T cd05091 163 VKISDLGLFREVY 175 (283)
T ss_pred eEecccccccccc
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=202.46 Aligned_cols=150 Identities=31% Similarity=0.422 Sum_probs=133.3
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||.||++.... ++.||+|.+... .....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 468889999999999999999754 789999998642 2234567889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+++++|.+++... ..++...+..++.||+.||.|||+.+ ++|+||+|+||||+.++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998542 45789999999999999999999977 999999999999999999999999999977543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=201.83 Aligned_cols=151 Identities=32% Similarity=0.562 Sum_probs=132.8
Q ss_pred CCcccceeecccCceeEEEEEec------CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
.+|...++||+|+||.||++... ++..+++|.+..........|.+|+.+++.++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999742 256799998877666667789999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCce
Q 007336 514 IYEFMPNKSLDSFIFDQTR------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ 581 (607)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 135789999999999999999999887 9999999999999999999
Q ss_pred EEeecccceeec
Q 007336 582 KISDFGLVRTFG 593 (607)
Q Consensus 582 ki~DfGla~~~~ 593 (607)
||+|||+++.+.
T Consensus 162 kL~dfg~~~~~~ 173 (280)
T cd05092 162 KIGDFGMSRDIY 173 (280)
T ss_pred EECCCCceeEcC
Confidence 999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=201.39 Aligned_cols=148 Identities=28% Similarity=0.371 Sum_probs=129.5
Q ss_pred cccceeecccCceeEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
|+..+.||+|+||+||++... +++.+|+|.+.... ....+.+.+|+.++++++|+||+.+.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999875 48899999986421 22345678899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999998886432 335899999999999999999999887 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=207.41 Aligned_cols=139 Identities=25% Similarity=0.308 Sum_probs=118.7
Q ss_pred ecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHHHHHccC---CCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 448 lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
||+|+||+||+++... ++.||||++.+.. ......+..|..++... +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999998754 8899999986421 22333455566666554 799999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|+|..++.. ...+++.....++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 999998853 345789999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-23 Score=214.78 Aligned_cols=148 Identities=30% Similarity=0.481 Sum_probs=128.2
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
-|+.++.||.|+||.||.++... ...||||++.-. +......+..|+..+.+++|||++...|++......+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 57777899999999999999754 678999998642 33345678999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||- |+-.++|.-. .+.+..-.+..|+.+.+.||+|||+.+ .||||||+.||||++.+.|||+|||.|.+..+
T Consensus 107 YCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 995 6777776432 345778888899999999999999987 89999999999999999999999999998764
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=201.09 Aligned_cols=149 Identities=32% Similarity=0.540 Sum_probs=131.0
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+|++.+.||+|+||.||+|+.. ++..||||++... .....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 4889999988642 223346788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++ ++|.+++........+++..+..++.||++||.|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 98 689888865444466899999999999999999999887 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=200.92 Aligned_cols=150 Identities=30% Similarity=0.535 Sum_probs=129.0
Q ss_pred cCCcccceeecccCceeEEEEEec-CCc----EEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~----~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
.++|++.++||+|+||+||+|+.. ++. .||+|.+.. ......+++.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 357888899999999999999853 343 489998864 334456789999999999999999999999975 4567
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+++||+++|+|.+++... ...+++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998642 345889999999999999999999987 999999999999999999999999999977
Q ss_pred cC
Q 007336 593 GG 594 (607)
Q Consensus 593 ~~ 594 (607)
..
T Consensus 160 ~~ 161 (279)
T cd05109 160 DI 161 (279)
T ss_pred cc
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=198.71 Aligned_cols=151 Identities=32% Similarity=0.521 Sum_probs=135.4
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
..++|++.++||+|+||.||++...++..||||.+... ....+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 45689999999999999999999888889999998753 23456799999999999999999999999988899999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence 99999999996532 345899999999999999999999887 9999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=200.28 Aligned_cols=149 Identities=28% Similarity=0.486 Sum_probs=133.1
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.++|++.+.||+|+||.||+++.. +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 347888899999999999999875 4789999998754445556788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 999999999853 335789999999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=200.99 Aligned_cols=142 Identities=25% Similarity=0.456 Sum_probs=121.0
Q ss_pred eecccCceeEEEEEecCC---cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCC
Q 007336 447 KLGEGGFGPVYKGTLVDG---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (607)
Q Consensus 447 ~lg~G~fg~Vy~g~~~~~---~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 522 (607)
.||+|+||.||++...++ ..+++|.+... .....+.|.+|+.+++.++||||+++++.|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999986443 34667766543 23456789999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 523 LDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 523 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
|.+++..... ....++.....++.||++||+|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 9999965322 234677778889999999999999877 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-23 Score=214.94 Aligned_cols=156 Identities=28% Similarity=0.460 Sum_probs=130.0
Q ss_pred cceeecccCceeEEEEEecC-CcEEEEEEec--c--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe--EEEEEE
Q 007336 444 INNKLGEGGFGPVYKGTLVD-GQEIAVKRLS--K--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--KLLIYE 516 (607)
Q Consensus 444 ~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~--~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~--~~lV~E 516 (607)
..++||+|+|-+||+|.+.. |.+||--.++ . .++...++|..|+.+|+.|+||||++++..+.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 34799999999999998754 6677643322 2 244566899999999999999999999999987665 679999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CceEEeecccceeecCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGD 595 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~-~~~ki~DfGla~~~~~~ 595 (607)
.+..|+|..|+.+. ..+..+....+++||++||.|||++. ++|||||||.+||+|+.+ |.|||.|+|||.++...
T Consensus 124 L~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999553 34678899999999999999999986 789999999999999865 89999999999988654
Q ss_pred CCccCccceecC
Q 007336 596 ETEGNTNRVVGT 607 (607)
Q Consensus 596 ~~~~~~~~~~GT 607 (607)
.. ..++||
T Consensus 200 ~a----ksvIGT 207 (632)
T KOG0584|consen 200 HA----KSVIGT 207 (632)
T ss_pred cc----ceeccC
Confidence 42 236787
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=198.22 Aligned_cols=149 Identities=32% Similarity=0.588 Sum_probs=133.5
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
.++|++.+.||+|+||.||++... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 347888899999999999999874 78999999876433 5678999999999999999999999999989999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999986432 235899999999999999999999887 9999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-22 Score=199.53 Aligned_cols=143 Identities=29% Similarity=0.403 Sum_probs=123.8
Q ss_pred ecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCCh
Q 007336 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (607)
Q Consensus 448 lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (607)
||+|+||.||++.... ++.+|+|.+.... ......+..|+.++++++||||+++.+.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999998754 8999999986421 12234556799999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 98885432 334789999999999999999999877 99999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=198.72 Aligned_cols=152 Identities=26% Similarity=0.458 Sum_probs=133.2
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||.||+|+.. +++.||||.+.. ........+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999975 588999998753 23344567899999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+++++|.+++.... ....++......++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885322 2345788999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=204.03 Aligned_cols=152 Identities=34% Similarity=0.513 Sum_probs=132.2
Q ss_pred cCCcccceeecccCceeEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCe
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 510 (607)
.++|.+.+.||+|+||.||++... .+..||||+++.. .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357888899999999999999742 2457999988753 234456799999999999 79999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++||||+++|+|.+++.... ...+++.++..++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999986422 334899999999999999999999887 9999999999999999999999999998
Q ss_pred eecC
Q 007336 591 TFGG 594 (607)
Q Consensus 591 ~~~~ 594 (607)
.+..
T Consensus 190 ~~~~ 193 (302)
T cd05055 190 DIMN 193 (302)
T ss_pred cccC
Confidence 7643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=202.68 Aligned_cols=151 Identities=26% Similarity=0.493 Sum_probs=134.9
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
...+|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 3468999999999999999999964 589999999876444556778999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+...
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999999843 34788999999999999999999877 999999999999999999999999999876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=202.39 Aligned_cols=151 Identities=31% Similarity=0.445 Sum_probs=135.6
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
+.++|++.+.||+|+||.||++... ++..+|+|.+........+.|..|+.++++++||||+++++.+..+...++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 3467899999999999999999975 478999999876556667789999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++....
T Consensus 83 ~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 83 FCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred ccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 99999999998542 235889999999999999999999987 9999999999999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=200.48 Aligned_cols=152 Identities=32% Similarity=0.505 Sum_probs=131.3
Q ss_pred hhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEEeC------
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG------ 508 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~------ 508 (607)
.+.+.|++.+.||+|+||.||+|...+ ++.||+|.+... ......+..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 356678888999999999999998754 788999998653 23456788899999998 799999999998753
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccc
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGl 588 (607)
...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4578999999999999998642 2346889999999999999999999987 99999999999999999999999999
Q ss_pred ceeec
Q 007336 589 VRTFG 593 (607)
Q Consensus 589 a~~~~ 593 (607)
++.+.
T Consensus 158 ~~~~~ 162 (272)
T cd06637 158 SAQLD 162 (272)
T ss_pred ceecc
Confidence 98764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=212.60 Aligned_cols=145 Identities=24% Similarity=0.344 Sum_probs=126.6
Q ss_pred cCCcccceeecccCceeEEEEEecC---CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~---~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
..+|.+.+.||+|+||.||++...+ +..|++|.+... ..+.+|+.++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 4579999999999999999997543 567999987642 23467999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+. ++|.+++. ....+++..++.++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 68888883 3346899999999999999999999887 999999999999999999999999999877543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-23 Score=216.28 Aligned_cols=153 Identities=32% Similarity=0.526 Sum_probs=133.8
Q ss_pred CCcccceeecccCceeEEEEEecC--C--cEEEEEEecccch-hhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~--~--~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
+++.+.++||+|.||.|++|.+.. | -.||||.+..... .....|++|+.+|.+|+|+|+++|+|+..+ ...+||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 455666899999999999999853 3 3699999976433 367889999999999999999999999987 788999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+|.++.|+|.+.|++ .....+.......++.|||.||.||.++. +|||||.++|+||-....+||+||||.|-++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999987 34455677888899999999999999877 99999999999999999999999999999976
Q ss_pred CCC
Q 007336 595 DET 597 (607)
Q Consensus 595 ~~~ 597 (607)
.+.
T Consensus 265 ned 267 (1039)
T KOG0199|consen 265 NED 267 (1039)
T ss_pred CCc
Confidence 554
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.1e-22 Score=200.17 Aligned_cols=149 Identities=29% Similarity=0.385 Sum_probs=129.7
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.|+..+.||+|+||.||++... .++.||||.+.... ......+..|+.++++++|+||+.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3667789999999999999875 47899999886421 2234567889999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++....
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 999999999885432 235789999999999999999999876 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=204.57 Aligned_cols=150 Identities=33% Similarity=0.596 Sum_probs=129.5
Q ss_pred CCcccceeecccCceeEEEEEecC-Cc--EEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~--~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV 514 (607)
++|++.+.||+|+||.||+|.... +. .+++|.+... .......+.+|+.++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 578888999999999999999754 43 4688877642 344567889999999999 899999999999999999999
Q ss_pred EEcCCCCChHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCce
Q 007336 515 YEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ 581 (607)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999996432 1235789999999999999999999877 9999999999999999999
Q ss_pred EEeecccceee
Q 007336 582 KISDFGLVRTF 592 (607)
Q Consensus 582 ki~DfGla~~~ 592 (607)
||+|||+++..
T Consensus 164 kl~dfg~~~~~ 174 (303)
T cd05088 164 KIADFGLSRGQ 174 (303)
T ss_pred EeCccccCccc
Confidence 99999999743
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=204.46 Aligned_cols=153 Identities=33% Similarity=0.535 Sum_probs=131.7
Q ss_pred hcCCcccceeecccCceeEEEEEec--------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~ 507 (607)
..++|.+.++||+|+||.||+++.. ....+|+|.+... ......++..|+.++.++ +||||+++++++.+
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3357888899999999999999752 2457899988742 334567789999999999 69999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEE
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nil 574 (607)
....++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+.+ ++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 999999999999999999996532 1245889999999999999999999877 999999999999
Q ss_pred EcCCCceEEeecccceeec
Q 007336 575 LDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 575 l~~~~~~ki~DfGla~~~~ 593 (607)
+++++.+||+|||+++.+.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 167 VTEDNVMKIADFGLARGVH 185 (314)
T ss_pred EcCCCcEEEcccccccccc
Confidence 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.8e-22 Score=196.37 Aligned_cols=143 Identities=34% Similarity=0.531 Sum_probs=127.4
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCChH
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 524 (607)
++||+|+||.||+|...++..+|+|.+.... ......|.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998888999999986532 334457899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 525 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++... ...+++..+..++.|++.+|.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 998542 235789999999999999999999877 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=198.68 Aligned_cols=144 Identities=26% Similarity=0.360 Sum_probs=127.6
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
+|++.++||+|+||.||++... .++.||+|.+... ......++.+|+.++.+++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5778899999999999999864 5789999988643 3344567999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++++|..+. .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999997553 3578888899999999999999887 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=203.89 Aligned_cols=152 Identities=32% Similarity=0.540 Sum_probs=131.6
Q ss_pred cCCcccceeecccCceeEEEEEecC--------CcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEeC
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~ 508 (607)
.++|.+.+.||+|+||.||+++... ...+|+|.+... ......++..|+.++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3578999999999999999997532 346999998753 234556788999999999 799999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill 575 (607)
...++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999965321 235889999999999999999999876 9999999999999
Q ss_pred cCCCceEEeecccceeec
Q 007336 576 DQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 576 ~~~~~~ki~DfGla~~~~ 593 (607)
+.++.+||+|||+++.+.
T Consensus 174 ~~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 174 TEDNVMKIADFGLARDIH 191 (307)
T ss_pred cCCCcEEECCCccccccc
Confidence 999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=198.51 Aligned_cols=150 Identities=31% Similarity=0.498 Sum_probs=132.3
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
..++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++. .+..++||||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 346788899999999999999998888999999987532 34568899999999999999999999864 4568999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.+.
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 82 MENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 99999999986432 346789999999999999999999877 9999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-22 Score=200.75 Aligned_cols=150 Identities=33% Similarity=0.477 Sum_probs=134.6
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.+.|++.++||+|+||.||+|+... +..+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 3578899999999999999999865 789999998766666678899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++++|..++... ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999887542 235889999999999999999999876 9999999999999999999999999987653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=201.00 Aligned_cols=150 Identities=31% Similarity=0.532 Sum_probs=130.2
Q ss_pred CCcccceeecccCceeEEEEEe-----cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeC--CeE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 511 (607)
..|++.+.||+|+||.||.+++ ..+..||+|.++.. .....+.+.+|+.+++.++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3567889999999999999984 24678999998753 234457899999999999999999999999875 567
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998542 235799999999999999999999887 99999999999999999999999999987
Q ss_pred ecC
Q 007336 592 FGG 594 (607)
Q Consensus 592 ~~~ 594 (607)
+..
T Consensus 159 ~~~ 161 (284)
T cd05079 159 IET 161 (284)
T ss_pred ccc
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.5e-22 Score=195.86 Aligned_cols=151 Identities=27% Similarity=0.436 Sum_probs=134.0
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+|++.+.||+|+||.||+++.. ++..|++|.+.. .......++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999975 478999998763 2345667899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999653 2356889999999999999999999876 999999999999999999999999999977543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5e-22 Score=202.92 Aligned_cols=150 Identities=31% Similarity=0.563 Sum_probs=129.4
Q ss_pred CCcccceeecccCceeEEEEEecC-C--cEEEEEEecc-cchhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-G--QEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~--~~vavK~l~~-~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV 514 (607)
++|++.+.||+|+||.||+|...+ + ..+++|.++. ......+.|..|+.++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578888999999999999998754 3 3478888764 2334567799999999999 799999999999999999999
Q ss_pred EEcCCCCChHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCce
Q 007336 515 YEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ 581 (607)
+||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996422 1235889999999999999999999877 9999999999999999999
Q ss_pred EEeecccceee
Q 007336 582 KISDFGLVRTF 592 (607)
Q Consensus 582 ki~DfGla~~~ 592 (607)
||+|||+++..
T Consensus 159 kl~dfg~~~~~ 169 (297)
T cd05089 159 KIADFGLSRGE 169 (297)
T ss_pred EECCcCCCccc
Confidence 99999998743
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=207.68 Aligned_cols=144 Identities=22% Similarity=0.325 Sum_probs=125.5
Q ss_pred hhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
....+|++.+.||+|+||.||+|+... +..||+|..... ....|+.++++++||||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 344679999999999999999999864 678999975432 2346899999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
||+. ++|.+++.. ....+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+++..
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9995 688888754 2345899999999999999999999987 999999999999999999999999999854
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.5e-22 Score=197.24 Aligned_cols=143 Identities=31% Similarity=0.548 Sum_probs=123.3
Q ss_pred eecccCceeEEEEEec---CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCC
Q 007336 447 KLGEGGFGPVYKGTLV---DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (607)
Q Consensus 447 ~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 522 (607)
.||+|+||.||+|.+. .+..||+|.+.... ....++|.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 34579999886532 334567999999999999999999999885 456789999999999
Q ss_pred hHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++.+..+
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 148 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD 148 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCC
Confidence 9999853 2346899999999999999999999887 999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-22 Score=198.76 Aligned_cols=143 Identities=24% Similarity=0.394 Sum_probs=122.6
Q ss_pred eeecccCceeEEEEEecC-------------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 446 NKLGEGGFGPVYKGTLVD-------------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-------------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
+.||+|+||.||+|+... ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258888876544455668889999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc-------eEEee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-------PKISD 585 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~-------~ki~D 585 (607)
+||||+++|+|..++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999988532 345889999999999999999999877 999999999999987664 89999
Q ss_pred cccceeec
Q 007336 586 FGLVRTFG 593 (607)
Q Consensus 586 fGla~~~~ 593 (607)
||++..+.
T Consensus 156 ~g~~~~~~ 163 (262)
T cd05077 156 PGIPITVL 163 (262)
T ss_pred CCCCcccc
Confidence 99998664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=198.70 Aligned_cols=142 Identities=26% Similarity=0.443 Sum_probs=122.4
Q ss_pred eeecccCceeEEEEEecCCc-----------EEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 446 NKLGEGGFGPVYKGTLVDGQ-----------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~-----------~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986533 5777876543322 6789999999999999999999999988 778999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-------ceEEeecc
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-------NPKISDFG 587 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~-------~~ki~DfG 587 (607)
|||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999996532 25789999999999999999999877 99999999999999888 79999999
Q ss_pred cceeecC
Q 007336 588 LVRTFGG 594 (607)
Q Consensus 588 la~~~~~ 594 (607)
+++.+..
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9997543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.8e-22 Score=201.90 Aligned_cols=149 Identities=27% Similarity=0.499 Sum_probs=133.6
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
...+|++.+.||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 4458999999999999999999864 588999999876444556788999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 9999999999843 34788999999999999999999887 9999999999999999999999999988654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-22 Score=199.26 Aligned_cols=149 Identities=30% Similarity=0.559 Sum_probs=129.9
Q ss_pred CCcccceeecccCceeEEEEEecC-Cc----EEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
.+|++.+.||+|+||.||+|.... +. .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467888999999999999998643 32 58999886533 3456789999999999999999999999987 78899
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++|+|.+++... ...+++.....++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998643 334899999999999999999999876 9999999999999999999999999998775
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 161 ~ 161 (279)
T cd05057 161 V 161 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=201.96 Aligned_cols=152 Identities=25% Similarity=0.404 Sum_probs=133.0
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++|++.+.||+|+||.||++... .+..||+|.+... .......+.+|+.++.+++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999986 5889999988642 334457899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++++|..++........+++..+..++.+++.||.|||+.. +|+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999999999865333346899999999999999999999742 39999999999999999999999999998663
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-22 Score=205.06 Aligned_cols=152 Identities=30% Similarity=0.529 Sum_probs=131.1
Q ss_pred CCcccceeecccCceeEEEEEecC--------CcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCC
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~ 509 (607)
.+|.+.+.||+|+||.||+++... ...||+|.+... .....+++.+|+.+++++ +||||++++++|.+.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468888999999999999997521 236899987642 334567899999999999 8999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~ 576 (607)
..++++||+++|+|.+++.... ....+++..++.++.||++||.|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986422 2235789999999999999999999887 99999999999999
Q ss_pred CCCceEEeecccceeecC
Q 007336 577 QDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 577 ~~~~~ki~DfGla~~~~~ 594 (607)
+++.+||+|||+++.+..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 169 EDNVMKIADFGLARDVHN 186 (334)
T ss_pred CCCcEEECCcccceeccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=196.51 Aligned_cols=152 Identities=28% Similarity=0.480 Sum_probs=134.7
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||.||+|... +++.||+|.++. ......+.+.+|++++++++|+||+++++.+.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999986 689999998853 22334678999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+++++|.+++... .....+++..+..++.+++.||.|||+.+ |+||||+|+||++++++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998643 22455789999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.8e-22 Score=199.47 Aligned_cols=147 Identities=32% Similarity=0.481 Sum_probs=131.5
Q ss_pred cccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
|++.+.||+|+||.||++.... +..+++|.+........+.+.+|+.+++.++||||+++++.+..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5677899999999999999865 678899988765556677899999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++|..++.. ....+++..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 999988754 2345899999999999999999999987 9999999999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.3e-22 Score=233.72 Aligned_cols=142 Identities=27% Similarity=0.497 Sum_probs=122.3
Q ss_pred CCcccceeecccCceeEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
..+...+.||+|+||.||+|+. .++..||||++...... ...|++.+++++|||||+++|+|.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4567778999999999999997 46889999998653221 234578899999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
++|+|.++++ .++|..+.+|+.|||+||+|||..+.++|+||||||+||+++.++.+++. ||+++..
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 9999999994 27899999999999999999997766679999999999999999988876 7766544
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-21 Score=194.81 Aligned_cols=151 Identities=24% Similarity=0.408 Sum_probs=133.4
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+|+..+.||+|+||.||.++.. +++.+++|.+.. .......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5788899999999999999864 478899998764 2345567889999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999986432 346789999999999999999999877 999999999999999999999999999977443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-22 Score=199.07 Aligned_cols=153 Identities=31% Similarity=0.537 Sum_probs=131.7
Q ss_pred hcCCcccceeecccCceeEEEEEecC------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 510 (607)
..++|++.+.||+|+||.||+|.+.+ +..|++|.+... .......|..|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678899999999999999999754 467899987643 23445679999999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC---ceEE
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTR----RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKI 583 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~---~~ki 583 (607)
.++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865321 235899999999999999999999987 99999999999998754 5999
Q ss_pred eecccceeec
Q 007336 584 SDFGLVRTFG 593 (607)
Q Consensus 584 ~DfGla~~~~ 593 (607)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05036 161 ADFGMARDIY 170 (277)
T ss_pred ccCccccccC
Confidence 9999998763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.5e-22 Score=196.81 Aligned_cols=149 Identities=31% Similarity=0.492 Sum_probs=131.2
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccc-----hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
++|.+.+.||+|++|.||++... +++.|++|.+.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 47888999999999999999875 48899999876421 2234578899999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999854 235788888999999999999999887 9999999999999999999999999998764
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 156 ~ 156 (263)
T cd06625 156 T 156 (263)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=200.99 Aligned_cols=153 Identities=31% Similarity=0.543 Sum_probs=132.9
Q ss_pred hcCCcccceeecccCceeEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 510 (607)
..++|++.+.||+|+||.||++... ++..||+|.+... ......+|.+|+.++++++||||+++++++.++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467888999999999999999863 3578999988653 33445779999999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCC
Q 007336 511 KLLIYEFMPNKSLDSFIFDQT-------------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~ 571 (607)
.++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999996421 1134788899999999999999999887 999999999
Q ss_pred cEEEcCCCceEEeecccceeec
Q 007336 572 NVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 572 Nill~~~~~~ki~DfGla~~~~ 593 (607)
||++++++.+||+|||+++.+.
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred heEecCCCceEECccccceecc
Confidence 9999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.8e-22 Score=197.77 Aligned_cols=151 Identities=29% Similarity=0.543 Sum_probs=132.4
Q ss_pred cCCcccceeecccCceeEEEEEecC-C---cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~---~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
.++|+..+.||+|+||.||+|+... + ..+++|.+... .......+..|+.++++++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3467888999999999999999753 3 37999988653 34456779999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998542 245889999999999999999999887 9999999999999999999999999998775
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 159 ~ 159 (268)
T cd05063 159 D 159 (268)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=198.93 Aligned_cols=150 Identities=26% Similarity=0.419 Sum_probs=131.6
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999986 48899999886422 2234568899999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999998887632 335899999999999999999999977 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.1e-22 Score=199.25 Aligned_cols=150 Identities=29% Similarity=0.451 Sum_probs=131.2
Q ss_pred CCcccceeecccCceeEEEEEec------CCcEEEEEEecccchh-hHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
.+|++.+.||+|+||.||+++.. ....|++|.+...... ...++.+|+.++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888899999999999999864 2467999988653333 4678999999999999999999999999988999
Q ss_pred EEEEcCCCCChHHHHhcCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeec
Q 007336 513 LIYEFMPNKSLDSFIFDQTRR------TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~Df 586 (607)
+||||+++|+|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999653321 25899999999999999999999887 999999999999999999999999
Q ss_pred ccceee
Q 007336 587 GLVRTF 592 (607)
Q Consensus 587 Gla~~~ 592 (607)
|+++..
T Consensus 162 ~~~~~~ 167 (275)
T cd05046 162 SLSKDV 167 (275)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=196.12 Aligned_cols=149 Identities=31% Similarity=0.494 Sum_probs=129.7
Q ss_pred CCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
++|.+.+.||+|+||.||++...++..+|+|.+... ....+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 468888999999999999999877778999987643 234567889999999999999999999875 456789999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 99999999643 2345789999999999999999999877 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=195.42 Aligned_cols=148 Identities=32% Similarity=0.510 Sum_probs=131.4
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccc-----hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
+|+..+.||+|+||.||+|... ++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999986 68899999886422 23567899999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+||+++++|.+++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998542 34789999999999999999999887 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-22 Score=197.15 Aligned_cols=150 Identities=30% Similarity=0.501 Sum_probs=131.1
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
.++|++.++||+|+||.||++...++..+|+|.+.... ...+.|.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 34688889999999999999998888889999987532 23467999999999999999999999875 45678999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++++|.+++... ....+++..+..++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999998643 2345789999999999999999999987 99999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.4e-22 Score=212.03 Aligned_cols=149 Identities=23% Similarity=0.430 Sum_probs=122.1
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeC--------
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-------- 508 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-------- 508 (607)
...+|++.++||+|+||.||+|... .++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4568999999999999999999975 47899999885422 2335699999999999999999886432
Q ss_pred CeEEEEEEcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-ceEEeec
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDF 586 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~-~~ki~Df 586 (607)
...++||||+++ +|.+++... .....+++.....++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999985 676666432 23456889999999999999999999987 99999999999999765 6999999
Q ss_pred ccceeecC
Q 007336 587 GLVRTFGG 594 (607)
Q Consensus 587 Gla~~~~~ 594 (607)
|+|+.+..
T Consensus 216 Gla~~~~~ 223 (440)
T PTZ00036 216 GSAKNLLA 223 (440)
T ss_pred ccchhccC
Confidence 99997743
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=199.10 Aligned_cols=145 Identities=37% Similarity=0.544 Sum_probs=126.2
Q ss_pred ccceeecccCceeEEEEEe-----cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeC--CeEEEE
Q 007336 443 SINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 514 (607)
Q Consensus 443 ~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV 514 (607)
++.+.||+|+||+||++.. .++..||+|.+... .....+.|.+|+.++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7789999999999988653 34678999998653 234567889999999999999999999998764 357899
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999853 24899999999999999999999887 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=189.02 Aligned_cols=155 Identities=27% Similarity=0.359 Sum_probs=136.6
Q ss_pred hhcCCcccceeecccCceeEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCC-----e
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----E 510 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~-~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~ 510 (607)
...++|.+.++||+|+|+-||.++ +.+++.+|+|++.-...++.+..++|++..++++||||++++++...+. .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345689999999999999999998 4568899999997766678889999999999999999999998876443 4
Q ss_pred EEEEEEcCCCCChHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
.||+++|...|+|.+.+..... +..+++.+.++|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.|||-+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999865433 457999999999999999999999986 57999999999999999999999999988
Q ss_pred eee
Q 007336 590 RTF 592 (607)
Q Consensus 590 ~~~ 592 (607)
...
T Consensus 177 ~~a 179 (302)
T KOG2345|consen 177 TQA 179 (302)
T ss_pred ccc
Confidence 754
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=195.09 Aligned_cols=151 Identities=30% Similarity=0.483 Sum_probs=132.8
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
..++|++.++||+|+||.||++...++..+++|.+... ....+.|.+|+.++++++|+||+++.+.+.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 34678899999999999999999877888999988653 3345678999999999999999999999877 778999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 9999999999653 2345788999999999999999999876 99999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-22 Score=197.58 Aligned_cols=152 Identities=26% Similarity=0.463 Sum_probs=133.4
Q ss_pred CCcccceeecccCceeEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||.||++.. .++..++||.+... ......++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999996 46889999987642 2334568899999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+++++|.+++... .....+++.....++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 22456899999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=199.69 Aligned_cols=148 Identities=34% Similarity=0.517 Sum_probs=130.3
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccch-----hhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-----~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
+|++.+.||+|+||.||+|... +++.|+||.+..... .....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999975 488999999865321 2345677899999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ |+|+||+|+||+++.++.+||+|||+++.+..
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999985432 36899999999999999999999987 99999999999999999999999999997754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=200.60 Aligned_cols=148 Identities=29% Similarity=0.469 Sum_probs=129.2
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++|++.++||+|+||.||+++.. .++.||+|.+... .......+.+|+.++++++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57889999999999999999875 4789999998642 223345678899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++ ++|.+++... ...+++.....++.||++||+|||+.+ |+|+||||+|||+++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 98 5898888543 335788999999999999999999887 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=192.41 Aligned_cols=150 Identities=24% Similarity=0.399 Sum_probs=132.2
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
+|++.+.||+|+||.||++... +++.+|+|.++. ......+.+..|+.+++.++|+||+++++.+.++...++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999875 478999998854 23345677889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++++|.+++... ....++......++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.+..
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999999988542 3345788999999999999999999887 99999999999999999999999999987753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=200.20 Aligned_cols=146 Identities=21% Similarity=0.343 Sum_probs=129.9
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||.||++.... ++.|++|.+.... ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368888999999999999999754 7899999886532 234567889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 999999999999542 35788999999999999999999877 99999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=195.10 Aligned_cols=142 Identities=32% Similarity=0.513 Sum_probs=123.3
Q ss_pred eecccCceeEEEEEec---CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCC
Q 007336 447 KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (607)
Q Consensus 447 ~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 521 (607)
+||+|+||.||+|.+. ++..+|+|+++.. .....+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 4688999988642 2345678999999999999999999999985 45678999999999
Q ss_pred ChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 99999853 235789999999999999999999887 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=195.87 Aligned_cols=148 Identities=30% Similarity=0.479 Sum_probs=128.1
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc-----chhhHHHHHHHHHHHccCCCCceeceEEEEEeC--CeE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 511 (607)
.+|++.+.||+|+||.||++...+ +..||||.+... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 478889999999999999998754 889999987531 123456788999999999999999999988764 457
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++||||+++++|.+++... ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998532 34788888999999999999999887 99999999999999999999999999986
Q ss_pred ec
Q 007336 592 FG 593 (607)
Q Consensus 592 ~~ 593 (607)
+.
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=194.35 Aligned_cols=147 Identities=37% Similarity=0.610 Sum_probs=130.4
Q ss_pred eeecccCceeEEEEEecC----CcEEEEEEecccch-hhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+.||+|+||.||++.... +..|++|.+..... ...+.+.+|+.++..++|+||+++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999754 78899999876332 2467899999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 521 KSLDSFIFDQTR------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 521 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999965321 366899999999999999999999977 99999999999999999999999999998764
Q ss_pred C
Q 007336 595 D 595 (607)
Q Consensus 595 ~ 595 (607)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=195.92 Aligned_cols=146 Identities=32% Similarity=0.525 Sum_probs=129.6
Q ss_pred CcccceeecccCceeEEEEEecCCcEEEEEEeccc------chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~------~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
+|...+.||+|+||+||+|...+++.+|||.+... .......+.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 46778899999999999999878899999987632 123345688999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||+++++|.+++.+. ..+++.....++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++.+
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999542 34788999999999999999999877 999999999999999999999999999865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=196.20 Aligned_cols=147 Identities=31% Similarity=0.467 Sum_probs=128.5
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccc----------hhhHHHHHHHHHHHccCCCCceeceEEEEEeCC
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS----------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~----------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~ 509 (607)
+|.+.+.||+|+||.||+|... +++.||+|.++... ....+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999864 48899999875311 112356888999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998543 45788999999999999999999877 999999999999999999999999999
Q ss_pred eeec
Q 007336 590 RTFG 593 (607)
Q Consensus 590 ~~~~ 593 (607)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-23 Score=195.29 Aligned_cols=151 Identities=30% Similarity=0.480 Sum_probs=130.4
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEec--ccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~--~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
..++|++.+.||+|.|+.|++.... .|+.+|+|.+. +.+....+++.+|+++-+.|+||||++|.....+...++||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4567888899999999999998764 48889998875 34455788999999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC---CceEEeeccccee
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRT 591 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~---~~~ki~DfGla~~ 591 (607)
+|+|.+++|..-|-. +...++....+.++||+++|.|.|.++ |||||+||+|+||.+. --+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999765522 245678888899999999999999988 9999999999999643 3589999999999
Q ss_pred ecC
Q 007336 592 FGG 594 (607)
Q Consensus 592 ~~~ 594 (607)
+++
T Consensus 163 l~~ 165 (355)
T KOG0033|consen 163 VND 165 (355)
T ss_pred eCC
Confidence 973
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=198.08 Aligned_cols=158 Identities=27% Similarity=0.434 Sum_probs=133.9
Q ss_pred HHhHHhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEE---
Q 007336 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCI--- 506 (607)
Q Consensus 432 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~--- 506 (607)
+..+..+.++|++.+.||+|+||.||++.... ++.+|+|.+... .....++.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 34556678899999999999999999998754 789999987642 22345688899999999 6999999999885
Q ss_pred --eCCeEEEEEEcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEE
Q 007336 507 --QGEEKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (607)
Q Consensus 507 --~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki 583 (607)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345689999999999999988542 23346788999999999999999999877 999999999999999999999
Q ss_pred eecccceeec
Q 007336 584 SDFGLVRTFG 593 (607)
Q Consensus 584 ~DfGla~~~~ 593 (607)
+|||+++.+.
T Consensus 166 ~dfg~~~~~~ 175 (286)
T cd06638 166 VDFGVSAQLT 175 (286)
T ss_pred ccCCceeecc
Confidence 9999998764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=199.22 Aligned_cols=151 Identities=27% Similarity=0.513 Sum_probs=134.5
Q ss_pred hcCCcccceeecccCceeEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
...+|+..+.||.|+||.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 345799999999999999999986 4588999999875444456788999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|+++++|..++.. ..+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+...
T Consensus 97 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 97 YLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred ecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 9999999998843 34789999999999999999999987 999999999999999999999999999876443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=193.91 Aligned_cols=151 Identities=26% Similarity=0.491 Sum_probs=134.8
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.++|++.+.||+|+||.||++.... +..+++|.+........+.+.+|+.++++++||||+++++.+.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 4678999999999999999999754 778999998765445677899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+++++|.+++... ...++...+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 9999999988542 245789999999999999999999887 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=194.84 Aligned_cols=144 Identities=32% Similarity=0.482 Sum_probs=127.4
Q ss_pred eeecccCceeEEEEEecC--C--cEEEEEEecccch-hhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~--~--~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
++||+|++|.||+|.+.. + ..||||.+..... ...+.+..|+.++++++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 2 3699999876444 567789999999999999999999999988 888999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++|.+++.+... ..+++.....++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999965432 46899999999999999999999887 99999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=193.45 Aligned_cols=148 Identities=28% Similarity=0.501 Sum_probs=128.7
Q ss_pred CCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEe-CCeEEEEEEcC
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFM 518 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~ 518 (607)
++|++.+.||+|+||.||++... +..|++|.++.. ...+.|.+|+.++++++|+|++++++++.. ++..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888899999999999999864 778999988642 235678999999999999999999998654 45689999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 999999998643 2345889999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=195.26 Aligned_cols=147 Identities=31% Similarity=0.547 Sum_probs=129.1
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccch---------hhHHHHHHHHHHHccCCCCceeceEEEEEeCCe
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE---------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 510 (607)
+|.+.+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999874 478999998754211 223578899999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999954 245788899999999999999999887 9999999999999999999999999999
Q ss_pred eec
Q 007336 591 TFG 593 (607)
Q Consensus 591 ~~~ 593 (607)
.+.
T Consensus 155 ~~~ 157 (267)
T cd06628 155 KLE 157 (267)
T ss_pred ccc
Confidence 775
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=205.03 Aligned_cols=147 Identities=31% Similarity=0.438 Sum_probs=125.0
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCC-----
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 509 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~----- 509 (607)
..++|++.+.||+|+||.||++... .+..||||++... ......++.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3468999999999999999999875 4889999998642 2344567889999999999999999999986543
Q ss_pred -eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccc
Q 007336 510 -EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (607)
Q Consensus 510 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGl 588 (607)
..++||||+++ +|...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999975 5655552 23678888899999999999999987 99999999999999999999999999
Q ss_pred ceeec
Q 007336 589 VRTFG 593 (607)
Q Consensus 589 a~~~~ 593 (607)
++...
T Consensus 170 a~~~~ 174 (359)
T cd07876 170 ARTAC 174 (359)
T ss_pred ccccc
Confidence 98654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=220.76 Aligned_cols=159 Identities=25% Similarity=0.366 Sum_probs=132.0
Q ss_pred HhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeC--Ce
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EE 510 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~ 510 (607)
....++|.+.++||+|+||+||++.... +..||+|.+.. ........|..|+.++..++|||||++++++.+. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 4455789999999999999999999765 67889998764 2344567899999999999999999999988653 56
Q ss_pred EEEEEEcCCCCChHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceEecccCCCcEEEcC--------
Q 007336 511 KLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSR----LRIIHRDLKASNVLLDQ-------- 577 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~----~~ivHrDlkp~Nill~~-------- 577 (607)
.+|||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999986432 23468999999999999999999998531 34999999999999964
Q ss_pred ---------CCceEEeecccceeecC
Q 007336 578 ---------DMNPKISDFGLVRTFGG 594 (607)
Q Consensus 578 ---------~~~~ki~DfGla~~~~~ 594 (607)
...+||+|||+++.+..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred cccccccCCCCceEEccCCccccccc
Confidence 23489999999997743
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=200.38 Aligned_cols=149 Identities=32% Similarity=0.609 Sum_probs=126.6
Q ss_pred CCcccceeecccCceeEEEEEecC-Cc----EEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
++|+..+.||+|+||.||+|.... +. .||+|.+... ......++.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 467788899999999999998643 43 4788887653 233345789999999999999999999998754 4679
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999998542 335788999999999999999999887 9999999999999999999999999999775
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 161 ~ 161 (303)
T cd05110 161 G 161 (303)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.7e-23 Score=204.93 Aligned_cols=160 Identities=26% Similarity=0.446 Sum_probs=139.7
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
..|+..+.||+|.||.||+|.... ++.||+|++.- ......+++..|+.++..++|+||.+.+|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 356777899999999999999755 78899999864 3455678899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~~ 597 (607)
|.+|++.+.|. ....+++....-|.+++..||.|||+++ .+|||||+.||||.+++.+||+|||.+-.+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999883 3445577777788999999999999987 99999999999999999999999999999876665
Q ss_pred ccCccceecC
Q 007336 598 EGNTNRVVGT 607 (607)
Q Consensus 598 ~~~~~~~~GT 607 (607)
+. .+++||
T Consensus 167 rr--~tfvGT 174 (467)
T KOG0201|consen 167 RR--KTFVGT 174 (467)
T ss_pred cc--cccccc
Confidence 43 457787
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=195.98 Aligned_cols=149 Identities=26% Similarity=0.466 Sum_probs=129.1
Q ss_pred CCcccceeecccCceeEEEEEecC----CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
++|.+.++||+|+||.||+|...+ ...|+||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 468888999999999999998643 2468999876533 4556789999999999999999999999875 556899
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++|+|.+++... ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999999542 235799999999999999999999877 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=194.90 Aligned_cols=143 Identities=35% Similarity=0.614 Sum_probs=123.6
Q ss_pred eeecccCceeEEEEEecC-Cc--EEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-~~--~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+.||+|+||.||+|++.+ +. .+++|.++.. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999855 33 5788887642 344567899999999999 899999999999999999999999999
Q ss_pred CChHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 521 KSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 521 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
|+|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986422 1234789999999999999999999876 9999999999999999999999999
Q ss_pred ccee
Q 007336 588 LVRT 591 (607)
Q Consensus 588 la~~ 591 (607)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=200.90 Aligned_cols=144 Identities=21% Similarity=0.219 Sum_probs=115.4
Q ss_pred HhhcCCcccceeecccCceeEEEEEec--CCcEEEEEEeccc-----chhhHHHHHHHHHHHccCCCCceeceEEEEEeC
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~--~~~~vavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~ 508 (607)
....++|.+.+.||+|+||+||+|... +++.||||++... .....+.|.+|+.++.+++|+|++..+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 344568999999999999999999875 4677899986532 12345679999999999999999864322 2
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeccc-CCCcEEEcCCCceEEeecc
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDl-kp~Nill~~~~~~ki~DfG 587 (607)
+..+|||||+++++|.. + . ... ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~-~--~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-A-R--PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHH-h-C--ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 45799999999999963 2 1 111 1357889999999999987 999999 9999999999999999999
Q ss_pred cceeecCC
Q 007336 588 LVRTFGGD 595 (607)
Q Consensus 588 la~~~~~~ 595 (607)
+|+.+...
T Consensus 158 lA~~~~~~ 165 (365)
T PRK09188 158 LASVFRRR 165 (365)
T ss_pred cceecccC
Confidence 99987543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=196.56 Aligned_cols=149 Identities=32% Similarity=0.558 Sum_probs=130.9
Q ss_pred CCcccceeecccCceeEEEEEec-----CCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCceeceEEEEEe--CCeE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK 511 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-----~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~ 511 (607)
..|++.+.||+|+||.||++++. .+..+|||.+..... ...+.|.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35777799999999999999864 257899999875433 256789999999999999999999999987 5578
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999543 235899999999999999999999887 99999999999999999999999999998
Q ss_pred ec
Q 007336 592 FG 593 (607)
Q Consensus 592 ~~ 593 (607)
+.
T Consensus 159 ~~ 160 (284)
T cd05038 159 LP 160 (284)
T ss_pred cc
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=204.22 Aligned_cols=149 Identities=30% Similarity=0.455 Sum_probs=127.1
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeC------
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------ 508 (607)
..++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4468999999999999999999874 4789999998652 223456678899999999999999999987643
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccc
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGl 588 (607)
...++++|++ +++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3468999988 688988773 234889999999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 007336 589 VRTFGG 594 (607)
Q Consensus 589 a~~~~~ 594 (607)
++.+..
T Consensus 165 ~~~~~~ 170 (343)
T cd07878 165 ARQADD 170 (343)
T ss_pred ceecCC
Confidence 997654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=196.37 Aligned_cols=151 Identities=28% Similarity=0.408 Sum_probs=126.4
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHH-HccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
++|++.+.||+|+||.||+++.. +++.||+|+++.. ......++..|+.. ++.++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999976 4899999998653 22233455556554 666799999999999999999999999
Q ss_pred cCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|++ |+|.+++... .....+++..+..++.||+.||+|||++. +++||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 997 7888887542 23356899999999999999999999862 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8e-23 Score=195.39 Aligned_cols=152 Identities=28% Similarity=0.458 Sum_probs=125.4
Q ss_pred CCcccceeecccCceeEEEEEecC-----CcEEEEEEecccch-hh-HHHHHHHHHHHccCCCCceeceEEEEEe-CCeE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISE-QG-LKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEK 511 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-----~~~vavK~l~~~~~-~~-~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~ 511 (607)
..|+....||+|.||.||++.-.+ ...+|||+++..+. .+ ...-.+|+.+++.++||||+.|..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468888899999999999996432 33789999875321 11 2345679999999999999999999887 7788
Q ss_pred EEEEEcCCCCChHHHHhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC----CceEEee
Q 007336 512 LLIYEFMPNKSLDSFIFD--QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISD 585 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~----~~~ki~D 585 (607)
+|++||.+. +|...|+- ..+...++......|+.||+.|+.|||++. |+||||||.||||..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999975 67777642 233457899999999999999999999998 9999999999999877 8999999
Q ss_pred cccceeecCC
Q 007336 586 FGLVRTFGGD 595 (607)
Q Consensus 586 fGla~~~~~~ 595 (607)
|||||++.+.
T Consensus 180 lGlaR~~~~p 189 (438)
T KOG0666|consen 180 LGLARLFNNP 189 (438)
T ss_pred ccHHHHhhcc
Confidence 9999998543
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=191.89 Aligned_cols=143 Identities=34% Similarity=0.567 Sum_probs=128.1
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccch-hhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCChH
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 524 (607)
++||+|+||.||++...+++.|++|.+..... ...+.+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987799999998875332 35678999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 525 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++... ...+++..+..++.+++.+|+|||+++ ++||||+|+|||++.++.+||+|||+++...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 998542 235788999999999999999999887 9999999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=192.97 Aligned_cols=148 Identities=28% Similarity=0.524 Sum_probs=131.5
Q ss_pred CCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
.+|++.+.||+|+||.||++...++..+|+|.+... ......|.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 467788999999999999999877889999988642 2234678999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++|.+++... ...+++..+..++.+++.+|+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVL 151 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecc
Confidence 99999998542 235789999999999999999999887 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=192.61 Aligned_cols=149 Identities=30% Similarity=0.510 Sum_probs=134.4
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.++|++.+.||+|+||.||++.... ++.+++|.+.... ..+++.+|++++++++|+||+++++.+.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH--HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 4678899999999999999999865 7899999986532 267899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+++++|.+++.. ....+++.....++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 999999999854 2346899999999999999999999887 99999999999999999999999999997754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=197.16 Aligned_cols=147 Identities=31% Similarity=0.473 Sum_probs=128.6
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++|++.+.||+|++|.||+|... +++.||||.+.... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999975 57899999986422 22234577899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+++ +|.+++.... ..+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 984 8999885432 35788999999999999999999887 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=193.20 Aligned_cols=148 Identities=30% Similarity=0.505 Sum_probs=132.5
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+|++.+.||+|+||.||++... +++.|++|.+..... ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 588999999875332 4678899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 999999999854 234788899999999999999999987 99999999999999999999999999988754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=222.91 Aligned_cols=170 Identities=24% Similarity=0.282 Sum_probs=145.7
Q ss_pred hHHhHHhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCceeceEEEEE
Q 007336 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506 (607)
Q Consensus 431 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~ 506 (607)
...++....++|.++++||+|+||.|..+++.. ++.+|+|++.+ ..+....-|+.|..+|...+.+-|+.+.-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 345566677899999999999999999999865 78899999987 44566778999999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeec
Q 007336 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (607)
Q Consensus 507 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~Df 586 (607)
+..++|||||||+||+|-.++.+. ..+|+.....++..|.-||.-||+-+ +|||||||+|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999999542 25788887788889999999999877 999999999999999999999999
Q ss_pred ccceeecCCCCccCccceecC
Q 007336 587 GLVRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~GT 607 (607)
|-+-.+..+.+-. ....+||
T Consensus 220 GsClkm~~dG~V~-s~~aVGT 239 (1317)
T KOG0612|consen 220 GSCLKMDADGTVR-SSVAVGT 239 (1317)
T ss_pred hhHHhcCCCCcEE-eccccCC
Confidence 9998887655432 2234676
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.5e-21 Score=191.53 Aligned_cols=152 Identities=30% Similarity=0.493 Sum_probs=134.7
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++|++.+.||.|+||+||+|... ++..+++|++... .......+.+|+..++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999965 4788999998642 233567899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+++++|.+++........+++.....++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 999999999965433356899999999999999999999887 99999999999999999999999999987654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=196.43 Aligned_cols=150 Identities=31% Similarity=0.440 Sum_probs=128.4
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++++|.+.+.||+|+||.||+|... ++..|++|.+.... ......+.+|+.+++.++|+||+++.+++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999875 48899999986432 233346788999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||++ ++|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9996 6777776432 234678888889999999999999887 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=192.97 Aligned_cols=148 Identities=31% Similarity=0.490 Sum_probs=128.2
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc-----chhhHHHHHHHHHHHccCCCCceeceEEEEEe--CCeE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK 511 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~ 511 (607)
.+|+..+.||+|+||.||++.... +..|++|++... .....+.+.+|+.++++++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 468888999999999999998754 889999987532 12345678899999999999999999998875 3567
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999854 234788999999999999999999876 99999999999999999999999999986
Q ss_pred ec
Q 007336 592 FG 593 (607)
Q Consensus 592 ~~ 593 (607)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.6e-21 Score=194.95 Aligned_cols=149 Identities=31% Similarity=0.540 Sum_probs=130.9
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
+|++.++||+|++|.||+|+.. ++..||||.+.... ......+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999985 48899999986532 233466788999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++ +|.+++........+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 85 88888865444456899999999999999999999887 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=203.51 Aligned_cols=148 Identities=29% Similarity=0.430 Sum_probs=125.7
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeC------
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------ 508 (607)
..++|++.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3468999999999999999999875 4789999998652 234456788999999999999999999987643
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccc
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGl 588 (607)
...++||||+++ +|..++. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 346999999975 6766663 23688888999999999999999887 99999999999999999999999999
Q ss_pred ceeecC
Q 007336 589 VRTFGG 594 (607)
Q Consensus 589 a~~~~~ 594 (607)
++....
T Consensus 173 a~~~~~ 178 (364)
T cd07875 173 ARTAGT 178 (364)
T ss_pred ccccCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=199.21 Aligned_cols=145 Identities=21% Similarity=0.278 Sum_probs=125.3
Q ss_pred cceeeccc--CceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 444 INNKLGEG--GFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 444 ~~~~lg~G--~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
+.++||+| +|++||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999875 4889999998642 2334566788999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+..+
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 9999999985432 234789999999999999999999887 999999999999999999999999865443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=204.22 Aligned_cols=148 Identities=30% Similarity=0.438 Sum_probs=125.6
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeC------
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------ 508 (607)
..++|++.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999875 4789999998752 234456788899999999999999999988643
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccc
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGl 588 (607)
...++||||+++ +|..++. ..+++..+..++.|+++||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 346899999975 5666652 23788888999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 007336 589 VRTFGG 594 (607)
Q Consensus 589 a~~~~~ 594 (607)
++....
T Consensus 166 ~~~~~~ 171 (355)
T cd07874 166 ARTAGT 171 (355)
T ss_pred cccCCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=199.28 Aligned_cols=147 Identities=30% Similarity=0.478 Sum_probs=129.5
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
.|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444467999999999999875 478999999876555566779999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 9999998842 34788999999999999999999987 99999999999999999999999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-21 Score=192.68 Aligned_cols=149 Identities=30% Similarity=0.518 Sum_probs=125.9
Q ss_pred cccceeecccCceeEEEEEec----CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCC------
Q 007336 442 FSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------ 509 (607)
|.+.+.||+|+||.||+|.+. .+..||||.+... .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999864 2578999988642 3445678899999999999999999999987543
Q ss_pred eEEEEEEcCCCCChHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeec
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQT---RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~Df 586 (607)
..++++||+++|+|..++.... ....+++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875321 2235788999999999999999999887 999999999999999999999999
Q ss_pred ccceeec
Q 007336 587 GLVRTFG 593 (607)
Q Consensus 587 Gla~~~~ 593 (607)
|+++.+.
T Consensus 158 g~~~~~~ 164 (273)
T cd05074 158 GLSKKIY 164 (273)
T ss_pred ccccccc
Confidence 9999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=195.56 Aligned_cols=160 Identities=32% Similarity=0.468 Sum_probs=135.9
Q ss_pred hhHHhHHhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEEe
Q 007336 430 FELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (607)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~ 507 (607)
+...++..+.++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344566677899999999999999999999975 47899999886532 2345678899999988 89999999999875
Q ss_pred C-----CeEEEEEEcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCce
Q 007336 508 G-----EEKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (607)
Q Consensus 508 ~-----~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ 581 (607)
. ...++||||+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3579999999999999988532 23456889999999999999999999876 9999999999999999999
Q ss_pred EEeecccceeec
Q 007336 582 KISDFGLVRTFG 593 (607)
Q Consensus 582 ki~DfGla~~~~ 593 (607)
||+|||+++.+.
T Consensus 168 kl~dfg~~~~~~ 179 (291)
T cd06639 168 KLVDFGVSAQLT 179 (291)
T ss_pred EEeecccchhcc
Confidence 999999998764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=199.05 Aligned_cols=143 Identities=26% Similarity=0.447 Sum_probs=118.2
Q ss_pred eeecccCceeEEEEEec---CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEe--CCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~ 520 (607)
++||+|+||.||+|+.. .++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 58999999999999864 35789999986532 23457789999999999999999998864 456789999986
Q ss_pred CChHHHHhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE----cCCCceEEeecccce
Q 007336 521 KSLDSFIFDQ------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVR 590 (607)
Q Consensus 521 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill----~~~~~~ki~DfGla~ 590 (607)
++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +..+.+||+|||+|+
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 4787776421 12235888999999999999999999987 9999999999999 456789999999999
Q ss_pred eecC
Q 007336 591 TFGG 594 (607)
Q Consensus 591 ~~~~ 594 (607)
.+..
T Consensus 161 ~~~~ 164 (317)
T cd07868 161 LFNS 164 (317)
T ss_pred ccCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=196.60 Aligned_cols=147 Identities=27% Similarity=0.482 Sum_probs=129.9
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
.|+..+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 46667889999999999998754 778999988642 2345568999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 99999998842 35788999999999999999999877 99999999999999999999999999987653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=197.65 Aligned_cols=149 Identities=30% Similarity=0.462 Sum_probs=130.8
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
++|++.++||+|+||.||++...+ ++.||+|++... .....+.+.+|+.+++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 368888999999999999999864 789999987642 22235678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|+++++|..+... ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999887643 234799999999999999999999887 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-21 Score=196.78 Aligned_cols=150 Identities=26% Similarity=0.320 Sum_probs=133.0
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||.||++...+ ++.+|+|.+.... ....+.+..|+.+++.++|+||+++++.+.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999999865 8899999986532 135567899999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||+++++|.+++... ....+++.....++.||++||+|||+.+ ++|+||||+||+|+.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999998542 3356899999999999999999999887 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=193.84 Aligned_cols=148 Identities=27% Similarity=0.494 Sum_probs=129.7
Q ss_pred CcccceeecccCceeEEEEEe-cCCcEEEEEEecccc------hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
+|+..+.||+|+||.||++.. .+++.||+|.+.... ....+.++.|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999986 458899999886422 1235688999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-ceEEeecccceee
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTF 592 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~-~~ki~DfGla~~~ 592 (607)
|+||+++++|.+++.+ ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||+++.+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999854 235788999999999999999999987 99999999999998776 5999999999877
Q ss_pred cC
Q 007336 593 GG 594 (607)
Q Consensus 593 ~~ 594 (607)
..
T Consensus 155 ~~ 156 (268)
T cd06630 155 AA 156 (268)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=191.86 Aligned_cols=143 Identities=32% Similarity=0.566 Sum_probs=121.9
Q ss_pred eeecccCceeEEEEEecC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEe-CCeEEEEEEcCC
Q 007336 446 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFMP 519 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~ 519 (607)
+.||+|+||.||+|...+ ...||+|++... .....+.+..|+.+++.++||||+++++++.. +...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 357999988542 34456788999999999999999999998864 455789999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+|+|.+++... ...+++..++.++.||++||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999542 234677888899999999999999876 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=195.63 Aligned_cols=144 Identities=27% Similarity=0.457 Sum_probs=123.6
Q ss_pred eeecccCceeEEEEEecC--------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 446 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+.||+|+||.||+|.... ...|++|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998643 234888887654445567889999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc--------eEEeecccc
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--------PKISDFGLV 589 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~--------~ki~DfGla 589 (607)
+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999643 235789999999999999999999887 999999999999987765 699999998
Q ss_pred eeecC
Q 007336 590 RTFGG 594 (607)
Q Consensus 590 ~~~~~ 594 (607)
.....
T Consensus 156 ~~~~~ 160 (258)
T cd05078 156 ITVLP 160 (258)
T ss_pred cccCC
Confidence 76543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=193.96 Aligned_cols=149 Identities=28% Similarity=0.418 Sum_probs=132.9
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
+|++.+.||+|+||.||++.... +..||+|.+.+. .....+.+.+|+.++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 47888999999999999999864 889999998652 22456789999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|+++++|.+++... ..+++.....++.||++||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998542 45788999999999999999999887 999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-21 Score=190.66 Aligned_cols=150 Identities=39% Similarity=0.642 Sum_probs=131.3
Q ss_pred cccceeecccCceeEEEEEecC-----CcEEEEEEecccchh-hHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 442 FSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~~-----~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
|++.+.||+|+||.||+++..+ +..||+|.+...... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566899999999999999754 378999998754332 5678999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999854322 22799999999999999999999887 999999999999999999999999999877543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=194.10 Aligned_cols=149 Identities=30% Similarity=0.471 Sum_probs=132.4
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+|++.+.||+|+||.||+|+.. ++..|++|++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999975 58899999986532 33456899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
+ +++|.+++.... ..+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||+++.+...
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999985433 45899999999999999999999887 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.3e-21 Score=189.27 Aligned_cols=150 Identities=25% Similarity=0.426 Sum_probs=132.2
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+|++.+.||+|+||.||+++.. +++.|++|.+.. ......+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999875 478999999864 2334556889999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999988542 2335789999999999999999999877 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=191.49 Aligned_cols=146 Identities=33% Similarity=0.575 Sum_probs=127.3
Q ss_pred CCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
++|++.+.||+|+||.||++.. .++.||+|.+... ...+.+.+|+.++++++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688889999999999999975 5788999988642 2346789999999999999999999998654 4789999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS 151 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence 999999996532 345789999999999999999999877 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.8e-21 Score=192.03 Aligned_cols=147 Identities=29% Similarity=0.471 Sum_probs=129.9
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
-|+..++||+|+||.||+|... ++..||+|.+... .......+.+|+.++++++||||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667789999999999999874 5789999987642 2344567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++++|.+++.. ..+++.....++.+++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 99999999842 35789999999999999999999877 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=195.19 Aligned_cols=148 Identities=26% Similarity=0.346 Sum_probs=129.1
Q ss_pred CcccceeecccCceeEEEEEec----CCcEEEEEEecccc----hhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 511 (607)
+|++.+.||+|+||.||+++.. ++..||+|++.... ....+.+.+|+.++.++ +|+||+++.+.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4778899999999999999863 57899999986522 22346788999999999 599999999999999999
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++||||+++++|.+++.. ...+++.....++.|+++||.|||+.+ ++||||+|+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999854 234788888899999999999999877 99999999999999999999999999987
Q ss_pred ecC
Q 007336 592 FGG 594 (607)
Q Consensus 592 ~~~ 594 (607)
+..
T Consensus 155 ~~~ 157 (290)
T cd05613 155 FHE 157 (290)
T ss_pred ccc
Confidence 754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=195.45 Aligned_cols=150 Identities=28% Similarity=0.504 Sum_probs=133.3
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
..++|.+.+.||+|+||.||++... ++..|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 3468899999999999999999864 578999999865444556788999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..+..
T Consensus 97 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred cCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999843 34688899999999999999999887 99999999999999999999999999886643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=194.68 Aligned_cols=149 Identities=28% Similarity=0.480 Sum_probs=121.8
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEecccc--hhhHHHHHHHHHHHccC---CCCceeceEEEEEeC-----C
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQG-----E 509 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~~-----~ 509 (607)
+|++.+.||+|+||.||+++... ++.||+|.++... ......+.+|+.++..+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47888999999999999999764 7899999886421 11223455666666554 799999999998642 4
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999998 48888885432 345789999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 007336 590 RTFGG 594 (607)
Q Consensus 590 ~~~~~ 594 (607)
+.+..
T Consensus 156 ~~~~~ 160 (288)
T cd07863 156 RIYSC 160 (288)
T ss_pred ccccC
Confidence 87753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=195.73 Aligned_cols=148 Identities=25% Similarity=0.346 Sum_probs=130.6
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++|++.+.||+|+||+||++... +++.||+|.+... .....+.+.+|+++++.++||||+++++.+......+|||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46888899999999999999875 4788999987643 234567899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+++++|.+++.. ...+++.....++.+++.+|.|||+.. +++||||+|+||++++++.++|+|||+++.+
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 999999998854 235789999999999999999999742 3999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-20 Score=188.34 Aligned_cols=150 Identities=27% Similarity=0.382 Sum_probs=129.9
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEe-CCeEEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYE 516 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E 516 (607)
+|++.+.||+|++|.||++.... ++.|++|++... .....+.+.+|+.++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47888999999999999999754 788999998642 33455678999999999999999999988764 446789999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|+++++|.+++... ....+++.++..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999998653 2345899999999999999999999887 99999999999999999999999999997743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-21 Score=192.49 Aligned_cols=149 Identities=28% Similarity=0.471 Sum_probs=133.1
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++|++.+.||.|+||.||+|... +++.|++|.+... .......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999975 4789999998643 234556789999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
+++++|.+++... .+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999998532 6899999999999999999999877 999999999999999999999999999988643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.7e-21 Score=189.76 Aligned_cols=143 Identities=36% Similarity=0.577 Sum_probs=123.8
Q ss_pred eeecccCceeEEEEEecC----CcEEEEEEecccch-hhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
++||+|+||.||+|.... +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998633 26899999875332 35678999999999999999999999876 5567999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|+|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.+...
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 9999999543 25789999999999999999999877 999999999999999999999999999977433
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.3e-21 Score=191.83 Aligned_cols=147 Identities=28% Similarity=0.475 Sum_probs=130.9
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
.|+..+.||+|+||.||+|... .+..||+|.+... .......+.+|+.++++++|+||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 5667789999999999999975 4789999988643 2345678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++++|.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999999843 34788889999999999999999877 99999999999999999999999999987754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.8e-21 Score=189.70 Aligned_cols=150 Identities=27% Similarity=0.376 Sum_probs=134.8
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecccch-hhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++|++.+.||+|++|.||+++... ++.|+||++..... .....+.+|+..+.+++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368888999999999999999875 89999999875332 4567899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
+++++|.+++... ..++...+..++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999543 558899999999999999999998 76 999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.6e-21 Score=196.17 Aligned_cols=150 Identities=27% Similarity=0.458 Sum_probs=127.3
Q ss_pred CcccceeecccCceeEEEEEecC---CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeC--CeEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 512 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~---~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~ 512 (607)
+|++.++||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999999754 7899999987622 33346778899999999999999999999988 7899
Q ss_pred EEEEcCCCCChHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC----CCceEEeec
Q 007336 513 LIYEFMPNKSLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ----DMNPKISDF 586 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~----~~~~ki~Df 586 (607)
+||||+++ +|.+++..... ...++......++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999985 66666643221 236788999999999999999999887 999999999999999 899999999
Q ss_pred ccceeecC
Q 007336 587 GLVRTFGG 594 (607)
Q Consensus 587 Gla~~~~~ 594 (607)
|+++.+..
T Consensus 157 g~~~~~~~ 164 (316)
T cd07842 157 GLARLFNA 164 (316)
T ss_pred ccccccCC
Confidence 99997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.9e-21 Score=195.80 Aligned_cols=143 Identities=27% Similarity=0.450 Sum_probs=118.2
Q ss_pred eeecccCceeEEEEEecC---CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEe--CCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~---~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~ 520 (607)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 589999999999999753 4689999886532 23467889999999999999999999864 4567899999875
Q ss_pred CChHHHHhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE----cCCCceEEeecccce
Q 007336 521 KSLDSFIFDQ------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVR 590 (607)
Q Consensus 521 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill----~~~~~~ki~DfGla~ 590 (607)
+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 677766321 12235788999999999999999999887 9999999999999 566789999999999
Q ss_pred eecC
Q 007336 591 TFGG 594 (607)
Q Consensus 591 ~~~~ 594 (607)
.+..
T Consensus 161 ~~~~ 164 (317)
T cd07867 161 LFNS 164 (317)
T ss_pred ccCC
Confidence 7754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.1e-21 Score=191.38 Aligned_cols=148 Identities=27% Similarity=0.480 Sum_probs=130.7
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCC---CCceeceEEEEEeCCeEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~ 515 (607)
.|++.+.||+|+||.||+|... +++.|++|.+... .....+++.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777889999999999999974 5889999988642 3345567889999998886 999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+++++|.+++.. ..+++.....++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999999843 25889999999999999999999887 999999999999999999999999999877543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=196.89 Aligned_cols=146 Identities=31% Similarity=0.468 Sum_probs=128.4
Q ss_pred cccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
|+....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 333457999999999999875 5889999998654444566788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++|..++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+..
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~ 169 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 169 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence 999988732 34789999999999999999999887 99999999999999999999999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=193.60 Aligned_cols=150 Identities=29% Similarity=0.476 Sum_probs=129.7
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
....|++.+.||+|+||.||+|+.. +++.||+|.+... ......++.+|+.+++.++||||+++.+++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 4456888899999999999999975 4889999988642 22344678899999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++...
T Consensus 93 v~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 93 VMEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EHHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999997 5776666432 235899999999999999999999887 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-22 Score=191.00 Aligned_cols=161 Identities=27% Similarity=0.328 Sum_probs=135.9
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
-++|..+++||+|.||+|..++-+ .++.+|||++++ ........-..|-+++...+||.+..|--.+...+++++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 357889999999999999999864 488999999986 3445566677899999999999999999889999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||..+|.|.-+|. +...+++....-+-.+|+.||.|||+.+ ||.||||.+|.|||.+|++||+||||+|.-..
T Consensus 247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999988883 3445666666668889999999999987 99999999999999999999999999985432
Q ss_pred CCCccCccceecC
Q 007336 595 DETEGNTNRVVGT 607 (607)
Q Consensus 595 ~~~~~~~~~~~GT 607 (607)
. ...+.+++||
T Consensus 321 ~--g~t~kTFCGT 331 (516)
T KOG0690|consen 321 Y--GDTTKTFCGT 331 (516)
T ss_pred c--cceeccccCC
Confidence 2 2345567887
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.4e-21 Score=193.87 Aligned_cols=150 Identities=29% Similarity=0.420 Sum_probs=127.3
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCe-----
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE----- 510 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~----- 510 (607)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999975 48899999876422 223457888999999994 6999999999987665
Q ss_pred EEEEEEcCCCCChHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCceEEeecc
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFG 587 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~-~~~~ki~DfG 587 (607)
.++||||+++ +|.+++..... ...+++..+..++.||++||.|||+.+ |+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 88888754322 346799999999999999999999887 999999999999998 8899999999
Q ss_pred cceeec
Q 007336 588 LVRTFG 593 (607)
Q Consensus 588 la~~~~ 593 (607)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=201.97 Aligned_cols=147 Identities=25% Similarity=0.381 Sum_probs=127.5
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCC-C-----CceeceEEEEEeCCeEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-H-----RNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H-----~nIv~l~g~~~~~~~~~l 513 (607)
+|++.+.||+|+||+|.++.... ++.||||+++.. ..-..+-..|+.+|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 89999999999999999998755 899999999763 445566677999999886 4 479999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC--CceEEeeccccee
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLVRT 591 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~--~~~ki~DfGla~~ 591 (607)
|+|.+. -+|.++|... +...++......|+.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.|..
T Consensus 266 VfELL~-~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999885 6999999653 3445889999999999999999999887 9999999999999754 4699999999986
Q ss_pred ec
Q 007336 592 FG 593 (607)
Q Consensus 592 ~~ 593 (607)
..
T Consensus 341 ~~ 342 (586)
T KOG0667|consen 341 ES 342 (586)
T ss_pred cC
Confidence 54
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=195.68 Aligned_cols=147 Identities=27% Similarity=0.488 Sum_probs=127.8
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+|++.+.||+|+||.||+++.. ++..||+|++... .......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999985 4889999988642 222345678899999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++ ++|.+++... ...+++.....++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 97 5787777432 345899999999999999999999887 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=189.52 Aligned_cols=148 Identities=30% Similarity=0.497 Sum_probs=128.3
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecc-----cchhhHHHHHHHHHHHccCCCCceeceEEEEEeC--CeE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK-----ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~-----~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 511 (607)
.+|++.+.||+|+||.||+++... +..||+|.+.. ........+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 468889999999999999998754 88999998742 1234456889999999999999999999998764 457
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999998532 34788889999999999999999887 99999999999999999999999999987
Q ss_pred ec
Q 007336 592 FG 593 (607)
Q Consensus 592 ~~ 593 (607)
+.
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.4e-21 Score=193.80 Aligned_cols=150 Identities=29% Similarity=0.443 Sum_probs=129.5
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeC--CeEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 514 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV 514 (607)
++|++.+.||+|+||.||+|+... ++.+++|.++... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 468888999999999999999864 7899999986422 22334577899999999999999999999887 789999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||++ ++|.+++.... ..+++.....++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99998 58988885422 35899999999999999999999887 99999999999999999999999999997754
Q ss_pred C
Q 007336 595 D 595 (607)
Q Consensus 595 ~ 595 (607)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=193.28 Aligned_cols=150 Identities=25% Similarity=0.404 Sum_probs=131.1
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
++|++.+.||+|+||.||++...+ ++.|++|.++.. .....+.+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368889999999999999999864 789999988642 23345678999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|++++.+..++.. ...+++.....++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9998777766532 334789999999999999999999887 999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=189.57 Aligned_cols=153 Identities=24% Similarity=0.487 Sum_probs=129.2
Q ss_pred CcccceeecccCceeEEEEEecC--CcEEEEEEecc----------cchhhHHHHHHHHHHHcc-CCCCceeceEEEEEe
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSK----------ISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ 507 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~--~~~vavK~l~~----------~~~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~ 507 (607)
+|++.+.||+|+||.||++.... ++.+|+|.+.. .......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999865 67899998753 122344567788888865 799999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeec
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~Df 586 (607)
++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.. +++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999987542 23456889999999999999999999632 3999999999999999999999999
Q ss_pred ccceeecCC
Q 007336 587 GLVRTFGGD 595 (607)
Q Consensus 587 Gla~~~~~~ 595 (607)
|++......
T Consensus 159 g~~~~~~~~ 167 (269)
T cd08528 159 GLAKQKQPE 167 (269)
T ss_pred cceeecccc
Confidence 999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=186.17 Aligned_cols=149 Identities=32% Similarity=0.527 Sum_probs=133.2
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccch--hhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+|++.+.||+|++|.||+++.. +++.|++|.+..... ...+.+.+|++++++++|+|++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999875 478999999876432 4567899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999998542 46899999999999999999999887 999999999999999999999999999987543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=187.28 Aligned_cols=150 Identities=25% Similarity=0.439 Sum_probs=131.0
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+|++.+.||+|+||.||++... .++.+|||.+... .....+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999875 4788999988642 334567899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CceEEeecccceeecC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGG 594 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~-~~~ki~DfGla~~~~~ 594 (607)
+++++|.+++... ....+++..+..++.+++++|.|||+.+ ++|+||+|+||+++++ ..+||+|||+++.+..
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999643 2345789999999999999999999987 9999999999999865 4689999999997754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-21 Score=193.72 Aligned_cols=148 Identities=31% Similarity=0.522 Sum_probs=129.3
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 4889999988642 222345788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++ ++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 96 6898888543 2356899999999999999999999877 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.2e-21 Score=192.18 Aligned_cols=145 Identities=41% Similarity=0.610 Sum_probs=125.0
Q ss_pred eeecccCceeEEEEEecC-------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 446 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+.||+|+||.||+|+..+ +..++||.+... ......++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 257899987643 234567899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-----ceEEeeccc
Q 007336 518 MPNKSLDSFIFDQT----RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-----NPKISDFGL 588 (607)
Q Consensus 518 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~-----~~ki~DfGl 588 (607)
+++++|.+++.+.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996532 2245789999999999999999999876 99999999999999877 899999999
Q ss_pred ceeec
Q 007336 589 VRTFG 593 (607)
Q Consensus 589 a~~~~ 593 (607)
++.+.
T Consensus 158 ~~~~~ 162 (269)
T cd05044 158 ARDIY 162 (269)
T ss_pred ccccc
Confidence 98664
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.7e-21 Score=191.75 Aligned_cols=158 Identities=30% Similarity=0.508 Sum_probs=133.6
Q ss_pred hHHhHHhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEEe-
Q 007336 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ- 507 (607)
Q Consensus 431 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~- 507 (607)
++.++..+.+.|++.+.||+|+||.||+|.... ++.+|+|.+... .....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 344555567889999999999999999999754 788999988653 33456788899999888 79999999999863
Q ss_pred -----CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceE
Q 007336 508 -----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (607)
Q Consensus 508 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~k 582 (607)
....+++|||+++|+|.+++... ....+++..+..++.||+.||.|||+.+ |+|+||+|+||++++++.+|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45679999999999999998643 2345788888999999999999999987 99999999999999999999
Q ss_pred Eeecccceeec
Q 007336 583 ISDFGLVRTFG 593 (607)
Q Consensus 583 i~DfGla~~~~ 593 (607)
|+|||+++.+.
T Consensus 162 l~dfg~~~~~~ 172 (282)
T cd06636 162 LVDFGVSAQLD 172 (282)
T ss_pred EeeCcchhhhh
Confidence 99999988653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=191.89 Aligned_cols=152 Identities=29% Similarity=0.508 Sum_probs=135.9
Q ss_pred HhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
...++.|+..+.||+|+||.||++... ++..|++|.+..... ..+.+.+|+.+++.++|+||+++++.+......++|
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 346677888899999999999999986 588999999875433 567889999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+||+++++|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+.
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 99999999999996532 36899999999999999999999877 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=191.43 Aligned_cols=151 Identities=28% Similarity=0.356 Sum_probs=129.9
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeC--CeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 515 (607)
++|...+.||.|++|.||++.... ++.+|+|.+... ......++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 367888999999999999999854 788999988753 234567799999999999999999999998654 3679999
Q ss_pred EcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 516 EFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||+++++|.+++... .....++......++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999887532 23455788899999999999999999887 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=189.97 Aligned_cols=153 Identities=30% Similarity=0.502 Sum_probs=132.7
Q ss_pred hhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEEeCC-----
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE----- 509 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~----- 509 (607)
.++++|++.+.||+|+||.||+|... .++.+++|.+.... ...+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45689999999999999999999985 47889999886533 3456799999999999 7999999999997654
Q ss_pred -eEEEEEEcCCCCChHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 510 -EKLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 510 -~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4799999999999999985422 2456889999999999999999999887 9999999999999999999999999
Q ss_pred cceeec
Q 007336 588 LVRTFG 593 (607)
Q Consensus 588 la~~~~ 593 (607)
++..+.
T Consensus 159 ~~~~~~ 164 (275)
T cd06608 159 VSAQLD 164 (275)
T ss_pred cceecc
Confidence 998654
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.1e-21 Score=204.03 Aligned_cols=154 Identities=23% Similarity=0.378 Sum_probs=121.0
Q ss_pred hhcCCcccceeecccCceeEEEEEe-----------------cCCcEEEEEEecccchhhHHH--------------HHH
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTL-----------------VDGQEIAVKRLSKISEQGLKE--------------LKN 485 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~-----------------~~~~~vavK~l~~~~~~~~~~--------------f~~ 485 (607)
...++|++.++||+|+||.||+|.+ ..++.||||++........++ +..
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3567899999999999999999964 234679999986533222233 334
Q ss_pred HHHHHccCCCCce-----eceEEEEEe--------CCeEEEEEEcCCCCChHHHHhcCC---------------------
Q 007336 486 EVILFSKLQHRNL-----VKLLGCCIQ--------GEEKLLIYEFMPNKSLDSFIFDQT--------------------- 531 (607)
Q Consensus 486 E~~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~--------------------- 531 (607)
|+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++|+...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6677777776654 678888753 346799999999999999986421
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 532 RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 532 ~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
....+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 1123567888899999999999999877 9999999999999999999999999998654
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=208.16 Aligned_cols=153 Identities=24% Similarity=0.387 Sum_probs=120.1
Q ss_pred hcCCcccceeecccCceeEEEEEecC--CcEEEEE------------------EecccchhhHHHHHHHHHHHccCCCCc
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD--GQEIAVK------------------RLSKISEQGLKELKNEVILFSKLQHRN 497 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~--~~~vavK------------------~l~~~~~~~~~~f~~E~~~l~~l~H~n 497 (607)
..++|++.++||+|+||+||++.... +...++| .+. ........+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45689999999999999999987543 1112221 111 12234567889999999999999
Q ss_pred eeceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE
Q 007336 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR--RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575 (607)
Q Consensus 498 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill 575 (607)
|+++++++...+..++|+|++. ++|.+++..... ...........|+.||+.||.|||+.+ ||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999986 567777643211 112234566789999999999999887 9999999999999
Q ss_pred cCCCceEEeecccceeecCC
Q 007336 576 DQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 576 ~~~~~~ki~DfGla~~~~~~ 595 (607)
+.++.+||+|||+++.+...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~ 320 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKE 320 (501)
T ss_pred CCCCCEEEEeCCCceecCcc
Confidence 99999999999999987543
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=190.23 Aligned_cols=142 Identities=31% Similarity=0.415 Sum_probs=124.5
Q ss_pred ecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCCh
Q 007336 448 LGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (607)
Q Consensus 448 lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (607)
||+|+||+||++... +++.+|+|.+... .......+..|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 4889999988642 122345678899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 999865332 35789999999999999999999887 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.9e-21 Score=189.98 Aligned_cols=149 Identities=28% Similarity=0.377 Sum_probs=132.1
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++|+..+.||+|+||.||++... +++.|++|.+... .....+++.+|+.++++++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999986 4889999988653 234567789999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++++|.+++.... ..++......++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||++..+.
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 99999999985432 567889999999999999999998 65 9999999999999999999999999987663
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-20 Score=183.19 Aligned_cols=150 Identities=35% Similarity=0.564 Sum_probs=134.6
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
.|+..+.||+|++|.||++... ++..+++|++..........+.+|+.++++++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999986 588999999876544567889999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
+++|.+++.... ..+++..+..++.|++.+|.|||..+ ++|+||+|+||++++++.+||+|||++..+...
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999999985432 46899999999999999999999876 999999999999999999999999999887654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-22 Score=206.80 Aligned_cols=150 Identities=29% Similarity=0.455 Sum_probs=132.9
Q ss_pred hcCCcccceeecccCceeEEEEEecCC-cEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~-~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
+.+.|.|+-.||.|+||.||++..++. -.-|.|.+...+....+.|+-|+.+++..+||+||+|++.+...+.++|+.|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 445677788999999999999997764 3456677776677888999999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
||+||-.+..+.+.. ..|...++.-++++++.||.|||++. |||||||+.|||++-+|.++|+|||.+-..
T Consensus 110 FC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred ecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccc
Confidence 999999999886543 45889999999999999999999987 999999999999999999999999987654
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=193.00 Aligned_cols=151 Identities=29% Similarity=0.482 Sum_probs=128.9
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCC-----
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 509 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~----- 509 (607)
..++|++.+.||+|+||.||+|.... ++.||+|+++... ......+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 45689999999999999999999864 7899999986422 233456788999999999999999999987654
Q ss_pred -----eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEe
Q 007336 510 -----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (607)
Q Consensus 510 -----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~ 584 (607)
..++|+||+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 68999999986 676766432 345899999999999999999999987 9999999999999999999999
Q ss_pred ecccceeecC
Q 007336 585 DFGLVRTFGG 594 (607)
Q Consensus 585 DfGla~~~~~ 594 (607)
|||+++.+..
T Consensus 159 dfg~~~~~~~ 168 (302)
T cd07864 159 DFGLARLYNS 168 (302)
T ss_pred cccccccccC
Confidence 9999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=201.03 Aligned_cols=170 Identities=32% Similarity=0.532 Sum_probs=144.2
Q ss_pred hHHhHHhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEEe-
Q 007336 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ- 507 (607)
Q Consensus 431 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~- 507 (607)
.++.+...++.|++.+.||.|.+|.||+++.. +++.+|+|++... ....++...|..+++.. +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34555667889999999999999999999864 4888999988653 34556777788888877 79999999999874
Q ss_pred ----CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEE
Q 007336 508 ----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (607)
Q Consensus 508 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki 583 (607)
++.++||||||.+|+..+++.... ...+.|..+..|++.++.|+.|||.+. +||||||=.||||+.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 567899999999999999997644 677899999999999999999999887 999999999999999999999
Q ss_pred eecccceeecCCCCccCccceecC
Q 007336 584 SDFGLVRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 584 ~DfGla~~~~~~~~~~~~~~~~GT 607 (607)
.|||++..+.. +..+.++.+||
T Consensus 165 vDFGvSaQlds--T~grRnT~iGt 186 (953)
T KOG0587|consen 165 VDFGVSAQLDS--TVGRRNTFIGT 186 (953)
T ss_pred eeeeeeeeeec--ccccccCcCCC
Confidence 99999998864 33445556776
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=187.10 Aligned_cols=155 Identities=27% Similarity=0.477 Sum_probs=130.7
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEe--CCeEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIY 515 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV~ 515 (607)
+|++.+.||.|+||.||++... ++..||+|.+.. ......+++..|+.++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999864 478899998864 234456778999999999999999999998764 44578999
Q ss_pred EcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 516 EFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
||+++++|.+++... .....+++.....++.||+.||.|||..+ ..+++|+||+|+||++++++.+||+|||+++.+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998643 22456899999999999999999999332 234999999999999999999999999999987
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
...
T Consensus 161 ~~~ 163 (265)
T cd08217 161 GHD 163 (265)
T ss_pred cCC
Confidence 543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=189.05 Aligned_cols=141 Identities=29% Similarity=0.371 Sum_probs=117.7
Q ss_pred eecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHHH---HHccCCCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVI---LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 447 ~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~---~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
.||+|+||.||++...+ ++.+|+|.+.+.. ......+.+|.. ++...+||||+.+.+.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999754 7899999886421 122233444443 3344579999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 9999999854 235899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-21 Score=200.49 Aligned_cols=156 Identities=31% Similarity=0.466 Sum_probs=131.0
Q ss_pred eecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCChHH
Q 007336 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525 (607)
Q Consensus 447 ~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 525 (607)
+||+|.||+||-|++.+ ...+|||.+.....+....+.+|+.+-+.++|.|||+.+|.|.+++..-+.||.+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999876 45799999977666777789999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCceEEeecccceeecCCCCccCccce
Q 007336 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGDETEGNTNRV 604 (607)
Q Consensus 526 ~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~-~~~~ki~DfGla~~~~~~~~~~~~~~~ 604 (607)
+|+..=..-.-.+.+.-.+..||++||.|||++. |||||||-+||||+- .|.+||+|||-+|.+.+-.. .|.++
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc--ccccc
Confidence 9964211111256667778999999999999987 999999999999974 68899999999998865433 23445
Q ss_pred ecC
Q 007336 605 VGT 607 (607)
Q Consensus 605 ~GT 607 (607)
.||
T Consensus 737 TGT 739 (1226)
T KOG4279|consen 737 TGT 739 (1226)
T ss_pred ccc
Confidence 565
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=187.09 Aligned_cols=141 Identities=28% Similarity=0.371 Sum_probs=125.9
Q ss_pred ecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCCh
Q 007336 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (607)
Q Consensus 448 lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (607)
||.|+||.||+++... ++.+++|.+.+. .....+.+.+|+.+++.++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999864 789999998652 223456799999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 999954 234788999999999999999999877 99999999999999999999999999997754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.1e-21 Score=181.33 Aligned_cols=141 Identities=18% Similarity=0.179 Sum_probs=108.3
Q ss_pred ceeecccCceeEEEEEecCCcEEEEEEecccch--hh-------HHHH-----------------HHHHHHHccCCCCce
Q 007336 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE--QG-------LKEL-----------------KNEVILFSKLQHRNL 498 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~--~~-------~~~f-----------------~~E~~~l~~l~H~nI 498 (607)
...||+|+||.||+|...+|+.||||+++.... .. ...| ..|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 368999999999999988899999999865211 01 1122 348899999987776
Q ss_pred eceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecccCCCcEEEcC
Q 007336 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL-HQDSRLRIIHRDLKASNVLLDQ 577 (607)
Q Consensus 499 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~ivHrDlkp~Nill~~ 577 (607)
.....+.. ...+|||||++++++...+.. ...++......++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 223899999999877654322 23578889999999999999999 6766 99999999999998
Q ss_pred CCceEEeecccceeecC
Q 007336 578 DMNPKISDFGLVRTFGG 594 (607)
Q Consensus 578 ~~~~ki~DfGla~~~~~ 594 (607)
++.++|+|||+|...+.
T Consensus 153 ~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred CCcEEEEEccccccCCC
Confidence 47899999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-20 Score=184.14 Aligned_cols=150 Identities=31% Similarity=0.482 Sum_probs=133.9
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeC--CeEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 515 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 515 (607)
+|++.+.||+|++|.||+|... ++..|++|.+.... ....+.+.+|+.++++++|+||+++++.+.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999986 58899999986533 35578899999999999999999999999988 8899999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+++++|.+++.... .+++..+..++.+++++|+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999985432 6899999999999999999999977 999999999999999999999999999988654
Q ss_pred C
Q 007336 596 E 596 (607)
Q Consensus 596 ~ 596 (607)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.4e-21 Score=194.13 Aligned_cols=152 Identities=26% Similarity=0.353 Sum_probs=132.0
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
+-|.+.+.||+|-|..|-++++. .|..||||++.+. +......+..|++-|+.++|||||+|+.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45777899999999999999864 5899999999864 33445678899999999999999999999988999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCceEEeecccceeecCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~-~~~~~ki~DfGla~~~~~~ 595 (607)
.-.+|+|.+||-++.. -+.+....+++.||+.|+.|.|+.. +|||||||+||++- .-|-+||.|||++-.+.+.
T Consensus 98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999965443 3778888899999999999999877 99999999998875 5688999999999888654
Q ss_pred C
Q 007336 596 E 596 (607)
Q Consensus 596 ~ 596 (607)
+
T Consensus 173 ~ 173 (864)
T KOG4717|consen 173 K 173 (864)
T ss_pred c
Confidence 4
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=188.84 Aligned_cols=140 Identities=29% Similarity=0.413 Sum_probs=125.6
Q ss_pred ecccCceeEEEEEecC-CcEEEEEEecccch---hhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCCh
Q 007336 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (607)
Q Consensus 448 lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (607)
||+|+||.||+++... ++.+++|.+..... ...+.+.+|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999875 88999999865322 4567889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
.+++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~ 144 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGL 144 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence 9998542 25899999999999999999999887 9999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5e-21 Score=197.95 Aligned_cols=147 Identities=24% Similarity=0.392 Sum_probs=129.2
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
.-|..++.||-|+||+|-++...| ...+|+|.|++. .+.+....++|..||+..+.+-||+|+--|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457778899999999999998766 567899999763 4456778899999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
||++||++..+|- +...+++.....++.++.+|+++.|.-+ +|||||||+|||||.+|++||+||||+.=+
T Consensus 709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 9999999999883 4556777777777888999999999876 999999999999999999999999998643
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=186.88 Aligned_cols=150 Identities=27% Similarity=0.478 Sum_probs=130.9
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+|++.+.||+|+||.||++.... +..+|+|.+... .....+.+.+|+.+++.++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47888999999999999999864 788999988642 223456788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-ceEEeecccceeecC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGG 594 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~-~~ki~DfGla~~~~~ 594 (607)
+++++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||||+||++++++ .+||+|||++..+..
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999998643 2345799999999999999999999887 99999999999999885 469999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-21 Score=192.44 Aligned_cols=156 Identities=27% Similarity=0.373 Sum_probs=137.6
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..+.|+.-++||+|+||.|+-.+... |+-+|.|++.+ ..+++...-++|.+++.+++.+.||.+--.++..+.++|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 34568888999999999999998765 88899998864 244566778899999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+..|.||+|.-+|+.... ..+++....-++.+|+.||++||... ||.|||||+|||||+.|+++|+|+|||..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999976544 45788888889999999999999876 9999999999999999999999999999987
Q ss_pred CCCC
Q 007336 594 GDET 597 (607)
Q Consensus 594 ~~~~ 597 (607)
+.+.
T Consensus 339 ~g~~ 342 (591)
T KOG0986|consen 339 EGKP 342 (591)
T ss_pred CCCc
Confidence 6554
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-20 Score=188.55 Aligned_cols=149 Identities=29% Similarity=0.480 Sum_probs=126.3
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
++|++.+.||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47888999999999999999975 58899999886422 2334678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~-~~~~ki~DfGla~~~~ 593 (607)
|++ ++|.+++.... ...+++.....++.||+.||+|||+.+ ++||||+|+||++++ ++.+||+|||+++.+.
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 57877774322 233578888899999999999999887 999999999999985 5679999999998664
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=195.35 Aligned_cols=149 Identities=30% Similarity=0.539 Sum_probs=127.6
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccC-CCCceeceEEEEEeC--CeE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG--EEK 511 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~--~~~ 511 (607)
..++|++.+.||+|+||.||+|... ++..+|+|++.. ........+..|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888999999999999999975 478999998854 2233455677899999999 999999999998653 367
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999998 599888843 26789999999999999999999877 99999999999999999999999999987
Q ss_pred ecC
Q 007336 592 FGG 594 (607)
Q Consensus 592 ~~~ 594 (607)
+..
T Consensus 157 ~~~ 159 (337)
T cd07852 157 LSE 159 (337)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=203.54 Aligned_cols=150 Identities=24% Similarity=0.323 Sum_probs=119.5
Q ss_pred HHhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCC------CCceeceEEEEEe
Q 007336 435 IANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ------HRNLVKLLGCCIQ 507 (607)
Q Consensus 435 ~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~------H~nIv~l~g~~~~ 507 (607)
+....++|++.++||+|+||+||++.... ++.||||+++... ...+++..|+.++..++ |.+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 34456889999999999999999998754 7889999986532 23344556666666554 4568899998876
Q ss_pred C-CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCC------
Q 007336 508 G-EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDM------ 579 (607)
Q Consensus 508 ~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivHrDlkp~Nill~~~~------ 579 (607)
. .+.++|||++ +++|.+++.. ...+++..+..|+.||+.||.|||++ + ||||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 4 4678999988 6788888754 24588999999999999999999974 5 99999999999998765
Q ss_pred ----------ceEEeecccceee
Q 007336 580 ----------NPKISDFGLVRTF 592 (607)
Q Consensus 580 ----------~~ki~DfGla~~~ 592 (607)
.+||+|||++...
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred cccccCCCCceEEECCCCccccC
Confidence 4999999988643
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=189.79 Aligned_cols=142 Identities=30% Similarity=0.485 Sum_probs=127.1
Q ss_pred eeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCChH
Q 007336 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 524 (607)
.+||+|+||.||++... ++..||||++........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999875 58899999986544455677999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 525 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+++.. ..+++.....++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++..+..
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 98732 24788999999999999999999887 99999999999999999999999999887643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-20 Score=191.26 Aligned_cols=151 Identities=28% Similarity=0.487 Sum_probs=126.9
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe----
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE---- 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~---- 510 (607)
..++|++.++||+|+||.||++... +++.||||.+... .......+.+|+.++++++||||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3457999999999999999999975 4889999988542 22233456789999999999999999999876543
Q ss_pred ----EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeec
Q 007336 511 ----KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (607)
Q Consensus 511 ----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~Df 586 (607)
.++||||+++ +|.+++.. ....+++.....++.||+.||+|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 4999999974 78777743 2335799999999999999999999887 999999999999999999999999
Q ss_pred ccceeecC
Q 007336 587 GLVRTFGG 594 (607)
Q Consensus 587 Gla~~~~~ 594 (607)
|+++.+..
T Consensus 164 g~~~~~~~ 171 (310)
T cd07865 164 GLARAFSL 171 (310)
T ss_pred CCcccccC
Confidence 99987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=5e-20 Score=190.02 Aligned_cols=148 Identities=28% Similarity=0.489 Sum_probs=127.9
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.|+..+.||+|+||.||+++.. ++..||+|.+... .......+..|+.++++++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4777789999999999999975 4789999998642 22344678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|++ |+|.+++... ...+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 997 5777776432 345899999999999999999999887 99999999999999999999999999886643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-20 Score=193.74 Aligned_cols=150 Identities=29% Similarity=0.463 Sum_probs=128.4
Q ss_pred hhcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCC----
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE---- 509 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~---- 509 (607)
...++|++.+.||+|+||.||++... ++..||||++... .....+.+.+|+.++++++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35678999999999999999999864 5889999998542 2334457889999999999999999999987653
Q ss_pred --eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 510 --EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 510 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 6789888742 35789999999999999999999887 9999999999999999999999999
Q ss_pred cceeecC
Q 007336 588 LVRTFGG 594 (607)
Q Consensus 588 la~~~~~ 594 (607)
+++.+..
T Consensus 164 ~~~~~~~ 170 (343)
T cd07880 164 LARQTDS 170 (343)
T ss_pred ccccccc
Confidence 9987643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=187.78 Aligned_cols=148 Identities=30% Similarity=0.482 Sum_probs=129.4
Q ss_pred cccceeecccCceeEEEEEecC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeC--CeEEEEEE
Q 007336 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIYE 516 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E 516 (607)
|++.+.||+|+||.||+|+..+ ++.+|+|++.... ......+.+|+.++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5677899999999999999764 7899999987642 33456788999999999999999999999988 78999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|+++ +|.+++... ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9984 888887542 246889999999999999999999887 999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-20 Score=187.36 Aligned_cols=146 Identities=29% Similarity=0.474 Sum_probs=129.2
Q ss_pred cccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444479999999999999864 5789999988654445566788999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++.+..
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 999999854 34788999999999999999999987 99999999999999999999999999886643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=190.32 Aligned_cols=150 Identities=33% Similarity=0.486 Sum_probs=133.2
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV 514 (607)
++|.+.+.||+|+||.||+++.. +++.|++|.+... .....+.+..|..++.+++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999975 5889999988642 2334567889999999998 99999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999954 236899999999999999999999887 99999999999999999999999999997754
Q ss_pred C
Q 007336 595 D 595 (607)
Q Consensus 595 ~ 595 (607)
.
T Consensus 155 ~ 155 (280)
T cd05581 155 N 155 (280)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=209.38 Aligned_cols=159 Identities=32% Similarity=0.482 Sum_probs=135.6
Q ss_pred HHhhcCCcccceeecccCceeEEEEEecC--------CcEEEEEEecc-cchhhHHHHHHHHHHHccC-CCCceeceEEE
Q 007336 435 IANATDNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGC 504 (607)
Q Consensus 435 ~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~ 504 (607)
.+...++..+.+.||+|.||+|++|.... ...||||.++. ......+.+..|+.+|..+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 34455566677799999999999998531 35799999875 3345678899999999988 69999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhcCC-----C------C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCC
Q 007336 505 CIQGEEKLLIYEFMPNKSLDSFIFDQT-----R------R--TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571 (607)
Q Consensus 505 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~ 571 (607)
|..+...++|+||++.|+|.+||+... . . ..+.....+.++.|||.||+||++.. +|||||++|
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999997544 0 0 23888999999999999999999876 999999999
Q ss_pred cEEEcCCCceEEeecccceeecCCC
Q 007336 572 NVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 572 Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
||||.++..+||+||||||...+.+
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~ 472 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKD 472 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCC
Confidence 9999999999999999999765443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-21 Score=196.79 Aligned_cols=151 Identities=26% Similarity=0.359 Sum_probs=128.1
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecccch--------hhHHHHHHHHHHHccCC---CCceeceEEEEEe
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE--------QGLKELKNEVILFSKLQ---HRNLVKLLGCCIQ 507 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~--------~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~ 507 (607)
.+|+..+.+|+|+||.|+.+.++. ..+|+||.+.+..- ...-..-.|+++|+.++ |+||++++.++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 358888999999999999999865 67899999876211 11123557999999997 9999999999999
Q ss_pred CCeEEEEEEcC-CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeec
Q 007336 508 GEEKLLIYEFM-PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (607)
Q Consensus 508 ~~~~~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~Df 586 (607)
++..+|+||-. ++-+|.++|. ....+++.....|+.||+.|+++||+++ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999976 4558999984 3445788888999999999999999998 999999999999999999999999
Q ss_pred ccceeecCCC
Q 007336 587 GLVRTFGGDE 596 (607)
Q Consensus 587 Gla~~~~~~~ 596 (607)
|-|-.....+
T Consensus 715 gsaa~~ksgp 724 (772)
T KOG1152|consen 715 GSAAYTKSGP 724 (772)
T ss_pred cchhhhcCCC
Confidence 9998665443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=176.99 Aligned_cols=142 Identities=19% Similarity=0.211 Sum_probs=111.7
Q ss_pred ceeecccCceeEEEEEecCCcEEEEEEecccchh--------------------------hHHHHHHHHHHHccCCCCce
Q 007336 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ--------------------------GLKELKNEVILFSKLQHRNL 498 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~--------------------------~~~~f~~E~~~l~~l~H~nI 498 (607)
...||+|+||+||+|...+|+.||||++...... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998752110 01234678899999999987
Q ss_pred eceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcC
Q 007336 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQ 577 (607)
Q Consensus 499 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivHrDlkp~Nill~~ 577 (607)
.....+... ..+|||||++++++...... ...++......++.+++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 555444332 24899999998865443211 2346778888999999999999999 76 99999999999999
Q ss_pred CCceEEeecccceeecCC
Q 007336 578 DMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 578 ~~~~ki~DfGla~~~~~~ 595 (607)
++.++|+|||+|+.+..+
T Consensus 153 ~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 153 DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred CCCEEEEEcccceecCCC
Confidence 889999999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-20 Score=186.95 Aligned_cols=141 Identities=28% Similarity=0.359 Sum_probs=118.0
Q ss_pred eecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHH---HHHccCCCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 447 KLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEV---ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 447 ~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~---~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
.||+|+||.||++.... ++.||+|.+.+.. ......+..|. .+++...||||+++++.+.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999998754 7899999886421 12222344443 34455689999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++|..++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 9999998843 346899999999999999999999877 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-20 Score=190.44 Aligned_cols=151 Identities=34% Similarity=0.506 Sum_probs=128.5
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeC--CeEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 512 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~ 512 (607)
..++|++.+.||+|+||.||+|.... ++.||+|.++... ......+.+|+.++++++|+||+++++++.+. +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 34689999999999999999999854 8899999886422 12233567899999999999999999998765 4679
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||++ ++|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+||++++++.+||+|||+++.+
T Consensus 85 lv~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999997 4788887542 245899999999999999999999987 999999999999999999999999999987
Q ss_pred cC
Q 007336 593 GG 594 (607)
Q Consensus 593 ~~ 594 (607)
..
T Consensus 159 ~~ 160 (309)
T cd07845 159 GL 160 (309)
T ss_pred CC
Confidence 54
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=188.90 Aligned_cols=148 Identities=28% Similarity=0.369 Sum_probs=128.3
Q ss_pred CcccceeecccCceeEEEEEec----CCcEEEEEEecccc----hhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 511 (607)
+|++.+.||+|+||.||+++.. ++..||||.+.+.. ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999853 46789999986421 23346788999999999 599999999999999999
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++||||+++|+|.+++.. ...+++.....++.|++++|.|||+.+ ++||||+|+||+++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999999853 245788899999999999999999876 99999999999999999999999999987
Q ss_pred ecC
Q 007336 592 FGG 594 (607)
Q Consensus 592 ~~~ 594 (607)
+..
T Consensus 155 ~~~ 157 (288)
T cd05583 155 FLA 157 (288)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-21 Score=211.95 Aligned_cols=149 Identities=30% Similarity=0.497 Sum_probs=120.1
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeC-------
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------- 508 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------- 508 (607)
...+|+.++.||+||||.||+++.+ ||+.+|||++.- .+......+.+|+.++++|+|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4457888899999999999999864 799999999864 2445567788999999999999999765411000
Q ss_pred --------------------------------------------------------------------------------
Q 007336 509 -------------------------------------------------------------------------------- 508 (607)
Q Consensus 509 -------------------------------------------------------------------------------- 508 (607)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 007336 509 --------------------------------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556 (607)
Q Consensus 509 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH 556 (607)
..+|+=||||+.-+|.+++.+..... .....++++++|++||+|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 11356688888888888875432211 45667789999999999999
Q ss_pred hCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 557 ~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
+.+ ||||||||.||+||++..|||.|||+|..
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 988 99999999999999999999999999997
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=193.64 Aligned_cols=148 Identities=27% Similarity=0.454 Sum_probs=127.0
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCC-----eE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EK 511 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~ 511 (607)
.++|++.++||+|+||.||+|... +++.||||.+... .......+..|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999864 4889999998642 2334567888999999999999999999876543 47
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++|+||++ ++|..++. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999997 47877763 235889999999999999999999987 99999999999999999999999999987
Q ss_pred ecC
Q 007336 592 FGG 594 (607)
Q Consensus 592 ~~~ 594 (607)
...
T Consensus 156 ~~~ 158 (336)
T cd07849 156 ADP 158 (336)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-20 Score=193.33 Aligned_cols=148 Identities=31% Similarity=0.448 Sum_probs=126.7
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeC------
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------ 508 (607)
..++|++.+.||+|+||.||++... +++.||||.+.+ ........+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4468999999999999999999975 588999999864 2334456778899999999999999999988643
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccc
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGl 588 (607)
...++||||++ ++|.+.+.. .++......++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34689999996 578877732 1788889999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 007336 589 VRTFGG 594 (607)
Q Consensus 589 a~~~~~ 594 (607)
++....
T Consensus 165 ~~~~~~ 170 (353)
T cd07850 165 ARTAGT 170 (353)
T ss_pred ceeCCC
Confidence 997754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=187.88 Aligned_cols=147 Identities=31% Similarity=0.527 Sum_probs=128.3
Q ss_pred cccceeecccCceeEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
|++.+.||+|++|.||+|... ++..|++|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999875 58999999886422 233467889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+ ++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.+||+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 68999885432 245899999999999999999999876 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.9e-20 Score=191.80 Aligned_cols=154 Identities=31% Similarity=0.449 Sum_probs=130.2
Q ss_pred HHhHHhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeC
Q 007336 432 LATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (607)
Q Consensus 432 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~ 508 (607)
..++...+++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++.+++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3456667889999999999999999999864 5889999998652 223456788999999999999999999988643
Q ss_pred ------CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceE
Q 007336 509 ------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (607)
Q Consensus 509 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~k 582 (607)
...++++|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 2357888876 7899887732 34789999999999999999999887 99999999999999999999
Q ss_pred Eeecccceeec
Q 007336 583 ISDFGLVRTFG 593 (607)
Q Consensus 583 i~DfGla~~~~ 593 (607)
|+|||+++...
T Consensus 161 l~dfg~~~~~~ 171 (345)
T cd07877 161 ILDFGLARHTD 171 (345)
T ss_pred Eeccccccccc
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-21 Score=184.81 Aligned_cols=141 Identities=30% Similarity=0.412 Sum_probs=125.9
Q ss_pred eeecccCceeEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEEEEcCCCCCh
Q 007336 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~-~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (607)
+.||+|+++.|--+. +..+.++|||++.+.......+..+|++++...+ |+||++|+.|++++...|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999887 4679999999999877777888999999999985 99999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc---eEEeecccceee
Q 007336 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLVRTF 592 (607)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~---~ki~DfGla~~~ 592 (607)
..+|.+ +..+.+....++..+||.||.|||..+ |.||||||+|||-..... +||+||.|+.-+
T Consensus 164 LshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 164 LSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred HHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence 999954 345788888999999999999999887 999999999999976544 799999987644
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.8e-20 Score=185.85 Aligned_cols=146 Identities=25% Similarity=0.380 Sum_probs=123.3
Q ss_pred cccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCC-CCceeceEEEEEeC--CeEEEEEE
Q 007336 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIYE 516 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~E 516 (607)
|++.++||+|+||.||+++.. ++..||+|+++.. ..........|+.++.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999875 4889999998652 2222334457888888885 99999999999987 88999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|++ ++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++. +.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 5888877542 246899999999999999999999887 999999999999999 9999999999987743
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-19 Score=181.04 Aligned_cols=152 Identities=26% Similarity=0.422 Sum_probs=134.4
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+|++.+.||+|+||.||++... ++..+++|++... ......++..|+++++.++|+|++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999985 4789999998753 235567889999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999986532 2356899999999999999999999987 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-20 Score=183.31 Aligned_cols=142 Identities=28% Similarity=0.354 Sum_probs=120.0
Q ss_pred eeecccCceeEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHH-HccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+.||+|+||.||+|... .++.||+|.+.+.. ......+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 47899999986532 1223344455444 4556899999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 999999853 235788999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-20 Score=193.47 Aligned_cols=148 Identities=24% Similarity=0.445 Sum_probs=127.4
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEe----CCeEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKL 512 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~ 512 (607)
++|++.+.||+|+||.||++... ++..||+|++... .......+.+|+.++++++||||+++.+++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 68899999999999999999875 4889999998652 22345677889999999999999999988763 34679
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||+. ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999996 689888843 344899999999999999999999877 999999999999999999999999999876
Q ss_pred cC
Q 007336 593 GG 594 (607)
Q Consensus 593 ~~ 594 (607)
..
T Consensus 158 ~~ 159 (334)
T cd07855 158 SS 159 (334)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=169.99 Aligned_cols=156 Identities=27% Similarity=0.391 Sum_probs=128.9
Q ss_pred HhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecc-cchhhHHHHHHHHHHHcc-CCCCceeceEEEEEeCCeEE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~-~~~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~ 512 (607)
....+.......||+|++|.|-+-++. .|...|+|++.. ...+..++...|+.+..+ ...|.+|.++|...+....+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 334455555678999999999888864 589999999974 455666778888887654 57999999999999999999
Q ss_pred EEEEcCCCCChHHHHhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 513 LIYEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
+.||.|. -||+.|-.+ ..+...+++...=+||..+.+||.|||++ ..+||||+||+||||+.+|++||+|||++..
T Consensus 122 IcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEccccccee
Confidence 9999995 577766432 13566789999999999999999999985 4699999999999999999999999999987
Q ss_pred ecC
Q 007336 592 FGG 594 (607)
Q Consensus 592 ~~~ 594 (607)
+.+
T Consensus 199 L~d 201 (282)
T KOG0984|consen 199 LVD 201 (282)
T ss_pred ehh
Confidence 753
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-20 Score=191.14 Aligned_cols=149 Identities=27% Similarity=0.466 Sum_probs=127.5
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeC-----Ce
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 510 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~~ 510 (607)
.++|.+.+.||+|+||.||+++.. ++..||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357899999999999999999875 4889999998642 233455678899999999999999999988654 34
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++|+||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 688888843 345889999999999999999999887 9999999999999999999999999998
Q ss_pred eecC
Q 007336 591 TFGG 594 (607)
Q Consensus 591 ~~~~ 594 (607)
....
T Consensus 157 ~~~~ 160 (337)
T cd07858 157 TTSE 160 (337)
T ss_pred ccCC
Confidence 7643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-19 Score=181.10 Aligned_cols=149 Identities=23% Similarity=0.297 Sum_probs=120.8
Q ss_pred HhhcCCcccceee--cccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHcc-CCCCceeceEEEEEeCCeE
Q 007336 436 ANATDNFSINNKL--GEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 436 ~~~~~~~~~~~~l--g~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~~~~~ 511 (607)
....++|++.+.+ |+|+||.||++... ++..+|+|.+........ |+..... .+||||+++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3344567776666 99999999999875 478899998764221111 1211111 2799999999999999999
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-ceEEeecccce
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVR 590 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~-~~ki~DfGla~ 590 (607)
++||||+++++|.+++... ..+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+++
T Consensus 85 ~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 9999999999999998542 36899999999999999999999887 99999999999999998 99999999998
Q ss_pred eecCC
Q 007336 591 TFGGD 595 (607)
Q Consensus 591 ~~~~~ 595 (607)
.+...
T Consensus 159 ~~~~~ 163 (267)
T PHA03390 159 IIGTP 163 (267)
T ss_pred ecCCC
Confidence 77543
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.82 E-value=9e-20 Score=186.16 Aligned_cols=152 Identities=25% Similarity=0.393 Sum_probs=126.4
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccc-hhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV 514 (607)
..++|++.+.||+|+||.||++.... ++.||||.+.... .....++..|+.++.+.+ ||||+++++++.++...++|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34578888999999999999999875 8899999987532 234456667777666665 99999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||++ ++|.+++... ...+++..+..++.||++||+|||+.. +|+||||+|+||++++++.+||+|||+++.+..
T Consensus 93 ~e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 93 MELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eeccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99986 4777766432 236899999999999999999999742 399999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.2e-20 Score=182.67 Aligned_cols=152 Identities=29% Similarity=0.502 Sum_probs=132.7
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+|++.++||+|+||.||+++.. +++.+++|.+... ......++..|+.++++++|+||+++.+++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999865 4789999998642 234456788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
+++++|.+++.+.. ....+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999985522 2356789999999999999999999887 999999999999999999999999999877543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-20 Score=190.31 Aligned_cols=147 Identities=27% Similarity=0.438 Sum_probs=125.7
Q ss_pred CCcc-cceeecccCceeEEEEEec-CCcEEEEEEecccchhh--------------HHHHHHHHHHHccCCCCceeceEE
Q 007336 440 DNFS-INNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQG--------------LKELKNEVILFSKLQHRNLVKLLG 503 (607)
Q Consensus 440 ~~~~-~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~--------------~~~f~~E~~~l~~l~H~nIv~l~g 503 (607)
++|. +.+.||+|+||+||++... .++.||||.+....... ...+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 3467999999999999975 48899999886422111 124778999999999999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEE
Q 007336 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (607)
Q Consensus 504 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki 583 (607)
++..++..++||||++ |+|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 689888843 345788999999999999999999877 999999999999999999999
Q ss_pred eecccceeec
Q 007336 584 SDFGLVRTFG 593 (607)
Q Consensus 584 ~DfGla~~~~ 593 (607)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (335)
T PTZ00024 161 ADFGLARRYG 170 (335)
T ss_pred CCccceeecc
Confidence 9999998775
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=9e-20 Score=189.03 Aligned_cols=150 Identities=29% Similarity=0.449 Sum_probs=128.2
Q ss_pred HhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEe-CCeE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEK 511 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~ 511 (607)
...+++|++.+.||+|+||.||++... ++..||||++.+. .....+.+..|+.++..++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999865 5889999987542 22345678899999999999999999999876 5578
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++|+||+ +++|..++.. ..+++.....++.|+++||.|||+.+ |+||||+|+|||+++++.+||+|||+++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 4689888742 34678888889999999999999887 99999999999999999999999999986
Q ss_pred ec
Q 007336 592 FG 593 (607)
Q Consensus 592 ~~ 593 (607)
..
T Consensus 158 ~~ 159 (328)
T cd07856 158 QD 159 (328)
T ss_pred cC
Confidence 53
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.3e-20 Score=185.74 Aligned_cols=148 Identities=30% Similarity=0.447 Sum_probs=127.4
Q ss_pred cccceeecccCceeEEEEEecC-CcEEEEEEecccch-hhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEEEEcC
Q 007336 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
|++.+.||+|+||.||+|+..+ ++.|+||++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5677899999999999999865 78899999865321 22334557899999999 999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+|+|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 789988885432 346899999999999999999999987 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=187.93 Aligned_cols=146 Identities=29% Similarity=0.457 Sum_probs=122.9
Q ss_pred CcccceeecccCceeEEEEEecC---CcEEEEEEeccc--chhhHHHHHHHHHHHccC-CCCceeceEEEEEeC----Ce
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG----EE 510 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~---~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~----~~ 510 (607)
+|++.+.||+|+||.||++.... +..||+|++... .....+.+.+|+.++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47788999999999999999753 678999988642 223356788899999999 599999999976533 34
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++++||++ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688899886 689888843 345889999999999999999999887 9999999999999999999999999998
Q ss_pred eec
Q 007336 591 TFG 593 (607)
Q Consensus 591 ~~~ 593 (607)
.+.
T Consensus 154 ~~~ 156 (332)
T cd07857 154 GFS 156 (332)
T ss_pred ecc
Confidence 765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-20 Score=187.05 Aligned_cols=153 Identities=30% Similarity=0.400 Sum_probs=126.5
Q ss_pred CCcccceeecccCceeEEEEEe-cCCcEEEEEEe--ccc-----chhhHHHHHHHHHHHccCCCCceeceEEEEEe-CCe
Q 007336 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRL--SKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEE 510 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l--~~~-----~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~ 510 (607)
++|-++.+||+|+|+.||++.+ ...+-||||+- .+. .....+.-.+|-++-+.|+||-||++++++.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4577778999999999999985 44778999864 221 11123445678899999999999999999875 456
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCceEEeecc
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFG 587 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~---~~~~ki~DfG 587 (607)
.+-|+|||++.+|+-||. ....+++.....|+.||+.||.||.+.. ++|||-||||.||||.+ -|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 789999999999999994 4556889999999999999999999874 78999999999999954 4779999999
Q ss_pred cceeecCCC
Q 007336 588 LVRTFGGDE 596 (607)
Q Consensus 588 la~~~~~~~ 596 (607)
|++++.++.
T Consensus 619 LSKIMdddS 627 (775)
T KOG1151|consen 619 LSKIMDDDS 627 (775)
T ss_pred hhhhccCCc
Confidence 999997654
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-19 Score=184.64 Aligned_cols=145 Identities=30% Similarity=0.502 Sum_probs=125.2
Q ss_pred cccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
|...++||+|+||+||+|+.. .+..|++|++... .......+.+|+.+++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999875 4789999998642 223446788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
++ |+|.+++.. ....+++..+..++.||+.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 96 577777643 2345889999999999999999999887 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=188.36 Aligned_cols=141 Identities=28% Similarity=0.380 Sum_probs=122.3
Q ss_pred eeeccc--CceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEG--GFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G--~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
+.||+| +||+||+++.. .++.||+|.+... .....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 99999999975 5899999998642 233457889999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+||+.+.
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 99999986532 234788999999999999999999877 9999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=187.19 Aligned_cols=145 Identities=23% Similarity=0.252 Sum_probs=123.6
Q ss_pred cceeecccCceeEEEEEecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCC
Q 007336 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (607)
Q Consensus 444 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 521 (607)
+.+.+|.|+++.|++++. +++.||||++... .....+.+..|+.+++.++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344556666666666655 6889999998643 3456678999999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+|.+++.... ...+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..+.
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeec
Confidence 9999986432 234788888999999999999999887 9999999999999999999999999987663
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=185.40 Aligned_cols=149 Identities=30% Similarity=0.494 Sum_probs=127.6
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
..|+..+.||+|+||.||+|+.. ++..+++|.+.. .......++.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777789999999999999975 478899998863 22334567889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+. |+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..+..
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9997 6787776432 234788999999999999999999877 99999999999999999999999999987653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.2e-20 Score=189.87 Aligned_cols=148 Identities=30% Similarity=0.496 Sum_probs=129.9
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCC-----eEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 512 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~ 512 (607)
+|++.+.||+|+||.||+++... +..|+||++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47888999999999999999765 8899999987532 345578999999999999999999999998775 789
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||++ ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 588888843 236899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.9e-20 Score=184.95 Aligned_cols=150 Identities=29% Similarity=0.418 Sum_probs=123.8
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEeccc-chhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+|...++||+|+||.||++.... ++.+|+|.+... .......+.+|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 45566889999999999999754 789999998642 2345567889999999996 99999999999998899999999
Q ss_pred CCCCChHHHHhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFD--QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++. +|.++... ......+++.....++.+++.||+|||+.. +++||||||+||++++++.+||+|||+++.+.
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 874 55443211 112356899999999999999999999752 39999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-19 Score=182.38 Aligned_cols=149 Identities=19% Similarity=0.275 Sum_probs=111.1
Q ss_pred hcCCcccceeecccCceeEEEEEecCC----cEEEEEEecccchhh-----------HHHHHHHHHHHccCCCCceeceE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKISEQG-----------LKELKNEVILFSKLQHRNLVKLL 502 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~----~~vavK~l~~~~~~~-----------~~~f~~E~~~l~~l~H~nIv~l~ 502 (607)
..++|++.++||+|+||.||+|...++ ..+++|......... ......+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999997553 455665432211110 01123344556778999999999
Q ss_pred EEEEeCC----eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC
Q 007336 503 GCCIQGE----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (607)
Q Consensus 503 g~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~ 578 (607)
+++.... ..++++|++.. ++.+.+.. ....++..+..|+.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 9876543 34688887753 56555532 223467888899999999999999887 9999999999999999
Q ss_pred CceEEeecccceeec
Q 007336 579 MNPKISDFGLVRTFG 593 (607)
Q Consensus 579 ~~~ki~DfGla~~~~ 593 (607)
+.+||+|||+|+.+.
T Consensus 163 ~~~~l~DFGla~~~~ 177 (294)
T PHA02882 163 NRGYIIDYGIASHFI 177 (294)
T ss_pred CcEEEEEcCCceeec
Confidence 999999999999874
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.6e-19 Score=180.47 Aligned_cols=149 Identities=30% Similarity=0.505 Sum_probs=124.1
Q ss_pred cccceeecccCceeEEEEEecC-CcEEEEEEeccc--chhhHHHHHHHHHHHccC---CCCceeceEEEEEeCCe-----
Q 007336 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEE----- 510 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~~~~----- 510 (607)
|++.+.||+|+||.||+++... +..+|+|++... .......+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999865 889999998642 122234566777766554 69999999999988776
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.+++|||++ ++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||+++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999998 48988885432 235899999999999999999999987 9999999999999999999999999998
Q ss_pred eecCC
Q 007336 591 TFGGD 595 (607)
Q Consensus 591 ~~~~~ 595 (607)
.+...
T Consensus 156 ~~~~~ 160 (287)
T cd07838 156 IYSFE 160 (287)
T ss_pred eccCC
Confidence 87543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=182.42 Aligned_cols=148 Identities=33% Similarity=0.515 Sum_probs=129.0
Q ss_pred cccceeecccCceeEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
|++.+.||+|++|.||++... +++.+++|++.... ......+..|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456789999999999999875 58889999986532 234567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
++ +|.+++... ...+++..+..++.||++||.|||+.+ |+|+||+|+||++++++.+||+|||.+..+...
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 85 888887542 246889999999999999999999987 999999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=185.81 Aligned_cols=150 Identities=31% Similarity=0.529 Sum_probs=125.9
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCC------
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------ 509 (607)
.++|++.++||+|+||.||+++.. +++.+|||++.... ......+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999975 47899999885422 222346778999999999999999999876543
Q ss_pred --eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 510 --EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 510 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
..++|+||+.. +|...+.. ....+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 45899999975 67666643 2345899999999999999999999987 9999999999999999999999999
Q ss_pred cceeecC
Q 007336 588 LVRTFGG 594 (607)
Q Consensus 588 la~~~~~ 594 (607)
+++.+..
T Consensus 161 ~~~~~~~ 167 (311)
T cd07866 161 LARPYDG 167 (311)
T ss_pred cchhccC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.3e-19 Score=187.07 Aligned_cols=146 Identities=29% Similarity=0.486 Sum_probs=124.0
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCC------
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------ 509 (607)
.++|.+.+.||+|+||.||+|... +++.||||++.+. .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999964 5899999998642 2233456889999999999999999999987543
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
..++|+||+.. +|..++ ...+++..+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999974 676654 234788999999999999999999887 999999999999999999999999999
Q ss_pred eeec
Q 007336 590 RTFG 593 (607)
Q Consensus 590 ~~~~ 593 (607)
+...
T Consensus 165 ~~~~ 168 (342)
T cd07879 165 RHAD 168 (342)
T ss_pred cCCC
Confidence 8653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=188.46 Aligned_cols=147 Identities=28% Similarity=0.449 Sum_probs=125.8
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeC---------
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--------- 508 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--------- 508 (607)
..+|.+.+.||+|+||.||+|.... +..||+|++........+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 3689999999999999999998754 789999998765555667889999999999999999999776543
Q ss_pred -----CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCceE
Q 007336 509 -----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPK 582 (607)
Q Consensus 509 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~-~~~~k 582 (607)
...++||||++ ++|.+++.. ..+++.....++.||++||.|||+.+ |+||||||+||+++. +..+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35689999998 588888732 34788999999999999999999887 999999999999974 56789
Q ss_pred Eeecccceeec
Q 007336 583 ISDFGLVRTFG 593 (607)
Q Consensus 583 i~DfGla~~~~ 593 (607)
|+|||+++.+.
T Consensus 156 l~dfg~~~~~~ 166 (342)
T cd07854 156 IGDFGLARIVD 166 (342)
T ss_pred ECCcccceecC
Confidence 99999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=209.98 Aligned_cols=152 Identities=30% Similarity=0.438 Sum_probs=130.8
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
+-++.-...||.|.||.||-+...+ |...|+|-++. ..........+|+.++..++|||+|+.+|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3456666799999999999998655 78889997753 22345567889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|||++|+|.+.+.. ...+++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|+.|||-|+.+.+.
T Consensus 1314 EyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999843 344666666778899999999999988 999999999999999999999999999998765
Q ss_pred C
Q 007336 596 E 596 (607)
Q Consensus 596 ~ 596 (607)
.
T Consensus 1388 ~ 1388 (1509)
T KOG4645|consen 1388 A 1388 (1509)
T ss_pred h
Confidence 3
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=177.17 Aligned_cols=141 Identities=31% Similarity=0.417 Sum_probs=125.7
Q ss_pred ecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCCh
Q 007336 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (607)
Q Consensus 448 lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (607)
||+|+||.||++.... ++.+++|.+.+.. ......+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999764 8899999886522 23566889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 9998542 35789999999999999999999977 99999999999999999999999999987754
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=182.47 Aligned_cols=147 Identities=33% Similarity=0.516 Sum_probs=129.2
Q ss_pred cccceeecccCceeEEEEEecC-CcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
|+..+.||+|.||.||+|+... ++.+++|.+.... ....+.+..|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4566889999999999999865 8899999987532 334567889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+ ++|.+++.... ..+++..+..++.++++||+|||+.+ |+||||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 8 58999985432 45899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=180.58 Aligned_cols=150 Identities=30% Similarity=0.439 Sum_probs=124.8
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEeccc-----chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
+|.+.++||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998754 444555555431 223344677889999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 515 YEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++ +.+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988642 23456899999999999999999999877 999999999999975 569999999998774
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=178.76 Aligned_cols=160 Identities=26% Similarity=0.394 Sum_probs=138.7
Q ss_pred HHhHHhhcCCcccceeecccCceeEEEEEec------CCcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEE
Q 007336 432 LATIANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGC 504 (607)
Q Consensus 432 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~ 504 (607)
..++.....+++...++.+|.||.||.|.+. +.+.|.+|.++. .++.+...|..|..++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4556666678888899999999999999654 346788888875 566778899999999999999999999999
Q ss_pred EEeC-CeEEEEEEcCCCCChHHHHh-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC
Q 007336 505 CIQG-EEKLLIYEFMPNKSLDSFIF-----DQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (607)
Q Consensus 505 ~~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~ 578 (607)
+.++ ...+.+|.++.-|+|+.||. +......+...+...++.|++.||+|||..+ +||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 9864 55789999999999999997 4455567888899999999999999999887 9999999999999999
Q ss_pred CceEEeecccceeecC
Q 007336 579 MNPKISDFGLVRTFGG 594 (607)
Q Consensus 579 ~~~ki~DfGla~~~~~ 594 (607)
.++||+|-.|+|.+-+
T Consensus 433 LqVkltDsaLSRDLFP 448 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFP 448 (563)
T ss_pred eeEEeccchhccccCc
Confidence 9999999999997643
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-20 Score=183.55 Aligned_cols=161 Identities=27% Similarity=0.332 Sum_probs=130.2
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 513 (607)
..+|..+.+||+|+||.|.++.-+. .+.+|||++++. .....+--+.|-++++.. +-|.++++..++..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3468888999999999999998655 567999999762 223344455677777766 57899999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+.+|+|...++. -..+.+....-+|.+||.||-+||+.+ ||.||||.+|||||.+|++||+||||++.--
T Consensus 428 VMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999988854 233556677789999999999999987 9999999999999999999999999998532
Q ss_pred CCCCccCccceecC
Q 007336 594 GDETEGNTNRVVGT 607 (607)
Q Consensus 594 ~~~~~~~~~~~~GT 607 (607)
-+ ...|.+++||
T Consensus 502 ~~--~~TTkTFCGT 513 (683)
T KOG0696|consen 502 FD--GVTTKTFCGT 513 (683)
T ss_pred cC--CcceeeecCC
Confidence 21 2235557887
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-21 Score=180.76 Aligned_cols=150 Identities=30% Similarity=0.559 Sum_probs=121.3
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeC--------C
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--------E 509 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--------~ 509 (607)
.|.-..+||+|.||.||+++..+ ++.||+|++-- .....-..-.+|+.++..++|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 45556789999999999998754 77789886532 1222234456799999999999999999888532 2
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
..+||+++|+ .+|.-+|.+ +...++..++.+++.++..||.|+|... |+|||+||+|+||+.++.+||+|||+|
T Consensus 98 t~ylVf~~ce-hDLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCE-HDLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhh-hhHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 3689999997 478777743 3345788889999999999999999876 999999999999999999999999999
Q ss_pred eeecCCC
Q 007336 590 RTFGGDE 596 (607)
Q Consensus 590 ~~~~~~~ 596 (607)
|.+.-.+
T Consensus 172 r~fs~~~ 178 (376)
T KOG0669|consen 172 RAFSTSK 178 (376)
T ss_pred cceeccc
Confidence 9886443
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=183.95 Aligned_cols=162 Identities=26% Similarity=0.363 Sum_probs=136.9
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecc--cchhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 515 (607)
...|+++++||.||.+.||++...+.+.+|+|++.. .+.+...-|++|+.+|.+|+ |.+||+|++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 346899999999999999999988888899988653 45677888999999999995 999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||= ..+|..+|.... ....+| .+..+-.|++.++.++|.++ |||.||||.|+|+- .|.+||+|||+|+-+..+
T Consensus 440 E~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 975 479999996532 333445 56668899999999999988 99999999999985 466999999999999888
Q ss_pred CCccCccceecC
Q 007336 596 ETEGNTNRVVGT 607 (607)
Q Consensus 596 ~~~~~~~~~~GT 607 (607)
.+.......+||
T Consensus 513 TTsI~kdsQvGT 524 (677)
T KOG0596|consen 513 TTSIVKDSQVGT 524 (677)
T ss_pred ccceeeccccCc
Confidence 776555556776
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=187.05 Aligned_cols=149 Identities=30% Similarity=0.475 Sum_probs=128.4
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe----
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE---- 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~---- 510 (607)
..++|++.+.||+|+||.||+|+... ++.||||++... .......+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 45689999999999999999999854 789999988642 23345667889999999999999999988776554
Q ss_pred --EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccc
Q 007336 511 --KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (607)
Q Consensus 511 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGl 588 (607)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5699888843 35899999999999999999999887 99999999999999999999999999
Q ss_pred ceeecC
Q 007336 589 VRTFGG 594 (607)
Q Consensus 589 a~~~~~ 594 (607)
+..+..
T Consensus 165 ~~~~~~ 170 (343)
T cd07851 165 ARHTDD 170 (343)
T ss_pred cccccc
Confidence 987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7e-21 Score=178.89 Aligned_cols=152 Identities=29% Similarity=0.472 Sum_probs=123.9
Q ss_pred cceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCC-----eEEEEE
Q 007336 444 INNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKLLIY 515 (607)
Q Consensus 444 ~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~lV~ 515 (607)
..+.||-|+||.||..+++ +|+.||.|++... .-...+.+.+|+.++..++|.|++..++...... +.|+|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 3468999999999999975 5899999998652 2234578889999999999999999888765432 356788
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|.|. .+|.++|- ....++.....-+.+||++||.|||+.+ |+||||||.|.|++++...||+||||||.-+.+
T Consensus 137 ELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 8875 57777773 3455777777788999999999999987 999999999999999999999999999987766
Q ss_pred CCccCcc
Q 007336 596 ETEGNTN 602 (607)
Q Consensus 596 ~~~~~~~ 602 (607)
+...+|.
T Consensus 210 ~~~hMTq 216 (449)
T KOG0664|consen 210 DRLNMTH 216 (449)
T ss_pred hhhhhHH
Confidence 6554443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=166.06 Aligned_cols=138 Identities=20% Similarity=0.297 Sum_probs=105.7
Q ss_pred cceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccC-----CCCceeceEEEEEeCC---eEE-EE
Q 007336 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-----QHRNLVKLLGCCIQGE---EKL-LI 514 (607)
Q Consensus 444 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-----~H~nIv~l~g~~~~~~---~~~-lV 514 (607)
-.+.||+|+||.||. ++.....+||++........+.+.+|+.+++.+ .||||++++|++.++. ..+ +|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 347899999999996 444333478887654344567899999999999 5799999999998864 333 78
Q ss_pred EEc--CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEecccCCCcEEEcC----CCceEEeecc
Q 007336 515 YEF--MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL-LYLHQDSRLRIIHRDLKASNVLLDQ----DMNPKISDFG 587 (607)
Q Consensus 515 ~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl-~yLH~~~~~~ivHrDlkp~Nill~~----~~~~ki~DfG 587 (607)
+|| +++|+|.+++.+. .++.. ..++.+++.++ +|||+++ ||||||||+|||++. +..++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 6689999999431 24444 35577888777 9999988 999999999999974 3479999954
Q ss_pred cceee
Q 007336 588 LVRTF 592 (607)
Q Consensus 588 la~~~ 592 (607)
-++.+
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 44433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.9e-18 Score=166.75 Aligned_cols=149 Identities=34% Similarity=0.498 Sum_probs=132.2
Q ss_pred cccceeecccCceeEEEEEecC-CcEEEEEEecccchh-hHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
|++.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|+..+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999876 789999998764333 57789999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
+++|.+++..... .+++.....++.+++.++.|||+.+ ++|+||+|.||+++.++.++|+|||++..+...
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9999999854322 1789999999999999999999886 999999999999999999999999999988654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.3e-19 Score=172.66 Aligned_cols=133 Identities=21% Similarity=0.161 Sum_probs=114.4
Q ss_pred cCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCChHHHHhc
Q 007336 451 GGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD 529 (607)
Q Consensus 451 G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 529 (607)
|.||.||++... +++.+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999975 47899999986532 233455555666799999999999999999999999999999999854
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 530 QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 530 ~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
. ..+++.....++.|+++||.|||+.+ |+||||||+||++++++.++|+|||+++.+..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~ 137 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED 137 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccc
Confidence 2 34889999999999999999999877 99999999999999999999999998876643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.4e-19 Score=152.84 Aligned_cols=80 Identities=48% Similarity=0.747 Sum_probs=67.1
Q ss_pred CCCCCCceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCcee
Q 007336 10 KSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYF 89 (607)
Q Consensus 10 ~~~~~~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~l 89 (607)
.+.+ .++||.||++.|. ...+.|.|+.+|+|+|.|.+|.++|+|++.+.....++ .|+|+|||||++.. +.+|
T Consensus 37 ~~~~-~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~~~~~~~~-~L~ddGnlvl~~~~----~~~~ 109 (116)
T cd00028 37 KGSS-RTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVL-VLLDDGNLVLYDSD----GNFL 109 (116)
T ss_pred eCCC-CeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEecccCCCCceEE-EEeCCCCEEEECCC----CCEE
Confidence 3444 6899999999994 45588999999999999999999999998752234455 99999999999975 6789
Q ss_pred EeeccCC
Q 007336 90 WQSFDYP 96 (607)
Q Consensus 90 WQSFd~P 96 (607)
|||||||
T Consensus 110 W~Sf~~P 116 (116)
T cd00028 110 WQSFDYP 116 (116)
T ss_pred EcCCCCC
Confidence 9999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.1e-19 Score=192.80 Aligned_cols=149 Identities=23% Similarity=0.344 Sum_probs=106.3
Q ss_pred hcCCcccceeecccCceeEEEEEecC-----CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEE------EE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC------CI 506 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-----~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~------~~ 506 (607)
..++|++.++||+|+||.||+|++.+ +..||||++..... .+.+..|. +....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e~--l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNER--VRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHHH--HHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999999854 58899998764322 11222221 122222222222111 24
Q ss_pred eCCeEEEEEEcCCCCChHHHHhcCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 007336 507 QGEEKLLIYEFMPNKSLDSFIFDQTRR-----------------TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK 569 (607)
Q Consensus 507 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlk 569 (607)
.+...+|||||+++++|.+++...... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999988542210 01122345578999999999999887 9999999
Q ss_pred CCcEEEcC-CCceEEeecccceeec
Q 007336 570 ASNVLLDQ-DMNPKISDFGLVRTFG 593 (607)
Q Consensus 570 p~Nill~~-~~~~ki~DfGla~~~~ 593 (607)
|+||||++ ++.+||+|||+|+.+.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~ 307 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLR 307 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccc
Confidence 99999986 5789999999998664
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.3e-20 Score=187.83 Aligned_cols=159 Identities=25% Similarity=0.326 Sum_probs=136.6
Q ss_pred CCcccceeecccCceeEEEEEecCCc-EEEEEEecc---cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVDGQ-EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~~~-~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
.+++.+..||-|+||.|=+.+..... .+|+|.+++ .+..+.+....|..+|...+.|.||+|+-.+.+.+..||+|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666678999999999999876533 488888865 45566788899999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|-|-+|.|-..|++. ..++......++..+.+|++|||..+ ||.|||||+|.|||.+|.+||.|||+||.++..
T Consensus 500 EaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999653 34566666668888999999999887 999999999999999999999999999999743
Q ss_pred CCccCccceecC
Q 007336 596 ETEGNTNRVVGT 607 (607)
Q Consensus 596 ~~~~~~~~~~GT 607 (607)
. .|.+++||
T Consensus 574 ~---KTwTFcGT 582 (732)
T KOG0614|consen 574 R---KTWTFCGT 582 (732)
T ss_pred C---ceeeecCC
Confidence 3 57889998
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.7e-20 Score=172.50 Aligned_cols=149 Identities=32% Similarity=0.438 Sum_probs=121.8
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+.+.+..||.|+||+|+|-.++. |+..|||+++.. ......+++.|.....+- +.||||+++|.+..++.-++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 44445689999999999998755 899999999753 345667888888865554 789999999999999999999999
Q ss_pred CCCCChHHH---HhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSF---IFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~---l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|. -||+.+ ++. .+...+++...-+|...+.+||.||.+.- .|||||+||+||||+..|.+||+|||++..+.
T Consensus 145 Md-~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred Hh-hhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 95 465544 222 23456788888889999999999998754 69999999999999999999999999987653
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.6e-19 Score=170.75 Aligned_cols=147 Identities=27% Similarity=0.335 Sum_probs=119.3
Q ss_pred hcCCcccc-eeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHcc-CCCCceeceEEEEEe----CCe
Q 007336 438 ATDNFSIN-NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ----GEE 510 (607)
Q Consensus 438 ~~~~~~~~-~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~----~~~ 510 (607)
.+++|++. ++||-|-.|.|.....+. ++.+|+|.+... ..-++|+++--. -.|||||.+++++.. ..-
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45566654 589999999999998754 788999987542 233556665433 369999999999864 344
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCceEEeecc
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFG 587 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~---~~~~ki~DfG 587 (607)
+++|||+|+||.|...+.++. ...+++++...|+.||+.|+.|||+.+ |.||||||+|+|... |-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 689999999999999997643 456899999999999999999999987 999999999999964 4568999999
Q ss_pred cceeec
Q 007336 588 LVRTFG 593 (607)
Q Consensus 588 la~~~~ 593 (607)
+||.-.
T Consensus 210 FAK~t~ 215 (400)
T KOG0604|consen 210 FAKETQ 215 (400)
T ss_pred cccccC
Confidence 999765
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.4e-19 Score=167.13 Aligned_cols=150 Identities=24% Similarity=0.387 Sum_probs=122.9
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc-chhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 516 (607)
++.+.+..||.|+-|+|++.++.. |..+|||.+.+. ...+.++++..+.++.+-+ .|.||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 345556789999999999999865 789999999763 3445667777787776665 8999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
.|.. -++.+|.. ....+++...=++...+.+||.||.+++ +|||||+||+|||+|+.|++|++|||++..+.+
T Consensus 172 lMs~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 172 LMST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence 8842 34444432 2345788888889999999999998754 699999999999999999999999999988754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.1e-19 Score=169.70 Aligned_cols=163 Identities=25% Similarity=0.347 Sum_probs=133.5
Q ss_pred hhcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 511 (607)
...++|.++.+||+|+|.+|..+++.. .+.+|+|++++. ......-...|-.++... +||.+|.|..++.....+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 345689999999999999999999865 678999998762 223344455666666665 799999999999999999
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++|.||+++|+|.-++. ++..|++.....+..+|.-||.|||+.+ ||.||||..|||||..+++||+|+|++|.
T Consensus 327 ffvieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999977764 3445788888888889999999999987 99999999999999999999999999985
Q ss_pred ecCCCCccCccceecC
Q 007336 592 FGGDETEGNTNRVVGT 607 (607)
Q Consensus 592 ~~~~~~~~~~~~~~GT 607 (607)
--++ ...|.+++||
T Consensus 401 ~l~~--gd~tstfcgt 414 (593)
T KOG0695|consen 401 GLGP--GDTTSTFCGT 414 (593)
T ss_pred CCCC--CcccccccCC
Confidence 4322 2345667887
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-18 Score=186.83 Aligned_cols=158 Identities=30% Similarity=0.447 Sum_probs=121.1
Q ss_pred cccceeecccCcee-EEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 442 FSINNKLGEGGFGP-VYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 442 ~~~~~~lg~G~fg~-Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
|...+.+|.|+-|+ ||+|.+ ++++||||++-. .......+|+..++.- +|||||+++|.-.++..+|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44557889999985 799998 688999998753 3344567899988877 69999999999888999999999996
Q ss_pred CCChHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---C--CceEEeecccceeec
Q 007336 520 NKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---D--MNPKISDFGLVRTFG 593 (607)
Q Consensus 520 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~---~--~~~ki~DfGla~~~~ 593 (607)
-+|.+++...... ....-.....+..|++.||+|||+.+ ||||||||.||||+. + ..++|+|||++|.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 6999999653111 11111334567889999999999976 999999999999976 3 468999999999998
Q ss_pred CCCCcc-CccceecC
Q 007336 594 GDETEG-NTNRVVGT 607 (607)
Q Consensus 594 ~~~~~~-~~~~~~GT 607 (607)
.+.+.- ......||
T Consensus 663 ~~~sS~~r~s~~sGt 677 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGT 677 (903)
T ss_pred CCcchhhcccCCCCc
Confidence 776542 23334444
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.7e-19 Score=162.34 Aligned_cols=147 Identities=26% Similarity=0.466 Sum_probs=124.1
Q ss_pred hcCCcccceeecccCceeEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCceeceEEEEEeCC--eEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE--EKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~--~~~l 513 (607)
..++|++.+++|+|.++.||.|.. .+.+.++||.++.. ..+.+.+|+.++..+. ||||++|++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 346899999999999999999984 45788999998753 4567889999999997 999999999988754 4579
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CceEEeecccceee
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTF 592 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~-~~~ki~DfGla~~~ 592 (607)
|+||+.+-+...+- ..+.-..+..++.++++||.|.|+.+ |+|||+||.|++||.. -..+|+|+|||..+
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998876554 23555667778999999999999988 9999999999999964 56999999999988
Q ss_pred cCCC
Q 007336 593 GGDE 596 (607)
Q Consensus 593 ~~~~ 596 (607)
.+..
T Consensus 184 Hp~~ 187 (338)
T KOG0668|consen 184 HPGK 187 (338)
T ss_pred CCCc
Confidence 6554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.5e-17 Score=156.66 Aligned_cols=143 Identities=37% Similarity=0.600 Sum_probs=126.6
Q ss_pred ecccCceeEEEEEecC-CcEEEEEEecccchh-hHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCChHH
Q 007336 448 LGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525 (607)
Q Consensus 448 lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 525 (607)
||+|.+|.||++.... ++.+++|++...... ..+.+.+|+..++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 889999998753322 35789999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCceEEeecccceeecCC
Q 007336 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 526 ~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~-~~~~ki~DfGla~~~~~~ 595 (607)
++.... ..+++..+..++.++++++.|||+.+ ++|+||+|.||+++. ++.++|+|||++......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 985421 35789999999999999999999987 999999999999999 899999999999977543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=160.86 Aligned_cols=135 Identities=19% Similarity=0.274 Sum_probs=113.7
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccc--------hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~--------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
+.||+|++|.||+|.. .+..|++|+..... ......+.+|+.++..++|++|.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 67788899754311 11234688899999999999998888888778888999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|+|||++ ++.++|+|||+++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999988431 12 77889999999999999887 99999999999999 788999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-17 Score=162.37 Aligned_cols=138 Identities=30% Similarity=0.457 Sum_probs=123.2
Q ss_pred CceeEEEEEecC-CcEEEEEEecccchhh-HHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCChHHHHhc
Q 007336 452 GFGPVYKGTLVD-GQEIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFD 529 (607)
Q Consensus 452 ~fg~Vy~g~~~~-~~~vavK~l~~~~~~~-~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 529 (607)
+||.||+++..+ ++.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999865 8899999987643333 68899999999999999999999999999999999999999999999854
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 530 QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 530 ~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
.. .+++..+..++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||++..+...
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~ 140 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPG 140 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence 32 2789999999999999999999986 999999999999999999999999999987653
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-17 Score=144.86 Aligned_cols=75 Identities=48% Similarity=0.788 Sum_probs=64.9
Q ss_pred CceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeecc
Q 007336 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (607)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd 94 (607)
.++||+|||+.|+... +.|.|..+|+|+|.|.+|.++|+|++........+ .|+|+|||||++.. +.+||||||
T Consensus 40 ~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~S~t~~~~~~~~~-~L~ddGnlvl~~~~----~~~~W~Sf~ 113 (114)
T smart00108 40 RTVVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWSSNTTGANGNYVL-VLLDDGNLVIYDSD----GNFLWQSFD 113 (114)
T ss_pred CcEEEECCCCCCCCCC-EEEEEeCCCCEEEEeCCCCEEEEecccCCCCceEE-EEeCCCCEEEECCC----CCEEeCCCC
Confidence 6899999999998765 88999999999999999999999998622344555 99999999999875 579999999
Q ss_pred C
Q 007336 95 Y 95 (607)
Q Consensus 95 ~ 95 (607)
|
T Consensus 114 ~ 114 (114)
T smart00108 114 Y 114 (114)
T ss_pred C
Confidence 7
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=182.46 Aligned_cols=141 Identities=20% Similarity=0.272 Sum_probs=114.0
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEeccc-------chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI-------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~-------~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 511 (607)
...|...+.||+|+||.||+|.+.+...++.+++.+. .....+++.+|+.++..++|++++....++.+....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3445667899999999999998755443332223221 112345788999999999999999888888887788
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999873 34678999999999999987 9999999999999 678899999999997
Q ss_pred ecC
Q 007336 592 FGG 594 (607)
Q Consensus 592 ~~~ 594 (607)
...
T Consensus 477 ~~~ 479 (535)
T PRK09605 477 SDL 479 (535)
T ss_pred CCc
Confidence 643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.3e-18 Score=160.38 Aligned_cols=147 Identities=24% Similarity=0.433 Sum_probs=120.2
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEE-EEeCCeEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGC-CIQGEEKLLIY 515 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~-~~~~~~~~lV~ 515 (607)
.+.|.+.+.||+|.||.+-+++++. .+.+++|.+.+ .....++|.+|...--.| .|.||+.-++. +...+...+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3578888999999999999999876 67889998865 345577888888765555 68999987754 55667788999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE-cC-CCceEEeecccceeec
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-DQ-DMNPKISDFGLVRTFG 593 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill-~~-~~~~ki~DfGla~~~~ 593 (607)
||+|.|+|.+-+.. .-+.+....+++.|++.||.|+|+.. +||||||.+|||| +. ...+||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999887732 33567777889999999999999987 9999999999999 33 3479999999998765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=162.04 Aligned_cols=146 Identities=18% Similarity=0.171 Sum_probs=111.9
Q ss_pred CcccceeecccCceeEEEEE--ecCCcEEEEEEecccchh------------------------hHHHHHHHHHHHccCC
Q 007336 441 NFSINNKLGEGGFGPVYKGT--LVDGQEIAVKRLSKISEQ------------------------GLKELKNEVILFSKLQ 494 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~--~~~~~~vavK~l~~~~~~------------------------~~~~f~~E~~~l~~l~ 494 (607)
-|++.+.||+|+||.||+|. ..+|+.||||++...... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57888999999999999998 567999999988642110 1123568999999997
Q ss_pred CCc--eeceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCc
Q 007336 495 HRN--LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (607)
Q Consensus 495 H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~N 572 (607)
|.. +.++++. ...+|||||+++.+|...... ...++......++.||+.+|.+||+.+ +|+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 633 3444443 235899999999888765422 223455566789999999999999865 39999999999
Q ss_pred EEEcCCCceEEeecccceeecCCC
Q 007336 573 VLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 573 ill~~~~~~ki~DfGla~~~~~~~ 596 (607)
|+++ ++.++|+|||+|...+...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCCcc
Confidence 9999 8899999999999775543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=158.61 Aligned_cols=140 Identities=14% Similarity=0.138 Sum_probs=114.0
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccch---hhHHH------HHHHHHHHccCCCCceeceEEEEEeC
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE---QGLKE------LKNEVILFSKLQHRNLVKLLGCCIQG 508 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~---~~~~~------f~~E~~~l~~l~H~nIv~l~g~~~~~ 508 (607)
..++|...+++|+|+||.||.... ++..+|||.+..... ..... +.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999765 577899999864221 22222 67899999999999999998886643
Q ss_pred --------CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc
Q 007336 509 --------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (607)
Q Consensus 509 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~ 580 (607)
...+|||||++|.+|.++.. ++. ....+++.+|..||..+ ++|||++|+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 34789999999999987641 222 24568999999999987 99999999999999988
Q ss_pred eEEeecccceeec
Q 007336 581 PKISDFGLVRTFG 593 (607)
Q Consensus 581 ~ki~DfGla~~~~ 593 (607)
++|+|||..+...
T Consensus 173 i~liDfg~~~~~~ 185 (232)
T PRK10359 173 LRIIDLSGKRCTA 185 (232)
T ss_pred EEEEECCCccccc
Confidence 9999999998764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.9e-17 Score=152.21 Aligned_cols=133 Identities=20% Similarity=0.232 Sum_probs=105.8
Q ss_pred cceeecccCceeEEEEEecCCcEEEEEEecccch----hhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEEEEcC
Q 007336 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE----QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 444 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~----~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
....|++|+||+||.+.- ++..++.+.+..... .....|.+|++++++++ |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 347899999999997765 677888777765322 11236889999999995 5889999886 4569999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeccc-CCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL-KASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDl-kp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++.+|...+. . ....++.|++++|.++|+.+ |+|||| ||.|||+++++.++|+|||+|....+
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999865431 1 11347789999999999987 999999 79999999999999999999996543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.6e-17 Score=156.67 Aligned_cols=146 Identities=18% Similarity=0.179 Sum_probs=111.9
Q ss_pred HHhhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccch----------------------hhHHHHHHHHHHHcc
Q 007336 435 IANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE----------------------QGLKELKNEVILFSK 492 (607)
Q Consensus 435 ~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~----------------------~~~~~f~~E~~~l~~ 492 (607)
+......|.+.+.||+|+||.||++...+++.||||++..... .....+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3333334777899999999999999988899999998653110 011235678888888
Q ss_pred CCCCc--eeceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCC
Q 007336 493 LQHRN--LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570 (607)
Q Consensus 493 l~H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp 570 (607)
+.|++ +...++ ....++||||+++++|..... . .....++.+++.++.++|+.+ |+||||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---L------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---c------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 88874 444443 244589999999999876541 0 234568899999999999976 99999999
Q ss_pred CcEEEcCCCceEEeecccceeecCCC
Q 007336 571 SNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 571 ~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
+||++++++.++|+|||++..+..+.
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~~~ 179 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDHPN 179 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCCcc
Confidence 99999999999999999998776543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-17 Score=156.36 Aligned_cols=132 Identities=22% Similarity=0.328 Sum_probs=108.4
Q ss_pred eecccCceeEEEEEecCCcEEEEEEecccc--------hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 447 ~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~--------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
.||+|+||.||+|.+ ++..|++|...... ....+++.+|+.++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 56789999854311 112366889999999999988766666666777789999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++++|.+++..... .++.+++++|.+||+.+ ++|+|++|+||+++ ++.++|+|||+++...
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 99999988743110 68999999999999887 99999999999999 8899999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-18 Score=181.75 Aligned_cols=152 Identities=26% Similarity=0.443 Sum_probs=135.1
Q ss_pred hhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
...++|++...+|.|.+|.|||++... +...|+|.++-.......-...|+.+++..+|||||.++|-+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 456789999999999999999999754 7889999987655666777888999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||.+|+|.+.-+. -..+.+.++...++...+||+|||+.+ =+|||||=.|||+++.+.+|++|||.+-.++.
T Consensus 92 EycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh
Confidence 99999999887543 345788888899999999999999987 69999999999999999999999999887753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=8e-17 Score=149.48 Aligned_cols=150 Identities=22% Similarity=0.373 Sum_probs=122.6
Q ss_pred hcCCcccceeecccCceeEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCC-CceeceEEEEEeCCeEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~ 515 (607)
..++|.++++||.|+||.+|.|.. ..|.+||||.-+... ....+..|..+.+.++| ..|..+..+..+.....|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 446899999999999999999985 459999999765422 22356778888888876 67888888888888999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC---CceEEeecccceee
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRTF 592 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~---~~~ki~DfGla~~~ 592 (607)
|.+ +-+|++++.-..+ .++..+.+-+|-|++.-++|+|..+ +|||||||+|+|..-+ ..+-++||||||.+
T Consensus 91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 988 5788887643232 3678899999999999999999988 9999999999998644 45789999999988
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
-+.
T Consensus 165 ~d~ 167 (341)
T KOG1163|consen 165 RDI 167 (341)
T ss_pred ccc
Confidence 543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.5e-17 Score=169.21 Aligned_cols=147 Identities=27% Similarity=0.359 Sum_probs=120.7
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHH-ccCCCCceeceEEEEEeCCeEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILF-SKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l-~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
.++.|.+...+|.|+|+.|-.+.... ++..++|++.+... +-.+|+.++ ..-+||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 35678888899999999999988654 78899999976422 223355343 3447999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE-cCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill-~~~~~~ki~DfGla~~~~~ 594 (607)
|.+.++-|.+.++... .....+..|+.+|+.++.|||+++ +|||||||+|||+ ++.++++|+|||.++...+
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877774322 222677789999999999999987 9999999999999 5899999999999998865
Q ss_pred C
Q 007336 595 D 595 (607)
Q Consensus 595 ~ 595 (607)
+
T Consensus 469 ~ 469 (612)
T KOG0603|consen 469 S 469 (612)
T ss_pred h
Confidence 5
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.5e-16 Score=151.56 Aligned_cols=149 Identities=21% Similarity=0.387 Sum_probs=121.8
Q ss_pred CcccceeecccCceeEEEEE-ecCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEEEcC
Q 007336 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~-~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
+|.+.++||+|+||.++.|+ +-+++.||||.-.+.+ ..-+++.|-+..+.| ..++|..++-|-.++.+..||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 78999999999999999998 4578999999754422 233566677777766 4689999998888888999999988
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-----CceEEeecccceeec
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-----MNPKISDFGLVRTFG 593 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~-----~~~ki~DfGla~~~~ 593 (607)
+-+|+++..-. ...++.++...||.|++.-++|+|++. +|.|||||+|+||... ..+.|+||||||.+.
T Consensus 107 -GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 56888876332 234788999999999999999999987 9999999999999653 348999999999986
Q ss_pred CCCC
Q 007336 594 GDET 597 (607)
Q Consensus 594 ~~~~ 597 (607)
+..+
T Consensus 181 Dp~T 184 (449)
T KOG1165|consen 181 DPKT 184 (449)
T ss_pred Cccc
Confidence 5544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=7e-16 Score=159.20 Aligned_cols=145 Identities=27% Similarity=0.382 Sum_probs=118.7
Q ss_pred CcccceeecccCceeEEEEEecCC--cEEEEEEecccchhhHHHHHHHHHHHccCCC----CceeceEEEE-EeCCeEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVDG--QEIAVKRLSKISEQGLKELKNEVILFSKLQH----RNLVKLLGCC-IQGEEKLL 513 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~~--~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H----~nIv~l~g~~-~~~~~~~l 513 (607)
+|.+.++||+|+||.||.+..... ..+|+|............+..|..++..+.+ +++..++... ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997653 4788887654322222267778888888863 5788888888 46778899
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-----CceEEeeccc
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-----MNPKISDFGL 588 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~-----~~~ki~DfGl 588 (607)
||+.+ +-+|.++..... ...++..+.++|+.|++.+|++||+.+ +|||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99977 678988764433 466889999999999999999999987 9999999999999754 4689999999
Q ss_pred ce
Q 007336 589 VR 590 (607)
Q Consensus 589 a~ 590 (607)
|+
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 99
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2e-16 Score=158.26 Aligned_cols=147 Identities=25% Similarity=0.493 Sum_probs=126.2
Q ss_pred HhhcCCcccceeecccCceeEEEEEecC----CcEEEEEEecccchhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCe
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE 510 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~ 510 (607)
....+.|..+++||+|.|++||++++.. .+.||+|.+...+ ...+..+|++++..+. |.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3445678888999999999999998643 5789999987643 3356889999999984 8999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CceEEeecccc
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLV 589 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~-~~~ki~DfGla 589 (607)
..+|+||++.-...++... ++...+..+++.+.+||+|+|+++ ||||||||.|+|.+.. +.-.|.|||||
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 9999999999999988843 567888889999999999999998 9999999999999864 56799999999
Q ss_pred eeec
Q 007336 590 RTFG 593 (607)
Q Consensus 590 ~~~~ 593 (607)
....
T Consensus 181 ~~~d 184 (418)
T KOG1167|consen 181 QRYD 184 (418)
T ss_pred HHHH
Confidence 8543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.2e-16 Score=152.78 Aligned_cols=154 Identities=20% Similarity=0.273 Sum_probs=126.1
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCC--Cc----eeceEEEEEeCCe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RN----LVKLLGCCIQGEE 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H--~n----Iv~l~g~~~~~~~ 510 (607)
.+++|.+..++|+|.||.|-+..+.. +..||||+++... ...+.-+-|++++.++.+ |+ +|.+.+++.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 36789999999999999999998755 6889999987643 344556679999999842 33 7888888999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-------------
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ------------- 577 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~------------- 577 (607)
.++|+|.+ +-|+.+||.. +....++..++..|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999988 4599999954 34456788999999999999999999987 999999999999832
Q ss_pred -------CCceEEeecccceeecCCCC
Q 007336 578 -------DMNPKISDFGLVRTFGGDET 597 (607)
Q Consensus 578 -------~~~~ki~DfGla~~~~~~~~ 597 (607)
+..+||+|||-|..-...++
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~hs 267 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHHS 267 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCcc
Confidence 23489999999997665553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-15 Score=137.72 Aligned_cols=136 Identities=22% Similarity=0.178 Sum_probs=114.7
Q ss_pred cceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCC--CceeceEEEEEeCCeEEEEEEcCCCC
Q 007336 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMPNK 521 (607)
Q Consensus 444 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~g 521 (607)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| ..+++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999854 7899998865332 5678899999999976 58999998888778899999999988
Q ss_pred ChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||+++..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 77533 55666778999999999999865456999999999999999899999999999854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-15 Score=144.36 Aligned_cols=139 Identities=20% Similarity=0.228 Sum_probs=98.0
Q ss_pred ceeecccCceeEEEEEecCCcEEEEEEecccch--hhHHHH----------------------HHHHHHHccCCCCc--e
Q 007336 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE--QGLKEL----------------------KNEVILFSKLQHRN--L 498 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~--~~~~~f----------------------~~E~~~l~~l~H~n--I 498 (607)
.+.||+|+||+||++...+++.||||.+..... .....+ ..|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 468999999999999988899999998764211 111111 34555555554432 4
Q ss_pred eceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcC
Q 007336 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQ 577 (607)
Q Consensus 499 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivHrDlkp~Nill~~ 577 (607)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 245899999999654321111000 11 4567789999999999998 65 99999999999999
Q ss_pred CCceEEeecccceeecCC
Q 007336 578 DMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 578 ~~~~ki~DfGla~~~~~~ 595 (607)
++.++|+|||+|.....+
T Consensus 150 ~~~~~liDfg~a~~~~~~ 167 (187)
T cd05119 150 DGKVYIIDVPQAVEIDHP 167 (187)
T ss_pred CCcEEEEECcccccccCc
Confidence 899999999999877653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.9e-16 Score=150.77 Aligned_cols=146 Identities=32% Similarity=0.440 Sum_probs=117.4
Q ss_pred CCcccceeecccCceeEEEEEe-cCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCC------e
Q 007336 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------E 510 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------~ 510 (607)
.+|.-+..+|.|.- .|-.+.+ ..++.||+|++.. ......++-.+|..++..++|+||++++.++.... .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35555667777776 4444433 3478999998754 23344566778999999999999999999997654 3
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++|||||. .+|...+. ..++..+...|..|++.|+.|||+.+ |+||||||+||++..+...||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 589999996 68887774 34678888999999999999999987 9999999999999999999999999999
Q ss_pred eecCC
Q 007336 591 TFGGD 595 (607)
Q Consensus 591 ~~~~~ 595 (607)
.-+.+
T Consensus 167 ~e~~~ 171 (369)
T KOG0665|consen 167 TEDTD 171 (369)
T ss_pred ccCcc
Confidence 66544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=3e-15 Score=151.82 Aligned_cols=134 Identities=26% Similarity=0.366 Sum_probs=110.3
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCC-----C---CceeceEEEEEe---
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----H---RNLVKLLGCCIQ--- 507 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-----H---~nIv~l~g~~~~--- 507 (607)
.+|.+.++||-|-|++||++.+.. .+-||+|+.+. .+...+.-+.|+.+|+.++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 689999999999999999998754 67899999875 3455667788999998873 3 349999999975
Q ss_pred -CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC
Q 007336 508 -GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (607)
Q Consensus 508 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~ 578 (607)
+.+.+||+|++. .+|..+|.. ....-++...+.+|++||+.||.|||.++ +|||-||||+||||...
T Consensus 157 NG~HVCMVfEvLG-dnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVLG-DNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhhh-hHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 567899999994 566666643 23345789999999999999999999987 79999999999999654
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.6e-15 Score=116.55 Aligned_cols=66 Identities=44% Similarity=1.024 Sum_probs=57.1
Q ss_pred CCCCCceEEEeeccCCCCcccccccCCChHhHHHhhhcCCceeEEeeeccCCCCceeeeecccccce
Q 007336 281 YSRQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDM 347 (607)
Q Consensus 281 c~~~~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~~~~~l~n~ 347 (607)
|+.+|+|+++++|++|++....+..+.++++|++.||+||||+||+|.+.. ++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 445789999999999998776665678999999999999999999998654 567899999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.3e-14 Score=142.62 Aligned_cols=136 Identities=17% Similarity=0.182 Sum_probs=105.4
Q ss_pred eeec-ccCceeEEEEEecCCcEEEEEEecccc-------------hhhHHHHHHHHHHHccCCCCce--eceEEEEEeCC
Q 007336 446 NKLG-EGGFGPVYKGTLVDGQEIAVKRLSKIS-------------EQGLKELKNEVILFSKLQHRNL--VKLLGCCIQGE 509 (607)
Q Consensus 446 ~~lg-~G~fg~Vy~g~~~~~~~vavK~l~~~~-------------~~~~~~f~~E~~~l~~l~H~nI--v~l~g~~~~~~ 509 (607)
..|| .|+.|+||..... +..++||++.+.. ......+.+|+.++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8999999999874 6788898775310 1223567889999999998875 67777754432
Q ss_pred e----EEEEEEcCCC-CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEe
Q 007336 510 E----KLLIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (607)
Q Consensus 510 ~----~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~ 584 (607)
. .++|+||+++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 689888743 123433 3568999999999987 9999999999999999999999
Q ss_pred ecccceeec
Q 007336 585 DFGLVRTFG 593 (607)
Q Consensus 585 DfGla~~~~ 593 (607)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999998754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.2e-14 Score=144.70 Aligned_cols=150 Identities=33% Similarity=0.516 Sum_probs=127.3
Q ss_pred cccceeecccCceeEEEEEecCCcEEEEEEecccch---hhHHHHHHHHHHHccCCCC-ceeceEEEEEeCCeEEEEEEc
Q 007336 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE---QGLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~lV~Ey 517 (607)
|.+.+.||.|+|+.||++... ..+++|.+..... .....|.+|+.+++.+.|+ +++++...+......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567789999999999999986 7889998875322 2467899999999999988 799999999777778999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-ceEEeecccceeecCCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGGDE 596 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~-~~ki~DfGla~~~~~~~ 596 (607)
+.++++.+++........++......+..|++.++.|+|+.+ ++|||+||+||+++... .+|++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977643221135788899999999999999999987 99999999999999998 79999999999765443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.3e-15 Score=150.77 Aligned_cols=154 Identities=21% Similarity=0.261 Sum_probs=128.0
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCC------CceeceEEEEEeCCe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH------RNLVKLLGCCIQGEE 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H------~nIv~l~g~~~~~~~ 510 (607)
-..+|.+.-..|+|-|++|..|.... ++.||||++... +.-.+.=+.|+++|.+|+. -+.++|+-.|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 34578877889999999999998754 889999999763 3333444679999999852 468999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CceEEeecccc
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLV 589 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~-~~~ki~DfGla 589 (607)
++||+|-+. -+|.+.|..-.+.--|.......++.|+.-||..|...+ |+|.||||.|||+++. ..+||||||-|
T Consensus 509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 999999875 588888876666666788888899999999999999877 9999999999999976 45799999999
Q ss_pred eeecCCC
Q 007336 590 RTFGGDE 596 (607)
Q Consensus 590 ~~~~~~~ 596 (607)
...+.++
T Consensus 585 ~~~~ene 591 (752)
T KOG0670|consen 585 SFASENE 591 (752)
T ss_pred ccccccc
Confidence 9876554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.5e-14 Score=148.98 Aligned_cols=140 Identities=25% Similarity=0.305 Sum_probs=99.3
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccchhhH----------------------------------------HHHHH
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGL----------------------------------------KELKN 485 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~----------------------------------------~~f~~ 485 (607)
+.||.|++|+||+|++.+|+.||||+......... -.|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999854211000 02445
Q ss_pred HHHHHccC----C-CCceeceEEEE-EeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 007336 486 EVILFSKL----Q-HRNLVKLLGCC-IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR-GLLYLHQD 558 (607)
Q Consensus 486 E~~~l~~l----~-H~nIv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gl~yLH~~ 558 (607)
|...+.++ + +++| .+-.++ ......+|||||+++++|.++...... .. .+..++..+++ .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 55555444 2 3333 222222 224457999999999999887642111 11 23456666666 47888987
Q ss_pred CCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 559 ~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+ ++|+|++|.||++++++.++|+|||+++.+.+
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 6 99999999999999999999999999998864
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.7e-14 Score=158.33 Aligned_cols=148 Identities=24% Similarity=0.364 Sum_probs=111.7
Q ss_pred hhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCC---CCceeceEEEEEeCCeEEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~l 513 (607)
.....|.|.+.||+|+||+||+|...+++.||+|.-+.... =+|--=.+++.+|+ -+-|..+..+..-.+.-+|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 34457888999999999999999998899999998654211 11111122223333 1233344444445666789
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-------CCceEEeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-------DMNPKISDF 586 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~-------~~~~ki~Df 586 (607)
|+||.+.|+|.+++. ....++|.....++.|+++-+++||..+ |||+||||+|+||.. ...++|+||
T Consensus 772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence 999999999999994 4567899999999999999999999987 999999999999942 345899999
Q ss_pred ccceeec
Q 007336 587 GLVRTFG 593 (607)
Q Consensus 587 Gla~~~~ 593 (607)
|-+-.+.
T Consensus 846 G~siDm~ 852 (974)
T KOG1166|consen 846 GRSIDMK 852 (974)
T ss_pred ccceeee
Confidence 9987664
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.1e-12 Score=105.16 Aligned_cols=80 Identities=44% Similarity=0.982 Sum_probs=64.4
Q ss_pred CCCCCCC---CceEEEeeccCCCCcccccccCCChHhHHHhhhcCCceeEEeeeccCCCCceeeeecccccceecCCCCC
Q 007336 278 PLNYSRQ---DGFIKFTELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFGELIDMRDFPGGG 354 (607)
Q Consensus 278 ~l~c~~~---~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~~~~~l~n~~~~~~~~ 354 (607)
+++|... +.|..+.++++|+..... ...++++|++.|++||+|+||+|.+ ++++|.+|.+.+.+.+.....+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 4567543 689999999999876543 6678999999999999999999974 3567999999999877654456
Q ss_pred ceeeeeec
Q 007336 355 QDFYIRMS 362 (607)
Q Consensus 355 ~~~ylkv~ 362 (607)
.++|||++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 78999984
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.5e-12 Score=117.39 Aligned_cols=130 Identities=23% Similarity=0.155 Sum_probs=96.4
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCcee-ceEEEEEeCCeEEEEEEcCCCCChH
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMPNKSLD 524 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~gsL~ 524 (607)
+.|+.|.++.||+.+.. +..+++|....... ....+..|+..+..+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 57899999999999874 77899998754321 233567788888888665544 455443 33458999999998875
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 525 SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 525 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
... . ....++.+++++|+.||+.. +..++|+|++|.||+++ ++.++|+|||.+..
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 420 0 11235678999999999876 33469999999999999 66899999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.1e-12 Score=102.42 Aligned_cols=71 Identities=18% Similarity=0.251 Sum_probs=60.8
Q ss_pred CCCCCceEEEeeccCCCCcccccccCCChHhHHHhhhc---CCceeEEeeeccCCCCceeeeecccc-cceecCCCCCce
Q 007336 281 YSRQDGFIKFTELKLPDATSSWVSKSMNLKECREGCLE---NSSCMAYTNSDIRGGGSGCAMWFGEL-IDMRDFPGGGQD 356 (607)
Q Consensus 281 c~~~~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~~~~~~~~~C~~~~~~l-~n~~~~~~~~~~ 356 (607)
|...++|+++.++++|++.. .++++|++.|++ ||+|.||+|.+. +.+|.+|.++| .|++.+..++.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence 33467899999999998764 579999999999 999999999742 35899999999 999888777899
Q ss_pred eeee
Q 007336 357 FYIR 360 (607)
Q Consensus 357 ~ylk 360 (607)
+|+|
T Consensus 76 Ly~r 79 (80)
T cd00129 76 LYEN 79 (80)
T ss_pred eEeE
Confidence 9998
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.3e-11 Score=133.30 Aligned_cols=147 Identities=20% Similarity=0.244 Sum_probs=93.6
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecccchh----------------------------------hHH---
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ----------------------------------GLK--- 481 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~----------------------------------~~~--- 481 (607)
..|+. +.||+|++|+||+|++.+ |+.||||++.+.-.. ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999988 999999998642100 011
Q ss_pred ---HHHHHHHHHccC----CCCceeceEEEEEe-CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHH-HH
Q 007336 482 ---ELKNEVILFSKL----QHRNLVKLLGCCIQ-GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR-GL 552 (607)
Q Consensus 482 ---~f~~E~~~l~~l----~H~nIv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gl 552 (607)
+|.+|+..+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++..-... ..+... ++...++ -+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~--g~d~~~---la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA--GTDMKL---LAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc--CCCHHH---HHHHHHHHHH
Confidence 133444444433 24443433333332 4567899999999999875311111 112111 2222221 12
Q ss_pred HHHHhCCCCceEecccCCCcEEEcCCC----ceEEeecccceeecCC
Q 007336 553 LYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGLVRTFGGD 595 (607)
Q Consensus 553 ~yLH~~~~~~ivHrDlkp~Nill~~~~----~~ki~DfGla~~~~~~ 595 (607)
.-++..+ ++|+|++|.||+++.++ .+++.|||++..+.+.
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 2334445 99999999999999888 9999999999988644
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.4e-12 Score=139.06 Aligned_cols=145 Identities=26% Similarity=0.300 Sum_probs=110.5
Q ss_pred cceeecccCceeEEEEEecC-CcEEEEEEec----c-cc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 444 INNKLGEGGFGPVYKGTLVD-GQEIAVKRLS----K-IS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 444 ~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~----~-~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
....+|.|++|.|+...... ....+.|... . .. ......+..|..+-..++|+|++..+....+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 34789999999777776432 3333333221 1 11 1222236678888889999999887777777666666699
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|+++ +|..++.. ...+....+..++.|+..|+.|||+.+ |.|||||++|++++.++.+||+|||.+..+.-+
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 99998843 235677777889999999999999988 999999999999999999999999999987543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=7.4e-12 Score=144.90 Aligned_cols=85 Identities=16% Similarity=0.223 Sum_probs=66.2
Q ss_pred cCCC-CceeceEEEE-------EeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 007336 492 KLQH-RNLVKLLGCC-------IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563 (607)
Q Consensus 492 ~l~H-~nIv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i 563 (607)
.++| +||+++++.+ .+....++++||+ .++|.++|.. ....+++..++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3445 5788888877 2334567788987 5699999953 2345899999999999999999999887 9
Q ss_pred EecccCCCcEEEcCCCceE
Q 007336 564 IHRDLKASNVLLDQDMNPK 582 (607)
Q Consensus 564 vHrDlkp~Nill~~~~~~k 582 (607)
|||||||+||||+..+.+|
T Consensus 102 vHrDlKP~NiLl~~~~~~k 120 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVS 120 (793)
T ss_pred eeccCCchhEEEcccCcEE
Confidence 9999999999996533333
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.4e-12 Score=119.97 Aligned_cols=140 Identities=26% Similarity=0.453 Sum_probs=114.9
Q ss_pred cccceeecccCceeEEEEEecCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 442 FSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
+.+..+|.+.-.|..|+|++.. ..+++|++.- ......+.|..|.-.++-+.||||+.++|.|.......++..|||
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 4445688899999999999964 4555566542 334455789999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEe
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~ 584 (607)
.|+|...|++.. .-..+..+..+++++||+||+|||+..+ -|----|.++.++||++.+++|+
T Consensus 271 ~gslynvlhe~t-~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 271 FGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred chHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee
Confidence 999999997643 3457888999999999999999999762 23344688999999999998876
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.5e-10 Score=105.11 Aligned_cols=133 Identities=20% Similarity=0.293 Sum_probs=102.1
Q ss_pred eeecccCceeEEEEEecCCcEEEEE-Eeccc---c----hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVK-RLSKI---S----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK-~l~~~---~----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
..+++|+-+.++.+.+.+ ..+++| ++++. + ....++.++|++++++++--.|....-+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 467899999999997743 345555 34331 1 12235678899999998776666666667788888999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++-.|.+.|... ...++..+-+-+.-||..+ |||+||.++||++..+. +.++||||++.-.
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 9999999998442 2456777778888899988 99999999999998776 9999999998544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.5e-10 Score=102.14 Aligned_cols=148 Identities=26% Similarity=0.299 Sum_probs=109.1
Q ss_pred cceeecccCceeEEEEEecCCcEEEEE-Eeccc-------chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 444 INNKLGEGGFGPVYKGTLVDGQEIAVK-RLSKI-------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 444 ~~~~lg~G~fg~Vy~g~~~~~~~vavK-~l~~~-------~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
....|.+|+-+.|+++.+. |+...|| ++.+. ......+.++|++.+.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999884 5555555 34331 1223457889999999887666666556677777788999
Q ss_pred EcCCC-CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc---eEEeeccccee
Q 007336 516 EFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLVRT 591 (607)
Q Consensus 516 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~---~ki~DfGla~~ 591 (607)
||+++ .++.+++.........+ .....++..|-+.+.-||.+. |||+||.++||+|..++. +.++||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99986 47888886544333222 222578888899999999988 999999999999976553 58999999875
Q ss_pred ecCCC
Q 007336 592 FGGDE 596 (607)
Q Consensus 592 ~~~~~ 596 (607)
-..++
T Consensus 166 s~~~E 170 (229)
T KOG3087|consen 166 SRLPE 170 (229)
T ss_pred ccCcc
Confidence 54333
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.7e-10 Score=105.04 Aligned_cols=137 Identities=14% Similarity=0.110 Sum_probs=97.9
Q ss_pred eeecccCceeEEEEEecC-------CcEEEEEEeccc-------------c---------hhhHHHHH----HHHHHHcc
Q 007336 446 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKI-------------S---------EQGLKELK----NEVILFSK 492 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-------~~~vavK~l~~~-------------~---------~~~~~~f~----~E~~~l~~ 492 (607)
..||.|--+.||.|.-.+ +..+|||..+.. . ......+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 478999976421 0 01122333 78888888
Q ss_pred CCC--CceeceEEEEEeCCeEEEEEEcCCCCChHH-HHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEeccc
Q 007336 493 LQH--RNLVKLLGCCIQGEEKLLIYEFMPNKSLDS-FIFDQTRRTLLDWSQRFHIICGTARGLLYL-HQDSRLRIIHRDL 568 (607)
Q Consensus 493 l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~ivHrDl 568 (607)
+.. -++.+++++ ...+|||||+.+..+.. .|. ...++......+..+++.+|..| |..+ +||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 853 456666654 45689999998754422 221 12244455667788999999999 7766 999999
Q ss_pred CCCcEEEcCCCceEEeecccceeecC
Q 007336 569 KASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 569 kp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++.|||++ ++.+.|+|||.|-..+.
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999997 46799999999987753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.5e-10 Score=110.00 Aligned_cols=142 Identities=19% Similarity=0.232 Sum_probs=109.2
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccch-hhHHHHHHHHHHHccCCC--CceeceEEEEEeCC---eEEEEEEcCC
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-QGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE---EKLLIYEFMP 519 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H--~nIv~l~g~~~~~~---~~~lV~Ey~~ 519 (607)
+.|+.|.++.||+++..+|..+++|....... .....+..|..++..+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987668899998754221 135678899999999876 44677887766542 5689999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS---------------------------------------- 559 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~---------------------------------------- 559 (607)
+.++.+.+.. ..++...+..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888665421 23567777788888888888888521
Q ss_pred -------------CCceEecccCCCcEEEcC--CCceEEeeccccee
Q 007336 560 -------------RLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRT 591 (607)
Q Consensus 560 -------------~~~ivHrDlkp~Nill~~--~~~~ki~DfGla~~ 591 (607)
+..++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 66789999999874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.2e-11 Score=130.43 Aligned_cols=144 Identities=27% Similarity=0.299 Sum_probs=114.0
Q ss_pred eecccCceeEEEEEe----cCCcEEEEEEecccch--hhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEEEEcCC
Q 007336 447 KLGEGGFGPVYKGTL----VDGQEIAVKRLSKISE--QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 447 ~lg~G~fg~Vy~g~~----~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
.+|+|.||.|+...- ..+..+|+|.+++... ........|..++...+ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999987653 2366788887765211 11125667888888887 9999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
+|.|...+.. ....+......+...+|-+++++|+.+ |+|||+|++||+++.+|++|+.|||++|.+-..+
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 9999887733 333455555556677889999999887 9999999999999999999999999999875443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.8e-09 Score=107.27 Aligned_cols=150 Identities=25% Similarity=0.379 Sum_probs=100.0
Q ss_pred CcccceeecccCceeEEEEEecC-CcEEEEEEecc---cchhhHHHHHHHHHHHccCCC----------CceeceEEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH----------RNLVKLLGCCI 506 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H----------~nIv~l~g~~~ 506 (607)
.+...+.||.|+++.||.+++.+ ++++|+|.... ......+.+++|...+..+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 44556899999999999999976 89999998642 233467788888877766543 11222222211
Q ss_pred ---------eCC--------eEEEEEEcCCCCChHHHHh---cCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 007336 507 ---------QGE--------EKLLIYEFMPNKSLDSFIF---DQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565 (607)
Q Consensus 507 ---------~~~--------~~~lV~Ey~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivH 565 (607)
... ..+++|+-+ .++|.+++. .... ...+....++.+..|+++.+++||+.+ +||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 125677766 478877753 2111 223455667788899999999999988 999
Q ss_pred cccCCCcEEEcCCCceEEeecccceeecC
Q 007336 566 RDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 566 rDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+||+|+|++++++|.++|+||+.....+.
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~ 197 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT 197 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc
Confidence 99999999999999999999998876653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.6e-10 Score=118.52 Aligned_cols=100 Identities=32% Similarity=0.520 Sum_probs=90.6
Q ss_pred HccCCCCceeceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 007336 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK 569 (607)
Q Consensus 490 l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlk 569 (607)
|+.+.|.|+.+++|.+.+++..+.|.+||..|+|.+.+.. ....++|.....+.++|++||+|||... -..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678999999999999999999999999999999999965 3455899999999999999999999854 23999999
Q ss_pred CCcEEEcCCCceEEeecccceeec
Q 007336 570 ASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 570 p~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++|+++|..+.+||+|||+..+..
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cccceeeeeEEEEechhhhccccc
Confidence 999999999999999999998874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=8.2e-11 Score=130.43 Aligned_cols=143 Identities=18% Similarity=0.253 Sum_probs=113.3
Q ss_pred CcccceeecccCceeEEEEEecCCcEEEEEEecc-cchhhHHHHHHHHHH--HccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK-ISEQGLKELKNEVIL--FSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~-~~~~~~~~f~~E~~~--l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++...+.||.+.|=+|.+++.++|. |+||++.+ ......+.|.++++- +..++|||.+.+.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666789999999999999998776 88888754 333444555444433 5566899998877665555666788888
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
.. .+|.+.| ..+..|...++.-|+.|++.||.-.|..+ |+|+|||.+||||+.-+-+.|+||.--|.
T Consensus 103 vk-hnLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 103 VK-HNLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKP 169 (1431)
T ss_pred Hh-hhhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCC
Confidence 85 4788877 34566777888889999999999999887 99999999999999999999999987664
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.8e-08 Score=97.23 Aligned_cols=141 Identities=17% Similarity=0.107 Sum_probs=99.0
Q ss_pred eecccCceeEEEEEecCCcEEEEEEecccch-----------hhHHHHHHHHHHHccCCCCc--eeceEEEEEeC-----
Q 007336 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISE-----------QGLKELKNEVILFSKLQHRN--LVKLLGCCIQG----- 508 (607)
Q Consensus 447 ~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~-----------~~~~~f~~E~~~l~~l~H~n--Iv~l~g~~~~~----- 508 (607)
.+-+-....|++..+ +|+.+.||+...... .....+.+|...+.++...+ .+.++++....
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344334444667665 577899997643211 11124778888888875433 34556665432
Q ss_pred CeEEEEEEcCCCC-ChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-------CCc
Q 007336 509 EEKLLIYEFMPNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-------DMN 580 (607)
Q Consensus 509 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~-------~~~ 580 (607)
...+||+|++++- +|.+++.+.. ....+...+..++.+++..+.-||..+ |+|+|+++.||||+. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 2468999999986 8998874321 123455667789999999999999988 999999999999975 467
Q ss_pred eEEeecccceee
Q 007336 581 PKISDFGLVRTF 592 (607)
Q Consensus 581 ~ki~DfGla~~~ 592 (607)
+.|+||+.++.-
T Consensus 184 ~~LIDl~r~~~~ 195 (268)
T PRK15123 184 LSVIDLHRAQIR 195 (268)
T ss_pred EEEEECCccccc
Confidence 999999999753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.2e-08 Score=92.89 Aligned_cols=126 Identities=22% Similarity=0.273 Sum_probs=81.4
Q ss_pred EEEEEecCCcEEEEEEeccc--------------ch------------hhHHHHHHHHHHHccCCCC--ceeceEEEEEe
Q 007336 456 VYKGTLVDGQEIAVKRLSKI--------------SE------------QGLKELKNEVILFSKLQHR--NLVKLLGCCIQ 507 (607)
Q Consensus 456 Vy~g~~~~~~~vavK~l~~~--------------~~------------~~~~~f~~E~~~l~~l~H~--nIv~l~g~~~~ 507 (607)
||.|...++..+|||..+.. .+ .......+|.+.|.++... ++.+++.+.
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-- 79 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-- 79 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--
Confidence 89999888999999976421 00 1123467899999999765 466666442
Q ss_pred CCeEEEEEEcCC--CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecccCCCcEEEcCCCceEEe
Q 007336 508 GEEKLLIYEFMP--NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL-HQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (607)
Q Consensus 508 ~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~ivHrDlkp~Nill~~~~~~ki~ 584 (607)
...|||||++ +..+..+. +.. ++......++.+++..+..+ |..+ |||+||.+.|||++++ .+.|+
T Consensus 80 --~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred --CCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 3479999998 55554432 211 11223345677777766664 6665 9999999999999988 89999
Q ss_pred ecccceeecC
Q 007336 585 DFGLVRTFGG 594 (607)
Q Consensus 585 DfGla~~~~~ 594 (607)
|||.|.....
T Consensus 149 Df~qav~~~~ 158 (188)
T PF01163_consen 149 DFGQAVDSSH 158 (188)
T ss_dssp -GTTEEETTS
T ss_pred ecCcceecCC
Confidence 9999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=8.7e-09 Score=102.99 Aligned_cols=90 Identities=24% Similarity=0.447 Sum_probs=68.6
Q ss_pred CCCCceeceEEEEEeC---------------------------CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHH
Q 007336 493 LQHRNLVKLLGCCIQG---------------------------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545 (607)
Q Consensus 493 l~H~nIv~l~g~~~~~---------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 545 (607)
.+|||||++.++|.+. ...||||.-.+ .+|..||..+ ..+.....-|+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~l 347 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVIL 347 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHH
Confidence 3699999988876432 23578887665 5888888542 23455566688
Q ss_pred HHHHHHHHHHHhCCCCceEecccCCCcEEE--cCCC--ceEEeecccce
Q 007336 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLL--DQDM--NPKISDFGLVR 590 (607)
Q Consensus 546 ~~ia~gl~yLH~~~~~~ivHrDlkp~Nill--~~~~--~~ki~DfGla~ 590 (607)
.|+++|+.|||.++ |.|||+|++|||| |+|. ...|+|||.+-
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence 99999999999988 9999999999998 3443 46899999764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.2e-09 Score=118.50 Aligned_cols=152 Identities=28% Similarity=0.359 Sum_probs=118.6
Q ss_pred cCCcccceeecccCceeEEEEEecC--CcEEEEEEeccc--chhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD--GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~--~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~l 513 (607)
...|.+.+.||+|+|+.|-...... ...+|+|.+... +....+....|..+-..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3456777789999999998887644 345666665442 2333445555777767776 9999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEecccCCCcEEEcCCC-ceEEeeccccee
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH-QDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRT 591 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~~~ivHrDlkp~Nill~~~~-~~ki~DfGla~~ 591 (607)
+.||..++++.+.+... .....+......+..|+..++.|+| ..+ +.||||||+|.+++..+ ..|++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999998877321 1112344555668899999999999 666 99999999999999999 999999999998
Q ss_pred ecC
Q 007336 592 FGG 594 (607)
Q Consensus 592 ~~~ 594 (607)
+..
T Consensus 175 ~~~ 177 (601)
T KOG0590|consen 175 YRN 177 (601)
T ss_pred ccc
Confidence 866
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.8e-07 Score=94.00 Aligned_cols=141 Identities=22% Similarity=0.326 Sum_probs=109.9
Q ss_pred ceeEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEE----eCCeEEEEEEcCCC-CChHHH
Q 007336 453 FGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI----QGEEKLLIYEFMPN-KSLDSF 526 (607)
Q Consensus 453 fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~----~~~~~~lV~Ey~~~-gsL~~~ 526 (607)
-.+.|++.. .+|..+++|++.....+....-..-++.++++.|+|||++..++. .+..++|||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788875 468999999994322222222334567789999999999998876 34567899999986 467766
Q ss_pred HhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 527 IFDQT------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 527 l~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
-+... ....+++..++.++.|++.||.++|+.+ +..+-|.|++||++.+..++|+..|+..++..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 2234678899999999999999999988 88899999999999999999999999998876
Q ss_pred CC
Q 007336 595 DE 596 (607)
Q Consensus 595 ~~ 596 (607)
+.
T Consensus 446 d~ 447 (655)
T KOG3741|consen 446 DP 447 (655)
T ss_pred CC
Confidence 66
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.4e-07 Score=97.31 Aligned_cols=122 Identities=16% Similarity=0.226 Sum_probs=98.6
Q ss_pred cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHH
Q 007336 462 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQR 541 (607)
Q Consensus 462 ~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~ 541 (607)
.++.+|.|...+.......+...+-+..++.++||||++++......+..|||+|-+. .|..++.+. .....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHHHH
Confidence 4577888888776444445567778889999999999999999999999999999873 566666332 23344
Q ss_pred HHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 542 ~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
.-.+.||+.||.|||..+ .++|++|.-..|+|++.|+.||.+|-++....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 456789999999999766 59999999999999999999999999886553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=1e-06 Score=84.67 Aligned_cols=108 Identities=26% Similarity=0.273 Sum_probs=83.9
Q ss_pred HHHHHHHHHHHccCCC--CceeceEEEEEeCC----eEEEEEEcCCCC-ChHHHHhcCCCCCCCCHHHHHHHHHHHHHHH
Q 007336 480 LKELKNEVILFSKLQH--RNLVKLLGCCIQGE----EKLLIYEFMPNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552 (607)
Q Consensus 480 ~~~f~~E~~~l~~l~H--~nIv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl 552 (607)
.....+|...+..++. -...+.+++..... ..+||+|++++- +|.+++..... ++...+..++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 3456777777777643 34566777766532 348999999974 89998854222 45666778999999999
Q ss_pred HHHHhCCCCceEecccCCCcEEEcCCC---ceEEeecccceeec
Q 007336 553 LYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLVRTFG 593 (607)
Q Consensus 553 ~yLH~~~~~~ivHrDlkp~Nill~~~~---~~ki~DfGla~~~~ 593 (607)
+-||..+ |+|+|+++.|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999988 99999999999999887 89999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.9e-07 Score=96.83 Aligned_cols=142 Identities=17% Similarity=0.234 Sum_probs=91.9
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccchhh------------------------------HH----------HHHH
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG------------------------------LK----------ELKN 485 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~------------------------------~~----------~f~~ 485 (607)
+.|+.++-|+||+|++.+|+.||||+....-... .+ .+..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6789999999999999999999999876421000 01 1233
Q ss_pred HHHHHccC----C-CCceeceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 007336 486 EVILFSKL----Q-HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG-LLYLHQDS 559 (607)
Q Consensus 486 E~~~l~~l----~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-l~yLH~~~ 559 (607)
|..-+.++ + .+++.-.-=+..-.....|+|||++|-.+.++..-.. ...+.+. |+..++++ +..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 44333333 2 2333222222233567799999999999988753222 2234222 33333332 22333334
Q ss_pred CCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 560 ~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
++|.|..|.||+++.++.+.+.|||+...+.+.
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999999987643
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.3e-06 Score=75.42 Aligned_cols=86 Identities=24% Similarity=0.390 Sum_probs=58.9
Q ss_pred EEEecCCcEEEEcCC-CcEEEeeCCccCcCC-ceEEEEecCCCeEEeeCCCCCCCceeEeeccCCCcccCCCCeeccccc
Q 007336 34 LMINKTGNLVLTSQS-NIVVWSAYLSKEVQT-PVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (607)
Q Consensus 34 l~~~~~G~L~l~d~~-g~~vWst~~~~~~~~-~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~ 111 (607)
+....+|+||+.+.. +.++|++++...... ..+ .|.++|||||++.. +.++|+|=. .
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l-~l~~dGnLvl~~~~----g~~vW~S~t---~------------- 82 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTL-TLQSDGNLVLYDGD----GRVVWSSNT---T------------- 82 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEE-EEeCCCCEEEEeCC----CCEEEEecc---c-------------
Confidence 334468999998775 589999997643222 445 89999999999874 568998711 1
Q ss_pred cCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEe
Q 007336 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRT 156 (607)
Q Consensus 112 ~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~ 156 (607)
...+.|.+.|+++|+..++-- .+.+.|.|
T Consensus 83 ---------------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~S 111 (114)
T smart00108 83 ---------------GANGNYVLVLLDDGNLVIYDS-DGNFLWQS 111 (114)
T ss_pred ---------------CCCCceEEEEeCCCCEEEECC-CCCEEeCC
Confidence 123457888888888755422 24577865
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.7e-06 Score=83.70 Aligned_cols=136 Identities=18% Similarity=0.198 Sum_probs=91.9
Q ss_pred ccceeecccCceeEEEEEecCCcEEEEEEeccc--------------------ch--hhHHHHHHHHHHHccCCCC--ce
Q 007336 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--------------------SE--QGLKELKNEVILFSKLQHR--NL 498 (607)
Q Consensus 443 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--------------------~~--~~~~~f~~E~~~l~~l~H~--nI 498 (607)
.+.++||.|--+.||.|..+.|.++|||.=+.. +. .....-.+|.+.|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 455799999999999999999999999953210 00 0112245777888888654 66
Q ss_pred eceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC
Q 007336 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (607)
Q Consensus 499 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~ 578 (607)
.+.+++ +...+||||+++-.|...- -..-.... |+..|++-+.-+-..+ |||+|+.+=||+++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~---il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDE---ILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc-----CcccCHHH---HHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 666654 5568999999986664321 01122233 3333444333333444 9999999999999999
Q ss_pred CceEEeecccceeec
Q 007336 579 MNPKISDFGLVRTFG 593 (607)
Q Consensus 579 ~~~ki~DfGla~~~~ 593 (607)
+.+.++||=-+-..+
T Consensus 239 g~~~vIDwPQ~v~~~ 253 (304)
T COG0478 239 GDIVVIDWPQAVPIS 253 (304)
T ss_pred CCEEEEeCcccccCC
Confidence 999999997665543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.1e-07 Score=103.90 Aligned_cols=112 Identities=26% Similarity=0.387 Sum_probs=76.9
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
...+|..+++|..|++|.||..+++. .+.+|+| +.+..- ..++ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l----ilRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----ILRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch----hhhc---cccccCCccee-----------------
Confidence 44678889999999999999998865 5677874 332110 0111 33334455544
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|+=...+. ....++-. ++.+++|||+.+ |+|||+||+|.||+.-|++|+.||||.+..
T Consensus 136 ----gDc~tllk---~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ----GDCATLLK---NIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ----chhhhhcc---cCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 33333331 11223322 277899999887 999999999999999999999999999864
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=5.4e-06 Score=78.41 Aligned_cols=139 Identities=16% Similarity=0.139 Sum_probs=101.3
Q ss_pred ecccCceeEEEEEecCCcEEEEEEecc-c----c-hhhHHHHHHHHHHHccCCC--CceeceEEEEEeCC----eEEEEE
Q 007336 448 LGEGGFGPVYKGTLVDGQEIAVKRLSK-I----S-EQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE----EKLLIY 515 (607)
Q Consensus 448 lg~G~fg~Vy~g~~~~~~~vavK~l~~-~----~-~~~~~~f~~E~~~l~~l~H--~nIv~l~g~~~~~~----~~~lV~ 515 (607)
-+.||-+.|+.-.+. |..+-+|+... . . +.+...|.+|...|.++.. ..+.+++.+..... .-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 356888889987764 44788888652 1 1 3466789999999988854 33555552222211 247999
Q ss_pred EcCCC-CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc--eEEeeccccee
Q 007336 516 EFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLVRT 591 (607)
Q Consensus 516 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~--~ki~DfGla~~ 591 (607)
|-+++ -+|.+++.+. .....+...+..+..+|++.+.-||..+ +.|+|+-+.||+++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 5898888442 2234567778899999999999999988 999999999999986666 99999986664
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.6e-06 Score=73.74 Aligned_cols=86 Identities=22% Similarity=0.301 Sum_probs=59.5
Q ss_pred Eec-CCcEEEEcCC-CcEEEeeCCccC-cCCceEEEEecCCCeEEeeCCCCCCCceeEeeccCCCcccCCCCeecccccc
Q 007336 36 INK-TGNLVLTSQS-NIVVWSAYLSKE-VQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKT 112 (607)
Q Consensus 36 ~~~-~G~L~l~d~~-g~~vWst~~~~~-~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~~ 112 (607)
... +|+||+.+.. +.++|++++... .....+ .|.++|||||.+.+ +.++|||=-.
T Consensus 26 ~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l-~l~~dGnLvl~~~~----g~~vW~S~~~----------------- 83 (116)
T cd00028 26 MQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTL-TLQSDGNLVIYDGS----GTVVWSSNTT----------------- 83 (116)
T ss_pred CCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEE-EEecCCCeEEEcCC----CcEEEEeccc-----------------
Confidence 344 8999998765 589999997642 233445 89999999999865 5689986421
Q ss_pred CccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeCC
Q 007336 113 GLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (607)
Q Consensus 113 g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 158 (607)
.+.+.+.+.|+++|+..++-. .+.+.|.|..
T Consensus 84 --------------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~ 114 (116)
T cd00028 84 --------------RVNGNYVLVLLDDGNLVLYDS-DGNFLWQSFD 114 (116)
T ss_pred --------------CCCCceEEEEeCCCCEEEECC-CCCEEEcCCC
Confidence 024567888888888665432 2457787643
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.1e-06 Score=82.07 Aligned_cols=62 Identities=24% Similarity=0.193 Sum_probs=53.9
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|+|.+++... ...+++..+..|+.||++||.|||+.+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence 7899999542 345899999999999999999999864 999999999999999 9999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.6e-06 Score=68.99 Aligned_cols=73 Identities=38% Similarity=0.800 Sum_probs=54.6
Q ss_pred CCceEEEeeccCCCCcccccccCCChHhHHHhhhc-CCceeEEeeeccCCCCceeeeec-ccccceecCCCCCceeeee
Q 007336 284 QDGFIKFTELKLPDATSSWVSKSMNLKECREGCLE-NSSCMAYTNSDIRGGGSGCAMWF-GELIDMRDFPGGGQDFYIR 360 (607)
Q Consensus 284 ~~~f~~~~~~~~p~~~~~~~~~~~~~~~C~~~Cl~-nCsC~a~~~~~~~~~~~~C~~~~-~~l~n~~~~~~~~~~~ylk 360 (607)
...|..++++.+++.... .....++++|++.|++ +|+|.||.|.. +..+|.+|. +++.+....+..+.++|.+
T Consensus 3 ~~~f~~~~~~~l~~~~~~-~~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRI-VISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred CceeEEecCccCCCCcce-eEcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 356888999998855442 2346789999999999 99999999974 345799998 7777776445555566654
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.32 E-value=8.8e-06 Score=79.29 Aligned_cols=138 Identities=17% Similarity=0.172 Sum_probs=84.3
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCc--eeceEEEEEeCCeEEEEEEcCCCCC-
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIYEFMPNKS- 522 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gs- 522 (607)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 24566778765422 3345688998888876443 4677888877777889999999863
Q ss_pred hHHHH---------------------hcCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHh-CCCCceEeccc
Q 007336 523 LDSFI---------------------FDQTRRTLLDWSQRF-HIIC----------GTAR-GLLYLHQ-DSRLRIIHRDL 568 (607)
Q Consensus 523 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------~ia~-gl~yLH~-~~~~~ivHrDl 568 (607)
+...+ +.... ...+...+. ++-. .+.+ ...+|.. ..+..++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 11000 000100000 0000 0011 1222221 12345789999
Q ss_pred CCCcEEEcCCCceEEeecccce
Q 007336 569 KASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 569 kp~Nill~~~~~~ki~DfGla~ 590 (607)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999886
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.29 E-value=5.1e-07 Score=95.79 Aligned_cols=150 Identities=25% Similarity=0.334 Sum_probs=116.0
Q ss_pred Ccccceeecc--cCceeEEEEEe--c-CCcEEEEEEecc--cchhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEE
Q 007336 441 NFSINNKLGE--GGFGPVYKGTL--V-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 441 ~~~~~~~lg~--G~fg~Vy~g~~--~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 512 (607)
.|.+...+|. |.+|.||.+.. . ++..+|+|+-+. ..+.....=.+|+...+++ .|+|.++....+..++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4555578999 99999999986 3 477899987432 2223333334566666666 4999999888899999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEecccCCCcEEEcCC-CceEEeecc
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR----GLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFG 587 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gl~yLH~~~~~~ivHrDlkp~Nill~~~-~~~ki~DfG 587 (607)
+=+|++. .+|.++... ....++......+..+... ||.++|+.. ++|-|+||.||++..+ ..+++.|||
T Consensus 195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999886 677777643 3334566666777777777 999999987 9999999999999999 889999999
Q ss_pred cceeecCCC
Q 007336 588 LVRTFGGDE 596 (607)
Q Consensus 588 la~~~~~~~ 596 (607)
+...++...
T Consensus 269 ~v~~i~~~~ 277 (524)
T KOG0601|consen 269 LVSKISDGN 277 (524)
T ss_pred eeEEccCCc
Confidence 999987655
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.6e-06 Score=80.24 Aligned_cols=106 Identities=24% Similarity=0.221 Sum_probs=82.9
Q ss_pred HHHHHHHccCCC-CceeceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 007336 484 KNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562 (607)
Q Consensus 484 ~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 562 (607)
.+|..++..+++ +++.+++|.|- .++|.||.+.+++...-.....-...+|..|.+||.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357788888876 69999999993 4789999998765421000011123589999999999999999999865445
Q ss_pred eEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 563 ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+.-.|++|+|+-+++++.+|++|...+-...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8899999999999999999999998776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.26 E-value=4.2e-07 Score=96.44 Aligned_cols=149 Identities=24% Similarity=0.252 Sum_probs=114.2
Q ss_pred hhcCCcccceeecccCceeEEEEEec--CCcEEEEEEecccchhhHH--HHHHHHHHHccC-CCCceeceEEEEEeCCeE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKISEQGLK--ELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~--~~~~vavK~l~~~~~~~~~--~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 511 (607)
....+|..+..||.+.|+.|++...+ ++..+++|.+.+....... .-..|+.+...+ .|.++++....+.+....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888999999999999988754 4678888887653222111 122344444444 588888877777777777
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CceEEeecccce
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVR 590 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~-~~~ki~DfGla~ 590 (607)
++=.||++++++...+ .-...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 8999999999987665 22345778888899999999999999766 9999999999999886 788999999986
Q ss_pred e
Q 007336 591 T 591 (607)
Q Consensus 591 ~ 591 (607)
.
T Consensus 416 ~ 416 (524)
T KOG0601|consen 416 R 416 (524)
T ss_pred c
Confidence 3
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=7.7e-07 Score=87.34 Aligned_cols=95 Identities=24% Similarity=0.295 Sum_probs=78.6
Q ss_pred HHccCCCCceeceEEEEEeCC-----eEEEEEEcCCCCChHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 007336 489 LFSKLQHRNLVKLLGCCIQGE-----EKLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562 (607)
Q Consensus 489 ~l~~l~H~nIv~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 562 (607)
-+-.+-|.|||++..++.+.+ +..++.|||.-|+|..+|++.. ....+......+++.||..||.|||+.. ++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 344567999999999986543 4679999999999999997533 2445666777789999999999999975 78
Q ss_pred eEecccCCCcEEEcCCCceEEe
Q 007336 563 IIHRDLKASNVLLDQDMNPKIS 584 (607)
Q Consensus 563 ivHrDlkp~Nill~~~~~~ki~ 584 (607)
|+|+++..+-|++..++-+||.
T Consensus 199 iihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred cccCCcchhheeecCCceEEec
Confidence 9999999999999999988876
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.6e-05 Score=74.17 Aligned_cols=139 Identities=15% Similarity=0.148 Sum_probs=90.4
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHH---------HHHHHHccCC---CCceeceEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELK---------NEVILFSKLQ---HRNLVKLLGCC 505 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~---------~E~~~l~~l~---H~nIv~l~g~~ 505 (607)
..++|...+++-......|.+-.. ++....+|..+.......+.|. +++..+.+++ -..++.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 456788888888877777777665 5688888877543222222222 2233333332 22233333332
Q ss_pred Ee-----CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc
Q 007336 506 IQ-----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (607)
Q Consensus 506 ~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~ 580 (607)
.. ....+|||||++|..|.++.. ++. .++..++++|.-||+.+ +.|+|..|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 22 234569999999988866531 222 24566778899999988 99999999999998655
Q ss_pred eEEeecccceee
Q 007336 581 PKISDFGLVRTF 592 (607)
Q Consensus 581 ~ki~DfGla~~~ 592 (607)
++++||+..+..
T Consensus 173 i~iID~~~k~~~ 184 (229)
T PF06176_consen 173 IRIIDTQGKRMS 184 (229)
T ss_pred EEEEECcccccc
Confidence 999999987754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.16 E-value=2e-05 Score=77.96 Aligned_cols=141 Identities=15% Similarity=0.144 Sum_probs=85.0
Q ss_pred eecccCc-eeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEEEEcCCCCChH
Q 007336 447 KLGEGGF-GPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSLD 524 (607)
Q Consensus 447 ~lg~G~f-g~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 524 (607)
.|..|.. ..||+.... +..+.||+..... ...+..|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555655 688998764 4678888765432 345667888877763 344667788777666789999999998776
Q ss_pred HHH-------------------hcCCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----C
Q 007336 525 SFI-------------------FDQTR-RTLLD--WSQRFHIIC--------------------GTARGLLYLHQ----D 558 (607)
Q Consensus 525 ~~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~gl~yLH~----~ 558 (607)
... +.... ..... ....+.... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 11100 00111 000000000 01111222211 1
Q ss_pred CCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 559 ~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
..+.++|+|+.|.|||++++..+.|+||+.|..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234599999999999999988889999998874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.4e-05 Score=76.35 Aligned_cols=144 Identities=20% Similarity=0.179 Sum_probs=85.7
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC--ceeceEEEEEeC---CeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGCCIQG---EEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~--nIv~l~g~~~~~---~~~~lV~Ey~~~ 520 (607)
+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++...... ...+++||++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 678999999999999876 68999987543 4556777888888777433 356777655433 346899999999
Q ss_pred CChHH----------------HH---hcC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 007336 521 KSLDS----------------FI---FDQ-TRRTLLDWSQ---------RFHI------------ICGTAR-GLLYLHQ- 557 (607)
Q Consensus 521 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-gl~yLH~- 557 (607)
..+.. .+ +.. .......+.. .... ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 11 111 0111111111 0000 011222 2333332
Q ss_pred ---CCCCceEecccCCCcEEEc-CCCceEEeecccceee
Q 007336 558 ---DSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTF 592 (607)
Q Consensus 558 ---~~~~~ivHrDlkp~Nill~-~~~~~ki~DfGla~~~ 592 (607)
..+..++|+|+.|.|||++ +++.+.|+||+.+..-
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2345699999999999999 6666689999988754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.14 E-value=5.5e-07 Score=93.94 Aligned_cols=81 Identities=28% Similarity=0.417 Sum_probs=71.9
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
..++.|++|...+|.++|.........++...+.++.|++.|+.| ++ .+|||+||.||....+..+||.||||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 467999999999999999766666677889999999999999999 44 899999999999999999999999999
Q ss_pred eeecCCC
Q 007336 590 RTFGGDE 596 (607)
Q Consensus 590 ~~~~~~~ 596 (607)
.......
T Consensus 404 ts~~~~~ 410 (516)
T KOG1033|consen 404 TSQDKDE 410 (516)
T ss_pred eecccCC
Confidence 8776555
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.8e-05 Score=85.12 Aligned_cols=142 Identities=14% Similarity=0.186 Sum_probs=87.4
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccchhh-------------------------------------HHHHHHHHH
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG-------------------------------------LKELKNEVI 488 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~-------------------------------------~~~f~~E~~ 488 (607)
+.|+..+.|+||+|++++|+.||||+.+..-+.. .-.|..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999875421100 001334443
Q ss_pred HHcc----CCCCce---eceEEEEE-eCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 007336 489 LFSK----LQHRNL---VKLLGCCI-QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSR 560 (607)
Q Consensus 489 ~l~~----l~H~nI---v~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~ 560 (607)
-..+ +.|-++ |.+=.++. -...+.|+||||+|..+.+...-. ..-++......-+.++..-+ |-..+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~~l~~~~~~q--If~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID--KRGISPHDILNKLVEAYLEQ--IFKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH--HcCCCHHHHHHHHHHHHHHH--HHhcC-
Confidence 3322 345441 11212222 245689999999998776653211 11233333333333222222 22223
Q ss_pred CceEecccCCCcEEEcC----CCceEEeecccceeecC
Q 007336 561 LRIIHRDLKASNVLLDQ----DMNPKISDFGLVRTFGG 594 (607)
Q Consensus 561 ~~ivHrDlkp~Nill~~----~~~~ki~DfGla~~~~~ 594 (607)
++|+|-.|.||+++. +..+.+-||||.+.+..
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999984 67899999999987753
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.94 E-value=9.6e-05 Score=85.93 Aligned_cols=79 Identities=15% Similarity=0.330 Sum_probs=57.1
Q ss_pred ceeecccCceeEEEEEecCC---cEEEEEEecccc-hhhHHHHHHHHHHHccCC-CCce--eceEEEEEeC---CeEEEE
Q 007336 445 NNKLGEGGFGPVYKGTLVDG---QEIAVKRLSKIS-EQGLKELKNEVILFSKLQ-HRNL--VKLLGCCIQG---EEKLLI 514 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~~~---~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~-H~nI--v~l~g~~~~~---~~~~lV 514 (607)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|.++++.+. |++| .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999877553 366777654321 123456889999999885 6665 7888888764 356899
Q ss_pred EEcCCCCCh
Q 007336 515 YEFMPNKSL 523 (607)
Q Consensus 515 ~Ey~~~gsL 523 (607)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999997653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00013 Score=70.14 Aligned_cols=152 Identities=19% Similarity=0.219 Sum_probs=92.5
Q ss_pred HHhHHhhcCCccccee---ecccCceeEEEEEecCCcEEEEEEecccchhh---------HHH---------------HH
Q 007336 432 LATIANATDNFSINNK---LGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG---------LKE---------------LK 484 (607)
Q Consensus 432 ~~~~~~~~~~~~~~~~---lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~---------~~~---------------f~ 484 (607)
+..+.....+..+.+. |+.|--+.||+|.-.++..+|||+.+...... ..+ -.
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 3444444444444444 55677778999988778999999876421110 001 12
Q ss_pred HHHHHHccCC--CCceeceEEEEEeCCeEEEEEEcCCCCCh-HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 007336 485 NEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561 (607)
Q Consensus 485 ~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~ 561 (607)
.|..-|.++. +-.+.+.+++. ...|||||+....+ .-.|.+ -.+.......+..++++.|.-|-...
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 4444454442 33344444442 34799999975421 111111 11122244556667777777776633
Q ss_pred ceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 562 ~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++||+||+.=|||+. ++.+.|+|||-|-....
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 499999999999999 88999999999887653
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00031 Score=66.56 Aligned_cols=133 Identities=16% Similarity=0.268 Sum_probs=89.0
Q ss_pred ceeecccCceeEEEEEecCCcEEEEEEecccc----------------hhhHHHHHHHHHHHccCC------CCceeceE
Q 007336 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS----------------EQGLKELKNEVILFSKLQ------HRNLVKLL 502 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~----------------~~~~~~f~~E~~~l~~l~------H~nIv~l~ 502 (607)
...||+|+.-.||. +++.....||++.... ....+++++|+.....+. +..|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 36899999999995 4556677888876533 122455666666554444 88899999
Q ss_pred EEEEeCCeEEEEEEcCCC------CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc
Q 007336 503 GCCIQGEEKLLIYEFMPN------KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (607)
Q Consensus 503 g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~ 576 (607)
|+...+...-+|+|.+.+ -+|.+++.+ ..++. ...+.+. +-..||-++. |+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEE
Confidence 999998888889887643 367888733 23444 3333333 3355666655 99999999999995
Q ss_pred CC--C--ceEEee-cccce
Q 007336 577 QD--M--NPKISD-FGLVR 590 (607)
Q Consensus 577 ~~--~--~~ki~D-fGla~ 590 (607)
.. + .+.|+| ||-..
T Consensus 153 ~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred ecCCCceEEEEEeCCCCcc
Confidence 43 2 466666 34433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00026 Score=66.56 Aligned_cols=125 Identities=27% Similarity=0.385 Sum_probs=89.9
Q ss_pred CCcccceeecccCc-eeEEEEEecCCcEEEEEEecc------------cch---------hhHHHHHHHHHHHccCC---
Q 007336 440 DNFSINNKLGEGGF-GPVYKGTLVDGQEIAVKRLSK------------ISE---------QGLKELKNEVILFSKLQ--- 494 (607)
Q Consensus 440 ~~~~~~~~lg~G~f-g~Vy~g~~~~~~~vavK~l~~------------~~~---------~~~~~f~~E~~~l~~l~--- 494 (607)
.+++.++.||.|.- |.||+++. +|+.+|+|..+. ... .....|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 68888999999999 99999998 577999998321 000 12346889999888875
Q ss_pred CCce--eceEEEEEeC------------------CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 007336 495 HRNL--VKLLGCCIQG------------------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554 (607)
Q Consensus 495 H~nI--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~y 554 (607)
+.++ |+.+||..-. ..+.||.||++... .+.. .-+.+|.+-|.-
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4456 8999987422 11357778776432 1121 234567777888
Q ss_pred HHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 555 LH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
+|..+ |+-+|++++|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99877 999999999987 3489999865
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00038 Score=70.85 Aligned_cols=77 Identities=12% Similarity=0.060 Sum_probs=56.3
Q ss_pred cceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCC---CceeceEEEEEeC---CeEEEEEEc
Q 007336 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH---RNLVKLLGCCIQG---EEKLLIYEF 517 (607)
Q Consensus 444 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H---~nIv~l~g~~~~~---~~~~lV~Ey 517 (607)
-.+.||.|..+.||+....++ .+.+|..+. ......|..|...++.+.. ..+.+++++|..+ +..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 346899999999999876555 456666432 1134578889998888753 4678888888643 557999999
Q ss_pred CCCCCh
Q 007336 518 MPNKSL 523 (607)
Q Consensus 518 ~~~gsL 523 (607)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0003 Score=69.12 Aligned_cols=140 Identities=18% Similarity=0.224 Sum_probs=75.8
Q ss_pred eeecccCce-eEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC---ceeceEEEEEeCC---eEEEEEEcC
Q 007336 446 NKLGEGGFG-PVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCIQGE---EKLLIYEFM 518 (607)
Q Consensus 446 ~~lg~G~fg-~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~---nIv~l~g~~~~~~---~~~lV~Ey~ 518 (607)
+.|+.|+.. .||+. +..+++|.... ......+..|.+++..+... -+.++++.....+ ..++|||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457766665 58865 23566676543 22345788898888776532 3444454443322 347899999
Q ss_pred CCCChHHH------------------HhcCCCCC--C-----------C-CHHHHH--HHH-------HHHHHH-HH-HH
Q 007336 519 PNKSLDSF------------------IFDQTRRT--L-----------L-DWSQRF--HII-------CGTARG-LL-YL 555 (607)
Q Consensus 519 ~~gsL~~~------------------l~~~~~~~--~-----------l-~~~~~~--~i~-------~~ia~g-l~-yL 555 (607)
+|.++.+. |+...... . + .|.... .+. .+.+.. ++ ++
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 98776322 11110000 0 0 111110 000 011111 11 11
Q ss_pred Hh--CCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 556 HQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 556 H~--~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
+. ..+..++|+|+.+.|||++++...-|+||+.|..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1234589999999999998776678999998763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00079 Score=65.99 Aligned_cols=141 Identities=18% Similarity=0.239 Sum_probs=79.6
Q ss_pred eeecccCceeEEEEEecC--CcEEEEEEecccchhhHHHHHHHHHHHccCCCCc-eeceEEEEEeCCeEEEEEEcCCCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD--GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYEFMPNKS 522 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~--~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~Ey~~~gs 522 (607)
+.|..|-...+|+....+ +..+++|........ .....+|+.++..+...+ ..++++... ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567788888999988664 578888876542211 122346777777774333 344444332 248999999877
Q ss_pred hHHH-------H----------hcCCCCC--------CCC-HHHHHHHHH----------------------HHHHHHHH
Q 007336 523 LDSF-------I----------FDQTRRT--------LLD-WSQRFHIIC----------------------GTARGLLY 554 (607)
Q Consensus 523 L~~~-------l----------~~~~~~~--------~l~-~~~~~~i~~----------------------~ia~gl~y 554 (607)
+... + +...... ... +.....+.. .+..-+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 1 1111110 111 211111110 11111112
Q ss_pred H----HhC-CCCceEecccCCCcEEEcC-CCceEEeeccccee
Q 007336 555 L----HQD-SRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRT 591 (607)
Q Consensus 555 L----H~~-~~~~ivHrDlkp~Nill~~-~~~~ki~DfGla~~ 591 (607)
| ... .+..++|+|+.+.|||+++ +..+.|+||-.|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2 111 2346999999999999998 57899999998863
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0014 Score=68.92 Aligned_cols=75 Identities=15% Similarity=0.221 Sum_probs=53.7
Q ss_pred eeecccCceeEEEEEecCC-cEEEEEEeccc-----c--hhhHHHHHHHHHHHccCC---CCceeceEEEEEeCCeEEEE
Q 007336 446 NKLGEGGFGPVYKGTLVDG-QEIAVKRLSKI-----S--EQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~-~~vavK~l~~~-----~--~~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV 514 (607)
+.||.|.+..||+....+| +.|+||.-... . +...+++..|.+.|..+. ...+.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998776 58999974321 1 224566777877777652 2456777766 44567899
Q ss_pred EEcCCCCC
Q 007336 515 YEFMPNKS 522 (607)
Q Consensus 515 ~Ey~~~gs 522 (607)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00064 Score=67.70 Aligned_cols=139 Identities=17% Similarity=0.131 Sum_probs=76.8
Q ss_pred eecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCce-eceEEEEEeCCeEEEEEEcCCCCChHH
Q 007336 447 KLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMPNKSLDS 525 (607)
Q Consensus 447 ~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL~~ 525 (607)
.+..|-...+|+... ++..+++|..........-...+|..+++.+....+ .++++... ..+||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 355677788998873 566788887543222111234667777777754333 34444432 368999999876542
Q ss_pred H-----------------HhcCCC-CCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCceEecccCCCc
Q 007336 526 F-----------------IFDQTR-RTLLDWSQR-FHIICG---------TARGLLYLHQD-----SRLRIIHRDLKASN 572 (607)
Q Consensus 526 ~-----------------l~~~~~-~~~l~~~~~-~~i~~~---------ia~gl~yLH~~-----~~~~ivHrDlkp~N 572 (607)
. |+.... ...++...+ .++..+ +..-+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 111111 111121111 111111 11112222211 12458999999999
Q ss_pred EEEcCCCceEEeeccccee
Q 007336 573 VLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 573 ill~~~~~~ki~DfGla~~ 591 (607)
|++++++ ++|+||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998863
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0015 Score=56.16 Aligned_cols=73 Identities=26% Similarity=0.422 Sum_probs=48.0
Q ss_pred CceEEEc-cCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEec--CCCeEEeeCCCCCCCceeEe
Q 007336 15 HEVVWVA-NRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD--SGNLVLRDEHDGDSETYFWQ 91 (607)
Q Consensus 15 ~t~VW~A-nr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld--~GNlVl~~~~~~~~~~~lWQ 91 (607)
.++||.. +...+.. ..+.+.|..+|||||.|..+.++|++... ...+.. .+.+ .||++ .... ..+.|.
T Consensus 38 ~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~--ptdt~L-~~q~l~~~~~~-~~~~----~~~sw~ 108 (114)
T PF01453_consen 38 GSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDY--PTDTLL-PGQKLGDGNVT-GKND----SLTSWS 108 (114)
T ss_dssp TEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTS--SS-EEE-EEET--TSEEE-EEST----SSEEEE
T ss_pred CCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCC--CccEEE-eccCcccCCCc-cccc----eEEeEC
Confidence 4679999 4344432 45889999999999999999999999422 223333 6666 88888 5432 467888
Q ss_pred eccCC
Q 007336 92 SFDYP 96 (607)
Q Consensus 92 SFd~P 96 (607)
|=+.|
T Consensus 109 s~~dp 113 (114)
T PF01453_consen 109 SNTDP 113 (114)
T ss_dssp SS---
T ss_pred CCCCC
Confidence 87666
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0017 Score=66.11 Aligned_cols=142 Identities=20% Similarity=0.164 Sum_probs=84.2
Q ss_pred ceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCc--eeceEEE------EEeCCeEEEEEE
Q 007336 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGC------CIQGEEKLLIYE 516 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n--Iv~l~g~------~~~~~~~~lV~E 516 (607)
.+.|..|....+|+.... +..+++|+... ........|+.++..+++.+ +.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 356777877889988754 44688887654 23345666777777664332 4444432 123445689999
Q ss_pred cCCCCChHH----HH----------hcCC--------CCCCCCHHHHHH----------HHHHHHHHHHHHHh----CCC
Q 007336 517 FMPNKSLDS----FI----------FDQT--------RRTLLDWSQRFH----------IICGTARGLLYLHQ----DSR 560 (607)
Q Consensus 517 y~~~gsL~~----~l----------~~~~--------~~~~l~~~~~~~----------i~~~ia~gl~yLH~----~~~ 560 (607)
|++|..+.. .+ +... ......|..... ....+...+.++.. .-+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 11 1100 001122322110 11223344555543 123
Q ss_pred CceEecccCCCcEEEcCCCceEEeecccce
Q 007336 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 561 ~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
..++|+|+.|.|||++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 459999999999999998878999998876
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0018 Score=59.11 Aligned_cols=130 Identities=21% Similarity=0.283 Sum_probs=86.4
Q ss_pred cceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceec-eEEEEEeCCeEEEEEEcCCCCC
Q 007336 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK-LLGCCIQGEEKLLIYEFMPNKS 522 (607)
Q Consensus 444 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~-l~g~~~~~~~~~lV~Ey~~~gs 522 (607)
..+.|++|.+|.||++.+. +..+|+|.-.. ......+..|++++..++-.++.. ++.+- ..++.|||+.|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 3468999999999999985 55888887654 334567888999998888766543 33332 2345599999988
Q ss_pred hHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC-CCcEEEcCCCceEEeecccceeec
Q 007336 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK-ASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlk-p~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|.+.-.. .+..+... +++. +|.-+ ..+|-|..|. |...+|-.+..+.|+||--|..-.
T Consensus 99 L~~~~~~------~~rk~l~~----vlE~-a~~LD--~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 99 LGKLEIG------GDRKHLLR----VLEK-AYKLD--RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhhhc------ccHHHHHH----HHHH-HHHHH--HhccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 8765421 13333333 3343 33322 1247787773 666666666699999999998443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0031 Score=64.43 Aligned_cols=141 Identities=26% Similarity=0.368 Sum_probs=81.2
Q ss_pred eeecccCceeEEEEEecC-------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCce-eceEEEEEeCCeEEEEEEc
Q 007336 446 NKLGEGGFGPVYKGTLVD-------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey 517 (607)
+.+..|-.-.+|+....+ ++.+++|+..... ........|.+++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456666667888887654 4778888865422 222345667777766643333 355555532 368999
Q ss_pred CCCCChHHH-----------------HhcCCCCC------CCC--HHHHHH--------------------------HHH
Q 007336 518 MPNKSLDSF-----------------IFDQTRRT------LLD--WSQRFH--------------------------IIC 546 (607)
Q Consensus 518 ~~~gsL~~~-----------------l~~~~~~~------~l~--~~~~~~--------------------------i~~ 546 (607)
++|..+... |+...... ..+ |..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 01111110 111 111100 111
Q ss_pred HHHHHHHHHHh------CCCCceEecccCCCcEEEcCC----CceEEeeccccee
Q 007336 547 GTARGLLYLHQ------DSRLRIIHRDLKASNVLLDQD----MNPKISDFGLVRT 591 (607)
Q Consensus 547 ~ia~gl~yLH~------~~~~~ivHrDlkp~Nill~~~----~~~ki~DfGla~~ 591 (607)
.+..-+..|.. ..+..++|+|+.|.|||++++ +.++|+||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22233344432 234579999999999999985 8899999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.01 Score=61.14 Aligned_cols=141 Identities=20% Similarity=0.205 Sum_probs=74.6
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC--ceeceEE------EEEeCCeEEEEEEc
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLG------CCIQGEEKLLIYEF 517 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~--nIv~l~g------~~~~~~~~~lV~Ey 517 (607)
+.|..|....+|+....++ .+++|+...... +....|+.++..|... .+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777788998876544 678887752222 2223344444433211 1333332 11234567899999
Q ss_pred CCCCChH-----------HHH---hcCCC--------CCCCCH-HHHHHH------------H-HHHHHHHHHHHhC---
Q 007336 518 MPNKSLD-----------SFI---FDQTR--------RTLLDW-SQRFHI------------I-CGTARGLLYLHQD--- 558 (607)
Q Consensus 518 ~~~gsL~-----------~~l---~~~~~--------~~~l~~-~~~~~i------------~-~~ia~gl~yLH~~--- 558 (607)
++|..+. ..| +.... ...+.| .....- . ..+...+..+.+.
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9987542 111 11100 001112 111111 1 1111222333211
Q ss_pred -CCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 559 -SRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 559 -~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
-+.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999977666899999885
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0011 Score=51.99 Aligned_cols=48 Identities=17% Similarity=0.420 Sum_probs=33.8
Q ss_pred eeccCCCCcccccccCCChHhHHHhhhcCCceeEEeeeccCCCCceeeeecc
Q 007336 291 TELKLPDATSSWVSKSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFG 342 (607)
Q Consensus 291 ~~~~~p~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~~~~ 342 (607)
.+++++..+.... ...+.++|++.|+.+|+|.||.|.. +...|+++..
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~ 57 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSS 57 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccC
Confidence 3555554443322 2458999999999999999999973 2345988655
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.015 Score=58.73 Aligned_cols=75 Identities=19% Similarity=0.250 Sum_probs=47.7
Q ss_pred ccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccC---CCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 443 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
+..+.|+.|....+|+.. .+++.+.||.-.. .....|..|..-|+.| .-..+.+++++....+..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 334678889999999987 5678899997652 3345677787776666 34567889998887777899999998
Q ss_pred CC
Q 007336 520 NK 521 (607)
Q Consensus 520 ~g 521 (607)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0079 Score=60.52 Aligned_cols=32 Identities=22% Similarity=0.432 Sum_probs=26.5
Q ss_pred CceEecccCCCcEEEcCCCc-eEEeecccceee
Q 007336 561 LRIIHRDLKASNVLLDQDMN-PKISDFGLVRTF 592 (607)
Q Consensus 561 ~~ivHrDlkp~Nill~~~~~-~ki~DfGla~~~ 592 (607)
..++|+|+.|.|||+++++. .-|.||+.+.+-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999997554 579999998743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.014 Score=60.80 Aligned_cols=141 Identities=18% Similarity=0.266 Sum_probs=78.5
Q ss_pred eeecccCceeEEEEEecC-----CcEEEEEEecccchhhHHHHHHHHHHHccCCCCcee-ceEEEEEeCCeEEEEEEcCC
Q 007336 446 NKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-----~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~ 519 (607)
+.+..|-.-.+|+....+ +..+++|.......... .-.+|..++..+...++. ++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345556677888877532 35788887654322222 225677777777544443 455555332 5899998
Q ss_pred CCChHHH-----------------HhcCC-C--CCCCCHHHHHHHHHH-----------------HHHHHHHH----Hh-
Q 007336 520 NKSLDSF-----------------IFDQT-R--RTLLDWSQRFHIICG-----------------TARGLLYL----HQ- 557 (607)
Q Consensus 520 ~gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~~-----------------ia~gl~yL----H~- 557 (607)
+.+|... ++... . .....|.....+..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 11111 0 001112222222211 11112222 21
Q ss_pred CCCCceEecccCCCcEEEcC-CCceEEeeccccee
Q 007336 558 DSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRT 591 (607)
Q Consensus 558 ~~~~~ivHrDlkp~Nill~~-~~~~ki~DfGla~~ 591 (607)
..+..++|+|+++.|||+++ ++.++|+||..|..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346899999999999986 46899999998874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.00023 Score=80.33 Aligned_cols=150 Identities=17% Similarity=0.229 Sum_probs=101.6
Q ss_pred hhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
...+.+.+.+-+.++.++.++.+.-.. +...++|.... ......+..+.+-.+.-.-+||.+++...-+....+..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 345677788888899999999876432 33333333221 11122233333333333345677776665556677889
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
||++|..+++|...|+... ..+..........+..+++|||... ++|||++|.|+|+..+++.+++|||+.+..
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999886533 2232222334555788999999865 899999999999999999999999966544
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.034 Score=56.95 Aligned_cols=143 Identities=23% Similarity=0.213 Sum_probs=79.8
Q ss_pred ceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC--ceeceEEEE------EeCCeEEEEEE
Q 007336 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGCC------IQGEEKLLIYE 516 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~--nIv~l~g~~------~~~~~~~lV~E 516 (607)
.+.++.|....+|+....++ .+++|+..... ..++...|..++..|... .+.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 35677777788998875444 56678764421 123344455655555322 234444321 12455689999
Q ss_pred cCCCCChH----H-------H---HhcCCCC---------CCCCHHHHH------------HHHHHHHHHHHHHHh----
Q 007336 517 FMPNKSLD----S-------F---IFDQTRR---------TLLDWSQRF------------HIICGTARGLLYLHQ---- 557 (607)
Q Consensus 517 y~~~gsL~----~-------~---l~~~~~~---------~~l~~~~~~------------~i~~~ia~gl~yLH~---- 557 (607)
|++|..+. . . ++..... ....|.... .....+.+.+++|..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99886532 1 0 1110000 011222111 011223345555543
Q ss_pred CCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 558 ~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
..+..++|+|+.+.||++++++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 224569999999999999998877899999884
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.034 Score=56.52 Aligned_cols=146 Identities=16% Similarity=0.280 Sum_probs=80.6
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEec-ccchhhHHHHHHHHHHHccCCC--CceeceEEEEEeCC--eEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE--EKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~-~~~~~~~~~f~~E~~~l~~l~H--~nIv~l~g~~~~~~--~~~lV~Ey~~~ 520 (607)
+.+..|..-.+|..... ++..++++-. ...........+|..+|+.+.- .-+.+.++.|.++. ..+.||+|+++
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 34433333344444332 6677777221 1222344556677777777643 33456677787766 56999999988
Q ss_pred CChHH------------------HHhc---C--------------CCCCCCCHHHHHHHH--------HHHHHHHHHHHh
Q 007336 521 KSLDS------------------FIFD---Q--------------TRRTLLDWSQRFHII--------CGTARGLLYLHQ 557 (607)
Q Consensus 521 gsL~~------------------~l~~---~--------------~~~~~l~~~~~~~i~--------~~ia~gl~yLH~ 557 (607)
..+.+ +|.. - ..++.-.|......+ -....-..+|++
T Consensus 110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 42211 1100 0 000111111111100 012223445543
Q ss_pred C-----CCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 558 D-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 558 ~-----~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+ ++..++|+|+.+.|++++.+..+-|.||+++..=
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 3 2346999999999999999888999999999743
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.14 Score=53.82 Aligned_cols=73 Identities=12% Similarity=0.126 Sum_probs=48.0
Q ss_pred ceeecccCceeEEEEEecCCcEEEEEEecc----cch---hhHHHHHHHHHHHccCC---CCceeceEEEEEeCCeEEEE
Q 007336 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSK----ISE---QGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~----~~~---~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV 514 (607)
.+.||.|..-.||+... +++.++||+-.. ... ....+-..|...|+.+. ...+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 36789999999999876 456788997542 111 12333334455554442 357888888876 446789
Q ss_pred EEcCCC
Q 007336 515 YEFMPN 520 (607)
Q Consensus 515 ~Ey~~~ 520 (607)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.054 Score=55.94 Aligned_cols=79 Identities=13% Similarity=0.159 Sum_probs=49.1
Q ss_pred eecccCceeEEEEEecCC-cEEEEEEecc----cc---hhhHHHHHHHHHHHccCC--CC-ceeceEEEEEeCCeEEEEE
Q 007336 447 KLGEGGFGPVYKGTLVDG-QEIAVKRLSK----IS---EQGLKELKNEVILFSKLQ--HR-NLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 447 ~lg~G~fg~Vy~g~~~~~-~~vavK~l~~----~~---~~~~~~f~~E~~~l~~l~--H~-nIv~l~g~~~~~~~~~lV~ 515 (607)
.||.|....||++...++ +.|+||.-.. .. +...++..-|...|.... -| .+.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 578999999999998654 6899997432 11 223445555666665442 24 34444433 556667999
Q ss_pred EcCCCC-ChHHHH
Q 007336 516 EFMPNK-SLDSFI 527 (607)
Q Consensus 516 Ey~~~g-sL~~~l 527 (607)
|+++.. .|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999654 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.0097 Score=59.53 Aligned_cols=131 Identities=18% Similarity=0.223 Sum_probs=85.6
Q ss_pred CcccceeecccCceeEEEEEecCCcEEEEEEec--ccc-------h-----------hhHH--HHHHHHHHHccCC-CCc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLS--KIS-------E-----------QGLK--ELKNEVILFSKLQ-HRN 497 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~--~~~-------~-----------~~~~--~f~~E~~~l~~l~-H~n 497 (607)
-++..+.||-|--+-||.+-..+|++.++|.=. +.+ + .... .-..|...|+.|. |..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 356778999999999999999889998888321 110 0 0011 1235666676664 322
Q ss_pred -eeceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc
Q 007336 498 -LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (607)
Q Consensus 498 -Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~ 576 (607)
+.+.+ +.+..++|||++.+-.|...- ...+..++..- +..-+.-|..++ +||+|..-=||+|+
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~---lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVR------HVEDPPTLYDD---LMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeee------ecCChHHHHHH---HHHHHHHHHHcC---ceecccchheeEEe
Confidence 33334 335668999999887775332 12333443333 333344555555 99999999999999
Q ss_pred CCCceEEeecc
Q 007336 577 QDMNPKISDFG 587 (607)
Q Consensus 577 ~~~~~ki~DfG 587 (607)
++..++++||=
T Consensus 237 dd~~i~vIDFP 247 (465)
T KOG2268|consen 237 DDDKIVVIDFP 247 (465)
T ss_pred cCCCEEEeech
Confidence 99999999995
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.0017 Score=69.96 Aligned_cols=143 Identities=17% Similarity=0.112 Sum_probs=95.7
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCc-eeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~E 516 (607)
.+..+...+-.++++.++++|.+....+....+.+... ....-++++|.+.+||| .+..++-+..+...+++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 33444455678899999999987544444445554321 44556888999999999 6666666666777889999
Q ss_pred cCCCC-ChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 517 FMPNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 517 y~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|+..+ +-.... ......+...+...+.+.-+++++|||+.. -+||| ||+..+ ...|..||+.+..+.+.
T Consensus 315 i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 315 ICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 99877 221111 001112333344456667788999999854 48998 777766 66899999998877543
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.21 Score=47.84 Aligned_cols=75 Identities=16% Similarity=0.245 Sum_probs=51.4
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccC---CCCceeceEEEEEeCCeEEEEEEcCCCCC
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 522 (607)
+.+.-|..-..|.... +..++.||.-. ......|.+|+.-+..+ +-..+.+++.+-.+..+.+||+||++-|.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3455554444454432 35678888643 33456788887655544 45668888888889999999999999877
Q ss_pred hH
Q 007336 523 LD 524 (607)
Q Consensus 523 L~ 524 (607)
++
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 65
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.098 Score=53.77 Aligned_cols=136 Identities=23% Similarity=0.290 Sum_probs=77.2
Q ss_pred CceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCc------eeceEEE----EEeCCeEEEEEEcCCCC
Q 007336 452 GFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN------LVKLLGC----CIQGEEKLLIYEFMPNK 521 (607)
Q Consensus 452 ~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n------Iv~l~g~----~~~~~~~~lV~Ey~~~g 521 (607)
.--.+|+....+++. ++|..... ....++..|+..+..+.-.. |..+=|- ...+...+-|+||++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 445688888777666 77776653 33445555666665552211 2222121 11123678899999998
Q ss_pred ChHH-H----H----------h----c----C-CCCCCCCHHH-------------HHHHHHHHHHHHHHHHhC----CC
Q 007336 522 SLDS-F----I----------F----D----Q-TRRTLLDWSQ-------------RFHIICGTARGLLYLHQD----SR 560 (607)
Q Consensus 522 sL~~-~----l----------~----~----~-~~~~~l~~~~-------------~~~i~~~ia~gl~yLH~~----~~ 560 (607)
.+.. . + + + + .......|.. ......++...+..+.+. -+
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8772 1 1 1 0 0 1112334431 001223344445555432 11
Q ss_pred ---CceEecccCCCcEEEcCCCc-eEEeecccce
Q 007336 561 ---LRIIHRDLKASNVLLDQDMN-PKISDFGLVR 590 (607)
Q Consensus 561 ---~~ivHrDlkp~Nill~~~~~-~ki~DfGla~ 590 (607)
..+||+|+.|.||+++.+.. +.+.||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 22999999999999999885 8999999775
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.16 Score=51.99 Aligned_cols=139 Identities=22% Similarity=0.248 Sum_probs=88.7
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEeccc-----ch----hh-------------HHH----HHHHHHHHccCCCCcee
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKI-----SE----QG-------------LKE----LKNEVILFSKLQHRNLV 499 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~-----~~----~~-------------~~~----f~~E~~~l~~l~H~nIv 499 (607)
-.|..|--+-||.++-.+|..+|||+.+.. ++ .+ .+. -..|++-+.+++...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 467788889999999999999999987531 00 00 011 12455666666544432
Q ss_pred ceEEEEEeCCeEEEEEEcCCCCChH-HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC
Q 007336 500 KLLGCCIQGEEKLLIYEFMPNKSLD-SFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (607)
Q Consensus 500 ~l~g~~~~~~~~~lV~Ey~~~gsL~-~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~ 578 (607)
..--... ....|||+|+.....- -.| +...+.......+-.+++.-|.-|-..| ++||.||.-=|+|+. +
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw~aPkL----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGWAAPKL----KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCceee--ecceEeeeeccCCCCcCccc----ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence 1111110 1236999999632211 111 2233555666777778888888888777 599999999999984 5
Q ss_pred CceEEeecccceeec
Q 007336 579 MNPKISDFGLVRTFG 593 (607)
Q Consensus 579 ~~~ki~DfGla~~~~ 593 (607)
|.+.|+|.+-+....
T Consensus 301 G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHD 315 (520)
T ss_pred CEEEEEEccccccCC
Confidence 678999988765443
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.39 Score=49.04 Aligned_cols=29 Identities=24% Similarity=0.347 Sum_probs=25.4
Q ss_pred CceEecccCCCcEEEcCCCceEEeecccce
Q 007336 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 561 ~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 46999999999999988 668999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.085 Score=50.15 Aligned_cols=100 Identities=15% Similarity=0.163 Sum_probs=65.8
Q ss_pred EEEEEEecccchh-hHHHHHHHHHHHccCCCCceeceEEEEEeCCe-EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHH
Q 007336 466 EIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH 543 (607)
Q Consensus 466 ~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~ 543 (607)
+..+|++....-. ....|..+.+++++++ .|+++. .+..+ .-++.|+|-.- .... ..
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~---NDn~~~yGvIlE~Cy~~------------~i~~----~N 145 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK---NDNNYKYGVILERCYKI------------KINF----SN 145 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee---cCCCceeEEEEeeccCc------------ccch----hH
Confidence 3456666554333 4567888888888876 566666 23333 34888887321 1111 11
Q ss_pred HHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 544 i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
++..=++.|.-.|+.. ...+|+|-.|+||+-|..|.+||.|=+
T Consensus 146 ~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 146 FITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred HHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChh
Confidence 2222246788889654 569999999999999999999999966
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.044 Score=52.69 Aligned_cols=30 Identities=30% Similarity=0.494 Sum_probs=21.6
Q ss_pred ceEecccCCCcEEE-cCCCceEEeeccccee
Q 007336 562 RIIHRDLKASNVLL-DQDMNPKISDFGLVRT 591 (607)
Q Consensus 562 ~ivHrDlkp~Nill-~~~~~~ki~DfGla~~ 591 (607)
.+.|.||.|.|||+ +.++.++|+||-.|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 8899999999998874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.91 E-value=0.074 Score=54.29 Aligned_cols=72 Identities=19% Similarity=0.205 Sum_probs=55.0
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
..+++|++. +++|. ......|.+.+.|+.+.+.-+.-|... .++-|||+.-.||||+ +|++-|+||-++
T Consensus 300 y~yl~~kdh-gt~is-------~ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPIS-------IIKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceee-------eeecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence 446777765 34442 223457888899999887777666653 4689999999999999 999999999999
Q ss_pred eee
Q 007336 590 RTF 592 (607)
Q Consensus 590 ~~~ 592 (607)
|+-
T Consensus 369 Rl~ 371 (488)
T COG5072 369 RLS 371 (488)
T ss_pred ecc
Confidence 943
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 607 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-33 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-27 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-25 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 9e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 2e-97
Identities = 74/202 (36%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 417 ENEDQNI-DLELPLFELATIANATDNFS------INNKLGEGGFGPVYKGTLVDGQEIAV 469
EN+ + D F + N T+NF NK+GEGGFG VYKG + + +AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 470 KRLSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS 525
K+L+ + +E+ ++ E+ + +K QH NLV+LLG G++ L+Y +MPN SL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585
+ L W R I G A G+ +LH++ IHRD+K++N+LLD+ KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 586 FGLVRTFGGDETEGNTNRVVGT 607
FGL R T+R+VGT
Sbjct: 177 FGLARASEKFAQTVMTSRIVGT 198
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 4e-89
Identities = 79/180 (43%), Positives = 109/180 (60%), Gaps = 3/180 (1%)
Query: 430 FELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLK-ELKNEVI 488
F L + A+DNFS N LG GGFG VYKG L DG +AVKRL + QG + + + EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICG 547
+ S HRNL++L G C+ E+LL+Y +M N S+ S + ++ + LDW +R I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ARGL YLH +IIHRD+KA+N+LLD++ + DFGL + +T T V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 1e-82
Identities = 77/206 (37%), Positives = 118/206 (57%), Gaps = 10/206 (4%)
Query: 408 TENSRETDQENEDQNIDLELPL----FELATIANATDNFSINNKLGEGGFGPVYKGTLVD 463
++ S+ T+ N+ + +P L + AT+NF +G G FG VYKG L D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 464 GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523
G ++A+KR + S QG++E + E+ S +H +LV L+G C + E +LIY++M N +L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 524 DSFIFDQTRRTL-LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582
++ T+ + W QR I G ARGL YLH + IIHRD+K+ N+LLD++ PK
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 583 ISDFGLVRTF-GGDETEGNTNRVVGT 607
I+DFG+ + D+T +T V GT
Sbjct: 180 ITDFGISKKGTELDQTHLST-VVKGT 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 6e-64
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 20/203 (9%)
Query: 416 QENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI 475
+ + ++L L + + G FG V+K + + +AVK
Sbjct: 3 HHHHHHSSGVDLGTENLYF---QSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQ 58
Query: 476 SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIYEFMPNKSLDSFIFDQT 531
+Q + + EV ++H N+++ +G +G + LI F SL F+
Sbjct: 59 DKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---- 113
Query: 532 RRTLLDWSQRFHIICGTARGLLYLHQD-------SRLRIIHRDLKASNVLLDQDMNPKIS 584
+ ++ W++ HI ARGL YLH+D + I HRD+K+ NVLL ++ I+
Sbjct: 114 KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 585 DFGLVRTFGGDETEGNTNRVVGT 607
DFGL F ++ G+T+ VGT
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 1e-54
Identities = 56/187 (29%), Positives = 80/187 (42%), Gaps = 23/187 (12%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
DN + +G G +G VYKG+L D + +AVK S + Q K + ++H N
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68
Query: 498 LVKLLGCCIQGE-----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+ + + + E LL+ E+ PN SL ++ T DW + RGL
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGL 124
Query: 553 LYLHQD------SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG------DETEGN 600
YLH + + I HRDL + NVL+ D ISDFGL G E +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 601 TNRVVGT 607
VGT
Sbjct: 185 AISEVGT 191
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-47
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 401 RRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT 460
+I + + +D +I +L +I K+G G FG V++
Sbjct: 12 DYDIPTTENLYFQGAMDGDDMDIPWC----DL----------NIKEKIGAGSFGTVHRAE 57
Query: 461 LVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518
G ++AVK L + + E EV + +L+H N+V +G Q ++ E++
Sbjct: 58 W-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL 116
Query: 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578
SL + R LD +R + A+G+ YLH I+HR+LK+ N+L+D+
Sbjct: 117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKK 175
Query: 579 MNPKISDFGLVRTFGGDETEGNTNRVVGT 607
K+ DFGL R T ++ GT
Sbjct: 176 YTVKVCDFGLSRLK--ASTFLSSKSAAGT 202
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-44
Identities = 43/169 (25%), Positives = 70/169 (41%), Gaps = 11/169 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G G FG V K +++A+K++ SE K E+ S++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KL G C+ L+ E+ SL + + + ++G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 560 RLRIIHRDLKASNVLLDQDMN-PKISDFGLVRTFGGDETEGNTNRVVGT 607
+IHRDLK N+LL KI DFG + + + G+
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGS 166
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-44
Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 7/157 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 497
+ KL E G ++KG G +I VK L S + ++ E H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 498 LVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++ +LG C I +MP SL + + + T + D SQ ARG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFL 127
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
H L I L + +V++D+DM +IS + +F
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 6/165 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ LG+G FG K T G+ + +K L + E+ + EV + L+H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+K +G + + I E++ +L I + WSQR A G+ YLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS- 126
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
+ IIHRDL + N L+ ++ N ++DFGL R ++T+ R
Sbjct: 127 --MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 49/181 (27%), Positives = 86/181 (47%), Gaps = 23/181 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQG-------LKELKNEVILFS 491
+ ++G+GGFG V+KG LV D +A+K L +G +E + EV + S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 492 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
L H N+VKL G ++ EF+P L + D+ + WS + ++ A G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALG 134
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ Y+ I+HRDL++ N+ L + K++DFGL + ++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 607 T 607
Sbjct: 189 N 189
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-42
Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 17/170 (10%)
Query: 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ----GLKELKNEVILFSKLQHRNLV 499
+ +G GGFG VY+ G E+AVK ++ ++ ++ E LF+ L+H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
L G C++ L+ EF L+ + + + ARG+ YLH ++
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 560 RLRIIHRDLKASNVLLDQDMNP--------KISDFGLVRTFGGDETEGNT 601
+ IIHRDLK+SN+L+ Q + KI+DFGL R +
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 10/170 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 497
++ ++G G FG VYKG ++AVK L + + Q L+ KNEV + K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ +G + ++ ++ SL + T + + I TARG+ YLH
Sbjct: 82 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
IIHRDLK++N+ L +D KI DFGL ++ G+
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-40
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 20/212 (9%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQE 466
E+ R+ ++++ LPL TIA + ++G+G +G V+ G G++
Sbjct: 7 PGESLRDLIEQSQSSGSGSGLPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEK 62
Query: 467 IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMPNKS 522
+AVK E + E+ ++H N++ + I+G LI ++ N S
Sbjct: 63 VAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGS 121
Query: 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR-----IIHRDLKASNVLLDQ 577
L ++ + T LD + + GL +LH + I HRDLK+ N+L+ +
Sbjct: 122 LYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177
Query: 578 DMNPKISDFGLVRTF--GGDETEGNTNRVVGT 607
+ I+D GL F +E + N VGT
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 27/203 (13%)
Query: 410 NSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAV 469
+ +T ++ +I E +L I +G+G FG VY G E+A+
Sbjct: 17 KASQTSIFLQEWDIPFE----QL----------EIGELIGKGRFGQVYHGRW--HGEVAI 60
Query: 470 KRL--SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
+ + + +E LK K EV+ + + +H N+V +G C+ +I ++L S +
Sbjct: 61 RLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
+ + +LD ++ I +G+ YLH I+H+DLK+ NV D + I+DFG
Sbjct: 121 --RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFG 174
Query: 588 LVRTFGGDETEGNTNR---VVGT 607
L G + ++ G
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGW 197
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 24/187 (12%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILF--S 491
T+A + ++ +G+G +G V++G+ G+ +AVK S + K E L+
Sbjct: 5 TVA---RDITLLECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTV 57
Query: 492 KLQHRNLVKLLGCCIQGEEK----LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
L+H N++ + + LI + SL ++ + T LD I+
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLS 113
Query: 548 TARGLLYLHQDSRLR-----IIHRDLKASNVLLDQDMNPKISDFGLVR--TFGGDETEGN 600
A GL +LH + I HRDLK+ N+L+ ++ I+D GL + ++ +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 601 TNRVVGT 607
N VGT
Sbjct: 174 NNPRVGT 180
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 22/214 (10%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQ 465
+ ++ + LPL TIA + +G+G FG V++G G+
Sbjct: 11 SEGTTLKDLIYDMTTSGSGSGLPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGE 66
Query: 466 EIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMPN 520
E+AVK S E+ +E E+ L+H N++ + + L+ ++ +
Sbjct: 67 EVAVKIFSSREERSWFREA--EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 124
Query: 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-----SRLRIIHRDLKASNVLL 575
SL ++ R + + TA GL +LH + + I HRDLK+ N+L+
Sbjct: 125 GSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180
Query: 576 DQDMNPKISDFGLVRTF--GGDETEGNTNRVVGT 607
++ I+D GL D + N VGT
Sbjct: 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 9/157 (5%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ KLGEGGF V L DG A+KR+ +Q +E + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 500 KLLGCCIQ----GEEKLLIYEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLY 554
+L+ C++ E L+ F +L + I + + L Q ++ G RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591
+H HRDLK +N+LL + P + D G +
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 7/159 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRL-SKISEQGLKELKNEVILFSKLQHRN 497
++ + ++G G FG V+ G L D +AVK + + E + + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+V+L+G C Q + ++ E + +F+ +T L ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
IHRDL A N L+ + KISDFG+ R
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKISEQGLKELKNEVILFSKL 493
+ + +LGEG FG V+ + +AVK L + SE ++ + E L + L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF------------IFDQTRRTLLDWSQR 541
QH+++V+ G C +G L+++E+M + L+ F + L Q
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ A G++YL + L +HRDL N L+ Q + KI DFG+ R
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-33
Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ ++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C++ L+ EFM + L ++ +T+R L + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+IHRDL A N L+ ++ K+SDFG+ R D+
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKISEQGLKELKNEVILFSKL 493
+ + +LGEG FG V+ + +AVK L + K+ + E L + L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLLDWSQ 540
QH ++VK G C G+ ++++E+M + L+ F + + L SQ
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
HI A G++YL + +HRDL N L+ ++ KI DFG+ R
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 12/164 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ +LG+G FG V G+ +AVK+L +E+ L++ + E+ + LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+VK G C + LI E++P SL ++ Q + +D + +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
YL R IHRDL N+L++ + KI DFGL + D+
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 11/154 (7%)
Query: 443 SINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 497
N +G G FG VY GTL+D AVK L++I + + E I+ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 498 LVKLLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++ LLG C++ E L + +M + L +FI + A+G+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL- 144
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ + +HRDL A N +LD+ K++DFGL R
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 12/164 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ +LG+G FG V G+ +AVK+L +E+ L++ + E+ + LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+VK G C + LI E++P SL ++ Q + +D + +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
YL R IHRDL N+L++ + KI DFGL + D+
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 2e-32
Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ ++ +LG G FG V G ++AVK + K E E KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
K G C + ++ E++ N L +++ ++ L+ SQ + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ IHRDL A N L+D+D+ K+SDFG+ R D+
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 17/165 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRLSKI-SEQGLKELKNEVILFSK 492
+ +++ +LG+G FG VY+G + +A+K +++ S + E NE + +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------IFDQTRRTLLDWSQRFHII 545
++V+LLG QG+ L+I E M L S+ + + S+ +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G+ YL + + +HRDL A N ++ +D KI DFG+ R
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 44/157 (28%), Positives = 67/157 (42%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V G ++A+K + K E E + L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C + +I E+M N L +++ + R Q + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ +HRDL A N L++ K+SDFGL R DE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 7e-32
Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 11/154 (7%)
Query: 443 SINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 497
N +G G FG VY GTL+D AVK L++I + + E I+ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 498 LVKLLGCCIQGEEKLL-IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++ LLG C++ E L + +M + L +FI + A+G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ + +HRDL A N +LD+ K++DFGL R
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 13/165 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRL-SKISEQGLKELKNEVILFSKL 493
LGEG FG V G+++AVK L + + +LK E+ + L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 494 QHRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H N+VK G C + LI EF+P+ SL ++ + ++ Q+ +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ YL + +HRDL A NVL++ + KI DFGL + D+
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 52/169 (30%), Positives = 82/169 (48%), Gaps = 20/169 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 493
F LG G FG VYKG + E +A+K L + S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ----TRRTLLDWSQRFHIICGTA 549
+ ++ +LLG C+ LI + MP L ++ + + LL+W A
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+G+ YL R++HRDL A NVL+ + KI+DFGL + G +E E
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 51/165 (30%), Positives = 66/165 (40%), Gaps = 15/165 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL---VDGQEI--AVKRL-SKISEQGLKELKNEVILFSKL 493
LGEG FG V DG AVK L + Q K E+ + L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 494 QHRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H +++K GCC L+ E++P SL ++ R + +Q G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ YLH IHRDL A NVLLD D KI DFGL +
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 17/165 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE----IAVKRLSK--ISEQGLKELKNEVILFSKL 493
+ + LGEG FG V +G L +AVK + S++ ++E +E
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 494 QHRNLVKLLGCCIQGE-----EKLLIYEFMPNKSLDSFI---FDQTRRTLLDWSQRFHII 545
H N+++LLG CI+ + ++I FM L +++ +T + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A G+ YL S +HRDL A N +L DM ++DFGL +
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 11/153 (7%)
Query: 444 INNKLGEGGFGPVYKGTLVDGQE----IAVKRLSKI-SEQGLKELKNEVILFSKLQHRNL 498
+ +G+G FG VY G +D + A+K LS+I Q ++ E +L L H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 499 VKLLGCCIQGEE-KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+ L+G + E ++ +M + L FI ++ + ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL-- 140
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ + +HRDL A N +LD+ K++DFGL R
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 12/166 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ ++LG+G FG V G +AVK+L ++ + E+ + L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+VK G + L+ E++P+ L F+ Q R LD S+ +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
YL R +HRDL A N+L++ + + KI+DFGL + D+
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 494
I +G G G V G L +++ A+K L + +E+ ++ +E + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+++L G +G +++ E+M N SLD+F+ +T Q ++ G G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
L S L +HRDL A NVL+D ++ K+SDFGL R D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 23/171 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
+LGE FG VYKG L Q +A+K L +E ++E +L ++
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLLDWS 539
LQH N+V LLG + + +I+ + + L F D+T ++ L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 540 QRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
H++ A G+ YL S ++H+DL NVL+ +N KISD GL R
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 38/171 (22%), Positives = 74/171 (43%), Gaps = 9/171 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 496
+ + K+GEG FG DG++ +K +S++S + +E + EV + + ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+V+ + ++ ++ L I Q + L Q L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVH 142
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+I+HRD+K+ N+ L +D ++ DFG+ R +GT
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 40/173 (23%), Positives = 78/173 (45%), Gaps = 21/173 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFS 491
++ N LG+G F ++KG + E+ +K L K + + S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 492 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
KL H++LV G C+ G+E +L+ EF+ SLD+++ + + ++ + + A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNP--------KISDFGLVRTFGGDE 596
+ +L +IH ++ A N+LL ++ + K+SD G+ T +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 22/168 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSK--ISEQGLKELKNEVILFSKL 493
F++ LG+G FG V + L ++AVK L I+ ++E E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 494 QHRNLVKLLGCCIQGEEK------LLIYEFMPNKSLDSFIFDQTRRTL-----LDWSQRF 542
H ++ KL+G ++ K ++I FM + L +F+ R L
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL--LASRIGENPFNLPLQTLV 140
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ A G+ YL S IHRDL A N +L +DM ++DFGL R
Sbjct: 141 RFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 8/152 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 77
Query: 500 KLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+LLG ++ + L I E+M SL ++ + R++L + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+HRDL A NVL+ +D K+SDFGL +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 6/158 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ ++ +KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+LLG C + +I EFM +L ++ + R + ++ + + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ IHRDL A N L+ ++ K++DFGL R GD
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 21/169 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE---IAVKRL-SKISEQGLKELKNEVILFSKL-Q 494
++ + +GEG FG V K + A+KR+ S+ ++ E+ + KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLLDWSQR 541
H N++ LLG C L E+ P+ +L F + + L Q
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
H ARG+ YL S+ + IHRDL A N+L+ ++ KI+DFGL R
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 51/162 (31%), Positives = 83/162 (51%), Gaps = 10/162 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKLQ 494
N SI+ +G G FG V G L +EI A+K L +E+ ++ E + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+++L G + + +++ E+M N SLDSF+ + Q ++ G A G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
L S + +HRDL A N+L++ ++ K+SDFGL R D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 11/163 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 493
+ +G G FG VYKG L +A+K L +E+ + E + +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H N+++L G + + ++I E+M N +LD F+ + + Q ++ G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
YL + + +HRDL A N+L++ ++ K+SDFGL R D
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 53/185 (28%), Positives = 82/185 (44%), Gaps = 28/185 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+F +G GGFG V+K +DG+ +KR+ +E + + EV +KL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66
Query: 499 VKLLGC---------------CIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRF 542
V GC + L I EF +L+ +I ++ R LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
+ +G+ Y+H ++I+RDLK SN+ L KI DFGLV + + +G
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRT 179
Query: 603 RVVGT 607
R GT
Sbjct: 180 RSKGT 184
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 12/165 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRL-SKISEQGLKELKNEVILFSKL 493
LG G FG V+KG + E + +K + K Q + + + ++ L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H ++V+LLG C L+ +++P SL + + R L + A+G+
Sbjct: 73 DHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMY 129
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
YL ++HR+L A NVLL +++DFG+ D+ +
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
N ++ LG G FG VY+G + ++AVK L ++ SEQ + E ++ SK
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGT 548
H+N+V+ +G +Q + ++ E M L SF+ ++ + L H+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVR 590
A G YL IHRD+ A N LL KI DFG+ R
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 48/179 (26%), Positives = 75/179 (41%), Gaps = 31/179 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
+N +GEG FG V++ +AVK L + S + + E L ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF---------------------IFDQT 531
+ N+VKLLG C G+ L++E+M L+ F
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 532 RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
L +++ I A G+ YL S + +HRDL N L+ ++M KI+DFGL R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 50/181 (27%), Positives = 78/181 (43%), Gaps = 35/181 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
N + LGEG FG V K T +AVK L + S L++L +E + +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT---- 548
+ H +++KL G C Q LLI E+ SL F+ + R + +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNSSSLD 140
Query: 549 -------------------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589
++G+ YL + ++++HRDL A N+L+ + KISDFGL
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 590 R 590
R
Sbjct: 198 R 198
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 249
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+LLG ++ + L ++ E+M SL ++ + R++L + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+HRDL A NVL+ +D K+SDFGL +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 26/174 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILF 490
D ++ LGEG FG V V +AVK L +E+ L +L +E+ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLL 536
+ +H+N++ LLG C Q +I E+ +L + ++ +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ ARG+ YL + + IHRDL A NVL+ ++ KI+DFGL R
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V+ G ++AVK L K E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L Q E +I E+M N SL F+ L ++ + A G+ ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
IHRDL+A+N+L+ ++ KI+DFGL R +E
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRL-SKISEQGLKELKNEVILFSKL 493
F LG G FG VYKG + E +A+K L S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
+ ++ +LLG C+ LI + MP L ++ + + + + A+G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
YL R++HRDL A NVL+ + KI+DFGL + G +E E
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSKI-SEQGLKELKNEVILFSK 492
N ++ LG G FG VY+G + ++AVK L ++ SEQ + E ++ SK
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGT 548
H+N+V+ +G +Q + ++ E M L SF+ ++ + L H+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVR 590
A G YL IHRD+ A N LL KI DFG+ R
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 46/176 (26%), Positives = 74/176 (42%), Gaps = 17/176 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 497
+F LG GGFG V++ VD A+KR+ E +++ EV +KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 498 LVKLLGCCI---------QGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+V+ + K+ +Y + ++L ++ + + S HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
A + +LH ++HRDLK SN+ D K+ DFGLV DE E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 26/174 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRL-SKISEQGLKELKNEVILF 490
D ++ LGEG FG V V +AVK L +E+ L +L +E+ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLL 536
+ +H+N++ LLG C Q +I E+ +L + ++ +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ ARG+ YL + + IHRDL A NVL+ ++ KI+DFGL R
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 444 INNKLGEGGFGPVYKGTLVDGQE---IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLV 499
+ +LG G FG V +G ++ +A+K L + + +E+ E + +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L+G C Q E +L+ E L F+ +R + S ++ + G+ YL
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+HRDL A NVLL KISDFGL + G D++
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-30
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 6/158 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ ++ +KLG G +G VY+G +AVK L K ++E E + +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+LLG C + +I EFM +L ++ + R + ++ + + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ IHR+L A N L+ ++ K++DFGL R GD
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-30
Identities = 46/157 (29%), Positives = 72/157 (45%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG G FG V+ T ++AVK + K ++ E + LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
KL + E +I EFM SL F+ + + A G+ ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ IHRDL+A+N+L+ + KI+DFGL R +E
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 9/163 (5%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506
LG+G +G VY G L + IA+K + + + + L E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF- 88
Query: 507 QGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIH 565
+ I+ E +P SL + + + + GL YLH + +I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 566 RDLKASNVLLDQDM-NPKISDFGLVRTFGGDETEGNTNRVVGT 607
RD+K NVL++ KISDFG + G T GT
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGT 186
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 51/176 (28%), Positives = 72/176 (40%), Gaps = 30/176 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL-SKISEQGLKELKNEVILFSK 492
+ S LG G FG V + T + +AVK L + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT--- 548
L H N+V LLG C G L+I E+ L +F+ + +R S+ I
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL--RRKRDSFICSKTSPAIMEDDEL 140
Query: 549 --------------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A+G+ +L + IHRDL A N+LL KI DFGL R
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 47/161 (29%), Positives = 69/161 (42%), Gaps = 10/161 (6%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNL 498
+ L EGGF VY+ + G+E A+KRL E+ + + EV KL H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 499 VKLLGCCIQGEEK-------LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
V+ G+E+ L+ + L F+ R L I T R
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
+ ++H+ + IIHRDLK N+LL K+ DFG T
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 42/162 (25%), Positives = 70/162 (43%), Gaps = 11/162 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSK-ISEQGLKELKNEVILFSKLQ 494
+ + +GEG FG V++G + + + A+K S+ ++ E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + +I E L SF+ Q R+ LD + + L Y
Sbjct: 75 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
L R +HRD+ A NVL+ + K+ DFGL R
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 12/174 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQH 495
NF I K+G G F VY+ L+DG +A+K++ + + + E+ L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 496 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGLL 553
N++K I+ + +L I E L I ++ L+ + L
Sbjct: 92 PNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
++H R++HRD+K +NV + K+ D GL R F T ++ +VGT
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 54/172 (31%), Positives = 76/172 (44%), Gaps = 26/172 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL-SKISEQGLKELKNEVILFSK 492
+N LG G FG V + T + +AVK L S + L +E+ + S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT--- 548
L QH N+V LLG C G L+I E+ L +F+ + + +L+ F I T
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTAST 163
Query: 549 ----------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A+G+ +L + IHRD+ A NVLL KI DFGL R
Sbjct: 164 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-29
Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 19/205 (9%)
Query: 398 RKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVY 457
K R + + E ++ L L L + +LG G FG V
Sbjct: 303 DKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA---------DIELGCGNFGSVR 353
Query: 458 KGTL-VDGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513
+G + ++I A+K L + +E+ E + +L + +V+L+G C Q E +L
Sbjct: 354 QGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 412
Query: 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+ E L F+ +R + S ++ + G+ YL +HR+L A NV
Sbjct: 413 VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNV 467
Query: 574 LLDQDMNPKISDFGLVRTFGGDETE 598
LL KISDFGL + G D++
Sbjct: 468 LLVNRHYAKISDFGLSKALGADDSY 492
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 46/195 (23%), Positives = 79/195 (40%), Gaps = 32/195 (16%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+F LG+G FG V K +D + A+K++ +E+ L + +EV+L + L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 498 LVKLLGC----------CIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHI 544
+V+ ++K ++ E+ N +L I + + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF------------ 592
L Y+H IIHRDLK N+ +D+ N KI DFGL +
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 593 GGDETEGNTNRVVGT 607
+ N +GT
Sbjct: 179 NLPGSSDNLTSAIGT 193
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 22/184 (11%)
Query: 426 ELPLFELATIANATDNFSINNKLGEGGFGPVYKGTL--VDGQEI--AVKRL---SKISEQ 478
E PL L + D + KLG+G FG V +G G+ + AVK L +
Sbjct: 5 EGPLQSLTCLIGEKD-LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE 63
Query: 479 GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR----T 534
+ + EV L HRNL++L G + ++ E P SL + T
Sbjct: 64 AMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
L ++ A G+ YL R IHRDL A N+LL KI DFGL+R
Sbjct: 123 LSRYAV------QVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173
Query: 595 DETE 598
++
Sbjct: 174 NDDH 177
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 10/176 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHR 496
+++ + +G G +G K DG+ + K ++E + L +EV L +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 497 NLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLL 553
N+V+ I L + E+ L S I T+ R LD ++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 554 YLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
H+ D ++HRDLK +NV LD N K+ DFGL R D + T VGT
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGT 179
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 45/173 (26%), Positives = 70/173 (40%), Gaps = 25/173 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 492
D + LG G FG V + + +AVK L + + L +E+ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 493 L-QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSF-------------IFDQTRRTLLD 537
+ H N+V LLG C + L +I EF +L ++ + + L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
A+G+ +L + + IHRDL A N+LL + KI DFGL R
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 12/180 (6%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVIL 489
+ + + + I +LG+G FG VYK G A K + SE+ L++ E+ +
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEI 69
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
+ H +VKLLG + ++ EF P ++D+ + L Q +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQML 127
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG--DETEGNTNRVVGT 607
L +LH RIIHRDLKA NVL+ + + +++DFG +T + +GT
Sbjct: 128 EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGT 180
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 9e-29
Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 11/162 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRLSKI-SEQGLKELKNEVILFSKLQ 494
++ +N LGEG FG VY+G G++I AVK K + ++ +E ++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + E +I E P L ++ + + L + + Y
Sbjct: 72 HPHIVKLIGII-EEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
L + +HRD+ N+L+ K+ DFGL R ++
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 16/208 (7%)
Query: 403 NIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-L 461
+ TEN + L + + K+GEG G V
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAALR--MVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK 67
Query: 462 VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521
G+++AVK + +Q + L NEV++ QH N+V++ + GEE ++ EF+
Sbjct: 68 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGG 127
Query: 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581
+L D + L+ Q + + L YLH +IHRD+K+ ++LL D
Sbjct: 128 ALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRV 180
Query: 582 KISDFGLVRTFGGDETEGNTNR--VVGT 607
K+SDFG F ++ R +VGT
Sbjct: 181 KLSDFG----FCAQISKDVPKRKSLVGT 204
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 49/174 (28%), Positives = 74/174 (42%), Gaps = 26/174 (14%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKI-SEQGLKELKNEVILF 490
D + LGEG FG V + ++AVK L +E+ L +L +E+ +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSF-------------IFDQTRRTLL 536
+ +H+N++ LLG C Q +I E+ +L + L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590
ARG+ YL + + IHRDL A NVL+ +D KI+DFGL R
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 46/181 (25%), Positives = 71/181 (39%), Gaps = 35/181 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE------IAVKRL-SKISEQGLKELKNEVILFSK 492
+N LG G FG V T + +AVK L K + L +E+ + ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT--- 548
L H N+V LLG C LI+E+ L +++ +++R + +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL--RSKREKFSEDEIEYENQKRLEE 162
Query: 549 -------------------ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589
A+G+ +L +HRDL A NVL+ KI DFGL
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 590 R 590
R
Sbjct: 220 R 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 45/182 (24%), Positives = 92/182 (50%), Gaps = 14/182 (7%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV 487
L + ++ + ++ K+G+G G VY + GQE+A+++++ + + + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
++ + ++ N+V L + G+E ++ E++ SL D T +D Q +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG--DETEGNTNRVV 605
+ L +LH + ++IHRD+K+ N+LL D + K++DFG F + + +V
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMV 177
Query: 606 GT 607
GT
Sbjct: 178 GT 179
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 14/172 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNL 498
+SI ++G GG V++ Q A+K L + Q L +NE+ +KLQ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 499 --VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++L ++ + ++ E N L+S++ ++ +D +R + +
Sbjct: 89 KIIRLYD-YEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
HQ I+H DLK +N L+ D K+ DFG+ D T + VGT
Sbjct: 144 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 191
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-28
Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG+G FG V+ GT +A+K L K + E + KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L + E ++ E+M SL F+ + L Q + A G+ Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
R+ +HRDL+A+N+L+ +++ K++DFGL R +E
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 14/182 (7%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV 487
L E + + F + KLGEG +G VYK GQ +A+K++ E L+E+ E+
Sbjct: 18 LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEI 75
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
+ + ++VK G + + ++ E+ S+ I + R L + I+
Sbjct: 76 SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQS 133
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG--DETEGNTNRVV 605
T +GL YLH R IHRD+KA N+LL+ + + K++DFG G +T N V+
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFG----VAGQLTDTMAKRNTVI 186
Query: 606 GT 607
GT
Sbjct: 187 GT 188
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 46/157 (29%), Positives = 68/157 (43%), Gaps = 12/157 (7%)
Query: 447 KLGEGGFGPVYKGTL-VDGQEI--AVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKL 501
+LG G FG V KG + AVK L EL E + +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 502 LGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRL 561
+G C + E +L+ E L+ ++ Q R + ++ + G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHV-KDKNIIELVHQVSMGMKYL---EES 136
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+HRDL A NVLL KISDFGL + DE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-28
Identities = 42/172 (24%), Positives = 76/172 (44%), Gaps = 14/172 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
+SI ++G GG V++ Q A+K ++ Q L +NE+ +KLQ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 499 --VKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++L ++ + ++ E N L+S++ ++ +D +R + +
Sbjct: 70 KIIRLYD-YEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
HQ I+H DLK +N L+ D K+ DFG+ D T + VGT
Sbjct: 125 HQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGT 172
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-28
Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 6/157 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG+G FG V+ GT +A+K L K + E + KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L + E ++ E+M SL F+ + L Q + A G+ Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
R+ +HRDL+A+N+L+ +++ K++DFGL R +E
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 46/209 (22%), Positives = 87/209 (41%), Gaps = 24/209 (11%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQ 465
+ E +++ D E + + ++N + ++G G F VYKG
Sbjct: 1 QEERNQQQDDIEELETKAVG--------MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTV 52
Query: 466 EIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI---QGEEKLLIY-EFMP 519
E+A + K+++ + K E + LQH N+V+ +G++ +++ E M
Sbjct: 53 EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112
Query: 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QD 578
+ +L +++ R ++ +GL +LH + IIHRDLK N+ +
Sbjct: 113 SGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPT 168
Query: 579 MNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ KI D GL + V+GT
Sbjct: 169 GSVKIGDLGLATL----KRASFAKAVIGT 193
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 12/171 (7%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKR--LSKISEQGLKELKNEVILFSKLQHRNL 498
+SI ++G GG V++ Q A+K L + Q L +NE+ +KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 499 --VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++L ++ + + N L+S++ ++ +D +R + +H
Sbjct: 117 KIIRLYD-YEITDQYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
Q I+H DLK +N L+ D K+ DFG+ D T + VG
Sbjct: 173 Q---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGA 219
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 16/156 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
+ LG+GGF ++ + D + A K + K + + +E + E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGL 552
+++V G + + + ++ E +SL + R+ L + R+++ I G
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL---GC 128
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
YLH R R+IHRDLK N+ L++D+ KI DFGL
Sbjct: 129 QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 16/156 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
+ LG+GGF ++ + D + A K + K + + +E + E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGL 552
+++V G + + + ++ E +SL + R+ L + R+++ I G
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL---GC 154
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
YLH+ R+IHRDLK N+ L++D+ KI DFGL
Sbjct: 155 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGL 187
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 16/183 (8%)
Query: 429 LFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELK 484
+ EL + FS ++G G FG VY + + + +A+K++S K S + +++
Sbjct: 43 VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102
Query: 485 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI 544
EV KL+H N ++ GC ++ L+ E+ + D + + L + +
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAV 159
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
G +GL YLH +IHRD+KA N+LL + K+ DFG N+
Sbjct: 160 THGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANS--F 210
Query: 605 VGT 607
VGT
Sbjct: 211 VGT 213
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 11/162 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEI--AVKRL-SKISEQGLKELKNEVILFSKLQ 494
+ + +GEG FG V++G + + + A+K + S+ ++ E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + +I E L SF+ Q R+ LD + + L Y
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
L R +HRD+ A NVL+ + K+ DFGL R
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 50/218 (22%), Positives = 87/218 (39%), Gaps = 23/218 (10%)
Query: 398 RKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVY 457
K + + K + ++NE + +L + + ++G G FG V+
Sbjct: 17 AKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVD-YEYREEVHWMTHQPRVGRGSFGEVH 75
Query: 458 KGT-LVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514
+ G + AVK RL + E++ + L +V L G +G + I
Sbjct: 76 RMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREG-PWVNI 127
Query: 515 Y-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+ E + SL I + L + + + GL YLH RI+H D+KA NV
Sbjct: 128 FMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNV 181
Query: 574 LLDQDMNP-KISDFGL---VRTFGGDETEGNTNRVVGT 607
LL D + + DFG ++ G ++ + + GT
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 48/156 (30%), Positives = 89/156 (57%), Gaps = 15/156 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
++F + N LG+G F VY+ + G E+A+K + K + + G+ + ++NEV + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTARGL 552
++++L + + L+ E N ++ ++ ++ + + ++ F II G +
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG----M 125
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
LYLH I+HRDL SN+LL ++MN KI+DFGL
Sbjct: 126 LYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGL 158
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 40/169 (23%), Positives = 72/169 (42%), Gaps = 13/169 (7%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 494
+ + +++ LG+G V++G G A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 495 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H+N+VKL + EF P SL + + + + L S+ ++ G
Sbjct: 66 HKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 552 LLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDE 596
+ +L + I+HR++K N++ D K++DFG R DE
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 15/186 (8%)
Query: 430 FELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVI 488
+L+ + + F + +G G +G VYKG + GQ A+K + ++ +E+K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72
Query: 489 LFSKL-QHRNLVKLLGCCIQG-----EEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQR 541
+ K HRN+ G I+ +++L L+ EF S+ + T+ L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWI 131
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
+I RGL +LHQ ++IHRD+K NVLL ++ K+ DFG+ D T G
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRR 186
Query: 602 NRVVGT 607
N +GT
Sbjct: 187 NTFIGT 192
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 56/174 (32%), Positives = 90/174 (51%), Gaps = 19/174 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
+NF K+GEG +G VYK + G+ +A+K++ +E ++E+ L +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKE 58
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
L H N+VKLL I E KL L++EF+ + L F+ D + T + + +G
Sbjct: 59 LNHPNIVKLL-DVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQG 115
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
L + H R++HRDLK N+L++ + K++DFGL R F G T+ VV
Sbjct: 116 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV 165
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 40/169 (23%), Positives = 72/169 (42%), Gaps = 13/169 (7%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 494
+ + +++ LG+G V++G G A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 495 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H+N+VKL + EF P SL + + + + L S+ ++ G
Sbjct: 66 HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 552 LLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDE 596
+ +L + I+HR++K N++ D K++DFG R DE
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 44/173 (25%), Positives = 67/173 (38%), Gaps = 15/173 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKL-QH 495
+F ++LG G +G V+K DG+ AVKR + EV K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 496 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
V+L + L + E SL + L +Q + + T L +
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
LH ++H D+K +N+ L K+ DFGL+ G T G G
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGD 219
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 18/178 (10%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILF 490
+++ F KLG G + VYKG G +A+K + SE+G ++E+ L
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 491 SKLQHRNLVKLLGCCIQGEEKL-LIYEFMPN--KSLDSFIFDQTRRTLLDWSQRFHIICG 547
+L+H N+V+L I E KL L++EFM N K L+ + +
Sbjct: 58 KELKHENIVRLY-DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+GL + H++ +I+HRDLK N+L+++ K+ DFGL R F G ++ VV
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV 170
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 58/173 (33%), Positives = 87/173 (50%), Gaps = 19/173 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKL 493
+ + K+GEG +G VYK G+ +A+KR+ +E ++E+ L +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS----LLKEL 76
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N+V L+ I E L L++EFM K L + +T L SQ + RG+
Sbjct: 77 HHPNIVSLI-DVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLYQLLRGV 132
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+ HQ RI+HRDLK N+L++ D K++DFGL R F G T+ VV
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 49/174 (28%), Positives = 89/174 (51%), Gaps = 11/174 (6%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKL 493
A+ + F+ K+G+G FG V+KG + +A+K + + +E +++++ E+ + S+
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
+ K G ++ + +I E++ S D LD +Q I+ +GL
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLD 133
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
YLH + + IHRD+KA+NVLL + K++DFG+ +T+ N VGT
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGT 182
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 54/173 (31%), Positives = 86/173 (49%), Gaps = 15/173 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 493
+ + LGEG F VYK Q +A+K++ K+ N E+ L +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
H N++ LL + + L+++FM L+ I + +L S + T +GL
Sbjct: 70 SHPNIIGLLDA-FGHKSNISLVFDFME-TDLEVII--KDNSLVLTPSHIKAYMLMTLQGL 125
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
YLHQ I+HRDLK +N+LLD++ K++DFGL ++F G T++VV
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV 174
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 49/173 (28%), Positives = 86/173 (49%), Gaps = 19/173 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSKL 493
+ + +KLGEG + VYKG + +A+K + E+G ++E+ L L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H N+V L I E+ L L++E++ +K L ++ +++ + RGL
Sbjct: 58 KHANIVTLH-DIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGL 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
Y H+ +++HRDLK N+L+++ K++DFGL R T+ N VV
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV 162
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 45/174 (25%), Positives = 83/174 (47%), Gaps = 20/174 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
+ K+GEG +G V+K + +A+KR+ + L+E+ L +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKE 57
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
L+H+N+V+L + ++KL L++EF + L + + LD + +G
Sbjct: 58 LKHKNIVRLH-DVLHSDKKLTLVFEFCD-QDLKKYF--DSCNGDLDPEIVKSFLFQLLKG 113
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
L + H ++HRDLK N+L++++ K+++FGL R F G + VV
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 2e-24
Identities = 47/173 (27%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ------GLKELKNEVILFSKL 493
+ + K+GEG +G VYK G+ A+K++ E ++E+ + +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS----ILKEL 57
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H N+VKL I +++L L++E + + L + L+ + G+
Sbjct: 58 KHSNIVKLY-DVIHTKKRLVLVFEHLD-QDLKKLL--DVCEGGLESVTAKSFLLQLLNGI 113
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
Y H R++HRDLK N+L++++ KI+DFGL R F G T+ +V
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 24/160 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
++F I LG+G FG VY +A+K L K + + G++ L+ EV + S L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGT 548
N+++L G ++ LI E+ P ++ + + ++ +F I
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTV----YRELQK-----LSKFDEQRTATYITEL 118
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
A L Y H R+IHRD+K N+LL KI+DFG
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW 155
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 45/194 (23%), Positives = 72/194 (37%), Gaps = 35/194 (18%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNEVILFSKL-Q 494
T F K+G G FG V+K +DG A+KR + EV + L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 495 HRNLVKLLGCCIQGEEKLLIY-EFMPNKSLDSFIFDQTRR-TLLDWSQRFHIICGTARGL 552
H ++V+ + + +LI E+ SL I + R + ++ ++ RGL
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNP-------------------KISDFGLVRTFG 593
Y+H ++H D+K SN+ + + P KI D G V
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 594 GDETEGNTNRVVGT 607
+ E G
Sbjct: 186 SPQVE------EGD 193
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 45/181 (24%), Positives = 81/181 (44%), Gaps = 13/181 (7%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQ 494
D++ + +G G V +++A+KR++ + + + EL E+ S+
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSL-----DSFIFDQTRRTLLDWSQRFHIICGTA 549
H N+V + +E L+ + + S+ + + +LD S I+
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL---VRTFGGDETEGNTNRVVG 606
GL YLH++ IHRD+KA N+LL +D + +I+DFG+ + T G VG
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 607 T 607
T
Sbjct: 189 T 189
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 50/181 (27%), Positives = 77/181 (42%), Gaps = 28/181 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
D+ +LG G +G V K V GQ +AVKR+ + ++ Q K L ++ I +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTAR 550
V G + + + E M + SLD F + ++D Q I +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVG 606
L +LH S+L +IHRD+K SNVL++ K+ DFG LV + G
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK-------DIDAG 171
Query: 607 T 607
Sbjct: 172 C 172
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 31/161 (19%), Positives = 62/161 (38%), Gaps = 9/161 (5%)
Query: 432 LATIANATDNFSINNKLGEG--GFGPVYKGT-LVDGQEIAVKR--LSKISEQGLKELKNE 486
+++ + + +G+G V G+ + V+R L S + + L+ E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+ + H N+V I E ++ FM S + ++ +I+
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQ 135
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
G + L Y+H +HR +KAS++L+ D +S
Sbjct: 136 GVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLR 173
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 44/170 (25%), Positives = 70/170 (41%), Gaps = 16/170 (9%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHR 496
+ + +LG GGFG V + G+++A+K+ + +E E+ + KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 497 NLVKLLGCCIQGEEKL-------LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
N+V G +KL L E+ L ++ L ++ +
Sbjct: 73 NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTFGGDE 596
L YLH+ RIIHRDLK N++L Q + KI D G + E
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 40/173 (23%), Positives = 76/173 (43%), Gaps = 18/173 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 493
+ + K+GEG +G V+K GQ +A+K K E + E+ + +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H NLV LL + + +L L++E+ + ++ + + + I T + +
Sbjct: 60 KHPNLVNLL-EVFRRKRRLHLVFEYC-DHTVLHEL--DRYQRGVPEHLVKSITWQTLQAV 115
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+ H+ IHRD+K N+L+ + K+ DFG R ++ + V
Sbjct: 116 NFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA 164
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 51/185 (27%), Positives = 79/185 (42%), Gaps = 38/185 (20%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
D + KLGEG +G VYK V + +A+KR+ E+ ++E+ L +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKE 89
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF---HIICGT 548
LQHRN+++L I +L LI+E+ + + +D + I
Sbjct: 90 LQHRNIIELK-SVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSFL 138
Query: 549 A---RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-----KISDFGLVRTFGGDETEGN 600
G+ + H R +HRDLK N+LL KI DFGL R F G
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 601 TNRVV 605
T+ ++
Sbjct: 195 THEII 199
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 40/174 (22%), Positives = 73/174 (41%), Gaps = 31/174 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSK-----------------ISEQGL 480
+++ I L +G F + L D + A+K+ K +
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 481 KELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFI-----FDQTRRT 534
+ KNE+ + + +++ + G I +++ +IYE+M N S+ F D+
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+ II Y+H + I HRD+K SN+L+D++ K+SDFG
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGE 198
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 41/175 (23%), Positives = 73/175 (41%), Gaps = 18/175 (10%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLV 499
+F + LG G G + + D +++AVKR+ + EV L + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ C + + + E +L ++ + + + ++ T GL +LH
Sbjct: 82 RYF-CTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS- 136
Query: 559 SRLRIIHRDLKASNVLL-----DQDMNPKISDFGLVRTFGGDETE-GNTNRVVGT 607
L I+HRDLK N+L+ + ISDFGL + + V GT
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 20/173 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
++ ++G G +G V K GQ +AVKR+ S + E+ K+L ++ ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTAR 550
+V+ G + + + E M + S D F + I T +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEG 599
L +L L+IIHRD+K SN+LLD+ N K+ DFG LV + G
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAG 187
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-23
Identities = 45/185 (24%), Positives = 82/185 (44%), Gaps = 33/185 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKG--TLVDGQEIAVKRLSKISEQG------------LKELKN 485
+ ++GEG +G V+K G+ +A+KR+ + + L+ L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 486 EVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
+H N+V+L E KL L++E + ++ L +++ D+ +
Sbjct: 71 F-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTET 121
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN 600
++ RGL +LH R++HRDLK N+L+ K++DFGL R +
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 176
Query: 601 TNRVV 605
T+ VV
Sbjct: 177 TSVVV 181
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 24/160 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 495
D+F I LG+G FG VY +A+K L K + ++G++ L+ E+ + S L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGT 548
N++++ +++ L+ EF P L + + ++ RF +
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQK-----HGRFDEQRSATFMEEL 123
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
A L Y H ++IHRD+K N+L+ KI+DFG
Sbjct: 124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGW 160
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 41/183 (22%), Positives = 76/183 (41%), Gaps = 34/183 (18%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
++ +G G FG V++ LV+ E+A+K++ + +EL+ + ++H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94
Query: 499 VKLLGCCIQGEEKL------LIYEFMP---NKSLDSFIFDQTRRTLLDWSQRFHI----- 544
V L +K L+ E++P ++ + + +L I
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML------LIKLYMY 148
Query: 545 -ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTN 602
+ R L Y+H + I HRD+K N+LLD K+ DFG + E N +
Sbjct: 149 QLL---RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200
Query: 603 RVV 605
+
Sbjct: 201 YIC 203
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 47/189 (24%), Positives = 81/189 (42%), Gaps = 35/189 (18%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG---------------LK 481
AT + ++G G +G VYK G +A+K + + G L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 482 ELKNEVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLL 536
L+ +H N+V+L+ E K+ L++E + ++ L +++ D+ L
Sbjct: 67 RLEAF-------EHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGL 117
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
++ RGL +LH + I+HRDLK N+L+ K++DFGL R +
Sbjct: 118 PAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174
Query: 597 TEGNTNRVV 605
T VV
Sbjct: 175 A--LTPVVV 181
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 18/173 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN-----EVILFSKL 493
+ + +GEG +G V K G+ +A+K K E ++ E+ L +L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQL 81
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+H NLV LL + +++ L++EF+ + ++ + + LD+ + G+
Sbjct: 82 RHENLVNLL-EVCKKKKRWYLVFEFV-DHTILDDL--ELFPNGLDYQVVQKYLFQIINGI 137
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+ H IIHRD+K N+L+ Q K+ DFG RT E + V
Sbjct: 138 GFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA 186
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 54/181 (29%), Positives = 74/181 (40%), Gaps = 28/181 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LGEG F V + A+K L K I E + + E + S+L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR---- 550
VKL Q +EKL + N L R+ F C R
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGEL----LKYIRK-----IGSFDETC--TRFYTA 137
Query: 551 ----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
L YLH IIHRDLK N+LL++DM+ +I+DFG + + + N VG
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 607 T 607
T
Sbjct: 195 T 195
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 2e-21
Identities = 47/237 (19%), Positives = 76/237 (32%), Gaps = 72/237 (30%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 497
+F +G GGFG V++ VD A+KR+ E +++ EV +KL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 498 LVKLLGCCIQG----------------------------------EEKLL-------IYE 516
+V+ ++ + + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 517 FMPNKSLDSFIFDQT----RRTLLDWSQR------------FHIICGTARGLLYLHQDSR 560
+ S +++ Q + L DW R HI A + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 561 LRIIHRDLKASNVLLDQDMNPKISDFGLVR----------TFGGDETEGNTNRVVGT 607
++HRDLK SN+ D K+ DFGLV VGT
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 34/187 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQ------GLKELKNEVILFSK 492
+ K+G+G FG V+K GQ++A+K++ +E+ L+E+K IL
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK---IL-QL 72
Query: 493 LQHRNLVKLLGCCIQGEEKL--------LIYEFMPN---KSLDSFIFDQTRRTLLDWSQR 541
L+H N+V L+ C L+++F + L + S+
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN------VLVKFTLSEI 126
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN- 600
++ GL Y+H++ +I+HRD+KA+NVL+ +D K++DFGL R F +
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 601 --TNRVV 605
TNRVV
Sbjct: 184 RYTNRVV 190
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 24/233 (10%), Positives = 55/233 (23%), Gaps = 41/233 (17%)
Query: 399 KRRRNIAEKTENSRETDQENEDQNIDLEL-----PLFELATIANATDNFSINNKLGEGGF 453
KR + + + + + + ++ + L G
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDR 75
Query: 454 GPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCC---- 505
V+ V+ ++ A+K + S L+ L ++L + +
Sbjct: 76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135
Query: 506 ------IQGEEK----------------LLIYEFMP---NKSLDSFIFDQTRRTLLDWSQ 540
+Q + LL+ + F R
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
+ R L ++H N+ + D + D + G
Sbjct: 196 LHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 44/180 (24%), Positives = 75/180 (41%), Gaps = 8/180 (4%)
Query: 411 SRETDQENEDQNIDLELPLFELATIANAT-DNFSINNKLGEGGFGPVYKGTLV-DGQEIA 468
E + +E Q LE L + + D+F ++LG G G V+K + G +A
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62
Query: 469 VKRLS-KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI 527
K + +I ++ E+ + + +V G E + E M SLD +
Sbjct: 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122
Query: 528 FDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587
R + + +GL YL + +I+HRD+K SN+L++ K+ DFG
Sbjct: 123 KKAGR---IPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFG 177
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 37/175 (21%), Positives = 67/175 (38%), Gaps = 19/175 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 496
++ ++G G G V+K G IAVK++ +++ K + ++ ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+V+ G I + + E M + + + + L YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGP--IPERILGKMTVAIVKALYYLK 141
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFG----LVRTFGGDETEGNTNRVVGT 607
+ +IHRD+K SN+LLD+ K+ DFG LV +R G
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-------DRSAGC 187
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-21
Identities = 44/189 (23%), Positives = 70/189 (37%), Gaps = 29/189 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNL 498
+ LG G G V G+ +AVKR+ E+ +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 499 VKLLGCCIQGEEKL-LIYEFMPNKSLDSFI----FDQTRRTLLDWSQRFHIICGTARGLL 553
++ C + L + E N +L + L ++ A G+
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 554 YLHQDSRLRIIHRDLKASNVLLD-------------QDMNPKISDFGLVRTFGGDET--E 598
+LH L+IIHRDLK N+L+ +++ ISDFGL + ++
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 599 GNTNRVVGT 607
N N GT
Sbjct: 187 TNLNNPSGT 195
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 45/183 (24%), Positives = 82/183 (44%), Gaps = 33/183 (18%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+++ +G G FG VY+ L D G+ +A+K++ + +EL+ + KL H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108
Query: 498 LVKLLGCCIQGEEKL------LIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHI----- 544
+V+L EK L+ +++P +++ + + ++TL ++
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPV----IYVKLYMY 163
Query: 545 -ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGGDETEGNTN 602
+ R L Y+H I HRD+K N+LLD D K+ DFG + E N +
Sbjct: 164 QLF---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVS 215
Query: 603 RVV 605
+
Sbjct: 216 YIC 218
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 7e-21
Identities = 28/169 (16%), Positives = 51/169 (30%), Gaps = 22/169 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQGLKELKNEVILFSK 492
+ +++ LGEG F VY+ T D Q+ +K + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI--FDQTRRTLLDWSQRFHIICGTAR 550
+K + +L+ E +L + I + T ++
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLL-----------DQDMNPKISDFGL 588
+ +H IIH D+K N +L D + D G
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 41/151 (27%), Positives = 66/151 (43%), Gaps = 18/151 (11%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVKLL 502
LGEG +G V + AVK L K G +K E+ L +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 503 GCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRF--HIICGTARGLLYLHQ 557
+ EEK +Y E+ + +R + + + +I G YLH
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH- 126
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
I+H+D+K N+LL KIS G+
Sbjct: 127 --SQGIVHKDIKPGNLLLTTGGTLKISALGV 155
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 4e-20
Identities = 50/207 (24%), Positives = 82/207 (39%), Gaps = 15/207 (7%)
Query: 407 KTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQ 465
+S + ++ +F + + ++ + KLG G +G V V
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 466 EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523
E A+K + K +S +L EV + L H N++KL L+ E L
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123
Query: 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMN 580
I + + +D + + G+ YLH+ I+HRDLK N+LL ++D
Sbjct: 124 FDEIIHRMKFNEVDAAVIIKQVLS---GVTYLHK---HNIVHRDLKPENLLLESKEKDAL 177
Query: 581 PKISDFGLVRTFGGDETEGNTNRVVGT 607
KI DFGL F + +GT
Sbjct: 178 IKIVDFGLSAVFENQKK---MKERLGT 201
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 4e-20
Identities = 39/167 (23%), Positives = 71/167 (42%), Gaps = 25/167 (14%)
Query: 444 INNKLGEGGFGPVYKG---TLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
K+G G +G VYK D ++ A+K++ IS +E + L +L+H N+
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNV 80
Query: 499 VKLLGCCIQ-GEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF------HIICGTAR 550
+ L + + K+ L++++ L I + ++
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTFG 593
G+ YLH + ++HRDLK +N+L+ + KI+D G R F
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 32/247 (12%), Positives = 68/247 (27%), Gaps = 38/247 (15%)
Query: 390 VLIAGYLIRKRRRNIAEKTENSRE-TDQENEDQNIDLELPLFELATIANATDNFSINNKL 448
V+I R + N+ +E + D + P + + L
Sbjct: 22 VVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVL 81
Query: 449 GEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ---------- 494
G+ + T G+ V +K++K EV+ L+
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 495 ---------------HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSF--IFDQTR-RT 534
+ ++++ +Y M + + +
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 535 LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594
L R + R L LH ++H L+ +++LDQ ++ F + G
Sbjct: 202 SLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 595 DETEGNT 601
+
Sbjct: 259 RVVSSVS 265
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 13/161 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 497
N+ + +G+G F V ++ G+E+A+K + ++++ L++L EV + L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 498 LVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH-IICGTARGLLYL 555
+VKL I+ E+ L LI E+ + ++ R + +F I+ Y
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YC 130
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
H + RI+HRDLKA N+LLD DMN KI+DFG F
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 91.3 bits (226), Expect = 6e-20
Identities = 30/194 (15%), Positives = 53/194 (27%), Gaps = 38/194 (19%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH-------- 495
LG+ + T G+ V +K++K EV+ L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 496 --------RNLVKLLGCCIQGEEK--------LLIYEFMPNKSLDSFIF------DQTRR 533
+LVK + L + P + F +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 534 TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
L R + R L LH ++H L+ +++LDQ ++ F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 594 GDETEGNTNRVVGT 607
G R
Sbjct: 262 GASAVSPIGRGFAP 275
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 9e-20
Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+ ++I LG+G FG V K + QE AVK ++K + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 496 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N++KL E+ Y E L I + R + D ++ + G+
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS---GI 134
Query: 553 LYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
Y+H+ I+HRDLK N+LL ++D + KI DFGL F + +GT
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 40/179 (22%), Positives = 66/179 (36%), Gaps = 19/179 (10%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ 494
+ +++ N +G G +G V A K++ K + + K E+ + L
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 495 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
H N+++L E+ IY E L + + D ++ +
Sbjct: 65 HPNIIRLYETF---EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS---A 118
Query: 552 LLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ Y H+ L + HRDLK N L D K+ DFGL F + VGT
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGT 171
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 41/191 (21%), Positives = 72/191 (37%), Gaps = 39/191 (20%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKN----EVILFS 491
D F + G+G FG V G G +A+K K+ + +N + +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---KVIQD--PRFRNRELQIMQDLA 74
Query: 492 KLQHRNLVKLLGC-CIQGEEKL------LIYEFMP---NKSLDSFIFDQTRRTLLDWSQR 541
L H N+V+L GE ++ E++P ++ ++ Q +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI----- 129
Query: 542 FHI------ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGLVRTFGG 594
I + R + LH S + + HRD+K NVL+++ K+ DFG +
Sbjct: 130 -LIKVFLFQLI---RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 595 DETEGNTNRVV 605
E N +
Sbjct: 185 SEP--NVAYIC 193
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 18/177 (10%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ 494
+D + LG+G FG V + GQE AVK +SK + + L EV L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H N++KL + + L+ E L I + R + +D ++ + G+
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS---GIT 140
Query: 554 YLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
Y+H+ +I+HRDLK N+LL +D N +I DFGL F + +GT
Sbjct: 141 YMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGT 191
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 45/200 (22%), Positives = 80/200 (40%), Gaps = 11/200 (5%)
Query: 402 RNIAEKTENSRETDQENEDQNIDLEL-PLFELATIANATDNFSINNKLGEGGFGPVYKGT 460
+ K + + D + ++I + P + D + I +LG G FG V++
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 461 -LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519
G+ K ++ +KNE+ + ++L H L+ L E +LI EF+
Sbjct: 72 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131
Query: 520 NKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578
L D + + + + C GL ++H+ I+H D+K N++ +
Sbjct: 132 GGELFDRIAAEDYKMSEAEVINYMRQACE---GLKHMHE---HSIVHLDIKPENIMCETK 185
Query: 579 MNP--KISDFGLVRTFGGDE 596
KI DFGL DE
Sbjct: 186 KASSVKIIDFGLATKLNPDE 205
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 3e-19
Identities = 48/218 (22%), Positives = 83/218 (38%), Gaps = 17/218 (7%)
Query: 398 RKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFS----INNKLGEGGF 453
R + K + T N D + + + D+ I+ +LG G F
Sbjct: 111 RGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAF 170
Query: 454 GPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512
G V++ T G A K + E + ++ E+ S L+H LV L E +
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 513 LIYEFMPNKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571
+IYEFM L + + + + + + +C GL ++H+ +H DLK
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK---GLCHMHE---NNYVHLDLKPE 284
Query: 572 NVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVGT 607
N++ + K+ DFGL + + GT
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGT 319
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 53/168 (31%), Positives = 73/168 (43%), Gaps = 20/168 (11%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
LGEG +G V V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 506 IQGEEKL-LIYEFMPNKSLDSFIFD---QTRRTLLDWSQRF--HIICGTARGLLYLHQDS 559
+ L E+ L FD +QRF ++ G YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ I HRD+K N+LLD+ N KISDFGL F + E N++ GT
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 41/215 (19%), Positives = 78/215 (36%), Gaps = 25/215 (11%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDG 464
+ + + + Q++ E L + A + + +G G V + G
Sbjct: 60 KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119
Query: 465 QEIAVKRLSK--------ISEQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIY 515
E AVK + E+ + + E IL H +++ L+ E ++
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---ESSSFMF 176
Query: 516 ---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572
+ M L ++ ++ + + + + +LH I+HRDLK N
Sbjct: 177 LVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE---AVSFLHA---NNIVHRDLKPEN 230
Query: 573 VLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+LLD +M ++SDFG E + GT
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGT 262
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 20/168 (11%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVILFS 491
+S + LG G FG V+ +E+ VK + K I + L ++ E+ + S
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 492 KLQHRNLVKLLGCCIQGEEKL-LIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFH-IICGT 548
+++H N++K+L + + L+ E + L +FI R S F ++
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
YL IIHRD+K N+++ +D K+ DFG +
Sbjct: 144 G----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK 184
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 21/178 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+ ++I LG+G FG V K + QE AVK ++K + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 496 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N++KL E+ Y E L I + R + D ++ + G+
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS---GI 134
Query: 553 LYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
Y+H+ I+HRDLK N+LL ++D + KI DFGL F + +GT
Sbjct: 135 TYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGT 186
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 53/168 (31%), Positives = 73/168 (43%), Gaps = 20/168 (11%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
LGEG +G V V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 506 IQGEEKL-LIYEFMPNKSLDSFIFD---QTRRTLLDWSQRF--HIICGTARGLLYLHQDS 559
+ L E+ L FD +QRF ++ G YLH
Sbjct: 74 RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ I HRD+K N+LLD+ N KISDFGL F + E N++ GT
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 9e-19
Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 14/155 (9%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LG G FG V G + G ++AVK L++ I + +K E+ +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH-IICGTARGLLYLHQDSRL 561
I ++ E++ L +I R ++ + F I+ Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCH---RH 130
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
++HRDLK NVLLD MN KI+DFGL E
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 46/184 (25%), Positives = 68/184 (36%), Gaps = 24/184 (13%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKL 493
D F KLG G FG V+ G E +K ++K Q E ++ E+ + L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 494 QHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRR----TLLDWSQRFHIIC 546
H N++K+ E+ +Y E L I R + ++ +
Sbjct: 78 DHPNIIKIFEVF---EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNR 603
L Y H ++H+DLK N+L KI DFGL F DE +
Sbjct: 135 N---ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STN 185
Query: 604 VVGT 607
GT
Sbjct: 186 AAGT 189
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 43/181 (23%), Positives = 72/181 (39%), Gaps = 22/181 (12%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVIL 489
D + ++ LG G G V +++A++ +SK ++ E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
KL H ++K+ E+ ++ E M L + R F+ +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-- 250
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ YLH+ IIHRDLK NVLL ++D KI+DFG + G + G
Sbjct: 251 -AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 303
Query: 607 T 607
T
Sbjct: 304 T 304
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVKRLS---KISEQGLKELKNEVILFSKLQHRNLV 499
I +KLG GG VY + ++A+K + + E+ LK + EV S+L H+N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 500 KLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
++ EE Y E++ +L +I L + G+ + H
Sbjct: 75 SMID---VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH 128
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+RI+HRD+K N+L+D + KI DFG+ + + + TN V+GT
Sbjct: 129 ---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGT 175
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 2e-18
Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 21/178 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+DN+ + +LG+G F V + G E A K ++ +S + ++L+ E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 496 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
N+V+L +E+ Y + + L I + + D S I +
Sbjct: 65 PNIVRLHDSI---QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---SI 118
Query: 553 LYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
Y H I+HR+LK N+LL + K++DFGL E + GT
Sbjct: 119 AYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 170
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 4e-18
Identities = 55/185 (29%), Positives = 78/185 (42%), Gaps = 34/185 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
D F LG GGFG V+ + ++ A K+L+K +G + E + +K+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMP---------NKSLDSFIFDQTRRTLLDWSQRF--- 542
R +V L + + L L+ M N D+ F + R F
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR-------AIFYTA 296
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
I+ G L +LHQ II+RDLK NVLLD D N +ISD GL +T+ T
Sbjct: 297 QIVSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TK 347
Query: 603 RVVGT 607
GT
Sbjct: 348 GYAGT 352
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 44/181 (24%), Positives = 71/181 (39%), Gaps = 22/181 (12%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--------ISEQGLKELKNEVIL 489
D + ++ LG G G V +++A+K +SK ++ E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
KL H ++K+ E+ ++ E M L + R F+ +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL-- 125
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
+ YLH IIHRDLK NVLL ++D KI+DFG + G + G
Sbjct: 126 -AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 178
Query: 607 T 607
T
Sbjct: 179 T 179
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 39/167 (23%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LGEG FG V T Q++A+K +S+ + + + ++ E+ L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFI---------FD---QTRRTLLDWSQRF--HIICGTA 549
Y+ + + D + FD + +R D +RF IIC
Sbjct: 75 -----------YDVITTPT-DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
Y H R +I+HRDLK N+LLD ++N KI+DFGL
Sbjct: 123 ----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 405 AEKTENSRETDQENEDQNIDLELP--LFELATI----ANATDNFSINNK--LGEGGFGPV 456
A+ TE + +D+ P F+ + ++++ LG G FG V
Sbjct: 46 ADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQV 105
Query: 457 YKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515
+K G ++A K + + +E+KNE+ + ++L H NL++L + +L+
Sbjct: 106 HKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM 165
Query: 516 EFMPNKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574
E++ L D I + T LD IC G+ ++HQ + I+H DLK N+L
Sbjct: 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMHQ---MYILHLDLKPENIL 219
Query: 575 L-DQDMNP-KISDFGLVRTFGGDET 597
++D KI DFGL R + E
Sbjct: 220 CVNRDAKQIKIIDFGLARRYKPREK 244
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 46/203 (22%), Positives = 83/203 (40%), Gaps = 51/203 (25%)
Query: 433 ATIANATDNFSINN-----KLGEGGFGPVYKGT-LVDGQEIAVKRLSK------------ 474
+ ++ D +N ++G+G +G V D A+K LSK
Sbjct: 1 GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRR 60
Query: 475 --------------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY---EF 517
++++ E+ + KL H N+VKL+ + + +Y E
Sbjct: 61 PPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFEL 119
Query: 518 MPNKSLDSFIFDQTRRTLL--DWSQRFH--IICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+ + + L D ++ + +I G + YLH +IIHRD+K SN+
Sbjct: 120 VNQGPV----MEVPTLKPLSEDQARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNL 168
Query: 574 LLDQDMNPKISDFGLVRTFGGDE 596
L+ +D + KI+DFG+ F G +
Sbjct: 169 LVGEDGHIKIADFGVSNEFKGSD 191
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 43/180 (23%), Positives = 68/180 (37%), Gaps = 20/180 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE---------LKNEV- 487
+N+ LG G V + +E AVK + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 488 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
IL H N+++L L+++ M L ++ ++ + + + +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ LH+ L I+HRDLK N+LLD DMN K++DFG E V GT
Sbjct: 136 ---VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGT 186
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 28/220 (12%)
Query: 406 EKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDG 464
+ + Q I + ++ +++ KLG G +G V
Sbjct: 2 HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 465 QEIAVKRLSK-------------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511
E A+K + K E+ +E+ NE+ L L H N++KL + ++
Sbjct: 62 SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF-EDKKY 120
Query: 512 L-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L+ EF L I ++ + D + I G+ YLH+ I+HRD+K
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS---GICYLHK---HNIVHRDIKP 174
Query: 571 SNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
N+LL + +N KI DFGL F D +GT
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGT 211
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 44/176 (25%), Positives = 70/176 (39%), Gaps = 20/176 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
F LG G F V+ + G+ A+K + K L+NE+ + K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 498 LVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
+V L E Y + + L I ++ T D S + + Y
Sbjct: 68 IVTLEDIY---ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS---AVKY 121
Query: 555 LHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
LH+ I+HRDLK N+L +++ I+DFGL + G + GT
Sbjct: 122 LHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGT 170
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 7e-18
Identities = 46/183 (25%), Positives = 76/183 (41%), Gaps = 20/183 (10%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK-----RLSKISEQGLKE-LKNEVI 488
+ D++ + +LG G F V K G+E A K RLS +E ++ EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ +++H N++ L + +LI E + L F+ ++ T + +Q I
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD- 119
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRV 604
G+ YLH RI H DLK N++L + K+ DFG+ +
Sbjct: 120 --GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNI 171
Query: 605 VGT 607
GT
Sbjct: 172 FGT 174
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 8e-18
Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 14/155 (9%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 503
LG G FG V G + G ++AVK L++ I + ++ E+ +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 504 CCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH-IICGTARGLLYLHQDSRL 561
I + ++ E++ L +I R + + F I+ G Y H R
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCH---RH 135
Query: 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
++HRDLK NVLLD MN KI+DFGL E
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 51/176 (28%), Positives = 74/176 (42%), Gaps = 19/176 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
+ F LG+GGFG V + ++ A K+L K +G NE + K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF---HIICGTARG 551
R +V L + ++ L L+ M L I+ + + F I CG
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG---- 298
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
L LH R RI++RDLK N+LLD + +ISD GL +T VGT
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 32/175 (18%), Positives = 68/175 (38%), Gaps = 29/175 (16%)
Query: 444 INNKLGEGGFGPVYKG--TLVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 500
+ + GG G +Y V+G+ + +K L + + E +++ H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 501 LLGCCIQGEE-----KLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+ E + Y E++ +SL +++ L ++ + L
Sbjct: 144 IFN---FVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPAL 195
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
YLH + +++ DLK N++L ++ K+ D G V + GT
Sbjct: 196 SYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGT 240
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 44/182 (24%), Positives = 68/182 (37%), Gaps = 21/182 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 492
D + + +G+G F V + GQ+ AVK + + ++LK E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLL----DWSQRFHIICGT 548
L+H ++V+LL +++EFM L I + + S I
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE- 141
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
L Y H IIHRD+K VLL + K+ FG+ G V
Sbjct: 142 --ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RV 194
Query: 606 GT 607
GT
Sbjct: 195 GT 196
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 44/174 (25%), Positives = 68/174 (39%), Gaps = 16/174 (9%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
TD + + +G G + + E AVK + K +E++ IL QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
++ L G+ ++ E M L I Q + + S I + YLH
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITK---TVEYLHA 134
Query: 558 DSRLRIIHRDLKASNVLL-DQDMNP---KISDFGLVRTFGGDETEGNTNRVVGT 607
++HRDLK SN+L D+ NP +I DFG + + T T
Sbjct: 135 ---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 33/175 (18%), Positives = 63/175 (36%), Gaps = 14/175 (8%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
+ + I LG G FG V++ + K + +K E+ + + +H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSL-DSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
RN++ L EE ++I+EF+ + + + H +C L +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE---ALQF 117
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDETEGNTNRVVGT 607
LH I H D++ N++ + KI +FG R + +
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTA 166
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 49/180 (27%), Positives = 74/180 (41%), Gaps = 17/180 (9%)
Query: 439 TDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-H 495
D + + LGEG V L+ QE AVK + K + EV + + Q H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
RN+++L+ + + L++E M S+ S I + L+ S + L +L
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS---ALDFL 127
Query: 556 HQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTF--GGDETEGNTNR---VVGT 607
H I HRDLK N+L +Q KI DF L GD + +T G+
Sbjct: 128 HN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 40/217 (18%), Positives = 70/217 (32%), Gaps = 52/217 (23%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK-----RLSKISEQGLKELKNEVILFSK 492
+ + +G+G +G V A+K ++ +I+ + ++ +K EV L K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 493 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF--------- 542
L H N+ +L + E+ + L+ E L + + +
Sbjct: 85 LHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 543 ----------------------------HIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574
+I+ L YLH I HRD+K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200
Query: 575 L--DQDMNPKISDFGLVRTFGGDETEGNT--NRVVGT 607
++ K+ DFGL + F GT
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 17/176 (9%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 495
+DN+ + +LG+G F V + G E A K ++ +S + ++L+ E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
N+V+L IQ E L+++ + L I + + D S I + Y
Sbjct: 88 PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE---SIAY 143
Query: 555 LHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
H I+HR+LK N+LL + K++DFGL E + GT
Sbjct: 144 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGT 193
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 45/182 (24%), Positives = 72/182 (39%), Gaps = 20/182 (10%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVIL 489
N D + +LG G F V K G + A K + K ++++ EV +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
++QH N++ L + +LI E + L F+ ++ T + ++ I
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN-- 125
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G+ YLH L+I H DLK N++L KI DFGL +
Sbjct: 126 -GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 606 GT 607
GT
Sbjct: 179 GT 180
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 44/183 (24%), Positives = 69/183 (37%), Gaps = 20/183 (10%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVI 488
D + I +LG G F V K G E A K + K +E++ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ ++ H N++ L + +LI E + L F+ + + + + I
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD- 126
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTFGGDETEGNTNRV 604
G+ YLH +I H DLK N++L P K+ DFGL +
Sbjct: 127 --GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNI 178
Query: 605 VGT 607
GT
Sbjct: 179 FGT 181
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 42/176 (23%), Positives = 82/176 (46%), Gaps = 23/176 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
D + I + +G G +G V + ++ + +A+K++ ++ E L+E+ + +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA----ILN 107
Query: 492 KLQHRNLVKLLGCCIQGEEKL-----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+L H ++VK+L I + + ++ E +T L + + ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF--RTPVYLTELHIKT-LLY 163
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
G+ Y+H S I+HRDLK +N L++QD + K+ DFGL RT E +
Sbjct: 164 NLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 43/183 (23%), Positives = 69/183 (37%), Gaps = 20/183 (10%)
Query: 436 ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKIS------EQGLKELKNEVI 488
D + I +LG G F V K G E A K + K +E++ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ ++ H N++ L + +LI E + L F+ + + + + I
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD- 126
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVRTFGGDETEGNTNRV 604
G+ YLH +I H DLK N++L + K+ DFGL +
Sbjct: 127 --GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNI 178
Query: 605 VGT 607
GT
Sbjct: 179 FGT 181
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 41/161 (25%), Positives = 65/161 (40%), Gaps = 19/161 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEVILFSK 492
+ + LG GGFG VY G + D +A+K + K + EV+L K
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 493 LQHR--NLVKLLGCCIQGEEKL-LIYEF-MPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ +++LL + + LI E P + L FI T R L
Sbjct: 103 VSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQV 158
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGL 588
+ + H ++HRD+K N+L+D + K+ DFG
Sbjct: 159 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS 196
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 46/187 (24%), Positives = 83/187 (44%), Gaps = 22/187 (11%)
Query: 432 LATI--ANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNE 486
+ATI T+ + + +LG+G F V + ++ GQE A ++ +S + ++L+ E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFH 543
+ L+H N+V+L E+ Y + + L I + + D S
Sbjct: 61 ARICRLLKHPNIVRLHDSI---SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ 117
Query: 544 IICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGN 600
I +L+ HQ + ++HR+LK N+LL + K++DFGL G++
Sbjct: 118 QILE---AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 601 TNRVVGT 607
GT
Sbjct: 172 G--FAGT 176
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 6e-17
Identities = 41/176 (23%), Positives = 79/176 (44%), Gaps = 23/176 (13%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ- 494
D++ + KLG G + V++ + + +++ VK L + + K++K E+ + L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRG 89
Query: 495 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTAR 550
N++ L + L++E + N +TL D+ RF++ I +
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEIL---K 141
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDETEGNTNRVV 605
L Y H S I+HRD+K NV++D + ++ D+GL + RV
Sbjct: 142 ALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVA 192
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 401 RRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT 460
R ++ +K S + + + +N++L + L ++FS++ +G GGFG VY
Sbjct: 158 RGDVFQKFIESDKFTRFCQWKNVELNIHL--------TMNDFSVHRIIGRGGFGEVYGCR 209
Query: 461 LVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKL- 512
D ++ A+K L K +QG NE I+ S + +V + +KL
Sbjct: 210 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLS 268
Query: 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLK 569
I + M L + + RF+ II G L ++H +++RDLK
Sbjct: 269 FILDLMNGGDLHYHL--SQHGVFSEADMRFYAAEIILG----LEHMHN---RFVVYRDLK 319
Query: 570 ASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+N+LLD+ + +ISD GL F + VGT
Sbjct: 320 PANILLDEHGHVRISDLGLACDFSKKKPHA----SVGT 353
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 48/202 (23%), Positives = 78/202 (38%), Gaps = 19/202 (9%)
Query: 416 QENEDQNIDLELPLFELATIANATDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLS 473
+ +DL ++ N + + + +K LG G F V + GQE A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 474 K--ISEQGLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQ 530
K + E+ +E+ + + ++ L E +LI E+ + S +
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE 123
Query: 531 TRRTL--LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISD 585
+ D + I G+ YLHQ I+H DLK N+LL + KI D
Sbjct: 124 LAEMVSENDVIRLIKQILE---GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 586 FGLVRTFGGDETEGNTNRVVGT 607
FG+ R G ++GT
Sbjct: 178 FGMSRKIGHACE---LREIMGT 196
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 39/167 (23%), Positives = 71/167 (42%), Gaps = 29/167 (17%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK------ISEQGLKELKNEV----I 488
+ + LG+GGFG V+ G L D ++A+K + + EV
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEF-MPNKSLDSFIFDQTRRTLL--DWSQRF-- 542
+ + H +++LL + +E L+ E +P + L +I T + L S+ F
Sbjct: 91 VGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGPSRCFFG 146
Query: 543 HIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP-KISDFGL 588
++ + + H ++HRD+K N+L+D K+ DFG
Sbjct: 147 QVVAA----IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGS 186
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 21/176 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 497
+D F + ++LG G VY+ + A+K L K ++ K ++ E+ + +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 498 LVKLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
++KL E I E + L I ++ + D + I + Y
Sbjct: 110 IIKLKEIF---ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE---AVAY 163
Query: 555 LHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
LH+ I+HRDLK N+L D KI+DFGL + V GT
Sbjct: 164 LHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGT 213
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 39/171 (22%), Positives = 67/171 (39%), Gaps = 17/171 (9%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLV 499
+ +G GG G VY+ V + +A+K +S+ S+ + ++ E +LQ ++V
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 500 KLLGCCIQGEEKLLIY---EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
+ GE +Y + L + + R+ L + I+ L H
Sbjct: 98 PIHD---FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
HRD+K N+L+ D + DFG+ DE VGT
Sbjct: 152 AA---GATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGT 198
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 38/177 (21%), Positives = 72/177 (40%), Gaps = 23/177 (12%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVK----RLSKISEQGLKELKNEVILFSKLQHRNL 498
+ LG GG V+ L D +++AVK L++ + E + L H +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAI 74
Query: 499 VKLLGCCIQGEEKL-------LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
V + GE + ++ E++ +L + + + + +I +
Sbjct: 75 VAVYD---TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQA 128
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE-TEGNTNRVVGT 607
L + H + IIHRD+K +N+++ K+ DFG+ R + T V+GT
Sbjct: 129 LNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 40/213 (18%), Positives = 82/213 (38%), Gaps = 57/213 (26%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
++ +S+ LG G FG V + ++ G+ A+K++ + +EL + L H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDH 59
Query: 496 RNLVKLLGCCIQGEEKL--------------------------------------LIYEF 517
N++KL+ ++ +I E+
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 518 MPNKSLDSFI--FDQTRRTLLDWSQRFHI--ICGTARGLLYLHQDSRLRIIHRDLKASNV 573
+P +L + F ++ R++ +I + R + ++H L I HRD+K N+
Sbjct: 120 VP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF---RAVGFIHS---LGICHRDIKPQNL 172
Query: 574 LLDQDMNP-KISDFGLVRTFGGDETEGNTNRVV 605
L++ N K+ DFG + +E + +
Sbjct: 173 LVNSKDNTLKLCDFGSAKKL--IPSEPSVAYIC 203
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 42/185 (22%), Positives = 72/185 (38%), Gaps = 35/185 (18%)
Query: 439 TDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQH 495
TD++ ++ + LG G G V + GQ+ A+K L + + EV +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGG 81
Query: 496 RNLVKLLGCC---IQGEEKL-LIYEFMPNKSLDSFIFDQ-TRRTLLDWSQR-----FHII 545
++V +L G+ L +I E M L F + R +++R I
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDI 137
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTN 602
+ +LH I HRD+K N+L ++D K++DFG + T+
Sbjct: 138 GT---AIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQ 187
Query: 603 RVVGT 607
T
Sbjct: 188 TPCYT 192
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 40/173 (23%), Positives = 71/173 (41%), Gaps = 26/173 (15%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G +G V G+++A+K+LS+ + +EL L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLK 78
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+QH N++ LL + L+ FM L + + ++ ++
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQY-LV 132
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+GL Y+H ++HRDLK N+ +++D KI DFGL R + T
Sbjct: 133 YQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 24/159 (15%)
Query: 448 LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 505
+G G FG + + +AVK + + + E ++ E+I L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEV- 84
Query: 506 IQGEEKL-LIYEFMPNKSLDSFIFD---QTRRTLLDWSQRF--HIICGTARGLLYLHQDS 559
I L +I E+ L ++ R D ++ F ++ G + Y H
Sbjct: 85 ILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH--- 133
Query: 560 RLRIIHRDLKASNVLLDQD--MNPKISDFGLVRTFGGDE 596
++I HRDLK N LLD KI DFG ++
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 40/166 (24%), Positives = 62/166 (37%), Gaps = 16/166 (9%)
Query: 447 KLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGC 504
LGEG F K Q AVK +SK + + E+ + H N+VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRII 564
L+ E + L I + + + S + + ++H + ++
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS---AVSHMHD---VGVV 128
Query: 565 HRDLKASNVLL---DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
HRDLK N+L + ++ KI DFG R D T T
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFT 172
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 75.3 bits (184), Expect = 6e-15
Identities = 35/202 (17%), Positives = 62/202 (30%), Gaps = 52/202 (25%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRL--------SKISEQGLKELKNEVIL 489
T+ K+GEG FG V++ D +A+K + + ++ +E+ E+I+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 490 FSKLQ---------HRNLVKLLGCCI-----------------------------QGEEK 511
+L + L +++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571
L I +D +Q R L + I+ L LR HRDL
Sbjct: 137 LFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWG 191
Query: 572 NVLLDQDMNPKISDFGLVRTFG 593
NVLL + K+ ++
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSST 213
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 56/217 (25%), Positives = 86/217 (39%), Gaps = 34/217 (15%)
Query: 405 AEKTENSRETDQENEDQNIDLELPLFELATIANAT-DNFSINNKLGEGGFGPVYKGTLVD 463
A K + +E+ +E + + L +E + A D F LG G FG V +
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 464 GQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFM 518
A+K L K LK++ NE + + LVKL + L ++ E++
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMVMEYV 123
Query: 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR--------GLLYLHQDSRLRIIHRDLKA 570
+ F RR RF AR YLH L +I+RDLK
Sbjct: 124 AGGEM----FSHLRR-----IGRFSE--PHARFYAAQIVLTFEYLHS---LDLIYRDLKP 169
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
N+L+DQ +++DFG + +G T + GT
Sbjct: 170 ENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 27/179 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
D+F I +G+G FG V D +++ A+K ++K + ++ + E+ + L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI------ICGT 548
LV L Q EE + ++ + + L R L + F IC
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDL---------RYHLQQNVHFKEETVKLFICEL 124
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
L YL RIIHRD+K N+LLD+ + I+DF + + + GT
Sbjct: 125 VMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 45/217 (20%), Positives = 88/217 (40%), Gaps = 32/217 (14%)
Query: 399 KRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYK 458
+R +NI E E ++ + + + ++F I +G G FG V
Sbjct: 47 RREKNILEYLEWAKPFTSKVKQMRLHR--------------EDFEILKVIGRGAFGEVAV 92
Query: 459 GTLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQHRNLVKLLGCCIQGEEKL-L 513
L + ++ A+K L+K E + E + + + L Q + L L
Sbjct: 93 VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYL 151
Query: 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLKA 570
+ ++ L + + R + + RF+ ++ + +HQ L +HRD+K
Sbjct: 152 VMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAEMVIA----IDSVHQ---LHYVHRDIKP 203
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
N+L+D + + +++DFG D T ++ VGT
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGT 239
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 36/176 (20%), Positives = 67/176 (38%), Gaps = 30/176 (17%)
Query: 428 PLFELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNE 486
++ A D + LG G G V + ++ A+K L + + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60
Query: 487 V-ILFSKLQHRNLVKLLGCC---IQGEEKL-LIYEFMPNKSLDSFIFDQ-TRRTLLDWSQ 540
V + + Q ++V+++ G + L ++ E + L F + R +++
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTE 116
Query: 541 R-----FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGL 588
R I + YLH + I HRD+K N+L + K++DFG
Sbjct: 117 REASEIMKSIGEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 35/175 (20%), Positives = 70/175 (40%), Gaps = 31/175 (17%)
Query: 439 TDNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQH 495
D++ + ++ LG G G V + ++ A+K L + + EV + + Q
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQC 114
Query: 496 RNLVKLLGCC---IQGEEKL-LIYEFMPNKSLDSFIFDQ-TRRTLLDWSQR-----FHII 545
++V+++ G + L ++ E + L F + R +++R I
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSI 170
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFGGDET 597
+ YLH + I HRD+K N+L + K++DFG + +
Sbjct: 171 GEA---IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 23/177 (12%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
DN+ I + +G G +G VY + +A+K+++++ E L+E+ + +
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT----ILN 80
Query: 492 KLQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
+L+ +++L I K ++ E L +T L + + I+
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF--KTPIFLTEEHIKT-ILY 136
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
G ++H IIHRDLK +N LL+QD + K+ DFGL RT ++ N
Sbjct: 137 NLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 46/220 (20%), Positives = 86/220 (39%), Gaps = 38/220 (17%)
Query: 399 KRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVY- 457
+ + +A+ + + ++ + D+F I +G G F V
Sbjct: 34 AQDKYVADFLQWAEPIVVRLKEVRLQR--------------DDFEILKVIGRGAFSEVAV 79
Query: 458 ---KGTLVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511
K T GQ A+K ++K + + + E + R + +L Q E
Sbjct: 80 VKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENY 135
Query: 512 L-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRD 567
L L+ E+ L + + R + + RF+ I+ + +H+ L +HRD
Sbjct: 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA----IDSVHR---LGYVHRD 187
Query: 568 LKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+K N+LLD+ + +++DFG D T + VGT
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGT 226
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 39/178 (21%), Positives = 68/178 (38%), Gaps = 30/178 (16%)
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQG---------------LKEL 483
+++ + G +G V G +G +A+KR+ G L+E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 484 KNEVILFSKLQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDW 538
+ L + H N++ L + E + L+ E M L I +R ++
Sbjct: 81 R----LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISP 133
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
+ + GL LH+ ++HRDL N+LL + + I DF L R D
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 46/180 (25%), Positives = 73/180 (40%), Gaps = 28/180 (15%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G G V V + +A+K+LS+ + +EL L
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMK 116
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+ H+N++ LL + ++ L+ E M L I + L + ++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI----QMELDHERMSY-LL 170
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G+ +LH IIHRDLK SN+++ D KI DFGL RT + T VV
Sbjct: 171 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV 225
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 44/180 (24%), Positives = 78/180 (43%), Gaps = 25/180 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSK 492
++ + +GEG +G V ++ +A+K++S Q L+E+K + +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 493 LQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
+H N++ + E++ ++ + M L + Q L + + +
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICY-FLYQ 136
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN--TNRVV 605
RGL Y+H S ++HRDLK SN+LL+ + KI DFGL R D T V
Sbjct: 137 ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 20/159 (12%)
Query: 440 DNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSK--ISEQGLKELKNEVILFSKL 493
F + LG+G FG V+ K + D +++ A+K L K + + K E + ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 494 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTA 549
H +VKL Q E KL LI +F+ L F + +F+ +
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALA-- 138
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
L +LH L II+RDLK N+LLD++ + K++DFGL
Sbjct: 139 --LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL 172
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 32/164 (19%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 495
+F I LG G FG V+ A+K L K LK++ +E ++ S + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH----------I 544
++++ G Q +++ +I +++ L F R+ SQRF +
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGEL----FSLLRK-----SQRFPNPVAKFYAAEV 115
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
L YLH II+RDLK N+LLD++ + KI+DFG
Sbjct: 116 CLA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGF 152
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 41/173 (23%), Positives = 70/173 (40%), Gaps = 25/173 (14%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G +G V G ++A+K+L + + +EL+ L
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLK 79
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
++H N++ LL + L+ FM L + + L + ++
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLV 134
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+GL Y+H IIHRDLK N+ +++D KI DFGL R + T
Sbjct: 135 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 184
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 44/198 (22%), Positives = 75/198 (37%), Gaps = 17/198 (8%)
Query: 402 RNIAEKTENSRETDQENEDQNIDLELPLFELATIANAT------DNFSINNKLGEGGFGP 455
+ +A+ + + + + E+ + F LG+G FG
Sbjct: 104 QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGK 163
Query: 456 VYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511
V A+K L K +++ + E + +H L L Q ++
Sbjct: 164 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDR 222
Query: 512 L-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKA 570
L + E+ L F R + RF+ L YLH S +++RDLK
Sbjct: 223 LCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDYLH--SEKNVVYRDLKL 277
Query: 571 SNVLLDQDMNPKISDFGL 588
N++LD+D + KI+DFGL
Sbjct: 278 ENLMLDKDGHIKITDFGL 295
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 45/217 (20%), Positives = 83/217 (38%), Gaps = 34/217 (15%)
Query: 399 KRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYK 458
++ +NI ++T + D + +++ + +G G FG V
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKA--------------EDYEVVKVIGRGAFGEVQL 87
Query: 459 GTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL-L 513
+++ A+K LSK I E + + +V+L Q + L +
Sbjct: 88 VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYM 146
Query: 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLKA 570
+ E+MP L W+ RF+ ++ L +H + IHRD+K
Sbjct: 147 VMEYMPGGDL--VNLMSNYDVPEKWA-RFYTAEVVLA----LDAIHS---MGFIHRDVKP 196
Query: 571 SNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
N+LLD+ + K++DFG + + VGT
Sbjct: 197 DNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGT 232
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 44/180 (24%), Positives = 74/180 (41%), Gaps = 28/180 (15%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ +G G G V + + +A+K+LS+ + +EL L
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMK 79
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
+ H+N++ LL + ++ ++ E M +L I + L + ++
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSY-LL 133
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
G+ +LH IIHRDLK SN+++ D KI DFGL RT + T VV
Sbjct: 134 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV 188
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 49/205 (23%), Positives = 74/205 (36%), Gaps = 41/205 (20%)
Query: 404 IAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVD 463
I++ E ++ L + +F +G+G FG V
Sbjct: 2 ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKA 61
Query: 464 GQEI-AVKRLSK--ISEQGLKELKNEV--------ILFSKLQHRNLVKLLGCCIQGEEKL 512
+ AVK L K I + K E +L ++H LV L Q +KL
Sbjct: 62 EEVFYAVKVLQKKAILK------KKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKL 114
Query: 513 -LIYEFMPNKSL-----DSFIFDQTRRTLLDWSQRF---HIICGTARGLLYLHQDSRLRI 563
+ +++ L F + R RF I L YLH L I
Sbjct: 115 YFVLDYINGGELFYHLQRERCFLEPR-------ARFYAAEIASA----LGYLHS---LNI 160
Query: 564 IHRDLKASNVLLDQDMNPKISDFGL 588
++RDLK N+LLD + ++DFGL
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGL 185
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 12/154 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LG+G FG V A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 496 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
L L Q ++L + E+ L F R + RF+ L Y
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEY 120
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
LH +++RD+K N++LD+D + KI+DFGL
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGL 151
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 48/173 (27%), Positives = 77/173 (44%), Gaps = 25/173 (14%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ + + +G G +G V G +AVK+LS+ + +EL+ L
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLK 83
Query: 492 KLQHRNLVKLL------GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHII 545
++H N++ LL + + L+ M L++ + Q L D +F +I
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQK---LTDDHVQF-LI 138
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
RGL Y+H IIHRDLK SN+ +++D KI DFGL R + T
Sbjct: 139 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 71.2 bits (174), Expect = 5e-13
Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 13/155 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 494
+F+ LG+G FG V E+ AVK L K I + ++ E +L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
L +L C Q ++L + E++ L + Q R + F+ A GL
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHA-VFYAAE-IAIGLF 456
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+L II+RDLK NV+LD + + KI+DFG+
Sbjct: 457 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM 488
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 31/164 (18%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK--ISEQGLKELKNEV--------I 488
+F+ LG+G FG V E+ AVK L K + + ++V +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ------DDDVECTMVEKRV 73
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---I 544
L + L +L C Q ++L + E++ L + Q R + F+ I
Sbjct: 74 LALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHA-VFYAAEI 130
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
G L +L II+RDLK NV+LD + + KI+DFG+
Sbjct: 131 AIG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM 167
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 9e-13
Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 22/161 (13%)
Query: 440 DNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSK---ISEQGLKE-LKNEVILFS 491
+ F + LG+GG+G V+ K T + +I A+K L K + K E +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 492 KLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRF---HIICG 547
+++H +V L+ Q KL LI E++ L F+ + ++ + F I
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMA 133
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
L +LHQ II+RDLK N++L+ + K++DFGL
Sbjct: 134 ----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL 167
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 13/155 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 494
++F ++ LG+G FG V+ + A+K L K + + ++ E +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H L + C Q +E L + E++ L Q+ F+ GL
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAE-IILGLQ 132
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
+LH I++RDLK N+LLD+D + KI+DFG+
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGM 164
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 494
+F + +G G + V L I A+K + K ++ + ++ E +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 495 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTAR 550
H LV L C Q E +L + E++ L Q +R L + RF+ I
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--- 122
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
L YLH+ II+RDLK NVLLD + + K++D+G+
Sbjct: 123 -LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM 156
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 47/195 (24%), Positives = 80/195 (41%), Gaps = 23/195 (11%)
Query: 403 NIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGTLV 462
N+ + ++E E N + +F + +G G + V L
Sbjct: 19 NLYFQGAMGSGIEEEKEAMNTRESGKASSSLGL----QDFDLLRVIGRGSYAKVLLVRLK 74
Query: 463 DGQEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQHRNLVKLLGCCIQGEEKL-LIYE 516
I A++ + K ++ + ++ E + H LV L C Q E +L + E
Sbjct: 75 KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIE 133
Query: 517 FMPNKSLDSFIFDQTRRTLLDWSQRFH---IICGTARGLLYLHQDSRLRIIHRDLKASNV 573
++ L Q +R L + RF+ I L YLH+ II+RDLK NV
Sbjct: 134 YVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA----LNYLHE---RGIIYRDLKLDNV 184
Query: 574 LLDQDMNPKISDFGL 588
LLD + + K++D+G+
Sbjct: 185 LLDSEGHIKLTDYGM 199
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 51/161 (31%), Positives = 76/161 (47%), Gaps = 25/161 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEI-AVKRLSK--ISEQGLKELKNEV--------I 488
DNF LG+G FG V + + ++ AVK L K I + ++V I
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ------DDDVECTMTEKRI 76
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
L H L +L CC Q ++L + EF+ L F ++RR + RF+
Sbjct: 77 LSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARA-RFYAAE- 132
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588
L++LH II+RDLK NVLLD + + K++DFG+
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGM 170
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 23/175 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-----LKELKNEVILFSK 492
+ +F + + LGEG +G V T G+ +A+K++ + L+E+K +
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK----ILKH 65
Query: 493 LQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
+H N++ + E +I E M L I Q L D ++ I
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQM---LSDDHIQY-FIYQ 120
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
T R + LH + +IHRDLK SN+L++ + + K+ DFGL R + +
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 44/188 (23%), Positives = 79/188 (42%), Gaps = 32/188 (17%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN---EVILFSKLQ 494
+ LG GG G V+ + +A+K KI + +K+ E+ + +L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLD 66
Query: 495 HRNLVKLL----------GCCIQGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540
H N+VK+ + +L ++ E+M L + + LL+
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGP---LLEEHA 122
Query: 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDETEG 599
R + RGL Y+H + ++HRDLK +N+ ++ +D+ KI DFGL R +
Sbjct: 123 RL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 600 N--TNRVV 605
+ +V
Sbjct: 179 GHLSEGLV 186
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 34/162 (20%), Positives = 61/162 (37%), Gaps = 19/162 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRL-SKISEQGLKELKNEVILFSK 492
D + LG G FG V + + +AVK L + + L +E+ +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 493 L-QHRNLVKLLGCCIQ-GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
+ H N+V LLG C + G ++I EF +L +++ S+R + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592
G + + I DLK + + S F ++
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 27/87 (31%), Positives = 38/87 (43%), Gaps = 9/87 (10%)
Query: 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563
EEK L D + T L+ +S + A+G+ +L + +
Sbjct: 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ------VAKGMEFL---ASRKC 214
Query: 564 IHRDLKASNVLLDQDMNPKISDFGLVR 590
IHRDL A N+LL + KI DFGL R
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG------LKELKNEVILFS 491
+ + KLG+G +G V+K G+ +AVK++ + +E+ IL
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM---ILTE 64
Query: 492 KLQHRNLVKLLGCCI--QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
H N+V LL + L++++M L + I L +++ ++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANI---LEPVHKQY-VVYQLI 119
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
+ + YLH S ++HRD+K SN+LL+ + + K++DFGL R+F N
Sbjct: 120 KVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 24/181 (13%)
Query: 440 DNFSINNKLGEGGFGPVY---KGTLVDGQEI-AVKRLSK---ISEQGLKE-LKNE-VILF 490
+NF + LG G +G V+ K + D ++ A+K L K + + E + E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 491 SKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFH---IIC 546
Q LV L Q E KL LI +++ L F R + + + I+
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVL 170
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
L +LH+ L II+RD+K N+LLD + + ++DFGL + F DETE G
Sbjct: 171 A----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCG 222
Query: 607 T 607
T
Sbjct: 223 T 223
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 37/162 (22%), Positives = 71/162 (43%), Gaps = 21/162 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 497
+ + + K+G G FG +Y GT + G+E+A+K ++ L E ++ +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL---- 553
+ + C +G+ +++ E + SL+ +F+ R + A ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLED-LFNFCSRKF-----SLKTVLLLADQMISRIE 119
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLVRTF 592
Y+H + IHRD+K N L+ I DFGL + +
Sbjct: 120 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 17/148 (11%), Positives = 45/148 (30%), Gaps = 12/148 (8%)
Query: 447 KLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHRNLVKLL 502
G ++ +++A+ + + + L+E + + S++ + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 503 GCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562
L++ E++ SL T + A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 563 IIHRDLKASNVLLDQDMNPKISDFGLVR 590
+ S V + D + ++ +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 37/162 (22%), Positives = 72/162 (44%), Gaps = 21/162 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ F + K+G G FG +Y GT + +E+A+K + ++ L E ++ LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTG 64
Query: 499 V-KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL---- 553
+ + ++G+ +L+ + + SL+ +F+ R L + A ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKL-----SLKTVLMLADQMINRVE 117
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPK---ISDFGLVRTF 592
++H S +HRD+K N L+ I DFGL + +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 35/166 (21%), Positives = 80/166 (48%), Gaps = 27/166 (16%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RN 497
++ + ++GEG FG +++GT L++ Q++A+K + S+ L++E + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTG 67
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLL-- 553
+ + +G +L+ + + SL+ + D R +F + + A+ +L
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCGR-------KFSVKTVAMAAKQMLAR 118
Query: 554 --YLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLVRTF 592
+H+ S +++RD+K N L+ + + + DFG+V+ +
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 4e-08
Identities = 16/84 (19%), Positives = 29/84 (34%), Gaps = 9/84 (10%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y VW +N ++ GN V+ +W+++ + VL L +
Sbjct: 34 YDHSTSVWASNTGILGKKGC-KAVLQSDGNFVVYDAEGRSLWASHSVRG-NGNYVLVLQE 91
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
GN+V+ W + Y
Sbjct: 92 DGNVVIYGSD-------IWSTGTY 108
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 2e-04
Identities = 13/68 (19%), Positives = 23/68 (33%), Gaps = 5/68 (7%)
Query: 25 NPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGD 84
++ ++ + NLVL + VW++ + L GN V+ D
Sbjct: 14 QSLDVEPYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEG-- 70
Query: 85 SETYFWQS 92
W S
Sbjct: 71 --RSLWAS 76
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 38/165 (23%), Positives = 68/165 (41%), Gaps = 27/165 (16%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNL 498
NF + K+G G FG + G L + +A+K S +L E + +L +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGI 67
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHI--ICGTARGLL--- 553
++ G+ ++ E + SL+ +FD R F + + A L+
Sbjct: 68 PQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDR-------TFSLKTVLMIAIQLISRM 118
Query: 554 -YLHQDSRLRIIHRDLKASNVLLDQDMNPK-----ISDFGLVRTF 592
Y+H + +I+RD+K N L+ + N I DF L + +
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 42/171 (24%), Positives = 66/171 (38%), Gaps = 39/171 (22%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQ 494
D + I++ +G+G FG V K V+ + +A+K Q E++ +L +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR---LL-ELMN 108
Query: 495 HR------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTRRTLLDW 538
+V L C+ E +L +Y+ + N + + TR+
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRNTNFRGVSLNLTRKFA--- 163
Query: 539 SQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFG 587
Q LL+L L IIH DLK N+LL KI DFG
Sbjct: 164 QQMC-------TALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 32/181 (17%), Positives = 63/181 (34%), Gaps = 41/181 (22%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLS--KISEQGLKELKNEVILFSKLQHRNL 498
+ + +G+GGFG +Y + + + K+ L E+ + +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 499 V---------------KLLGCCIQGEEKLLIYEFMP----NKSLDSFIFDQTRRTLLDWS 539
+ K G + + Y FM L I++ +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKS-YRFMIMDRFGSDLQK-IYEANAK------ 147
Query: 540 QRFHI--ICGTARGLL----YLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLVRT 591
RF + + +L Y+H+ +H D+KASN+LL+ ++ D+GL
Sbjct: 148 -RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
Query: 592 F 592
+
Sbjct: 204 Y 204
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 42/168 (25%), Positives = 65/168 (38%), Gaps = 41/168 (24%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELKNEVILFSKLQHR- 496
+ + +G+G FG V K Q +A+K + + Q +E++ IL L+ +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR---IL-EHLRKQD 154
Query: 497 -----NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTRRTLLDWSQR 541
N++ +L C+ E LL +YE + F R
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPLVR--------- 203
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP--KISDFG 587
+ L LH + RIIH DLK N+LL Q K+ DFG
Sbjct: 204 -KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 34/184 (18%), Positives = 67/184 (36%), Gaps = 40/184 (21%)
Query: 441 NFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + K+G GGFG +Y ++ A + K+ Q L +E+ + ++ ++ +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 500 ---------KLLG-----CCIQGEEKLLIYEFMP----NKSLDSFIFDQTRRTLLDWSQR 541
LG E K Y FM L + +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK---------ISGQNGT 147
Query: 542 FHI--ICGTARGLL----YLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLVRTFG 593
F + +L Y+H++ +H D+KA+N+LL ++ +D+GL +
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204
Query: 594 GDET 597
+
Sbjct: 205 PNGN 208
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 4e-07
Identities = 20/81 (24%), Positives = 32/81 (39%), Gaps = 10/81 (12%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + VW +N + L + GNLV+ QSN V+W + + + VL L
Sbjct: 35 YDSGKPVWASNTGGLGSGCRLTL--HNNGNLVIYDQSNRVIWQTKTNGK-EDHYVLVLQQ 91
Query: 72 SGNLVLRDEHDGDSETYFWQS 92
N+V+ W +
Sbjct: 92 DRNVVIYG-------PVVWAT 105
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 39/170 (22%), Positives = 74/170 (43%), Gaps = 35/170 (20%)
Query: 444 INNKLGEGGFGPVYKGT-LVDGQEIAVKRL---SKISEQGLKELK-------NEVILFSK 492
+ KLG G F V+ +V+ +A+K + +E E+K +
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 493 LQHRNLVKLLGC-CIQGEEKL---LIYEFMPNKSLDSFIFDQTRRTL-LDWSQRFHIICG 547
+ +++KLL +G + +++E + ++L + I R + L + ++
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI----- 136
Query: 548 TAR----GLLYLHQDSRLRIIHRDLKASNVLLDQDMNP------KISDFG 587
++ GL Y+H R IIH D+K NVL++ +P KI+D G
Sbjct: 137 -SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-06
Identities = 17/81 (20%), Positives = 25/81 (30%), Gaps = 10/81 (12%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y +W +N S L + GNLV+ +N VW + + L L
Sbjct: 35 YQNGRQIWASNTDR--RGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGD-NGKYALVLQK 91
Query: 72 SGNLVLRDEHDGDSETYFWQS 92
G V+ W
Sbjct: 92 DGRFVIYG-------PVLWSL 105
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-06
Identities = 15/66 (22%), Positives = 28/66 (42%), Gaps = 3/66 (4%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N N ++ G LV+ + N+ VW + ++ + VL L
Sbjct: 45 YDNNNPIWATNTGGLGNGCR--AVLQPDGVLVVITNENVTVWQSPVAGK-AGHYVLVLQP 101
Query: 72 SGNLVL 77
N+V+
Sbjct: 102 DRNVVI 107
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 3e-04
Identities = 19/92 (20%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 2 MLADKEPNKSYPPHEVVWVANRLNPINDSFGFLMINKT-GNLVLTSQSNIVVWSAYLSKE 60
++ K+P+ ++P +++ L + + + I +T NLVL +N +W+ +
Sbjct: 3 IIFSKQPDDNHP--QILHATESLEILFGTHVYRFIMQTDCNLVLY-DNNNPIWATN-TGG 58
Query: 61 VQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92
+ L G LV+ + WQS
Sbjct: 59 LGNGCRAVLQPDGVLVVITNEN----VTVWQS 86
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 27/178 (15%), Positives = 63/178 (35%), Gaps = 35/178 (19%)
Query: 441 NFSINNKLGEGGFGPVYKGT---------LVDGQEIAVKRLSKISEQGLKELK------- 484
+ + + G +Y+ Q+ ++K L + E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAK 101
Query: 485 -NEVILFSKLQHRNLV---KLLGCCIQGEEKLLIYEFMP----NKSLDSFIFDQTRRTLL 536
+V + KL L+ +G + ++ Y F+ +SL S D + + +L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQS-ALDVSPKHVL 156
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI--SDFGLVRTF 592
+ C L +LH++ +H ++ A N+ +D + ++ + +G +
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 42/184 (22%), Positives = 66/184 (35%), Gaps = 44/184 (23%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQHR- 496
F + K+G+G FG V + + + AVK + K + E IL K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD---IL-KKIQNDD 92
Query: 497 ----NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTR---RTLLDWS 539
N+VK G C+ E L +YE + + + F + + +L
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHIEDIKLYCIEIL--- 147
Query: 540 QRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG 599
+ L YL ++ + H DLK N+LLD K T G
Sbjct: 148 ----------KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 600 NTNR 603
T
Sbjct: 195 RTKS 198
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 5e-06
Identities = 17/81 (20%), Positives = 30/81 (37%), Gaps = 8/81 (9%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + VW + + L + GNLV+ S S +W++ + L L
Sbjct: 34 YDNNRAVWASGTNGKASGCV--LKMQNDGNLVIYSGSR-AIWASN-TNRQNGNYYLILQR 89
Query: 72 SGNLVLRDEHDGDSETYFWQS 92
N+V+ D + W +
Sbjct: 90 DRNVVIYDNSN----NAIWAT 106
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 38/174 (21%), Positives = 62/174 (35%), Gaps = 46/174 (26%)
Query: 442 FSINNKLGEGGFGPVYKG--TLVDGQEIAVK---RLSKISEQGLKELKNEVILFSKLQHR 496
+ I + LGEG FG V + G+ +AVK + + E E++ +L L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ---VL-EHLNTT 71
Query: 497 ------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTR---RTLLD 537
V++L CI E LL Y+F+ F D R +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENGFLPFRLDHIRKMAYQIC- 128
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591
+ + +LH ++ H DLK N+L Q + + + R
Sbjct: 129 ------------KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 37/189 (19%), Positives = 62/189 (32%), Gaps = 59/189 (31%)
Query: 439 TDNFSINNKLGEGGFGPVYKG--TLVDGQEIAVK---RLSKISEQGLKELKNEVILFSKL 493
+ + I LGEG FG V + ++A+K + K E E+ +L K+
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VL-KKI 73
Query: 494 QHR------NLVKLLGC-------CIQGEEKLL---IYEFMPNKSLDSFIFDQTRRTLLD 537
+ + V + CI E LL +EF+ + + R
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENNFQPYPLPHVR----- 126
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP---------------- 581
H+ L +LH ++ H DLK N+L
Sbjct: 127 -----HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178
Query: 582 ---KISDFG 587
+++DFG
Sbjct: 179 TSIRVADFG 187
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 3e-05
Identities = 41/246 (16%), Positives = 79/246 (32%), Gaps = 60/246 (24%)
Query: 379 IVISTAALLAVVLIAGYLIRKRRRNIAEKTENSRETDQENEDQNIDLELPLFELATIANA 438
I++S A+ + + L+ K+ + + E + + F ++ I
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK------------FLMSPIKTE 101
Query: 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIA---VKRLSKISE--QGLKELK--------- 484
S+ ++ +Y D Q A V RL + Q L EL+
Sbjct: 102 QRQPSMMTRMYIEQRDRLYN----DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 485 ----------NEVILFSKLQHRNLVKL----LGCCIQGEEKL-----LIYEFMPNKSLDS 525
+V L K+Q + K+ L C E L L+Y+ PN + S
Sbjct: 158 VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRS 217
Query: 526 FIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585
+ + R LL ++ +++ + +++ KI
Sbjct: 218 DHSSNIKLRIHSIQAEL-------RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI-- 268
Query: 586 FGLVRT 591
L+ T
Sbjct: 269 --LLTT 272
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 6e-05
Identities = 17/69 (24%), Positives = 26/69 (37%), Gaps = 3/69 (4%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N D L + GNLV+ S N +W++ E V L
Sbjct: 34 YDVDKPIWATNTGG--LDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGE-NGNYVCVLQK 90
Query: 72 SGNLVLRDE 80
N+V+
Sbjct: 91 DRNVVIYGT 99
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-05
Identities = 18/64 (28%), Positives = 27/64 (42%), Gaps = 3/64 (4%)
Query: 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSG 73
+ W +N N FL +N G L++ +WS+ S + Q VL L D G
Sbjct: 40 GGKYGWQSNTHG--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSK-QGEYVLILQDDG 96
Query: 74 NLVL 77
V+
Sbjct: 97 FGVI 100
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 2e-04
Identities = 14/73 (19%), Positives = 26/73 (35%), Gaps = 3/73 (4%)
Query: 16 EVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNL 75
W +N N N L + G LV+ + VW + ++ V+ + G L
Sbjct: 37 NGNWQSNTAN--NGRDCKLTLTDYGELVIKNGDGSTVWKSG-AQSVKGNYAAVVHPDGRL 93
Query: 76 VLRDEHDGDSETY 88
V+ + +
Sbjct: 94 VVFGPSVFKIDPW 106
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 2e-04
Identities = 12/66 (18%), Positives = 23/66 (34%), Gaps = 3/66 (4%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
+ + VW N ++ G + + + NI VW++ + V L
Sbjct: 165 FDRDDRVWSTNTAGKGTGCR--AVLQPNGRMDVLTNQNIAVWTSG-NSRSAGRYVFVLQP 221
Query: 72 SGNLVL 77
NL +
Sbjct: 222 DRNLAI 227
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 4e-04
Identities = 19/149 (12%), Positives = 42/149 (28%), Gaps = 11/149 (7%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
+ VW +N + ++ G LV+ + N + WS+ VL L
Sbjct: 41 FDSDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGS-IGNYVLVLQP 96
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGD 131
+ + DS T S ++ + S
Sbjct: 97 DRTVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHP-------QTLHATQSLQL 149
Query: 132 FIWAIERQDNPEVVMWKGSRKFYRTGPWN 160
+ + + + +V++ + + T
Sbjct: 150 SPYRLSMETDCNLVLFDRDDRVWSTNTAG 178
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 20/151 (13%)
Query: 439 TDNFSINNKLGEGGFGPVYKG-TLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--- 494
+ + KLG G F V+ + + +A+K + K +E + +E+ L ++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94
Query: 495 -----HRNLVKLLGC-CIQGEE---KLLIYEFMPNKSLDSFIFDQTRRTL-LDWSQRFHI 544
+V+LL I G +++E + L +I + L L ++ I
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKK--I 151
Query: 545 ICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575
I +GL YLH ++ RIIH D+K N+LL
Sbjct: 152 IQQVLQGLDYLH--TKCRIIHTDIKPENILL 180
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 38.7 bits (90), Expect = 8e-04
Identities = 12/61 (19%), Positives = 24/61 (39%), Gaps = 3/61 (4%)
Query: 17 VVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLV 76
+VW + F+ + +G L +T V+ + + + VL L +G V
Sbjct: 46 IVWESGTSG--RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQ-EGDYVLILQINGQAV 102
Query: 77 L 77
+
Sbjct: 103 V 103
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 607 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.98 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.98 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.98 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.96 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.96 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.96 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.96 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.95 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.95 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.95 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.94 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.94 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.94 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.94 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.94 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.94 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.94 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.94 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.94 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.94 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.94 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.94 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.94 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.94 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.94 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.94 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.93 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.93 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.93 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.93 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.93 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.93 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.93 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.93 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.93 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.93 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.93 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.93 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.93 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.93 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.93 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.93 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.93 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.93 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.93 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.93 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.93 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.93 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.93 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.93 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.93 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.93 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.93 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.93 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.93 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.93 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.93 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.93 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.93 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.93 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.93 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.93 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.93 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.93 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.93 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.93 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.92 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.92 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.92 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.92 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.92 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.92 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.92 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.92 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.92 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.92 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.92 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.92 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.92 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.92 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.92 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.92 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.92 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.92 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.92 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.92 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.92 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.92 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.92 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.92 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.92 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.92 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.92 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.92 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.92 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.92 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.92 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.92 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.92 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.92 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.92 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.92 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.92 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.92 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.92 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.92 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.92 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.92 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.92 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.92 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.92 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.92 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.92 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.92 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.92 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.92 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.92 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.92 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.92 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.92 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.92 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.92 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.91 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.91 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.91 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.91 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.91 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.91 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.91 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.91 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.91 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.91 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.91 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.91 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.91 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.91 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.91 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.91 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.91 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.91 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.91 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.91 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.91 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.91 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.91 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.91 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.91 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.91 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.91 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.91 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.91 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.91 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.91 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.91 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.91 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.91 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.91 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.91 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.91 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.91 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.91 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.91 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.91 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.91 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.91 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.91 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.91 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.91 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.91 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.91 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.91 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.91 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.91 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.91 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.91 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.91 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.91 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.91 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.91 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.91 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.9 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.9 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.9 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.9 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.9 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.9 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.9 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.9 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.9 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.9 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.9 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.9 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.9 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.9 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.9 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.9 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.9 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.9 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.9 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.9 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.9 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.9 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.9 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.9 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.9 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.9 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.89 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.89 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.89 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.89 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.89 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.89 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.89 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.89 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.89 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.89 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.89 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.89 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.89 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.89 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.89 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.89 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.88 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.88 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.88 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.88 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.88 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.88 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.87 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.87 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.87 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.87 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.87 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.87 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.87 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.68 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.66 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.61 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.59 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.53 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.48 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.42 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.35 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.35 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.3 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.28 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.21 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.15 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.05 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.05 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.01 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.84 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.83 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 98.76 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.74 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.63 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.54 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.42 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.27 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.26 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.95 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.89 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.72 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.67 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.2 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.1 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.01 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.99 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.95 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.93 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.82 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.51 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.87 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.84 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.41 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.97 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 87.46 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 85.08 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.31 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.23 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.12 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=301.11 Aligned_cols=166 Identities=31% Similarity=0.542 Sum_probs=141.9
Q ss_pred cCCcccceeecccCceeEEEEEec------CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
.++|.+.++||+|+||+||+|++. ++..||||+++.......++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 457888999999999999999874 36789999998776777889999999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceE
Q 007336 513 LIYEFMPNKSLDSFIFDQT----------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~k 582 (607)
||||||++|+|.++|.... ....++|..+++|+.|||+||+|||+++ ||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999996532 2456999999999999999999999987 99999999999999999999
Q ss_pred EeecccceeecCCCCccCccceecC
Q 007336 583 ISDFGLVRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 583 i~DfGla~~~~~~~~~~~~~~~~GT 607 (607)
|+|||+|+.+........+....||
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt 193 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLP 193 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEEC
T ss_pred ECCcccceecCCCCceeecCceecC
Confidence 9999999987554433233334454
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=301.66 Aligned_cols=166 Identities=29% Similarity=0.502 Sum_probs=134.9
Q ss_pred cCCcccceeecccCceeEEEEEec------CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
.++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+.+|++++|||||+++|+|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356788899999999999999864 36789999998777777889999999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc
Q 007336 513 LIYEFMPNKSLDSFIFDQTR------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN 580 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~ 580 (607)
||||||++|+|.++|..... ...++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999975321 245899999999999999999999987 999999999999999999
Q ss_pred eEEeecccceeecCCCCccCccceecC
Q 007336 581 PKISDFGLVRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 581 ~ki~DfGla~~~~~~~~~~~~~~~~GT 607 (607)
+||+|||+|+.+........++...||
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt 223 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLP 223 (329)
T ss_dssp EEECCCC----------------CCCC
T ss_pred EEEcccccceeccCCCcceecCccccc
Confidence 999999999987654433333344554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=298.30 Aligned_cols=165 Identities=29% Similarity=0.478 Sum_probs=139.6
Q ss_pred CCcccceeecccCceeEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
.++++.++||+|+||+||+|++. +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677799999999999999873 3678999999753 3345678999999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC
Q 007336 513 LIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~ 579 (607)
||||||++|+|.++|..... ...++|..+++|+.|||+||+|||+.+ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999964321 246899999999999999999999987 99999999999999999
Q ss_pred ceEEeecccceeecCCCCccCccceecC
Q 007336 580 NPKISDFGLVRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 580 ~~ki~DfGla~~~~~~~~~~~~~~~~GT 607 (607)
.+||+|||+|+.+........+...+||
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt 210 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLP 210 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred CEEECCcccceeccCCCceeEecccccC
Confidence 9999999999987654433334444555
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=292.66 Aligned_cols=163 Identities=28% Similarity=0.484 Sum_probs=133.7
Q ss_pred hhcCCcccceeecccCceeEEEEEecCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
...+++.+.++||+|+||+||+|++. ..||||+++. ......++|.+|+.++++++|||||+++|+|.+ +..+||
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 34567888999999999999999875 3699999864 344567889999999999999999999999865 567999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||||++|+|.++|... ...++|..++.|+.|||+||+|||+.+ ||||||||+||||++++.+||+|||+|+.+..
T Consensus 110 mEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 9999999999999643 345899999999999999999999987 99999999999999999999999999998765
Q ss_pred CCCccCccceecC
Q 007336 595 DETEGNTNRVVGT 607 (607)
Q Consensus 595 ~~~~~~~~~~~GT 607 (607)
......+...+||
T Consensus 185 ~~~~~~~~~~~GT 197 (307)
T 3omv_A 185 WSGSQQVEQPTGS 197 (307)
T ss_dssp ---------CCCC
T ss_pred CCcceeecccccC
Confidence 4443334456676
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=290.99 Aligned_cols=162 Identities=30% Similarity=0.431 Sum_probs=145.2
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.++||+|+||+||+++.. +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 4899999999752 2344678999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+++|+|.++|.. ...+++.....++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+..+
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999954 345899999999999999999999987 999999999999999999999999999999766
Q ss_pred CCccCccceecC
Q 007336 596 ETEGNTNRVVGT 607 (607)
Q Consensus 596 ~~~~~~~~~~GT 607 (607)
.....+..++||
T Consensus 186 ~~~~~~~~~~GT 197 (311)
T 4aw0_A 186 SKQARANSFVGT 197 (311)
T ss_dssp TTCCCBCCCCSC
T ss_pred CCcccccCcccC
Confidence 555556677887
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=292.60 Aligned_cols=162 Identities=23% Similarity=0.406 Sum_probs=135.4
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
++|++.++||+|+||+||+|+.. +++.||||++.+ ......+.|.+|+.++++++|||||++++++.+++..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999975 489999999865 244556789999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
||++|+|.++|... +...+++.....|+.||+.||+|||+.+ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999653 3445789999999999999999999987 9999999999999999999999999999875322
Q ss_pred CccCccceecC
Q 007336 597 TEGNTNRVVGT 607 (607)
Q Consensus 597 ~~~~~~~~~GT 607 (607)
. .++.++||
T Consensus 180 ~--~~~~~~GT 188 (350)
T 4b9d_A 180 E--LARACIGT 188 (350)
T ss_dssp H--HHHHHHSC
T ss_pred c--cccccCCC
Confidence 1 22335665
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=290.76 Aligned_cols=160 Identities=29% Similarity=0.452 Sum_probs=142.0
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
...|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 356999999999999999999985 4899999999765445566789999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~~ 597 (607)
|++|+|.+++.. ..+++.....|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+..+..
T Consensus 153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999999854 34899999999999999999999987 99999999999999999999999999998865443
Q ss_pred ccCccceecC
Q 007336 598 EGNTNRVVGT 607 (607)
Q Consensus 598 ~~~~~~~~GT 607 (607)
. ...++||
T Consensus 226 ~--~~~~~GT 233 (346)
T 4fih_A 226 R--RKSLVGT 233 (346)
T ss_dssp C--BCCCCSC
T ss_pred c--ccccccC
Confidence 2 3446777
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=289.02 Aligned_cols=192 Identities=16% Similarity=0.143 Sum_probs=143.1
Q ss_pred CCCceEEEccCCCCCCCC----cceEEEecCCcEEE--EcCCCcEEEeeCCccC-----cCCceEEEEecCCCeEEeeCC
Q 007336 13 PPHEVVWVANRLNPINDS----FGFLMINKTGNLVL--TSQSNIVVWSAYLSKE-----VQTPVVLQLLDSGNLVLRDEH 81 (607)
Q Consensus 13 ~~~t~VW~Anr~~pv~~~----~~~l~~~~~G~L~l--~d~~g~~vWst~~~~~-----~~~~~~~~Lld~GNlVl~~~~ 81 (607)
+++ |||+|||++||.++ +++|+|+.+|+|+| .|++|++||+|++... ..+++| +|+|+|||||++
T Consensus 51 ~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a-~L~d~GNlVl~~-- 126 (276)
T 3m7h_A 51 NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHL-VLQDDGNIVLVD-- 126 (276)
T ss_dssp TTE-EEEECSTTSTTEEEEECCCTTCCSEEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEE-EECTTSCEEEEE--
T ss_pred CCC-eEEECCCCCCcCCcccccceEEEEeCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEE-EEeCCCCEEecC--
Confidence 566 99999999999874 68999999999999 8888999999987531 123455 999999999997
Q ss_pred CCCCCceeEeeccCCCcccCCCCeeccccccCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcC-CeEEEEeCCCC
Q 007336 82 DGDSETYFWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKG-SRKFYRTGPWN 160 (607)
Q Consensus 82 ~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~-~~~y~~~~~~~ 160 (607)
+.+|||| ||||||||||+|+.+..+|. .| ++.+||++|.|++.|+++|. +++++. ..+||++++|+
T Consensus 127 ----~~~lWqS--~ptdtlLpg~~~~~~l~~g~--~L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~ 193 (276)
T 3m7h_A 127 ----SLALWNG--TPAIPLVPGAIDSLLLAPGS--EL---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQG 193 (276)
T ss_dssp ----EEEEEES--CTTSCCCCSCTTCEEECSSE--EE---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTT
T ss_pred ----CceeeCc--ccccccccccccccccccCc--cc---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCC
Confidence 3689999 99999999999988887774 36 57899999999999999885 445654 58999999997
Q ss_pred CccccCCCCCCCCceEEEEEecCc-eEEEEEEecCCCeEEEEEEeeecceEEEEEEecCCCcEEEEeeecC
Q 007336 161 GLRFSAPSLRPNPIFSFSFVSNDV-ELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPR 230 (607)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~r~~l~~~G~~~~~~~~~~~~~~W~~~~~~~~ 230 (607)
+... ...+... ..+.+.+++. ..++++.. ....+|++|+.|| ++++|.| +..|..+|.+|.
T Consensus 194 ~~~~-~l~l~~d--GnLvl~d~~~~~vWsS~t~--~~~~~rl~Ld~dG-nLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 194 KGAV-RAVFQGD--GNLVVYGAGNAVLWHSHTG--GHASAVLRLQANG-SIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp TTCC-EEEECTT--SCEEEECTTSCEEEECSCT--TCTTCEEEECTTS-CEEEEEE---EEEEESSSCCTT
T ss_pred CccE-EEEEcCC--CeEEEEeCCCcEEEEecCC--CCCCEEEEEcCCc-cEEEEcC---CCeEEccCccCC
Confidence 5321 1112222 2334444433 34433322 2234799999999 9999998 234665555543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=292.65 Aligned_cols=160 Identities=29% Similarity=0.452 Sum_probs=142.2
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.+.|++.++||+|+||.||+|+... |+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 4579999999999999999999854 899999999765445566789999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~~ 597 (607)
|++|+|.+++.. ..+++.....|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999853 34899999999999999999999987 99999999999999999999999999998865443
Q ss_pred ccCccceecC
Q 007336 598 EGNTNRVVGT 607 (607)
Q Consensus 598 ~~~~~~~~GT 607 (607)
. ...++||
T Consensus 303 ~--~~~~~GT 310 (423)
T 4fie_A 303 R--RKSLVGT 310 (423)
T ss_dssp C--BCCCEEC
T ss_pred c--ccccccC
Confidence 2 3446777
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=287.88 Aligned_cols=174 Identities=26% Similarity=0.406 Sum_probs=145.9
Q ss_pred hHHhHHhhcCCcccceeecccCceeEEEEEecC------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCC-CceeceE
Q 007336 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQH-RNLVKLL 502 (607)
Q Consensus 431 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H-~nIv~l~ 502 (607)
+..+.+...++|++.++||+|+||+||+|++.. ++.||||++... .....++|.+|+.+|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 334556677899999999999999999998643 357999999753 34456789999999999965 9999999
Q ss_pred EEEEeC-CeEEEEEEcCCCCChHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeccc
Q 007336 503 GCCIQG-EEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL 568 (607)
Q Consensus 503 g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDl 568 (607)
|+|.+. +..+||||||++|+|.++|+.... ...+++..++.|+.|||+||+|||+.+ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999764 568999999999999999975321 345899999999999999999999987 999999
Q ss_pred CCCcEEEcCCCceEEeecccceeecCCCCccCccceecC
Q 007336 569 KASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 569 kp~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~GT 607 (607)
||+||||++++.+||+|||+|+.+..+.....+...+||
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt 250 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeecccccc
Confidence 999999999999999999999988665544444455665
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=279.18 Aligned_cols=154 Identities=27% Similarity=0.449 Sum_probs=128.1
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCC--------
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-------- 509 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-------- 509 (607)
++|++.+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 36899999999999999999975 5899999998653 3345578999999999999999999999987644
Q ss_pred ----eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEee
Q 007336 510 ----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (607)
Q Consensus 510 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~D 585 (607)
..+|||||+++|+|.+++.........++...+.|+.||++||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976555455677888999999999999999987 99999999999999999999999
Q ss_pred cccceeecCCC
Q 007336 586 FGLVRTFGGDE 596 (607)
Q Consensus 586 fGla~~~~~~~ 596 (607)
||+|+.+..+.
T Consensus 162 FGla~~~~~~~ 172 (299)
T 4g31_A 162 FGLVTAMDQDE 172 (299)
T ss_dssp CCCC-------
T ss_pred CccceecCCCc
Confidence 99999886543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-33 Score=277.64 Aligned_cols=157 Identities=26% Similarity=0.411 Sum_probs=133.0
Q ss_pred ccceeecccCceeEEEEEecC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEe----CCeEEEEE
Q 007336 443 SINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIY 515 (607)
Q Consensus 443 ~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 515 (607)
++.++||+|+||+||+|.... +..||||++.. ......+.|.+|+.++++++|||||++++++.+ .+..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 566789999999999999864 88999999864 334556789999999999999999999999875 24578999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~-~~~~ki~DfGla~~~~~ 594 (607)
|||++|+|.++|.. ...+++..+..|+.||+.||+|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999954 345899999999999999999999875 45999999999999984 78999999999986543
Q ss_pred CCCccCccceecC
Q 007336 595 DETEGNTNRVVGT 607 (607)
Q Consensus 595 ~~~~~~~~~~~GT 607 (607)
. .+..++||
T Consensus 185 ~----~~~~~~GT 193 (290)
T 3fpq_A 185 S----FAKAVIGT 193 (290)
T ss_dssp T----SBEESCSS
T ss_pred C----ccCCcccC
Confidence 2 23345776
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=280.39 Aligned_cols=162 Identities=25% Similarity=0.381 Sum_probs=130.9
Q ss_pred CCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCC----eEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lV~ 515 (607)
++|.+.++||+|+||+||+|++ +|+.||||++.... .....+..|+..+.+++|||||+++|+|.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3578889999999999999998 58999999997532 22233445667778899999999999998754 579999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS-----RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
|||++|+|.++|.. ..++|..+.+|+.|+|+||+|||+++ .++||||||||+||||++++.+||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999964 34899999999999999999999862 3469999999999999999999999999999
Q ss_pred eecCCCCc--cCccceecC
Q 007336 591 TFGGDETE--GNTNRVVGT 607 (607)
Q Consensus 591 ~~~~~~~~--~~~~~~~GT 607 (607)
........ ..+...+||
T Consensus 157 ~~~~~~~~~~~~~~~~~GT 175 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp EEETTTTEESCC-----CC
T ss_pred cccCCCCceeeeccccccc
Confidence 88654432 223345666
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=280.08 Aligned_cols=158 Identities=26% Similarity=0.344 Sum_probs=132.7
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.+.|++.++||+|+||+||+|+... ++.||||+++... .+.+|+.++++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 4578888999999999999999754 8999999997522 124699999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-ceEEeecccceeecCCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGGDE 596 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~-~~ki~DfGla~~~~~~~ 596 (607)
|++|+|.++|.. ...+++.....|+.||+.||+|||+++ ||||||||+||||+.++ .+||+|||+|+.+..+.
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999954 345899999999999999999999987 99999999999999987 69999999999886543
Q ss_pred Ccc---CccceecC
Q 007336 597 TEG---NTNRVVGT 607 (607)
Q Consensus 597 ~~~---~~~~~~GT 607 (607)
... ....++||
T Consensus 206 ~~~~~~~~~~~~GT 219 (336)
T 4g3f_A 206 LGKSLLTGDYIPGT 219 (336)
T ss_dssp --------CCCCCC
T ss_pred cccceecCCccccC
Confidence 221 22345677
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-32 Score=271.80 Aligned_cols=158 Identities=28% Similarity=0.473 Sum_probs=125.6
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 4899999998652 2234567999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+ +|+|.+++.. ...+++.....++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6899999854 345899999999999999999999987 999999999999999999999999999977543
Q ss_pred CCccCccceecC
Q 007336 596 ETEGNTNRVVGT 607 (607)
Q Consensus 596 ~~~~~~~~~~GT 607 (607)
.. ....+||
T Consensus 166 ~~---~~~~~GT 174 (275)
T 3hyh_A 166 NF---LKTSCGS 174 (275)
T ss_dssp ------------
T ss_pred Cc---cCCeeEC
Confidence 32 2235666
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.3e-33 Score=280.22 Aligned_cols=160 Identities=28% Similarity=0.333 Sum_probs=130.8
Q ss_pred CCcccceeecccCceeEEEEEec----CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
++|++.+.||+|+||+||+|+.. .++.||||++++. ......++.+|+.++++++|||||++++++.+++..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 3678999998652 22334578899999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++|+|.++|.. ...+++.....++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999954 345899999999999999999999987 9999999999999999999999999999765
Q ss_pred CCCCccCccceecC
Q 007336 594 GDETEGNTNRVVGT 607 (607)
Q Consensus 594 ~~~~~~~~~~~~GT 607 (607)
..... ...++||
T Consensus 178 ~~~~~--~~~~~GT 189 (304)
T 3ubd_A 178 DHEKK--AYSFCGT 189 (304)
T ss_dssp ---CC--CCSCCCC
T ss_pred CCCcc--ccccccC
Confidence 43332 3345776
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-30 Score=268.72 Aligned_cols=161 Identities=25% Similarity=0.434 Sum_probs=135.1
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEe------CCe
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GEE 510 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~------~~~ 510 (607)
++|++.+.||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999975 4899999999752 33456778999999999999999999999764 356
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.+||||||+ |+|.+++.. ...+++.....|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 789999843 456899999999999999999999987 9999999999999999999999999999
Q ss_pred eecCCCC--ccCccceecC
Q 007336 591 TFGGDET--EGNTNRVVGT 607 (607)
Q Consensus 591 ~~~~~~~--~~~~~~~~GT 607 (607)
.+..... .......+||
T Consensus 207 ~~~~~~~~~~~~~~~~~GT 225 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVAT 225 (398)
T ss_dssp CC-------CCCCCSSCCC
T ss_pred ecccCccccccccccceeC
Confidence 8754322 2234456776
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=254.85 Aligned_cols=178 Identities=12% Similarity=0.171 Sum_probs=132.7
Q ss_pred CceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeecc
Q 007336 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (607)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd 94 (607)
.|+||+|||+.| ..++|+|+.||+|||.|++|++||+|++....+...+ +|+|+|||||++. ++|||||
T Consensus 44 ~~~vW~an~~~~---~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~~~~~~~~-~l~d~Gnlvl~~~-------~~W~S~~ 112 (236)
T 1dlp_A 44 DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVL-VLQPDRTVTIYGP-------GLWDSGT 112 (236)
T ss_dssp SSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEE-EECSSSCEEEECS-------EEEECSC
T ss_pred CEEEEECCCCCC---CCeEEEEcCCCcEEEEcCCCcEEEeCCccccCCcEEE-EEeCCCCEEEecC-------CEEECCC
Confidence 689999999998 4589999999999999999999999987642233455 9999999999852 7999999
Q ss_pred CCCccc-CCCCeecccc-ccCc-----cceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeCCCCCccccC-
Q 007336 95 YPSDTL-LPGMKLGWDL-KTGL-----ERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSA- 166 (607)
Q Consensus 95 ~PTDTl-Lpgq~l~~~~-~~g~-----~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~- 166 (607)
|||||+ ||+| +.+. .+|. +++|++ ..||++|.|++.++++| +++++++..+||++++|++. +..
T Consensus 113 ~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~s---~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~ 184 (236)
T 1dlp_A 113 SNKGSVVVANN--GNSILYSTQGNDNHPQTLHA---TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCR 184 (236)
T ss_dssp CCSSCCCCSSC--CCEECCCC--CCCCCCEECS---SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCE
T ss_pred CCCcccccCCc--cceEEecCCcCCCccceEEc---CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceE
Confidence 998776 5554 3333 3333 467874 78999999999999988 67788888899999999653 333
Q ss_pred CCCCCCCceEEEEEecCceEEEEEEecCCCeEEEEEEeeecceEEEEE
Q 007336 167 PSLRPNPIFSFSFVSNDVELYYTFNITNKAVISRIVMNQTLYVRRRFI 214 (607)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~~~~~~~ 214 (607)
+.+.....+ +.+..+..+.+.++..... ..+|++||+|| ++++|.
T Consensus 185 ~~L~~~Gnl-~ly~~~~~~vw~s~~~~~~-~~~rl~Ld~dG-~l~ly~ 229 (236)
T 1dlp_A 185 AVLQPNGRM-DVLTNQNIAVWTSGNSRSA-GRYVFVLQPDR-NLAIYG 229 (236)
T ss_dssp EEEETTTEE-EEEETTTEEEEECCCCCSS-SCCEEEECSSS-CEEEEC
T ss_pred EEECCCCcE-EEEeCCCcEEEEeCCCCCC-CCEEEEEcCCC-cEEEeC
Confidence 555444322 2233344455555544333 35899999999 999884
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=277.43 Aligned_cols=159 Identities=27% Similarity=0.373 Sum_probs=136.1
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccc---hhhH---HHHHHHHHHHccCCCCceeceEEEEEeCCeE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGL---KELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~---~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 511 (607)
.++|++.++||+|+||+||+++... ++.||||++.+.. .... .+.+.++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 4689999999999999999999864 8999999996521 1222 2334456778889999999999999999999
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
+|||||+++|+|.++|.. ...+++.....++.||+.||+|||+.+ ||||||||+||||+.++++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999999954 345899999999999999999999987 99999999999999999999999999998
Q ss_pred ecCCCCccCccceecC
Q 007336 592 FGGDETEGNTNRVVGT 607 (607)
Q Consensus 592 ~~~~~~~~~~~~~~GT 607 (607)
+.... +.+.+||
T Consensus 342 ~~~~~----~~t~~GT 353 (689)
T 3v5w_A 342 FSKKK----PHASVGT 353 (689)
T ss_dssp CSSCC----CCSCCSC
T ss_pred cCCCC----CCCccCC
Confidence 86543 3346787
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-29 Score=258.74 Aligned_cols=149 Identities=23% Similarity=0.371 Sum_probs=131.6
Q ss_pred HhhcCCcccceeecccCceeEEEEEec----CCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCe
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 510 (607)
....++|++.++||+|+||+||+|+.. .++.||||++.+. ....++.+|+.++..+ +|||||++++++.+.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345678999999999999999999863 3678999998653 2345688899999988 69999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CceEEeecccc
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLV 589 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~-~~~ki~DfGla 589 (607)
.+|||||+++|+|.+++. .+++.....++.||+.||+|||+.+ ||||||||+||||+.+ +.+||+|||+|
T Consensus 95 ~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 999999999999999982 3789999999999999999999988 9999999999999877 79999999999
Q ss_pred eeecCC
Q 007336 590 RTFGGD 595 (607)
Q Consensus 590 ~~~~~~ 595 (607)
+.+...
T Consensus 166 ~~~~~~ 171 (361)
T 4f9c_A 166 QGTHDT 171 (361)
T ss_dssp EECTTC
T ss_pred cccCCc
Confidence 977543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=272.16 Aligned_cols=161 Identities=27% Similarity=0.439 Sum_probs=141.3
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.++|++.+.||+|+||.||+++... |+.||||++........+.+.+|+.+|+.++|||||++++++.+....+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 3589999999999999999999854 899999999775556677899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC--CceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~--~~~ki~DfGla~~~~~~ 595 (607)
|++|+|.++|.+ +...+++.....++.||+.||.|||+++ |+||||||+||||+.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999853 3346899999999999999999999987 9999999999999854 89999999999998654
Q ss_pred CCccCccceecC
Q 007336 596 ETEGNTNRVVGT 607 (607)
Q Consensus 596 ~~~~~~~~~~GT 607 (607)
.. ....+||
T Consensus 311 ~~---~~~~~GT 319 (573)
T 3uto_A 311 QS---VKVTTGT 319 (573)
T ss_dssp SE---EEEECSS
T ss_pred Cc---eeeeEEC
Confidence 32 2234565
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=245.83 Aligned_cols=162 Identities=41% Similarity=0.711 Sum_probs=145.2
Q ss_pred hHHhHHhhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe
Q 007336 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 431 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 510 (607)
.+.++...+++|++.+.||+|+||.||+|++.+++.||||++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 34456668889999999999999999999988899999999877656677889999999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
.++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999864322 235899999999999999999999987 999999999999999999999999999
Q ss_pred eeecCC
Q 007336 590 RTFGGD 595 (607)
Q Consensus 590 ~~~~~~ 595 (607)
+.....
T Consensus 187 ~~~~~~ 192 (321)
T 2qkw_B 187 KKGTEL 192 (321)
T ss_dssp EECSSS
T ss_pred cccccc
Confidence 976543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-26 Score=236.93 Aligned_cols=152 Identities=30% Similarity=0.506 Sum_probs=138.4
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.++|.+.++||+|+||+||+++... ++.||+|++........+.|.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 4578899999999999999999854 889999998776677788999999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
+++|+|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999653 345899999999999999999999987 999999999999999999999999999987543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=252.28 Aligned_cols=161 Identities=19% Similarity=0.256 Sum_probs=141.3
Q ss_pred hHHhHHhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEE
Q 007336 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCI 506 (607)
Q Consensus 431 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~ 506 (607)
.+.++....++|++.++||+|+||+||+++... ++.||||++.+.. ......+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 455666778899999999999999999999865 7889999997521 122334889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeec
Q 007336 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (607)
Q Consensus 507 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~Df 586 (607)
+.+..+|||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999642 345899999999999999999999987 999999999999999999999999
Q ss_pred ccceeecCCC
Q 007336 587 GLVRTFGGDE 596 (607)
Q Consensus 587 Gla~~~~~~~ 596 (607)
|+|+.+..+.
T Consensus 220 Gla~~~~~~~ 229 (437)
T 4aw2_A 220 GSCLKLMEDG 229 (437)
T ss_dssp TTCEECCTTS
T ss_pred hhhhhcccCC
Confidence 9999876544
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=238.44 Aligned_cols=153 Identities=25% Similarity=0.434 Sum_probs=135.0
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCC--------
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-------- 509 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-------- 509 (607)
++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 57899999999999999999986 5899999998642 3345678999999999999999999999987654
Q ss_pred -------------------------------------------------eEEEEEEcCCCCChHHHHhcCCCCCCCCHHH
Q 007336 510 -------------------------------------------------EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQ 540 (607)
Q Consensus 510 -------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~ 540 (607)
..++||||+++++|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 2789999999999999997765556677888
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 541 RFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 541 ~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 9999999999999999987 999999999999999999999999999988654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=234.56 Aligned_cols=152 Identities=26% Similarity=0.495 Sum_probs=137.5
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
..++|++.+.||+|+||+||++... +++.||||++........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 4468999999999999999999964 588999999876555556789999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
|+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999954 24789999999999999999999987 9999999999999999999999999999876544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=243.19 Aligned_cols=156 Identities=31% Similarity=0.535 Sum_probs=136.8
Q ss_pred hcCCcccceeecccCceeEEEEEec--------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~ 507 (607)
..++|++.+.||+|+||.||+|+.. .+..||||+++.. .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4468999999999999999999863 2457999999753 345567899999999999 89999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEE
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nil 574 (607)
.+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999975331 235789999999999999999999987 999999999999
Q ss_pred EcCCCceEEeecccceeecCCC
Q 007336 575 LDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 575 l~~~~~~ki~DfGla~~~~~~~ 596 (607)
|+.++.+||+|||+|+.+....
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~ 257 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNID 257 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCC
T ss_pred ECCCCCEEEccccCCcccCccc
Confidence 9999999999999999876443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-27 Score=241.01 Aligned_cols=170 Identities=44% Similarity=0.753 Sum_probs=148.2
Q ss_pred CCchhHHhHHhhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEE
Q 007336 427 LPLFELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCC 505 (607)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~ 505 (607)
.+.+++.++....++|++.+.||+|+||.||+|+..+++.||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 45677889999999999999999999999999998889999999987532 22234689999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEe
Q 007336 506 IQGEEKLLIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (607)
Q Consensus 506 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~ 584 (607)
...+..++||||+++|+|.+++.... ....+++..+..|+.|++.||+|||+....+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997643 23458999999999999999999999833349999999999999999999999
Q ss_pred ecccceeecCCC
Q 007336 585 DFGLVRTFGGDE 596 (607)
Q Consensus 585 DfGla~~~~~~~ 596 (607)
|||+++.+....
T Consensus 177 Dfg~~~~~~~~~ 188 (326)
T 3uim_A 177 DFGLAKLMDYKD 188 (326)
T ss_dssp CCSSCEECCSSS
T ss_pred cCccccccCccc
Confidence 999999875433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-26 Score=235.77 Aligned_cols=147 Identities=31% Similarity=0.463 Sum_probs=134.5
Q ss_pred cccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 442 FSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
|+..+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 677789999999999999986 5899999999765555677899999999999999999999999999999999999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 127 ~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 127 GALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp CBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred CCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccC
Confidence 999999842 35899999999999999999999987 999999999999999999999999999987654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.7e-27 Score=247.39 Aligned_cols=161 Identities=20% Similarity=0.260 Sum_probs=141.3
Q ss_pred hHHhHHhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEE
Q 007336 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCI 506 (607)
Q Consensus 431 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~ 506 (607)
.+.+.....++|++.+.||+|+||+||+++.. +++.||||++.+. .....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44555667789999999999999999999985 5899999999752 2223456889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeec
Q 007336 507 QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (607)
Q Consensus 507 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~Df 586 (607)
+.+..+|||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ||||||||+||||+.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999999642 235899999999999999999999987 999999999999999999999999
Q ss_pred ccceeecCCC
Q 007336 587 GLVRTFGGDE 596 (607)
Q Consensus 587 Gla~~~~~~~ 596 (607)
|+|+.+..+.
T Consensus 207 Gla~~~~~~~ 216 (412)
T 2vd5_A 207 GSCLKLRADG 216 (412)
T ss_dssp TTCEECCTTS
T ss_pred hhheeccCCC
Confidence 9999886543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=249.23 Aligned_cols=157 Identities=20% Similarity=0.269 Sum_probs=138.6
Q ss_pred HHhHHhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEe
Q 007336 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (607)
Q Consensus 432 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~ 507 (607)
+.++....++|++.++||+|+||+||+++... ++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 44556677899999999999999999999865 789999998652 12233458899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
.+..+|||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999999854 24789999999999999999999987 9999999999999999999999999
Q ss_pred cceeecCC
Q 007336 588 LVRTFGGD 595 (607)
Q Consensus 588 la~~~~~~ 595 (607)
+|+.+...
T Consensus 214 ~a~~~~~~ 221 (410)
T 3v8s_A 214 TCMKMNKE 221 (410)
T ss_dssp TCEECCTT
T ss_pred eeEeeccC
Confidence 99987654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=234.25 Aligned_cols=166 Identities=40% Similarity=0.673 Sum_probs=146.9
Q ss_pred CCchhHHhHHhhcCCcccc------eeecccCceeEEEEEecCCcEEEEEEeccc----chhhHHHHHHHHHHHccCCCC
Q 007336 427 LPLFELATIANATDNFSIN------NKLGEGGFGPVYKGTLVDGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQHR 496 (607)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~------~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~----~~~~~~~f~~E~~~l~~l~H~ 496 (607)
.+.+.+.++..++++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4567788888888888776 8999999999999987 6889999998642 234467899999999999999
Q ss_pred ceeceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc
Q 007336 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (607)
Q Consensus 497 nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~ 576 (607)
||+++++++.+.+..++||||+++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999965444556899999999999999999999987 99999999999999
Q ss_pred CCCceEEeecccceeecCCC
Q 007336 577 QDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 577 ~~~~~ki~DfGla~~~~~~~ 596 (607)
+++.+||+|||+++......
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFA 187 (307)
T ss_dssp TTCCEEECCCTTCEECCSCS
T ss_pred CCCcEEEeeccccccccccc
Confidence 99999999999999876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=236.81 Aligned_cols=164 Identities=32% Similarity=0.537 Sum_probs=136.4
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCC----eEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~l 513 (607)
..++|++.++||+|+||+||+|+.. ++.||||++... ......+..|+.++++++||||+++++++.+.. ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4468999999999999999999875 789999998653 334456667999999999999999999998754 3699
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCceEecccCCCcEEEcCCCceEEeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-------SRLRIIHRDLKASNVLLDQDMNPKISDF 586 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-------~~~~ivHrDlkp~Nill~~~~~~ki~Df 586 (607)
||||+++|+|.+++.. ..+++..+..++.||++||+|||+. ...+|+||||||+||||+.++.+||+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999999954 2489999999999999999999987 0113999999999999999999999999
Q ss_pred ccceeecCCCCccCccceecC
Q 007336 587 GLVRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 587 Gla~~~~~~~~~~~~~~~~GT 607 (607)
|+|+.+.............||
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt 196 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGT 196 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCC
T ss_pred CcccccccccCccccccCccC
Confidence 999988655443333334444
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=238.68 Aligned_cols=153 Identities=30% Similarity=0.468 Sum_probs=137.2
Q ss_pred hhcCCcccceeecccCceeEEEEEe-cCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
...++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3456899999999999999999998 46899999998653 34556788999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++|+|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999998543 34889999999999999999999987 9999999999999999999999999998775
Q ss_pred CC
Q 007336 594 GD 595 (607)
Q Consensus 594 ~~ 595 (607)
..
T Consensus 166 ~~ 167 (328)
T 3fe3_A 166 VG 167 (328)
T ss_dssp SS
T ss_pred CC
Confidence 43
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=238.05 Aligned_cols=151 Identities=29% Similarity=0.418 Sum_probs=132.5
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 58899999986432 2334678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999843 345899999999999999999999987 999999999999999999999999999987543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=238.21 Aligned_cols=149 Identities=23% Similarity=0.290 Sum_probs=134.2
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
.++|++.+.||+|+||+||+++.. +++.||||++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357999999999999999999986 4899999999753 234567789999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999854 345789999999999999999999987 9999999999999999999999999999653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=239.52 Aligned_cols=150 Identities=29% Similarity=0.417 Sum_probs=133.2
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 512 (607)
..++|++.+.||+|+||+||+++... ++.||||++.+. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 45789999999999999999999764 889999999752 234556788999999988 7999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999999542 45899999999999999999999987 999999999999999999999999999865
Q ss_pred c
Q 007336 593 G 593 (607)
Q Consensus 593 ~ 593 (607)
.
T Consensus 175 ~ 175 (353)
T 3txo_A 175 I 175 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-26 Score=240.33 Aligned_cols=151 Identities=25% Similarity=0.398 Sum_probs=135.8
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
.++|++.+.||+|+||.||+++... ++.||+|.+.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3679999999999999999999765 789999998652 234467889999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999954 345899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 007336 595 D 595 (607)
Q Consensus 595 ~ 595 (607)
.
T Consensus 168 ~ 168 (384)
T 4fr4_A 168 E 168 (384)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=236.12 Aligned_cols=160 Identities=29% Similarity=0.520 Sum_probs=133.8
Q ss_pred HhHHhhcCCcccceeecccCceeEEEEEecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe
Q 007336 433 ATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 433 ~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 510 (607)
.+.....++|++.+.||+|+||+||+++. .++.||||++... .....++|.+|+.++++++||||+++++++.+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34445567899999999999999999987 5889999998653 34456789999999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++||||+++|+|.+++........+++..++.++.||+.||+|||+.+ .+|+||||||+||||+.++.+||+|||+++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999999999965433345899999999999999999999864 349999999999999999999999999998
Q ss_pred eecC
Q 007336 591 TFGG 594 (607)
Q Consensus 591 ~~~~ 594 (607)
....
T Consensus 188 ~~~~ 191 (309)
T 3p86_A 188 LKAS 191 (309)
T ss_dssp ----
T ss_pred cccc
Confidence 6643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.6e-26 Score=233.55 Aligned_cols=150 Identities=26% Similarity=0.399 Sum_probs=134.7
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
.++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357999999999999999999985 4899999998752 223467788999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999964 235789999999999999999999887 99999999999999999999999999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.8e-26 Score=234.28 Aligned_cols=153 Identities=30% Similarity=0.520 Sum_probs=135.4
Q ss_pred hcCCcccceeecccCceeEEEEEec----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
..++|++.+.||+|+||.||+|++. .+..||||++... .....+.|.+|+.++++++||||+++++++.+++..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3467899999999999999999984 3456999999753 4455678999999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||+++|+|.+++... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 127 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999999542 345899999999999999999999987 999999999999999999999999999988
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
...
T Consensus 202 ~~~ 204 (325)
T 3kul_A 202 EDD 204 (325)
T ss_dssp C--
T ss_pred ccC
Confidence 654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=241.96 Aligned_cols=153 Identities=27% Similarity=0.480 Sum_probs=136.3
Q ss_pred hhcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
...++|.+.+.||+|+||.||+|+.. +++.||||.+... .....++|.+|+.++++++||||+++++++.+.+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34568899999999999999999986 5889999998753 334456789999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++|+|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+||||++++.+||+|||+|+....
T Consensus 191 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999999642 335889999999999999999999987 99999999999999999999999999997643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=234.39 Aligned_cols=152 Identities=28% Similarity=0.391 Sum_probs=135.2
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccch------hhHHHHHHHHHHHccCCCCceeceEEEEEeCCe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 510 (607)
..++|++.+.||+|+||.||+++.. +++.||||.+.+... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467999999999999999999986 488999999875321 135789999999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC----ceEEeec
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDF 586 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~----~~ki~Df 586 (607)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999943 345899999999999999999999987 99999999999998877 7999999
Q ss_pred ccceeecCC
Q 007336 587 GLVRTFGGD 595 (607)
Q Consensus 587 Gla~~~~~~ 595 (607)
|+++.+...
T Consensus 164 G~a~~~~~~ 172 (361)
T 2yab_A 164 GLAHEIEDG 172 (361)
T ss_dssp SSCEECCTT
T ss_pred CCceEcCCC
Confidence 999987653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=231.07 Aligned_cols=150 Identities=27% Similarity=0.443 Sum_probs=134.3
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
.++|++.+.||+|+||.||+++.. .+..||+|.+.. ......+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999975 488999999853 2344567899999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999542 35899999999999999999999987 99999999999999999999999999987754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=241.24 Aligned_cols=153 Identities=19% Similarity=0.227 Sum_probs=131.6
Q ss_pred HHhhcCCcccceeecccCceeEEEEE------ecCCcEEEEEEecccchhhHHHHHHHHHHHccCC---CCceeceEEEE
Q 007336 435 IANATDNFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCC 505 (607)
Q Consensus 435 ~~~~~~~~~~~~~lg~G~fg~Vy~g~------~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~---H~nIv~l~g~~ 505 (607)
+....++|.+.++||+|+||+||+|. ...++.||||++.... ..++..|+.++..++ |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 34456789999999999999999994 3457899999997543 446677777777776 99999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC------
Q 007336 506 IQGEEKLLIYEFMPNKSLDSFIFDQ--TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ------ 577 (607)
Q Consensus 506 ~~~~~~~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~------ 577 (607)
...+..+|||||+++|+|.+++... .....+++..+..|+.||++||+|||+.+ ||||||||+||||+.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 9999999999999999999999642 23456899999999999999999999987 999999999999998
Q ss_pred -----CCceEEeecccceeec
Q 007336 578 -----DMNPKISDFGLVRTFG 593 (607)
Q Consensus 578 -----~~~~ki~DfGla~~~~ 593 (607)
++.+||+|||+|+.+.
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~ 234 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMK 234 (365)
T ss_dssp -----CTTEEECCCTTCEEGG
T ss_pred ccccccCCEEEeeCchhhhhh
Confidence 8999999999998765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=236.36 Aligned_cols=152 Identities=27% Similarity=0.388 Sum_probs=133.2
Q ss_pred HhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCe
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 510 (607)
....++|.+.+.||+|+||.||+++... ++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 3456789999999999999999999864 889999999753 123456788899988876 99999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999954 235889999999999999999999987 9999999999999999999999999999
Q ss_pred eec
Q 007336 591 TFG 593 (607)
Q Consensus 591 ~~~ 593 (607)
...
T Consensus 167 ~~~ 169 (345)
T 1xjd_A 167 ENM 169 (345)
T ss_dssp CCC
T ss_pred hcc
Confidence 654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=240.55 Aligned_cols=152 Identities=32% Similarity=0.549 Sum_probs=128.5
Q ss_pred cCCcccceeecccCceeEEEEEec----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
.++|++.+.||+|+||.||+|++. .+..||||+++.. .....++|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999875 4678999998753 34556789999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++|+|.+++... ...+++..++.|+.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999642 345899999999999999999999987 9999999999999999999999999999876
Q ss_pred CC
Q 007336 594 GD 595 (607)
Q Consensus 594 ~~ 595 (607)
..
T Consensus 199 ~~ 200 (373)
T 2qol_A 199 DD 200 (373)
T ss_dssp --
T ss_pred cC
Confidence 44
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=240.18 Aligned_cols=164 Identities=27% Similarity=0.468 Sum_probs=139.6
Q ss_pred hhHHhHHhhcCCcccceeecccCceeEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceece
Q 007336 430 FELATIANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKL 501 (607)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l 501 (607)
+.........++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 344556667789999999999999999999842 3578999999753 344567899999999999 89999999
Q ss_pred EEEEEeCCe-EEEEEEcCCCCChHHHHhcCCC------------------------------------------------
Q 007336 502 LGCCIQGEE-KLLIYEFMPNKSLDSFIFDQTR------------------------------------------------ 532 (607)
Q Consensus 502 ~g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------ 532 (607)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987554 8999999999999999965432
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 533 ---------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 533 ---------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
...+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122889999999999999999999987 9999999999999999999999999999775443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=241.25 Aligned_cols=150 Identities=23% Similarity=0.347 Sum_probs=131.3
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 512 (607)
..++|++.++||+|+||+||+++... ++.||||++++. .....+.+..|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 34689999999999999999999865 788999999753 223345678899998876 8999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+..
T Consensus 130 lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999999854 245899999999999999999999987 999999999999999999999999999964
Q ss_pred c
Q 007336 593 G 593 (607)
Q Consensus 593 ~ 593 (607)
.
T Consensus 204 ~ 204 (396)
T 4dc2_A 204 L 204 (396)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-26 Score=235.08 Aligned_cols=149 Identities=25% Similarity=0.352 Sum_probs=133.3
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~l 513 (607)
.++|++.+.||+|+||.||+++... ++.||||++.+. .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 3579999999999999999999864 789999999753 334566788999999887 89999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+...
T Consensus 88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999998542 35899999999999999999999987 9999999999999999999999999999653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=229.46 Aligned_cols=151 Identities=22% Similarity=0.321 Sum_probs=135.3
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.++|++.+.||+|+||.||+++... ++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4689999999999999999999864 788999998653 34556789999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC--CCceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~--~~~~ki~DfGla~~~~~~ 595 (607)
+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999943 2345899999999999999999999987 999999999999987 789999999999988543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-26 Score=232.20 Aligned_cols=158 Identities=32% Similarity=0.508 Sum_probs=138.0
Q ss_pred HhhcCCcccceeecccCceeEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeC
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~ 508 (607)
....++|.+.+.||+|+||.||+++.. ++..||||++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 345578999999999999999999862 3478999998753 345567899999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecc
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTR---------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRD 567 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrD 567 (607)
+..++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccc
Confidence 999999999999999999975432 234889999999999999999999987 99999
Q ss_pred cCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 568 LKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 568 lkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
|||+|||+++++.+||+|||+++.+....
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~ 204 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEED 204 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTS
T ss_pred cchheEEEcCCCCEEEccccccccccccc
Confidence 99999999999999999999999875543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=230.99 Aligned_cols=155 Identities=28% Similarity=0.435 Sum_probs=136.7
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCC--eEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV 514 (607)
.++|.+.+.||+|+||+||+|+... ++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4579999999999999999999865 8899999987532 344677889999999999999999999998765 67999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE----cCCCceEEeecccce
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVR 590 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill----~~~~~~ki~DfGla~ 590 (607)
|||+++++|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+|+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976544455899999999999999999999987 9999999999999 788889999999999
Q ss_pred eecCCC
Q 007336 591 TFGGDE 596 (607)
Q Consensus 591 ~~~~~~ 596 (607)
.+....
T Consensus 165 ~~~~~~ 170 (319)
T 4euu_A 165 ELEDDE 170 (319)
T ss_dssp ECCTTC
T ss_pred ecCCCC
Confidence 876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=7.5e-26 Score=235.09 Aligned_cols=150 Identities=25% Similarity=0.319 Sum_probs=135.1
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
.++|++.+.||+|+||.||+++.. +++.||||++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 358999999999999999999986 4899999998652 223467889999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999999642 34889999999999999999999987 99999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=236.87 Aligned_cols=160 Identities=30% Similarity=0.523 Sum_probs=140.1
Q ss_pred HHhHHhhcCCcccceeecccCceeEEEEEecC------CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEE
Q 007336 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGC 504 (607)
Q Consensus 432 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~ 504 (607)
+..+....++|++.+.||+|+||.||+++... ++.||||.+... .....+.|.+|+.++++++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34445567899999999999999999999753 478999999753 34456789999999999999999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 007336 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTR---------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563 (607)
Q Consensus 505 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i 563 (607)
+.+.+..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 9999999999999999999999965321 156899999999999999999999987 9
Q ss_pred EecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 564 vHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+||||||+||||++++.+||+|||+++.+..
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 226 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYS 226 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCccccc
Confidence 9999999999999999999999999987643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=7e-26 Score=238.42 Aligned_cols=157 Identities=31% Similarity=0.496 Sum_probs=137.5
Q ss_pred HhhcCCcccceeecccCceeEEEEEec--------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCC 505 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~ 505 (607)
....++|.+.++||+|+||.||+|+.. .+..||||++... .....+++.+|+.+++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344578999999999999999999863 2357999998753 345567899999999999 999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCc
Q 007336 506 IQGEEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (607)
Q Consensus 506 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~N 572 (607)
.+.+..++||||+++|+|.+++..... ...+++..++.|+.||+.||+|||+.+ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 999999999999999999999975432 245899999999999999999999987 9999999999
Q ss_pred EEEcCCCceEEeecccceeecCC
Q 007336 573 VLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 573 ill~~~~~~ki~DfGla~~~~~~ 595 (607)
|||++++.+||+|||+|+.+...
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~ 244 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHI 244 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCC
T ss_pred EEEcCCCcEEEcccCcccccccc
Confidence 99999999999999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=234.19 Aligned_cols=150 Identities=25% Similarity=0.322 Sum_probs=133.7
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 512 (607)
..++|++.+.||+|+||.||+++... ++.||||++.+. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 45689999999999999999999865 788999999753 224456788999999988 8999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999999542 34889999999999999999999987 999999999999999999999999999965
Q ss_pred c
Q 007336 593 G 593 (607)
Q Consensus 593 ~ 593 (607)
.
T Consensus 172 ~ 172 (353)
T 2i0e_A 172 I 172 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=235.90 Aligned_cols=158 Identities=30% Similarity=0.494 Sum_probs=134.7
Q ss_pred HhhcCCcccceeecccCceeEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEe
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~ 507 (607)
....++|++.+.||+|+||.||+|+.. .+..||||.+... .....+.+.+|+.++.++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 445678999999999999999999962 3568999998753 234457899999999999 89999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhcCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecc
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQTRR--------------------TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRD 567 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrD 567 (607)
.+..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+.+ |+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 99999999999999999999653321 34789999999999999999999987 99999
Q ss_pred cCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 568 LKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 568 lkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
|||+||||+.++.+||+|||+++.+....
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~ 226 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDS 226 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCc
Confidence 99999999999999999999999775443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.9e-26 Score=225.93 Aligned_cols=150 Identities=27% Similarity=0.508 Sum_probs=135.7
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
.++|++.+.||+|+||.||+++..+++.||+|++... ....+++.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 4578999999999999999999988899999999753 234567999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999954 2345899999999999999999999987 99999999999999999999999999987643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=228.05 Aligned_cols=150 Identities=28% Similarity=0.455 Sum_probs=128.3
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccch--------------------------hhHHHHHHHHHHHc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE--------------------------QGLKELKNEVILFS 491 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--------------------------~~~~~f~~E~~~l~ 491 (607)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999975 478999999864221 12356899999999
Q ss_pred cCCCCceeceEEEEEe--CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccC
Q 007336 492 KLQHRNLVKLLGCCIQ--GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLK 569 (607)
Q Consensus 492 ~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlk 569 (607)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||++||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998765 2346899999999999999999999987 9999999
Q ss_pred CCcEEEcCCCceEEeecccceeecCC
Q 007336 570 ASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 570 p~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|+|||++.++.+||+|||+++.+...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHHEEECCCCCEEEecCCCccccccc
Confidence 99999999999999999999987543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-25 Score=233.18 Aligned_cols=152 Identities=26% Similarity=0.392 Sum_probs=136.0
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.++|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999985 4889999998765555667899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC--CCceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~--~~~~ki~DfGla~~~~~~ 595 (607)
+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999853 2345899999999999999999999987 999999999999974 477999999999988654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-25 Score=224.45 Aligned_cols=149 Identities=28% Similarity=0.467 Sum_probs=130.9
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
++|++.++||+|+||+||+|+... ++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 579999999999999999999854 889999998642 33445788899999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9986 55555533 2345899999999999999999999987 99999999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=224.23 Aligned_cols=153 Identities=29% Similarity=0.471 Sum_probs=137.3
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
..++|++.+.||+|+||.||+++..++..||||++... ....+++.+|+.++.+++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 45689999999999999999999988889999999753 23456799999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999643 335899999999999999999999987 9999999999999999999999999999775443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-26 Score=246.26 Aligned_cols=155 Identities=29% Similarity=0.504 Sum_probs=138.6
Q ss_pred HhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
.....+|++.++||+|+||.||+|++.. +..||||.++.. ....++|.+|+.++++++||||++++++|.+.+..+||
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 3345678999999999999999999875 789999999753 33467899999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++|+|.++|.... ...+++..++.|+.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+..
T Consensus 295 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999996532 345899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 007336 595 D 595 (607)
Q Consensus 595 ~ 595 (607)
+
T Consensus 371 ~ 371 (495)
T 1opk_A 371 D 371 (495)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=233.03 Aligned_cols=154 Identities=27% Similarity=0.388 Sum_probs=134.0
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc-----hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
.++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999975 48999999986421 124678999999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc---eEEeeccc
Q 007336 513 LIYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGL 588 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~---~ki~DfGl 588 (607)
+||||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988875432 2345899999999999999999999987 999999999999987654 99999999
Q ss_pred ceeecCC
Q 007336 589 VRTFGGD 595 (607)
Q Consensus 589 a~~~~~~ 595 (607)
++.+...
T Consensus 180 a~~~~~~ 186 (351)
T 3c0i_A 180 AIQLGES 186 (351)
T ss_dssp CEECCTT
T ss_pred eeEecCC
Confidence 9988654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=228.90 Aligned_cols=152 Identities=34% Similarity=0.486 Sum_probs=133.3
Q ss_pred hhcCCcccceeecccCceeEEEEEecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
...++|++.++||+|+||+||+++..+++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 345789999999999999999999988999999998642 223356788999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||++ ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 98 ~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFME-KDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCS-EEHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCC-CCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99998 478887754 2345899999999999999999999987 99999999999999999999999999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.9e-26 Score=232.87 Aligned_cols=150 Identities=26% Similarity=0.376 Sum_probs=125.4
Q ss_pred hcCCcccceeecccCceeEEEEEe----cCCcEEEEEEecccc----hhhHHHHHHHHHHHccCCCCceeceEEEEEeCC
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTL----VDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~----~~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~ 509 (607)
..++|++.+.||+|+||.||+++. ..++.||+|++.+.. ......+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 346899999999999999999987 368899999987532 234566889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999999854 235788999999999999999999987 999999999999999999999999999
Q ss_pred eeec
Q 007336 590 RTFG 593 (607)
Q Consensus 590 ~~~~ 593 (607)
+...
T Consensus 169 ~~~~ 172 (327)
T 3a62_A 169 KESI 172 (327)
T ss_dssp ----
T ss_pred cccc
Confidence 8654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=244.97 Aligned_cols=155 Identities=27% Similarity=0.364 Sum_probs=137.5
Q ss_pred hhcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
...++|++.+.||+|+||.||+++.. +++.||||++.+. .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 34567999999999999999999985 5899999998652 2234567899999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+
T Consensus 261 lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999996532 334899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
...
T Consensus 337 ~~~ 339 (576)
T 2acx_A 337 PEG 339 (576)
T ss_dssp CTT
T ss_pred ccC
Confidence 544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-25 Score=228.60 Aligned_cols=149 Identities=27% Similarity=0.392 Sum_probs=133.6
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecccch------hhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
++|.+.+.||+|+||.||+++... ++.||||.+..... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 468899999999999999999864 88999999865321 23678999999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC----ceEEeeccc
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGL 588 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~----~~ki~DfGl 588 (607)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999943 345899999999999999999999987 99999999999999887 799999999
Q ss_pred ceeecC
Q 007336 589 VRTFGG 594 (607)
Q Consensus 589 a~~~~~ 594 (607)
++.+..
T Consensus 165 a~~~~~ 170 (326)
T 2y0a_A 165 AHKIDF 170 (326)
T ss_dssp CEECCT
T ss_pred CeECCC
Confidence 998854
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-26 Score=232.41 Aligned_cols=159 Identities=28% Similarity=0.489 Sum_probs=124.6
Q ss_pred hHHhhcCCcccceeecccCceeEEEEEecCC----cEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEe
Q 007336 434 TIANATDNFSINNKLGEGGFGPVYKGTLVDG----QEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (607)
Q Consensus 434 ~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~----~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~ 507 (607)
+.....++|++.+.||+|+||.||+|+.... ..||||.+... .....+.+.+|+.++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 3445667899999999999999999997543 27999998653 34557789999999999999999999999987
Q ss_pred CCeE------EEEEEcCCCCChHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC
Q 007336 508 GEEK------LLIYEFMPNKSLDSFIFDQT---RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (607)
Q Consensus 508 ~~~~------~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~ 578 (607)
.... ++||||+++|+|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||||+++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 7655 89999999999999985432 2235899999999999999999999987 9999999999999999
Q ss_pred CceEEeecccceeecCC
Q 007336 579 MNPKISDFGLVRTFGGD 595 (607)
Q Consensus 579 ~~~ki~DfGla~~~~~~ 595 (607)
+.+||+|||+|+.+...
T Consensus 174 ~~~kl~Dfg~a~~~~~~ 190 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSG 190 (323)
T ss_dssp SCEEECCCCC-------
T ss_pred CCEEEeecccccccccc
Confidence 99999999999977543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-26 Score=229.98 Aligned_cols=153 Identities=30% Similarity=0.564 Sum_probs=132.9
Q ss_pred hcCCcccceeecccCceeEEEEEe-----cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeC--Ce
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EE 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~ 510 (607)
..++|++.+.||+|+||.||++++ .+++.||||++........+.|.+|+.++++++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 346899999999999999999984 24789999999876666778899999999999999999999998653 45
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 79999999999999999653 234899999999999999999999987 9999999999999999999999999999
Q ss_pred eecCC
Q 007336 591 TFGGD 595 (607)
Q Consensus 591 ~~~~~ 595 (607)
.+...
T Consensus 163 ~~~~~ 167 (295)
T 3ugc_A 163 VLPQD 167 (295)
T ss_dssp -----
T ss_pred cccCC
Confidence 87543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=238.49 Aligned_cols=153 Identities=32% Similarity=0.548 Sum_probs=133.2
Q ss_pred hcCCcccceeecccCceeEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 510 (607)
..++|++.+.||+|+||.||+|++. .+..||||++... .......+.+|+.++++++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3467999999999999999999953 3568999998653 44556689999999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC---ceEE
Q 007336 511 KLLIYEFMPNKSLDSFIFDQT----RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKI 583 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~---~~ki 583 (607)
.++||||+++|+|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+||||+.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999996532 2245899999999999999999999987 99999999999999554 5999
Q ss_pred eecccceeec
Q 007336 584 SDFGLVRTFG 593 (607)
Q Consensus 584 ~DfGla~~~~ 593 (607)
+|||+|+.+.
T Consensus 226 ~DFG~a~~~~ 235 (367)
T 3l9p_A 226 GDFGMARDIY 235 (367)
T ss_dssp CCCHHHHHHH
T ss_pred CCCccccccc
Confidence 9999998663
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-26 Score=245.40 Aligned_cols=154 Identities=30% Similarity=0.462 Sum_probs=136.5
Q ss_pred HHhhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 435 IANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 435 ~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
.....++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++||||+++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 345567899999999999999999999888999999997632 45678999999999999999999999986 6678999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++|+|.++|... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 261 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999999642 2235788999999999999999999987 99999999999999999999999999997753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-26 Score=233.84 Aligned_cols=160 Identities=32% Similarity=0.491 Sum_probs=138.0
Q ss_pred hHHhhcCCcccceeecccCceeEEEEEecC------CcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEE
Q 007336 434 TIANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCC 505 (607)
Q Consensus 434 ~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~ 505 (607)
......++|++.+.||+|+||.||+|.... ...||+|.+... .....+.+.+|+.+++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345566889999999999999999999743 247999998753 334567899999999999 899999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEE
Q 007336 506 IQGEEKLLIYEFMPNKSLDSFIFDQT-----------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (607)
Q Consensus 506 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nil 574 (607)
.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999986421 1345789999999999999999999987 999999999999
Q ss_pred EcCCCceEEeecccceeecCCC
Q 007336 575 LDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 575 l~~~~~~ki~DfGla~~~~~~~ 596 (607)
|+.++.+||+|||+++.+....
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~ 218 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDS 218 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCT
T ss_pred ECCCCeEEECcccccccccccc
Confidence 9999999999999999775443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-25 Score=231.92 Aligned_cols=151 Identities=28% Similarity=0.471 Sum_probs=134.1
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
.++|++.+.||+|+||.||++... +++.||+|++.. ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999975 488999999864 23445678999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC---ceEEeecccceee
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLVRTF 592 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~---~~ki~DfGla~~~ 592 (607)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 108 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999843 345899999999999999999999987 99999999999998654 5999999999987
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
...
T Consensus 182 ~~~ 184 (362)
T 2bdw_A 182 NDS 184 (362)
T ss_dssp TTC
T ss_pred cCC
Confidence 643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-25 Score=239.00 Aligned_cols=152 Identities=28% Similarity=0.479 Sum_probs=136.3
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|.+.+.||+|+||.||+|+.. +++.||||++.+.. ....+.+.+|+.+++.++||||+++++++...+..+|
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3468999999999999999999986 58999999996532 2345679999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 94 v~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 94 VMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999999853 345899999999999999999999987 9999999999999999999999999999876
Q ss_pred CC
Q 007336 594 GD 595 (607)
Q Consensus 594 ~~ 595 (607)
..
T Consensus 168 ~~ 169 (476)
T 2y94_A 168 DG 169 (476)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-25 Score=229.82 Aligned_cols=158 Identities=30% Similarity=0.527 Sum_probs=136.7
Q ss_pred HhhcCCcccceeecccCceeEEEEEec--------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCC 505 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~ 505 (607)
....++|++.+.||+|+||.||+|+.. ++..||||++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 334578999999999999999999873 3678999998753 345567899999999999 899999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCc
Q 007336 506 IQGEEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (607)
Q Consensus 506 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~N 572 (607)
.+.+..++||||+++|+|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 999999999999999999999965332 234889999999999999999999987 9999999999
Q ss_pred EEEcCCCceEEeecccceeecCCC
Q 007336 573 VLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 573 ill~~~~~~ki~DfGla~~~~~~~ 596 (607)
|||+.++.+||+|||+++.+....
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~ 211 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNID 211 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTS
T ss_pred EEEcCCCCEEEccccccccccccc
Confidence 999999999999999999876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-25 Score=231.94 Aligned_cols=149 Identities=30% Similarity=0.414 Sum_probs=127.5
Q ss_pred ccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCCC
Q 007336 443 SINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 521 (607)
Q Consensus 443 ~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 521 (607)
...+.||+|+||.||+|+.. +++.||+|++........+++.+|+.++++++||||+++++++.+.+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33578999999999999975 48899999998755566788999999999999999999999999999999999999999
Q ss_pred ChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE--cCCCceEEeecccceeecCCC
Q 007336 522 SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL--DQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 522 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill--~~~~~~ki~DfGla~~~~~~~ 596 (607)
+|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||| +.++.+||+|||+++.+....
T Consensus 172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 999988642 345889999999999999999999987 9999999999999 567899999999999886543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-25 Score=241.56 Aligned_cols=156 Identities=29% Similarity=0.404 Sum_probs=138.0
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|.+.+.||+|+||+||+++.. +++.||||++.+. .......+..|+.++++++||||+++++++.+....+|
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 3468999999999999999999986 4899999999652 22345678999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 514 IYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999865432 346899999999999999999999987 999999999999999999999999999987
Q ss_pred cCCC
Q 007336 593 GGDE 596 (607)
Q Consensus 593 ~~~~ 596 (607)
....
T Consensus 340 ~~~~ 343 (543)
T 3c4z_A 340 KAGQ 343 (543)
T ss_dssp CTTC
T ss_pred cCCC
Confidence 6543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=235.13 Aligned_cols=150 Identities=24% Similarity=0.295 Sum_probs=123.8
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHHHH-HccCCCCceeceEEEEEeCCeEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
..++|++.+.||+|+||.||+++... ++.||||++.+.. ....+.+..|..+ ++.++||||+++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 34689999999999999999999865 7899999997532 2334566677776 57789999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|||||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999999854 235788899999999999999999987 999999999999999999999999999864
Q ss_pred c
Q 007336 593 G 593 (607)
Q Consensus 593 ~ 593 (607)
.
T Consensus 190 ~ 190 (373)
T 2r5t_A 190 I 190 (373)
T ss_dssp B
T ss_pred c
Confidence 3
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-25 Score=238.42 Aligned_cols=151 Identities=28% Similarity=0.489 Sum_probs=133.8
Q ss_pred hhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCC-eEEEEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIY 515 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~lV~ 515 (607)
...++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 34568899999999999999999985 7899999997532 4578999999999999999999999998765 789999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+++|+|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++....
T Consensus 267 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp ECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999999999653 2344789999999999999999999987 99999999999999999999999999997643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.5e-26 Score=242.80 Aligned_cols=150 Identities=24% Similarity=0.286 Sum_probs=124.8
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|+.+++.++||||+++++++.+.+..+|
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999975 4889999998752 33445678899999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+ ||||||||+||||+.++.+||+|||+|+..
T Consensus 226 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999999854 3458999999999999999999998 66 999999999999999999999999999865
Q ss_pred c
Q 007336 593 G 593 (607)
Q Consensus 593 ~ 593 (607)
.
T Consensus 300 ~ 300 (446)
T 4ejn_A 300 I 300 (446)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-25 Score=221.55 Aligned_cols=153 Identities=23% Similarity=0.390 Sum_probs=137.2
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
..++|++.+.||+|+||.||+|.... +..||+|++........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34579999999999999999999865 67899999976555567889999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE---cCCCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill---~~~~~~ki~DfGla~~~~ 593 (607)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999998854 234899999999999999999999987 9999999999999 788999999999999876
Q ss_pred CCC
Q 007336 594 GDE 596 (607)
Q Consensus 594 ~~~ 596 (607)
...
T Consensus 161 ~~~ 163 (277)
T 3f3z_A 161 PGK 163 (277)
T ss_dssp TTS
T ss_pred Ccc
Confidence 443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=224.58 Aligned_cols=153 Identities=27% Similarity=0.437 Sum_probs=134.1
Q ss_pred HhhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
....++|++.+.||+|+||.||++...++..||||++.... ...+++.+|+.++.+++||||+++++++.+.+..++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 34456899999999999999999999888899999997532 33567999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 99 EYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred eccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999999642 345899999999999999999999987 99999999999999999999999999987643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=228.12 Aligned_cols=158 Identities=32% Similarity=0.480 Sum_probs=137.7
Q ss_pred HhhcCCcccceeecccCceeEEEEEe------cCCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEe
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 507 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~ 507 (607)
....++|++.+.||+|+||.||+|+. ..++.||||++... .....+.+.+|+.++.++ +||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34456899999999999999999985 23678999998753 234567899999999999 99999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCc
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQTR---------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASN 572 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~N 572 (607)
.+..++||||+++|+|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence 9999999999999999999965432 124899999999999999999999987 9999999999
Q ss_pred EEEcCCCceEEeecccceeecCCC
Q 007336 573 VLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 573 ill~~~~~~ki~DfGla~~~~~~~ 596 (607)
||++.++.+||+|||+++.+....
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~ 199 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDS 199 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCT
T ss_pred EEEcCCCCEEEccccccccccccc
Confidence 999999999999999999876544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.6e-26 Score=230.45 Aligned_cols=152 Identities=22% Similarity=0.374 Sum_probs=129.5
Q ss_pred hcCCcccceeecccCceeEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe---
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--- 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~--- 510 (607)
..++|++.+.||+|+||.||+++. .+++.||||++... .......+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 456899999999999999999997 45889999998753 33445689999999999999999999999876543
Q ss_pred -EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 511 -KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 511 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 49999999999999999542 35899999999999999999999987 999999999999999999999999999
Q ss_pred eeecCC
Q 007336 590 RTFGGD 595 (607)
Q Consensus 590 ~~~~~~ 595 (607)
+.+...
T Consensus 164 ~~~~~~ 169 (311)
T 3ork_A 164 RAIADS 169 (311)
T ss_dssp ------
T ss_pred cccccc
Confidence 987543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=230.93 Aligned_cols=151 Identities=26% Similarity=0.438 Sum_probs=133.1
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|.+.+.||+|+||.||+|... +++.||||++.+.. ......+.+|+.+++.++||||+++++++......++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3468999999999999999999974 58899999986521 2234578999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+ +|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 87 v~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99999 68898888542 35899999999999999999999987 9999999999999999999999999999775
Q ss_pred CC
Q 007336 594 GD 595 (607)
Q Consensus 594 ~~ 595 (607)
..
T Consensus 160 ~~ 161 (336)
T 3h4j_B 160 DG 161 (336)
T ss_dssp TS
T ss_pred CC
Confidence 43
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-25 Score=225.96 Aligned_cols=150 Identities=28% Similarity=0.328 Sum_probs=127.7
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.++||+|+||+||+|+.. +++.||||++... ......++..|+..+.++ +||||+++++++.+++..+|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999986 5899999998642 233344555566555554 9999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+ +++|.+++... ...+++..+..|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 67898888543 345899999999999999999999987 999999999999999999999999999987543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=230.69 Aligned_cols=159 Identities=28% Similarity=0.488 Sum_probs=137.9
Q ss_pred HhHHhhcCCcccceeecccCceeEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEE
Q 007336 433 ATIANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCC 505 (607)
Q Consensus 433 ~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~ 505 (607)
.+.....++|++.+.||+|+||.||+|+.. .++.||||.+... .......+.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344556678999999999999999999864 2678999998753 334556799999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC
Q 007336 506 IQGEEKLLIYEFMPNKSLDSFIFDQT-------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD 578 (607)
Q Consensus 506 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~ 578 (607)
.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence 99999999999999999999986421 1245689999999999999999999987 9999999999999999
Q ss_pred CceEEeecccceeecC
Q 007336 579 MNPKISDFGLVRTFGG 594 (607)
Q Consensus 579 ~~~ki~DfGla~~~~~ 594 (607)
+.+||+|||+++.+..
T Consensus 175 ~~~kl~Dfg~~~~~~~ 190 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYE 190 (322)
T ss_dssp CCEEECCTTCCCGGGG
T ss_pred CeEEECcCcccccccc
Confidence 9999999999987643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=230.19 Aligned_cols=152 Identities=31% Similarity=0.576 Sum_probs=128.4
Q ss_pred cCCcccceeecccCceeEEEEEecC-Cc----EEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
.++|++.++||+|+||+||+|++.. ++ .||+|.+.. ......++|.+|+.++++++||||++++++|.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 3579999999999999999999643 43 468888754 23345678999999999999999999999998755 77
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999999653 345899999999999999999999987 999999999999999999999999999987
Q ss_pred cCCC
Q 007336 593 GGDE 596 (607)
Q Consensus 593 ~~~~ 596 (607)
....
T Consensus 168 ~~~~ 171 (327)
T 3poz_A 168 GAEE 171 (327)
T ss_dssp TTTC
T ss_pred cCCc
Confidence 6544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=225.02 Aligned_cols=148 Identities=28% Similarity=0.476 Sum_probs=132.1
Q ss_pred CCcccceeecccCceeEEEEEecCCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++|++.+.||+|+||+||+++...++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999999779999999986432 22346788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
+++ +|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG 151 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence 985 898888542 345889999999999999999999987 9999999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8e-25 Score=222.08 Aligned_cols=148 Identities=28% Similarity=0.453 Sum_probs=125.7
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHcc--CCCCceeceEEEEEeC----CeE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQG----EEK 511 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~--l~H~nIv~l~g~~~~~----~~~ 511 (607)
..++|++.+.||+|+||+||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 346899999999999999999988 6889999998653 33445555555554 8999999999997653 457
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecccCCCcEEEcCCCceEE
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH--------QDSRLRIIHRDLKASNVLLDQDMNPKI 583 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--------~~~~~~ivHrDlkp~Nill~~~~~~ki 583 (607)
++||||+++|+|.+++. ...+++..+..++.||+.||+||| +.+ |+||||||+||||+.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 89999999999999993 235899999999999999999999 555 999999999999999999999
Q ss_pred eecccceeecCCC
Q 007336 584 SDFGLVRTFGGDE 596 (607)
Q Consensus 584 ~DfGla~~~~~~~ 596 (607)
+|||+|+.+....
T Consensus 155 ~Dfg~a~~~~~~~ 167 (301)
T 3q4u_A 155 ADLGLAVMHSQST 167 (301)
T ss_dssp CCCTTCEEEETTT
T ss_pred eeCCCeeeccccc
Confidence 9999999876544
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=234.20 Aligned_cols=154 Identities=27% Similarity=0.430 Sum_probs=135.7
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCC--eEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~--~~~lV 514 (607)
.++|.+.++||+|+||+||+|+... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4579999999999999999999865 8999999987532 344677889999999999999999999998765 67999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE----cCCCceEEeecccce
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKISDFGLVR 590 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill----~~~~~~ki~DfGla~ 590 (607)
|||+++|+|.+++........+++..+..++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+|+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999965444445899999999999999999999987 9999999999999 778889999999999
Q ss_pred eecCC
Q 007336 591 TFGGD 595 (607)
Q Consensus 591 ~~~~~ 595 (607)
.+...
T Consensus 165 ~~~~~ 169 (396)
T 4eut_A 165 ELEDD 169 (396)
T ss_dssp ECCCG
T ss_pred EccCC
Confidence 87544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.4e-25 Score=230.36 Aligned_cols=152 Identities=20% Similarity=0.268 Sum_probs=136.3
Q ss_pred hcCCcccceeeccc--CceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 438 ATDNFSINNKLGEG--GFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 438 ~~~~~~~~~~lg~G--~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
..++|++.++||+| +||.||+++.. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45689999999999 99999999986 5899999998753 3445678889999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||+++|+|.+++.... ...+++..+..|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++..+
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999996532 245899999999999999999999987 999999999999999999999999998765
Q ss_pred c
Q 007336 593 G 593 (607)
Q Consensus 593 ~ 593 (607)
.
T Consensus 179 ~ 179 (389)
T 3gni_B 179 I 179 (389)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=236.97 Aligned_cols=153 Identities=27% Similarity=0.414 Sum_probs=133.3
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
..++|++.+.||+|+||.||++... +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3457999999999999999999875 5889999998652 334567799999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc---CCCceEEeeccccee
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRT 591 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~---~~~~~ki~DfGla~~ 591 (607)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 89 ~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999998643 45899999999999999999999987 99999999999998 467899999999988
Q ss_pred ecCCC
Q 007336 592 FGGDE 596 (607)
Q Consensus 592 ~~~~~ 596 (607)
+....
T Consensus 163 ~~~~~ 167 (444)
T 3soa_A 163 VEGEQ 167 (444)
T ss_dssp CCTTC
T ss_pred ecCCC
Confidence 76543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=219.92 Aligned_cols=150 Identities=29% Similarity=0.419 Sum_probs=134.5
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.++|++.+.||+|+||.||+++.. +++.||||.+... .....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357899999999999999999986 5889999998642 23456789999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|+++++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999998843 345899999999999999999999987 99999999999999999999999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=230.96 Aligned_cols=149 Identities=24% Similarity=0.317 Sum_probs=130.5
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
..++|++.+.||+|+||+||+++.. +++.||||++... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4568999999999999999999986 5889999999753 2334678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc--eEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~--~ki~DfGla~~~~ 593 (607)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+|+...
T Consensus 97 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999999854 234899999999999999999999987 999999999999987765 9999999998543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=230.94 Aligned_cols=152 Identities=26% Similarity=0.368 Sum_probs=131.6
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCC--CceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~l 513 (607)
..++|++.+.||+|+||.||++...+++.||||++.. ......+.+.+|+.++.+++| |||+++++++.++...+|
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 4467999999999999999999998899999999864 344556789999999999976 999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||| +.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+|+.+.
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 567899999965 345889999999999999999999987 99999999999997 5789999999999876
Q ss_pred CCCC
Q 007336 594 GDET 597 (607)
Q Consensus 594 ~~~~ 597 (607)
....
T Consensus 159 ~~~~ 162 (343)
T 3dbq_A 159 PDTT 162 (343)
T ss_dssp ----
T ss_pred cccc
Confidence 5443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=241.27 Aligned_cols=154 Identities=28% Similarity=0.489 Sum_probs=132.8
Q ss_pred HhhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
....++|++.++||+|+||.||+|.+.++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 34556889999999999999999999888889999997532 345789999999999999999999999876 6789999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+...
T Consensus 258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999532 2245889999999999999999999987 999999999999999999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-25 Score=226.93 Aligned_cols=150 Identities=22% Similarity=0.316 Sum_probs=132.2
Q ss_pred cCCcccceeecccCceeEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.++|++.+.||+|+||.||+|+. .+++.||||.+.... ..+.+.+|+.+++++ +||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999997 458899999986432 234688999999999 99999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc-----eEEeeccccee
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISDFGLVRT 591 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~-----~ki~DfGla~~ 591 (607)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+|+.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999653 346899999999999999999999987 999999999999999887 99999999998
Q ss_pred ecCCC
Q 007336 592 FGGDE 596 (607)
Q Consensus 592 ~~~~~ 596 (607)
+....
T Consensus 160 ~~~~~ 164 (330)
T 2izr_A 160 YIDPE 164 (330)
T ss_dssp SBCTT
T ss_pred eecCC
Confidence 75543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.1e-25 Score=224.70 Aligned_cols=152 Identities=31% Similarity=0.493 Sum_probs=119.8
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457999999999999999999875 48899999986532 2344678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQT---RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|++ |+|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999885421 2245889999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 160 ~ 160 (317)
T 2pmi_A 160 I 160 (317)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=222.45 Aligned_cols=149 Identities=27% Similarity=0.404 Sum_probs=133.4
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
++|++.+.||+|+||+||+++... ++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 579999999999999999999865 899999988642 23345678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999998743 345899999999999999999999987 99999999999999999999999999998753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=239.01 Aligned_cols=149 Identities=26% Similarity=0.461 Sum_probs=123.0
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeC-----Ce
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 510 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~~ 510 (607)
.++|++.+.||+|+||.||+|+.. +++.||||++.+ ......+.+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999875 488999999865 2344567899999999999999999999999543 46
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++||||+. ++|.+++.. ...+++..+..++.||++||+|||+.+ ||||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 789998853 345899999999999999999999987 9999999999999999999999999999
Q ss_pred eecC
Q 007336 591 TFGG 594 (607)
Q Consensus 591 ~~~~ 594 (607)
.+..
T Consensus 205 ~~~~ 208 (458)
T 3rp9_A 205 TVDY 208 (458)
T ss_dssp CTTS
T ss_pred hccC
Confidence 8753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=223.06 Aligned_cols=150 Identities=27% Similarity=0.494 Sum_probs=134.4
Q ss_pred cCCcccceeecccCceeEEEEEecC-C-------cEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-G-------QEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~-------~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 510 (607)
.++|.+.+.||+|+||.||+|+... + ..||+|.+........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4578999999999999999998754 3 4799999977666677889999999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc--------eE
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--------PK 582 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~--------~k 582 (607)
.++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999653 334889999999999999999999987 999999999999998887 99
Q ss_pred Eeecccceeec
Q 007336 583 ISDFGLVRTFG 593 (607)
Q Consensus 583 i~DfGla~~~~ 593 (607)
|+|||+++...
T Consensus 162 l~Dfg~~~~~~ 172 (289)
T 4fvq_A 162 LSDPGISITVL 172 (289)
T ss_dssp ECCCCSCTTTS
T ss_pred eccCccccccc
Confidence 99999997653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=234.92 Aligned_cols=151 Identities=27% Similarity=0.488 Sum_probs=132.2
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeC-----C
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----E 509 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~ 509 (607)
..++|++.+.||+|+||.||+|+... ++.||||++.. ......+.+.+|+.++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 45689999999999999999999754 78899999975 2344567899999999999999999999999876 5
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
..++||||++ ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6899999987 699999853 345899999999999999999999987 999999999999999999999999999
Q ss_pred eeecCC
Q 007336 590 RTFGGD 595 (607)
Q Consensus 590 ~~~~~~ 595 (607)
+.+...
T Consensus 177 ~~~~~~ 182 (432)
T 3n9x_A 177 RTINSE 182 (432)
T ss_dssp EEC---
T ss_pred cccccc
Confidence 987543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=230.16 Aligned_cols=153 Identities=27% Similarity=0.501 Sum_probs=129.9
Q ss_pred cCCcccceeecccCceeEEEEEecC-Cc----EEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
.++|++.+.||+|+||.||+|+... ++ .||+|.+... .......+.+|+.++++++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 3578999999999999999999754 43 3788877542 2233456788999999999999999999986 45688
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999999643 345888999999999999999999987 999999999999999999999999999987
Q ss_pred cCCCC
Q 007336 593 GGDET 597 (607)
Q Consensus 593 ~~~~~ 597 (607)
.....
T Consensus 166 ~~~~~ 170 (325)
T 3kex_A 166 PPDDK 170 (325)
T ss_dssp CCCTT
T ss_pred Ccccc
Confidence 65443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.8e-25 Score=228.47 Aligned_cols=149 Identities=28% Similarity=0.399 Sum_probs=121.9
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
..++|++.+.||+|+||.||+|+... ++.||||++... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 45679999999999999999999865 789999998753 245678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~---~~~~ki~DfGla~~~~ 593 (607)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+++.+.
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999853 345899999999999999999999987 999999999999975 8899999999999775
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 203 ~ 203 (349)
T 2w4o_A 203 H 203 (349)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=229.44 Aligned_cols=157 Identities=24% Similarity=0.324 Sum_probs=132.9
Q ss_pred HHhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-----chhhHHHHHHHHHHHccCCCCceeceEEEEEeC
Q 007336 435 IANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (607)
Q Consensus 435 ~~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~ 508 (607)
+....++|++.+.||+|+||.||++... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3445568999999999999999999975 4789999998642 234567899999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhcCC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQT-------------------------------------RRTLLDWSQRFHIICGTARG 551 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~g 551 (607)
+..++||||+++|+|.+++.... ....+++..+..|+.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999984210 01123567788899999999
Q ss_pred HHHHHhCCCCceEecccCCCcEEEcCCC--ceEEeecccceeecC
Q 007336 552 LLYLHQDSRLRIIHRDLKASNVLLDQDM--NPKISDFGLVRTFGG 594 (607)
Q Consensus 552 l~yLH~~~~~~ivHrDlkp~Nill~~~~--~~ki~DfGla~~~~~ 594 (607)
|+|||+.+ |+||||||+||||+.++ .+||+|||+++.+..
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~ 222 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYK 222 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGG
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccc
Confidence 99999987 99999999999998776 899999999997743
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=226.42 Aligned_cols=162 Identities=25% Similarity=0.306 Sum_probs=139.6
Q ss_pred CCchhHHhHHhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-----CCceec
Q 007336 427 LPLFELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----HRNLVK 500 (607)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-----H~nIv~ 500 (607)
...+.+.+.....++|++.++||+|+||+||+++.. +++.||||++.. .....+.+..|+.+++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 334455566667789999999999999999999984 488999999875 2345567788999998886 999999
Q ss_pred eEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---
Q 007336 501 LLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--- 577 (607)
Q Consensus 501 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~--- 577 (607)
+++++...+..+|||||+ +++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 999999999999999999 899999996532 335889999999999999999999987 999999999999976
Q ss_pred ----------------------CCceEEeecccceeecC
Q 007336 578 ----------------------DMNPKISDFGLVRTFGG 594 (607)
Q Consensus 578 ----------------------~~~~ki~DfGla~~~~~ 594 (607)
++.+||+|||+|+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 78899999999997654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=224.41 Aligned_cols=160 Identities=28% Similarity=0.514 Sum_probs=129.7
Q ss_pred HHhHHhhcCCcccceeecccCceeEEEEEecC----CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEE
Q 007336 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCC 505 (607)
Q Consensus 432 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~ 505 (607)
+.++....++|.+.+.||+|+||.||+|+... +..||||++... .....+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 34445566789999999999999999998743 458999998642 345567899999999999999999999999
Q ss_pred EeCCe-----EEEEEEcCCCCChHHHHhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC
Q 007336 506 IQGEE-----KLLIYEFMPNKSLDSFIFDQ---TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 577 (607)
Q Consensus 506 ~~~~~-----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~ 577 (607)
.+... .++||||+++++|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+|||++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence 87553 49999999999999998532 23456899999999999999999999887 999999999999999
Q ss_pred CCceEEeecccceeecC
Q 007336 578 DMNPKISDFGLVRTFGG 594 (607)
Q Consensus 578 ~~~~ki~DfGla~~~~~ 594 (607)
++.+||+|||+++.+..
T Consensus 183 ~~~~kl~Dfg~~~~~~~ 199 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYS 199 (313)
T ss_dssp TSCEEECSCSCC-----
T ss_pred CCcEEEeecCcceeccc
Confidence 99999999999987754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=221.51 Aligned_cols=152 Identities=32% Similarity=0.540 Sum_probs=131.6
Q ss_pred CCcccceeecccCceeEEEEEe-----cCCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeC--CeE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 511 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~ 511 (607)
+.|++.+.||+|+||.||++++ ..++.||||++... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4688899999999999999984 35789999998743 334567899999999999999999999999876 568
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999999542 345899999999999999999999987 99999999999999999999999999998
Q ss_pred ecCCC
Q 007336 592 FGGDE 596 (607)
Q Consensus 592 ~~~~~ 596 (607)
+....
T Consensus 176 ~~~~~ 180 (302)
T 4e5w_A 176 IETDK 180 (302)
T ss_dssp CCTTC
T ss_pred ccCCC
Confidence 76543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=217.96 Aligned_cols=152 Identities=30% Similarity=0.541 Sum_probs=135.0
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|++.+.||+|+||.||+++.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 3457999999999999999999974 58999999986422 2234679999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999999642 345899999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 164 ~ 164 (278)
T 3cok_A 164 M 164 (278)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-25 Score=225.52 Aligned_cols=163 Identities=28% Similarity=0.461 Sum_probs=138.2
Q ss_pred hHHhHHhhcCCcccceeecccCceeEEEEEe------cCCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceE
Q 007336 431 ELATIANATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLL 502 (607)
Q Consensus 431 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~ 502 (607)
.........++|++.+.||+|+||.||+++. .+++.||||++... .....+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3445555678999999999999999999985 23578999998753 334567899999999999 799999999
Q ss_pred EEEEeCC-eEEEEEEcCCCCChHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeccc
Q 007336 503 GCCIQGE-EKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL 568 (607)
Q Consensus 503 g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDl 568 (607)
+++...+ ..++||||+++++|.+++..... ...+++..+..++.||++||.|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9998754 48999999999999999965332 123789999999999999999999987 999999
Q ss_pred CCCcEEEcCCCceEEeecccceeecCCC
Q 007336 569 KASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 569 kp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
||+|||++.++.+||+|||+++.+....
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 202 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDP 202 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCT
T ss_pred ccceEEECCCCCEEECCCccccccccCc
Confidence 9999999999999999999999775443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-25 Score=221.80 Aligned_cols=151 Identities=33% Similarity=0.540 Sum_probs=125.0
Q ss_pred HhhcCCcccceeecccCceeEEEEEecCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
+...++|++.++||+|+||.||+|+.. ..||||+++. ......+.|.+|+.++++++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 334568999999999999999999864 4699999864 2345567899999999999999999999965 5566899
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 97 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999854 3355899999999999999999999987 9999999999999999999999999998765
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 172 ~ 172 (289)
T 3og7_A 172 R 172 (289)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=218.80 Aligned_cols=155 Identities=28% Similarity=0.420 Sum_probs=134.2
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV 514 (607)
.++|++.+.||+|+||.||+++.. +++.||||++... ......++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 457999999999999999999986 5899999998752 334567788999999998 999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC---------------
Q 007336 515 YEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--------------- 578 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~--------------- 578 (607)
|||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999964321 255899999999999999999999987 9999999999999844
Q ss_pred ----CceEEeecccceeecCCC
Q 007336 579 ----MNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 579 ----~~~ki~DfGla~~~~~~~ 596 (607)
..+||+|||+++.+....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~ 188 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ 188 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC
T ss_pred cCCceEEEEcccccccccCCcc
Confidence 479999999999876543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-24 Score=223.61 Aligned_cols=153 Identities=27% Similarity=0.468 Sum_probs=135.8
Q ss_pred cCCcccceeecccCceeEEEEEe-----cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEE--eCCeE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI--QGEEK 511 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~--~~~~~ 511 (607)
.++|++.+.||+|+||.||++++ ..++.||||++........+.+.+|+.++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35799999999999999999984 347899999998766667788999999999999999999999987 45568
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 8999999999999999642 234899999999999999999999987 99999999999999999999999999998
Q ss_pred ecCCC
Q 007336 592 FGGDE 596 (607)
Q Consensus 592 ~~~~~ 596 (607)
+....
T Consensus 177 ~~~~~ 181 (327)
T 3lxl_A 177 LPLDK 181 (327)
T ss_dssp CCTTC
T ss_pred cccCC
Confidence 75443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=218.42 Aligned_cols=151 Identities=25% Similarity=0.385 Sum_probs=135.3
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|.+.+.||+|+||.||++.... ++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34579999999999999999999865 788999998652 33456789999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999998854 245889999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 167 ~ 167 (294)
T 2rku_A 167 Y 167 (294)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.3e-25 Score=227.47 Aligned_cols=153 Identities=26% Similarity=0.369 Sum_probs=134.1
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc--------hhhHHHHHHHHHHHccCCCCceeceEEEEEeC
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~ 508 (607)
..++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4468999999999999999999964 48899999987532 11344678899999999999999999999999
Q ss_pred CeEEEEEEcCCCC-ChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 509 EEKLLIYEFMPNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 509 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
+..++||||+..| +|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999877 99999854 335899999999999999999999987 9999999999999999999999999
Q ss_pred cceeecCCC
Q 007336 588 LVRTFGGDE 596 (607)
Q Consensus 588 la~~~~~~~ 596 (607)
+++.+....
T Consensus 176 ~a~~~~~~~ 184 (335)
T 3dls_A 176 SAAYLERGK 184 (335)
T ss_dssp TCEECCTTC
T ss_pred cceECCCCC
Confidence 999876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-24 Score=223.38 Aligned_cols=151 Identities=25% Similarity=0.385 Sum_probs=135.5
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|.+.+.||+|+||.||+++... ++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34679999999999999999999865 788999998652 33456789999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998854 245899999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 193 ~ 193 (335)
T 2owb_A 193 Y 193 (335)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=229.27 Aligned_cols=148 Identities=22% Similarity=0.293 Sum_probs=125.3
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecccc--------hhhHHHHHHHHHHHccCC---------CCceece
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQ---------HRNLVKL 501 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~--------~~~~~~f~~E~~~l~~l~---------H~nIv~l 501 (607)
.++|++.+.||+|+||+||+|+. +++.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45788999999999999999998 68999999987531 223477888988888775 8888888
Q ss_pred EEEEE------------------------------eCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 007336 502 LGCCI------------------------------QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551 (607)
Q Consensus 502 ~g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 551 (607)
.+++. +....+|||||+++|++.+.+.+ ..+++..+..|+.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 88754 26788999999999977666622 457999999999999999
Q ss_pred HHHHH-hCCCCceEecccCCCcEEEcCCC--------------------ceEEeecccceeecC
Q 007336 552 LLYLH-QDSRLRIIHRDLKASNVLLDQDM--------------------NPKISDFGLVRTFGG 594 (607)
Q Consensus 552 l~yLH-~~~~~~ivHrDlkp~Nill~~~~--------------------~~ki~DfGla~~~~~ 594 (607)
|+||| +.+ ||||||||+||||+.++ .+||+|||+|+.+..
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 99999 877 99999999999999887 899999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-25 Score=223.21 Aligned_cols=156 Identities=29% Similarity=0.506 Sum_probs=139.1
Q ss_pred HhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
....++|++.+.||+|+||.||+|.... +..||||.+... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3456789999999999999999999865 788999998753 34567899999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 88 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 88 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999999653 2345899999999999999999999987 99999999999999999999999999997754
Q ss_pred CC
Q 007336 595 DE 596 (607)
Q Consensus 595 ~~ 596 (607)
..
T Consensus 164 ~~ 165 (288)
T 3kfa_A 164 DT 165 (288)
T ss_dssp SS
T ss_pred Cc
Confidence 43
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-25 Score=220.66 Aligned_cols=154 Identities=27% Similarity=0.407 Sum_probs=132.7
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.++|.+.++||+|+||.||+++.. ++..||+|++... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 357899999999999999999975 4889999998653 23456789999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE---cCCCceEEeecccceee
Q 007336 517 FMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTF 592 (607)
Q Consensus 517 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill---~~~~~~ki~DfGla~~~ 592 (607)
|+++|+|.+++... .....+++..+..|+.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999998543 22356899999999999999999999987 9999999999999 45678999999999877
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
...
T Consensus 178 ~~~ 180 (285)
T 3is5_A 178 KSD 180 (285)
T ss_dssp ---
T ss_pred CCc
Confidence 543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=6.6e-25 Score=220.37 Aligned_cols=153 Identities=29% Similarity=0.493 Sum_probs=134.2
Q ss_pred hhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
...++|++.+.||+|+||.||+|...++..||||.+... ....+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 345689999999999999999999888889999998753 234678999999999999999999999986 456899999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 88 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 88 YMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred cCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999998532 1225899999999999999999999987 999999999999999999999999999987543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=245.34 Aligned_cols=162 Identities=26% Similarity=0.323 Sum_probs=137.9
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 512 (607)
..++|++.++||+|+||.||+++... ++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 45689999999999999999999865 788999999752 233456788899999887 7999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|||||+++|+|.+++... ..+++..+..|+.||+.||+|||+.+ ||||||||+||||+.++++||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999642 35899999999999999999999987 999999999999999999999999999975
Q ss_pred cCCCCccCccceecC
Q 007336 593 GGDETEGNTNRVVGT 607 (607)
Q Consensus 593 ~~~~~~~~~~~~~GT 607 (607)
...... +..++||
T Consensus 493 ~~~~~~--~~~~~GT 505 (674)
T 3pfq_A 493 IWDGVT--TKTFCGT 505 (674)
T ss_dssp CCTTCC--BCCCCSC
T ss_pred ccCCcc--cccccCC
Confidence 433322 3334555
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-24 Score=217.18 Aligned_cols=151 Identities=28% Similarity=0.416 Sum_probs=132.4
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
.|.....||+|+||.||+|+.. ++..||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4445568999999999999974 478999999976555567789999999999999999999999999999999999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-CCceEEeecccceeecC
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGG 594 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~-~~~~ki~DfGla~~~~~ 594 (607)
+++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+..
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999976544455778999999999999999999987 999999999999987 89999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=231.74 Aligned_cols=151 Identities=25% Similarity=0.335 Sum_probs=133.4
Q ss_pred cCCcccceeecccCceeEEEEEe----cCCcEEEEEEeccc----chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCC
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTL----VDGQEIAVKRLSKI----SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 509 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~----~~~~~vavK~l~~~----~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~ 509 (607)
.++|++.+.||+|+||.||+++. ..++.||||++++. .....+.+.+|+.++.++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999997 35889999998652 123345677899999999 6999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
..+|||||+++|+|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999999642 35889999999999999999999987 999999999999999999999999999
Q ss_pred eeecCC
Q 007336 590 RTFGGD 595 (607)
Q Consensus 590 ~~~~~~ 595 (607)
+.+...
T Consensus 207 ~~~~~~ 212 (355)
T 1vzo_A 207 KEFVAD 212 (355)
T ss_dssp EECCGG
T ss_pred eecccC
Confidence 987543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.7e-25 Score=220.69 Aligned_cols=152 Identities=26% Similarity=0.432 Sum_probs=124.8
Q ss_pred hcCCcccceeecccCceeEEEEEecC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
..++|++.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.++++++||||+++++++ .++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 44689999999999999999998743 457999998753 344567899999999999999999999997 456789
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999999643 345899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
...
T Consensus 167 ~~~ 169 (281)
T 1mp8_A 167 EDS 169 (281)
T ss_dssp ---
T ss_pred Ccc
Confidence 543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.9e-25 Score=217.74 Aligned_cols=150 Identities=28% Similarity=0.498 Sum_probs=135.5
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
.++|++.+.||+|+||.||++...+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 45788999999999999999999888899999997632 34468999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999653 345789999999999999999999987 99999999999999999999999999987643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=229.44 Aligned_cols=149 Identities=28% Similarity=0.549 Sum_probs=124.1
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCC-CCceeceEEEEEeCC--eE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE--EK 511 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~--~~ 511 (607)
..++|++.+.||+|+||.||+|... +++.||||++.. ........+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4568999999999999999999975 488999999864 23455677889999999997 999999999998654 68
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++||||++ ++|..++.. ..+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 689998854 35789999999999999999999987 99999999999999999999999999998
Q ss_pred ecC
Q 007336 592 FGG 594 (607)
Q Consensus 592 ~~~ 594 (607)
+..
T Consensus 159 ~~~ 161 (388)
T 3oz6_A 159 FVN 161 (388)
T ss_dssp SSS
T ss_pred ccc
Confidence 743
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=245.40 Aligned_cols=153 Identities=28% Similarity=0.487 Sum_probs=135.1
Q ss_pred HhhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
....++|++.++||+|+||.||+|++.++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..+|||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 34556789999999999999999999888889999997532 345789999999999999999999999866 6789999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+++|+|.++|... ....+++..++.|+.||++||+|||+.+ ||||||||+||||++++.+||+|||+++.+..
T Consensus 341 e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 999999999999532 2245889999999999999999999987 99999999999999999999999999997753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-25 Score=230.85 Aligned_cols=149 Identities=26% Similarity=0.367 Sum_probs=129.8
Q ss_pred CCcccceeecccCceeEEEEEecCCcEEEEEEecc--cchhhHHHHHHHHHHHccCC--CCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~ 515 (607)
.+|++.+.||+|+||.||++....++.||||++.. ......+.+.+|+.++.+++ ||||+++++++...+..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 46999999999999999999988899999999864 33456678999999999996 599999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
| +.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+|+.+...
T Consensus 136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 6788999999653 35788899999999999999999987 99999999999995 578999999999987654
Q ss_pred C
Q 007336 596 E 596 (607)
Q Consensus 596 ~ 596 (607)
.
T Consensus 208 ~ 208 (390)
T 2zmd_A 208 T 208 (390)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=222.25 Aligned_cols=151 Identities=28% Similarity=0.400 Sum_probs=134.5
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccch------hhHHHHHHHHHHHccCCCCceeceEEEEEeCCeE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 511 (607)
.++|++.+.||+|+||.||+++.. +++.||||.+..... ...+++.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 357899999999999999999986 488999999865221 1367899999999999999999999999999999
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC----ceEEeecc
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG 587 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~----~~ki~DfG 587 (607)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999954 345789999999999999999999987 99999999999999888 79999999
Q ss_pred cceeecCC
Q 007336 588 LVRTFGGD 595 (607)
Q Consensus 588 la~~~~~~ 595 (607)
+++.+...
T Consensus 165 ~~~~~~~~ 172 (321)
T 2a2a_A 165 LAHEIEDG 172 (321)
T ss_dssp TCEECCTT
T ss_pred cceecCcc
Confidence 99987643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-24 Score=216.24 Aligned_cols=152 Identities=28% Similarity=0.465 Sum_probs=134.6
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
..++|++.+.||+|+||.||++.... ++.||+|++.. ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 35689999999999999999999754 88999999864 2344567889999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc---eEEeeccccee
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLVRT 591 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~---~ki~DfGla~~ 591 (607)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 84 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999988854 245899999999999999999999987 999999999999987655 99999999988
Q ss_pred ecCC
Q 007336 592 FGGD 595 (607)
Q Consensus 592 ~~~~ 595 (607)
....
T Consensus 158 ~~~~ 161 (284)
T 3kk8_A 158 VNDS 161 (284)
T ss_dssp CCSS
T ss_pred cccC
Confidence 7543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=218.82 Aligned_cols=151 Identities=30% Similarity=0.416 Sum_probs=132.8
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|++.+.||+|+||.||++.... +..||||++.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 45689999999999999999998765 6789999986421 2235678999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999998542 34789999999999999999999887 9999999999999999999999999997654
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 161 ~ 161 (279)
T 3fdn_A 161 S 161 (279)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=217.69 Aligned_cols=153 Identities=33% Similarity=0.560 Sum_probs=125.5
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccc----hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|++.+.||+|+||.||++... ++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 3468999999999999999999974 8899999986522 2335789999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC--------CCceEEee
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--------DMNPKISD 585 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~--------~~~~ki~D 585 (607)
||||+++++|.+++. ...+++..+..++.|++.||+|||+.+..+|+||||||+|||++. ++.+||+|
T Consensus 84 v~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999984 235899999999999999999999987555899999999999986 67899999
Q ss_pred cccceeecCC
Q 007336 586 FGLVRTFGGD 595 (607)
Q Consensus 586 fGla~~~~~~ 595 (607)
||+++.+...
T Consensus 160 fg~~~~~~~~ 169 (271)
T 3dtc_A 160 FGLAREWHRT 169 (271)
T ss_dssp CCC-------
T ss_pred CCcccccccc
Confidence 9999877543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=221.71 Aligned_cols=149 Identities=28% Similarity=0.364 Sum_probs=130.2
Q ss_pred cCCcccc-eeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEE
Q 007336 439 TDNFSIN-NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 439 ~~~~~~~-~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
.+.|++. +.||+|+||.||+++.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3577774 78999999999999964 5899999999765555677899999999885 7999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc---eEEeecccceee
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFGLVRTF 592 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~---~ki~DfGla~~~ 592 (607)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.+
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999642 35789999999999999999999987 999999999999998776 999999999876
Q ss_pred c
Q 007336 593 G 593 (607)
Q Consensus 593 ~ 593 (607)
.
T Consensus 165 ~ 165 (316)
T 2ac3_A 165 K 165 (316)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=219.43 Aligned_cols=149 Identities=33% Similarity=0.505 Sum_probs=131.8
Q ss_pred CCc-ccceeecccCceeEEEEEec-----CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeC--Ce
Q 007336 440 DNF-SINNKLGEGGFGPVYKGTLV-----DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EE 510 (607)
Q Consensus 440 ~~~-~~~~~lg~G~fg~Vy~g~~~-----~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~ 510 (607)
++| ++.++||+|+||.||++.+. +++.||||++... .....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 88999999999999998753 4788999999753 345567899999999999999999999999984 67
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 8999999999999999954 23899999999999999999999987 9999999999999999999999999999
Q ss_pred eecCC
Q 007336 591 TFGGD 595 (607)
Q Consensus 591 ~~~~~ 595 (607)
.+...
T Consensus 183 ~~~~~ 187 (318)
T 3lxp_A 183 AVPEG 187 (318)
T ss_dssp ECCTT
T ss_pred ccccc
Confidence 88643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=222.77 Aligned_cols=153 Identities=26% Similarity=0.458 Sum_probs=127.0
Q ss_pred HhhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHcc--CCCCceeceEEEEEeC----C
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQG----E 509 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~--l~H~nIv~l~g~~~~~----~ 509 (607)
....++|++.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++.. ++||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 334568999999999999999999985 899999998643 22344445555544 4999999999999987 7
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecccCCCcEEEcCCCceEEe
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS-----RLRIIHRDLKASNVLLDQDMNPKIS 584 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~ivHrDlkp~Nill~~~~~~ki~ 584 (607)
..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.. +.+|+||||||+||||+.++.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 88999999999999999954 24899999999999999999999871 1249999999999999999999999
Q ss_pred ecccceeecCCC
Q 007336 585 DFGLVRTFGGDE 596 (607)
Q Consensus 585 DfGla~~~~~~~ 596 (607)
|||+|+.+....
T Consensus 185 Dfg~a~~~~~~~ 196 (337)
T 3mdy_A 185 DLGLAVKFISDT 196 (337)
T ss_dssp CCTTCEECC---
T ss_pred eCCCceeecccc
Confidence 999998875443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=223.94 Aligned_cols=149 Identities=29% Similarity=0.482 Sum_probs=131.6
Q ss_pred CCcccceeecccCceeEEEEEe-cCCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
+.|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999997 45889999998642 2334567999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||++ |+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||||++++.+||+|||+++.+..
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9998 6888877432 345899999999999999999999987 99999999999999999999999999987753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=232.25 Aligned_cols=150 Identities=26% Similarity=0.385 Sum_probs=127.4
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccc--------hhhHHHHHHHHHHHccCCCCceeceEEEEEeC
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~ 508 (607)
..++|.+.+.||+|+||+||+|.... ++.||||++.+.. ......+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 45789999999999999999999754 7899999986421 112235889999999999999999999974 5
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC---ceEEee
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISD 585 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~---~~ki~D 585 (607)
+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 568999999999999998843 345899999999999999999999987 99999999999997544 599999
Q ss_pred cccceeecC
Q 007336 586 FGLVRTFGG 594 (607)
Q Consensus 586 fGla~~~~~ 594 (607)
||+|+.+..
T Consensus 286 FG~a~~~~~ 294 (419)
T 3i6u_A 286 FGHSKILGE 294 (419)
T ss_dssp SSTTTSCC-
T ss_pred cccceecCC
Confidence 999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=216.86 Aligned_cols=152 Identities=32% Similarity=0.565 Sum_probs=133.0
Q ss_pred hcCCcccce-eecccCceeEEEEEec---CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 438 ATDNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 438 ~~~~~~~~~-~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
..++|.+.+ .||+|+||.||+|.+. .+..||||.+... .....+.+.+|+.++++++||||+++++++ +.+..+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 345676766 9999999999999864 4778999999763 345677899999999999999999999999 566789
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 86 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence 99999999999999953 3445899999999999999999999987 999999999999999999999999999988
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
...
T Consensus 161 ~~~ 163 (287)
T 1u59_A 161 GAD 163 (287)
T ss_dssp TTC
T ss_pred ccC
Confidence 544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-24 Score=215.99 Aligned_cols=151 Identities=28% Similarity=0.468 Sum_probs=135.6
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.+.|++.+.||+|+||.||+|+.. +++.||||.+... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356899999999999999999875 4889999998643 23456789999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
|+++++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+....
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999842 45899999999999999999999987 9999999999999999999999999999876543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=221.52 Aligned_cols=153 Identities=30% Similarity=0.562 Sum_probs=134.9
Q ss_pred hcCCcccceeecccCceeEEEEEe-----cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCC--e
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTL-----VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--E 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~--~ 510 (607)
..++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 345789999999999999999984 357899999998766666788999999999999999999999987644 6
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++||||+++++|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 79999999999999999653 245899999999999999999999987 9999999999999999999999999999
Q ss_pred eecCC
Q 007336 591 TFGGD 595 (607)
Q Consensus 591 ~~~~~ 595 (607)
.+...
T Consensus 194 ~~~~~ 198 (326)
T 2w1i_A 194 VLPQD 198 (326)
T ss_dssp ECCSS
T ss_pred hcccc
Confidence 87644
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=220.39 Aligned_cols=154 Identities=28% Similarity=0.414 Sum_probs=133.9
Q ss_pred hhcCCcccceeecccCceeEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEe----CCeE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEK 511 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~ 511 (607)
...++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 3456899999999999999999997 4589999999876566677889999999999999999999999873 3467
Q ss_pred EEEEEcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 512 LLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
++||||+++|+|.+++... .....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 8999999999999998642 22456899999999999999999999987 9999999999999999999999999988
Q ss_pred eec
Q 007336 591 TFG 593 (607)
Q Consensus 591 ~~~ 593 (607)
...
T Consensus 183 ~~~ 185 (317)
T 2buj_A 183 QAC 185 (317)
T ss_dssp ESC
T ss_pred hcc
Confidence 653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=241.62 Aligned_cols=151 Identities=31% Similarity=0.552 Sum_probs=130.5
Q ss_pred cCCcccce-eecccCceeEEEEEec---CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 439 TDNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 439 ~~~~~~~~-~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
.+++.+.+ .||+|+||.||+|.+. ++..||||+++.. .....++|.+|+.++++++|||||++++++.. +..+|
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34555555 7999999999999874 3567999999763 33467889999999999999999999999976 56899
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++|+|.+++.. ....+++..+..|+.||+.||+|||+.+ ||||||||+||||++++.+||+|||+|+.+.
T Consensus 413 v~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999999999954 3456899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 007336 594 GD 595 (607)
Q Consensus 594 ~~ 595 (607)
.+
T Consensus 488 ~~ 489 (613)
T 2ozo_A 488 AD 489 (613)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=222.16 Aligned_cols=141 Identities=27% Similarity=0.330 Sum_probs=124.5
Q ss_pred eeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEEEEcCCCCCh
Q 007336 446 NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (607)
+.||+|+||.||++... +++.||||++.+. ....+.+|+.++..+. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 68999999999999985 4889999998642 4467788999999997 99999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC---ceEEeecccceeecCC
Q 007336 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---NPKISDFGLVRTFGGD 595 (607)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~---~~ki~DfGla~~~~~~ 595 (607)
.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999965 345899999999999999999999987 99999999999998765 8999999999976543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.6e-24 Score=223.92 Aligned_cols=155 Identities=22% Similarity=0.395 Sum_probs=136.3
Q ss_pred HHhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc--------hhhHHHHHHHHHHHccC-CCCceeceEEE
Q 007336 435 IANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--------EQGLKELKNEVILFSKL-QHRNLVKLLGC 504 (607)
Q Consensus 435 ~~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--------~~~~~~f~~E~~~l~~l-~H~nIv~l~g~ 504 (607)
.....++|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445568999999999999999999986 58999999986422 12245688999999998 79999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEe
Q 007336 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (607)
Q Consensus 505 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~ 584 (607)
+......+|||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999964 245899999999999999999999987 9999999999999999999999
Q ss_pred ecccceeecCC
Q 007336 585 DFGLVRTFGGD 595 (607)
Q Consensus 585 DfGla~~~~~~ 595 (607)
|||+++.+...
T Consensus 243 DfG~~~~~~~~ 253 (365)
T 2y7j_A 243 DFGFSCHLEPG 253 (365)
T ss_dssp CCTTCEECCTT
T ss_pred ecCcccccCCC
Confidence 99999988644
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=222.39 Aligned_cols=153 Identities=30% Similarity=0.507 Sum_probs=129.8
Q ss_pred hcCCcccceeecccCceeEEEEEecC-----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-----~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 511 (607)
...+|++.+.||+|+||.||+|.... +..||||.+... .......+.+|+.++++++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 34578888999999999999998753 235999998753 344566799999999999999999999999999999
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++||||+++|+|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999999643 345899999999999999999999987 99999999999999999999999999998
Q ss_pred ecCC
Q 007336 592 FGGD 595 (607)
Q Consensus 592 ~~~~ 595 (607)
+...
T Consensus 197 ~~~~ 200 (333)
T 1mqb_A 197 LEDD 200 (333)
T ss_dssp ----
T ss_pred hccc
Confidence 7543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.5e-24 Score=216.43 Aligned_cols=151 Identities=25% Similarity=0.415 Sum_probs=129.2
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc----hhhHHHHHHHHHHHccCCCCceeceEEEEE--eCCeE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCI--QGEEK 511 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~--~~~~~ 511 (607)
.++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999975 47899999987532 234678999999999999999999999985 34578
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++||||++++ |.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999977 77776543 2446899999999999999999999987 99999999999999999999999999998
Q ss_pred ecC
Q 007336 592 FGG 594 (607)
Q Consensus 592 ~~~ 594 (607)
+..
T Consensus 159 ~~~ 161 (305)
T 2wtk_C 159 LHP 161 (305)
T ss_dssp CCT
T ss_pred cCc
Confidence 754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=228.31 Aligned_cols=149 Identities=32% Similarity=0.554 Sum_probs=123.2
Q ss_pred CcccceeecccCceeEEEEEecC--C--cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEe-CCeEEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLI 514 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~--~--~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~lV 514 (607)
.|++.+.||+|+||.||+|++.+ + ..||||.+... .....++|.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46778999999999999998743 2 36899998653 34566789999999999999999999999865 4577999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++|+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++.+..
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999964 2345789999999999999999999987 99999999999999999999999999997744
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=218.51 Aligned_cols=152 Identities=31% Similarity=0.528 Sum_probs=131.1
Q ss_pred cCCcccceeecccCceeEEEEEecC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEe-CCeEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKL 512 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~ 512 (607)
..+|++.+.||+|+||.||+|+..+ ...||+|.+... .....+.+.+|+.++++++||||+++++++.+ ++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468888999999999999998643 235899998753 34556789999999999999999999999765 45679
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999964 3345789999999999999999999987 999999999999999999999999999977
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
...
T Consensus 179 ~~~ 181 (298)
T 3f66_A 179 YDK 181 (298)
T ss_dssp SCG
T ss_pred ccc
Confidence 543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=222.27 Aligned_cols=152 Identities=31% Similarity=0.576 Sum_probs=126.1
Q ss_pred cCCcccceeecccCceeEEEEEecC-Cc----EEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
.++|++.++||+|+||.||+|.... ++ .|++|.+.. ......+++.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 4689999999999999999999743 44 367777754 23445678999999999999999999999998765 78
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+|+||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999999653 345899999999999999999999987 999999999999999999999999999987
Q ss_pred cCCC
Q 007336 593 GGDE 596 (607)
Q Consensus 593 ~~~~ 596 (607)
....
T Consensus 168 ~~~~ 171 (327)
T 3lzb_A 168 GAEE 171 (327)
T ss_dssp ----
T ss_pred cCcc
Confidence 5443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-24 Score=233.21 Aligned_cols=152 Identities=32% Similarity=0.456 Sum_probs=132.2
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccch-------------hhHHHHHHHHHHHccCCCCceeceEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISE-------------QGLKELKNEVILFSKLQHRNLVKLLG 503 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~-------------~~~~~f~~E~~~l~~l~H~nIv~l~g 503 (607)
..++|.+.++||+|+||+||+++... ++.||||++.+... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45689999999999999999999864 78999999865221 23567899999999999999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC---c
Q 007336 504 CCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM---N 580 (607)
Q Consensus 504 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~---~ 580 (607)
++.+....++||||+++|+|.+++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999999854 245899999999999999999999987 99999999999998776 6
Q ss_pred eEEeecccceeecCC
Q 007336 581 PKISDFGLVRTFGGD 595 (607)
Q Consensus 581 ~ki~DfGla~~~~~~ 595 (607)
+||+|||+|+.+...
T Consensus 188 ~kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD 202 (504)
T ss_dssp EEECCCTTCEECCTT
T ss_pred EEEEECCCCEEcCCC
Confidence 999999999988654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-24 Score=218.44 Aligned_cols=152 Identities=19% Similarity=0.262 Sum_probs=130.5
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++.+++||||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3468999999999999999999975 5889999998753 23345789999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999999642 35899999999999999999999987 9999999999999999999999999998775
Q ss_pred CC
Q 007336 594 GD 595 (607)
Q Consensus 594 ~~ 595 (607)
..
T Consensus 186 ~~ 187 (309)
T 2h34_A 186 DE 187 (309)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-24 Score=221.04 Aligned_cols=150 Identities=30% Similarity=0.489 Sum_probs=130.5
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
.++|++.+.||+|+||.||+++... ++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3579999999999999999999865 889999998542 2334567889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999988743 335899999999999999999999987 99999999999999999999999999987654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=224.25 Aligned_cols=152 Identities=20% Similarity=0.301 Sum_probs=127.0
Q ss_pred hcCCcccceeecccCceeEEEEEecC------CcEEEEEEecccchhh-----------HHHHHHHHHHHccCCCCceec
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQG-----------LKELKNEVILFSKLQHRNLVK 500 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~~~~-----------~~~f~~E~~~l~~l~H~nIv~ 500 (607)
..++|++.+.||+|+||.||+|.+.. ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998865 3689999986532211 123445667788899999999
Q ss_pred eEEEEEeC----CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc
Q 007336 501 LLGCCIQG----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD 576 (607)
Q Consensus 501 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~ 576 (607)
+++++... ...+|||||+ +++|.+++... ...+++..++.|+.||+.||+|||+.+ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999874 4579999999 99999999652 345899999999999999999999987 99999999999999
Q ss_pred --CCCceEEeecccceeecCC
Q 007336 577 --QDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 577 --~~~~~ki~DfGla~~~~~~ 595 (607)
.++.+||+|||+|+.+...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~ 207 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPE 207 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGG
T ss_pred cCCCCeEEEEECCcceecccC
Confidence 8899999999999987543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=232.88 Aligned_cols=149 Identities=30% Similarity=0.438 Sum_probs=125.5
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeC------
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------ 508 (607)
..++|++.++||+|+||+||++.... ++.||||++.+. .....+++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 35689999999999999999998754 889999999753 345567889999999999999999999999654
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccc
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGl 588 (607)
...+|||||++++ |.+.+. ..+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 3579999999865 666652 23789999999999999999999987 99999999999999999999999999
Q ss_pred ceeecCC
Q 007336 589 VRTFGGD 595 (607)
Q Consensus 589 a~~~~~~ 595 (607)
|+.....
T Consensus 211 a~~~~~~ 217 (464)
T 3ttj_A 211 ARTAGTS 217 (464)
T ss_dssp C-----C
T ss_pred eeecCCC
Confidence 9987543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.7e-24 Score=215.04 Aligned_cols=153 Identities=25% Similarity=0.359 Sum_probs=135.0
Q ss_pred hhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc---------hhhHHHHHHHHHHHccCC-CCceeceEEEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---------EQGLKELKNEVILFSKLQ-HRNLVKLLGCC 505 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---------~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~ 505 (607)
...++|++.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999985 47899999986421 123467889999999995 99999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEee
Q 007336 506 IQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (607)
Q Consensus 506 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~D 585 (607)
......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999964 245899999999999999999999987 99999999999999999999999
Q ss_pred cccceeecCC
Q 007336 586 FGLVRTFGGD 595 (607)
Q Consensus 586 fGla~~~~~~ 595 (607)
||+++.+...
T Consensus 168 fg~~~~~~~~ 177 (298)
T 1phk_A 168 FGFSCQLDPG 177 (298)
T ss_dssp CTTCEECCTT
T ss_pred ccchhhcCCC
Confidence 9999987543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=233.50 Aligned_cols=151 Identities=30% Similarity=0.399 Sum_probs=129.3
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
.++|++.++||+|+||+||+++.. .+..||||++.+. .......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 347999999999999999999986 4789999998753 2334577899999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC---CceEEeecccceee
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRTF 592 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~---~~~ki~DfGla~~~ 592 (607)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.. +.+||+|||+|+.+
T Consensus 116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999988542 34789999999999999999999987 9999999999999764 55999999999988
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
...
T Consensus 190 ~~~ 192 (494)
T 3lij_A 190 ENQ 192 (494)
T ss_dssp BTT
T ss_pred CCC
Confidence 654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-24 Score=216.84 Aligned_cols=149 Identities=28% Similarity=0.508 Sum_probs=131.9
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEe----------
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ---------- 507 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~---------- 507 (607)
.++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 357899999999999999999975 589999999865 34556789999999999999999999999876
Q ss_pred ---CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEe
Q 007336 508 ---GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (607)
Q Consensus 508 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~ 584 (607)
....++||||+++++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 34578999999999999999642 345788899999999999999999987 9999999999999999999999
Q ss_pred ecccceeec
Q 007336 585 DFGLVRTFG 593 (607)
Q Consensus 585 DfGla~~~~ 593 (607)
|||+++.+.
T Consensus 159 dfg~~~~~~ 167 (303)
T 1zy4_A 159 DFGLAKNVH 167 (303)
T ss_dssp CCCCCSCTT
T ss_pred eCcchhhcc
Confidence 999998764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=218.63 Aligned_cols=149 Identities=30% Similarity=0.492 Sum_probs=131.7
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
..++|++.+.||+|+||.||+|+... ++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 44689999999999999999999864 88999999876555667889999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
|+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 99999999998542 244899999999999999999999987 99999999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=7.6e-24 Score=218.56 Aligned_cols=149 Identities=34% Similarity=0.548 Sum_probs=122.6
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHH--HHccCCCCceeceEEEEEe-----CCe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVI--LFSKLQHRNLVKLLGCCIQ-----GEE 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~--~l~~l~H~nIv~l~g~~~~-----~~~ 510 (607)
..++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.. .+..++||||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 456899999999999999999987 68999999986532 233444444 4556899999999987653 225
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCceEecccCCCcEEEcCCCceEEe
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS------RLRIIHRDLKASNVLLDQDMNPKIS 584 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------~~~ivHrDlkp~Nill~~~~~~ki~ 584 (607)
.++||||+++|+|.+++... ..++..+..|+.||++||+|||+.. +.+|+||||||+||||+.++.+||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 68999999999999999542 3488999999999999999999871 1139999999999999999999999
Q ss_pred ecccceeecC
Q 007336 585 DFGLVRTFGG 594 (607)
Q Consensus 585 DfGla~~~~~ 594 (607)
|||+|+.+..
T Consensus 163 DFG~a~~~~~ 172 (336)
T 3g2f_A 163 DFGLSMRLTG 172 (336)
T ss_dssp CCTTCEECSS
T ss_pred eccceeeccc
Confidence 9999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=214.64 Aligned_cols=151 Identities=26% Similarity=0.456 Sum_probs=135.2
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|.+.+.||+|+||.||+++.. +++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999986 58999999986522 2345688999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999999543 34789999999999999999999987 9999999999999999999999999998775
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 163 ~ 163 (276)
T 2h6d_A 163 D 163 (276)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=216.91 Aligned_cols=153 Identities=29% Similarity=0.474 Sum_probs=131.8
Q ss_pred hhcCCcccce-eecccCceeEEEEEec---CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe
Q 007336 437 NATDNFSINN-KLGEGGFGPVYKGTLV---DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 437 ~~~~~~~~~~-~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 510 (607)
...++|.+.+ .||+|+||.||+|.+. .++.||||++... .....+++.+|+.+++.++||||+++++++ +.+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3446788887 9999999999999653 3678999998753 233467899999999999999999999999 6677
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred cEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 89999999999999999652 34889999999999999999999987 9999999999999999999999999999
Q ss_pred eecCCC
Q 007336 591 TFGGDE 596 (607)
Q Consensus 591 ~~~~~~ 596 (607)
.+....
T Consensus 166 ~~~~~~ 171 (291)
T 1xbb_A 166 ALRADE 171 (291)
T ss_dssp ECCTTC
T ss_pred eeccCC
Confidence 876543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=221.87 Aligned_cols=154 Identities=32% Similarity=0.543 Sum_probs=131.1
Q ss_pred hcCCcccceeecccCceeEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 510 (607)
..++|++.+.||+|+||.||+|+.. .+..||||.+... ......++.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 4468999999999999999999842 3678999998643 34556789999999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCceEE
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTR----RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKI 583 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~---~~~~ki 583 (607)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999975432 245889999999999999999999987 999999999999994 456999
Q ss_pred eecccceeecC
Q 007336 584 SDFGLVRTFGG 594 (607)
Q Consensus 584 ~DfGla~~~~~ 594 (607)
+|||+++.+..
T Consensus 185 ~Dfg~~~~~~~ 195 (327)
T 2yfx_A 185 GDFGMARDIYR 195 (327)
T ss_dssp CCCHHHHHHHC
T ss_pred Ccccccccccc
Confidence 99999986643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.8e-25 Score=231.00 Aligned_cols=152 Identities=18% Similarity=0.227 Sum_probs=125.7
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecc---cchhhHHHHHHHH---HHHccCCCCceeceE-------E
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEV---ILFSKLQHRNLVKLL-------G 503 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~---~~~~~~~~f~~E~---~~l~~l~H~nIv~l~-------g 503 (607)
..++|++.+.||+|+||+||+|+.. +++.||||++.. ......+.|.+|+ .++++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 4568999999999999999999974 589999999863 2344567899999 566667899999998 6
Q ss_pred EEEeCC-----------------eEEEEEEcCCCCChHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 007336 504 CCIQGE-----------------EKLLIYEFMPNKSLDSFIFDQTR----RTLLDWSQRFHIICGTARGLLYLHQDSRLR 562 (607)
Q Consensus 504 ~~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 562 (607)
++.+.+ ..+|||||+ +|+|.+++..... ...+++..++.|+.||++||+|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 666553 278999999 6899999964211 123446888899999999999999987
Q ss_pred eEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 563 ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+||||||+||||+.++.+||+|||+|+..+
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 9999999999999999999999999999654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=4e-24 Score=214.93 Aligned_cols=149 Identities=32% Similarity=0.521 Sum_probs=130.9
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEe----------
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ---------- 507 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~---------- 507 (607)
.++|++.+.||+|+||.||+++.. +++.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 357899999999999999999986 58999999987533 356789999999999999999999864
Q ss_pred ------CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCce
Q 007336 508 ------GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (607)
Q Consensus 508 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ 581 (607)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 34478999999999999999643 2346899999999999999999999987 9999999999999999999
Q ss_pred EEeecccceeecCC
Q 007336 582 KISDFGLVRTFGGD 595 (607)
Q Consensus 582 ki~DfGla~~~~~~ 595 (607)
||+|||+++.+...
T Consensus 162 kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 162 KIGDFGLVTSLKND 175 (284)
T ss_dssp EECCCTTCEESSCC
T ss_pred EECcchhheecccc
Confidence 99999999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=214.33 Aligned_cols=149 Identities=26% Similarity=0.423 Sum_probs=132.7
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccc------hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
++|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46889999999999999999986 48999999986521 123678999999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC----ceEEeeccc
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFGL 588 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~----~~ki~DfGl 588 (607)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999954 235899999999999999999999987 99999999999999877 799999999
Q ss_pred ceeecC
Q 007336 589 VRTFGG 594 (607)
Q Consensus 589 a~~~~~ 594 (607)
++.+..
T Consensus 159 ~~~~~~ 164 (283)
T 3bhy_A 159 AHKIEA 164 (283)
T ss_dssp CEECC-
T ss_pred ceeccC
Confidence 998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=217.95 Aligned_cols=149 Identities=30% Similarity=0.481 Sum_probs=129.7
Q ss_pred CcccceeecccCceeEEEEEecC-C---cEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeE-EEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK-LLI 514 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~-~---~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~-~lV 514 (607)
.|.+.++||+|+||+||+|+..+ + ..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45666899999999999998643 2 37999998753 335567899999999999999999999999876665 999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+.+|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999964 3345789999999999999999999987 99999999999999999999999999986643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.8e-24 Score=214.46 Aligned_cols=151 Identities=19% Similarity=0.339 Sum_probs=132.4
Q ss_pred hcCCcccceeecccCceeEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
..++|++.+.||+|+||.||+|+. .+++.||||++... ...+.+.+|+.++..+ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 346799999999999999999996 45899999998643 2334678899999999 7999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc-----eEEeecccce
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKISDFGLVR 590 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~-----~ki~DfGla~ 590 (607)
||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 99999999653 335899999999999999999999887 999999999999987776 9999999999
Q ss_pred eecCCC
Q 007336 591 TFGGDE 596 (607)
Q Consensus 591 ~~~~~~ 596 (607)
.+....
T Consensus 160 ~~~~~~ 165 (298)
T 1csn_A 160 FYRDPV 165 (298)
T ss_dssp ESBCTT
T ss_pred cccccc
Confidence 886543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=219.29 Aligned_cols=150 Identities=33% Similarity=0.591 Sum_probs=129.9
Q ss_pred CCcccceeecccCceeEEEEEecC-CcE--EEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQE--IAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~--vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV 514 (607)
++|++.+.||+|+||.||+++... +.. ||||.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 578999999999999999999754 554 599988652 334556799999999999 999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCce
Q 007336 515 YEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ 581 (607)
|||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996532 2346899999999999999999999987 9999999999999999999
Q ss_pred EEeecccceee
Q 007336 582 KISDFGLVRTF 592 (607)
Q Consensus 582 ki~DfGla~~~ 592 (607)
||+|||+++..
T Consensus 182 kL~Dfg~~~~~ 192 (327)
T 1fvr_A 182 KIADFGLSRGQ 192 (327)
T ss_dssp EECCTTCEESS
T ss_pred EEcccCcCccc
Confidence 99999999844
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=220.20 Aligned_cols=151 Identities=27% Similarity=0.441 Sum_probs=126.7
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
.++|++.+.||+|+||.||+++.. ++.||||++.. ....+.|.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 357888999999999999999874 78899999864 345678999999999999999999999876 4478999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc-eEEeecccceeecC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-PKISDFGLVRTFGG 594 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~-~ki~DfGla~~~~~ 594 (607)
++|+|.+++........+++..++.++.||++||+|||+.+..+|+||||||+||||+.++. +||+|||+++.+..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999976544456789999999999999999999943345999999999999998886 79999999987643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=214.83 Aligned_cols=152 Identities=28% Similarity=0.470 Sum_probs=125.4
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc-----hhhHHHHHHHHHHHccC---CCCceeceEEEEEeC
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-----EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQG 508 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~~~ 508 (607)
..++|++.++||+|+||+||+|+.. +++.||||++.... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999974 58899999986421 11124556676666655 599999999999876
Q ss_pred C-----eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEE
Q 007336 509 E-----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKI 583 (607)
Q Consensus 509 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki 583 (607)
. ..++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999998 69999986532 334899999999999999999999987 999999999999999999999
Q ss_pred eecccceeecC
Q 007336 584 SDFGLVRTFGG 594 (607)
Q Consensus 584 ~DfGla~~~~~ 594 (607)
+|||+|+.+..
T Consensus 162 ~Dfg~a~~~~~ 172 (308)
T 3g33_A 162 ADFGLARIYSY 172 (308)
T ss_dssp CSCSCTTTSTT
T ss_pred eeCccccccCC
Confidence 99999987754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=5.1e-24 Score=214.51 Aligned_cols=151 Identities=28% Similarity=0.408 Sum_probs=133.9
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccc---hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|++.+.||+|+||.||+++... ++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 34679999999999999999999864 7789999986421 2235678999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999998643 34789999999999999999999887 9999999999999999999999999998765
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 166 ~ 166 (284)
T 2vgo_A 166 S 166 (284)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.4e-24 Score=214.00 Aligned_cols=151 Identities=25% Similarity=0.395 Sum_probs=130.7
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEe----CCeEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKL 512 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~ 512 (607)
..|.+.+.||+|+||.||+|.... +..||+|.+.. ......+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 457888999999999999999754 78899999864 234556789999999999999999999999876 35579
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCceEEeeccccee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRT 591 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~-~~~~~ki~DfGla~~ 591 (607)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||+++.
T Consensus 106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999954 245789999999999999999999864 3599999999999998 789999999999986
Q ss_pred ecC
Q 007336 592 FGG 594 (607)
Q Consensus 592 ~~~ 594 (607)
...
T Consensus 182 ~~~ 184 (290)
T 1t4h_A 182 KRA 184 (290)
T ss_dssp CCT
T ss_pred ccc
Confidence 543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.8e-24 Score=222.96 Aligned_cols=153 Identities=25% Similarity=0.385 Sum_probs=135.2
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchh-----------------hHHHHHHHHHHHccCCCCceec
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQ-----------------GLKELKNEVILFSKLQHRNLVK 500 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~-----------------~~~~f~~E~~~l~~l~H~nIv~ 500 (607)
..++|++.+.||+|+||.||+++. +++.||||.+...... ..+.+.+|+.++++++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 346899999999999999999999 8999999998652211 1278999999999999999999
Q ss_pred eEEEEEeCCeEEEEEEcCCCCChHHH------HhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcE
Q 007336 501 LLGCCIQGEEKLLIYEFMPNKSLDSF------IFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNV 573 (607)
Q Consensus 501 l~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivHrDlkp~Ni 573 (607)
+++++.+.+..++||||+++++|.++ +.. .....+++..+..++.||+.||.|||+ .+ |+||||||+||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI 183 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence 99999999999999999999999998 432 224668999999999999999999998 76 99999999999
Q ss_pred EEcCCCceEEeecccceeecCC
Q 007336 574 LLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 574 ll~~~~~~ki~DfGla~~~~~~ 595 (607)
|++.++.+||+|||+++.+...
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~ 205 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK 205 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT
T ss_pred EEcCCCcEEEeccccccccccc
Confidence 9999999999999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=224.24 Aligned_cols=158 Identities=24% Similarity=0.397 Sum_probs=132.8
Q ss_pred hHHhHHhhcCCcccceeecccCceeEEEEEecCCcEEEEEEeccc-----------chhhHHHHHHHHHHHccCCCCcee
Q 007336 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI-----------SEQGLKELKNEVILFSKLQHRNLV 499 (607)
Q Consensus 431 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~-----------~~~~~~~f~~E~~~l~~l~H~nIv 499 (607)
...++....++|++.+.||+|+||.||+|...++..||||++... .....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 355677788999999999999999999999888999999998542 122347899999999999999999
Q ss_pred ceEEEEEeC-----CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEE
Q 007336 500 KLLGCCIQG-----EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVL 574 (607)
Q Consensus 500 ~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nil 574 (607)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998653 35799999998 688888754 3346899999999999999999999987 999999999999
Q ss_pred EcCCCceEEeecccceeecC
Q 007336 575 LDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 575 l~~~~~~ki~DfGla~~~~~ 594 (607)
|+.++.+||+|||+++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~ 186 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTA 186 (362)
T ss_dssp ECTTCCEEECCTTC------
T ss_pred EcCCCCEEEEecCccccccc
Confidence 99999999999999986543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-24 Score=221.07 Aligned_cols=148 Identities=23% Similarity=0.418 Sum_probs=127.3
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
..++|++.+.||+|+||.||++.... ++.||||++.+... .+.+|+.++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 34579999999999999999999864 88999999975332 234577777777 7999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC----CceEEeeccccee
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD----MNPKISDFGLVRT 591 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~----~~~ki~DfGla~~ 591 (607)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999854 345899999999999999999999987 9999999999998543 3599999999998
Q ss_pred ecCC
Q 007336 592 FGGD 595 (607)
Q Consensus 592 ~~~~ 595 (607)
+...
T Consensus 170 ~~~~ 173 (342)
T 2qr7_A 170 LRAE 173 (342)
T ss_dssp CBCT
T ss_pred CcCC
Confidence 7644
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2e-24 Score=222.50 Aligned_cols=151 Identities=31% Similarity=0.483 Sum_probs=127.0
Q ss_pred HhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
....++|++.++||+|+||+||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345568999999999999999999875 58899999986532 233567889999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE-----cCCCceEEeecc
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-----DQDMNPKISDFG 587 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill-----~~~~~~ki~DfG 587 (607)
+||||++ |+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||| ++++.+||+|||
T Consensus 110 lv~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999998 5999998543 34899999999999999999999987 9999999999999 455569999999
Q ss_pred cceeec
Q 007336 588 LVRTFG 593 (607)
Q Consensus 588 la~~~~ 593 (607)
+|+.+.
T Consensus 183 ~a~~~~ 188 (329)
T 3gbz_A 183 LARAFG 188 (329)
T ss_dssp HHHHHC
T ss_pred CccccC
Confidence 998765
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=220.36 Aligned_cols=159 Identities=31% Similarity=0.504 Sum_probs=135.6
Q ss_pred hHHhHHhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEEe-
Q 007336 431 ELATIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ- 507 (607)
Q Consensus 431 ~~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~- 507 (607)
.+..+....++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++.++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34455567789999999999999999999984 5889999998653 23456788999999998 89999999999987
Q ss_pred -----CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceE
Q 007336 508 -----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582 (607)
Q Consensus 508 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~k 582 (607)
....++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 46789999999999999999653 2346889999999999999999999987 99999999999999999999
Q ss_pred EeecccceeecC
Q 007336 583 ISDFGLVRTFGG 594 (607)
Q Consensus 583 i~DfGla~~~~~ 594 (607)
|+|||+++.+..
T Consensus 170 l~Dfg~~~~~~~ 181 (326)
T 2x7f_A 170 LVDFGVSAQLDR 181 (326)
T ss_dssp ECCCTTTC----
T ss_pred EeeCcCceecCc
Confidence 999999987753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.91 E-value=5.8e-24 Score=225.02 Aligned_cols=146 Identities=24% Similarity=0.325 Sum_probs=123.0
Q ss_pred CCcccc-eeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHH-ccCCCCceeceEEEEEe----CCeEE
Q 007336 440 DNFSIN-NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILF-SKLQHRNLVKLLGCCIQ----GEEKL 512 (607)
Q Consensus 440 ~~~~~~-~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l-~~l~H~nIv~l~g~~~~----~~~~~ 512 (607)
++|.+. +.||+|+||+||++.... ++.||||++... ..+.+|+.++ +..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 466665 689999999999999754 889999998642 3456777776 45689999999999876 55689
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCceEEeecccc
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLV 589 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~---~~~~ki~DfGla 589 (607)
|||||+++|+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999996532 345899999999999999999999987 999999999999998 788999999999
Q ss_pred eeecC
Q 007336 590 RTFGG 594 (607)
Q Consensus 590 ~~~~~ 594 (607)
+....
T Consensus 212 ~~~~~ 216 (400)
T 1nxk_A 212 KETTS 216 (400)
T ss_dssp EECC-
T ss_pred cccCC
Confidence 97753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=218.92 Aligned_cols=156 Identities=26% Similarity=0.422 Sum_probs=120.9
Q ss_pred HhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
....++|++.+.||+|+||.||++... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345678999999999999999999864 58899999886422 3445678899999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccc
Q 007336 514 IYEFMPNKSLDSFIFDQ-----TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGl 588 (607)
||||+++++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998531 12456899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 007336 589 VRTFGG 594 (607)
Q Consensus 589 a~~~~~ 594 (607)
++.+..
T Consensus 168 ~~~~~~ 173 (303)
T 2vwi_A 168 SAFLAT 173 (303)
T ss_dssp HHHCC-
T ss_pred hheecc
Confidence 987643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.1e-24 Score=211.91 Aligned_cols=153 Identities=27% Similarity=0.407 Sum_probs=133.4
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeC--CeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~--~~~~l 513 (607)
..++|++.+.||+|+||.||+|+.. ++.||||++... .....+.|.+|+.++++++||||+++++++.+. ...++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 3457899999999999999999984 889999998752 345567899999999999999999999999877 67899
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred eecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999999653 2335899999999999999999999864 349999999999999999999999999876543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=7.5e-24 Score=216.67 Aligned_cols=148 Identities=27% Similarity=0.443 Sum_probs=125.3
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEE-----------
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI----------- 506 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~----------- 506 (607)
.++|++.+.||+|+||.||+|.... ++.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999865 8899999987666667788999999999999999999999873
Q ss_pred ---eCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCceE
Q 007336 507 ---QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPK 582 (607)
Q Consensus 507 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~-~~~~~k 582 (607)
+....++||||++ |+|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 699999842 35789999999999999999999987 99999999999997 567999
Q ss_pred EeecccceeecC
Q 007336 583 ISDFGLVRTFGG 594 (607)
Q Consensus 583 i~DfGla~~~~~ 594 (607)
|+|||+++.+..
T Consensus 162 l~Dfg~~~~~~~ 173 (320)
T 2i6l_A 162 IGDFGLARIMDP 173 (320)
T ss_dssp ECCCTTCBCC--
T ss_pred EccCccccccCC
Confidence 999999997753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=221.22 Aligned_cols=148 Identities=29% Similarity=0.493 Sum_probs=128.1
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccchh-hHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++|.+.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999986 5889999998653221 122456799999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++ |+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 98 5898888653 345889999999999999999999987 9999999999999999999999999998764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=222.91 Aligned_cols=152 Identities=33% Similarity=0.497 Sum_probs=126.2
Q ss_pred hhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchh-----hHHHHHHHHHHHccCCCCceeceEEEEEeCCe
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQ-----GLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~-----~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~ 510 (607)
...++|++.+.||+|+||.||+++... ++.||||++...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 345689999999999999999999854 889999998642211 12468899999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++||||+++ +|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 88888854 2345788899999999999999999987 9999999999999999999999999999
Q ss_pred eecC
Q 007336 591 TFGG 594 (607)
Q Consensus 591 ~~~~ 594 (607)
.+..
T Consensus 161 ~~~~ 164 (346)
T 1ua2_A 161 SFGS 164 (346)
T ss_dssp TTTS
T ss_pred eccC
Confidence 7753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.9e-24 Score=215.54 Aligned_cols=154 Identities=25% Similarity=0.454 Sum_probs=128.6
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecc---cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
..++|++.+.||+|+||.||++... +++.||||++.. ......+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3457999999999999999999974 589999999864 234556789999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 514 IYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
||||+++++|.+++... .....+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999998542 22456899999999999999999999987 999999999999999999999999999877
Q ss_pred cC
Q 007336 593 GG 594 (607)
Q Consensus 593 ~~ 594 (607)
..
T Consensus 187 ~~ 188 (310)
T 2wqm_A 187 SS 188 (310)
T ss_dssp --
T ss_pred cC
Confidence 54
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.3e-24 Score=213.62 Aligned_cols=152 Identities=32% Similarity=0.570 Sum_probs=129.4
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchh-------hHHHHHHHHHHHccCCCCceeceEEEEEeCC
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQ-------GLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~-------~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~ 509 (607)
..++|++.+.||+|+||.||+++.. +++.||||++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 4468999999999999999999985 5889999998642211 1167899999999999999999999986554
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc-----eEEe
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN-----PKIS 584 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~-----~ki~ 584 (607)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 6999999999999988643 346899999999999999999999864 34999999999999988776 9999
Q ss_pred ecccceeecC
Q 007336 585 DFGLVRTFGG 594 (607)
Q Consensus 585 DfGla~~~~~ 594 (607)
|||+++....
T Consensus 172 Dfg~~~~~~~ 181 (287)
T 4f0f_A 172 DFGLSQQSVH 181 (287)
T ss_dssp CCTTCBCCSS
T ss_pred CCCccccccc
Confidence 9999986543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-24 Score=222.88 Aligned_cols=149 Identities=24% Similarity=0.326 Sum_probs=134.0
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.++|++.+.||+|+||.||++... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999986 4889999998753 34556789999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+||||+.++.+||+|||+++.+.
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999542 3478999999999999999999985 5 9999999999999999999999999997653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-23 Score=219.23 Aligned_cols=150 Identities=29% Similarity=0.503 Sum_probs=129.5
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeC-------
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------- 508 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------- 508 (607)
.++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 368999999999999999999984 5899999998542 223345788999999999999999999999873
Q ss_pred -CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 509 -EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 509 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
+..++||||+++ +|.+.+... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 467999999985 777777442 235899999999999999999999987 9999999999999999999999999
Q ss_pred cceeecC
Q 007336 588 LVRTFGG 594 (607)
Q Consensus 588 la~~~~~ 594 (607)
+|+.+..
T Consensus 170 ~a~~~~~ 176 (351)
T 3mi9_A 170 LARAFSL 176 (351)
T ss_dssp TCEECCC
T ss_pred hcccccc
Confidence 9998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.5e-24 Score=218.29 Aligned_cols=150 Identities=25% Similarity=0.426 Sum_probs=130.8
Q ss_pred HhhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHcc--CCCCceeceEEEEEeCC----
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQGE---- 509 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~--l~H~nIv~l~g~~~~~~---- 509 (607)
....++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 33456899999999999999999998 5899999998642 34567778887776 79999999999998876
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecccCCCcEEEcCCCce
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH--------QDSRLRIIHRDLKASNVLLDQDMNP 581 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--------~~~~~~ivHrDlkp~Nill~~~~~~ 581 (607)
..++||||+++|+|.+++.. ..+++..+..++.||+.||+||| +.+ |+||||||+||||+.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999954 24799999999999999999999 555 9999999999999999999
Q ss_pred EEeecccceeecCCC
Q 007336 582 KISDFGLVRTFGGDE 596 (607)
Q Consensus 582 ki~DfGla~~~~~~~ 596 (607)
||+|||+++.+....
T Consensus 187 kL~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 187 CIADLGLAVRHDSAT 201 (342)
T ss_dssp EECCCTTCEEEETTT
T ss_pred EEEECCCceeccccc
Confidence 999999999886543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-23 Score=214.73 Aligned_cols=152 Identities=30% Similarity=0.505 Sum_probs=130.1
Q ss_pred hhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
...++|++.+.||+|+||.||+|.... ++.||||.+... ...+++.+|+.++.+++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 345689999999999999999999864 899999998753 23567899999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+++++|.+++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999853 2345899999999999999999999987 999999999999999999999999999987644
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=6.1e-24 Score=222.31 Aligned_cols=149 Identities=29% Similarity=0.457 Sum_probs=125.4
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCC-----
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 509 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~----- 509 (607)
..++|++.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3468999999999999999999985 489999999854 23345678899999999999999999999997653
Q ss_pred -eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccc
Q 007336 510 -EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (607)
Q Consensus 510 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGl 588 (607)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899999854 34789999999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 007336 589 VRTFGG 594 (607)
Q Consensus 589 a~~~~~ 594 (607)
|+....
T Consensus 175 a~~~~~ 180 (367)
T 1cm8_A 175 ARQADS 180 (367)
T ss_dssp CEECCS
T ss_pred cccccc
Confidence 998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.2e-24 Score=218.15 Aligned_cols=158 Identities=27% Similarity=0.402 Sum_probs=134.1
Q ss_pred hHHhhcCCcccc-eeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccC-CCCceeceEEEEEeC
Q 007336 434 TIANATDNFSIN-NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (607)
Q Consensus 434 ~~~~~~~~~~~~-~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~ 508 (607)
......+.|.+. +.||+|+||.||++... +++.||||++... ......++.+|+.++..+ +||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 334455577776 88999999999999986 4899999998753 223467889999999998 569999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCceEEee
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISD 585 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~---~~~~ki~D 585 (607)
+..++||||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||||+. ++.+||+|
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEee
Confidence 9999999999999999998542 2356899999999999999999999987 999999999999998 78999999
Q ss_pred cccceeecCC
Q 007336 586 FGLVRTFGGD 595 (607)
Q Consensus 586 fGla~~~~~~ 595 (607)
||+++.+...
T Consensus 178 fg~a~~~~~~ 187 (327)
T 3lm5_A 178 FGMSRKIGHA 187 (327)
T ss_dssp GGGCEEC---
T ss_pred CccccccCCc
Confidence 9999987543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-24 Score=220.50 Aligned_cols=157 Identities=31% Similarity=0.431 Sum_probs=135.0
Q ss_pred HhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCceeceEEEEEe------
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ------ 507 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~------ 507 (607)
.....+|++.++||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 334458999999999999999999975 58899999987656666778999999999996 9999999999953
Q ss_pred --CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEee
Q 007336 508 --GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISD 585 (607)
Q Consensus 508 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~D 585 (607)
....++||||++ |+|.+++........+++..+..|+.||+.||.|||+.+ .+|+||||||+||||+.++.+||+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence 334789999996 799998865444456899999999999999999999864 3499999999999999999999999
Q ss_pred cccceeecC
Q 007336 586 FGLVRTFGG 594 (607)
Q Consensus 586 fGla~~~~~ 594 (607)
||+++.+..
T Consensus 182 fg~~~~~~~ 190 (337)
T 3ll6_A 182 FGSATTISH 190 (337)
T ss_dssp CTTCBCCSS
T ss_pred Cccceeccc
Confidence 999998754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=215.17 Aligned_cols=146 Identities=23% Similarity=0.441 Sum_probs=129.5
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCceeceEEEEEe--CCeEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ--GEEKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~--~~~~~lV 514 (607)
.++|++.+.||+|+||.||+++.. +++.||||++... ..+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 367999999999999999999874 5889999998753 3467889999999997 9999999999988 6678999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-ceEEeecccceeec
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFG 593 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~-~~ki~DfGla~~~~ 593 (607)
|||+++++|.+++. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+|||+|+.+.
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999999883 2788999999999999999999987 99999999999999776 89999999999875
Q ss_pred CCC
Q 007336 594 GDE 596 (607)
Q Consensus 594 ~~~ 596 (607)
...
T Consensus 183 ~~~ 185 (330)
T 3nsz_A 183 PGQ 185 (330)
T ss_dssp TTC
T ss_pred CCC
Confidence 443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.3e-24 Score=217.12 Aligned_cols=150 Identities=26% Similarity=0.386 Sum_probs=127.3
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEecccc--------hhhHHHHHHHHHHHccCCCCceeceEEEEEeCC
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 509 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~ 509 (607)
.++|++.+.||+|+||.||++.... ++.||||.+.... ......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 3579999999999999999999754 7899999986421 122345889999999999999999999987655
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc---eEEeec
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDF 586 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~---~ki~Df 586 (607)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 7999999999999999843 345899999999999999999999987 999999999999987664 999999
Q ss_pred ccceeecCC
Q 007336 587 GLVRTFGGD 595 (607)
Q Consensus 587 Gla~~~~~~ 595 (607)
|+++.+...
T Consensus 162 g~~~~~~~~ 170 (322)
T 2ycf_A 162 GHSKILGET 170 (322)
T ss_dssp TTCEECCCC
T ss_pred ccceecccc
Confidence 999987543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.7e-24 Score=232.57 Aligned_cols=152 Identities=32% Similarity=0.460 Sum_probs=133.8
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
..++|++.++||+|+||+||+++.. +++.||||++.+. .......+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3457999999999999999999985 5889999998642 233467899999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc---CCCceEEeeccccee
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRT 591 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~---~~~~~ki~DfGla~~ 591 (607)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+|+.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999988542 35899999999999999999999987 99999999999995 456799999999987
Q ss_pred ecCC
Q 007336 592 FGGD 595 (607)
Q Consensus 592 ~~~~ 595 (607)
+...
T Consensus 174 ~~~~ 177 (486)
T 3mwu_A 174 FQQN 177 (486)
T ss_dssp BCCC
T ss_pred CCCC
Confidence 7543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.2e-24 Score=215.53 Aligned_cols=154 Identities=29% Similarity=0.363 Sum_probs=123.0
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
..++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4568999999999999999999974 5889999998653 223334455666668889999999999999999999999
Q ss_pred EEcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 515 YEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|||++ |+|.+++... .....+++..+..++.||+.||+|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99998 5888777432 2345689999999999999999999997 6 999999999999999999999999999877
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
...
T Consensus 161 ~~~ 163 (290)
T 3fme_A 161 VDD 163 (290)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.1e-24 Score=216.81 Aligned_cols=149 Identities=26% Similarity=0.395 Sum_probs=130.7
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.++|.+.+.||+|+||.||+++.. +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 357899999999999999999985 5899999999765444556789999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE---cCCCceEEeecccceeec
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill---~~~~~~ki~DfGla~~~~ 593 (607)
+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999998542 35789999999999999999999987 9999999999999 788999999999998654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=211.47 Aligned_cols=143 Identities=10% Similarity=0.068 Sum_probs=126.8
Q ss_pred cCCcccceeecccCceeEEEEEecC-CcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
.++|++.+.||+|+||.||+|+... ++.||||.+... .....+.|.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3689999999999999999999865 899999999753 234457899999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
|||+++++|.+++.. . .......+|+.||+.||+|||+.+ |+||||||+||||+.++.+||+++|..
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecccc
Confidence 999999999999832 1 244567889999999999999987 999999999999999999999987754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.6e-24 Score=222.16 Aligned_cols=153 Identities=24% Similarity=0.378 Sum_probs=125.4
Q ss_pred HhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeC------
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------ 508 (607)
....++|++.+.||+|+||.||+|+.. +++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999874 589999999865322 234699999999999999999998543
Q ss_pred --------------------------------CeEEEEEEcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 007336 509 --------------------------------EEKLLIYEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYL 555 (607)
Q Consensus 509 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yL 555 (607)
...++||||++ |+|.+.+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999998 5887777531 2345689999999999999999999
Q ss_pred HhCCCCceEecccCCCcEEEc-CCCceEEeecccceeecCCC
Q 007336 556 HQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 556 H~~~~~~ivHrDlkp~Nill~-~~~~~ki~DfGla~~~~~~~ 596 (607)
|+.+ |+||||||+|||++ .++.+||+|||+|+.+....
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 196 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE 196 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC
Confidence 9887 99999999999998 68899999999999875443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.3e-24 Score=230.18 Aligned_cols=151 Identities=34% Similarity=0.458 Sum_probs=134.6
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
.++|++.+.||+|+||.||+++.. +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457999999999999999999986 5899999998642 234567899999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE---cCCCceEEeeccccee
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRT 591 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill---~~~~~~ki~DfGla~~ 591 (607)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999999854 345899999999999999999999987 9999999999999 5678999999999998
Q ss_pred ecCC
Q 007336 592 FGGD 595 (607)
Q Consensus 592 ~~~~ 595 (607)
+...
T Consensus 179 ~~~~ 182 (484)
T 3nyv_A 179 FEAS 182 (484)
T ss_dssp BCCC
T ss_pred cccc
Confidence 7544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.2e-24 Score=238.76 Aligned_cols=144 Identities=31% Similarity=0.487 Sum_probs=125.7
Q ss_pred eeecccCceeEEEEEec---CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLV---DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
++||+|+||.||+|.+. .++.||||+++.. .....++|.+|+.++++++|||||++++++. .+..+|||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999763 3578999999753 2344678999999999999999999999996 4567899999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
|+|.+++.. ...+++..+..|+.||+.||+|||+.+ ||||||||+||||++++.+||+|||+|+.+..+.
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 999999954 345899999999999999999999987 9999999999999999999999999999875443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.4e-24 Score=213.05 Aligned_cols=156 Identities=29% Similarity=0.441 Sum_probs=132.2
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEe--CCeEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLL 513 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~l 513 (607)
.++|++.+.||+|+||.||+++.. +++.||+|.+.. ......+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999985 588999999864 234556789999999999999999999998865 567899
Q ss_pred EEEcCCCCChHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 514 IYEFMPNKSLDSFIFDQT-RRTLLDWSQRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
||||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999996432 2345899999999999999999999865 1239999999999999999999999999998
Q ss_pred eecC
Q 007336 591 TFGG 594 (607)
Q Consensus 591 ~~~~ 594 (607)
.+..
T Consensus 165 ~~~~ 168 (279)
T 2w5a_A 165 ILNH 168 (279)
T ss_dssp HC--
T ss_pred eecc
Confidence 7654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.9e-24 Score=212.78 Aligned_cols=152 Identities=27% Similarity=0.455 Sum_probs=130.7
Q ss_pred hcCCcccceeecccCceeEEEEEecC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
..++|.+.+.||+|+||.||+|+... +..||||.+... .....+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45689999999999999999998643 236999998753 34556789999999999999999999999764 4568
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999999642 345789999999999999999999987 999999999999999999999999999977
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
...
T Consensus 164 ~~~ 166 (281)
T 3cc6_A 164 EDE 166 (281)
T ss_dssp ---
T ss_pred ccc
Confidence 543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=8.2e-24 Score=219.43 Aligned_cols=149 Identities=19% Similarity=0.294 Sum_probs=122.9
Q ss_pred cCCcccceeecccCceeEEEEEec----CCcEEEEEEecccchh-----------hHHHHHHHHHHHccCCCCceeceEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKISEQ-----------GLKELKNEVILFSKLQHRNLVKLLG 503 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~~~~-----------~~~~f~~E~~~l~~l~H~nIv~l~g 503 (607)
.++|++.+.||+|+||.||+|... .+..||||++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999985 4678999998653211 1234667888999999999999999
Q ss_pred EEEe----CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC
Q 007336 504 CCIQ----GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM 579 (607)
Q Consensus 504 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~ 579 (607)
++.. ....++||||+ +++|.+++... ..+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67889999999 99999998542 26899999999999999999999987 99999999999999887
Q ss_pred --ceEEeecccceeecC
Q 007336 580 --NPKISDFGLVRTFGG 594 (607)
Q Consensus 580 --~~ki~DfGla~~~~~ 594 (607)
.+||+|||+|+.+..
T Consensus 189 ~~~~kL~Dfg~a~~~~~ 205 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCP 205 (345)
T ss_dssp TTSEEECCCTTCEESSG
T ss_pred CCcEEEEeCCCceeccc
Confidence 999999999998753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-23 Score=219.55 Aligned_cols=150 Identities=24% Similarity=0.413 Sum_probs=131.4
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeC-----Ce
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~~ 510 (607)
..++|++.+.||+|+||.||++... ++..||||++... .....+.+.+|+.++.+++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3468999999999999999999975 4788999998753 334457899999999999999999999999764 35
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++||||++ |+|.+++.. ..+++..+..|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 799999998 589998854 34899999999999999999999987 9999999999999999999999999999
Q ss_pred eecCC
Q 007336 591 TFGGD 595 (607)
Q Consensus 591 ~~~~~ 595 (607)
.....
T Consensus 177 ~~~~~ 181 (364)
T 3qyz_A 177 VADPD 181 (364)
T ss_dssp ECCGG
T ss_pred ecCCC
Confidence 87543
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=212.77 Aligned_cols=150 Identities=31% Similarity=0.519 Sum_probs=130.4
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 57999999999999999999986 58999999986432 2234678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|++ ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~-~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 155 (299)
T 2r3i_A 83 FLH-QDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155 (299)
T ss_dssp CCS-EEHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ccc-CCHHHHHHhhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence 998 69999986532 245789999999999999999999987 99999999999999999999999999987653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=238.00 Aligned_cols=148 Identities=18% Similarity=0.327 Sum_probs=128.5
Q ss_pred cCCcccceeecccCceeEEEEEec--CCcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe-----
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 510 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~--~~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~----- 510 (607)
.++|++.+.||+|+||.||++.+. +++.||||++.. ......+.+.+|+.++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999985 588999999864 334556789999999999999999999999987655
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.+|||||+++++|.+++.. .+++..++.|+.||++||.|||+.+ ||||||||+||||+.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999887632 5899999999999999999999987 9999999999999986 89999999999
Q ss_pred eecCC
Q 007336 591 TFGGD 595 (607)
Q Consensus 591 ~~~~~ 595 (607)
.+...
T Consensus 230 ~~~~~ 234 (681)
T 2pzi_A 230 RINSF 234 (681)
T ss_dssp ETTCC
T ss_pred hcccC
Confidence 87543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.90 E-value=9.3e-24 Score=223.09 Aligned_cols=151 Identities=24% Similarity=0.367 Sum_probs=125.1
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe------EE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE------KL 512 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~------~~ 512 (607)
..+|++.+.||+|+||.||+++...+..||+|++..... ...+|+.+++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 347999999999999999999998877899998864322 22369999999999999999999965433 78
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCceEEeeccccee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRT 591 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~-~~~~~ki~DfGla~~ 591 (607)
+||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+||||+ .++.+||+|||+|+.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999997655444322223456899999999999999999999987 99999999999999 799999999999998
Q ss_pred ecCCC
Q 007336 592 FGGDE 596 (607)
Q Consensus 592 ~~~~~ 596 (607)
+....
T Consensus 192 ~~~~~ 196 (394)
T 4e7w_A 192 LIAGE 196 (394)
T ss_dssp CCTTC
T ss_pred ccCCC
Confidence 75443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=217.24 Aligned_cols=149 Identities=28% Similarity=0.463 Sum_probs=131.3
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeC-----Ce
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~~ 510 (607)
..++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4568999999999999999999986 4889999998653 334566788999999999999999999998764 56
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999998 689998854 35899999999999999999999987 9999999999999999999999999999
Q ss_pred eecC
Q 007336 591 TFGG 594 (607)
Q Consensus 591 ~~~~ 594 (607)
.+..
T Consensus 161 ~~~~ 164 (353)
T 2b9h_A 161 IIDE 164 (353)
T ss_dssp ECC-
T ss_pred cccc
Confidence 8754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=219.16 Aligned_cols=147 Identities=29% Similarity=0.433 Sum_probs=125.0
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCC------
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 509 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~------ 509 (607)
.++|++.+.||+|+||.||++... .++.||||++.. ......+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999875 488999999865 23445677899999999999999999999997654
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
..++||||++ ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 6799999998 47888774 23789999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 007336 590 RTFGG 594 (607)
Q Consensus 590 ~~~~~ 594 (607)
+....
T Consensus 175 ~~~~~ 179 (371)
T 2xrw_A 175 RTAGT 179 (371)
T ss_dssp -----
T ss_pred ccccc
Confidence 97754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.8e-24 Score=213.38 Aligned_cols=150 Identities=28% Similarity=0.495 Sum_probs=125.8
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeC-CeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~E 516 (607)
..++|++.+.||+|+||.||+++. .++.||||.+... ...+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 346899999999999999999987 4889999998753 3457899999999999999999999997655 46899999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 96 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 96 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred cCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999995421 223788999999999999999999987 99999999999999999999999999987654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=8.5e-24 Score=221.12 Aligned_cols=149 Identities=30% Similarity=0.465 Sum_probs=116.2
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeC------
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 508 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------ 508 (607)
..++|++.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3478999999999999999999874 488999999865 2334567889999999999999999999998754
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccc
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGl 588 (607)
...++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5579999999 6899888843 45899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 007336 589 VRTFGG 594 (607)
Q Consensus 589 a~~~~~ 594 (607)
|+....
T Consensus 179 a~~~~~ 184 (367)
T 2fst_X 179 ARHTAD 184 (367)
T ss_dssp ------
T ss_pred cccccc
Confidence 997653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.2e-24 Score=234.69 Aligned_cols=141 Identities=20% Similarity=0.238 Sum_probs=110.5
Q ss_pred eecccCceeEEEEEe-cCCcEEEEEEeccc----------chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEE
Q 007336 447 KLGEGGFGPVYKGTL-VDGQEIAVKRLSKI----------SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 447 ~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~----------~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV 514 (607)
..+.|++|.+..++- --|+.+++|.+.+. .....++|.+|+++|+++ +|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456666666555432 23788999998642 234457899999999999 799999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||++|++|.++|.. ...++.. +|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+..
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999964 3345554 48899999999999988 99999999999999999999999999998765
Q ss_pred CC
Q 007336 595 DE 596 (607)
Q Consensus 595 ~~ 596 (607)
+.
T Consensus 392 ~~ 393 (569)
T 4azs_A 392 DC 393 (569)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-23 Score=210.26 Aligned_cols=148 Identities=24% Similarity=0.340 Sum_probs=127.1
Q ss_pred cCCcccc-eeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHH-ccCCCCceeceEEEEEe----CCeE
Q 007336 439 TDNFSIN-NKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILF-SKLQHRNLVKLLGCCIQ----GEEK 511 (607)
Q Consensus 439 ~~~~~~~-~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l-~~l~H~nIv~l~g~~~~----~~~~ 511 (607)
.++|.+. +.||+|+||.||++... +++.||||++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 78999999999999974 5889999998642 3466777777 66699999999999987 6678
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCceEEeeccc
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 588 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~---~~~~ki~DfGl 588 (607)
++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999997532 345899999999999999999999987 999999999999998 78899999999
Q ss_pred ceeecCC
Q 007336 589 VRTFGGD 595 (607)
Q Consensus 589 a~~~~~~ 595 (607)
|+.+.+.
T Consensus 167 a~~~~~~ 173 (299)
T 3m2w_A 167 AKETTGE 173 (299)
T ss_dssp CEECTTC
T ss_pred ccccccc
Confidence 9987543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.9e-24 Score=215.93 Aligned_cols=157 Identities=24% Similarity=0.348 Sum_probs=133.5
Q ss_pred HHhHHhhcCCcccceeecccCceeEEEEEecCCcEEEEEEecc--cchhhHHHHHHHHHHHccCC--CCceeceEEEEEe
Q 007336 432 LATIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQ 507 (607)
Q Consensus 432 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~ 507 (607)
+..+....++|++.+.||+|+||.||++...+++.||||++.. ......+.+.+|+.++.+++ ||||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 3344455678999999999999999999988899999999864 33456678999999999997 5999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
.+..++||| +.+++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||+++ +.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999 6688999999643 35789999999999999999999987 999999999999965 889999999
Q ss_pred cceeecCCC
Q 007336 588 LVRTFGGDE 596 (607)
Q Consensus 588 la~~~~~~~ 596 (607)
+++.+....
T Consensus 172 ~~~~~~~~~ 180 (313)
T 3cek_A 172 IANQMQPDT 180 (313)
T ss_dssp SSCC-----
T ss_pred ccccccCcc
Confidence 999875443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=210.91 Aligned_cols=151 Identities=30% Similarity=0.459 Sum_probs=124.4
Q ss_pred cCCcccceeecccCceeEEEEEecC--Cc--EEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD--GQ--EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~--~~--~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 511 (607)
.++|++.+.||+|+||.||+|++.. +. .||||++... .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4579999999999999999998632 33 6899988642 2345678999999999999999999999997655 7
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++|+||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999999642 245789999999999999999999987 99999999999999999999999999998
Q ss_pred ecCC
Q 007336 592 FGGD 595 (607)
Q Consensus 592 ~~~~ 595 (607)
+...
T Consensus 171 ~~~~ 174 (291)
T 1u46_A 171 LPQN 174 (291)
T ss_dssp CCC-
T ss_pred cccc
Confidence 7544
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.5e-24 Score=220.33 Aligned_cols=146 Identities=17% Similarity=0.311 Sum_probs=127.8
Q ss_pred cCCcccceeecccCceeEEEEEecC---------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceec---------
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD---------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK--------- 500 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~---------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~--------- 500 (607)
.++|++.+.||+|+||.||+|+... ++.||||.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999864 788999998653 46788999999999999987
Q ss_pred ------eEEEEEe-CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcE
Q 007336 501 ------LLGCCIQ-GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573 (607)
Q Consensus 501 ------l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Ni 573 (607)
+++++.. +...++||||+ +++|.+++... ....+++..++.|+.||+.||.|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6788877 67889999999 99999999653 2356899999999999999999999987 99999999999
Q ss_pred EEcCCC--ceEEeecccceeecC
Q 007336 574 LLDQDM--NPKISDFGLVRTFGG 594 (607)
Q Consensus 574 ll~~~~--~~ki~DfGla~~~~~ 594 (607)
|++.++ .+||+|||+++.+..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~ 213 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCP 213 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSG
T ss_pred EEcCCCCceEEEecCcceeeccC
Confidence 999998 899999999998754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=222.35 Aligned_cols=148 Identities=26% Similarity=0.418 Sum_probs=121.7
Q ss_pred CCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeC----C--eEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG----E--EKL 512 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~----~--~~~ 512 (607)
.+|++.+.||+|+||.||+|+... ++.||||++.... +.+.+|+.++++++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 368889999999999999999864 8999999986532 2234699999999999999999998642 2 257
Q ss_pred EEEEcCCCCChHHHHhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CceEEeecccce
Q 007336 513 LIYEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVR 590 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~-~~~ki~DfGla~ 590 (607)
+||||+++ +|.+.+.. ......+++..+..++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+|+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 56555532 123456899999999999999999999887 9999999999999965 568999999999
Q ss_pred eecCC
Q 007336 591 TFGGD 595 (607)
Q Consensus 591 ~~~~~ 595 (607)
.+...
T Consensus 206 ~~~~~ 210 (420)
T 1j1b_A 206 QLVRG 210 (420)
T ss_dssp ECCTT
T ss_pred hcccC
Confidence 87543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.5e-23 Score=208.80 Aligned_cols=152 Identities=31% Similarity=0.448 Sum_probs=134.0
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
..++|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4468999999999999999999986 5889999998642 234567899999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC---CceEEeeccccee
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD---MNPKISDFGLVRT 591 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~---~~~ki~DfGla~~ 591 (607)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999988542 35789999999999999999999987 9999999999999764 4699999999987
Q ss_pred ecCC
Q 007336 592 FGGD 595 (607)
Q Consensus 592 ~~~~ 595 (607)
+...
T Consensus 174 ~~~~ 177 (287)
T 2wei_A 174 FQQN 177 (287)
T ss_dssp BCCC
T ss_pred ecCC
Confidence 7543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.2e-23 Score=232.53 Aligned_cols=156 Identities=25% Similarity=0.413 Sum_probs=134.3
Q ss_pred hHHhhcCCcccceeecccCceeEEEEEecC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeC
Q 007336 434 TIANATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (607)
Q Consensus 434 ~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~ 508 (607)
+.....++|++.+.||+|+||.||+|.+.. +..||||++... .....+.|.+|+.++++++||||+++++++. +
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 334455789999999999999999998743 457999998753 3445578999999999999999999999984 4
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccc
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGl 588 (607)
+..++||||+++|+|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence 5689999999999999999643 345899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecCC
Q 007336 589 VRTFGGD 595 (607)
Q Consensus 589 a~~~~~~ 595 (607)
++.+...
T Consensus 538 a~~~~~~ 544 (656)
T 2j0j_A 538 SRYMEDS 544 (656)
T ss_dssp CCSCCC-
T ss_pred CeecCCC
Confidence 9987543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=217.68 Aligned_cols=158 Identities=23% Similarity=0.320 Sum_probs=118.9
Q ss_pred hHHhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe--
Q 007336 434 TIANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-- 510 (607)
Q Consensus 434 ~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~-- 510 (607)
......++|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|+..++.++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34556679999999999999999999985 4889999998653 2333456778888889999999999999976433
Q ss_pred -----EEEEEEcCCCCChHHHHhc-CCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceEecccCCCcEEEcC-CCce
Q 007336 511 -----KLLIYEFMPNKSLDSFIFD-QTRRTLLDWSQRFHIICGTARGLLYLH--QDSRLRIIHRDLKASNVLLDQ-DMNP 581 (607)
Q Consensus 511 -----~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH--~~~~~~ivHrDlkp~Nill~~-~~~~ 581 (607)
.++||||++++ |...+.. ......+++..+..++.||+.||.||| +.+ |+||||||+||||+. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 78999999864 4443322 234556889999999999999999999 666 999999999999997 8999
Q ss_pred EEeecccceeecCCC
Q 007336 582 KISDFGLVRTFGGDE 596 (607)
Q Consensus 582 ki~DfGla~~~~~~~ 596 (607)
||+|||+++.+....
T Consensus 172 kl~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE 186 (360)
T ss_dssp EECCCTTCBCCCTTS
T ss_pred EEeeCCCceecCCCC
Confidence 999999999876443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=218.46 Aligned_cols=149 Identities=12% Similarity=0.120 Sum_probs=113.1
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHH---HHHccCCCCceeceE-------EE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEV---ILFSKLQHRNLVKLL-------GC 504 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~---~~l~~l~H~nIv~l~-------g~ 504 (607)
..+|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+++|+ .+++. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 446889999999999999999975 58899999997632 34456778885 45555 799988755 45
Q ss_pred EEeC-----------------CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 007336 505 CIQG-----------------EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQR------FHIICGTARGLLYLHQDSRL 561 (607)
Q Consensus 505 ~~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gl~yLH~~~~~ 561 (607)
+... ...+|||||++ |+|.+++.... ..+++..+ +.++.||++||+|||+.+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 5433 23799999999 89999996532 23455556 788899999999999987
Q ss_pred ceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 562 RIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 562 ~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||||||||+||||+.++.+||+|||+|+..+.
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~ 246 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence 99999999999999999999999999997754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-22 Score=217.39 Aligned_cols=151 Identities=22% Similarity=0.278 Sum_probs=129.7
Q ss_pred hcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccC------CCCceeceEEEEEeCCe
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKL------QHRNLVKLLGCCIQGEE 510 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l------~H~nIv~l~g~~~~~~~ 510 (607)
...+|++.++||+|+||+||+|.... ++.||||++... ....+.+.+|+.++..+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 44679999999999999999998755 789999999753 34456677787777665 67899999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc--eEEeeccc
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN--PKISDFGL 588 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~--~ki~DfGl 588 (607)
.++||||++ ++|.+++.... ...+++..+..|+.||+.||+|||+.+ ||||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999997 68999886532 334899999999999999999999987 999999999999999887 99999999
Q ss_pred ceeecC
Q 007336 589 VRTFGG 594 (607)
Q Consensus 589 a~~~~~ 594 (607)
|+....
T Consensus 249 a~~~~~ 254 (429)
T 3kvw_A 249 SCYEHQ 254 (429)
T ss_dssp CEETTC
T ss_pred ceecCC
Confidence 987643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.89 E-value=3.2e-23 Score=212.87 Aligned_cols=153 Identities=27% Similarity=0.483 Sum_probs=127.2
Q ss_pred hhcCCcccceeecccCceeEEEEEec--CCcEEEEEEecccc--hhhHHHHHHHHHHHccC---CCCceeceEEEEE---
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCI--- 506 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~--~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l---~H~nIv~l~g~~~--- 506 (607)
...++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34578999999999999999999983 57899999986422 11223455666666555 8999999999997
Q ss_pred --eCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEe
Q 007336 507 --QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (607)
Q Consensus 507 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~ 584 (607)
.....++||||++ |+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4456799999998 69999986533 334899999999999999999999987 9999999999999999999999
Q ss_pred ecccceeecC
Q 007336 585 DFGLVRTFGG 594 (607)
Q Consensus 585 DfGla~~~~~ 594 (607)
|||+++.+..
T Consensus 163 Dfg~~~~~~~ 172 (326)
T 1blx_A 163 DFGLARIYSF 172 (326)
T ss_dssp SCCSCCCCCG
T ss_pred cCcccccccC
Confidence 9999987753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7.5e-23 Score=206.86 Aligned_cols=151 Identities=23% Similarity=0.418 Sum_probs=125.4
Q ss_pred hcCCcccceeecccCceeEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEE-EeCCeEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC-IQGEEKLLIY 515 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lV~ 515 (607)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+..|+.++..++|++++..++.+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999997 458899999865422 224578899999999988877776665 5677889999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE---cCCCceEEeecccceee
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTF 592 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill---~~~~~~ki~DfGla~~~ 592 (607)
||+ +++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998642 335899999999999999999999987 9999999999999 78899999999999988
Q ss_pred cCCC
Q 007336 593 GGDE 596 (607)
Q Consensus 593 ~~~~ 596 (607)
....
T Consensus 159 ~~~~ 162 (296)
T 4hgt_A 159 RDAR 162 (296)
T ss_dssp BCTT
T ss_pred cCcc
Confidence 6543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.6e-23 Score=215.98 Aligned_cols=148 Identities=28% Similarity=0.473 Sum_probs=127.0
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeE---
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK--- 511 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~--- 511 (607)
..++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3468999999999999999999975 4889999998752 334467889999999999999999999999877654
Q ss_pred ---EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccc
Q 007336 512 ---LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (607)
Q Consensus 512 ---~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGl 588 (607)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 68888772 23899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecC
Q 007336 589 VRTFGG 594 (607)
Q Consensus 589 a~~~~~ 594 (607)
++....
T Consensus 191 a~~~~~ 196 (371)
T 4exu_A 191 ARHADA 196 (371)
T ss_dssp C-----
T ss_pred cccccc
Confidence 997654
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.2e-23 Score=216.01 Aligned_cols=135 Identities=25% Similarity=0.365 Sum_probs=113.9
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCC--------CCceeceEEEEE---
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--------HRNLVKLLGCCI--- 506 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~--------H~nIv~l~g~~~--- 506 (607)
.++|++.++||+|+||+||+++.. +++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999875 4789999999753 445678889999998885 788999999987
Q ss_pred -eCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCC
Q 007336 507 -QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDM 579 (607)
Q Consensus 507 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivHrDlkp~Nill~~~~ 579 (607)
.....+|||||+ +++|.+++... ....+++..+..|+.||+.||+|||+. + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 455789999999 55666665442 234589999999999999999999997 6 99999999999999775
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=213.58 Aligned_cols=155 Identities=24% Similarity=0.383 Sum_probs=123.9
Q ss_pred HHhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccch------hhHHHHHHHHHHHccC----CCCceeceEE
Q 007336 435 IANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKL----QHRNLVKLLG 503 (607)
Q Consensus 435 ~~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~f~~E~~~l~~l----~H~nIv~l~g 503 (607)
.....++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3445678999999999999999999874 588999999865321 1233456788888887 8999999999
Q ss_pred EEEeCCeEEEEEEc-CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCce
Q 007336 504 CCIQGEEKLLIYEF-MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNP 581 (607)
Q Consensus 504 ~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~-~~~~~ 581 (607)
++...+..++|+|| +++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++ +++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 789999999964 234899999999999999999999987 99999999999999 88999
Q ss_pred EEeecccceeecCC
Q 007336 582 KISDFGLVRTFGGD 595 (607)
Q Consensus 582 ki~DfGla~~~~~~ 595 (607)
||+|||+++.+...
T Consensus 180 kl~dfg~~~~~~~~ 193 (312)
T 2iwi_A 180 KLIDFGSGALLHDE 193 (312)
T ss_dssp EECCCSSCEECCSS
T ss_pred EEEEcchhhhcccC
Confidence 99999999987643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-22 Score=204.95 Aligned_cols=151 Identities=23% Similarity=0.418 Sum_probs=128.8
Q ss_pred hcCCcccceeecccCceeEEEEEe-cCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEE-EeCCeEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTL-VDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC-IQGEEKLLIY 515 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~-~~~~~~~lV~ 515 (607)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+.+++.++|++++..+.++ .++...++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 346899999999999999999997 458999999986532 234688999999999988876666655 5677889999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE---cCCCceEEeecccceee
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTF 592 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill---~~~~~~ki~DfGla~~~ 592 (607)
||+ +++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 89999999642 345899999999999999999999987 9999999999999 48889999999999988
Q ss_pred cCCC
Q 007336 593 GGDE 596 (607)
Q Consensus 593 ~~~~ 596 (607)
....
T Consensus 159 ~~~~ 162 (296)
T 3uzp_A 159 RDAR 162 (296)
T ss_dssp BCTT
T ss_pred cccc
Confidence 6543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=220.49 Aligned_cols=148 Identities=26% Similarity=0.440 Sum_probs=115.2
Q ss_pred Cccc-ceeecccCceeEEEEEec---CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEe--CCeEEEE
Q 007336 441 NFSI-NNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLI 514 (607)
Q Consensus 441 ~~~~-~~~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV 514 (607)
.|++ .++||+|+||+||+|+.. +++.||||++.... ....+.+|+.++++++||||+++++++.. ....+||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 4555 358999999999999975 47889999997532 23468899999999999999999999965 6678999
Q ss_pred EEcCCCCChHHHHhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE----cCCCceEEe
Q 007336 515 YEFMPNKSLDSFIFDQ------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL----DQDMNPKIS 584 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill----~~~~~~ki~ 584 (607)
|||++ ++|.+++... .....+++..+..|+.||+.||+|||+.+ |+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99997 5777776421 12234899999999999999999999987 9999999999999 778899999
Q ss_pred ecccceeecC
Q 007336 585 DFGLVRTFGG 594 (607)
Q Consensus 585 DfGla~~~~~ 594 (607)
|||+|+.+..
T Consensus 175 Dfg~a~~~~~ 184 (405)
T 3rgf_A 175 DMGFARLFNS 184 (405)
T ss_dssp CTTCCC----
T ss_pred ECCCceecCC
Confidence 9999998754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-22 Score=207.84 Aligned_cols=151 Identities=22% Similarity=0.363 Sum_probs=130.6
Q ss_pred hcCCcccceeecccCceeEEEEEe-c-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCC------ceeceEEEEEeCC
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTL-V-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR------NLVKLLGCCIQGE 509 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~-~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~------nIv~l~g~~~~~~ 509 (607)
..++|++.+.||+|+||.||++.. . +++.||||++... ....+.+.+|+.+++.++|+ +++++++++.+.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 346899999999999999999987 3 5789999998753 34567788899998888665 4999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC------------
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ------------ 577 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~------------ 577 (607)
..++||||+ +++|.+++.... ...+++..+..++.||++||+|||+.+ |+||||||+||||+.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 999999999 899999986532 235789999999999999999999987 999999999999987
Q ss_pred -------CCceEEeecccceeecC
Q 007336 578 -------DMNPKISDFGLVRTFGG 594 (607)
Q Consensus 578 -------~~~~ki~DfGla~~~~~ 594 (607)
++.+||+|||+++....
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS
T ss_pred cccccccCCCceEeeCcccccCcc
Confidence 66899999999997654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=219.21 Aligned_cols=150 Identities=23% Similarity=0.410 Sum_probs=128.5
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCC-CceeceEEEEEeCCeEEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E 516 (607)
.++|++.++||+|+||.||+|+.. +++.||||++.... ...++..|+.++..++| ++|..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 468999999999999999999974 58999999876422 22357889999999987 566677777788889999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE---cCCCceEEeecccceeec
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL---DQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill---~~~~~~ki~DfGla~~~~ 593 (607)
|+ +++|.+++... ...+++..++.|+.||+.||+|||+.+ ||||||||+|||| +.++.+||+|||+|+.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999999642 345899999999999999999999987 9999999999999 688999999999999886
Q ss_pred CCC
Q 007336 594 GDE 596 (607)
Q Consensus 594 ~~~ 596 (607)
...
T Consensus 158 ~~~ 160 (483)
T 3sv0_A 158 DTS 160 (483)
T ss_dssp CTT
T ss_pred CCc
Confidence 544
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=208.72 Aligned_cols=153 Identities=27% Similarity=0.388 Sum_probs=127.2
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHH-HHccCCCCceeceEEEEEeCCeEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
..++|++.+.||+|+||.||++... +++.||||++... ......++..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3468899999999999999999985 5889999998753 2334455556665 77888999999999999999999999
Q ss_pred EEcCCCCChHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 515 YEFMPNKSLDSFIFDQ--TRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
|||+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+||||+.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999985 787776421 2245689999999999999999999997 6 99999999999999999999999999987
Q ss_pred ecC
Q 007336 592 FGG 594 (607)
Q Consensus 592 ~~~ 594 (607)
+..
T Consensus 176 ~~~ 178 (327)
T 3aln_A 176 LVD 178 (327)
T ss_dssp ---
T ss_pred ccc
Confidence 754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=6e-23 Score=213.53 Aligned_cols=147 Identities=28% Similarity=0.476 Sum_probs=127.2
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCe-----
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 510 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~----- 510 (607)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999975 4889999998652 33446788999999999999999999999987654
Q ss_pred -EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 511 -KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 511 -~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
.++||||++ ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 68887762 23899999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 007336 590 RTFGG 594 (607)
Q Consensus 590 ~~~~~ 594 (607)
+....
T Consensus 174 ~~~~~ 178 (353)
T 3coi_A 174 RHADA 178 (353)
T ss_dssp TC---
T ss_pred cCCCC
Confidence 87643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-23 Score=214.88 Aligned_cols=152 Identities=30% Similarity=0.544 Sum_probs=128.6
Q ss_pred hHHhhcCCcccceeecccCceeEEEEEecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeE
Q 007336 434 TIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 434 ~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 511 (607)
+.....++|++.+.||+|+||.||+|+... .||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 344456789999999999999999998753 5999988642 223345688899999999999999999999999999
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++||||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.
T Consensus 105 ~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999954 2345889999999999999999999987 99999999999998 67999999999887
Q ss_pred ec
Q 007336 592 FG 593 (607)
Q Consensus 592 ~~ 593 (607)
..
T Consensus 179 ~~ 180 (319)
T 2y4i_B 179 SG 180 (319)
T ss_dssp --
T ss_pred cc
Confidence 64
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=5.9e-23 Score=210.63 Aligned_cols=154 Identities=26% Similarity=0.384 Sum_probs=132.3
Q ss_pred HhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccch------hhHHHHHHHHHHHccCC--CCceeceEEEEE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE------QGLKELKNEVILFSKLQ--HRNLVKLLGCCI 506 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~ 506 (607)
....++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+..|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 445678999999999999999999864 588999999865321 12345778999999986 599999999999
Q ss_pred eCCeEEEEEEcCCC-CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCceEEe
Q 007336 507 QGEEKLLIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKIS 584 (607)
Q Consensus 507 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~-~~~~~ki~ 584 (607)
..+..++|+||+.+ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||||+ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999976 899999854 345789999999999999999999987 99999999999999 78999999
Q ss_pred ecccceeecCC
Q 007336 585 DFGLVRTFGGD 595 (607)
Q Consensus 585 DfGla~~~~~~ 595 (607)
|||+++.+...
T Consensus 193 Dfg~~~~~~~~ 203 (320)
T 3a99_A 193 DFGSGALLKDT 203 (320)
T ss_dssp CCTTCEECCSS
T ss_pred eCccccccccc
Confidence 99999987643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=217.27 Aligned_cols=149 Identities=24% Similarity=0.301 Sum_probs=119.8
Q ss_pred CcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEEEcCC
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMP 519 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~ 519 (607)
.|.+.+.||+|+||+||.+...+++.||||++... ..+.+.+|+.++.++ +||||+++++++.+.+..+|||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 45556889999999998776667999999998642 345678899999876 89999999999999999999999996
Q ss_pred CCChHHHHhcCCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-------------CceE
Q 007336 520 NKSLDSFIFDQTRRT----LLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-------------MNPK 582 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~-------------~~~k 582 (607)
|+|.+++....... ...+..+..++.||+.||+|||+.+ |+||||||+||||+.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999996532211 1133445789999999999999987 9999999999999754 4899
Q ss_pred EeecccceeecCCC
Q 007336 583 ISDFGLVRTFGGDE 596 (607)
Q Consensus 583 i~DfGla~~~~~~~ 596 (607)
|+|||+|+.+....
T Consensus 169 L~DFG~a~~~~~~~ 182 (434)
T 2rio_A 169 ISDFGLCKKLDSGQ 182 (434)
T ss_dssp ECCCTTCEECCC--
T ss_pred EcccccceecCCCC
Confidence 99999999886543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.2e-23 Score=228.32 Aligned_cols=154 Identities=25% Similarity=0.404 Sum_probs=132.1
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEe------CCe
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GEE 510 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~------~~~ 510 (607)
.++|++.+.||+|+||.||++... +++.||||++.. ......+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999875 488999999865 344556789999999999999999999999765 566
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCc---eEEeecc
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMN---PKISDFG 587 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~---~ki~DfG 587 (607)
.++||||+++|+|.+++........+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7999999999999999976554456889999999999999999999987 999999999999997665 9999999
Q ss_pred cceeecCC
Q 007336 588 LVRTFGGD 595 (607)
Q Consensus 588 la~~~~~~ 595 (607)
+++.+...
T Consensus 170 ~a~~~~~~ 177 (676)
T 3qa8_A 170 YAKELDQG 177 (676)
T ss_dssp CCCBTTSC
T ss_pred cccccccc
Confidence 99987543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.2e-22 Score=205.08 Aligned_cols=149 Identities=24% Similarity=0.302 Sum_probs=120.9
Q ss_pred hcCCcccce-eecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEe----CCeE
Q 007336 438 ATDNFSINN-KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEK 511 (607)
Q Consensus 438 ~~~~~~~~~-~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~ 511 (607)
..++|.+.+ .||+|+||.||++... +++.||||++... ....+ +....+..++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 445788854 6999999999999986 4899999998652 22222 22334566799999999999876 4457
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCceEEeeccc
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 588 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~---~~~~ki~DfGl 588 (607)
++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 89999999999999996532 346899999999999999999999987 999999999999986 45599999999
Q ss_pred ceeecC
Q 007336 589 VRTFGG 594 (607)
Q Consensus 589 a~~~~~ 594 (607)
++....
T Consensus 178 ~~~~~~ 183 (336)
T 3fhr_A 178 AKETTQ 183 (336)
T ss_dssp CEEC--
T ss_pred ceeccc
Confidence 997754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=215.94 Aligned_cols=150 Identities=24% Similarity=0.373 Sum_probs=121.2
Q ss_pred hhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
....+|++.+.||+|+||+|+.....+++.||||++.... ...+.+|+.+++++ +|||||++++++.+....+|||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3445789999999999999765555678999999986422 12356799999998 7999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-----CCceEEeecccce
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLVR 590 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~-----~~~~ki~DfGla~ 590 (607)
||++ |+|.+++.... ..+.+.....++.||++||.|||+.+ |+||||||+||||+. ...+||+|||+|+
T Consensus 98 E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9997 69999996532 22344456789999999999999987 999999999999953 3458899999999
Q ss_pred eecCC
Q 007336 591 TFGGD 595 (607)
Q Consensus 591 ~~~~~ 595 (607)
.+...
T Consensus 172 ~~~~~ 176 (432)
T 3p23_A 172 KLAVG 176 (432)
T ss_dssp CC---
T ss_pred eccCC
Confidence 87543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.9e-22 Score=207.45 Aligned_cols=155 Identities=25% Similarity=0.349 Sum_probs=129.9
Q ss_pred HhhcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-CC-----ceeceEEEEEeC
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HR-----NLVKLLGCCIQG 508 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~-----nIv~l~g~~~~~ 508 (607)
....++|++.+.||+|+||+||+|+.. +++.||||++... .....++..|+.++..++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 445679999999999999999999975 4788999999753 344567778888887774 44 499999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc--CCCceEEeec
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDF 586 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~--~~~~~ki~Df 586 (607)
+..+|||||++ ++|.+++.... ...+++..+..++.||+.||.|||++ ..+||||||||+||||+ .++.+||+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999997 59999986533 23489999999999999999999953 13599999999999995 5788999999
Q ss_pred ccceeecC
Q 007336 587 GLVRTFGG 594 (607)
Q Consensus 587 Gla~~~~~ 594 (607)
|+|+.+..
T Consensus 206 G~a~~~~~ 213 (382)
T 2vx3_A 206 GSSCQLGQ 213 (382)
T ss_dssp TTCEETTC
T ss_pred cCceeccc
Confidence 99998754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.1e-22 Score=203.72 Aligned_cols=151 Identities=23% Similarity=0.374 Sum_probs=116.7
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
..++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.++..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3467899999999999999999985 58999999986532 22334455566678889999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
|||+ ++.+..+... ....+++..+..++.||++||.|||+. + |+||||||+|||++.++.+||+|||+++.+.
T Consensus 103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 4455554432 234589999999999999999999984 6 9999999999999999999999999998765
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 177 ~ 177 (318)
T 2dyl_A 177 D 177 (318)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=9e-22 Score=204.24 Aligned_cols=151 Identities=20% Similarity=0.334 Sum_probs=128.4
Q ss_pred hcCCcccceeecccCceeEEEEEecC-C-cEEEEEEecccchhhHHHHHHHHHHHccCCCCc------eeceEEEEEeCC
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD-G-QEIAVKRLSKISEQGLKELKNEVILFSKLQHRN------LVKLLGCCIQGE 509 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~-~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n------Iv~l~g~~~~~~ 509 (607)
..++|++.+.||+|+||+||++.... + +.||||++... ....+.+.+|+.++++++|++ ++.+.+++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 34689999999999999999999753 4 68999998753 345677888999998887766 999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE--------------
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL-------------- 575 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill-------------- 575 (607)
..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||||
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 999999999 56676776542 2245899999999999999999999887 9999999999999
Q ss_pred -----cCCCceEEeecccceeecC
Q 007336 576 -----DQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 576 -----~~~~~~ki~DfGla~~~~~ 594 (607)
+.++.+||+|||+++....
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~ 194 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE 194 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS
T ss_pred ccccccCCCcEEEeecCccccccc
Confidence 6678999999999997643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.87 E-value=5.4e-22 Score=207.62 Aligned_cols=150 Identities=22% Similarity=0.344 Sum_probs=128.2
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-----------CCceeceEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCI 506 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~nIv~l~g~~~ 506 (607)
.++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999974 588999999875 3345567888999988876 899999999998
Q ss_pred eCC----eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEc-----
Q 007336 507 QGE----EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLD----- 576 (607)
Q Consensus 507 ~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivHrDlkp~Nill~----- 576 (607)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+. + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 678999999 899999986532 33488999999999999999999997 6 99999999999994
Q ss_pred -CCCceEEeecccceeecC
Q 007336 577 -QDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 577 -~~~~~ki~DfGla~~~~~ 594 (607)
..+.+||+|||+|+.+..
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE 190 (373)
T ss_dssp TTEEEEEECCCTTCEETTB
T ss_pred cCcceEEEcccccccccCC
Confidence 445799999999998754
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-22 Score=221.07 Aligned_cols=136 Identities=18% Similarity=0.239 Sum_probs=108.6
Q ss_pred ccceeecccCceeEEEEEecCCcEEEEEEecccc--------hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 443 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~--------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
...++||+|+||.||++.. .+..+++|+..... ....++|.+|+.++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3357899999999999954 57888888754311 11245689999999999999999777777788888999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++++|.+++.. +..++.||++||.|||+.+ |+||||||+|||+++ .+||+|||+|+.+..
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 4579999999999999987 999999999999999 999999999998865
Q ss_pred C
Q 007336 595 D 595 (607)
Q Consensus 595 ~ 595 (607)
.
T Consensus 482 ~ 482 (540)
T 3en9_A 482 D 482 (540)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-21 Score=197.29 Aligned_cols=143 Identities=20% Similarity=0.176 Sum_probs=114.6
Q ss_pred hHHhhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccch------------------hhHHHHHHHHHHHccCCC
Q 007336 434 TIANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISE------------------QGLKELKNEVILFSKLQH 495 (607)
Q Consensus 434 ~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~------------------~~~~~f~~E~~~l~~l~H 495 (607)
.+......|++.+.||+|+||.||+|...+++.||||.+..... .....+.+|+.++++++|
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 34444556778899999999999999996689999999864211 135678999999999994
Q ss_pred CceeceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEE
Q 007336 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLL 575 (607)
Q Consensus 496 ~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill 575 (607)
+++.+++.. +..++||||+++++|.+ +.. .....++.||++||.|||+.+ |+||||||+||||
T Consensus 164 ---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 164 ---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp ---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred ---CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 555554433 45699999999999987 411 123469999999999999987 9999999999999
Q ss_pred cCCCceEEeecccceeecC
Q 007336 576 DQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 576 ~~~~~~ki~DfGla~~~~~ 594 (607)
+ ++.+||+|||+|+....
T Consensus 227 ~-~~~vkl~DFG~a~~~~~ 244 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVEVGE 244 (282)
T ss_dssp E-TTEEEECCCTTCEETTS
T ss_pred E-CCcEEEEECCCCeECCC
Confidence 9 99999999999997754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.8e-20 Score=199.13 Aligned_cols=152 Identities=18% Similarity=0.240 Sum_probs=114.8
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCC-Cce----------ec--
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQH-RNL----------VK-- 500 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H-~nI----------v~-- 500 (607)
...+|...+.||+|+||.||+|+.. +++.||||++.... ....+.|++|+.+++.++| +|. +.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 4456788899999999999999964 58999999987322 2335789999999999987 221 11
Q ss_pred ---------eEEEEEe-----CCeEEEEEEcCCCCChHHHHhc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 007336 501 ---------LLGCCIQ-----GEEKLLIYEFMPNKSLDSFIFD----QTRRTLLDWSQRFHIICGTARGLLYLHQDSRLR 562 (607)
Q Consensus 501 ---------l~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ 562 (607)
+..+... ....+++|+++ +++|.+++.. ......+++..++.|+.||++||+|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111111 12346677755 6899988841 123445788899999999999999999987
Q ss_pred eEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 563 IIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 563 ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||||||+||||+.++.+||+|||+|+..+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~ 262 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecC
Confidence 9999999999999999999999999998764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=179.94 Aligned_cols=139 Identities=16% Similarity=0.170 Sum_probs=107.7
Q ss_pred CcccceeecccCceeEEEEEe-cCCcE--EEEEEecccch------------------------hhHHHHHHHHHHHccC
Q 007336 441 NFSINNKLGEGGFGPVYKGTL-VDGQE--IAVKRLSKISE------------------------QGLKELKNEVILFSKL 493 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~-~~~~~--vavK~l~~~~~------------------------~~~~~f~~E~~~l~~l 493 (607)
-|++.+.||+|+||.||+|.. .+|+. ||||.++.... .....+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367789999999999999998 67888 99998643210 1123688999999999
Q ss_pred CCCce--eceEEEEEeCCeEEEEEEcCCC-C----ChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEe
Q 007336 494 QHRNL--VKLLGCCIQGEEKLLIYEFMPN-K----SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH-QDSRLRIIH 565 (607)
Q Consensus 494 ~H~nI--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~~~ivH 565 (607)
+|+++ ..++.+ ...+|||||+.+ | +|.+++.. .++.....++.||+.+|.||| +.+ |||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88764 444432 356899999942 4 67666422 123456789999999999999 776 999
Q ss_pred cccCCCcEEEcCCCceEEeecccceeecC
Q 007336 566 RDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 566 rDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||||+|||+++ .+||+|||+|.....
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCC
Confidence 999999999998 999999999998754
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.8e-16 Score=135.33 Aligned_cols=98 Identities=22% Similarity=0.404 Sum_probs=78.1
Q ss_pred CCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeeccCCCcccCCC
Q 007336 24 LNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPG 103 (607)
Q Consensus 24 ~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PTDTlLpg 103 (607)
+.|+.+...+|.|..+|+|+|.+. +++||++++.+......+ +|+++|||||++ . +.++||||+
T Consensus 13 g~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l-~l~~~GNLvl~d-~----~~~~W~S~~--------- 76 (112)
T 1xd5_A 13 GGSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVL-KMQNDGNLVIYS-G----SRAIWASNT--------- 76 (112)
T ss_dssp TCEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEE-EECTTSCEEEEE-T----TEEEEECCC---------
T ss_pred CCEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEE-EEeCCCCEEEEc-C----CEEEEECCc---------
Confidence 345545557899999999999987 889999997643233455 999999999998 4 579999994
Q ss_pred CeeccccccCccceEEEeccCCCCCCceeEEEEecCCCceEEEEc-CCeEEEEeCCCCC
Q 007336 104 MKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWK-GSRKFYRTGPWNG 161 (607)
Q Consensus 104 q~l~~~~~~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~-~~~~y~~~~~~~~ 161 (607)
+|++|.|++.|+++|. +++++ ...+||++++|+|
T Consensus 77 ----------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ----------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ----------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ----------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 3456889999999988 55565 4679999999976
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=3.6e-16 Score=132.86 Aligned_cols=101 Identities=21% Similarity=0.368 Sum_probs=77.3
Q ss_pred ceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeeccC
Q 007336 16 EVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDY 95 (607)
Q Consensus 16 t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~ 95 (607)
..+|..++-. . +...+|.|..||+|||.| .+++||++++.+......+ +|+|+|||||++.. +.+|||||
T Consensus 8 ~~L~~g~~l~-~-~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l-~l~~dGNLVl~~~~----~~~~W~S~-- 77 (110)
T 3a0c_A 8 NSLFTGHSLE-V-GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRL-TLHNNGNLVIYDQS----NRVIWQTK-- 77 (110)
T ss_dssp CEECTTCEEE-E-TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEE-EECTTSCEEEECTT----CCEEEECC--
T ss_pred CEECCCCEEE-E-CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEE-EEeCCCCEEEECCC----CcEEEecC--
Confidence 3455555433 2 344789999999999998 5899999998643233456 99999999999864 57999999
Q ss_pred CCcccCCCCeeccccccCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeCCC
Q 007336 96 PSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPW 159 (607)
Q Consensus 96 PTDTlLpgq~l~~~~~~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~ 159 (607)
.+|++|.|++.|+++|+ ++++++ .||+++++
T Consensus 78 -----------------------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 -----------------------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp -----------------------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred -----------------------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 24567899999999988 556665 89999875
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.63 E-value=6.5e-16 Score=129.80 Aligned_cols=70 Identities=17% Similarity=0.360 Sum_probs=59.6
Q ss_pred CCceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEee
Q 007336 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (607)
Q Consensus 14 ~~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQS 92 (607)
..++||+|||+.|.... +.|+|+.||+|||.|++|.+||+|++........+ .|+|+|||||++. .||||
T Consensus 36 ~~~~vW~ant~~~~~~~-~~L~l~~dGnLvL~d~~~~~vWss~t~~~~~~~~l-~L~ddGNlVly~~-------~~W~S 105 (105)
T 4h3o_A 36 HSTSTWASNTEIGGKSG-CSAVLQSDGNFVVYDSSGRSLWASHSTRGSGNYIL-ILQDDGNVIIYGS-------DIWST 105 (105)
T ss_dssp TTEEEEECCCCCTTCCS-CEEEECTTSCEEEECTTCCEEEECCCCCCSSCEEE-EECTTSCEEEEES-------EEEEC
T ss_pred CCEEEEEecCCCCCCcc-EEEEEeCCccEEEECCCcEEEEEecCCCCCCCEEE-EEeCCCeEEEECC-------cEecC
Confidence 35899999999998654 79999999999999999999999997653334455 9999999999964 59998
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=7.5e-17 Score=166.55 Aligned_cols=139 Identities=13% Similarity=0.184 Sum_probs=98.9
Q ss_pred CCcccceeecccCceeEEEEEecCCcEEEEEEecccc--------------hhhHHH--------HHHHHHHHccCCCCc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS--------------EQGLKE--------LKNEVILFSKLQHRN 497 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~--------------~~~~~~--------f~~E~~~l~~l~H~n 497 (607)
.-|++...||+|+||.||+|...+|+.||||+++... ...... ...|...|.++++.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3488999999999999999999889999999865310 000111 124555666665444
Q ss_pred eeceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC
Q 007336 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 577 (607)
Q Consensus 498 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~ 577 (607)
+....-+... ..+|||||+++++|..+.. . .....++.||+.+|.|||+.+ ||||||||.||||++
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 3221111111 2379999999988865431 1 122457899999999999987 999999999999988
Q ss_pred CC----------ceEEeecccceee
Q 007336 578 DM----------NPKISDFGLVRTF 592 (607)
Q Consensus 578 ~~----------~~ki~DfGla~~~ 592 (607)
++ .+.|+||+-+...
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCcccccccccceEEEEeCCcccC
Confidence 76 3899999987654
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.61 E-value=4.4e-15 Score=127.74 Aligned_cols=86 Identities=21% Similarity=0.315 Sum_probs=70.1
Q ss_pred ceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeeccCCCcccCCCCeeccccc
Q 007336 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (607)
Q Consensus 32 ~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~ 111 (607)
.+|.|..+|+|+|.+. +++||++++........+ +|+|+|||||++.. +.+|||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l-~l~~dGNLVl~d~~----~~~lW~S~------------------ 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRA-VLQPDGVLVVITNE----NVTVWQSP------------------ 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEE-EECTTSCEEEECTT----CCEEEECS------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEE-EEccCCEEEEEeCC----CcEEEcCC------------------
Confidence 5688999999999987 899999997643223456 99999999999864 57999999
Q ss_pred cCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeCC
Q 007336 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (607)
Q Consensus 112 ~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 158 (607)
.+|++|.|++.|+++|+ +++++ .+||++|+
T Consensus 88 -------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 -------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp -------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred -------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 34567899999999998 55565 38999886
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=8.2e-15 Score=125.62 Aligned_cols=91 Identities=21% Similarity=0.358 Sum_probs=73.4
Q ss_pred cceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeeccCCCcccCCCCeecccc
Q 007336 31 FGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDL 110 (607)
Q Consensus 31 ~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~ 110 (607)
..+|.|..+|+|+|.+ .+++||++++.+......+ +|+++|||||++.. +.++||||++
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l-~l~~~GnLvl~d~~----~~~vW~S~~~--------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRL-TLLSDGNLVIYDHN----NNDVWGSACW--------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEE-EECTTSCEEEECTT----CCEEEECCCC---------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEE-EECCCCcEEEECCC----ceEEEEcCCC---------------
Confidence 3679999999999998 5889999997643233456 99999999999864 5689999997
Q ss_pred ccCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeCCCCCc
Q 007336 111 KTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGL 162 (607)
Q Consensus 111 ~~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~ 162 (607)
|++|.|++.++++|+ +++++. .||+|++|...
T Consensus 80 ----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 346778999999998 556654 89999999653
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.1e-14 Score=120.83 Aligned_cols=73 Identities=27% Similarity=0.371 Sum_probs=60.7
Q ss_pred CceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeecc
Q 007336 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (607)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd 94 (607)
.++||.||++.|. ..+.+.|..+|||||.|.+|.++|+|.+....+..++ +|+|+|||||++. ++||||+
T Consensus 38 ~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~~~~~~W~S~t~~~~g~~~l-~l~~dGnlvl~~~-------~~W~S~~ 107 (110)
T 3a0c_A 38 GKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVL-VLQQDRNVVIYGP-------VVWATGS 107 (110)
T ss_dssp TEEEEECCCTTSC--SSCEEEECTTSCEEEECTTCCEEEECCCCCSSSCCEE-EECTTSCEEEECS-------EEEECSC
T ss_pred CEEEEECCCCCCC--CcEEEEEeCCCCEEEECCCCcEEEecCCCCCCCCEEE-EEeCCccEEEECC-------CEecCCC
Confidence 6899999998773 3478999999999999999999999987643333455 9999999999862 6999999
Q ss_pred CCC
Q 007336 95 YPS 97 (607)
Q Consensus 95 ~PT 97 (607)
||.
T Consensus 108 ~~~ 110 (110)
T 3a0c_A 108 GPA 110 (110)
T ss_dssp CC-
T ss_pred cCC
Confidence 984
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-13 Score=118.31 Aligned_cols=74 Identities=20% Similarity=0.242 Sum_probs=61.8
Q ss_pred CceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeecc
Q 007336 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (607)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd 94 (607)
.++||+||++.|. ..+.|.|..+|||||.|.++.++|+|++....+..++ +|+|+|||||++. ++||||.
T Consensus 38 ~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~~~g~~~l-~l~~dGnlvl~~~-------~~W~S~~ 107 (115)
T 2dpf_A 38 GRQIWASNTDRRG--SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYAL-VLQKDGRFVIYGP-------VLWSLGP 107 (115)
T ss_dssp TEEEEECSCTTSC--SSCEEEECTTSCEEEECTTCCEEEECCCCCSSSCCEE-EECTTSCEEEECS-------EEECSST
T ss_pred CEEEEeCCCCCCC--CceEEEECCCCcEEEECCCceEEEEcCCCCCCCCEEE-EEeCCCeEEEECC-------CEEECCC
Confidence 6899999999884 3478999999999999998999999987632333455 9999999999852 7999999
Q ss_pred CCCc
Q 007336 95 YPSD 98 (607)
Q Consensus 95 ~PTD 98 (607)
++..
T Consensus 108 ~~~~ 111 (115)
T 2dpf_A 108 NGCR 111 (115)
T ss_dssp TCBC
T ss_pred CCCc
Confidence 8765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.42 E-value=5.2e-13 Score=113.80 Aligned_cols=74 Identities=20% Similarity=0.376 Sum_probs=60.1
Q ss_pred CceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeecc
Q 007336 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (607)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd 94 (607)
.++||+||++.+ ...+.|.|..+|||||.| ++.++|+|.+....+...+ +|+++|||||++.. +.++||||+
T Consensus 37 ~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~~~~~W~S~~~~~~g~~~l-~l~~dGnlvl~~~~----~~~~W~S~~ 108 (112)
T 1xd5_A 37 NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-GSRAIWASNTNRQNGNYYL-ILQRDRNVVIYDNS----NNAIWATHT 108 (112)
T ss_dssp TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-TTEEEEECCCCCSCCCCEE-EECTTSCEEEECTT----SCEEEECCC
T ss_pred CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-CCEEEEECCccCCCCCEEE-EEeCCCcEEEECCC----CceEEECCC
Confidence 589999999864 345789999999999999 8889999986543333455 99999999999743 568999999
Q ss_pred CC
Q 007336 95 YP 96 (607)
Q Consensus 95 ~P 96 (607)
+.
T Consensus 109 ~~ 110 (112)
T 1xd5_A 109 NV 110 (112)
T ss_dssp CC
T ss_pred cc
Confidence 74
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.35 E-value=2.8e-12 Score=110.14 Aligned_cols=68 Identities=19% Similarity=0.390 Sum_probs=56.8
Q ss_pred CceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEee
Q 007336 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (607)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQS 92 (607)
.++||+|||+.| ..++.|+|..+|||||.|.++.++|+|.+....+..++ +|+|+|||||++. ++|||
T Consensus 48 ~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~d~~~~~lW~S~~~~~~g~~~l-~l~~~Gnlvl~~~-------~~W~S 115 (119)
T 1b2p_A 48 NNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVL-VLQPDRNVVIYGD-------ALWAT 115 (119)
T ss_dssp TEEEEECCCTTS--CSSCEEEECTTSCEEEECTTCCEEEECSCCCCSSCEEE-EECTTSCEEEEES-------EEEEC
T ss_pred CEEEEeCCCccC--CCceEEEEccCCEEEEEeCCCcEEEcCCCCCCCCCEEE-EEECCCcEEEECc-------cEeCC
Confidence 689999999977 33478999999999999999999999987643334455 9999999999872 69998
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=1.9e-12 Score=109.56 Aligned_cols=69 Identities=25% Similarity=0.349 Sum_probs=56.7
Q ss_pred CceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeec
Q 007336 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSF 93 (607)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSF 93 (607)
.++||++|++.+ +..+.|.|..+|||||.|.++.++|++++.+......+ .|+|+|||||++. ++|||=
T Consensus 37 ~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~~~~~~~~-~L~ddGNlvly~~-------~~W~s~ 105 (109)
T 3dzw_A 37 DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVC-VLQKDRNVVIYGT-------ARWATG 105 (109)
T ss_dssp TEEEEECCCTTS--SSSCEEEECTTSCEEEECTTSCEEEECCCCCSSSCEEE-EECTTSCEEEEES-------CCCCCC
T ss_pred CEEEEECCcccC--CCCEEEEEeCCCCEEEECCCCCEEEECCCCCCCCCEEE-EEeCCCEEEEECC-------CEEeCC
Confidence 479999999876 33478999999999999999999999987643223445 9999999999974 589984
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=3.8e-12 Score=125.99 Aligned_cols=145 Identities=15% Similarity=0.046 Sum_probs=113.5
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 516 (607)
....|++...++.|+.+.||+.... ++.+++|............+.+|+.+++.+. |..+.++++++.+.+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3456888888888999999999754 6889999986422123346888999888874 6788899999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-------------------------------------- 558 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-------------------------------------- 558 (607)
|++|.+|.+.+. +......++.+++++|..||+.
T Consensus 91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999987631 1122346788999999999981
Q ss_pred ------------------CCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 559 ------------------SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 559 ------------------~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
.+..++|+|++|.|||++++..+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114589999999999998766678999998864
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.30 E-value=1.1e-11 Score=105.61 Aligned_cols=96 Identities=21% Similarity=0.241 Sum_probs=71.6
Q ss_pred CCCCCCCCcceEEEecCCcEEEEcC-CCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeeccCCCcccC
Q 007336 23 RLNPINDSFGFLMINKTGNLVLTSQ-SNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLL 101 (607)
Q Consensus 23 r~~pv~~~~~~l~~~~~G~L~l~d~-~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PTDTlL 101 (607)
.+.|+.....+|.+..||+|||.+. .+.++|++++.+......+ .|+++|||||++.. +.++|||=.+
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l-~l~~dGNLVl~d~~----~~~iW~S~t~------ 85 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFM-RLGHSGELDITDDR----LNTVFVSNTV------ 85 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEE-EECTTSCEEEECTT----SCEEEECSCC------
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEE-EEeCCCcEEEECCC----CCEEEECCCc------
Confidence 4667766668899999999999998 5899999997643223455 99999999999864 5689997331
Q ss_pred CCCeeccccccCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeCC
Q 007336 102 PGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (607)
Q Consensus 102 pgq~l~~~~~~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 158 (607)
...|.|.+.++.+|+..++ + .+.|.+++
T Consensus 86 -------------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 86 -------------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp -------------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred -------------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 0124478889988886554 4 58898874
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.28 E-value=1.1e-11 Score=105.59 Aligned_cols=68 Identities=18% Similarity=0.289 Sum_probs=56.4
Q ss_pred CceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEee
Q 007336 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (607)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQS 92 (607)
.++||.+|+..+- ..+.|.|..+|||||.|.+++++|++++....+...+ .|+|+|||||++ ..||+|
T Consensus 44 ~~~vWssnt~~~~--~~~~l~l~~dGNLVl~d~~~~~iW~S~t~~~~~~~~~-~L~~dGnlvly~-------~~~W~s 111 (113)
T 3mez_B 44 TNIVWESGTSGRG--QHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVL-ILQINGQAVVYG-------PAVWST 111 (113)
T ss_dssp TEEEEECCCTTSC--SSCEEEECTTSCEEEECTTSCEEEECSCCCSSSCCEE-EECTTSCEEEEC-------SEEEES
T ss_pred CEEEEECCcccCC--cCEEEEEeCCCcEEEECCCCCEEEECCCcCCCCCEEE-EEcCCceEEEec-------CCEecC
Confidence 5799999998763 3478999999999999999999999998643333455 999999999996 269997
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.5e-11 Score=102.72 Aligned_cols=67 Identities=22% Similarity=0.374 Sum_probs=54.3
Q ss_pred ceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEee
Q 007336 16 EVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (607)
Q Consensus 16 t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQS 92 (607)
.+||.+|++.. ...+.|.|..+|+|||.|.++.++|++++....+...+ .|+|+|||||++. .+|+|
T Consensus 42 ~~vW~snt~~~--~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~~~~~~~~-~L~~dGNlvly~~-------~~W~t 108 (110)
T 3r0e_B 42 KYGWQSNTHGN--GEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVL-ILQDDGFGVIYGP-------AIFET 108 (110)
T ss_dssp SSCEECCCTTS--SSSCEEEECTTSCEEEECTTCCEEEECCCCCSSSCCEE-EECTTSCEEEECS-------EEEES
T ss_pred eEEEECCCcCC--CcCEEEEEeCCCcEEEEeCCCCEEEEcCCcCCCCCEEE-EEcCCccEEEecC-------CEecC
Confidence 47999999863 33478999999999999999999999987542233455 9999999999973 69987
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.20 E-value=5.6e-11 Score=100.72 Aligned_cols=96 Identities=13% Similarity=0.173 Sum_probs=70.2
Q ss_pred CCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeeccCCCcccCCC
Q 007336 24 LNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPG 103 (607)
Q Consensus 24 ~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PTDTlLpg 103 (607)
+.++......|.+..||||||.+.++ +|++++.+......+ +|+++|||||++..+ +.++|||..+
T Consensus 14 g~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l-~l~~dGNLVl~~~~~---~~~vW~S~t~-------- 79 (111)
T 3mez_A 14 DNQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTL-RLNNRGQLEIHSANS---NTPVWVYPRS-------- 79 (111)
T ss_dssp TCEEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEE-EECTTSCEEEECSSC---SSCSEEESSS--------
T ss_pred CCEEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEE-EEcCCCcEEEEeCCC---CEEEEEeccc--------
Confidence 44555455789999999999999877 999998643223455 999999999998641 2359999731
Q ss_pred CeeccccccCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeCC
Q 007336 104 MKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (607)
Q Consensus 104 q~l~~~~~~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 158 (607)
.....|.|.+.++++|+..++ . ..+|.++.
T Consensus 80 ---------------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 80 ---------------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp ---------------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred ---------------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 011346789999999986554 3 68998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=2.1e-11 Score=120.07 Aligned_cols=140 Identities=16% Similarity=0.129 Sum_probs=102.8
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCc--eeceEEEEEeCCeEEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~E 516 (607)
...+.+....+.|..+.||+....+|..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3455553333456669999998777788999987543 2245778888888885444 5668888887778899999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS------------------------------------- 559 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------------------------------------- 559 (607)
|+++.+|. .. . .+ ...++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998884 21 1 11 1256777888888888642
Q ss_pred ------------------CCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 560 ------------------RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 560 ------------------~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+..++|+|++|.|||++++..++|+||+.|..-
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999988777789999998754
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.15 E-value=9e-11 Score=99.08 Aligned_cols=71 Identities=20% Similarity=0.285 Sum_probs=56.4
Q ss_pred EEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeeccCCC
Q 007336 18 VWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPS 97 (607)
Q Consensus 18 VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PT 97 (607)
+|.+|+..+ ...+.|+|..+|+|||.|.++.++|++++.+......+ .|+|+|||||++ ..+|+|
T Consensus 39 ~Wssnt~~~--~~~~~l~l~~dGnLvl~d~~~~~vWss~t~~~~~~~~~-~L~~dGNlvly~-------~~~W~s----- 103 (109)
T 3r0e_A 39 NWQSNTANN--GRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAA-VVHPDGRLVVFG-------PSVFKI----- 103 (109)
T ss_dssp TEECCCTTS--CSSCEEEECTTSCEEEECTTSCEEEECCCCCSSSCCEE-EEETTTEEEEEC-------SEEEEE-----
T ss_pred eEEcCCCCC--CCcEEEEEcCCCeEEEEeCCCCEEEcCCCcCCCcCEEE-EEcCCCeEEEEe-------cCEECC-----
Confidence 699999865 23578999999999999999999999987642233455 999999999996 269998
Q ss_pred cccCCC
Q 007336 98 DTLLPG 103 (607)
Q Consensus 98 DTlLpg 103 (607)
.|.+||
T Consensus 104 ~t~~~~ 109 (109)
T 3r0e_A 104 DPWVRG 109 (109)
T ss_dssp CTTSCC
T ss_pred CCccCC
Confidence 555554
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.05 E-value=5.5e-10 Score=94.39 Aligned_cols=90 Identities=16% Similarity=0.292 Sum_probs=65.2
Q ss_pred CCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeeccCCCcccCCCCe
Q 007336 26 PINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMK 105 (607)
Q Consensus 26 pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~ 105 (607)
++......|.+..||+|+|.+. .++|++++.+......+ +|+++|||||++.. +.++|||-.+-
T Consensus 20 ~L~sg~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l-~l~~dGNLvl~d~~----~~~iW~S~t~~--------- 83 (110)
T 3r0e_B 20 RLTAKNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFL-RLNHKGELIIKDDD----FKTIWSSRSSS--------- 83 (110)
T ss_dssp EEECSSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEE-EECTTSCEEEECTT----CCEEEECCCCC---------
T ss_pred EEEeCCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEE-EEeCCCcEEEEeCC----CCEEEEcCCcC---------
Confidence 3433447899999999999877 58999997642223455 99999999999864 56899985410
Q ss_pred eccccccCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeC
Q 007336 106 LGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTG 157 (607)
Q Consensus 106 l~~~~~~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~ 157 (607)
..|.|.+.++++|+..++ + ...|.+|
T Consensus 84 ----------------------~~~~~~~~L~~dGNlvly--~--~~~W~t~ 109 (110)
T 3r0e_B 84 ----------------------KQGEYVLILQDDGFGVIY--G--PAIFETS 109 (110)
T ss_dssp ----------------------SSSCCEEEECTTSCEEEE--C--SEEEESC
T ss_pred ----------------------CCCCEEEEEcCCccEEEe--c--CCEecCC
Confidence 123478888888886554 4 3788876
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=8.3e-10 Score=93.26 Aligned_cols=87 Identities=17% Similarity=0.301 Sum_probs=63.5
Q ss_pred cceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeeccCCCcccCCCCeecccc
Q 007336 31 FGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDL 110 (607)
Q Consensus 31 ~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~ 110 (607)
..+|.|..||+|+|.+. ++++|++++.+......+ .|+++|||||++.. +.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l-~l~~dGNLvl~~~~----~~~~W~S~t~~-------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHL-SMQSDGNLVVYSPR----NNPIWASNTGG-------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEE-EECTTSCEEEECTT----SCEEEECCCCC--------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEE-EEeCCCCEEEECCC----CCEEEECCCCC--------------
Confidence 37799999999999988 789999997643223455 99999999999864 56899986421
Q ss_pred ccCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeCC
Q 007336 111 KTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (607)
Q Consensus 111 ~~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 158 (607)
..+.|.+.++++|+..++ +. ..|.++.
T Consensus 80 -----------------~~~~~~~~L~ddGNlvly--~~--~~W~s~t 106 (109)
T 3dzw_A 80 -----------------ENGNYVCVLQKDRNVVIY--GT--ARWATGT 106 (109)
T ss_dssp -----------------SSSCEEEEECTTSCEEEE--ES--CCCCCCC
T ss_pred -----------------CCCCEEEEEeCCCEEEEE--CC--CEEeCCC
Confidence 124577888888886543 32 5566553
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=6.7e-10 Score=115.12 Aligned_cols=141 Identities=17% Similarity=0.220 Sum_probs=105.7
Q ss_pred ceeecccCceeEEEEEecCCcEEEEEEec--ccc-hhhHHHHHHHHHHHccCC--CCceeceEEEEEeC---CeEEEEEE
Q 007336 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLS--KIS-EQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQG---EEKLLIYE 516 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~--~~~-~~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~---~~~~lV~E 516 (607)
.+.|+.|.+..||+.... +..+++|+.. ... ......+.+|..+++.+. +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 478999999999998875 4678888765 321 122456788999988886 45688999998776 34799999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS------------------------------------- 559 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------------------------------------- 559 (607)
|+++..+.+.. ...++...+..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99998874321 123677888889999999999999731
Q ss_pred ------------------CCceEecccCCCcEEEcCCCc--eEEeeccccee
Q 007336 560 ------------------RLRIIHRDLKASNVLLDQDMN--PKISDFGLVRT 591 (607)
Q Consensus 560 ------------------~~~ivHrDlkp~Nill~~~~~--~ki~DfGla~~ 591 (607)
+..++|+|++|.|||++.++. +.|+||+++..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 69999999884
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.1e-09 Score=92.42 Aligned_cols=94 Identities=18% Similarity=0.338 Sum_probs=68.4
Q ss_pred CCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeeccCCCcccCC
Q 007336 23 RLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLP 102 (607)
Q Consensus 23 r~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PTDTlLp 102 (607)
.+.|+.+....|.+..||||||.++ +|++++.+......+ +|.++|||||++.. +.++|+|-..
T Consensus 14 ~g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l-~l~~dGnLvl~d~~----~~~vWss~t~------- 77 (109)
T 3r0e_A 14 TEGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKL-TLTDYGELVIKNGD----GSTVWKSGAQ------- 77 (109)
T ss_dssp TTCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEE-EECTTSCEEEECTT----SCEEEECCCC-------
T ss_pred CCCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEE-EEcCCCeEEEEeCC----CCEEEcCCCc-------
Confidence 4556655557899999999999985 799998753223455 99999999999864 5689976210
Q ss_pred CCeeccccccCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeCCCC
Q 007336 103 GMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWN 160 (607)
Q Consensus 103 gq~l~~~~~~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~ 160 (607)
...+.|.+.++++|+..+ ++ .+.|.+++|-
T Consensus 78 ------------------------~~~~~~~~~L~~dGNlvl--y~--~~~W~s~t~~ 107 (109)
T 3r0e_A 78 ------------------------SVKGNYAAVVHPDGRLVV--FG--PSVFKIDPWV 107 (109)
T ss_dssp ------------------------CSSSCCEEEEETTTEEEE--EC--SEEEEECTTS
T ss_pred ------------------------CCCcCEEEEEcCCCeEEE--Ee--cCEECCCCcc
Confidence 023457889998887654 44 5899999873
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.84 E-value=4.4e-09 Score=88.99 Aligned_cols=65 Identities=17% Similarity=0.141 Sum_probs=51.7
Q ss_pred EEEccCCCCCCCCcceEEEecCCcEEEEcCCCc-EEEeeCCcc--CcCCceEEEEecCCCeEEeeCCCCCCCceeEee
Q 007336 18 VWVANRLNPINDSFGFLMINKTGNLVLTSQSNI-VVWSAYLSK--EVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (607)
Q Consensus 18 VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~-~vWst~~~~--~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQS 92 (607)
||.+|+..+. ..+.|.|..+|||||.|.++. ++|++++.. ......+ .|+++|||||++ ..+|+|
T Consensus 40 vW~snt~~~~--~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~~~~~~~~~~l-~Lq~dGNlvly~-------~~~W~s 107 (111)
T 3mez_A 40 GFQSNTHGRG--VDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAA-TLGPDQHVTIYG-------PAIWST 107 (111)
T ss_dssp CEECCCTTSC--SSCEEEECTTSCEEEECSSCSSCSEEESSSCCCCSSCCEE-EECTTSCEEEEC-------SEEEEC
T ss_pred EEECCcccCC--cCEEEEEcCCCcEEEEeCCCCEEEEEeccccCCCCcCEEE-EECCCCeEEEec-------cCEEcc
Confidence 9999998762 347899999999999999876 599998632 1223455 999999999996 369997
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.83 E-value=2.3e-08 Score=83.54 Aligned_cols=84 Identities=19% Similarity=0.368 Sum_probs=60.6
Q ss_pred ceEEEecCCcEEEEcCCCcEEEeeCCccCc-CCceEEEEecCCCeEEeeCCCCCCCceeEeeccCCCcccCCCCeecccc
Q 007336 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEV-QTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDL 110 (607)
Q Consensus 32 ~~l~~~~~G~L~l~d~~g~~vWst~~~~~~-~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~ 110 (607)
-+|.+..||||||.+. +++||++++.... ....+ .|.++|||||+|.. +.++|.|-.
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L-~l~~dGnLvL~d~~----~~~vWss~t---------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSA-VLQSDGNFVVYDSS----GRSLWASHS---------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEE-EECTTSCEEEECTT----CCEEEECCC----------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEE-EEeCCccEEEECCC----cEEEEEecC----------------
Confidence 5689999999999875 6899999976432 23445 89999999999875 568998621
Q ss_pred ccCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEe
Q 007336 111 KTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRT 156 (607)
Q Consensus 111 ~~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~ 156 (607)
....+.|.+.|+++|+..+ ++. ..|.|
T Consensus 79 ---------------~~~~~~~~l~L~ddGNlVl--y~~--~~W~S 105 (105)
T 4h3o_A 79 ---------------TRGSGNYILILQDDGNVII--YGS--DIWST 105 (105)
T ss_dssp ---------------CCCSSCEEEEECTTSCEEE--EES--EEEEC
T ss_pred ---------------CCCCCCEEEEEeCCCeEEE--ECC--cEecC
Confidence 1134568889998888654 332 45653
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=1.9e-08 Score=99.43 Aligned_cols=70 Identities=23% Similarity=0.449 Sum_probs=58.8
Q ss_pred CceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeecc
Q 007336 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (607)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd 94 (607)
.+++|.+++..+- . ..|.+..+|+|++.|.++.++|++++.+. ....+ .|+++|||||++. .++|||||
T Consensus 183 ~~~yW~Sgt~~~~--~-~~l~l~~dGnLvl~d~~~~~vWsS~t~~~-~~~rl-~Ld~dGnLvly~~------~~~Wqsf~ 251 (276)
T 3m7h_A 183 GAATWNAGTQGKG--A-VRAVFQGDGNLVVYGAGNAVLWHSHTGGH-ASAVL-RLQANGSIAILDE------KPVWARFG 251 (276)
T ss_dssp SSEEEECCCTTTT--C-CEEEECTTSCEEEECTTSCEEEECSCTTC-TTCEE-EECTTSCEEEEEE------EEEEESSS
T ss_pred CeEEEECCCCCCc--c-EEEEEcCCCeEEEEeCCCcEEEEecCCCC-CCEEE-EEcCCccEEEEcC------CCeEEccC
Confidence 5789999998772 2 68999999999999998899999987642 33455 9999999999974 47999999
Q ss_pred C
Q 007336 95 Y 95 (607)
Q Consensus 95 ~ 95 (607)
|
T Consensus 252 ~ 252 (276)
T 3m7h_A 252 F 252 (276)
T ss_dssp C
T ss_pred c
Confidence 7
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.74 E-value=5.4e-08 Score=94.31 Aligned_cols=87 Identities=20% Similarity=0.311 Sum_probs=65.1
Q ss_pred ceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeeccCCCcccCCCCeeccccc
Q 007336 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (607)
Q Consensus 32 ~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~ 111 (607)
-+|.|..+|+|+|.+. +++||.+++.+. ....+ +|.++|||||+|.. +.+||+|+.+.
T Consensus 28 f~l~f~~~gnl~ly~~-~~~vW~an~~~~-~~~~l-~l~~dGnLvl~d~~----~~~vW~s~~~~--------------- 85 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRA-VLQSDGLLVILTAQ----NTIRWSSGTKG--------------- 85 (236)
T ss_dssp EEEEECTTSCEEEEES-SSEEECCCCCSC-SCCBC-CBCSSSCBCCBCTT----TCCSCCCCCCC---------------
T ss_pred EEEEECCCCcEEEEEC-CEEEEECCCCCC-CCeEE-EEcCCCcEEEEcCC----CcEEEeCCccc---------------
Confidence 6788888999999886 789999997653 44455 89999999999864 56899998741
Q ss_pred cCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeCCCC
Q 007336 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWN 160 (607)
Q Consensus 112 ~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~ 160 (607)
++|.|.+.|+++|+..+ ++. .+|.+..+.
T Consensus 86 ----------------~~~~~~~~l~d~Gnlvl--~~~--~~W~S~~~p 114 (236)
T 1dlp_A 86 ----------------SIGNYVLVLQPDRTVTI--YGP--GLWDSGTSN 114 (236)
T ss_dssp ----------------CSSCCEEEECSSSCEEE--ECS--EEEECSCCC
T ss_pred ----------------cCCcEEEEEeCCCCEEE--ecC--CEEECCCCC
Confidence 23456778887777544 322 788876553
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.54 E-value=1.3e-07 Score=95.34 Aligned_cols=136 Identities=20% Similarity=0.209 Sum_probs=98.8
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccC-CCCc--eeceEEEEEeCC---eEEEEEEcCC
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-QHRN--LVKLLGCCIQGE---EKLLIYEFMP 519 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~n--Iv~l~g~~~~~~---~~~lV~Ey~~ 519 (607)
+.++.|.+..||+.. ..+++|+... ......+.+|..+++.+ .+.. +.++++.....+ ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 568999999999753 5688887643 23456788999998877 3333 445555544333 2479999999
Q ss_pred CCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 007336 520 NKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD----------------------------------------- 558 (607)
Q Consensus 520 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~----------------------------------------- 558 (607)
|.+|..... ..++..++..++.++++.|+.||+.
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988865432 2356677777888888888888851
Q ss_pred --------------CCCceEecccCCCcEEEcC--CCceEEeecccceee
Q 007336 559 --------------SRLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRTF 592 (607)
Q Consensus 559 --------------~~~~ivHrDlkp~Nill~~--~~~~ki~DfGla~~~ 592 (607)
.+..++|+|++|.||++++ ...+.|+||+.+..-
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1245899999999999998 556899999999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.5e-06 Score=87.60 Aligned_cols=137 Identities=20% Similarity=0.141 Sum_probs=94.5
Q ss_pred ceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC---ceeceEEEEE-eCCeEEEEEEcCCC
Q 007336 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCI-QGEEKLLIYEFMPN 520 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~---nIv~l~g~~~-~~~~~~lV~Ey~~~ 520 (607)
.+.++.|....||+. +..+++|+... ......+..|..++..+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888888899987 56678887532 33456789999999988652 3667777775 34457899999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD------------------------------------------ 558 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~------------------------------------------ 558 (607)
..|...... .++...+..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888763211 123344444555555555555532
Q ss_pred ---------------CCCceEecccCCCcEEEcC---CCc-eEEeecccceee
Q 007336 559 ---------------SRLRIIHRDLKASNVLLDQ---DMN-PKISDFGLVRTF 592 (607)
Q Consensus 559 ---------------~~~~ivHrDlkp~Nill~~---~~~-~ki~DfGla~~~ 592 (607)
.+..++|+|++|.|||++. ++. +.|+||+.+..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2335799999999999987 455 589999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=2.3e-06 Score=84.39 Aligned_cols=137 Identities=17% Similarity=0.135 Sum_probs=97.4
Q ss_pred eeecccCce-eEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEEEEcCCCCC
Q 007336 446 NKLGEGGFG-PVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKS 522 (607)
Q Consensus 446 ~~lg~G~fg-~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 522 (607)
+.+..|..+ .||+..... +..+++|+-.. ....++.+|...++.+. +--+.++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556655 589877643 56788887643 24556788888887764 4447788999999999999999999988
Q ss_pred hHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 007336 523 LDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS------------------------------------------- 559 (607)
Q Consensus 523 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------------------------------------------- 559 (607)
+.+..... ......++.++++.|.-||...
T Consensus 107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 87654221 1122345566666666666421
Q ss_pred ------------CCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 560 ------------RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 560 ------------~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+..++|+|+.+.|||++.+..+-|+||+.+..-
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 123799999999999998877789999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=1.4e-06 Score=89.85 Aligned_cols=80 Identities=6% Similarity=0.000 Sum_probs=54.3
Q ss_pred ceee-cccCceeEEEEEec-------CCcEEEEEEecccc---hhhHHHHHHHHHHHccCCC---CceeceEEEEEeC--
Q 007336 445 NNKL-GEGGFGPVYKGTLV-------DGQEIAVKRLSKIS---EQGLKELKNEVILFSKLQH---RNLVKLLGCCIQG-- 508 (607)
Q Consensus 445 ~~~l-g~G~fg~Vy~g~~~-------~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H---~nIv~l~g~~~~~-- 508 (607)
.+.| +.|....+|+.... +++.+++|+..... ......+..|..+++.+.. ..+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999988764 25678888764321 0012456778887777642 3577788887655
Q ss_pred -CeEEEEEEcCCCCChH
Q 007336 509 -EEKLLIYEFMPNKSLD 524 (607)
Q Consensus 509 -~~~~lV~Ey~~~gsL~ 524 (607)
+..++||||+++..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=2.6e-05 Score=81.47 Aligned_cols=75 Identities=9% Similarity=0.139 Sum_probs=49.1
Q ss_pred ceeecccCceeEEEEEec-CCcEEEEEEecccch-------hhHHHHHHHHHHHccCCC--C-ceeceEEEEEeCCeEEE
Q 007336 445 NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISE-------QGLKELKNEVILFSKLQH--R-NLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-------~~~~~f~~E~~~l~~l~H--~-nIv~l~g~~~~~~~~~l 513 (607)
.+.||.|.++.||++... +++.++||....... ...+++..|.+++..+.+ + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 368999999999999764 467899997643211 123456778888776632 3 34456544 4555689
Q ss_pred EEEcCCCC
Q 007336 514 IYEFMPNK 521 (607)
Q Consensus 514 V~Ey~~~g 521 (607)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.89 E-value=6.1e-05 Score=76.64 Aligned_cols=141 Identities=17% Similarity=0.254 Sum_probs=78.8
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccC-----CCCceeceE-E--EEEeCCeEEEEEEc
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKL-----QHRNLVKLL-G--CCIQGEEKLLIYEF 517 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-----~H~nIv~l~-g--~~~~~~~~~lV~Ey 517 (607)
+.|+.|....||+....++ .+++|+.... . .++..|..++..+ ..|.++... | +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999887544 5888887652 2 2233344443333 234444310 0 12346678999999
Q ss_pred CCCCChH-----------H---HHhcCC-----C------CCCCCHHHHH------------------------------
Q 007336 518 MPNKSLD-----------S---FIFDQT-----R------RTLLDWSQRF------------------------------ 542 (607)
Q Consensus 518 ~~~gsL~-----------~---~l~~~~-----~------~~~l~~~~~~------------------------------ 542 (607)
+++..+. . .++... . .....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 0 111100 0 0112332211
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 543 -HIICGTARGLLYLHQ----------DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 543 -~i~~~ia~gl~yLH~----------~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
.+...+.+++.+|++ ..+..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 011223446667763 1235699999999999998888899999998863
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00015 Score=72.12 Aligned_cols=79 Identities=16% Similarity=0.206 Sum_probs=56.6
Q ss_pred CcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCC---CceeceEEEEEeCCeEEEEEEc
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQH---RNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H---~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.+.-.+.+|.|..+.||+.++.+|+.+.+|+...........|..|...|+.|.- .-+.+++++ + ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEe
Confidence 3455578999999999999999999999998654333334567888888877642 234555554 2 23789999
Q ss_pred CCCCCh
Q 007336 518 MPNKSL 523 (607)
Q Consensus 518 ~~~gsL 523 (607)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00053 Score=68.87 Aligned_cols=139 Identities=15% Similarity=0.101 Sum_probs=92.8
Q ss_pred cceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCC---CCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 444 INNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 444 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
-.+.|+.|.+..+|+... ++..+++|+.... ....|..|...|+.+. ...+.++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346799999999999876 4678888876532 3567888988887773 36688899998888889999999998
Q ss_pred CChHH--------H---HhcCCC-C------------------CCCCHHHHH---HHH----------------HHHHHH
Q 007336 521 KSLDS--------F---IFDQTR-R------------------TLLDWSQRF---HII----------------CGTARG 551 (607)
Q Consensus 521 gsL~~--------~---l~~~~~-~------------------~~l~~~~~~---~i~----------------~~ia~g 551 (607)
..+.. . |+.... . -.-+|...+ ++. ..+++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76521 1 222111 0 012454322 111 111111
Q ss_pred -HHHHHh-CCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 552 -LLYLHQ-DSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 552 -l~yLH~-~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
...|.. ..++.+||+|+.+.|++++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223421 2356799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00029 Score=74.09 Aligned_cols=73 Identities=12% Similarity=0.182 Sum_probs=45.1
Q ss_pred ceeecccCceeEEEEEecCCcEEEEEEecc----cchh-----hHHHHHHHHHHHc-cCCCCceeceEEEEEeCCeEEEE
Q 007336 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSK----ISEQ-----GLKELKNEVILFS-KLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~----~~~~-----~~~~f~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
.+.||.|....||+... +++.++||.... .... ....+..|+..+. ...+..+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 36789999999999964 467899994321 0111 2233444443322 22234566777665 5667999
Q ss_pred EEcC-CC
Q 007336 515 YEFM-PN 520 (607)
Q Consensus 515 ~Ey~-~~ 520 (607)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0016 Score=65.87 Aligned_cols=33 Identities=24% Similarity=0.341 Sum_probs=28.3
Q ss_pred CCceEecccCCCcEEEcCC----CceEEeecccceee
Q 007336 560 RLRIIHRDLKASNVLLDQD----MNPKISDFGLVRTF 592 (607)
Q Consensus 560 ~~~ivHrDlkp~Nill~~~----~~~ki~DfGla~~~ 592 (607)
+..++|+|+.+.|||++.+ ..+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4569999999999999875 67999999998743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.001 Score=70.00 Aligned_cols=72 Identities=19% Similarity=0.319 Sum_probs=48.0
Q ss_pred eeecccCceeEEEEEecC--------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCce-eceEEEEEeCCeEEEEEE
Q 007336 446 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E 516 (607)
+.|+.|-...+|+....+ +..+++|+.... ...+.+..|..++..+...++ .++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 578888889999998753 468888877431 112455678888877743333 56676543 2 28999
Q ss_pred cCCCCCh
Q 007336 517 FMPNKSL 523 (607)
Q Consensus 517 y~~~gsL 523 (607)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0017 Score=66.92 Aligned_cols=141 Identities=17% Similarity=0.234 Sum_probs=80.9
Q ss_pred eeecccCceeEEEEEecC--------CcEEEEEEecccchhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEEEE
Q 007336 446 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 516 (607)
+.|..|-...+|+....+ ++.+++|+.... ......+.+|.++++.+. +.-..++++++.+ . +|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g--~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--G--RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--E--EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--c--cEEE
Confidence 567778888899988642 468888876332 123455668888887764 2223566666543 2 9999
Q ss_pred cCCCCChHHH-----------------HhcCCC--CCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 007336 517 FMPNKSLDSF-----------------IFDQTR--RTLLD--WSQRFHIICGTA-------------------RGLLYLH 556 (607)
Q Consensus 517 y~~~gsL~~~-----------------l~~~~~--~~~l~--~~~~~~i~~~ia-------------------~gl~yLH 556 (607)
|+++..|..- |+.... ..... |.+..++..++. +.+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998655311 111100 11111 344444433321 1233332
Q ss_pred ----h-CCCCceEecccCCCcEEEcCC----CceEEeeccccee
Q 007336 557 ----Q-DSRLRIIHRDLKASNVLLDQD----MNPKISDFGLVRT 591 (607)
Q Consensus 557 ----~-~~~~~ivHrDlkp~Nill~~~----~~~ki~DfGla~~ 591 (607)
. ..+..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 123468999999999999876 7899999998874
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0054 Score=64.96 Aligned_cols=73 Identities=15% Similarity=0.138 Sum_probs=45.7
Q ss_pred eeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCce-eceEEEEEeCCeEEEEEEcCCCCCh
Q 007336 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFMPNKSL 523 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL 523 (607)
+.|+.|-...+|+....+ +..+++|+....... .-....|..++..+...++ .++++.+ .+. +||||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~G--~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TNG--RIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TTE--EEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CCe--EEEEeeCCccC
Confidence 578888889999998765 477888876432111 1112467777777754444 5677766 232 59999987554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0014 Score=65.32 Aligned_cols=138 Identities=12% Similarity=0.112 Sum_probs=73.1
Q ss_pred ceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCce-eceEEEEEeCCeEEEEEEcC-CCCC
Q 007336 445 NNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFM-PNKS 522 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~-~~gs 522 (607)
.+.|+.|....+|+. ..+++|+....... ......|...++.+....+ .+++++ +.+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578989999999998 55777876532111 1122446666655532222 455554 344457899999 6554
Q ss_pred hHHH------------------HhcCCCC--CCCC-HHHHHHHHH--------------HHHHHH----HHHHh-CCCCc
Q 007336 523 LDSF------------------IFDQTRR--TLLD-WSQRFHIIC--------------GTARGL----LYLHQ-DSRLR 562 (607)
Q Consensus 523 L~~~------------------l~~~~~~--~~l~-~~~~~~i~~--------------~ia~gl----~yLH~-~~~~~ 562 (607)
|... |+..... ...+ +.....+.. .+.+.+ ..|.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4310 1111100 0011 111111100 011111 11211 22345
Q ss_pred eEecccCCCcEEEcCCCceEEeeccccee
Q 007336 563 IIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 563 ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++|+|+.|.||| ..++.+.|+||..|..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5666789999998874
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0066 Score=61.10 Aligned_cols=142 Identities=15% Similarity=0.153 Sum_probs=79.1
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCC--ceeceEEE-----EEeCCeEEEEEEcC
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGC-----CIQGEEKLLIYEFM 518 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~--nIv~l~g~-----~~~~~~~~lV~Ey~ 518 (607)
..++ |....||+....+|+.+++|..... ....+.+..|..++..+... .+++++.. ....+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 7778899887766778999987532 11234556677666655321 23444432 22345668899999
Q ss_pred CCCChH-----HH---------Hhc----CC--CCCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 007336 519 PNKSLD-----SF---------IFD----QT--RRTLLDWSQR----FHI---------------ICGTARGLLYLHQ-- 557 (607)
Q Consensus 519 ~~gsL~-----~~---------l~~----~~--~~~~l~~~~~----~~i---------------~~~ia~gl~yLH~-- 557 (607)
++..+. .. ++. .. .....++... ..+ ...+.+.+..+.+
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 11 111 00 1111222211 000 0111122333322
Q ss_pred --CCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 558 --DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 558 --~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1235689999999999999 4 899999988764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0097 Score=59.67 Aligned_cols=143 Identities=15% Similarity=0.116 Sum_probs=78.2
Q ss_pred eeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCc--eeceEEE------EEeCCeEEEEEEc
Q 007336 446 NKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGC------CIQGEEKLLIYEF 517 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n--Iv~l~g~------~~~~~~~~lV~Ey 517 (607)
+.|+.|....+|+....++ .+++|..... ...+.+..|..++..+.... +.+++.. ....+..++|+||
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 5677788889999887555 6778877641 11233445666655543111 2233211 1234567899999
Q ss_pred CCCCChHH----H----------HhcCC----CC-----CCCCHHHHHH------------HHHHHHHHHHHHHhC----
Q 007336 518 MPNKSLDS----F----------IFDQT----RR-----TLLDWSQRFH------------IICGTARGLLYLHQD---- 558 (607)
Q Consensus 518 ~~~gsL~~----~----------l~~~~----~~-----~~l~~~~~~~------------i~~~ia~gl~yLH~~---- 558 (607)
+++..+.. . ++... .. ....|...+. +...+.+.+.+|++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865321 0 11100 00 0112332111 011244455666532
Q ss_pred CCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 559 ~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
.+..++|+|+.+.|||++++..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234699999999999999876668999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0035 Score=64.42 Aligned_cols=73 Identities=14% Similarity=0.169 Sum_probs=41.6
Q ss_pred eeecccCceeEEEEEecC---------CcEEEEEEecccchhhHHHHHHHHHHHccCCCCc-eeceEEEEEeCCeEEEEE
Q 007336 446 NKLGEGGFGPVYKGTLVD---------GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~---------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~ 515 (607)
+.|+.|..-.+|+....+ +..+++|+...... .......|..++..+...+ ..++++.. . -.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 567778888899988653 26788887654211 1112356777766664323 34666543 2 26899
Q ss_pred EcCCCCCh
Q 007336 516 EFMPNKSL 523 (607)
Q Consensus 516 Ey~~~gsL 523 (607)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99997543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.84 E-value=0.059 Score=54.54 Aligned_cols=33 Identities=24% Similarity=0.310 Sum_probs=28.8
Q ss_pred CCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 560 ~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+..++|+|+.+.||++++++.+.|+||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 356999999999999998888999999888753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.41 E-value=0.35 Score=50.32 Aligned_cols=73 Identities=16% Similarity=0.170 Sum_probs=44.7
Q ss_pred eeecccCceeEEEEEecC--------CcEEEEEEecccchhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEEEE
Q 007336 446 NKLGEGGFGPVYKGTLVD--------GQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 516 (607)
+.+..|-.-.+|+....+ +..+++|+....... .....+|..+++.+. +.-..++++.+ . -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 567778888899988753 577888876432211 112345666666653 22234555533 2 268999
Q ss_pred cCCCCCh
Q 007336 517 FMPNKSL 523 (607)
Q Consensus 517 y~~~gsL 523 (607)
|+++..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.97 E-value=0.74 Score=47.52 Aligned_cols=30 Identities=23% Similarity=0.355 Sum_probs=25.5
Q ss_pred ceEecccCCCcEEE------cCCCceEEeeccccee
Q 007336 562 RIIHRDLKASNVLL------DQDMNPKISDFGLVRT 591 (607)
Q Consensus 562 ~ivHrDlkp~Nill------~~~~~~ki~DfGla~~ 591 (607)
.++|+|+.+.|||+ +++..++++||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998874
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=87.46 E-value=0.64 Score=35.82 Aligned_cols=35 Identities=29% Similarity=0.530 Sum_probs=28.4
Q ss_pred cCCChHhHHHhhhcCCceeEEeeeccCCCCceeeeecc
Q 007336 305 KSMNLKECREGCLENSSCMAYTNSDIRGGGSGCAMWFG 342 (607)
Q Consensus 305 ~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~~~C~~~~~ 342 (607)
...++++|+..|+.+=.|.+|.|+. ....|+++.+
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~---~s~~CflKs~ 62 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNV---KSGLCYPKRG 62 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEET---TTTEEEEEES
T ss_pred cCCCHHHHHHHhhccCCCCeEEecc---CCCceEcccC
Confidence 3468999999999999999999973 2345988655
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=85.08 E-value=16 Score=34.95 Aligned_cols=65 Identities=12% Similarity=0.249 Sum_probs=40.6
Q ss_pred CCceEEEccCCCC-------CCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeC
Q 007336 14 PHEVVWVANRLNP-------INDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDE 80 (607)
Q Consensus 14 ~~t~VW~Anr~~p-------v~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~ 80 (607)
..+++|...+..+ +... +.+-++.++.+...|.+|..+|.-.+........+ ..+.+||+++-+.
T Consensus 24 tG~~~w~~~~~~~~~~~~~~~~pd-G~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~-~~~~dG~~lv~~~ 95 (276)
T 3no2_A 24 TKEIVWEYPLEKGWECNSVAATKA-GEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTA-RILPDGNALVAWC 95 (276)
T ss_dssp TTEEEEEEECCTTCCCCEEEECTT-SCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEE-EECTTSCEEEEEE
T ss_pred CCeEEEEeCCCccCCCcCeEECCC-CCEEEeCCCCEEEECCCCCEEEEEcCCCCcccccc-EECCCCCEEEEec
Confidence 4568899887542 1222 34444555666667888999999875421122334 6778888888654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.31 E-value=3.1 Score=38.69 Aligned_cols=88 Identities=7% Similarity=0.004 Sum_probs=62.1
Q ss_pred CCCceeceEEEEEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCceEecccCCCc
Q 007336 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL-YLHQDSRLRIIHRDLKASN 572 (607)
Q Consensus 494 ~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~-yLH~~~~~~ivHrDlkp~N 572 (607)
.||.+ -..+-.+++...+.|+--+++.=...+ ..++...+++++..|+.-.. +++. -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 67877 333446677777777765444322333 23577888888888877665 4543 5788899999
Q ss_pred EEEcCCCceEEeecccceeecC
Q 007336 573 VLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 573 ill~~~~~~ki~DfGla~~~~~ 594 (607)
|++|.++.++|.-.|+-..+.+
T Consensus 115 L~f~~~~~p~i~hRGi~~~lpP 136 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESLPP 136 (219)
T ss_dssp EEECTTCCEEESCCEETTTBSS
T ss_pred EEEeCCCcEEEEEcCCcccCCC
Confidence 9999999999999998666643
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.23 E-value=0.17 Score=53.46 Aligned_cols=61 Identities=15% Similarity=0.189 Sum_probs=18.2
Q ss_pred cceeecccCceeEEEEEecC-CcEEEE------EEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEe
Q 007336 444 INNKLGEGGFGPVYKGTLVD-GQEIAV------KRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 507 (607)
Q Consensus 444 ~~~~lg~G~fg~Vy~g~~~~-~~~vav------K~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~ 507 (607)
+.+.|| ||.||+|.+.. ..+||| |.... .+......|.+|..++..++|||+++..++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345676 99999999865 367888 66543 223344578889999999999999999887653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.12 E-value=2.6 Score=39.12 Aligned_cols=90 Identities=10% Similarity=0.058 Sum_probs=64.1
Q ss_pred CCCCceeceEEEEEeCCeEEEEEEcCCCC-ChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCC
Q 007336 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNK-SLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571 (607)
Q Consensus 493 l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~ 571 (607)
..||+++.. .+-.+.+...+.|+.-+.+ ++.. + ..++...+++++..|+.-..+++. -+|--|.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 368888866 4555666666655544322 2222 2 236788999999999887766654 378889999
Q ss_pred cEEEcCCCceEEeecccceeecCC
Q 007336 572 NVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 572 Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+++.++.++|.=.|+-..+.+.
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P~ 132 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDPL 132 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSCC
T ss_pred eEEEcCCCCEEEEEccCccCCCCC
Confidence 999999999999999986655443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 607 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-45 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-42 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-42 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-42 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-38 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-38 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-18 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 9e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 7e-10 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 9e-05 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 5e-09 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 8e-09 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 6e-08 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 7e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-48
Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 6/168 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ ++G G FG VYKG + + ++ + Q L+ KNEV + K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+G + ++ ++ SL + T + + I TA+G+ YLH S
Sbjct: 68 LFMGYSTAP-QLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
IIHRDLK++N+ L +D+ KI DFGL ++ G+
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 2e-45
Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 6/166 (3%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQH 495
N D + I +LG+G FG VYK + A K + SE+ L++ E+ + + H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+VKLL ++ EF ++D+ + + R L SQ + T L YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYL 126
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
H +IIHRDLKA N+L D + K++DFG+ ++
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 6e-45
Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 11/172 (6%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQH 495
D+F ++LG G G V+K + G +A K + I ++ E+ + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+V G E + E M SLD + R + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ +I+HRD+K SN+L++ K+ DFG+ + N VGT
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGT 166
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 4e-44
Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 7/168 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V+ G ++AVK L + E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L Q E +I E+M N SL F+ L ++ + A G+ ++ + +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
IHRDL+A+N+L+ ++ KI+DFGL R +E
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFP 173
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 6e-44
Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 16/181 (8%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNE 486
EL + FS ++G G FG VY + + + +A+K++S S + +++ E
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 487 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIIC 546
V KL+H N ++ GC ++ L+ E+ + D + L + +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTH 122
Query: 547 GTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
G +GL YLH +IHRD+KA N+LL + K+ DFG N VG
Sbjct: 123 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVG 173
Query: 607 T 607
T
Sbjct: 174 T 174
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 8e-44
Identities = 41/168 (24%), Positives = 75/168 (44%), Gaps = 7/168 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ ++G G FG V+ G ++ ++A+K + + ++ E + KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C++ L++EFM + L ++ Q + G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYLEE-- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+IHRDL A N L+ ++ K+SDFG+ R D+ ++
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFP 165
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-43
Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 8/170 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRN 497
+++ + LGEG +G V V + +AVK + + + +K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+VK G +G + L E+ L I + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ I HRD+K N+LLD+ N KISDFGL F + E N++ GT
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-43
Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 8/170 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+++ + +G G +G K DG+ + K L ++E + L +EV L +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 497 NLVKLLGCCIQGEEKLL--IYEFMPNKSLDSFIFDQTR-RTLLDWSQRFHIICGTARGLL 553
N+V+ I L + E+ L S I T+ R LD ++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 554 YLHQ--DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
H+ D ++HRDLK +NV LD N K+ DFGL R D +
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-42
Identities = 43/168 (25%), Positives = 68/168 (40%), Gaps = 7/168 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ + +LG G FG V G ++A+K + + E E + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L G C + +I E+M N L +++ + R Q + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ +HRDL A N L++ K+SDFGL R DE +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFP 164
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (385), Expect = 2e-42
Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 19/191 (9%)
Query: 430 FELATIANATDNFS---------INNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK-I 475
F A F+ I +G G FG V G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 476 SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL 535
+E+ ++ +E + + H N++ L G + ++I EFM N SLDSF+ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 536 LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595
Q ++ G A G+ YL + +HRDL A N+L++ ++ K+SDFGL R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 596 ETEGNTNRVVG 606
++ +G
Sbjct: 182 TSDPTYTSALG 192
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-42
Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 12/176 (6%)
Query: 438 ATDNFSI-NNKLGEGGFGPVYKGTLV---DGQEIAVKRLSKISEQG-LKELKNEVILFSK 492
DN I + +LG G FG V +G ++A+K L + +E+ +E+ E + +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
L + +V+L+G C Q E +L+ E L F+ + + S ++ + G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGN-TNRVVGT 607
YL + +HRDL A NVLL KISDFGL + G D++ +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 4e-42
Identities = 49/205 (23%), Positives = 84/205 (40%), Gaps = 31/205 (15%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSK-ISEQGLKEL 483
+L ++ +N +GEG FG V++ +AVK L + S +
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 484 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL-------- 535
+ E L ++ + N+VKLLG C G+ L++E+M L+ F+ + T+
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 536 -------------LDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPK 582
L +++ I A G+ YL + + +HRDL N L+ ++M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 583 ISDFGLVRTFGGDETEGNTNRVVGT 607
I+DFGL R +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIP 205
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (381), Expect = 5e-42
Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 6/166 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ ++ +KLG G +G VY+G +AVK L + ++E E + +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V+LLG C + +I EFM +L ++ + R+ + ++ + + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
+ IHRDL A N L+ ++ K++DFGL R GD +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 8e-42
Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 8/163 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V G G ++AVK + + + E + ++L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 500 KLLGCCIQGEEKL-LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+LLG ++ + L ++ E+M SL ++ + R++L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 559 SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
+HRDL A NVL+ +D K+SDFGL + + G
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 162
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-41
Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 6/166 (3%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
++ + KLG+G FG V+ GT +A+K L + E + KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+L + E ++ E+M SL F+ +T + L Q + A G+ Y+ +
Sbjct: 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER-- 131
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
+ +HRDL+A+N+L+ +++ K++DFGL R +E
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 176
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-41
Identities = 44/179 (24%), Positives = 77/179 (43%), Gaps = 17/179 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 499
+ +G+G FG V++G G+E+AVK S E+ + E+ L+H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENIL 60
Query: 500 KLLGCCIQGEEKL----LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
+ + L+ ++ + SL ++ R + + TA GL +L
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHL 116
Query: 556 HQD-----SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF--GGDETEGNTNRVVGT 607
H + + I HRDLK+ N+L+ ++ I+D GL D + N VGT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-40
Identities = 51/191 (26%), Positives = 70/191 (36%), Gaps = 26/191 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKISEQG-LKELKNEVILFSK 492
+ S LG G FG V + T +AVK L + + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL---------------L 536
L H N+V LLG C G L+I E+ L +F+ + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
D A+G+ +L IHRDL A N+LL KI DFGL R D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 597 TEGNTNRVVGT 607
Sbjct: 200 NYVVKGNARLP 210
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-40
Identities = 41/178 (23%), Positives = 90/178 (50%), Gaps = 10/178 (5%)
Query: 431 ELATIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVIL 489
+ ++ + ++ K+G+G G VY + GQE+A+++++ + + + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
+ ++ N+V L + G+E ++ E++ SL + + D Q +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECL 126
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ L +LH ++IHRD+K+ N+LL D + K++DFG +++ + +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGT 179
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 6e-40
Identities = 48/172 (27%), Positives = 72/172 (41%), Gaps = 14/172 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F I LG+G FG VY +A+K L K +L+ EV + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N+++L G LI E+ P ++ + ++ D + I A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
H R+IHRD+K N+LL KI+DFG + GT
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGT 167
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-40
Identities = 46/196 (23%), Positives = 73/196 (37%), Gaps = 31/196 (15%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSKISEQG-LKELKNEVILFSK 492
+N LG G FG V T ++AVK L + ++ + L +E+ + ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 493 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRR------------------ 533
L H N+V LLG C LI+E+ L +++ + +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 534 --TLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591
+L + A+G+ +L +HRDL A NVL+ KI DFGL R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 592 FGGDETEGNTNRVVGT 607
D
Sbjct: 214 IMSDSNYVVRGNARLP 229
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-39
Identities = 51/186 (27%), Positives = 80/186 (43%), Gaps = 24/186 (12%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDG---QEIAVKRLSKI-SEQGLKELKNEVILFSKL-Q 494
++ + +GEG FG V K + + A+KR+ + S+ ++ E+ + KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFI-------------FDQTRRTLLDWSQR 541
H N++ LLG C L E+ P+ +L F+ + + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 542 FHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
H ARG+ YL Q + IHRDL A N+L+ ++ KI+DFGL R G E
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 602 NRVVGT 607
Sbjct: 184 TMGRLP 189
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-38
Identities = 47/175 (26%), Positives = 66/175 (37%), Gaps = 13/175 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSK---ISEQGLKELKNEVILFSK 492
+ + KLG+G FG V +G +AVK L + + + EV
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
L HRNL++L G + K+ + E P SL + A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGM 124
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
YL R IHRDL A N+LL KI DFGL+R ++
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-38
Identities = 50/171 (29%), Positives = 71/171 (41%), Gaps = 10/171 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LGEG F V L +E A+K L K I E + + E + S+L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
VKL E+ + N L +I D + L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606
H IIHRDLK N+LL++DM+ +I+DFG + + + N VG
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-38
Identities = 44/169 (26%), Positives = 69/169 (40%), Gaps = 13/169 (7%)
Query: 445 NNKLGEGGFGPVYKGTLVD---GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLV 499
+ +LG G FG V KG + +AVK L EL E + +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
+++G C + E +L+ E L+ ++ + ++ + G+ YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES- 126
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN-RVVGT 607
+HRDL A NVLL KISDFGL + DE
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 141 bits (357), Expect = 6e-38
Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 8/161 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
D++ I+ +LG G FG V++ T G A K + E + ++ E+ S L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
V L E ++IYEFM L + D+ + + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 559 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDET 597
+H DLK N++ + K+ DFGL ++
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 7e-38
Identities = 42/174 (24%), Positives = 71/174 (40%), Gaps = 16/174 (9%)
Query: 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 498
+ ++G G F VYKG + E+A L +++ + K E + LQH N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 499 VKLLGCCIQGEEK----LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
V+ + +L+ E M + +L +++ R ++ +GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127
Query: 555 LHQDSRLRIIHRDLKASNVLL-DQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
LH + IIHRDLK N+ + + KI D GL V+GT
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGT 176
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 7e-38
Identities = 44/182 (24%), Positives = 81/182 (44%), Gaps = 17/182 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGTL------VDGQEIAVKRLSKI-SEQGLKELKNEVILFSK 492
+ +++ +LG+G FG VY+G +A+K +++ S + E NE + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIF-------DQTRRTLLDWSQRFHII 545
++V+LLG QG+ L+I E M L S++ + S+ +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 546 CGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVV 605
A G+ YL+ + + +HRDL A N ++ +D KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 606 GT 607
Sbjct: 197 LP 198
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 7e-38
Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 13/179 (7%)
Query: 435 IANATDNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSKI-SEQGLKELKNEVI 488
I T+ F LG G FG VYKG + E +A+K L + S + KE+ +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 489 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
+ + + + ++ +LLG C+ LI + MP L ++ + +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQI 120
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
A+G+ YL R++HRDL A NVL+ + KI+DFGL + G +E E +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-37
Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 15/175 (8%)
Query: 441 NFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQG-LKELKNEVILFSKLQH 495
+F N +G G FG VY GTL+D AVK L++I++ G + + E I+ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 496 RNLVKLLGCCIQGEEK-LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
N++ LLG C++ E L++ +M + L +FI ++T + F +
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR--VVGT 607
+ + + +HRDL A N +LD+ K++DFGL R E + N+
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-36
Identities = 45/190 (23%), Positives = 68/190 (35%), Gaps = 25/190 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGT------LVDGQEIAVKRLSKISEQGLKE--LKNEVILFS 491
D + LG G FG V + + +AVK L + + + IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 492 KLQHRNLVKLLGCCIQGEEKLLI-YEFMPNKSLDSFIFDQ-------------TRRTLLD 537
H N+V LLG C + L++ EF +L +++ + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 538 WSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
A+G+ +L + IHRDL A N+LL + KI DFGL R D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 598 EGNTNRVVGT 607
Sbjct: 190 YVRKGDARLP 199
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 138 bits (348), Expect = 1e-36
Identities = 40/161 (24%), Positives = 69/161 (42%), Gaps = 8/161 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
D + I +LG G FG V++ G+ K ++ +KNE+ + ++L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ L E +LI EF+ L I + + + ++ + + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH-- 144
Query: 559 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDET 597
I+H D+K N++ + KI DFGL DE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-36
Identities = 36/171 (21%), Positives = 73/171 (42%), Gaps = 5/171 (2%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-LKELKNEVILFS 491
+ + ++ + +GEG +G V V+ +A+K++S Q + E+ +
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 492 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARG 551
+ +H N++ + + + ++ + + ++ + L + + RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 552 LLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTN 602
L Y+H ++HRDLK SN+LL+ + KI DFGL R D
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 169
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (346), Expect = 2e-36
Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 13/165 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK---ISEQGLKELKNEVI---LFSK 492
++FS++ +G GGFG VY D G+ A+K L K +QG NE I L S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+V + ++ I + M L + + + + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
++H +++RDLK +N+LLD+ + +ISD GL F +
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-36
Identities = 42/173 (24%), Positives = 72/173 (41%), Gaps = 12/173 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKISEQGLKE-LKNEVILFSKLQ 494
+ + +GEG FG V++G + +A+K + ++E E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H ++VKL+G + +I E L SF+ + LD + + L Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
L R +HRD+ A NVL+ + K+ DFGL R + D T ++
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLP 172
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 9e-35
Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 11/168 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQE-----IAVKRLSK-ISEQGLKELKNEVILFSKL 493
+ +G G FG VYKG L +A+K L +E+ + E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 494 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLL 553
H N+++L G + + ++I E+M N +LD F+ ++ Q ++ G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMK 124
Query: 554 YLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
YL + +HRDL A N+L++ ++ K+SDFGL R D T
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 127 bits (320), Expect = 1e-33
Identities = 45/179 (25%), Positives = 72/179 (40%), Gaps = 20/179 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---------ISEQGLKELKNEVIL 489
+N+ LG G V + +E AVK + ++ + EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 490 FSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
K+ H N+++L L+++ M L ++ T + L + I+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ LH +L I+HRDLK N+LLD DMN K++DFG E V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGT 172
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 128 bits (323), Expect = 1e-33
Identities = 39/162 (24%), Positives = 71/162 (43%), Gaps = 10/162 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
+F I LG G FG V+ +G+ A+K L K + + ++ +E ++ S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++++ G ++ +I +++ L S + R +C L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LAL 117
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
II+RDLK N+LLD++ + KI+DFG +
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 35/161 (21%), Positives = 65/161 (40%), Gaps = 9/161 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ + I LG G FG V++ + K + K+ +K E+ + + +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ L EE ++I+EF+ + I T L+ + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 559 SRLRIIHRDLKASNVLLDQDMNP--KISDFGLVRTFGGDET 597
I H D++ N++ + KI +FG R +
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-33
Identities = 51/191 (26%), Positives = 78/191 (40%), Gaps = 26/191 (13%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV--------DGQEIAVKRLSK-ISEQGLKELKNEVILF 490
D + LGEG FG V + ++AVK L +E+ L +L +E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 491 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTL-------------L 536
+ +H+N++ LLG C Q +I E+ +L ++ + L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 537 DWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596
ARG+ YL + IHRDL A NVL+ +D KI+DFGL R +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 597 TEGNTNRVVGT 607
T
Sbjct: 190 YYKKTTNGRLP 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 125 bits (315), Expect = 6e-33
Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 8/164 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 497
+ + K+GEG +G VYK G+ A+K RL K E E+ + +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 498 LVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ 557
+VKL + +L++E + + L+ + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 558 DSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
R++HRDLK N+L++++ KI+DFGL R FG +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 4e-32
Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 8/165 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+NF K+GEG +G VYK + G+ +A+K++ +E E+ L +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+VKLL + L++EF+ D + T + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNT 601
R++HRDLK N+L++ + K++DFGL R FG
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-32
Identities = 42/170 (24%), Positives = 69/170 (40%), Gaps = 15/170 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+++ +G G FG VY+ L D G+ +A+K++ + E+ + KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNI 75
Query: 499 VKLLGCCIQGEEK------LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
V+L EK L+ +++P + L + R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNT 601
Y+H I HRD+K N+LLD D K+ DFG + E +
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (309), Expect = 7e-32
Identities = 37/173 (21%), Positives = 64/173 (36%), Gaps = 8/173 (4%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQG-LKELKNEVILFSKLQ 494
+ D + + LG G F V + +A+K ++K + +G ++NE+ + K++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H N+V L G LI + + L I + +I + Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKY 122
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
LH + + LD+D ISDFGL + + GT
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGT 172
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-31
Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 13/173 (7%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEV-ILFSKLQ 494
++F ++ LG+G FG V+ Q A+K L K + + ++ E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 495 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLY 554
H L + E + E++ L I + D S+ GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 555 LHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
LH I++RDLK N+LLD+D + KI+DFG+ + + + NT GT
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 119 bits (299), Expect = 8e-31
Identities = 37/178 (20%), Positives = 69/178 (38%), Gaps = 15/178 (8%)
Query: 439 TDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQ 494
+D + + LG GG V+ L +++AVK L + E + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 495 HRNLVKLLGCCI----QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
H +V + G ++ E++ +L + + + + +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEG-NTNRVVGT 607
L + H + IIHRD+K +N+++ K+ DFG+ R T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 1e-29
Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 19/181 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ K+G+G FG V+K GQ++A+K++ E E+ + L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 497 NLVKLLGCCIQGEEK--------LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGT 548
N+V L+ C L+++F + + TL + + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 549 ARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR--VVG 606
L L+ R +I+HRD+KA+NVL+ +D K++DFGL R F + V
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 607 T 607
T
Sbjct: 184 T 184
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-29
Identities = 50/168 (29%), Positives = 76/168 (45%), Gaps = 14/168 (8%)
Query: 446 NKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKE-----LKNEVILFSKLQHRNLV 499
+ LGEG F VYK Q +A+K++ K+ E+ L +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 500 KLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS 559
LL L+++FM + +L S + T +GL YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
I+HRDLK +N+LLD++ K++DFGL ++FG V T
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVT 163
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-28
Identities = 44/180 (24%), Positives = 74/180 (41%), Gaps = 16/180 (8%)
Query: 438 ATDNFSINNKLGEGGFGPVYKGTLV--DGQEIAVKRLSK--ISEQGLKELKNEVILFSKL 493
A + ++GEG +G V+K + G+ +A+KR+ E EV + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 494 ---QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDS---FIFDQTRRTLLDWSQRFHIICG 547
+H N+V+L C + + +D D+ + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
RGL +LH R++HRDLK N+L+ K++DFGL R + + VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 38/172 (22%), Positives = 66/172 (38%), Gaps = 12/172 (6%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 495
++F LG+G FG V G+ A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 496 RNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
L L + + E+ L + +R + + A + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+++RD+K N++LD+D + KI+DFGL + D GT
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGT 168
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (285), Expect = 3e-28
Identities = 45/200 (22%), Positives = 71/200 (35%), Gaps = 14/200 (7%)
Query: 402 RNIAEKTENSRETDQENEDQNIDLELPLFELATIANATDNFSINNKLGEGGFGPVYKGT- 460
+ +E+ + ED E P A + D F LG G FG V
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKH 62
Query: 461 LVDGQEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517
G A+K L K + + ++ NE + + LVKL ++ E+
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ 577
+ + S + R YLH L +I+RDLK N+L+DQ
Sbjct: 123 VAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQ 176
Query: 578 DMNPKISDFGLVRTFGGDET 597
+++DFG + G
Sbjct: 177 QGYIQVTDFGFAKRVKGRTW 196
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (274), Expect = 2e-27
Identities = 38/161 (23%), Positives = 68/161 (42%), Gaps = 9/161 (5%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ K+GEG +G V+K + +A+KR+ E E+ L +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 497 NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH 556
N+V+L ++ L++EF F + + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 557 QDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597
++HRDLK N+L++++ K+++FGL R FG
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 3e-27
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 7/168 (4%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ +G G +G V G ++A+K+L + SE K E+ L ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 497 NLVKLLGCCIQGEEKLLIYEF-MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
N++ LL E +F + + + + + L + ++ +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 556 HQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNR 603
H IIHRDLK N+ +++D KI DFGL R + T R
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR 182
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 109 bits (272), Expect = 5e-27
Identities = 32/179 (17%), Positives = 76/179 (42%), Gaps = 18/179 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
++ + ++GEG FG +++GT L++ Q++A+K + S+ +L++E + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ + Q ++ + SL+ + R+ + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHE- 119
Query: 559 SRLRIIHRDLKASNVLLDQDMNP-----KISDFGLVRTFGGDETEGN-----TNRVVGT 607
+++RD+K N L+ + + + DFG+V+ + T+ + + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 8e-27
Identities = 34/168 (20%), Positives = 67/168 (39%), Gaps = 19/168 (11%)
Query: 440 DNFSINNK-LGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEV-ILFSKLQHR 496
D++ + ++ LG G G V + ++ A+K L + + EV + + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65
Query: 497 NLVKLLGCCIQGEEK----LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
++V+++ L++ E + L S I D+ + + I+ +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAI 124
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNP---KISDFGLVRTFGGDET 597
YLH + I HRD+K N+L K++DFG + +
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 8e-27
Identities = 42/178 (23%), Positives = 66/178 (37%), Gaps = 19/178 (10%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKN------EVILFSK 492
+ + LG GGFG VY G + D +A+K + K EL N EV+L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 493 LQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
+ +++LL + + +LI E T R L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFGLVRTFGGDETEGNTNRVVGT 607
+ + H ++HRD+K N+L+D + K+ DFG + GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGT 172
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 5e-26
Identities = 45/182 (24%), Positives = 71/182 (39%), Gaps = 20/182 (10%)
Query: 437 NATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKIS------EQGLKELKNEVIL 489
N D + +LG G F V K G + A K + K ++++ EV +
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 490 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
++QH N++ L + +LI E + L F+ ++ L + +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQIL 123
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP----KISDFGLVRTFGGDETEGNTNRVV 605
G+ YLH L+I H DLK N++L P KI DFGL +
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 606 GT 607
GT
Sbjct: 178 GT 179
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (264), Expect = 6e-26
Identities = 36/177 (20%), Positives = 69/177 (38%), Gaps = 16/177 (9%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 498
+ + + K+G G FG +Y GT + G+E+A+K ++ +L E ++ +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 499 VKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD 558
+ + C + ++ + SL+ +R+ + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120
Query: 559 SRLRIIHRDLKASNVL---LDQDMNPKISDFGLVRTFGGDETEGN-----TNRVVGT 607
IHRD+K N L + I DFGL + + T + + GT
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 2e-25
Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 15/168 (8%)
Query: 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKIS----EQGLKELKNEVILFS 491
+NF + LG G +G V+ + G+ A+K L K + + + + E +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 492 KLQHR-NLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
++ LV L + LI +++ L + + + R T + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI----- 138
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETE 598
+L L +L II+RD+K N+LLD + + ++DFGL + F DETE
Sbjct: 139 -VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (252), Expect = 4e-24
Identities = 35/173 (20%), Positives = 73/173 (42%), Gaps = 20/173 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRN 497
D++ + KLG G + V++ + + +++ VK L + + K++K E+ + L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 498 LVKLLGCCIQGEEKL--LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYL 555
++ L + L++E + N L + + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 556 HQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
H + I+HRD+K NV++D + ++ D+GL + + N V +
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVAS 192
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.2 bits (241), Expect = 7e-24
Identities = 31/161 (19%), Positives = 53/161 (32%), Gaps = 20/161 (12%)
Query: 443 SINNKLGEGGFGPVYKGTLVDGQEIAVK--RLSKIS--------EQGLKELKNEVILFSK 492
+I +GEG V+ E VK ++ S + G I ++
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 493 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGL 552
+ R L KL G + +Y + N L I + + + ++ +
Sbjct: 63 NEFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEV 116
Query: 553 LYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593
+ I+H DL NVL+ + I DF G
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (248), Expect = 2e-23
Identities = 44/177 (24%), Positives = 73/177 (41%), Gaps = 21/177 (11%)
Query: 440 DNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 496
+ +G G G V V + +A+K+LS+ ++ K E++L + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 497 NLVKLLGCCI------QGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTAR 550
N++ LL + ++ L+ E M + D + +++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 551 GLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607
G+ +LH IIHRDLK SN+++ D KI DFGL RT G V T
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVT 181
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 3e-23
Identities = 46/175 (26%), Positives = 74/175 (42%), Gaps = 7/175 (4%)
Query: 434 TIANATDNFSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSK--ISEQGLKELKNEVILF 490
TI + + + +G G +G V G +AVK+LS+ S K E+ L
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 491 SKLQHRNLVKLLGCCIQGEE-KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTA 549
++H N++ LL + ++ + + + + + L +I
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 550 RGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRV 604
RGL Y+H IIHRDLK SN+ +++D KI DFGL R + T R
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW 183
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 84.3 bits (207), Expect = 3e-18
Identities = 31/180 (17%), Positives = 61/180 (33%), Gaps = 18/180 (10%)
Query: 442 FSINNKLGEGGFGPVYKGT-LVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 500
+ + KLG G F V+ +V+ +A+K + + + ++E+ L ++ + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 501 LLGCCIQGEEKLLIY-------------EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICG 547
KLL + F + + + I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 548 TARGLLYLHQDSRLRIIHRDLKASNVLLDQ-DMNPKISDFGLVRTFGGDETEGNTNRVVG 606
GL Y+H+ R IIH D+K NVL++ D + + + + +
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 65.4 bits (159), Expect = 9e-14
Identities = 16/84 (19%), Positives = 30/84 (35%), Gaps = 9/84 (10%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y VW +N ++ GN V+ +W+++ + VL L +
Sbjct: 34 YDHSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAEGRSLWASHSVRG-NGNYVLVLQE 91
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
GN+V+ + W + Y
Sbjct: 92 DGNVVIYG-------SDIWSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 54.9 bits (132), Expect = 7e-10
Identities = 16/102 (15%), Positives = 32/102 (31%), Gaps = 13/102 (12%)
Query: 2 MLADKEPNKSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEV 61
+L + N ++P + + S L + NLVL + + V + K
Sbjct: 12 ILYSTQGNDNHP-----QTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGK-- 64
Query: 62 QTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD--YPSDTLL 101
T L +G + + + W S + +
Sbjct: 65 GTGCRAVLQPNGRMDVLT----NQNIAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 40.3 bits (94), Expect = 9e-05
Identities = 13/68 (19%), Positives = 24/68 (35%), Gaps = 3/68 (4%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
+ + VW N ++ G + + + NI VW++ S+ V L
Sbjct: 50 FDRDDRVWSTNTAGKGTGCR--AVLQPNGRMDVLTNQNIAVWTSGNSRS-AGRYVFVLQP 106
Query: 72 SGNLVLRD 79
NL +
Sbjct: 107 DRNLAIYG 114
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 52.1 bits (124), Expect = 5e-09
Identities = 18/87 (20%), Positives = 30/87 (34%), Gaps = 8/87 (9%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + VW + + L + GNLV+ S S + S + L L
Sbjct: 34 YDNNRAVWASGTNGKASGCV--LKMQNDGNLVIYSGSRAIWASNTNRQ--NGNYYLILQR 89
Query: 72 SGNLVLRDEHDGDSETYFWQSFDYPSD 98
N+V+ D +S W + +
Sbjct: 90 DRNVVIYD----NSNNAIWATHTNVGN 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 51.6 bits (123), Expect = 8e-09
Identities = 17/84 (20%), Positives = 30/84 (35%), Gaps = 10/84 (11%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N F L + GNLV+ + SN +W++ + V L
Sbjct: 34 YDVDKPIWATNTGGLSRSCF--LSMQTDGNLVVYNPSNKPIWASNTGGQNGNYV-CILQK 90
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
N+V+ W + +
Sbjct: 91 DRNVVIYGTD-------RWATGTH 107
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 49.2 bits (117), Expect = 6e-08
Identities = 16/84 (19%), Positives = 30/84 (35%), Gaps = 10/84 (11%)
Query: 12 YPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLD 71
Y + +W N N ++ G LV+ + N+ VW + ++ + V L L
Sbjct: 45 YDNNNPIWATNTGGLGNGCR--AVLQPDGVLVVITNENVTVWQSPVAGKAGHYV-LVLQP 101
Query: 72 SGNLVLRDEHDGDSETYFWQSFDY 95
N+V+ W +
Sbjct: 102 DRNVVIYG-------DALWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 43.4 bits (102), Expect = 7e-06
Identities = 16/75 (21%), Positives = 25/75 (33%), Gaps = 7/75 (9%)
Query: 19 WVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLR 78
+ + S + NLVL S++ VW++ + T L G LV+
Sbjct: 15 QTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAG--ATGCRAVLQSDGLLVIL 71
Query: 79 DEHDGDSETYFWQSF 93
T W S
Sbjct: 72 T----AQNTIRWSSG 82
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 607 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.98 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.98 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.98 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.98 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.97 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.97 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.97 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.97 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.97 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.96 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.96 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.96 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.96 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.96 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.96 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.96 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.96 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.95 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.95 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.95 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.95 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.95 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.94 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.94 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.94 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.94 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.94 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.94 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.93 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.93 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.93 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.92 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.92 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.83 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.64 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.58 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.54 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.54 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.54 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.23 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.94 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.85 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.84 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.76 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.73 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.58 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.9 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.37 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.51 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.01 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.75 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.88 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 89.73 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 87.6 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 84.24 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 80.64 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.5 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 80.12 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-33 Score=278.05 Aligned_cols=163 Identities=29% Similarity=0.421 Sum_probs=139.9
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
.++|++.++||+|+||+||+|+.. +++.||||++.... ....+++.+|+.++++++|||||++++++.+++..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 457999999999999999999985 48999999986532 2345679999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
|+++|+|.++|.. ...+++..+..++.||+.||+|||+.+ ||||||||+||||++++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999999843 346899999999999999999999987 9999999999999999999999999999886554
Q ss_pred CccCccceecC
Q 007336 597 TEGNTNRVVGT 607 (607)
Q Consensus 597 ~~~~~~~~~GT 607 (607)
.....+..+||
T Consensus 158 ~~~~~~~~~GT 168 (271)
T d1nvra_ 158 RERLLNKMCGT 168 (271)
T ss_dssp EECCBCCCCSC
T ss_pred ccccccceeeC
Confidence 43334456676
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-33 Score=281.30 Aligned_cols=158 Identities=29% Similarity=0.496 Sum_probs=140.5
Q ss_pred hHHhhcCCcccceeecccCceeEEEEEecC-CcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 434 TIANATDNFSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 434 ~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
+.+...++|++.++||+|+||+||+|++.. ++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 334456789999999999999999999865 889999998753 345678999999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
|||||+++|+|.+++... ....+++..++.|+.|||+||+|||+++ ||||||||+||||++++.+||+|||+|+.+
T Consensus 90 iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999999999653 3456899999999999999999999987 999999999999999999999999999987
Q ss_pred cCCC
Q 007336 593 GGDE 596 (607)
Q Consensus 593 ~~~~ 596 (607)
..+.
T Consensus 166 ~~~~ 169 (287)
T d1opja_ 166 TGDT 169 (287)
T ss_dssp CSSS
T ss_pred CCCC
Confidence 6543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.9e-33 Score=276.65 Aligned_cols=162 Identities=31% Similarity=0.501 Sum_probs=132.7
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
..++|++.++||+|+||+||+|++. ..||||+++. ......+.|.+|+.++++++|||||+++|++.+ +..+|||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 4568999999999999999999864 4699999864 345567889999999999999999999999754 5679999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+++|+|.++|... ...+++..++.|+.|||+||+|||+.+ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999643 345899999999999999999999987 999999999999999999999999999988654
Q ss_pred CCccCccceecC
Q 007336 596 ETEGNTNRVVGT 607 (607)
Q Consensus 596 ~~~~~~~~~~GT 607 (607)
.......++.||
T Consensus 158 ~~~~~~~~~~gt 169 (276)
T d1uwha_ 158 SGSHQFEQLSGS 169 (276)
T ss_dssp --------CCCC
T ss_pred CCcccccccccC
Confidence 443334445555
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.2e-32 Score=272.66 Aligned_cols=160 Identities=27% Similarity=0.506 Sum_probs=140.7
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.++|++.++||+|+||+||+|+.. +++.||||++........+.+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 457999999999999999999974 4899999998765555567899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~~ 597 (607)
+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+..+..
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999998854 34899999999999999999999987 99999999999999999999999999998865433
Q ss_pred ccCccceecC
Q 007336 598 EGNTNRVVGT 607 (607)
Q Consensus 598 ~~~~~~~~GT 607 (607)
. ....+||
T Consensus 172 ~--~~~~~gt 179 (293)
T d1yhwa1 172 K--RSTMVGT 179 (293)
T ss_dssp C--BCCCCSC
T ss_pred c--ccccccC
Confidence 2 2234555
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=7.9e-33 Score=273.54 Aligned_cols=152 Identities=28% Similarity=0.515 Sum_probs=131.5
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
.++|++.++||+|+||+||+|++.+++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+.+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 3578999999999999999999988889999999763 344578999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
++|+|.+++.. ....+++..++.|+.|||+||+|||+.+ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 99999999864 3456899999999999999999999987 9999999999999999999999999999875443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=8.8e-33 Score=274.53 Aligned_cols=153 Identities=31% Similarity=0.513 Sum_probs=135.1
Q ss_pred hcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
..++|++.++||+|+||+||+|++.+++.||||+++.. ....++|.+|+.++++++|||||+++|++.+ +..+|||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 45688999999999999999999988899999999753 3446789999999999999999999998854 567899999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
+++|+|.+++... ....+++..++.|+.|||+||.|||+.+ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 89 ~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999999987532 2235899999999999999999999987 9999999999999999999999999999886543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=3.5e-32 Score=273.74 Aligned_cols=153 Identities=32% Similarity=0.524 Sum_probs=127.5
Q ss_pred cCCcccceeecccCceeEEEEEecC-C---cEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD-G---QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~---~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
.++|++.++||+|+||+||+|++.. + ..||||++.. ......++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3568888999999999999999753 2 3689998865 344566789999999999999999999999999999999
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++|+|.+++.. ....+++..++.|+.|||+||+|||+.+ ||||||||+||||++++.+||+|||+|+.+.
T Consensus 105 v~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999998854 2345899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCC
Q 007336 594 GDE 596 (607)
Q Consensus 594 ~~~ 596 (607)
...
T Consensus 180 ~~~ 182 (299)
T d1jpaa_ 180 DDT 182 (299)
T ss_dssp ---
T ss_pred CCC
Confidence 544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-32 Score=272.83 Aligned_cols=151 Identities=32% Similarity=0.454 Sum_probs=137.2
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.+.|++.+.||+|+||+||+|+.. +++.||||++........+.|.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 357899999999999999999975 4889999999776666678899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
+++|+|.+++.+. ...+++..+..++.||++||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+..
T Consensus 91 ~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 91 CAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 9999999998542 345899999999999999999999987 99999999999999999999999999987643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.2e-32 Score=271.29 Aligned_cols=162 Identities=30% Similarity=0.431 Sum_probs=137.5
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+.+..+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999985 5899999998652 2334578999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999999854 345899999999999999999999987 999999999999999999999999999998755
Q ss_pred CCccCccceecC
Q 007336 596 ETEGNTNRVVGT 607 (607)
Q Consensus 596 ~~~~~~~~~~GT 607 (607)
.........+||
T Consensus 162 ~~~~~~~~~~GT 173 (288)
T d1uu3a_ 162 SKQARANSFVGT 173 (288)
T ss_dssp --------CCCC
T ss_pred CcccccccccCC
Confidence 544444455676
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.1e-32 Score=265.71 Aligned_cols=150 Identities=30% Similarity=0.415 Sum_probs=134.9
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+.++++++|||||++++++.+++..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999985 4889999998642 2334577899999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
||+++|+|.+++.. ...+++..+..++.||++||+|||+.+ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999954 345899999999999999999999987 999999999999999999999999999877543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-31 Score=263.10 Aligned_cols=152 Identities=28% Similarity=0.460 Sum_probs=137.5
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
.++|++.++||+|+||+||+|++++++.||||++++. ....++|.+|+.++++++|||||+++|+|.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 3688999999999999999999988889999999763 334578999999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
++|+|..++... ...+++..+.+|+.|||+||+|||+.+ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 82 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 82 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TTEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999997543 345789999999999999999999987 9999999999999999999999999999876443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-31 Score=266.45 Aligned_cols=152 Identities=32% Similarity=0.552 Sum_probs=132.0
Q ss_pred cCCcccce-eecccCceeEEEEEecC---CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 439 TDNFSINN-KLGEGGFGPVYKGTLVD---GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 439 ~~~~~~~~-~lg~G~fg~Vy~g~~~~---~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
.++|.+.+ +||+|+||+||+|.+.. +..||||+++.. .....++|.+|+.++++++|||||+++|+|.. +..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 45677777 49999999999998642 457999999753 34556889999999999999999999999864 56789
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
||||+++|+|.+++.. ....+++..++.|+.|||+||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999999843 3346899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCC
Q 007336 594 GDE 596 (607)
Q Consensus 594 ~~~ 596 (607)
...
T Consensus 161 ~~~ 163 (285)
T d1u59a_ 161 ADD 163 (285)
T ss_dssp TCS
T ss_pred ccc
Confidence 544
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-32 Score=277.16 Aligned_cols=151 Identities=24% Similarity=0.321 Sum_probs=135.6
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
..++|++.++||+|+||+||+|+.. +++.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..+|||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4568999999999999999999975 4889999998753 3444678999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQD-SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+++|+|.+++.+. ..+++..+..++.||++||.|||+. + ||||||||+||||++++.+||+|||+|+.+.+
T Consensus 84 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999999642 3589999999999999999999974 5 99999999999999999999999999997743
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-31 Score=265.71 Aligned_cols=157 Identities=29% Similarity=0.426 Sum_probs=126.9
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEe--CCeEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLI 514 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~--~~~~~lV 514 (607)
++|++.+.||+|+||+||+|+.. +++.||||.+... .+...+.|.+|+.++++++|||||++++++.+ ....+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999975 4889999998652 34556789999999999999999999999975 4457899
Q ss_pred EEcCCCCChHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 515 YEFMPNKSLDSFIFDQ-TRRTLLDWSQRFHIICGTARGLLYLHQDS--RLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
|||+++|+|.+++... .....+++..+..++.||+.||.|||+.+ ..+||||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998643 22456899999999999999999999854 13599999999999999999999999999998
Q ss_pred ecCCC
Q 007336 592 FGGDE 596 (607)
Q Consensus 592 ~~~~~ 596 (607)
+..+.
T Consensus 164 ~~~~~ 168 (269)
T d2java1 164 LNHDT 168 (269)
T ss_dssp C----
T ss_pred cccCC
Confidence 86543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-31 Score=271.55 Aligned_cols=168 Identities=28% Similarity=0.428 Sum_probs=137.4
Q ss_pred hhcCCcccceeecccCceeEEEEEecCC------cEEEEEEecc-cchhhHHHHHHHHHHHccC-CCCceeceEEEEEeC
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVDG------QEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~~------~~vavK~l~~-~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~ 508 (607)
...++|++.++||+|+||+||+|+.... ..||||++.. ........|.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 3456899999999999999999987532 3699999864 2334456799999999998 899999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeccc
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQTR--------------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDL 568 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDl 568 (607)
+..+|||||+++|+|.++|..... ...+++..++.|+.||++||+|||+.+ ||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 999999999999999999965321 235899999999999999999999987 999999
Q ss_pred CCCcEEEcCCCceEEeecccceeecCCCCccCccceecC
Q 007336 569 KASNVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 569 kp~Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~GT 607 (607)
||+|||++.++.+||+|||+|+............+..||
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 229 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 229 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCC
Confidence 999999999999999999999987655443333334444
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-31 Score=268.07 Aligned_cols=152 Identities=29% Similarity=0.499 Sum_probs=131.7
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
.++|++.+.||+|+||+||+|++.+++.||||+++.. ....+.|.+|+.++++++|||||+++|+|. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 4679999999999999999999988889999999753 344678999999999999999999999985 45678999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
++|+|..++... ....++|..++.|+.|||.||+|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999998543 2345899999999999999999999987 9999999999999999999999999999875443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.97 E-value=1.1e-30 Score=268.19 Aligned_cols=153 Identities=27% Similarity=0.442 Sum_probs=137.7
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999975 5899999999876566678899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC--CCceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ--DMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~--~~~~ki~DfGla~~~~~~ 595 (607)
+++|+|.+++.+ ....+++..+..|+.||+.||.|||+.+ ||||||||+||||+. ++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999854 2345899999999999999999999987 999999999999964 678999999999988654
Q ss_pred C
Q 007336 596 E 596 (607)
Q Consensus 596 ~ 596 (607)
.
T Consensus 180 ~ 180 (350)
T d1koaa2 180 Q 180 (350)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.4e-31 Score=263.80 Aligned_cols=153 Identities=30% Similarity=0.518 Sum_probs=129.5
Q ss_pred cCCcccceeecccCceeEEEEEecCC-----cEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDG-----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~-----~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
.+.|++.++||+|+||+||+|.+... ..||||++.. .......+|.+|+.++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688889999999999999997642 4799999865 33445668999999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||+.+++|.+++... ...+++..++.++.|||.||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+
T Consensus 86 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999999988543 345899999999999999999999987 999999999999999999999999999988
Q ss_pred cCCC
Q 007336 593 GGDE 596 (607)
Q Consensus 593 ~~~~ 596 (607)
....
T Consensus 161 ~~~~ 164 (283)
T d1mqba_ 161 EDDP 164 (283)
T ss_dssp ----
T ss_pred cCCC
Confidence 6543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=2.5e-31 Score=268.15 Aligned_cols=162 Identities=30% Similarity=0.520 Sum_probs=141.1
Q ss_pred HHhHHhhcCCcccceeecccCceeEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEE
Q 007336 432 LATIANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGC 504 (607)
Q Consensus 432 ~~~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~ 504 (607)
+.+++.++++|++.+.||+|+||+||+|+.. +++.||||++... .....++|.+|+.++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4556667889999999999999999999864 2468999998753 34456789999999999999999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 007336 505 CIQGEEKLLIYEFMPNKSLDSFIFDQT---------------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRI 563 (607)
Q Consensus 505 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i 563 (607)
|.+.+..++||||+++|+|.++|.... ....+++..++.|+.|||.||+|||+.+ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 999999999999999999999996421 1234889999999999999999999987 9
Q ss_pred EecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 564 IHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 564 vHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
|||||||+||||+.++.+||+|||+|+.+....
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~ 194 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCc
Confidence 999999999999999999999999999775443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.2e-31 Score=259.48 Aligned_cols=149 Identities=26% Similarity=0.408 Sum_probs=128.6
Q ss_pred cccceeecccCceeEEEEEecC-CcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEe----CCeEEEE
Q 007336 442 FSINNKLGEGGFGPVYKGTLVD-GQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLI 514 (607)
Q Consensus 442 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~----~~~~~lV 514 (607)
|++.++||+|+||+||+|+... ++.||+|++.. ......+.|.+|++++++++|||||++++++.+ ....+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 3566789999999999999864 78999999864 234556789999999999999999999999875 3457899
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc-CCCceEEeecccceeec
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD-QDMNPKISDFGLVRTFG 593 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~-~~~~~ki~DfGla~~~~ 593 (607)
|||+++|+|.+++.. ...+++..+..++.||++||+|||+++ ++||||||||+||||+ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999954 345899999999999999999999875 4599999999999996 57899999999998654
Q ss_pred C
Q 007336 594 G 594 (607)
Q Consensus 594 ~ 594 (607)
.
T Consensus 167 ~ 167 (270)
T d1t4ha_ 167 A 167 (270)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.97 E-value=1.7e-30 Score=266.89 Aligned_cols=153 Identities=27% Similarity=0.400 Sum_probs=137.3
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.++|++.+.||+|+||+||+|+.. +++.||||++........+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999975 5899999999765555667889999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc--CCCceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD--QDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~--~~~~~ki~DfGla~~~~~~ 595 (607)
+++|+|.+++.. ....+++.....|+.||+.||.|||+.+ ||||||||+||||+ .++.+||+|||+|+.+..+
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999988743 3345899999999999999999999987 99999999999998 5789999999999988654
Q ss_pred C
Q 007336 596 E 596 (607)
Q Consensus 596 ~ 596 (607)
.
T Consensus 183 ~ 183 (352)
T d1koba_ 183 E 183 (352)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.6e-31 Score=260.93 Aligned_cols=145 Identities=30% Similarity=0.483 Sum_probs=125.9
Q ss_pred eeecccCceeEEEEEecC---CcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcCCC
Q 007336 446 NKLGEGGFGPVYKGTLVD---GQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 520 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~---~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 520 (607)
++||+|+||+||+|.+.+ ++.||||+++.. .....++|.+|+.++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998753 468999998642 33445789999999999999999999999864 557899999999
Q ss_pred CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCCC
Q 007336 521 KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDET 597 (607)
Q Consensus 521 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~~ 597 (607)
|+|.+++.. ...+++..++.|+.|||+||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 999999964 345899999999999999999999987 99999999999999999999999999998865443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-30 Score=266.04 Aligned_cols=161 Identities=24% Similarity=0.298 Sum_probs=140.3
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
.++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 357999999999999999999974 5899999999752 234567889999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ ||||||||+||||++++.+||+|||+|+.+..
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999854 345788899999999999999999987 99999999999999999999999999997754
Q ss_pred CCCccCccceecC
Q 007336 595 DETEGNTNRVVGT 607 (607)
Q Consensus 595 ~~~~~~~~~~~GT 607 (607)
.... ....+||
T Consensus 158 ~~~~--~~~~~GT 168 (337)
T d1o6la_ 158 DGAT--MKTFCGT 168 (337)
T ss_dssp TTCC--BCCCEEC
T ss_pred CCcc--cccceeC
Confidence 3322 3345676
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.2e-30 Score=263.31 Aligned_cols=149 Identities=30% Similarity=0.498 Sum_probs=133.0
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
..|+..+.||+|+||+||+|+.. +++.||||++... .....+.|.+|+.++++++|||||++++++.+.+..+|||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35899999999999999999975 5889999998653 2344567999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999877643 345899999999999999999999987 99999999999999999999999999997653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=6.5e-31 Score=265.16 Aligned_cols=152 Identities=27% Similarity=0.384 Sum_probs=123.4
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc-hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
..+.|++.+.||+|+||+||+|+.. +++.||||++.+.. ......+.+|+.++++++|||||++++++.+++..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3467999999999999999999985 48899999987532 233457889999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEc---CCCceEEeecccceee
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLD---QDMNPKISDFGLVRTF 592 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~---~~~~~ki~DfGla~~~ 592 (607)
||+++|+|.++|.. ...+++.....++.||+.||+|||+.+ ||||||||+|||+. +++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999954 345899999999999999999999987 99999999999995 5789999999999977
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
...
T Consensus 161 ~~~ 163 (307)
T d1a06a_ 161 DPG 163 (307)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=2.5e-30 Score=261.88 Aligned_cols=149 Identities=26% Similarity=0.404 Sum_probs=134.1
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999975 4899999998752 2344678999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+++|+|..++.. ...+++.....++.||+.||+|||+.+ ||||||||+||||++++.+||+|||+|+.+..
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999998854 344688888899999999999999887 99999999999999999999999999998754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.97 E-value=3.9e-30 Score=255.50 Aligned_cols=151 Identities=26% Similarity=0.368 Sum_probs=134.9
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc---------hhhHHHHHHHHHHHccCC-CCceeceEEEEEe
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---------EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ 507 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---------~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~ 507 (607)
.++|++.+.||+|+||+||+++.. +++.||||++.+.. ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999974 58899999986521 122346889999999997 9999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 508 GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 508 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
++..+|||||+++|+|.++|.. ...+++..+..++.||++||+|||+.+ ||||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999964 335899999999999999999999987 9999999999999999999999999
Q ss_pred cceeecCC
Q 007336 588 LVRTFGGD 595 (607)
Q Consensus 588 la~~~~~~ 595 (607)
+|+.+...
T Consensus 156 ~a~~~~~~ 163 (277)
T d1phka_ 156 FSCQLDPG 163 (277)
T ss_dssp TCEECCTT
T ss_pred heeEccCC
Confidence 99988654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9e-30 Score=255.59 Aligned_cols=151 Identities=26% Similarity=0.384 Sum_probs=134.5
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc------hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~------~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 511 (607)
.++|++.+.||+|+||+||+|+.. +|+.||||++++.. ....+.|.+|+.++++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357999999999999999999985 58999999986421 12367899999999999999999999999999999
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC----ceEEeecc
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM----NPKISDFG 587 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~----~~ki~DfG 587 (607)
+|||||+++|+|.++|.. ...+++..+..++.||+.||+|||+.+ ||||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999954 235899999999999999999999987 99999999999998876 49999999
Q ss_pred cceeecCC
Q 007336 588 LVRTFGGD 595 (607)
Q Consensus 588 la~~~~~~ 595 (607)
+|+.+...
T Consensus 163 ~a~~~~~~ 170 (293)
T d1jksa_ 163 LAHKIDFG 170 (293)
T ss_dssp TCEECTTS
T ss_pred hhhhcCCC
Confidence 99988543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.6e-30 Score=260.23 Aligned_cols=159 Identities=28% Similarity=0.495 Sum_probs=138.2
Q ss_pred HhhcCCcccceeecccCceeEEEEEec------CCcEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeC
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 508 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~ 508 (607)
+...++|++.++||+|+||+||+|++. ++..||||+++. ........|.+|+.++++++|||||+++|+|...
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 344578999999999999999999874 257899999975 3344556799999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhcC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCce
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQ-------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ 581 (607)
+..++||||+++|+|.+++... .....+++..+..|+.|+|+||.|||+.+ |+||||||+||||++++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceE
Confidence 9999999999999999998532 22345789999999999999999999987 9999999999999999999
Q ss_pred EEeecccceeecCCCC
Q 007336 582 KISDFGLVRTFGGDET 597 (607)
Q Consensus 582 ki~DfGla~~~~~~~~ 597 (607)
||+|||+|+.+.....
T Consensus 173 Kl~DFGla~~~~~~~~ 188 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDY 188 (308)
T ss_dssp EECCTTCCCGGGGGGC
T ss_pred EEeecccceeccCCcc
Confidence 9999999998765443
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.1e-30 Score=259.02 Aligned_cols=171 Identities=26% Similarity=0.415 Sum_probs=132.1
Q ss_pred hHHhhcCCcccceeecccCceeEEEEEecC------CcEEEEEEecc-cchhhHHHHHHHHHHHccC-CCCceeceEEEE
Q 007336 434 TIANATDNFSINNKLGEGGFGPVYKGTLVD------GQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCC 505 (607)
Q Consensus 434 ~~~~~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~ 505 (607)
+.+...++|++.++||+|+||.||+|+... ++.||||+++. ......+++..|...+.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 344455789999999999999999998642 46899999875 3344566788888877776 789999999998
Q ss_pred EeCC-eEEEEEEcCCCCChHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCC
Q 007336 506 IQGE-EKLLIYEFMPNKSLDSFIFDQT-------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKAS 571 (607)
Q Consensus 506 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~ 571 (607)
.+.+ ..++||||+++|+|.++|.... ....+++..++.++.|||+||+|||+.+ ||||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcc
Confidence 7654 5799999999999999996432 1345899999999999999999999987 999999999
Q ss_pred cEEEcCCCceEEeecccceeecCCCCccCccceecC
Q 007336 572 NVLLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 572 Nill~~~~~~ki~DfGla~~~~~~~~~~~~~~~~GT 607 (607)
||||++++.+||+|||+|+...............||
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt 199 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 199 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCG
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeC
Confidence 999999999999999999987655544444445565
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.4e-30 Score=260.14 Aligned_cols=162 Identities=30% Similarity=0.527 Sum_probs=131.8
Q ss_pred CCcccceeecccCceeEEEEEecC-Cc----EEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ----EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 513 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~l 513 (607)
.+|++.++||+|+||+||+|++.. ++ .||||+++. ......++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999998753 33 689998865 3345678899999999999999999999999865 5678
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeec
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFG 593 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~ 593 (607)
++||+.+|+|.+++... ...+++..++.|+.|||+||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999999988653 456899999999999999999999987 9999999999999999999999999999886
Q ss_pred CCCCccCccceecC
Q 007336 594 GDETEGNTNRVVGT 607 (607)
Q Consensus 594 ~~~~~~~~~~~~GT 607 (607)
.......+....||
T Consensus 163 ~~~~~~~~~~~~gt 176 (317)
T d1xkka_ 163 AEEKEYHAEGGKVP 176 (317)
T ss_dssp TTCC--------CC
T ss_pred cccccccccccccC
Confidence 55544333334454
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.8e-29 Score=254.88 Aligned_cols=151 Identities=22% Similarity=0.319 Sum_probs=134.2
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
.++|++.+.||+|+||+||+|... +++.||||.++.. ......+.+|+.+++.++|||||++++++.+.+..+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999985 4889999999764 33456788999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC--CceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD--MNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~--~~~ki~DfGla~~~~~~ 595 (607)
+++|+|.++|.. ....+++.....|+.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999953 2345899999999999999999999987 9999999999999854 57999999999987543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=1.5e-29 Score=261.13 Aligned_cols=151 Identities=26% Similarity=0.353 Sum_probs=131.0
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc---hhhHHHH---HHHHHHHccCCCCceeceEEEEEeCCeE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS---EQGLKEL---KNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~f---~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 511 (607)
.++|++.++||+|+||.||+|+.. +++.||||++.+.. ......+ ..|+.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999975 48999999986421 1222233 4457788889999999999999999999
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
+|||||+++|+|.++|.. ...+++..+..++.||+.||+|||+.+ ||||||||+||||++++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999954 345788999999999999999999987 99999999999999999999999999998
Q ss_pred ecCC
Q 007336 592 FGGD 595 (607)
Q Consensus 592 ~~~~ 595 (607)
+...
T Consensus 157 ~~~~ 160 (364)
T d1omwa3 157 FSKK 160 (364)
T ss_dssp CSSS
T ss_pred cCCC
Confidence 8654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=1.3e-29 Score=260.29 Aligned_cols=149 Identities=25% Similarity=0.324 Sum_probs=135.1
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 515 (607)
++|++.+.||+|+||.||+|+.. +++.||||++.+. .....+.+.+|+.+++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999985 5899999998642 2344577999999999999999999999999999999999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
||+.+|+|..++... ..+++.....|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999998543 35899999999999999999999987 99999999999999999999999999998854
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.9e-30 Score=253.01 Aligned_cols=152 Identities=26% Similarity=0.437 Sum_probs=125.0
Q ss_pred hcCCcccceeecccCceeEEEEEecC----CcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEE
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLVD----GQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 512 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 512 (607)
..++|++.+.||+|+||.||+|++.. +..||||.++.. .....+.|.+|+.++++++|||||+++|++. .+..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 34689999999999999999998743 356899998653 3445678999999999999999999999985 46789
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+||||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ ||||||||+|||+++++.+||+|||+|+.+
T Consensus 84 iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999998754 3345899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
...
T Consensus 159 ~~~ 161 (273)
T d1mp8a_ 159 EDS 161 (273)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.9e-29 Score=255.07 Aligned_cols=151 Identities=33% Similarity=0.594 Sum_probs=131.6
Q ss_pred CCcccceeecccCceeEEEEEecC-Cc--EEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEeCCeEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVD-GQ--EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~--~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~lV 514 (607)
++|++.++||+|+||+||+|++.+ +. .||||++... .....++|.+|+.++.++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578889999999999999999864 33 5788888643 334566899999999998 799999999999999999999
Q ss_pred EEcCCCCChHHHHhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCce
Q 007336 515 YEFMPNKSLDSFIFDQ-------------TRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNP 581 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ 581 (607)
|||+++|+|.++|+.. .....+++..+++++.|||+||.|||+.+ ||||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999643 23467899999999999999999999987 9999999999999999999
Q ss_pred EEeecccceeec
Q 007336 582 KISDFGLVRTFG 593 (607)
Q Consensus 582 ki~DfGla~~~~ 593 (607)
||+|||+|+...
T Consensus 167 kl~DfG~a~~~~ 178 (309)
T d1fvra_ 167 KIADFGLSRGQE 178 (309)
T ss_dssp EECCTTCEESSC
T ss_pred EEcccccccccc
Confidence 999999998664
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.8e-29 Score=252.95 Aligned_cols=151 Identities=25% Similarity=0.387 Sum_probs=126.5
Q ss_pred CCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeCC----eEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~lV~ 515 (607)
.+|.+.++||+|+||+||+|++ +|+.||||++.... .....+..|+..+..++|||||+++|+|.+.+ ..+|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 3577889999999999999997 68899999986432 22223334556667889999999999998754 578999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS-----RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
||+++|+|.++|.+ ..++|..++.++.|+|.||+|||+.. ..+||||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999964 24899999999999999999999741 3469999999999999999999999999999
Q ss_pred eecCCC
Q 007336 591 TFGGDE 596 (607)
Q Consensus 591 ~~~~~~ 596 (607)
.+....
T Consensus 157 ~~~~~~ 162 (303)
T d1vjya_ 157 RHDSAT 162 (303)
T ss_dssp EEETTT
T ss_pred cccCCC
Confidence 886543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-29 Score=251.76 Aligned_cols=153 Identities=30% Similarity=0.455 Sum_probs=125.4
Q ss_pred cCCcccceeecccCceeEEEEEecC--C--cEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVD--G--QEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~--~--~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 511 (607)
.++|++.+.||+|+||+||+|++.. + ..||||++.+. .....++|.+|+.++++++|||||+++|+|.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3579999999999999999998643 2 37899988652 33456789999999999999999999999965 467
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
++||||+++|+|.+++... ...+++..++.++.|||+||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 8999999999999888542 345899999999999999999999987 99999999999999999999999999998
Q ss_pred ecCCCC
Q 007336 592 FGGDET 597 (607)
Q Consensus 592 ~~~~~~ 597 (607)
+.....
T Consensus 161 ~~~~~~ 166 (273)
T d1u46a_ 161 LPQNDD 166 (273)
T ss_dssp CCC-CC
T ss_pred cccCCC
Confidence 865543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-29 Score=256.40 Aligned_cols=168 Identities=30% Similarity=0.430 Sum_probs=141.9
Q ss_pred hhcCCcccceeecccCceeEEEEEec------CCcEEEEEEeccc-chhhHHHHHHHHHHHccC-CCCceeceEEEEEeC
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLV------DGQEIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 508 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~~~ 508 (607)
...++|++.++||+|+||.||+|++. .++.||||+++.. ......+|.+|+.+++++ +|||||+++|+|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 44578999999999999999999863 3568999999753 344566899999999998 699999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcE
Q 007336 509 EEKLLIYEFMPNKSLDSFIFDQT---------------RRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573 (607)
Q Consensus 509 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Ni 573 (607)
+..+|||||+++|+|.++|+... ....+++..++.++.|||+||+|||+++ ||||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence 99999999999999999996532 2235899999999999999999999987 99999999999
Q ss_pred EEcCCCceEEeecccceeecCCCCccCccceecC
Q 007336 574 LLDQDMNPKISDFGLVRTFGGDETEGNTNRVVGT 607 (607)
Q Consensus 574 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~GT 607 (607)
|++.++.+||+|||+++.+.............||
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt 210 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred cccccCcccccccchheeccCCCcceEeeecccC
Confidence 9999999999999999988655443333334454
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.8e-29 Score=251.36 Aligned_cols=147 Identities=31% Similarity=0.553 Sum_probs=128.9
Q ss_pred ceeecccCceeEEEEEecCC----cEEEEEEecc-cchhhHHHHHHHHHHHccCCCCceeceEEEEEeC-CeEEEEEEcC
Q 007336 445 NNKLGEGGFGPVYKGTLVDG----QEIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEFM 518 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~~~----~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey~ 518 (607)
.++||+|+||+||+|++.++ ..||||++++ ......++|.+|+.++++++|||||+++|+|.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997542 3689999975 3455678899999999999999999999998874 5789999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
++|+|.+++.. ....+++..+++++.|+|+||.|||+.+ |+||||||+||||++++.+||+|||+++.+....
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999864 3445788999999999999999999987 9999999999999999999999999999876443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4e-29 Score=253.45 Aligned_cols=151 Identities=27% Similarity=0.400 Sum_probs=131.9
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHc-cCCCCceeceEEEEEeCCeEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFS-KLQHRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~-~l~H~nIv~l~g~~~~~~~~~lV 514 (607)
++|.+.+.||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++|||||++++++.+++..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999985 4889999999752 2234556677777655 68999999999999999999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecC
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGG 594 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~ 594 (607)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ ||||||||+|||+++++.+||+|||+|+.+..
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999954 334788999999999999999999987 99999999999999999999999999997754
Q ss_pred CC
Q 007336 595 DE 596 (607)
Q Consensus 595 ~~ 596 (607)
..
T Consensus 156 ~~ 157 (320)
T d1xjda_ 156 GD 157 (320)
T ss_dssp TT
T ss_pred cc
Confidence 33
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.2e-29 Score=250.00 Aligned_cols=151 Identities=28% Similarity=0.496 Sum_probs=126.3
Q ss_pred cCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeC-CeEEEEEEc
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEF 517 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~lV~Ey 517 (607)
.++|++.++||+|+||.||+|++ .+..||||+++.. ...++|.+|+.++++++||||++++|+|.+. +..+|||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 35788889999999999999998 4788999999753 3457899999999999999999999999764 557999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
+++|+|.++|... ....++|..++.|+.|||.||.|||+.+ ||||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC
Confidence 9999999999643 2235899999999999999999999987 9999999999999999999999999999875443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.5e-29 Score=251.16 Aligned_cols=151 Identities=30% Similarity=0.494 Sum_probs=129.7
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccc--hhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
++|++.++||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.++++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999974 58999999986422 2335689999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
|+.++.+ +++.. .....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+....+
T Consensus 82 ~~~~~~~-~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLK-KFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHH-HHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchh-hhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 9976544 44432 23455899999999999999999999987 999999999999999999999999999977543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.9e-29 Score=250.85 Aligned_cols=167 Identities=30% Similarity=0.456 Sum_probs=136.0
Q ss_pred hhcCCcccceeecccCceeEEEEEecC--------CcEEEEEEecc-cchhhHHHHHHHHHHHccC-CCCceeceEEEEE
Q 007336 437 NATDNFSINNKLGEGGFGPVYKGTLVD--------GQEIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCI 506 (607)
Q Consensus 437 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l-~H~nIv~l~g~~~ 506 (607)
...++|++.+.||+|+||.||+|+... +..||||++++ .......++.+|...+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 345689999999999999999998643 24799999975 3345567899999999888 8999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcE
Q 007336 507 QGEEKLLIYEFMPNKSLDSFIFDQTR-------------RTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNV 573 (607)
Q Consensus 507 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Ni 573 (607)
+++..++||||+++|+|.++|..... ...+++..++.++.|||.||+|||+.+ ||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 99999999999999999999965321 245899999999999999999999987 99999999999
Q ss_pred EEcCCCceEEeecccceeecCCCCccCccceec
Q 007336 574 LLDQDMNPKISDFGLVRTFGGDETEGNTNRVVG 606 (607)
Q Consensus 574 ll~~~~~~ki~DfGla~~~~~~~~~~~~~~~~G 606 (607)
|++.++.+||+|||+++..........+....|
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 199 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCC
T ss_pred eecCCCCeEeccchhhccccccccccccccCCC
Confidence 999999999999999998865544333333333
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.95 E-value=1e-28 Score=245.87 Aligned_cols=151 Identities=21% Similarity=0.360 Sum_probs=132.4
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc---chhhHHHHHHHHHHHccCCCCceeceEEEEEeCC----e
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----E 510 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~----~ 510 (607)
.++|++.+.||+|+||+||+|+.. +++.||||++++. .....+.|.+|+.+++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999974 5899999999652 2344567999999999999999999999998654 3
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.+|||||+++++|.+++.. ...+++.....|+.||+.||+|||+.+ ||||||||+||||+.++.++|+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999998854 345899999999999999999999987 9999999999999999999999999998
Q ss_pred eecCC
Q 007336 591 TFGGD 595 (607)
Q Consensus 591 ~~~~~ 595 (607)
.+...
T Consensus 160 ~~~~~ 164 (277)
T d1o6ya_ 160 AIADS 164 (277)
T ss_dssp ECC--
T ss_pred hhccc
Confidence 77543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.95 E-value=6.1e-29 Score=248.76 Aligned_cols=150 Identities=27% Similarity=0.439 Sum_probs=134.5
Q ss_pred CCcccceeecccCceeEEEEEecCCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey 517 (607)
++|++.++||+|+||+||+|+..+++.||||++... .....+.+.+|+.++++++|||||++++++.+.+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 589999999999999999999988999999998653 233457899999999999999999999999999999999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGD 595 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~ 595 (607)
+.++.+..+.. ....+++..+..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|..+...
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 99887777763 3456899999999999999999999987 999999999999999999999999999987543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7.3e-29 Score=249.77 Aligned_cols=146 Identities=32% Similarity=0.449 Sum_probs=124.8
Q ss_pred ceeecccCceeEEEEEec-CCcEEEEEEecccchh-----hHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEEcC
Q 007336 445 NNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQ-----GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 518 (607)
Q Consensus 445 ~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~-----~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 518 (607)
+++||+|+||+||+|+.. +++.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999975 4899999998653211 1346889999999999999999999999999999999999
Q ss_pred CCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 519 PNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 519 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
+++++..++ .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 988777665 23455788899999999999999999987 9999999999999999999999999999775443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7e-28 Score=245.83 Aligned_cols=149 Identities=23% Similarity=0.321 Sum_probs=126.1
Q ss_pred cCCcccce-eecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHcc-CCCCceeceEEEEEe----CCeE
Q 007336 439 TDNFSINN-KLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ----GEEK 511 (607)
Q Consensus 439 ~~~~~~~~-~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~-l~H~nIv~l~g~~~~----~~~~ 511 (607)
.++|.+.. .||+|+||+||+|+.. +++.||||++++. ..+.+|+.++.+ .+|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 45788765 5999999999999974 5899999998652 346678887654 589999999999875 3567
Q ss_pred EEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCceEEeeccc
Q 007336 512 LLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGL 588 (607)
Q Consensus 512 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~---~~~~ki~DfGl 588 (607)
+||||||++|+|.++|.+. ....+++..+..|+.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999999653 2346899999999999999999999987 999999999999986 46799999999
Q ss_pred ceeecCCC
Q 007336 589 VRTFGGDE 596 (607)
Q Consensus 589 a~~~~~~~ 596 (607)
|+.+....
T Consensus 161 a~~~~~~~ 168 (335)
T d2ozaa1 161 AKETTSHN 168 (335)
T ss_dssp CEECCCCC
T ss_pred eeeccCCC
Confidence 99876543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.5e-28 Score=241.23 Aligned_cols=150 Identities=27% Similarity=0.399 Sum_probs=128.4
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccc------hhhHHHHHHHHHHHccCC--CCceeceEEEEEeCC
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKIS------EQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGE 509 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~------~~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~~ 509 (607)
.++|++.++||+|+||+||+|+.. +++.||||++.+.. .....++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999975 58999999986421 112244678999999886 899999999999999
Q ss_pred eEEEEEEcCCC-CChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCC-CceEEeecc
Q 007336 510 EKLLIYEFMPN-KSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQD-MNPKISDFG 587 (607)
Q Consensus 510 ~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~-~~~ki~DfG 587 (607)
..++||||+.+ +++.+++.. ...+++..+..++.||++||+|||+.+ ||||||||+||||+.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 678787743 345899999999999999999999987 9999999999999854 789999999
Q ss_pred cceeecC
Q 007336 588 LVRTFGG 594 (607)
Q Consensus 588 la~~~~~ 594 (607)
+|+....
T Consensus 157 ~a~~~~~ 163 (273)
T d1xwsa_ 157 SGALLKD 163 (273)
T ss_dssp TCEECCS
T ss_pred cceeccc
Confidence 9997653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.2e-27 Score=236.83 Aligned_cols=151 Identities=27% Similarity=0.421 Sum_probs=135.2
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCCeEEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 516 (607)
++|++.++||+|+||+||+|+.. +++.||||+++. ......+.+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 588999999864 233456789999999999999999999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceeecCCC
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTFGGDE 596 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~~~~~ 596 (607)
++.+++|..++.. ...+++..+..++.|+++||+|||+.+ ||||||||+||||+.++.+||+|||+|+.+....
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999999888743 345789999999999999999999987 9999999999999999999999999999886443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.7e-27 Score=244.53 Aligned_cols=150 Identities=23% Similarity=0.392 Sum_probs=127.1
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc-chhhHHHHHHHHHHHccCCCCceeceEEEEEeCC----eEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKL 512 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~----~~~ 512 (607)
..+|++.++||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999999999999874 6899999999753 3345678999999999999999999999997643 235
Q ss_pred EEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccceee
Q 007336 513 LIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVRTF 592 (607)
Q Consensus 513 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~~ 592 (607)
+++||+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55667789999999953 24899999999999999999999987 999999999999999999999999999987
Q ss_pred cCC
Q 007336 593 GGD 595 (607)
Q Consensus 593 ~~~ 595 (607)
...
T Consensus 160 ~~~ 162 (345)
T d1pmea_ 160 DPD 162 (345)
T ss_dssp CGG
T ss_pred cCC
Confidence 544
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.9e-27 Score=244.62 Aligned_cols=149 Identities=26% Similarity=0.391 Sum_probs=124.0
Q ss_pred CcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceeceEEEEEeC------CeEEE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EEKLL 513 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------~~~~l 513 (607)
+|+..++||+|+||+||+|+.. +++.||||++.+... .+.+|+.++++++||||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888899999999999999985 489999999875322 234699999999999999999998653 24689
Q ss_pred EEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-ceEEeecccceee
Q 007336 514 IYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTF 592 (607)
Q Consensus 514 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~-~~ki~DfGla~~~ 592 (607)
||||++++.+..+.........+++..+..++.||+.||+|||+.+ ||||||||+||||+.++ .+||+|||+|+.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755444332234556899999999999999999999887 99999999999999775 8999999999988
Q ss_pred cCCC
Q 007336 593 GGDE 596 (607)
Q Consensus 593 ~~~~ 596 (607)
....
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 6543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.94 E-value=6.3e-27 Score=238.71 Aligned_cols=145 Identities=23% Similarity=0.445 Sum_probs=126.7
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCceeceEEEEEeC--CeEEEEE
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIY 515 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~ 515 (607)
++|++.++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+.++++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999974 5889999998753 3467889999999995 99999999999854 4589999
Q ss_pred EcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCC-ceEEeecccceeecC
Q 007336 516 EFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDM-NPKISDFGLVRTFGG 594 (607)
Q Consensus 516 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~-~~ki~DfGla~~~~~ 594 (607)
||+++++|..+. ..+++..+..++.||+.||.|||+.+ ||||||||+||||+.++ .+||+|||+|+.+..
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 24889999999999999999999988 99999999999998655 689999999998865
Q ss_pred CC
Q 007336 595 DE 596 (607)
Q Consensus 595 ~~ 596 (607)
..
T Consensus 183 ~~ 184 (328)
T d3bqca1 183 GQ 184 (328)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=8.8e-27 Score=239.43 Aligned_cols=150 Identities=29% Similarity=0.460 Sum_probs=124.9
Q ss_pred hcCCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeCC-----
Q 007336 438 ATDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 509 (607)
Q Consensus 438 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~~----- 509 (607)
..++|++.++||+|+||+||+|+.. +++.||||++++ ......+.+.+|+.+|+.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3468999999999999999999975 489999999975 23445678999999999999999999999998654
Q ss_pred -eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeeccc
Q 007336 510 -EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGL 588 (607)
Q Consensus 510 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGl 588 (607)
..+|||||+ +.+|..++.. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 469999999 5677776632 35899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecCC
Q 007336 589 VRTFGGD 595 (607)
Q Consensus 589 a~~~~~~ 595 (607)
|+.....
T Consensus 168 a~~~~~~ 174 (346)
T d1cm8a_ 168 ARQADSE 174 (346)
T ss_dssp CEECCSS
T ss_pred eeccCCc
Confidence 9987543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.2e-26 Score=235.48 Aligned_cols=152 Identities=28% Similarity=0.469 Sum_probs=127.8
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEeC-------
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------- 508 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~------- 508 (607)
.++|++.++||+|+||+||+|+.. +++.||||++.. ......+.+.+|+.++++++||||+++++.+...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 468999999999999999999974 589999999854 2334456789999999999999999999998653
Q ss_pred -CeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecc
Q 007336 509 -EEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFG 587 (607)
Q Consensus 509 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfG 587 (607)
...++||||++++.+..+. .....++......++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 3578999999988776554 23445788889999999999999999987 9999999999999999999999999
Q ss_pred cceeecCCC
Q 007336 588 LVRTFGGDE 596 (607)
Q Consensus 588 la~~~~~~~ 596 (607)
+|+.+....
T Consensus 163 ~~~~~~~~~ 171 (318)
T d3blha1 163 LARAFSLAK 171 (318)
T ss_dssp TCEECCC--
T ss_pred eeeeccccc
Confidence 999876433
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4.3e-27 Score=238.67 Aligned_cols=151 Identities=25% Similarity=0.358 Sum_probs=131.9
Q ss_pred CCcccceeecccCceeEEEEEec----CCcEEEEEEeccc----chhhHHHHHHHHHHHccCCC-CceeceEEEEEeCCe
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV----DGQEIAVKRLSKI----SEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEE 510 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~----~~~~~~~f~~E~~~l~~l~H-~nIv~l~g~~~~~~~ 510 (607)
++|++.+.||+|+||+||+|+.. +|+.||||.+++. .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 57999999999999999999852 3789999998642 22345678899999999966 899999999999999
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++||||+.+|+|.+++... ..++......++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999998543 34577888889999999999999987 9999999999999999999999999999
Q ss_pred eecCCC
Q 007336 591 TFGGDE 596 (607)
Q Consensus 591 ~~~~~~ 596 (607)
.+....
T Consensus 178 ~~~~~~ 183 (322)
T d1vzoa_ 178 EFVADE 183 (322)
T ss_dssp ECCGGG
T ss_pred hhcccc
Confidence 875443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.93 E-value=3.8e-26 Score=228.82 Aligned_cols=149 Identities=19% Similarity=0.347 Sum_probs=128.1
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCC-CceeceEEEEEeCCeEEEEEE
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYE 516 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E 516 (607)
.++|++.++||+|+||+||+|+.. +++.||||.+.... ....+++|++.+..++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 358999999999999999999975 48899999886432 23456778888888865 899999999999999999999
Q ss_pred cCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC-----CCceEEeeccccee
Q 007336 517 FMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ-----DMNPKISDFGLVRT 591 (607)
Q Consensus 517 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~-----~~~~ki~DfGla~~ 591 (607)
|+ +++|.+++... ...+++.....++.|++.||+|||+.+ ||||||||+||||+. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 68999988543 345899999999999999999999987 999999999999975 56799999999998
Q ss_pred ecCC
Q 007336 592 FGGD 595 (607)
Q Consensus 592 ~~~~ 595 (607)
+...
T Consensus 156 ~~~~ 159 (293)
T d1csna_ 156 YRDP 159 (293)
T ss_dssp SBCT
T ss_pred cccC
Confidence 8644
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.9e-26 Score=232.60 Aligned_cols=151 Identities=25% Similarity=0.430 Sum_probs=122.4
Q ss_pred cCCcccceeecccCceeEEEEEec-C-CcEEEEEEeccc--chhhHHHHHHHHHHHcc---CCCCceeceEEEEEe----
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-D-GQEIAVKRLSKI--SEQGLKELKNEVILFSK---LQHRNLVKLLGCCIQ---- 507 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~-~~~vavK~l~~~--~~~~~~~f~~E~~~l~~---l~H~nIv~l~g~~~~---- 507 (607)
.++|++.++||+|+||+||+|+.. + ++.||||+++.. .......+.+|+.+++. ++||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 567999998642 12222345566666554 589999999999864
Q ss_pred -CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeec
Q 007336 508 -GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDF 586 (607)
Q Consensus 508 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~Df 586 (607)
....+++|||++++.+..... .....+++.....++.||+.||+|||+.+ ||||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 235789999999887765543 23456889999999999999999999987 999999999999999999999999
Q ss_pred ccceeecC
Q 007336 587 GLVRTFGG 594 (607)
Q Consensus 587 Gla~~~~~ 594 (607)
|+++....
T Consensus 161 g~~~~~~~ 168 (305)
T d1blxa_ 161 GLARIYSF 168 (305)
T ss_dssp CSCCCCCG
T ss_pred hhhhhhcc
Confidence 99987643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=5.9e-26 Score=233.43 Aligned_cols=148 Identities=29% Similarity=0.437 Sum_probs=125.8
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEeccc--chhhHHHHHHHHHHHccCCCCceeceEEEEEeC-----Ce
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 510 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~~-----~~ 510 (607)
.++|++.++||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 568999999999999999999974 5899999999753 334556789999999999999999999998643 34
Q ss_pred EEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 511 KLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 511 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
.++++||+.+|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 4677788899999999843 34899999999999999999999987 9999999999999999999999999998
Q ss_pred eec
Q 007336 591 TFG 593 (607)
Q Consensus 591 ~~~ 593 (607)
...
T Consensus 170 ~~~ 172 (348)
T d2gfsa1 170 HTD 172 (348)
T ss_dssp CCT
T ss_pred ccC
Confidence 764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.92 E-value=1.6e-25 Score=225.07 Aligned_cols=149 Identities=23% Similarity=0.400 Sum_probs=121.9
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCCCCceece-EEEEEeCCeEEEEEEc
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL-LGCCIQGEEKLLIYEF 517 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nIv~l-~g~~~~~~~~~lV~Ey 517 (607)
++|++.+.||+|+||+||+|+.. +++.||||++.... ...++..|+++++.++|+|++.. .++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999974 48899999876532 23457889999999987765554 5555778888999999
Q ss_pred CCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcC---CCceEEeecccceeecC
Q 007336 518 MPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQ---DMNPKISDFGLVRTFGG 594 (607)
Q Consensus 518 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~---~~~~ki~DfGla~~~~~ 594 (607)
++ ++|...+.. ....+++..+..++.|++.||+|||+++ ||||||||+|||++. +..+||+|||+|+.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 566655543 2345899999999999999999999987 999999999999864 55799999999999865
Q ss_pred CC
Q 007336 595 DE 596 (607)
Q Consensus 595 ~~ 596 (607)
..
T Consensus 159 ~~ 160 (299)
T d1ckia_ 159 AR 160 (299)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.4e-25 Score=228.11 Aligned_cols=147 Identities=29% Similarity=0.424 Sum_probs=121.3
Q ss_pred cCCcccceeecccCceeEEEEEec-CCcEEEEEEecc--cchhhHHHHHHHHHHHccCCCCceeceEEEEEe------CC
Q 007336 439 TDNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GE 509 (607)
Q Consensus 439 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~nIv~l~g~~~~------~~ 509 (607)
.++|++.++||+|+||+||+|... +++.||||++.+ .......++.+|+.++++++|||||++++++.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 368999999999999999999975 489999999975 234455678999999999999999999999964 36
Q ss_pred eEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEeecccc
Q 007336 510 EKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKISDFGLV 589 (607)
Q Consensus 510 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~DfGla 589 (607)
..++||||+.++.+. .+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 789999999766554 432 24789999999999999999999987 999999999999999999999999999
Q ss_pred eeecC
Q 007336 590 RTFGG 594 (607)
Q Consensus 590 ~~~~~ 594 (607)
+....
T Consensus 167 ~~~~~ 171 (355)
T d2b1pa1 167 RTAGT 171 (355)
T ss_dssp -----
T ss_pred hcccc
Confidence 97754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=6e-22 Score=185.09 Aligned_cols=134 Identities=21% Similarity=0.195 Sum_probs=106.1
Q ss_pred ccceeecccCceeEEEEEecCCcEEEEEEecccc------------------hhhHHHHHHHHHHHccCCCCceeceEEE
Q 007336 443 SINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKIS------------------EQGLKELKNEVILFSKLQHRNLVKLLGC 504 (607)
Q Consensus 443 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~------------------~~~~~~f~~E~~~l~~l~H~nIv~l~g~ 504 (607)
.+.++||+|+||+||+|+..+|+.||||.++... ......+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4568999999999999999889999999864210 1112345578888999999999988765
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecccCCCcEEEcCCCceEEe
Q 007336 505 CIQGEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDSRLRIIHRDLKASNVLLDQDMNPKIS 584 (607)
Q Consensus 505 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ivHrDlkp~Nill~~~~~~ki~ 584 (607)
. ..+++|||+++..+.. ++......++.|++++|+|||+.+ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 2379999999866533 223334578999999999999987 99999999999999654 8999
Q ss_pred ecccceeecC
Q 007336 585 DFGLVRTFGG 594 (607)
Q Consensus 585 DfGla~~~~~ 594 (607)
|||+|+....
T Consensus 145 DFG~a~~~~~ 154 (191)
T d1zara2 145 DFPQSVEVGE 154 (191)
T ss_dssp CCTTCEETTS
T ss_pred ECCCcccCCC
Confidence 9999987753
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.83 E-value=6.5e-21 Score=196.40 Aligned_cols=151 Identities=21% Similarity=0.243 Sum_probs=120.3
Q ss_pred CCcccceeecccCceeEEEEEec-CCcEEEEEEecccchhhHHHHHHHHHHHccCC-----------CCceeceEEEEEe
Q 007336 440 DNFSINNKLGEGGFGPVYKGTLV-DGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCIQ 507 (607)
Q Consensus 440 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~nIv~l~g~~~~ 507 (607)
++|++.++||+|+||+||+|+.. +++.||||++++. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999974 5899999999763 334567788888887775 5789999988764
Q ss_pred --CCeEEEEEEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecccCCCcEEEcCCCc----
Q 007336 508 --GEEKLLIYEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQ-DSRLRIIHRDLKASNVLLDQDMN---- 580 (607)
Q Consensus 508 --~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~ivHrDlkp~Nill~~~~~---- 580 (607)
....+++++++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 35667777777665544333333445667889999999999999999998 54 999999999999986653
Q ss_pred --eEEeecccceeecC
Q 007336 581 --PKISDFGLVRTFGG 594 (607)
Q Consensus 581 --~ki~DfGla~~~~~ 594 (607)
+||+|||.|+....
T Consensus 169 ~~~kl~dfg~s~~~~~ 184 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE 184 (362)
T ss_dssp EEEEECCCTTCEETTB
T ss_pred ceeeEeeccccccccc
Confidence 89999999987643
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.64 E-value=2e-16 Score=133.87 Aligned_cols=99 Identities=16% Similarity=0.190 Sum_probs=80.5
Q ss_pred CCCCCCCceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCce
Q 007336 9 NKSYPPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETY 88 (607)
Q Consensus 9 ~~~~~~~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~ 88 (607)
|+++++++.+|++|++.|+....-+|.+..||||+|.+. +.++|++++.+......+ .|+++|||||++.. +.+
T Consensus 14 ~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~-~l~~~GnLvl~d~~----~~~ 87 (120)
T d1dlpa2 14 YSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA-VLQPNGRMDVLTNQ----NIA 87 (120)
T ss_dssp CCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEE-EEETTTEEEEEETT----TEE
T ss_pred EcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEE-EEeCCeeEEEEcCC----CCE
Confidence 577888999999999999987767899999999999986 678999987753334556 99999999999975 679
Q ss_pred eEeeccCCCcccCCCCeeccccccCccceEEEeccCCCCCCceeEEEEecCCCceE
Q 007336 89 FWQSFDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEV 144 (607)
Q Consensus 89 lWQSFd~PTDTlLpgq~l~~~~~~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~ 144 (607)
|||||. +.++|.|.+.|+++|..-+
T Consensus 88 lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvl 112 (120)
T d1dlpa2 88 VWTSGN-------------------------------SRSAGRYVFVLQPDRNLAI 112 (120)
T ss_dssp EEECCC-------------------------------CCSSSCCEEEECSSSCEEE
T ss_pred EEEeCC-------------------------------CCCCCcEEEEECCCCcEEE
Confidence 999983 2356788999999988654
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.58 E-value=2e-15 Score=125.53 Aligned_cols=73 Identities=19% Similarity=0.328 Sum_probs=61.5
Q ss_pred CCceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeec
Q 007336 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSF 93 (607)
Q Consensus 14 ~~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSF 93 (607)
..++||+||++.|+... +.|.|+.+|+|+|.|++|++||+|++....+..++ .|+|+|||||++. .+|||+
T Consensus 36 ~~~~vW~ant~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~s~t~~~~~~~~l-~L~ddGNlvly~~-------~~W~S~ 106 (109)
T d1kj1a_ 36 HSTSVWASNTGILGKKG-CKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVL-VLQEDGNVVIYGS-------DIWSTG 106 (109)
T ss_dssp TTEEEEECCCCCTTCCC-CEEEECTTSCEEEECSSSCEEEECCCCCCSSCCEE-EECTTSCEEEECC-------EEEECC
T ss_pred CCEEEEEeCCCCCCcee-EEEEEcCCceEEEEeCCCcEEEEEeeECCCCCEEE-EEeCCCcEEEECC-------CEecCC
Confidence 35789999999998654 78999999999999999999999987643344556 9999999999963 499998
Q ss_pred cC
Q 007336 94 DY 95 (607)
Q Consensus 94 d~ 95 (607)
-|
T Consensus 107 t~ 108 (109)
T d1kj1a_ 107 TY 108 (109)
T ss_dssp CC
T ss_pred Cc
Confidence 65
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.54 E-value=3e-15 Score=125.23 Aligned_cols=104 Identities=16% Similarity=0.238 Sum_probs=84.1
Q ss_pred CCCceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEee
Q 007336 13 PPHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (607)
Q Consensus 13 ~~~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQS 92 (607)
++.+..|+.+.+.++....-+|.+..||||||.+. +.++|++++.+ ..+..+ .|+++|||||++.. +.+||||
T Consensus 9 ~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~-~~~~~l-~l~~dGNLvl~d~~----~~~vWsS 81 (115)
T d1dlpa1 9 HEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAG-ATGCRA-VLQSDGLLVILTAQ----NTIRWSS 81 (115)
T ss_dssp SSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCS-CSCCBC-CBCSSSCBCCBCTT----TCCSCCC
T ss_pred CCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-CeeEEEcccCC-CCceEE-EEeccCCEEEEccC----CCEEEEc
Confidence 34566799999999987767899999999999884 67999999775 355666 99999999999875 5789998
Q ss_pred ccCCCcccCCCCeeccccccCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeCC
Q 007336 93 FDYPSDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (607)
Q Consensus 93 Fd~PTDTlLpgq~l~~~~~~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 158 (607)
+. +.+.|.|.+.|+++|... ++ +.++|.+|.
T Consensus 82 ~t-------------------------------~~~~g~y~l~Lq~DGNlv--lY--~~~~Wssgt 112 (115)
T d1dlpa1 82 GT-------------------------------KGSIGNYVLVLQPDRTVT--IY--GPGLWDSGT 112 (115)
T ss_dssp CC-------------------------------CCCSSCCEEEECSSSCEE--EE--CSEEEECSC
T ss_pred CC-------------------------------CCCCCCEEEEECCCCcEE--Ee--CCCeecCCC
Confidence 63 246788999999999864 44 347999875
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.54 E-value=1e-14 Score=122.23 Aligned_cols=77 Identities=18% Similarity=0.355 Sum_probs=62.4
Q ss_pred CCceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeec
Q 007336 14 PHEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSF 93 (607)
Q Consensus 14 ~~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSF 93 (607)
..++||.||++.|.. .+.|.|..+|+|+|.|. +.++|++++.+..+...+ .|+|+|||||++.. +.++|||+
T Consensus 36 ~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~-~~~~w~s~t~~~~~~~~l-~L~ddGNlvly~~~----~~~~W~S~ 107 (112)
T d1xd5a_ 36 NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYL-ILQRDRNVVIYDNS----NNAIWATH 107 (112)
T ss_dssp TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET-TEEEEECCCCCSCCCCEE-EECTTSCEEEECTT----SCEEEECC
T ss_pred CCcEEEEccCccCCC--CcEEEEeccccEEEEec-CCeEEEEeeccCCCceEE-EEcCCCCEEEECCC----CcEEecCC
Confidence 357899999998854 36899999999999997 567777776543344455 99999999999864 57899999
Q ss_pred cCCCc
Q 007336 94 DYPSD 98 (607)
Q Consensus 94 d~PTD 98 (607)
.+|++
T Consensus 108 t~~~n 112 (112)
T d1xd5a_ 108 TNVGN 112 (112)
T ss_dssp CCCCC
T ss_pred CccCC
Confidence 99986
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.54 E-value=8.4e-15 Score=121.64 Aligned_cols=71 Identities=23% Similarity=0.329 Sum_probs=59.3
Q ss_pred CceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeecc
Q 007336 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (607)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd 94 (607)
.++||.||++.|- ..+.|.|..+|+|+|.|++|.+||++++........+ .|+|+|||||++. .+||||+
T Consensus 37 ~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~~g~~vWsS~t~~~~~~~~l-~L~ddGNlVly~~-------~~W~S~t 106 (108)
T d1jpca_ 37 DKPIWATNTGGLS--RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVC-ILQKDRNVVIYGT-------DRWATGT 106 (108)
T ss_dssp TEEEEECCCTTSC--SSCEEEECTTSCEEEECTTCCEEEECCCCCSCSCEEE-EECTTSCEEEEEC-------CCCCCCC
T ss_pred CceeeEeCCCCCC--CccEEEEeccceEEEECCCccceEEccccCCCCcEEE-EEcCCCCEEEeCC-------CcccCCC
Confidence 5789999999884 3468999999999999999999999987653333344 9999999999964 3899998
Q ss_pred C
Q 007336 95 Y 95 (607)
Q Consensus 95 ~ 95 (607)
|
T Consensus 107 ~ 107 (108)
T d1jpca_ 107 H 107 (108)
T ss_dssp C
T ss_pred C
Confidence 7
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.23 E-value=1.4e-11 Score=103.29 Aligned_cols=70 Identities=20% Similarity=0.358 Sum_probs=57.7
Q ss_pred CceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeecc
Q 007336 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (607)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd 94 (607)
.++||.||+..|.. ...|.|..+|+|+|.|++|.+||++++.+......+ .|+|+|||||++. ++|||-.
T Consensus 48 ~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~g~~vWsS~t~~~~~~~~l-~Lq~DGNlvlYg~-------~~W~S~T 117 (119)
T d1b2pa_ 48 NNPIWATNTGGLGN--GCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVL-VLQPDRNVVIYGD-------ALWATQT 117 (119)
T ss_dssp TEEEEECCCTTSCS--SCEEEECTTSCEEEECTTCCEEEECSCCCCSSCEEE-EECTTSCEEEEES-------EEEECCC
T ss_pred CeEEEEecCCCCCc--ceEEEEEeCCCEEEECCCCcEEEECCCcCCCCceEE-EEcCCCCEEEECC-------CEeccCC
Confidence 57899999987753 368999999999999999999999987653333345 8999999999863 5999964
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.94 E-value=2.8e-09 Score=88.92 Aligned_cols=85 Identities=19% Similarity=0.302 Sum_probs=63.6
Q ss_pred eEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeeccCCCcccCCCCeecccccc
Q 007336 33 FLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLKT 112 (607)
Q Consensus 33 ~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~~ 112 (607)
+|.+-.||||||.++ +.++|++++.+......+ .|.++|||||.+.. +.+||+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l-~l~~dGnLvL~d~~----g~~vWsS~t------------------ 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRA-VLQPDGVLVVITNE----NVTVWQSPV------------------ 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEE-EECTTSCEEEECTT----CCEEEECSC------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEE-EEEeCCCEEEECCC----CcEEEECCC------------------
Confidence 477889999999876 568999997654334555 99999999999875 578997532
Q ss_pred CccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeCC
Q 007336 113 GLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGP 158 (607)
Q Consensus 113 g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~ 158 (607)
.-+.|.|.+.|+++|...+ + +.+.|.|+.
T Consensus 89 -------------~~~~~~~~l~Lq~DGNlvl--Y--g~~~W~S~T 117 (119)
T d1b2pa_ 89 -------------AGKAGHYVLVLQPDRNVVI--Y--GDALWATQT 117 (119)
T ss_dssp -------------CCCSSCEEEEECTTSCEEE--E--ESEEEECCC
T ss_pred -------------cCCCCceEEEEcCCCCEEE--E--CCCEeccCC
Confidence 1135678899999988655 3 247888764
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.85 E-value=1.1e-08 Score=84.11 Aligned_cols=87 Identities=20% Similarity=0.392 Sum_probs=63.8
Q ss_pred ceEEEecCCcEEEEcCCCcEEEeeCCccCc-CCceEEEEecCCCeEEeeCCCCCCCceeEeeccCCCcccCCCCeecccc
Q 007336 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEV-QTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDL 110 (607)
Q Consensus 32 ~~l~~~~~G~L~l~d~~g~~vWst~~~~~~-~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~ 110 (607)
-.|.+..||||+|.+ .+.+||++++.... ....+ .|.++|||||++.. +.++|+|=
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l-~l~~dGnLvl~~~~----g~~vW~s~----------------- 77 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKA-VLQSDGNFVVYDAE----GRSLWASH----------------- 77 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEE-EECTTSCEEEECSS----SCEEEECC-----------------
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEE-EEcCCceEEEEeCC----CcEEEEEe-----------------
Confidence 568889999999986 56799999876432 23455 89999999999875 67899871
Q ss_pred ccCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeCCC
Q 007336 111 KTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPW 159 (607)
Q Consensus 111 ~~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~ 159 (607)
...+.|.|.+.|+++|+..+ ++ .+.|.|+.+
T Consensus 78 --------------t~~~~~~~~l~L~ddGNlvl--y~--~~~W~S~t~ 108 (109)
T d1kj1a_ 78 --------------SVRGNGNYVLVLQEDGNVVI--YG--SDIWSTGTY 108 (109)
T ss_dssp --------------CCCCSSCCEEEECTTSCEEE--EC--CEEEECCCC
T ss_pred --------------eECCCCCEEEEEeCCCcEEE--EC--CCEecCCCc
Confidence 11134668899999988654 43 468887653
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.84 E-value=6.3e-09 Score=85.47 Aligned_cols=85 Identities=18% Similarity=0.353 Sum_probs=61.7
Q ss_pred ceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeeccCCCcccCCCCeeccccc
Q 007336 32 GFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFDYPSDTLLPGMKLGWDLK 111 (607)
Q Consensus 32 ~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~ 111 (607)
-+|.+..||||||.+. +.+||++++.+......+ .|.++|||||++.. +.+||+|
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l-~l~~~Gnlvl~~~~----g~~vWsS------------------- 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFL-SMQTDGNLVVYNPS----NKPIWAS------------------- 75 (108)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEE-EECTTSCEEEECTT----CCEEEEC-------------------
T ss_pred EEEEECCCCeEEEEeC-CceeeEeCCCCCCCccEE-EEeccceEEEECCC----ccceEEc-------------------
Confidence 5688999999999874 679999997754333455 99999999999875 6789986
Q ss_pred cCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeC
Q 007336 112 TGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTG 157 (607)
Q Consensus 112 ~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~ 157 (607)
......+.|.+.|+++|+.-++ .. +.|.|+
T Consensus 76 ------------~t~~~~~~~~l~L~ddGNlVly--~~--~~W~S~ 105 (108)
T d1jpca_ 76 ------------NTGGQNGNYVCILQKDRNVVIY--GT--DRWATG 105 (108)
T ss_dssp ------------CCCCSCSCEEEEECTTSCEEEE--EC--CCCCCC
T ss_pred ------------cccCCCCcEEEEEcCCCCEEEe--CC--CcccCC
Confidence 1112356788899988886543 32 356554
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.76 E-value=1.3e-09 Score=90.39 Aligned_cols=69 Identities=19% Similarity=0.294 Sum_probs=55.2
Q ss_pred CceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEeecc
Q 007336 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQSFD 94 (607)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQSFd 94 (607)
..+||.+|...+ ..+.+.|..+|+|||.|.++.+||++.+....+..++ .|+++|||||++. .+|+|-.
T Consensus 44 ~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~~g~y~l-~Lq~DGNlvlY~~-------~~Wssgt 112 (115)
T d1dlpa1 44 DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVL-VLQPDRTVTIYGP-------GLWDSGT 112 (115)
T ss_dssp SSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCEE-EECSSSCEEEECS-------EEEECSC
T ss_pred CeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEEEEcCCCCCCCCEEE-EECCCCcEEEeCC-------CeecCCC
Confidence 468999997643 3478999999999999999999999987653344455 9999999999853 5999854
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.73 E-value=8.2e-09 Score=86.31 Aligned_cols=68 Identities=21% Similarity=0.347 Sum_probs=52.6
Q ss_pred CceEEEccCCCCCCCCcceEEEecCCcEEEEcCCCcEEEeeCCccCcCCceEEEEecCCCeEEeeCCCCCCCceeEee
Q 007336 15 HEVVWVANRLNPINDSFGFLMINKTGNLVLTSQSNIVVWSAYLSKEVQTPVVLQLLDSGNLVLRDEHDGDSETYFWQS 92 (607)
Q Consensus 15 ~t~VW~Anr~~pv~~~~~~l~~~~~G~L~l~d~~g~~vWst~~~~~~~~~~~~~Lld~GNlVl~~~~~~~~~~~lWQS 92 (607)
..+||.++-. .......+.|..+|+|||.|.++.++|++++....+...+ .|.++|||||++. .+|.|
T Consensus 53 ~~~vW~s~t~--~~~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~~~~~~~~l-~Lq~DGnlvlY~~-------~~W~t 120 (120)
T d1dlpa2 53 DDRVWSTNTA--GKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVF-VLQPDRNLAIYGG-------ALWTT 120 (120)
T ss_dssp TBCCSCCCCC--SSCSSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCCEE-EECSSSCEEEECC-------CCCBC
T ss_pred CcEEEEEccc--cCCCcEEEEEeCCeeEEEEcCCCCEEEEeCCCCCCCcEEE-EECCCCcEEEeCC-------CcccC
Confidence 3568988743 3344468999999999999999999999987653344445 8999999999953 48875
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.58 E-value=1.2e-07 Score=78.27 Aligned_cols=111 Identities=13% Similarity=0.145 Sum_probs=68.7
Q ss_pred CcccCCCCeeccccccCccceEEEeccCCCCCCceeEEEEecCCCceEEEEcCCeEEEEeCCCCCccccCCCCCCCCceE
Q 007336 97 SDTLLPGMKLGWDLKTGLERRVTSWKSFDDPSPGDFIWAIERQDNPEVVMWKGSRKFYRTGPWNGLRFSAPSLRPNPIFS 176 (607)
Q Consensus 97 TDTlLpgq~l~~~~~~g~~~~L~s~~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~ 176 (607)
||||+|||.|..+. .|+ +|.|.|.|+.+|+. +++....++|.++......-....++..+.
T Consensus 1 tDtL~~gq~L~~g~------~l~---------~g~~~l~~q~DGNL--vly~~~~~vW~s~~~~~~~~~~l~l~~dGn-- 61 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGG------SLA---------EGGYLFIIQNDCNL--VLYDNNRAVWASGTNGKASGCVLKMQNDGN-- 61 (112)
T ss_dssp CCEEETTEEECTTC------EEE---------ETTEEEEECTTSCE--EEEETTEEEEECCCTTSCSSEEEEECTTSC--
T ss_pred CCEecCCCEecCCC------EEE---------ECCEEEEEcCCCCE--EEEcCCcEEEEccCccCCCCcEEEEecccc--
Confidence 89999999998875 564 39999999999885 456778899988754321111112222222
Q ss_pred EEEEecCceEEEEEEecCCCeEEEEEEeeecceEEEEEEecCCCcEEEEeeecCCCC
Q 007336 177 FSFVSNDVELYYTFNITNKAVISRIVMNQTLYVRRRFIWNKATQSWELYSDVPRDQC 233 (607)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~~~~~~~~~~~~~~W~~~~~~~~~~C 233 (607)
+.+.+.....+ ..........++++|++|| ++++|. . .....|+...+.|
T Consensus 62 Lvl~~~~~~~w-~s~t~~~~~~~~l~L~ddG-Nlvly~--~---~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 62 LVIYSGSRAIW-ASNTNRQNGNYYLILQRDR-NVVIYD--N---SNNAIWATHTNVG 111 (112)
T ss_dssp EEEEETTEEEE-ECCCCCSCCCCEEEECTTS-CEEEEC--T---TSCEEEECCCCCC
T ss_pred EEEEecCCeEE-EEeeccCCCceEEEEcCCC-CEEEEC--C---CCcEEecCCCccC
Confidence 22223322222 2122223335689999999 998884 2 2246888777665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.54 E-value=2.4e-07 Score=88.70 Aligned_cols=147 Identities=15% Similarity=0.071 Sum_probs=99.6
Q ss_pred HhhcCCcccceeecccCceeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeEEEE
Q 007336 436 ANATDNFSINNKLGEGGFGPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 436 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~lV 514 (607)
......|+..+..+-++...||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+..+++..++|
T Consensus 10 ~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 33334666655544444568998764 56677888876544334445677777766553 44467888888888999999
Q ss_pred EEcCCCCChHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 007336 515 YEFMPNKSLDSFIFDQTRRTLLDWSQRFHIICGTARGLLYLHQDS----------------------------------- 559 (607)
Q Consensus 515 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~----------------------------------- 559 (607)
||++++.++.+..... .....++.++++.++.||+..
T Consensus 89 ~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 9999998886554210 112234556666666666421
Q ss_pred ---------------------CCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 560 ---------------------RLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 560 ---------------------~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
...++|+|+.|.|||++++..+-|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11279999999999999877778999998874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.90 E-value=3e-05 Score=73.13 Aligned_cols=131 Identities=19% Similarity=0.161 Sum_probs=84.1
Q ss_pred eecccCc-eeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCC--CCceeceEEEEEeCCeEEEEEEcCCCCCh
Q 007336 447 KLGEGGF-GPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 523 (607)
Q Consensus 447 ~lg~G~f-g~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 523 (607)
.+..|.. ..||+....++..+++|...... ...+..|...++.+. ...+.+++++..+++..++||||+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555554 67899988777778888765432 224556666665553 33467788888888888999999988665
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 007336 524 DSFIFDQTRRTLLDWSQRFHIICGTARGLLYLH----------------------------------------------- 556 (607)
Q Consensus 524 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH----------------------------------------------- 556 (607)
.+.. ... ..++.++++.|+-||
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3210 000 011122222222222
Q ss_pred ----hC----CCCceEecccCCCcEEEcCCCceEEeeccccee
Q 007336 557 ----QD----SRLRIIHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 557 ----~~----~~~~ivHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
.. .+..++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 122389999999999999887788999999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.37 E-value=0.00022 Score=71.85 Aligned_cols=75 Identities=11% Similarity=0.184 Sum_probs=46.9
Q ss_pred eeecccCceeEEEEEecC-CcEEEEEEeccc---c----hhhHHHHHHHHHHHccC-CC--CceeceEEEEEeCCeEEEE
Q 007336 446 NKLGEGGFGPVYKGTLVD-GQEIAVKRLSKI---S----EQGLKELKNEVILFSKL-QH--RNLVKLLGCCIQGEEKLLI 514 (607)
Q Consensus 446 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~----~~~~~~f~~E~~~l~~l-~H--~nIv~l~g~~~~~~~~~lV 514 (607)
+.||.|..-.||+....+ ++.++||.-... . .....+...|...++.+ .+ ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 578999999999998755 678999964321 0 11223445566666544 22 345666654 55667899
Q ss_pred EEcCCCCC
Q 007336 515 YEFMPNKS 522 (607)
Q Consensus 515 ~Ey~~~gs 522 (607)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.51 E-value=0.0036 Score=60.77 Aligned_cols=135 Identities=13% Similarity=0.157 Sum_probs=76.0
Q ss_pred eeEEEEEecCCcEEEEEEecccchhhHHHHHHHHHHHccCCCCce--eceE-----EEEEeCCeEEEEEEcCCCCChH--
Q 007336 454 GPVYKGTLVDGQEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL--VKLL-----GCCIQGEEKLLIYEFMPNKSLD-- 524 (607)
Q Consensus 454 g~Vy~g~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~nI--v~l~-----g~~~~~~~~~lV~Ey~~~gsL~-- 524 (607)
=.||+.+..+|..+++|..... ....+++..|...+..|....+ +..+ ......+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999989999999987542 2234567777777766542222 1111 1123466778999999864331
Q ss_pred ---HH------H---hc------CCCCCCCCHHH-------------------HHHHHHHHHHHHHHHH----hCCCCce
Q 007336 525 ---SF------I---FD------QTRRTLLDWSQ-------------------RFHIICGTARGLLYLH----QDSRLRI 563 (607)
Q Consensus 525 ---~~------l---~~------~~~~~~l~~~~-------------------~~~i~~~ia~gl~yLH----~~~~~~i 563 (607)
.+ + +. ......+++.. +..+...+.+.+..+. +..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11 1 10 01111122111 1112222223333332 2234568
Q ss_pred EecccCCCcEEEcCCCceEEeeccccee
Q 007336 564 IHRDLKASNVLLDQDMNPKISDFGLVRT 591 (607)
Q Consensus 564 vHrDlkp~Nill~~~~~~ki~DfGla~~ 591 (607)
||+|+.+.|||++++ ..|+||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 46899998873
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.01 E-value=0.0061 Score=60.84 Aligned_cols=76 Identities=18% Similarity=0.274 Sum_probs=48.4
Q ss_pred CcccceeecccCceeEEEEEecCC--------cEEEEEEecccchhhHHHHHHHHHHHccCC-CCceeceEEEEEeCCeE
Q 007336 441 NFSINNKLGEGGFGPVYKGTLVDG--------QEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEK 511 (607)
Q Consensus 441 ~~~~~~~lg~G~fg~Vy~g~~~~~--------~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~nIv~l~g~~~~~~~~ 511 (607)
.+++ +.|+.|-.=.+|+....++ ..|.+++.-. .. ......+|..+++.+. |.-..++++++.+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 3444 5788888889999987542 4566665542 22 2234557888877774 3334577777642
Q ss_pred EEEEEcCCCCCh
Q 007336 512 LLIYEFMPNKSL 523 (607)
Q Consensus 512 ~lV~Ey~~~gsL 523 (607)
.+|+||+++..|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 589999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.75 E-value=0.2 Score=47.34 Aligned_cols=31 Identities=29% Similarity=0.312 Sum_probs=27.8
Q ss_pred CCceEecccCCCcEEEcCCCceEEeecccce
Q 007336 560 RLRIIHRDLKASNVLLDQDMNPKISDFGLVR 590 (607)
Q Consensus 560 ~~~ivHrDlkp~Nill~~~~~~ki~DfGla~ 590 (607)
+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4469999999999999998878899999886
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.88 E-value=0.038 Score=32.96 Aligned_cols=33 Identities=33% Similarity=0.761 Sum_probs=26.0
Q ss_pred CCCCCcccCCCCccccccCC-CCcccccCCceeCC
Q 007336 230 RDQCDTYGLCGAYGICIIGQ-SPVCQCLKGFKPKS 263 (607)
Q Consensus 230 ~~~C~~~~~CG~~g~C~~~~-~~~C~C~~gf~~~~ 263 (607)
.|+|.+-..||. |.|+.-- .-.|.|-.||+|..
T Consensus 1 tdECsignpCGn-GTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 1 TDECSVGNPCGN-GTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CCGGGTTCSSSS-SCEEECSSSEEECCSSSSCCCS
T ss_pred CCccccCCccCC-ceeeecccceEEeecCCcCCCc
Confidence 378999999996 7897543 45699999999863
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.73 E-value=0.072 Score=33.97 Aligned_cols=31 Identities=39% Similarity=0.786 Sum_probs=24.7
Q ss_pred CCCCc-ccCCCCccccccCC-CCcccccCCcee
Q 007336 231 DQCDT-YGLCGAYGICIIGQ-SPVCQCLKGFKP 261 (607)
Q Consensus 231 ~~C~~-~~~CG~~g~C~~~~-~~~C~C~~gf~~ 261 (607)
|+|.. ...|..+|.|.... .-.|.|++||+-
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G 36 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYTG 36 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEES
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCcC
Confidence 67876 56899999997653 457999999984
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.60 E-value=0.16 Score=31.62 Aligned_cols=31 Identities=42% Similarity=0.899 Sum_probs=23.5
Q ss_pred CCCCcccCCCCccccccC-CCCcccccCCceeC
Q 007336 231 DQCDTYGLCGAYGICIIG-QSPVCQCLKGFKPK 262 (607)
Q Consensus 231 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~~ 262 (607)
|+|. +..|...|.|... ..-.|.|++||+-.
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEGK 32 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEETT
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCcC
Confidence 4565 5789999999764 35679999999843
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.24 E-value=0.22 Score=30.94 Aligned_cols=31 Identities=19% Similarity=0.563 Sum_probs=23.5
Q ss_pred CCCCcccCCCCccccccC-CCCcccccCCceeC
Q 007336 231 DQCDTYGLCGAYGICIIG-QSPVCQCLKGFKPK 262 (607)
Q Consensus 231 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~~ 262 (607)
|+|. +..|...|.|... ..-.|.|++||+-.
T Consensus 2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~G~ 33 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQIGEFQCICMPGYEGV 33 (39)
T ss_dssp CTTT-TCCCCSSCEEEECSSCEEEECCTTEESS
T ss_pred cCCc-CCCCCCCCEEECCCCCEEEeCCCCCccC
Confidence 4564 5679999999764 35579999999853
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.64 E-value=0.22 Score=31.00 Aligned_cols=31 Identities=35% Similarity=0.602 Sum_probs=24.5
Q ss_pred CCCCCcccCCCCccccccC-CCCcccccCCcee
Q 007336 230 RDQCDTYGLCGAYGICIIG-QSPVCQCLKGFKP 261 (607)
Q Consensus 230 ~~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~ 261 (607)
.|+|. +..|-..|.|... ..-.|.|++||+-
T Consensus 3 ~d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G 34 (39)
T d1edmb_ 3 GDQCE-SNPCLNGGSCKDDINSYECWCPFGFEG 34 (39)
T ss_dssp CCTTT-TCCCCTTCEEEEETTEEEEECCTTCCS
T ss_pred cccCC-CCCCCCCcEEEcCCCCEEEECCCCCCC
Confidence 46786 6789999999754 3567999999974
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.50 E-value=0.6 Score=29.55 Aligned_cols=32 Identities=28% Similarity=0.514 Sum_probs=23.9
Q ss_pred CCCCCcccCCCCccccccCC-CCcccccCCceeC
Q 007336 230 RDQCDTYGLCGAYGICIIGQ-SPVCQCLKGFKPK 262 (607)
Q Consensus 230 ~~~C~~~~~CG~~g~C~~~~-~~~C~C~~gf~~~ 262 (607)
-|+|..+. |+.++.|.... +=.|.|++||+..
T Consensus 5 idEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~~ 37 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTDGSYRCECPFGYILA 37 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEES
T ss_pred eeccCCcC-CCCCCEeECCCCCeEeECCCCcccC
Confidence 47898665 55688997654 4579999999863
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.12 E-value=0.64 Score=29.09 Aligned_cols=30 Identities=30% Similarity=0.781 Sum_probs=22.7
Q ss_pred CCCCcccCCCCccccccCC-CCcccccCCceeC
Q 007336 231 DQCDTYGLCGAYGICIIGQ-SPVCQCLKGFKPK 262 (607)
Q Consensus 231 ~~C~~~~~CG~~g~C~~~~-~~~C~C~~gf~~~ 262 (607)
|+|..++.|. .+|.... .-.|.|++||...
T Consensus 2 dEC~~~~~C~--~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 2 DECQDPDTCS--QLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp CTTTTTTSCS--SCEECSSSCCEECCCTTEEEC
T ss_pred ccCCCCCCCC--CEeECCCCCEEeECCCCCeEC
Confidence 6788777774 5887554 4579999999975
|